{"meta":{"query_hash":"ed35f27523b6","filters":{"venue":"Urologic Oncology Seminars and Original Investigations"},"cohort_total":457,"direct_labels_cover":2,"predictions_cover":457,"exported":457,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/ed35f27523b6","api":"https://metacan.xera.ac/api/v1/cohort?venue=Urologic+Oncology+Seminars+and+Original+Investigations"},"results":[{"id":"W1168084273","doi":"10.1016/j.urolonc.2015.07.002","title":"Renal function in patients with Wilms tumor","year":2015,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children; Dalhousie University; Izaak Walton Killam Health Centre","funders":"","keywords":"Medicine; Wilms' tumor; Nephrectomy; Renal function; Nephron; Disease; Renal replacement therapy; Kidney; Kidney disease; Internal medicine; Intensive care medicine; Urology; Surgery","score_opus":0.020097623792095794,"score_gpt":0.28746553348045994,"score_spread":0.26736790968836416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1168084273","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028902662,0.9990067,0.00006732955,0.0001973123,0.000086443615,9.987302e-7,0.0000123346645,0.0000032476246,0.00033669767],"genre_scores_gemma":[0.0038457285,0.99530494,0.00012738472,0.00022142428,0.00028996984,0.000002441837,0.00003381039,9.766934e-7,0.00017330682],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998784,0.00002654168,0.000017125682,0.000023666573,0.00004096704,0.000013215011],"domain_scores_gemma":[0.99977785,0.00011706556,0.000038969472,0.000005042454,0.00003964413,0.00002137633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043369373,0.00048500695,0.0010895462,0.0011261308,0.00012922763,0.0005627193,0.00044697404,0.00047780375,0.00084619876],"category_scores_gemma":[0.00085746427,0.00012853964,0.00031791348,0.0013537233,0.00031866782,0.00047766374,0.00045584116,0.0009572402,0.00027665967],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013058781,0.000035223773,0.0037282284,0.00900482,0.00017247193,0.000808613,0.00004349638,0.00034813953,0.0007709014,0.0010874759,0.018405579,0.96546435],"study_design_scores_gemma":[0.00014426163,0.00019212418,0.036872927,0.013470229,0.0014110837,0.018859038,0.00029432992,0.0005574088,0.0014301571,0.0043169465,0.9223532,0.00009811451],"about_ca_topic_score_codex":0.0010087576,"about_ca_topic_score_gemma":0.0020240732,"teacher_disagreement_score":0.0011261308,"about_ca_system_score_codex":0.0003308519,"about_ca_system_score_gemma":0.0006740305,"threshold_uncertainty_score":0.002830863},"labels":[],"label_agreement":null},{"id":"W1525421321","doi":"10.1016/j.urolonc.2014.07.015","title":"Molecular profiling of ETS gene rearrangements in patients with prostate cancer registered in REDEEM clinical trial","year":2014,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Howard Hughes Medical Institute","keywords":"Dutasteride; Medicine; Placebo; Prostate cancer; Urology; Internal medicine; Prostate; Prostate-specific antigen; Oncology; Gynecology; Pathology; Cancer","score_opus":0.06643154723480511,"score_gpt":0.39528646442052867,"score_spread":0.32885491718572357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1525421321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99602073,0.00070159277,0.000159727,0.00017793618,0.000019103742,0.000035659563,0.0013857927,0.000010231368,0.0014891347],"genre_scores_gemma":[0.9968444,0.0001829329,0.00021230709,0.00016489126,0.000029059827,0.000041442334,0.0016596975,0.000007408464,0.00085789064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914765,0.00033314506,0.00006436202,0.00014905038,0.00015685013,0.00014889723],"domain_scores_gemma":[0.9989905,0.00034658,0.00037818262,0.00008314906,0.0000796662,0.000121884696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011805446,0.00016035825,0.00051461265,0.00039212438,0.00025268542,0.0008251459,0.00040690906,0.00046168198,0.0022238565],"category_scores_gemma":[0.002414122,0.00016989297,0.0003732675,0.0008683822,0.00023163385,0.00042077512,0.0002893087,0.00045692525,0.00037778573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01288673,0.000201507,0.95732594,0.00006751751,0.0002118852,0.000289151,0.00009613953,0.0006540849,0.009026936,0.00028879443,0.0013857255,0.017565679],"study_design_scores_gemma":[0.00037087264,0.0018937717,0.98995787,0.000017337412,0.00016581216,0.00071947667,0.0001879631,0.00080230826,0.0023620864,0.0003030842,0.00320515,0.000014386192],"about_ca_topic_score_codex":0.0005575462,"about_ca_topic_score_gemma":0.0012707604,"teacher_disagreement_score":0.0022238565,"about_ca_system_score_codex":0.0003668969,"about_ca_system_score_gemma":0.0003808191,"threshold_uncertainty_score":0.007439494},"labels":[],"label_agreement":null},{"id":"W1530023472","doi":"10.1016/j.urolonc.2013.12.014","title":"Underutilization of local salvage therapy after radiation therapy for prostate cancer","year":2014,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Radiation therapy; Prostate cancer; Androgen deprivation therapy; Prostatectomy; Salvage therapy; Brachytherapy; Prostate-specific antigen; Prostate; Surgery; Cancer; Oncology; Internal medicine; Chemotherapy","score_opus":0.0265850438433865,"score_gpt":0.32516677332495164,"score_spread":0.29858172948156514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1530023472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9542038,0.01235472,0.0009147072,0.02178162,0.00025051748,0.000057339614,0.0010967838,0.000057508503,0.009283097],"genre_scores_gemma":[0.9906303,0.0052567287,0.00042922318,0.0023608715,0.0002884335,0.000015736023,0.00030498777,0.00003667804,0.00067719497],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99504375,0.002218636,0.0005690171,0.00032318124,0.0012637441,0.0005816572],"domain_scores_gemma":[0.96806526,0.008953694,0.014326695,0.0013409967,0.003905913,0.0034073372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034843928,0.00012263223,0.00023504368,0.0015173646,0.0005213112,0.0014315131,0.0009455172,0.0005320302,0.0042456673],"category_scores_gemma":[0.029117191,0.00014344316,0.00048606054,0.0023459217,0.00063122687,0.0009662556,0.0009202145,0.0009654514,0.0003973161],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005129501,0.00018895179,0.8166908,0.00040095678,0.0001564626,0.0005472201,0.0015623961,0.0004953668,0.0008765509,0.00084327126,0.006879941,0.17084514],"study_design_scores_gemma":[0.000011130158,0.00028127874,0.98203516,0.00044432748,0.00014847459,0.0014641931,0.0029966661,0.00067846215,0.0006604464,0.0004252183,0.010835381,0.000019184734],"about_ca_topic_score_codex":0.017343413,"about_ca_topic_score_gemma":0.030315405,"teacher_disagreement_score":0.017343413,"about_ca_system_score_codex":0.0027154684,"about_ca_system_score_gemma":0.0053715697,"threshold_uncertainty_score":0.034484923},"labels":[],"label_agreement":null},{"id":"W1540035395","doi":"10.1016/j.urolonc.2015.04.004","title":"Heterogeneity in D׳Amico classification–based low-risk prostate cancer: Differences in upgrading and upstaging according to active surveillance eligibility","year":2015,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Prostatectomy; Medicine; Prostate cancer; Logistic regression; Pathological; Cancer; Prostate; Prostate-specific antigen; Oncology; Internal medicine; Biochemical recurrence; Urology","score_opus":0.06352850768014151,"score_gpt":0.3626464609168326,"score_spread":0.2991179532366911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1540035395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930187,0.001827479,0.00076380855,0.0003331837,0.00009925735,0.00004918114,0.001542298,0.000018838993,0.0023473396],"genre_scores_gemma":[0.9990397,0.000065213906,0.000053419222,0.00006962763,0.00003432555,0.00000808081,0.00056532706,0.000008079168,0.00015622204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9924799,0.0026760981,0.0009268148,0.0018837684,0.0009092141,0.001124162],"domain_scores_gemma":[0.9809318,0.009078705,0.0043002055,0.0031517206,0.0012473144,0.0012902283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006199177,0.0004173637,0.0012490697,0.0027829013,0.0006998149,0.0018690804,0.0016074368,0.0009911975,0.0039817877],"category_scores_gemma":[0.024990799,0.0004229764,0.003741935,0.0026106117,0.0007281982,0.001000839,0.0015753695,0.0010692485,0.000489781],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091703027,0.00003142123,0.99318075,0.0000303072,0.0015391984,0.000046379275,0.00012922398,0.0001328128,0.0002719383,0.00015128574,0.0003772186,0.0031925053],"study_design_scores_gemma":[0.00003802801,0.000098977696,0.99718624,0.000020762032,0.00049485517,0.00013954498,0.00022806058,0.0008096013,0.000077012926,0.0005163955,0.00037280872,0.000017650125],"about_ca_topic_score_codex":0.010561819,"about_ca_topic_score_gemma":0.012549256,"teacher_disagreement_score":0.010561819,"about_ca_system_score_codex":0.0006098255,"about_ca_system_score_gemma":0.000666791,"threshold_uncertainty_score":0.03278482},"labels":[],"label_agreement":null},{"id":"W1617055729","doi":"10.1016/j.urolonc.2015.06.005","title":"Lymph node counts are valid indicators of the quality of surgical care in bladder cancer: A population-based study","year":2015,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Institute for Clinical Evaluative Sciences; Cancer Care Ontario","keywords":"Cystectomy; Medicine; Bladder cancer; Lymph node; Hazard ratio; Proportional hazards model; Population; Cancer registry; Multivariate analysis; Dissection (medical); Multivariate statistics; Surgery; Cancer; Internal medicine; Oncology; Confidence interval; Statistics; Environmental health; Mathematics","score_opus":0.05391834992651538,"score_gpt":0.3802908898054138,"score_spread":0.3263725398788984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1617055729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99939466,0.00012521163,0.00007675012,0.000023824266,0.000005379067,0.000006112891,0.00014253572,0.0000014608949,0.00022395015],"genre_scores_gemma":[0.99973446,0.000039530434,0.000029654515,0.0000135525825,0.000006693632,0.000004672632,0.0001163858,0.0000012456246,0.000053872605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858993,0.00063651503,0.0001228258,0.00026583028,0.00022428899,0.00016060229],"domain_scores_gemma":[0.9960575,0.0013547715,0.0013024828,0.00046915034,0.00036860857,0.00044751912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017929228,0.00038799306,0.0004887049,0.00093965954,0.00051479513,0.0010757031,0.0006880879,0.00089812244,0.0011806553],"category_scores_gemma":[0.0068522063,0.00061131147,0.0009184578,0.001529455,0.0007038007,0.0011443404,0.0006685191,0.0010656639,0.00025965934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001512102,0.000052076903,0.9991528,0.0000040000264,0.000097500706,0.000015626945,0.000058778445,0.000022473334,0.000108801956,0.000007066519,0.000025489095,0.00030414847],"study_design_scores_gemma":[0.0000106167545,0.00015603796,0.99936527,0.00000174187,0.000059106387,0.000056457986,0.00014822827,0.00011227198,0.000026388068,0.000013512662,0.0000463114,0.0000039804177],"about_ca_topic_score_codex":0.003995647,"about_ca_topic_score_gemma":0.005050855,"teacher_disagreement_score":0.003995647,"about_ca_system_score_codex":0.0004918067,"about_ca_system_score_gemma":0.00039517847,"threshold_uncertainty_score":0.0094819665},"labels":[],"label_agreement":null},{"id":"W1634590582","doi":"10.1016/j.urolonc.2015.08.003","title":"The use of prognostic factors in metastatic renal cell carcinoma","year":2015,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"","keywords":"Temsirolimus; Medicine; Renal cell carcinoma; Intensive care medicine; Oncology; Systemic therapy; Disease; Internal medicine; Risk stratification; Targeted therapy; Clinical trial; Nephrectomy; Cancer; Discovery and development of mTOR inhibitors; Kidney; Breast cancer","score_opus":0.1859153957915972,"score_gpt":0.3636804763907399,"score_spread":0.17776508059914273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1634590582","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011798137,0.9994462,0.000035535824,0.00016342894,0.00007076051,0.0000014665804,0.000017518847,0.0000015825261,0.00014556074],"genre_scores_gemma":[0.0020188822,0.99728,0.00012106808,0.00028694977,0.00019759666,0.0000028074771,0.000032423934,6.951354e-7,0.00005943841],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99953043,0.00010924533,0.00013030987,0.00008500654,0.00011727794,0.00002774158],"domain_scores_gemma":[0.9978163,0.0014649048,0.00039047602,0.000036991343,0.00025245556,0.000038824757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016383928,0.0007162641,0.0022055244,0.002728786,0.00020563984,0.0013624661,0.000935799,0.0009134819,0.0016588223],"category_scores_gemma":[0.0040929103,0.0003048704,0.0013574039,0.0031197413,0.000598541,0.0013102188,0.00056114915,0.0013407373,0.00037512125],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016112933,0.000055799523,0.0033052843,0.03682731,0.00079461746,0.00017722603,0.00006623502,0.00036781287,0.00031611166,0.0013321616,0.013193578,0.94340277],"study_design_scores_gemma":[0.00020297099,0.00061843975,0.024306007,0.073266864,0.009688914,0.004157318,0.00043035025,0.0008150154,0.00124682,0.0039619473,0.8811276,0.0001776704],"about_ca_topic_score_codex":0.0019419851,"about_ca_topic_score_gemma":0.0033705044,"teacher_disagreement_score":0.002728786,"about_ca_system_score_codex":0.0006654074,"about_ca_system_score_gemma":0.0015745822,"threshold_uncertainty_score":0.008664787},"labels":[],"label_agreement":null},{"id":"W1763657513","doi":"10.1016/j.urolonc.2015.09.007","title":"Randomized controlled trials in testicular cancer: A demographic and quality assessment","year":2015,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Randomized controlled trial; Testicular cancer; Medicine; Cancer; Oncology; Internal medicine","score_opus":0.1195368534209402,"score_gpt":0.42628311427274884,"score_spread":0.30674626085180867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1763657513","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17579953,0.65504396,0.03515082,0.009556653,0.0048986017,0.10009284,0.012506258,0.00035535422,0.006596053],"genre_scores_gemma":[0.8008937,0.07503292,0.036290694,0.007881085,0.0014132339,0.073730096,0.003143777,0.00009418284,0.0015203573],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.6260969,0.27242428,0.076214895,0.007889759,0.015272442,0.0021016805],"domain_scores_gemma":[0.6542012,0.23164447,0.08464726,0.014204904,0.012284296,0.0030178507],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.13731474,0.0018793044,0.010266819,0.0036843382,0.0012716408,0.0040344987,0.0018118211,0.0036010188,0.006873764],"category_scores_gemma":[0.28125286,0.0014498885,0.020219633,0.0053781485,0.0027374378,0.0036356878,0.0023757888,0.0036977984,0.0005188188],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36220214,0.0008669502,0.024210304,0.1464837,0.39728403,0.00015535498,0.00082663755,0.00094791286,0.0006973947,0.0022859366,0.0040245764,0.060015034],"study_design_scores_gemma":[0.6105642,0.019569105,0.03938575,0.02319203,0.28614593,0.00033214557,0.00045835515,0.0016697799,0.000648724,0.005624026,0.012178624,0.00023130602],"about_ca_topic_score_codex":0.0020248552,"about_ca_topic_score_gemma":0.004246655,"teacher_disagreement_score":0.86268526,"about_ca_system_score_codex":0.0046304916,"about_ca_system_score_gemma":0.005144214,"threshold_uncertainty_score":0.72619843},"labels":[],"label_agreement":null},{"id":"W1801430028","doi":"10.1016/j.urolonc.2014.05.005","title":"Mental health outcomes in elderly men with prostate cancer","year":2014,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Cancer survivorship and care","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Mental health; Psychology; Gerontology; Medicine; Psychiatry","score_opus":0.018364223193624133,"score_gpt":0.3212303814919792,"score_spread":0.30286615829835506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1801430028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976706,0.00062976853,0.000014340041,0.00035660277,0.00002220866,0.000008294971,0.00035262824,0.0000011494344,0.00094434567],"genre_scores_gemma":[0.99898785,0.00033977357,0.000014302448,0.00012469852,0.00003140158,0.000005189393,0.0002605082,4.147057e-7,0.0002357973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997274,0.00006806075,0.000025752584,0.000027163418,0.00004358996,0.00010795361],"domain_scores_gemma":[0.9992335,0.000087252476,0.00028316322,0.000017689685,0.00010426454,0.00027415506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037227853,0.00017326885,0.0002873002,0.0005235164,0.00057752756,0.0006284746,0.00019911893,0.0003395105,0.001566586],"category_scores_gemma":[0.0024634067,0.00012489465,0.00053626846,0.0007714108,0.00021551561,0.00060064514,0.0008633256,0.00065593695,0.0001242487],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117972835,0.00011725934,0.99589455,0.000022797365,0.000083224615,0.00010862727,0.00025594188,0.000039102088,0.000036662244,0.000023868139,0.00034369447,0.0029561736],"study_design_scores_gemma":[0.0000058862843,0.00008335392,0.99889743,0.000011021962,0.00003753811,0.00006425391,0.0006799753,0.000037261725,0.000012259906,0.000026580454,0.00014151366,0.0000029284472],"about_ca_topic_score_codex":0.020080104,"about_ca_topic_score_gemma":0.033245727,"teacher_disagreement_score":0.020080104,"about_ca_system_score_codex":0.00054956507,"about_ca_system_score_gemma":0.00053950126,"threshold_uncertainty_score":0.03992641},"labels":[],"label_agreement":null},{"id":"W1818173544","doi":"10.1016/j.urolonc.2015.05.024","title":"The effect of metformin on cancer-specific survival outcomes in diabetic patients undergoing radical cystectomy for urothelial carcinoma of the bladder","year":2015,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Metformin; Hazard ratio; Proportional hazards model; Internal medicine; Cystectomy; Bladder cancer; Diabetes mellitus; Urology; Oncology; Retrospective cohort study; Cohort; Cancer; Confidence interval; Insulin; Endocrinology","score_opus":0.020514092967898783,"score_gpt":0.28898116767677345,"score_spread":0.26846707470887465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1818173544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99855846,0.0010025812,0.00006810569,0.00006485497,0.000011540337,0.0000046602286,0.00013202796,0.0000017887486,0.00015605227],"genre_scores_gemma":[0.999445,0.0002392879,0.00007133193,0.000025663803,0.000012886467,0.0000043999225,0.00014380891,7.376383e-7,0.000056777782],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992244,0.00030454033,0.00009853364,0.00012209032,0.00014230229,0.00010813178],"domain_scores_gemma":[0.99707294,0.00075334526,0.0016294534,0.00015624822,0.00015316854,0.00023484376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015296857,0.00022685707,0.00029956864,0.00047442265,0.00031066174,0.00059366116,0.0003696772,0.0003644662,0.0006476087],"category_scores_gemma":[0.005173898,0.00018294658,0.0008502201,0.00067131495,0.00020815185,0.00040298433,0.0004436365,0.00066728395,0.000089325826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046134848,0.000041094685,0.9970324,0.0000184029,0.00014385991,0.000025624373,0.00001570103,0.00006633709,0.00006297926,0.000008821257,0.000037670598,0.002085738],"study_design_scores_gemma":[0.000021074966,0.00034464247,0.99815255,0.000018937872,0.00021878257,0.00013491625,0.00008854515,0.0007308213,0.00009779599,0.000030759875,0.00015665356,0.000004426781],"about_ca_topic_score_codex":0.0020906695,"about_ca_topic_score_gemma":0.004290169,"teacher_disagreement_score":0.0020906695,"about_ca_system_score_codex":0.00044095606,"about_ca_system_score_gemma":0.00048713753,"threshold_uncertainty_score":0.00808984},"labels":[],"label_agreement":null},{"id":"W1833237843","doi":"10.1016/j.urolonc.2015.09.010","title":"Cost-effectiveness of multiparametric magnetic resonance imaging and targeted biopsy in diagnosing prostate cancer","year":2015,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Prostate cancer; Magnetic resonance imaging; Medicine; Cancer; Prostate; Biopsy; Radiology; Internal medicine","score_opus":0.05307605457392381,"score_gpt":0.35227181677924796,"score_spread":0.2991957622053242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1833237843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9549592,0.0317796,0.0025248104,0.0044916263,0.0002773242,0.0001103049,0.000827419,0.000050744973,0.004979006],"genre_scores_gemma":[0.9965078,0.0016776294,0.0009833958,0.00023616945,0.00013060763,0.000019468134,0.00023642184,0.000007026532,0.00020162766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99535614,0.0032200147,0.00026209035,0.0002972131,0.00062223215,0.00024231445],"domain_scores_gemma":[0.9800678,0.016719112,0.0011906713,0.00045665502,0.00074840686,0.00081736624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003807987,0.00073436537,0.0013713901,0.001712458,0.00027397362,0.0014250714,0.0010749548,0.0015763382,0.0028102493],"category_scores_gemma":[0.02697805,0.0005206582,0.0025268581,0.0011250109,0.00041663268,0.0018584162,0.0010137603,0.000967009,0.00024310603],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04053332,0.0020067603,0.61199296,0.0009815618,0.0040918114,0.0009808554,0.00020125962,0.043210007,0.0013888058,0.001578275,0.002242128,0.29079232],"study_design_scores_gemma":[0.0017358005,0.0087424815,0.8317307,0.00065764843,0.0074139433,0.0036963793,0.0007403271,0.13785774,0.0017513041,0.0031232627,0.002329577,0.00022090189],"about_ca_topic_score_codex":0.006571629,"about_ca_topic_score_gemma":0.008179662,"teacher_disagreement_score":0.006571629,"about_ca_system_score_codex":0.0021877454,"about_ca_system_score_gemma":0.0011012071,"threshold_uncertainty_score":0.0201388},"labels":[],"label_agreement":null},{"id":"W1834366147","doi":"10.1016/j.urolonc.2014.06.018","title":"GnRH antagonist associates with less adiposity and reduced characteristics of metabolic syndrome and atherosclerosis compared with orchiectomy and GnRH agonist in a preclinical mouse model","year":2014,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; Sunnybrook Health Science Centre; Health Sciences Centre; Thrombosis and Atherosclerosis Research Institute; University of Toronto; McMaster University","funders":"","keywords":"Orchiectomy; Medicine; Internal medicine; Endocrinology; Testosterone (patch); Androgen deprivation therapy; Agonist; Gonadotropin-releasing hormone agonist; Hormone; Luteinizing hormone; Gonadotropin-releasing hormone; Receptor; Prostate cancer","score_opus":0.04373456151893877,"score_gpt":0.3032731184062592,"score_spread":0.2595385568873204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1834366147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914067,0.0020494342,0.0022780483,0.0006156003,0.00026562653,0.000071266004,0.0017712667,0.00018037324,0.0013616418],"genre_scores_gemma":[0.97251296,0.004797591,0.004428602,0.0007428283,0.00019258361,0.00039004246,0.0031421266,0.00017528818,0.0136180725],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99964774,0.000051891013,0.000036024157,0.00009668609,0.000090686495,0.00007697226],"domain_scores_gemma":[0.9992889,0.000046753383,0.00026735492,0.00007758148,0.000052227297,0.00026719025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003846832,0.0009853147,0.0007601076,0.0012970843,0.00036820138,0.0007208494,0.0004830318,0.0007311692,0.0036100447],"category_scores_gemma":[0.00025608626,0.0004798769,0.0008541307,0.0004890348,0.00067840604,0.0006609352,0.00029817954,0.002377117,0.00055629906],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009502734,0.0018289394,0.0023135734,0.00021344725,0.00010027656,0.00043348296,0.0000536294,0.00014688676,0.9802469,0.00024693742,0.00046695076,0.0044462034],"study_design_scores_gemma":[0.0014892028,0.02154179,0.052089818,0.00012500053,0.0008160158,0.0023004462,0.00054988964,0.0013986866,0.90823096,0.0005858898,0.010788939,0.00008332089],"about_ca_topic_score_codex":0.0007957626,"about_ca_topic_score_gemma":0.0015609916,"teacher_disagreement_score":0.0036100447,"about_ca_system_score_codex":0.0003416134,"about_ca_system_score_gemma":0.0005823708,"threshold_uncertainty_score":0.012076795},"labels":[],"label_agreement":null},{"id":"W1948420521","doi":"10.1016/j.urolonc.2015.06.011","title":"Outcomes of squamous histology in bladder cancer: A population-based study","year":2015,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"University of California, San Diego; Ontario Ministry of Health and Long-Term Care; Cancer Care Ontario","keywords":"Medicine; Bladder cancer; Internal medicine; Hazard ratio; Cystectomy; Population; Cancer; Proportional hazards model; Histology; Oncology; Basal cell; Gastroenterology; Confidence interval","score_opus":0.05390703792996499,"score_gpt":0.3624586836176842,"score_spread":0.3085516456877192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1948420521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99920183,0.00018765662,0.000048579055,0.000029628936,0.0000046492255,0.00000844924,0.00031491314,0.0000018775758,0.0002023917],"genre_scores_gemma":[0.99945575,0.00009752032,0.000021604148,0.000025366848,0.000009601935,0.000008146383,0.00030909514,0.0000015678331,0.000071203154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988323,0.00034483953,0.00013326877,0.00030402045,0.0001765036,0.00020920041],"domain_scores_gemma":[0.99796116,0.00029686486,0.000840468,0.00021072483,0.00023408211,0.0004565873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010417869,0.00050714036,0.0008202271,0.0013035788,0.0007969938,0.0011486445,0.00075700897,0.0010097903,0.0015904823],"category_scores_gemma":[0.0031508387,0.0006360181,0.0017273772,0.0024956223,0.00061787135,0.0014860533,0.0011373239,0.0009554023,0.0002875792],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018473684,0.00007240998,0.9989034,0.0000082123615,0.00019488907,0.00006015514,0.000063776344,0.000020562915,0.00009993062,0.0000084830435,0.000044964534,0.0003383709],"study_design_scores_gemma":[0.000013233605,0.00016047971,0.9991572,0.0000037541406,0.00009544348,0.00012496098,0.00031046435,0.000052318814,0.000016169295,0.000017444037,0.00004342183,0.0000050208937],"about_ca_topic_score_codex":0.0076302816,"about_ca_topic_score_gemma":0.0073095737,"teacher_disagreement_score":0.0076302816,"about_ca_system_score_codex":0.00063266547,"about_ca_system_score_gemma":0.0004891421,"threshold_uncertainty_score":0.015171766},"labels":[],"label_agreement":null},{"id":"W1970401271","doi":"10.1016/j.urolonc.2005.07.001","title":"Active surveillance for genitourinary cancer: An overview","year":2006,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Genitourinary system; Cancer; Medicine; Internal medicine","score_opus":0.0602360152438203,"score_gpt":0.37243952861038976,"score_spread":0.3122035133665695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970401271","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00308835,0.98659873,0.00401759,0.0024437688,0.00043271767,0.00003158469,0.000052352898,0.00005119836,0.0032835489],"genre_scores_gemma":[0.03368828,0.95274293,0.00590087,0.00232158,0.0039610127,0.0000644931,0.00016984556,0.000017288925,0.00113371],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99893457,0.00033500994,0.00017884483,0.00019657891,0.00027864086,0.0000763254],"domain_scores_gemma":[0.99796474,0.0012220818,0.00024727595,0.000044065175,0.00037003655,0.00015180644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025443682,0.0009088036,0.0014657814,0.0029144057,0.0003805105,0.0016439541,0.0009299013,0.0018007023,0.0014751969],"category_scores_gemma":[0.002233426,0.00039432084,0.00107576,0.0013685862,0.00045621998,0.002979021,0.000871354,0.0015382804,0.0004452263],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046037993,0.00020082704,0.020104881,0.007151902,0.0003699553,0.0014693388,0.00025730694,0.0008404679,0.0013450438,0.002410574,0.013377827,0.95201147],"study_design_scores_gemma":[0.00037705904,0.0048645064,0.121499255,0.019584239,0.00381141,0.081151,0.0016289658,0.0054276655,0.0034327984,0.008870736,0.7491222,0.0002302609],"about_ca_topic_score_codex":0.0011350623,"about_ca_topic_score_gemma":0.0028442212,"teacher_disagreement_score":0.0029144057,"about_ca_system_score_codex":0.0009388251,"about_ca_system_score_gemma":0.00089049956,"threshold_uncertainty_score":0.013456106},"labels":[],"label_agreement":null},{"id":"W1971099042","doi":"10.1016/j.urolonc.2015.02.011","title":"Gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma: Predicting response and assessing outcomes","year":2015,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Cancer Institute","keywords":"Medicine; Bladder cancer; Gemcitabine; Cystectomy; Cisplatin; Dosing; Cohort; Urology; Internal medicine; Chemotherapy; Cancer; Neoadjuvant therapy; Oncology; Surgery","score_opus":0.05169494951561104,"score_gpt":0.3480347767821162,"score_spread":0.29633982726650515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971099042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99597555,0.0023102749,0.0001994301,0.0002669683,0.000046637175,0.000033940076,0.00010926002,0.000006602294,0.0010514085],"genre_scores_gemma":[0.9981382,0.00082327623,0.00032193318,0.00008639631,0.000046188194,0.000025891248,0.000299956,0.000003326809,0.00025479574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993679,0.00029836036,0.00008256118,0.00008040398,0.00009646454,0.00007426188],"domain_scores_gemma":[0.99876344,0.00052685814,0.00024789505,0.000063868436,0.00010843064,0.0002894458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013905367,0.00035012988,0.00061779626,0.00055302,0.00027023585,0.00083671,0.0003425321,0.00058532425,0.00061917887],"category_scores_gemma":[0.0042121983,0.00017911625,0.00049363653,0.00065026066,0.0002831576,0.000592263,0.00048250536,0.00070038164,0.00018524729],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075296094,0.00043175824,0.9319791,0.00007741674,0.00028913148,0.00017409516,0.00009414534,0.0009458203,0.0013386873,0.000057821275,0.00047961634,0.05660273],"study_design_scores_gemma":[0.00025231356,0.0051874476,0.982358,0.00007995733,0.0007120252,0.0008413048,0.0002860696,0.005714822,0.0021948765,0.00029171884,0.0020565533,0.000025035613],"about_ca_topic_score_codex":0.0006621892,"about_ca_topic_score_gemma":0.0018727615,"teacher_disagreement_score":0.0013905367,"about_ca_system_score_codex":0.0006179611,"about_ca_system_score_gemma":0.00050223497,"threshold_uncertainty_score":0.007353902},"labels":[],"label_agreement":null},{"id":"W1972705109","doi":"10.1016/s1078-1439(02)00182-5","title":"Long-term survival in phase II trials of gemcitabine plus cisplatin for advanced transitional cell cancer","year":2002,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Gemcitabine; Cisplatin; Oncology; Term (time); Cancer; Medicine; Internal medicine; Chemotherapy; Physics","score_opus":0.08471538991158399,"score_gpt":0.3853444164681769,"score_spread":0.3006290265565929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972705109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861427,0.010198281,0.00040569538,0.00066362805,0.0003048293,0.00051360484,0.0006280974,0.000039729926,0.0011033687],"genre_scores_gemma":[0.9916732,0.0036869603,0.00042285322,0.0005801,0.00018871701,0.00084152527,0.001178892,0.00002350233,0.0014042491],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99854976,0.0008277793,0.00010254643,0.00016973965,0.00008780944,0.00026235692],"domain_scores_gemma":[0.99822503,0.0004716751,0.00029500283,0.00018661126,0.00009415531,0.0007275231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046309903,0.000980012,0.0029029122,0.00056331494,0.0009658507,0.001393355,0.00077175896,0.0015332833,0.0021925026],"category_scores_gemma":[0.0027545032,0.0005121063,0.0026603243,0.0008024716,0.0011316695,0.0017061563,0.00072864426,0.004413039,0.0004761356],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85627013,0.013987965,0.008901201,0.0009109789,0.0028842904,0.00013875788,0.00036062518,0.0033093065,0.007266542,0.00020785118,0.002674993,0.103087395],"study_design_scores_gemma":[0.36754265,0.58147955,0.03857449,0.00016126902,0.0029775125,0.00028328426,0.00017017346,0.0013621908,0.002910342,0.0004978901,0.0039785197,0.00006219705],"about_ca_topic_score_codex":0.00088039105,"about_ca_topic_score_gemma":0.0027558934,"teacher_disagreement_score":0.0046309903,"about_ca_system_score_codex":0.0013376947,"about_ca_system_score_gemma":0.001592386,"threshold_uncertainty_score":0.02449137},"labels":[],"label_agreement":null},{"id":"W1973015781","doi":"10.1016/s1078-1439(03)00112-1","title":"A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma. Saad F, Gleason DM, Murray R, Tchekmedyian S, Venner P, Lacombe L, Chin JL, Vinholes JJ, Goas JA, Chen B, Zoledronic Acid Prostate Cancer Study Group, Uro-Oncology Clinic, Centre Hospitalier de l’Université, de Montreal, Hôpital Notre-Dame, Montréal, Québec, Canada","year":2003,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bone health and treatments","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Zoledronic acid; Medicine; Placebo; Prostate cancer; Urology; Bisphosphonate; Internal medicine; Surgery; Cancer; Osteoporosis; Pathology","score_opus":0.007543118203389244,"score_gpt":0.2509912808463947,"score_spread":0.24344816264300548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973015781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97163266,0.0135534,0.000692127,0.0018167725,0.0020498843,0.0042200093,0.0024756137,0.00017508677,0.0033843582],"genre_scores_gemma":[0.9840726,0.0050551663,0.0009490706,0.0012996937,0.00065088546,0.0028363485,0.0014680664,0.000021708269,0.0036465381],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99917716,0.0004085798,0.00007739235,0.00014910227,0.000068806614,0.00011881712],"domain_scores_gemma":[0.9988949,0.00034829174,0.00022370371,0.00010550591,0.00009205435,0.0003356151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017535031,0.0016234748,0.0043379045,0.00064373284,0.00076801,0.0011670524,0.0013191698,0.002080121,0.009367715],"category_scores_gemma":[0.002827497,0.0008602263,0.0021593475,0.0006164719,0.0016201,0.001178471,0.00048520463,0.0026799582,0.0012714178],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9916074,0.0016415003,0.00018961604,0.00039977115,0.00071697857,0.000020002219,0.000019826413,0.000094735755,0.00077414,0.00006161193,0.00036071823,0.004113778],"study_design_scores_gemma":[0.9878171,0.010980938,0.0005365391,0.000011801459,0.0002722458,0.000009804059,0.000009592322,0.00007986443,0.00007362546,0.00004676541,0.00015661097,0.0000051258385],"about_ca_topic_score_codex":0.0032441865,"about_ca_topic_score_gemma":0.0071958345,"teacher_disagreement_score":0.009367715,"about_ca_system_score_codex":0.0010692099,"about_ca_system_score_gemma":0.0016262316,"threshold_uncertainty_score":0.031338096},"labels":[],"label_agreement":null},{"id":"W1973263699","doi":"10.1016/j.urolonc.2013.06.010","title":"A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma","year":2013,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Stage (stratigraphy); Poisson regression; Population; Kidney cancer; Cancer; Relative survival; Internal medicine; Urology; Surgery; Oncology; Cancer registry; Kidney","score_opus":0.040194092652696946,"score_gpt":0.30852075393608525,"score_spread":0.2683266612833883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973263699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99741995,0.00035850634,0.0013792671,0.00018602419,0.000024845314,0.000014696629,0.0004062847,0.000016011461,0.00019441992],"genre_scores_gemma":[0.9986155,0.000107365304,0.00045039566,0.000029868397,0.00003441489,0.000014505171,0.00056026614,0.000006387296,0.00018131438],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962047,0.002608488,0.00018591592,0.000494869,0.00023097792,0.00027500527],"domain_scores_gemma":[0.9901007,0.0063287285,0.0011095459,0.0014398495,0.00034043356,0.0006807558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008247112,0.0007125173,0.0010884166,0.0013994604,0.00066386757,0.0015171004,0.0015518056,0.0013681692,0.0023018694],"category_scores_gemma":[0.012639033,0.0007457305,0.0048233364,0.0012827574,0.0006796916,0.00091957254,0.001187125,0.0020217665,0.00023013998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0139208045,0.00064033375,0.9511194,0.0001029565,0.010690372,0.00069763645,0.00021496443,0.010971857,0.0012495773,0.0011137704,0.00082503207,0.0084531475],"study_design_scores_gemma":[0.0012459854,0.0054476485,0.8757441,0.00004179863,0.009392043,0.0022673258,0.00093733583,0.09947656,0.0004655643,0.003541705,0.0012692201,0.00017067858],"about_ca_topic_score_codex":0.005005504,"about_ca_topic_score_gemma":0.0047890726,"teacher_disagreement_score":0.008247112,"about_ca_system_score_codex":0.0007659143,"about_ca_system_score_gemma":0.000734784,"threshold_uncertainty_score":0.0436154},"labels":[],"label_agreement":null},{"id":"W1973278919","doi":"10.1016/j.urolonc.2014.12.005","title":"Bcl-2 predicts response to neoadjuvant chemotherapy and is overexpressed in lymph node metastases of urothelial cancer of the bladder","year":2015,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cystectomy; Bladder cancer; Medicine; Chemotherapy; Lymph node; Oncology; Lymphadenectomy; Cancer; Urothelium; Primary tumor; Internal medicine; Stage (stratigraphy); Urology; Urinary bladder; Metastasis; Biology","score_opus":0.03753704234868138,"score_gpt":0.3315459649183967,"score_spread":0.29400892256971534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973278919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99792814,0.0011357104,0.00012539043,0.00010313254,0.00001965974,0.0000034387247,0.00013986391,0.000009786445,0.00053479534],"genre_scores_gemma":[0.9990539,0.00029368416,0.00008534967,0.00002157068,0.000026984986,0.0000031638053,0.00024059761,0.0000028291606,0.00027191665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998548,0.000038884264,0.000015621052,0.000024434608,0.00003802305,0.000028273584],"domain_scores_gemma":[0.99903905,0.0003253071,0.0003073115,0.000041006926,0.00011624563,0.00017111168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003771071,0.00025998137,0.00032755057,0.0008398748,0.00023663118,0.00071375247,0.0002802866,0.00041332596,0.0017359408],"category_scores_gemma":[0.002289809,0.00020947865,0.0001803044,0.00073766476,0.00028169065,0.00040865972,0.00031627587,0.00040728378,0.00023942559],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010577869,0.000063028914,0.984658,0.000039311726,0.000060504986,0.0002551476,0.000045426696,0.0002365155,0.00569726,0.000023817312,0.0002903957,0.007572774],"study_design_scores_gemma":[0.000029187668,0.0001284021,0.99557966,0.000012545681,0.00008727933,0.0008691573,0.00013751973,0.0012067157,0.0013987966,0.00008057789,0.00046201158,0.00000811479],"about_ca_topic_score_codex":0.0014581895,"about_ca_topic_score_gemma":0.0022156253,"teacher_disagreement_score":0.0017359408,"about_ca_system_score_codex":0.00026775303,"about_ca_system_score_gemma":0.00018686896,"threshold_uncertainty_score":0.00580734},"labels":[],"label_agreement":null},{"id":"W1974688292","doi":"10.1016/j.urolonc.2005.07.007","title":"Surveillance in stage I testicular seminoma","year":2006,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Seminoma; Medicine; Stage (stratigraphy); Adjuvant; Radiation therapy; Adjuvant chemotherapy; Chemotherapy; Adjuvant radiotherapy; Oncology; Internal medicine; Cancer","score_opus":0.05153275974282042,"score_gpt":0.36790123585231344,"score_spread":0.31636847610949304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974688292","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027547468,0.99915636,0.000060826136,0.000088738394,0.000076843564,0.0000017174864,0.000010764111,0.0000036610088,0.00032565478],"genre_scores_gemma":[0.00301611,0.99616456,0.0001662561,0.00018668215,0.00019212413,0.0000034054995,0.000030919,9.67285e-7,0.00023897493],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984777,0.000037262653,0.00003471953,0.000028582694,0.0000403973,0.0000112355265],"domain_scores_gemma":[0.99949753,0.0003138462,0.000107773056,0.000008746538,0.00005055747,0.000021539898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005701869,0.00043667146,0.0012874606,0.001666952,0.00012965457,0.00054626423,0.00058492133,0.000497223,0.0013986602],"category_scores_gemma":[0.0013085982,0.00021695945,0.00046456206,0.0014066148,0.00024209337,0.0007195018,0.00033938186,0.0006309788,0.00045311268],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102667604,0.000027249645,0.0013311248,0.013509161,0.000107189655,0.0006050948,0.000044113094,0.00030785875,0.000540193,0.00035515166,0.0113719115,0.9716983],"study_design_scores_gemma":[0.00015712318,0.0006693828,0.019128142,0.03226687,0.0020100798,0.022259612,0.00030005263,0.0006162802,0.0016667881,0.0016368522,0.91922176,0.00006712213],"about_ca_topic_score_codex":0.0013952997,"about_ca_topic_score_gemma":0.0034169513,"teacher_disagreement_score":0.001666952,"about_ca_system_score_codex":0.00035118475,"about_ca_system_score_gemma":0.0008230543,"threshold_uncertainty_score":0.0046789646},"labels":[],"label_agreement":null},{"id":"W1974717239","doi":"10.1016/j.urolonc.2012.08.003","title":"How reliable are “reputable sources” for medical information on the Internet? The case of hormonal therapy to treat prostate cancer","year":2012,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Health Literacy and Information Accessibility","field":"Health Professions","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Dalhousie University","funders":"","keywords":"Prostate cancer; The Internet; Medicine; Credibility; Hormonal therapy; Cancer; Health care; Gynecology; Internet privacy; Family medicine; Oncology; Internal medicine; Computer science; World Wide Web; Political science","score_opus":0.06485810781386597,"score_gpt":0.41765864254509216,"score_spread":0.3528005347312262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974717239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.48528156,0.004358481,0.0046098176,0.40899011,0.000363789,0.00006425545,0.0001445556,0.000042248437,0.09614522],"genre_scores_gemma":[0.98803353,0.0027920078,0.0014644519,0.0049260342,0.00037894645,0.000010768985,0.000032966385,0.000026472315,0.0023349265],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9937524,0.004263653,0.0003147242,0.00026814733,0.0006173706,0.0007836571],"domain_scores_gemma":[0.9440709,0.046480633,0.004235575,0.0014674992,0.0018372234,0.0019081541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068810526,0.0002595665,0.00033262838,0.001971919,0.005016193,0.004412421,0.0014281492,0.0074590896,0.004763539],"category_scores_gemma":[0.062660046,0.00036937266,0.0004275483,0.00226453,0.00586414,0.008501707,0.0027844964,0.005103151,0.00050831493],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042698902,0.000730707,0.114686765,0.0006331792,0.00010114437,0.42404357,0.12846014,0.0012699631,0.0014006214,0.15258281,0.034003038,0.14166105],"study_design_scores_gemma":[0.000094106756,0.00035432496,0.04171934,0.00157186,0.00030270798,0.44276547,0.2947798,0.006426858,0.0024280003,0.08437724,0.1249938,0.0001865629],"about_ca_topic_score_codex":0.011323172,"about_ca_topic_score_gemma":0.010994091,"teacher_disagreement_score":0.011323172,"about_ca_system_score_codex":0.0018838655,"about_ca_system_score_gemma":0.0020541472,"threshold_uncertainty_score":0.03639096},"labels":[],"label_agreement":null},{"id":"W1974722839","doi":"10.1016/j.urolonc.2012.02.016","title":"Commentary on “Health-related quality of life after single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for prostate cancer.” Morton GC, Loblaw DA, Chung H, Tsang G, Sankreacha R, Deabreu A, Zhang L, Mamedov A, Cheung P, Batchelar D, Danjoux C, Szumacher E, Department of Radiation Oncology, Odette Cancer Centre, University of Toronto, Toronto, ON, Canada","year":2012,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Advanced Radiotherapy Techniques","field":"Physics and Astronomy","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Brachytherapy; External beam radiotherapy; Prostate cancer; Nuclear medicine; External beam radiation; Radiation therapy; Medicine; Prostate; Cancer; Medical physics; Oncology; Radiology; Internal medicine","score_opus":0.017634384204724116,"score_gpt":0.30754890058762885,"score_spread":0.2899145163829047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974722839","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030405022,0.0036268441,0.00009337951,0.8717387,0.122721985,0.000024455308,0.00034142652,0.00002983453,0.0011192895],"genre_scores_gemma":[0.0020755348,0.0021139262,0.0001222711,0.9015683,0.09156334,0.00007211795,0.00015663356,0.000022830847,0.0023050644],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99581784,0.0013851677,0.0005660543,0.00052284554,0.0013469249,0.00036128916],"domain_scores_gemma":[0.9774125,0.014885016,0.00095099164,0.00042562868,0.0047795246,0.0015462536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005258981,0.0012943267,0.0025059544,0.00092996424,0.0029092834,0.0018159507,0.0049410765,0.037864827,0.0066143433],"category_scores_gemma":[0.02932846,0.0009997293,0.0023022175,0.0013784452,0.002285721,0.0026830419,0.001426622,0.041193016,0.004455766],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006965397,0.000011396178,0.00008819407,0.000105629915,0.000016209906,0.00012604611,0.00003602184,0.000031311512,0.00006743823,0.00032119788,0.99682474,0.0023022196],"study_design_scores_gemma":[0.00027024205,0.00010875794,0.002339802,0.0015607148,0.00015253105,0.0008116817,0.00031453502,0.00031167027,0.000420255,0.0028067091,0.99080324,0.00009987397],"about_ca_topic_score_codex":0.014380241,"about_ca_topic_score_gemma":0.019522032,"teacher_disagreement_score":0.037864827,"about_ca_system_score_codex":0.0046078963,"about_ca_system_score_gemma":0.005720168,"threshold_uncertainty_score":0.03343284},"labels":[],"label_agreement":null},{"id":"W1975290928","doi":"10.1016/j.urolonc.2013.08.029","title":"Highlights from the first symposium on upper tract urothelial carcinoma","year":2014,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Nephrotoxicity and Medicinal Plants","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Medicine; Urothelial carcinoma; Disease; Nephrotoxicity; Guideline; Intensive care medicine; Kidney; Internal medicine; Pathology; Bladder cancer; Cancer","score_opus":0.044753129765014985,"score_gpt":0.32534148012051495,"score_spread":0.28058835035549995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975290928","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024884252,0.9415869,0.00012880978,0.0102547705,0.044500057,0.000024613219,0.00010772852,0.000018217352,0.0031300988],"genre_scores_gemma":[0.001683426,0.9406395,0.0002632996,0.0085013565,0.041653633,0.00002301981,0.00025347946,0.000009368787,0.006972924],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99948174,0.00008616381,0.000071687544,0.00006785965,0.0002182806,0.00007431753],"domain_scores_gemma":[0.99879503,0.0002769965,0.00015686177,0.000023650153,0.00047782485,0.0002696929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014707162,0.0010275944,0.001305376,0.003164828,0.00040795855,0.0015730724,0.0008987272,0.0019243475,0.010031328],"category_scores_gemma":[0.0017445724,0.00028341092,0.00097416405,0.00246535,0.00040305272,0.0019196222,0.0015798061,0.0025031595,0.0034541488],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017704068,0.00006546696,0.00020916825,0.017055154,0.00011410402,0.00049667485,0.00009381806,0.00012571759,0.0018499391,0.0011449906,0.6156015,0.3630665],"study_design_scores_gemma":[0.00002735812,0.000082487626,0.00072485866,0.0032231105,0.00013060708,0.0008177973,0.000055548677,0.000021480415,0.00031312788,0.0004172835,0.9941704,0.00001593443],"about_ca_topic_score_codex":0.0008714292,"about_ca_topic_score_gemma":0.0027251018,"teacher_disagreement_score":0.010031328,"about_ca_system_score_codex":0.0009512106,"about_ca_system_score_gemma":0.0023111063,"threshold_uncertainty_score":0.03355807},"labels":[],"label_agreement":null},{"id":"W1978620795","doi":"10.1016/j.urolonc.2007.05.021","title":"Active surveillance for favorable risk prostate cancer: Rationale, risks, and results","year":2007,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Prostate cancer; Disease; Comorbidity; Cancer; Intervention (counseling); Intensive care medicine; Prostate; Internal medicine; Psychiatry","score_opus":0.11472434845677079,"score_gpt":0.4135257250205506,"score_spread":0.2988013765637798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978620795","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004078627,0.9996086,0.000029799778,0.00014631124,0.000037926242,0.0000021240785,0.0000062662707,9.1372385e-7,0.00012731734],"genre_scores_gemma":[0.00048372408,0.9991085,0.00009661016,0.00016238066,0.000076190016,0.0000036116953,0.000009824817,4.3374354e-7,0.000058804664],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994825,0.00015385561,0.00007964161,0.00009944545,0.00016068698,0.000023847842],"domain_scores_gemma":[0.9982274,0.0012950142,0.0002006685,0.000029563198,0.00020691384,0.00004044565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019397453,0.0010675096,0.0030403533,0.0020260958,0.00026189603,0.00113246,0.0015394717,0.0011055782,0.0020474186],"category_scores_gemma":[0.0029072685,0.00035292393,0.0010462278,0.0023767326,0.0007471324,0.0012313419,0.0005384348,0.0018418779,0.0008270655],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012595807,0.00004049416,0.0006381349,0.03280466,0.00032248895,0.00015025647,0.00004063916,0.0002480121,0.00032217786,0.0017380639,0.011788514,0.9517805],"study_design_scores_gemma":[0.00025469222,0.00041539813,0.008631223,0.07343155,0.0032008812,0.0057556,0.00031345908,0.00034023685,0.00079849624,0.006510465,0.90023816,0.000109796434],"about_ca_topic_score_codex":0.0016391923,"about_ca_topic_score_gemma":0.004776752,"teacher_disagreement_score":0.0030403533,"about_ca_system_score_codex":0.00092854764,"about_ca_system_score_gemma":0.0016249593,"threshold_uncertainty_score":0.010258496},"labels":[],"label_agreement":null},{"id":"W1979644682","doi":"10.1016/j.urolonc.2010.08.007","title":"Biochemical markers of bone turnover and clinical outcomes in men with prostate cancer","year":2010,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bone health and treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute","keywords":"Prostate cancer; Bone remodeling; Oncology; Medicine; Internal medicine; Cancer; Prostate","score_opus":0.049855942923154234,"score_gpt":0.4116193143829926,"score_spread":0.3617633714598384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979644682","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016638388,0.999653,0.000016294405,0.00005025132,0.000027674321,0.0000011132922,0.000010962114,0.0000010791633,0.000073217045],"genre_scores_gemma":[0.0018517957,0.99785596,0.000055205932,0.000089213274,0.000059602364,0.0000026901437,0.00002007401,2.922905e-7,0.0000651406],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997471,0.000046285197,0.00004940589,0.000043714626,0.00009824148,0.000015229315],"domain_scores_gemma":[0.99942446,0.0003269129,0.00013831782,0.00000854194,0.00007788499,0.000023881596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007238183,0.00072046753,0.002608955,0.001984824,0.00014903488,0.00070580875,0.0007986835,0.0007153937,0.0012975705],"category_scores_gemma":[0.0013941826,0.00032059953,0.0009025443,0.0026338338,0.00036818613,0.0005412228,0.00046622747,0.0010018211,0.0003636128],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034446988,0.000093264396,0.0045048823,0.040227193,0.0014440625,0.00018429178,0.000051054307,0.0002623089,0.00044338673,0.00047077614,0.0104872845,0.9414869],"study_design_scores_gemma":[0.0007806448,0.0013169815,0.13528423,0.081815116,0.018905971,0.008761571,0.0007930051,0.00092901895,0.0014978542,0.004721758,0.74493,0.00026375524],"about_ca_topic_score_codex":0.0030325064,"about_ca_topic_score_gemma":0.0074711335,"teacher_disagreement_score":0.0030325064,"about_ca_system_score_codex":0.0003569465,"about_ca_system_score_gemma":0.0010368184,"threshold_uncertainty_score":0.006029725},"labels":[],"label_agreement":null},{"id":"W1979753022","doi":"10.1016/j.urolonc.2013.10.003","title":"Assessing the quality of studies on the diagnostic accuracy of tumor markers","year":2014,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of British Columbia","funders":"National Cancer Institute","keywords":"Quality (philosophy); Medical physics; Relevance (law); Medicine; Quality assessment; Meta-analysis; Systematic review; Scale (ratio); Data science; Computer science; External quality assessment; MEDLINE; Pathology","score_opus":0.1817403107201343,"score_gpt":0.47916022913372835,"score_spread":0.29741991841359405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979753022","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00057001406,0.9982755,0.00023557006,0.0003566013,0.00011610905,0.000033143537,0.000170708,0.000002988428,0.00023921905],"genre_scores_gemma":[0.018370207,0.9782497,0.0012278878,0.0010783325,0.00037417348,0.00008485597,0.000514044,0.000009901221,0.000090778034],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9637698,0.01098669,0.016597604,0.003290335,0.004941123,0.00041445342],"domain_scores_gemma":[0.6611476,0.29639426,0.02598934,0.0041212174,0.011761212,0.0005864736],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.05375199,0.0017256325,0.009027208,0.012597018,0.00047343012,0.0044394624,0.0039370055,0.0031838878,0.0039893026],"category_scores_gemma":[0.2279248,0.0013225217,0.006336108,0.009579697,0.0022722657,0.004287304,0.0025710086,0.0018777961,0.00047679417],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009813501,0.000042403924,0.012085427,0.63988227,0.042440377,0.0002195436,0.00038518797,0.00053832936,0.00051405554,0.0012408361,0.0033996638,0.29827067],"study_design_scores_gemma":[0.00079021684,0.0005713086,0.031204248,0.59166944,0.23840359,0.0019366586,0.00083443796,0.00053824217,0.0017292985,0.0048551178,0.1272814,0.00018599433],"about_ca_topic_score_codex":0.0041018203,"about_ca_topic_score_gemma":0.0068817697,"teacher_disagreement_score":0.9909728,"about_ca_system_score_codex":0.0027327128,"about_ca_system_score_gemma":0.0051302644,"threshold_uncertainty_score":0.28427112},"labels":[],"label_agreement":null},{"id":"W1981161413","doi":"10.1016/j.urolonc.2011.12.015","title":"Patients and partners lack knowledge of androgen deprivation therapy side effects","year":2012,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Baker Hughes (Canada); University of Calgary","funders":"","keywords":"Medicine; Androgen deprivation therapy; Gynecomastia; Side effect (computer science); Psychosocial; Adverse effect; Prostate cancer; Sexual dysfunction; Oxandrolone; Libido; Osteoporosis; Internal medicine; Psychiatry; Hormone; Cancer","score_opus":0.06110046724457345,"score_gpt":0.3857950996238764,"score_spread":0.32469463237930296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981161413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9019007,0.0077957916,0.000982983,0.0072333305,0.00015107536,0.00010606675,0.0011477188,0.000080237194,0.08060208],"genre_scores_gemma":[0.9892184,0.002146171,0.00037249344,0.0018728995,0.00005303758,0.000021373073,0.00030670236,0.000007632791,0.006001105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877614,0.00039577016,0.00009583796,0.0001099641,0.00043217232,0.00019004913],"domain_scores_gemma":[0.99193245,0.0037853008,0.0022554926,0.0003685194,0.00049926765,0.0011590996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001167821,0.00021217081,0.0005261768,0.0010022006,0.000907232,0.0014386668,0.00035707717,0.0006442174,0.02287559],"category_scores_gemma":[0.008377201,0.00021868866,0.00030286307,0.0010384525,0.0005288631,0.0010174958,0.00071791036,0.00096368004,0.0014309884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016653947,0.0011314158,0.8667702,0.0004156895,0.0001442866,0.0037818544,0.0052238936,0.0001674699,0.0012100415,0.0011302576,0.0071048616,0.11275346],"study_design_scores_gemma":[0.00004794841,0.00078241614,0.89449173,0.00057150447,0.00027387135,0.03654993,0.02236547,0.00050945766,0.0010036263,0.0029698543,0.040362813,0.000071424525],"about_ca_topic_score_codex":0.0028196322,"about_ca_topic_score_gemma":0.0034336434,"teacher_disagreement_score":0.02287559,"about_ca_system_score_codex":0.00032886508,"about_ca_system_score_gemma":0.0007990565,"threshold_uncertainty_score":0.0765264},"labels":[],"label_agreement":null},{"id":"W1984429541","doi":"10.1016/j.urolonc.2004.12.012","title":"A multinomial Phase II study of lonafarnib (SCH 66336) in patients with refractory urothelial cancer☆","year":2005,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Hamilton Regional Laboratory Medicine Program; Princess Margaret Cancer Centre; BC Cancer Agency; University Health Network; Ottawa Regional Cancer Foundation","funders":"","keywords":"Medicine; Cancer; Chemotherapy; Internal medicine; Nausea; Farnesyltransferase; Phases of clinical research; Clinical trial; Oncology; Gastroenterology; Pharmacology; Prenylation; Biology","score_opus":0.02361446967630437,"score_gpt":0.3333784436525646,"score_spread":0.3097639739762602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984429541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913646,0.002805878,0.0004997548,0.00082561094,0.0002189303,0.0013057723,0.0012353766,0.00011324512,0.001630757],"genre_scores_gemma":[0.98222566,0.0033266197,0.0023638753,0.0015483975,0.00022937657,0.0023674364,0.0034029707,0.00005411457,0.0044814902],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999151,0.0004721824,0.000032473952,0.000108288536,0.00005544357,0.00018059116],"domain_scores_gemma":[0.9989453,0.00017052937,0.00017316412,0.00011677537,0.0000549938,0.0005392953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032423062,0.0017202958,0.0026734357,0.00051850535,0.00057168584,0.0010298,0.0008644147,0.0010302931,0.004452776],"category_scores_gemma":[0.0011258455,0.00075504754,0.001994222,0.0005606771,0.0013782949,0.0013212482,0.00056084787,0.003763057,0.0012972659],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7302305,0.046827283,0.011105118,0.0011445581,0.0024222129,0.00020584455,0.0004309325,0.002741667,0.03097849,0.0003785301,0.008971659,0.16456315],"study_design_scores_gemma":[0.68205345,0.2945052,0.015812503,0.00004786586,0.0009552885,0.00021142783,0.00010363359,0.0011019842,0.0013983967,0.00019477347,0.0035632919,0.000052266918],"about_ca_topic_score_codex":0.001970705,"about_ca_topic_score_gemma":0.007895335,"teacher_disagreement_score":0.004452776,"about_ca_system_score_codex":0.0010684604,"about_ca_system_score_gemma":0.0024949033,"threshold_uncertainty_score":0.017147124},"labels":[],"label_agreement":null},{"id":"W1985010411","doi":"10.1016/j.urolonc.2011.03.015","title":"Commentary on “Focal laser ablation for prostate cancer followed by radical prostatectomy: Validation of focal therapy and imaging accuracy”. Lindner U, Lawrentschuk N, Weersink RA, Davidson SR, Raz O, Hlasny E, Langer DL, Gertner MR, Van der Kwast T, Haider MA, Trachtenberg J, Surgical Oncology, Urology Division, University Health Network, University of Toronto, Toronto, Canada","year":2011,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network","funders":"","keywords":"Prostatectomy; Medicine; Ablation; Prostate cancer; Laser ablation; Ablation Therapy; Urology; Laser therapy; Prostate; Cancer; Laser; Internal medicine; Optics; Physics","score_opus":0.024716037998635965,"score_gpt":0.28929517743031846,"score_spread":0.2645791394316825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985010411","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028870624,0.003394959,0.00014236927,0.91058326,0.084100224,0.00003218011,0.00036553293,0.00003448282,0.0010582373],"genre_scores_gemma":[0.0016164957,0.0015033867,0.00016442708,0.9365845,0.058377206,0.000058273694,0.000088719695,0.000023383345,0.0015836576],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99107224,0.0026046569,0.0015245364,0.0011971695,0.0029724082,0.0006289831],"domain_scores_gemma":[0.9448839,0.03657253,0.0021370233,0.00090783474,0.013138663,0.0023601602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0096913865,0.0015149594,0.0026865285,0.0014649986,0.003761309,0.0023819301,0.0060222456,0.052229796,0.0053922953],"category_scores_gemma":[0.06918736,0.0015727818,0.0028233712,0.0017395829,0.0037252763,0.0036694482,0.0016397085,0.053517003,0.005739853],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007995998,0.0000072780263,0.0001191356,0.00015542077,0.000021051737,0.00014677508,0.00006357748,0.00003904706,0.00010221538,0.0005007453,0.99628437,0.0024804855],"study_design_scores_gemma":[0.0002788504,0.00010765845,0.0023114975,0.0020932776,0.00019302862,0.0010676351,0.00039282322,0.0003525406,0.0007289195,0.0040640924,0.98825955,0.00015008575],"about_ca_topic_score_codex":0.028771492,"about_ca_topic_score_gemma":0.034070384,"teacher_disagreement_score":0.052229796,"about_ca_system_score_codex":0.0072997464,"about_ca_system_score_gemma":0.0091924565,"threshold_uncertainty_score":0.05720806},"labels":[],"label_agreement":null},{"id":"W1988098038","doi":"10.1016/j.urolonc.2009.03.010","title":"Response to the article by J.E. Montie, Screen detected, low volume prostate cancer: The case for active treatment. Urol Oncol 2008;26:511–515.","year":2009,"lang":"en","type":"letter","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Prostate cancer; Gynecology; Prostate; Cancer; Volume (thermodynamics); Oncology; Urology; Internal medicine","score_opus":0.02118838575815288,"score_gpt":0.307055868829257,"score_spread":0.2858674830711041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988098038","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00055842847,0.0013275753,0.00007799123,0.9758859,0.020048099,0.000025274907,0.0000949677,0.00003290053,0.0019488357],"genre_scores_gemma":[0.0075226272,0.001947163,0.0002518746,0.94000983,0.038989805,0.000058742677,0.0001035724,0.00003476401,0.011081679],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99853945,0.00042951413,0.00017704553,0.00020777038,0.00039357712,0.000252732],"domain_scores_gemma":[0.99721414,0.0014070671,0.00022479937,0.000060034916,0.0006294747,0.00046458107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001743523,0.0010971982,0.0014725561,0.0007436412,0.0025248423,0.0022099402,0.0017107796,0.037710976,0.008376095],"category_scores_gemma":[0.015709495,0.0007323976,0.0010464999,0.000642729,0.0014497207,0.002539707,0.0010636167,0.029318335,0.006547389],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014329122,0.000033317938,0.0006101446,0.00007110627,0.00001322362,0.004475601,0.000095324176,0.000057911733,0.0001398925,0.0005046779,0.98975825,0.004097249],"study_design_scores_gemma":[0.00030694876,0.00022068075,0.0060611614,0.00058809825,0.00007704825,0.019659108,0.0009717346,0.0008330835,0.000491344,0.0036218502,0.9670269,0.0001422183],"about_ca_topic_score_codex":0.006559627,"about_ca_topic_score_gemma":0.009190024,"teacher_disagreement_score":0.037710976,"about_ca_system_score_codex":0.0041199755,"about_ca_system_score_gemma":0.002080428,"threshold_uncertainty_score":0.029892683},"labels":[],"label_agreement":null},{"id":"W1989627487","doi":"10.1016/j.urolonc.2012.04.013","title":"Presence of positive surgical margin in patients with organ-confined prostate cancer equals to extracapsular extension negative surgical margin. A plea for TNM staging system reclassification","year":2012,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Prostatectomy; Stage (stratigraphy); Biochemical recurrence; Prostate cancer; Urology; Concordance; Nomogram; T-stage; Proportional hazards model; Internal medicine; breakpoint cluster region; Cancer; Oncology","score_opus":0.027096447404884157,"score_gpt":0.31448194491298653,"score_spread":0.2873854975081024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989627487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97637933,0.003899878,0.00047307796,0.00058878365,0.00023534226,0.000024376794,0.0018835302,0.000028725264,0.016486892],"genre_scores_gemma":[0.99790096,0.0004017115,0.00014049993,0.000078023586,0.0000941769,0.00000716375,0.0005450814,0.0000032160783,0.0008291394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985194,0.00003585081,0.000015374557,0.000029943134,0.000040167546,0.00002672986],"domain_scores_gemma":[0.99954396,0.00011899503,0.00017623715,0.000022926428,0.000028092833,0.0001097449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029690503,0.00013932618,0.0001679268,0.0008176803,0.0001993853,0.0003691315,0.0002507324,0.00026269403,0.0052135456],"category_scores_gemma":[0.0014195234,0.00007827888,0.0002384503,0.000588916,0.0003216192,0.00037489212,0.0003401019,0.00044215418,0.0002990664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048624788,0.000029347148,0.98328364,0.00007702446,0.000052503434,0.00043594113,0.00005608674,0.00013469353,0.00072684814,0.00028095947,0.0020925342,0.012344252],"study_design_scores_gemma":[0.00001182668,0.00010624156,0.9935923,0.000034044228,0.00006136482,0.0030488092,0.00020940474,0.00026431607,0.00025163294,0.00042488804,0.001983184,0.000012073163],"about_ca_topic_score_codex":0.00144899,"about_ca_topic_score_gemma":0.003791996,"teacher_disagreement_score":0.0052135456,"about_ca_system_score_codex":0.00014348722,"about_ca_system_score_gemma":0.00026918872,"threshold_uncertainty_score":0.017441094},"labels":[],"label_agreement":null},{"id":"W1996353873","doi":"10.1016/j.urolonc.2013.01.005","title":"Treatment options in castration-resistant prostate cancer: Current therapies and emerging docetaxel-based regimens","year":2013,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Docetaxel; Enzalutamide; Cabazitaxel; Medicine; Prostate cancer; Dasatinib; Oncology; Clinical trial; Internal medicine; Abiraterone acetate; Pharmacology; Cancer; Androgen receptor; Androgen deprivation therapy; Tyrosine kinase","score_opus":0.035814512401961346,"score_gpt":0.3452954380920764,"score_spread":0.3094809256901151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996353873","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015563477,0.9523051,0.0017765516,0.020468002,0.0010770004,0.00002684496,0.000057601344,0.000025758014,0.008699697],"genre_scores_gemma":[0.14512219,0.8332708,0.0048489687,0.007867459,0.003273761,0.00006669122,0.00018650328,0.00002564671,0.0053379335],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997758,0.00006175643,0.000019927702,0.000032517575,0.00005924949,0.000050766525],"domain_scores_gemma":[0.99973184,0.000096921525,0.000056061574,0.000012881317,0.000045082495,0.00005732736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009987392,0.00026699743,0.0005890275,0.00038290813,0.00045759586,0.0014048463,0.00051071966,0.0004624153,0.0025475125],"category_scores_gemma":[0.00064504216,0.00011688545,0.00043398896,0.00067870255,0.00079768174,0.001637207,0.00064964587,0.0019956583,0.0003266017],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013796699,0.00034694772,0.003702059,0.002397899,0.00013102296,0.0008727349,0.0002740395,0.0021412491,0.006598636,0.018324926,0.031771064,0.93205976],"study_design_scores_gemma":[0.0007163224,0.002241307,0.019134646,0.0043657543,0.00044923628,0.0062670666,0.0011639313,0.0028353967,0.005263604,0.020128885,0.9373374,0.000096482894],"about_ca_topic_score_codex":0.001304887,"about_ca_topic_score_gemma":0.0073805526,"teacher_disagreement_score":0.0025475125,"about_ca_system_score_codex":0.0011075299,"about_ca_system_score_gemma":0.0011952815,"threshold_uncertainty_score":0.008522272},"labels":[],"label_agreement":null},{"id":"W1998283156","doi":"10.1016/j.urolonc.2010.07.010","title":"Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma","year":2010,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Hazard ratio; Lymphovascular invasion; Proportional hazards model; Cancer; Oncology; Stage (stratigraphy); Medicine; Cohort; Internal medicine; Confidence interval; Metastasis; Biology","score_opus":0.016191666841893222,"score_gpt":0.304917685033329,"score_spread":0.2887260181914358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998283156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967063,0.00053143234,0.0007498873,0.00006131434,0.000012753141,0.000009357523,0.000049317994,0.000034091343,0.0018456739],"genre_scores_gemma":[0.9992741,0.00017688944,0.00027805933,0.000009585059,0.000015014782,0.00000113493,0.000045832672,0.000003588807,0.00019583126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998996,0.000016110816,0.0000125570405,0.00001540303,0.00003889988,0.000017417555],"domain_scores_gemma":[0.9996586,0.00005170475,0.00013244685,0.000036296493,0.00004783828,0.000073232746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026164844,0.00024252334,0.00017250329,0.0011871555,0.00016532393,0.00045275243,0.00017402486,0.00019946496,0.0010796238],"category_scores_gemma":[0.00082921854,0.0002127232,0.00011089506,0.0006298898,0.00040628656,0.00035264262,0.00034044703,0.00020266902,0.0001890682],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076948834,0.00006398362,0.72721505,0.00013081045,0.00007080241,0.029410578,0.00031848525,0.00064974086,0.21162017,0.0007119862,0.00054469984,0.028494235],"study_design_scores_gemma":[0.000011498866,0.00019314887,0.9289516,0.000011630827,0.00007229811,0.05563173,0.00038585297,0.0013278227,0.011388939,0.00042652412,0.0015828595,0.000016060403],"about_ca_topic_score_codex":0.00081831525,"about_ca_topic_score_gemma":0.0017792806,"teacher_disagreement_score":0.0011871555,"about_ca_system_score_codex":0.00014844842,"about_ca_system_score_gemma":0.00015116527,"threshold_uncertainty_score":0.0036116838},"labels":[],"label_agreement":null},{"id":"W1998311214","doi":"10.1016/j.urolonc.2004.11.008","title":"A Phase II study of oxaliplatin in urothelial cancer","year":2005,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Oxaliplatin; Medicine; Cisplatin; Nausea; Internal medicine; Chemotherapy; Phases of clinical research; Oncology; Toxicity; Clinical endpoint; Urology; Cancer; Surgery; Clinical trial; Colorectal cancer","score_opus":0.04288365957811869,"score_gpt":0.3768328459018545,"score_spread":0.3339491863237358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998311214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99085593,0.0027912199,0.0007130756,0.00055350043,0.0002503297,0.0029201268,0.0006891325,0.00006166966,0.0011651391],"genre_scores_gemma":[0.986558,0.003028745,0.0016308979,0.0010544611,0.00033945625,0.0024226506,0.0017093244,0.000048136502,0.0032083262],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99867046,0.0007217797,0.000061328516,0.00019236769,0.000080153855,0.00027403326],"domain_scores_gemma":[0.998168,0.0003944889,0.00026071578,0.00024416184,0.00011392369,0.0008187329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037989193,0.0019326544,0.004485613,0.0009087421,0.00082641945,0.0017331574,0.0014707708,0.0023288466,0.0034834456],"category_scores_gemma":[0.0018028473,0.0011120542,0.0026026282,0.00086147635,0.0019866158,0.0014574996,0.00060331996,0.004521945,0.000788592],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8717867,0.06789397,0.0024909417,0.0005900049,0.0010234339,0.00015414921,0.00029791522,0.0013479675,0.015763765,0.00019091571,0.0013806801,0.037079528],"study_design_scores_gemma":[0.72536004,0.26851928,0.0028921324,0.000014925341,0.00033808406,0.00007663958,0.00005169113,0.00030236662,0.0014456036,0.00009433511,0.0008862488,0.000018648228],"about_ca_topic_score_codex":0.002484261,"about_ca_topic_score_gemma":0.0031655065,"teacher_disagreement_score":0.004485613,"about_ca_system_score_codex":0.001313164,"about_ca_system_score_gemma":0.0026948599,"threshold_uncertainty_score":0.020090818},"labels":[],"label_agreement":null},{"id":"W1999372811","doi":"10.1016/j.urolonc.2013.10.007","title":"Prognostic risk stratification derived from individual patient level data for men with advanced penile squamous cell carcinoma receiving first-line systemic therapy","year":2013,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Genital Health and Disease","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; BC Cancer Agency; McMaster University","funders":"","keywords":"Medicine; Internal medicine; Oncology; Proportional hazards model; Context (archaeology); Systemic therapy; Stage (stratigraphy); Multivariate analysis; Regimen; Lymphovascular invasion; Retrospective cohort study; Radiation therapy; Metastasis; Cancer; Breast cancer","score_opus":0.06310231854419623,"score_gpt":0.304568025433001,"score_spread":0.24146570688880475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999372811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963611,0.00032467497,0.00060018036,0.00009776683,0.000011395277,0.000010291222,0.0019005955,0.000018811463,0.00067512086],"genre_scores_gemma":[0.998307,0.000052175335,0.00026675314,0.000018153662,0.0000115835155,0.000004898309,0.0012420167,0.000003427093,0.000093960036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961865,0.0001277231,0.00004938428,0.00008107612,0.00006616457,0.000057082536],"domain_scores_gemma":[0.9978131,0.0009947974,0.0006160831,0.00024276758,0.00015324833,0.00018005309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007569946,0.00021779971,0.00053577515,0.0008117545,0.00017885733,0.00064196496,0.00021610905,0.00027723765,0.0016760118],"category_scores_gemma":[0.0038877125,0.000112580965,0.00070034224,0.0011812121,0.00013793477,0.00038563804,0.00040452043,0.000492802,0.00026997624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005838181,0.000018839679,0.9911521,0.000013896053,0.0002004465,0.00004294998,0.00003151411,0.0006956481,0.00046683854,0.00003632891,0.00025223396,0.0065052956],"study_design_scores_gemma":[0.000020500229,0.0001886011,0.99559325,0.000006202638,0.000171005,0.00019041452,0.00006437012,0.0029902863,0.00024991378,0.00014490947,0.00037321835,0.000007344106],"about_ca_topic_score_codex":0.0010685063,"about_ca_topic_score_gemma":0.0024403145,"teacher_disagreement_score":0.0016760118,"about_ca_system_score_codex":0.00022779839,"about_ca_system_score_gemma":0.00023077588,"threshold_uncertainty_score":0.00560683},"labels":[],"label_agreement":null},{"id":"W2001241431","doi":"10.1016/j.urolonc.2013.11.003","title":"Why is perioperative chemotherapy for bladder cancer underutilized?","year":2014,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Perioperative; Bladder cancer; Medicine; Intensive care medicine; Chemotherapy; Disease; Clinical Practice; Cancer; Oncology; Internal medicine; Surgery; Physical therapy","score_opus":0.07735356287464201,"score_gpt":0.4121752811838386,"score_spread":0.3348217183091966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001241431","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023971057,0.9978275,0.00002889649,0.001405893,0.00012450035,0.0000014138191,0.000015446347,0.0000016103677,0.0003549309],"genre_scores_gemma":[0.0026628983,0.99569666,0.000079943304,0.0012146783,0.00025268586,0.000003095688,0.000018284369,0.0000010560196,0.000070761234],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99929976,0.00021629008,0.00016098288,0.000104159146,0.00016147523,0.000057244746],"domain_scores_gemma":[0.99732995,0.0014155941,0.0007059893,0.000038921393,0.0004192621,0.00009034353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016569124,0.00029471144,0.0010414087,0.001567776,0.00020640652,0.0011655272,0.00059589214,0.001070541,0.0020128186],"category_scores_gemma":[0.0051944763,0.00020423156,0.00067056454,0.0026179862,0.0007303273,0.0013687753,0.00052261,0.0015595439,0.00034606401],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001869252,0.000027585857,0.0024642488,0.035702422,0.000561501,0.00023172659,0.00011123114,0.0002595816,0.00041857263,0.0033833068,0.028327845,0.92832494],"study_design_scores_gemma":[0.00012381421,0.00022001806,0.014721649,0.065443724,0.0026368764,0.0031792002,0.0006387293,0.000149673,0.0006198125,0.0037489596,0.90846235,0.00005509555],"about_ca_topic_score_codex":0.003499788,"about_ca_topic_score_gemma":0.0076474412,"teacher_disagreement_score":0.003499788,"about_ca_system_score_codex":0.0011186139,"about_ca_system_score_gemma":0.0037867255,"threshold_uncertainty_score":0.008762717},"labels":[],"label_agreement":null},{"id":"W2003123210","doi":"10.1016/j.urolonc.2012.11.014","title":"Adjuvant chemotherapy for upper-tract urothelial carcinoma treated with nephroureterectomy: Assessment of adequate renal function and influence on outcome","year":2013,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Manitoba; University of British Columbia; McMaster University; Western University; Université de Montréal; Université Laval; University of Alberta; Dalhousie University; McGill University","funders":"","keywords":"Medicine; Renal function; Urology; Proportional hazards model; Perioperative; Chemotherapy; Retrospective cohort study; Kidney disease; Nephrectomy; Internal medicine; Surgery; Kidney","score_opus":0.027546134111403348,"score_gpt":0.3241128512845948,"score_spread":0.2965667171731915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003123210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99731123,0.0019799822,0.000078252,0.000083881154,0.000017485027,0.0000075479284,0.00003681808,0.000003040068,0.00048171997],"genre_scores_gemma":[0.9991309,0.00056496344,0.000062433435,0.00003167952,0.000026996204,0.0000041214826,0.000075424956,9.489568e-7,0.00010254634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998592,0.000059230926,0.000016530896,0.000014467332,0.000022121269,0.000028288623],"domain_scores_gemma":[0.99938154,0.00024683014,0.00014955863,0.000028940665,0.000035325418,0.00015773236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046362734,0.00014776799,0.0003844753,0.00022640759,0.00018259403,0.0002260004,0.00012968387,0.00019283073,0.0004836487],"category_scores_gemma":[0.0019605723,0.000053282394,0.00034012343,0.0003027967,0.0001606815,0.00016559544,0.00018564214,0.00024169945,0.000048334765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018273728,0.00086183706,0.90905917,0.00011090316,0.00029097518,0.0006738055,0.000121419056,0.0009026907,0.0036462075,0.0000664927,0.00037061583,0.0656222],"study_design_scores_gemma":[0.00022383161,0.0050400696,0.9919065,0.000027082888,0.0003353538,0.00054551836,0.000059566195,0.0007638989,0.00048657006,0.000067541514,0.0005377578,0.000006200987],"about_ca_topic_score_codex":0.0015175453,"about_ca_topic_score_gemma":0.0037075258,"teacher_disagreement_score":0.0015175453,"about_ca_system_score_codex":0.00028861058,"about_ca_system_score_gemma":0.0004034931,"threshold_uncertainty_score":0.0030174255},"labels":[],"label_agreement":null},{"id":"W2003161920","doi":"10.1016/j.urolonc.2014.09.003","title":"Long-term oncologic outcomes of laparoscopic renal cryoablation as primary treatment for small renal masses","year":2014,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cryoablation; Medicine; Renal cell carcinoma; Cancer; Survival rate; Kidney cancer; Cryosurgery; Progression-free survival; Surgery; Retrospective cohort study; Internal medicine; Overall survival","score_opus":0.0518119510930411,"score_gpt":0.32842191378544,"score_spread":0.2766099626923989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003161920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940165,0.0032084868,0.00018789145,0.00027591482,0.000057158308,0.000013563256,0.0007156733,0.0000063358534,0.0015185458],"genre_scores_gemma":[0.99797374,0.00044703088,0.000039503924,0.000100290046,0.0000734912,0.000009612124,0.0009865288,0.0000035171001,0.00036635489],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994752,0.00010978341,0.000056926754,0.00007638811,0.00009423664,0.00018745268],"domain_scores_gemma":[0.99675924,0.0007770896,0.0012362946,0.00013455561,0.00028590474,0.000806838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009514939,0.00017479432,0.00042510746,0.0005846544,0.0004881353,0.00085480406,0.00039330366,0.0005125453,0.002424558],"category_scores_gemma":[0.0042631547,0.00009734367,0.0014268645,0.0005509303,0.00041315815,0.0009816226,0.0006758383,0.0008434577,0.00034912926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069343415,0.0007702649,0.95248514,0.00012877512,0.00080063863,0.0004726224,0.0002995828,0.0009372527,0.00064256234,0.00015446621,0.0009022884,0.035472006],"study_design_scores_gemma":[0.00008876326,0.0022239748,0.99480623,0.00004792846,0.0005127584,0.00052961154,0.000344825,0.00032509616,0.00019347211,0.00023106782,0.0006696066,0.000026702777],"about_ca_topic_score_codex":0.0023252864,"about_ca_topic_score_gemma":0.005260485,"teacher_disagreement_score":0.002424558,"about_ca_system_score_codex":0.0009077892,"about_ca_system_score_gemma":0.00046077848,"threshold_uncertainty_score":0.008111},"labels":[],"label_agreement":null},{"id":"W2004563844","doi":"10.1016/j.urolonc.2014.06.017","title":"Considerations on the use of urine markers in the management of patients with high-grade non–muscle-invasive bladder cancer","year":2014,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Bladder cancer; Medicine; Context (archaeology); Disease; Intensive care medicine; Cancer; Oncology; Internal medicine; Biology","score_opus":0.06858611587628025,"score_gpt":0.33241921388961726,"score_spread":0.263833098013337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004563844","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003977696,0.99884534,0.000041085474,0.0007355441,0.000134613,0.000001999256,0.000006516109,0.0000017842035,0.0001933492],"genre_scores_gemma":[0.0007124509,0.9980769,0.00019413616,0.0006898614,0.00023266254,0.000004563377,0.000014249602,6.6777466e-7,0.00007447832],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99886024,0.00039904096,0.00027241648,0.00010582583,0.0003139564,0.00004850418],"domain_scores_gemma":[0.996543,0.0023581127,0.0004023351,0.000036352994,0.0005827317,0.00007742852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027135746,0.0006639036,0.0027229723,0.0021990424,0.00032271113,0.0015889254,0.0015359113,0.0018515122,0.001665786],"category_scores_gemma":[0.005497071,0.00034383603,0.001348639,0.0018772358,0.000718588,0.0016594732,0.000703955,0.0029323085,0.0005849506],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015305015,0.000049515307,0.00079180347,0.039336186,0.00039169856,0.00037316515,0.00009678092,0.00031810248,0.0004757245,0.0023014783,0.03171302,0.92399937],"study_design_scores_gemma":[0.00013349394,0.00021177932,0.0049073375,0.099496014,0.0016704999,0.0035165837,0.00037409214,0.00033414073,0.00046057452,0.003971671,0.8848372,0.000086518834],"about_ca_topic_score_codex":0.0035105492,"about_ca_topic_score_gemma":0.009134943,"teacher_disagreement_score":0.0035105492,"about_ca_system_score_codex":0.000984211,"about_ca_system_score_gemma":0.0026151042,"threshold_uncertainty_score":0.014350951},"labels":[],"label_agreement":null},{"id":"W2007156943","doi":"10.1016/j.urolonc.2005.06.020","title":"Rationale for zoledronic acid therapy in men with hormone-sensitive prostate cancer with or without bone metastasis","year":2006,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bone health and treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Zoledronic acid; Medicine; Prostate cancer; Androgen deprivation therapy; Bone resorption; Bone metastasis; Oncology; Internal medicine; Bone disease; Cancer; Osteoporosis; Bone pain; Bone Density Conservation Agents; Osteoclast; Prostate; Bone mineral","score_opus":0.06848350571724603,"score_gpt":0.3856802598070544,"score_spread":0.31719675408980835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007156943","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015032735,0.9977119,0.00009817257,0.0010624349,0.00023322157,0.000012934313,0.00003602197,0.0000068752147,0.0006880193],"genre_scores_gemma":[0.002817226,0.992831,0.0006049873,0.0025390787,0.00040173848,0.0000338507,0.00007747844,0.00000284468,0.00069176743],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995883,0.00010207371,0.00010323714,0.000086845226,0.00009458767,0.000024938587],"domain_scores_gemma":[0.9995664,0.00024068706,0.00010256228,0.000009800846,0.00006120677,0.000019309107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011454353,0.00073860027,0.0028394784,0.0016692136,0.00030656325,0.0011166082,0.0015590013,0.0017622682,0.0034747284],"category_scores_gemma":[0.0014156819,0.00047933377,0.0011411889,0.0014514392,0.00073763874,0.0008231269,0.00046793764,0.0028871202,0.0013416806],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010320175,0.00012598773,0.0006113423,0.056672316,0.00061676087,0.0008586861,0.00007798926,0.0007287686,0.0027652837,0.0075997203,0.046327263,0.8825838],"study_design_scores_gemma":[0.002134253,0.00069972646,0.0040632016,0.029659985,0.0023158889,0.005344514,0.000097182834,0.0003956431,0.001300885,0.004191536,0.94970745,0.000089700814],"about_ca_topic_score_codex":0.0019340005,"about_ca_topic_score_gemma":0.0059231324,"teacher_disagreement_score":0.0034747284,"about_ca_system_score_codex":0.0013570582,"about_ca_system_score_gemma":0.0019004416,"threshold_uncertainty_score":0.011624157},"labels":[],"label_agreement":null},{"id":"W2009034973","doi":"10.1016/j.urolonc.2008.07.025","title":"The continued debate: Intermittent vs. continuous hormonal ablation for metastatic prostate cancer","year":2008,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Prostate cancer; Context (archaeology); Hormonal therapy; Prostate; Oncology; Androgen; Internal medicine; Androgen suppression; Cancer; Urology; Hormone","score_opus":0.04781095889643217,"score_gpt":0.3494929811726663,"score_spread":0.30168202227623414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009034973","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029346661,0.059473723,0.0005077324,0.91467917,0.01772133,0.000012174256,0.0001271913,0.000014860678,0.0045291577],"genre_scores_gemma":[0.08428174,0.045272272,0.0014741282,0.6932036,0.17233247,0.000082874656,0.00019163011,0.00012222584,0.0030389824],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9818472,0.010302484,0.0018051295,0.0018547537,0.003460295,0.0007300981],"domain_scores_gemma":[0.8739102,0.10551622,0.004398476,0.0033062033,0.008603121,0.0042657093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.057501778,0.0005144341,0.0024301163,0.0014339684,0.0026893879,0.006923649,0.0041937185,0.01791194,0.013437974],"category_scores_gemma":[0.109786764,0.00046226548,0.0021015692,0.0022949916,0.014876843,0.013216688,0.0026978257,0.027716152,0.0025031238],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006422631,0.00029183112,0.0034474651,0.0037140402,0.00065506325,0.00033681904,0.0013448283,0.00048889715,0.0014268804,0.13731545,0.31210625,0.5324498],"study_design_scores_gemma":[0.003644903,0.0012549899,0.010114611,0.008778078,0.0011803838,0.00092156,0.004667338,0.00083240523,0.0012393863,0.20856589,0.7585446,0.00025578303],"about_ca_topic_score_codex":0.0027314853,"about_ca_topic_score_gemma":0.005505307,"teacher_disagreement_score":0.057501778,"about_ca_system_score_codex":0.0053663165,"about_ca_system_score_gemma":0.0055412706,"threshold_uncertainty_score":0.30410212},"labels":[],"label_agreement":null},{"id":"W2011804899","doi":"10.1016/j.urolonc.2007.05.002","title":"Difficult decisions in urologic oncology: Management of high-grade T1 transitional cell carcinoma of the bladder","year":2007,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Cystectomy; Medicine; Urothelium; Bladder cancer; Transitional cell carcinoma; Urology; Urothelial carcinoma; Oncology; Carcinoma in situ; Carcinoma; Internal medicine; General surgery; Cancer; Urinary bladder","score_opus":0.06669640328523355,"score_gpt":0.3575625180258078,"score_spread":0.2908661147405742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011804899","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000078485406,0.9988932,0.00008477923,0.00041814474,0.00017541987,0.0000026531982,0.000004530513,0.0000028005802,0.00034000908],"genre_scores_gemma":[0.0008811935,0.998092,0.0002134976,0.00036625698,0.0002996948,0.0000028616034,0.000012900184,6.6988133e-7,0.00013087291],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994778,0.00017452108,0.00007151989,0.00006193126,0.00018712685,0.000027085869],"domain_scores_gemma":[0.9982822,0.0010949078,0.0002555,0.000021811502,0.00026647167,0.00007912303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011336667,0.0008171732,0.0019199016,0.0021165865,0.00033968856,0.0011963198,0.0014278146,0.001467704,0.0019901206],"category_scores_gemma":[0.0029727702,0.00031988326,0.0005750136,0.0026633535,0.00076383405,0.0016259915,0.00067288487,0.001820599,0.0007470865],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046245503,0.00005033233,0.00049436215,0.019153543,0.00015394278,0.00042036135,0.00007979069,0.00047530222,0.00026842512,0.0010308754,0.045133732,0.93269306],"study_design_scores_gemma":[0.00009021298,0.0001804226,0.00642637,0.039722875,0.0006513485,0.010363576,0.00053740275,0.0004779905,0.00034860166,0.004612313,0.93649894,0.00008984645],"about_ca_topic_score_codex":0.0025516879,"about_ca_topic_score_gemma":0.0073848646,"teacher_disagreement_score":0.0025516879,"about_ca_system_score_codex":0.0010270273,"about_ca_system_score_gemma":0.0017442727,"threshold_uncertainty_score":0.0074516535},"labels":[],"label_agreement":null},{"id":"W2013573526","doi":"10.1016/j.urolonc.2013.10.016","title":"Effect of body mass index on the outcomes of patients with upper and lower urinary tract cancers treated by radical surgery: Results from a Canadian multicenter collaboration","year":2014,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; University of British Columbia; McMaster University; University of Ottawa; Université de Montréal; Université Laval; University of Alberta; Dalhousie University; Western University; McGill University","funders":"","keywords":"Medicine; Cystectomy; Body mass index; Urology; Multivariate analysis; Internal medicine; Stage (stratigraphy); Bladder cancer; Urinary system; Radical surgery; Gastroenterology; Surgery; Cancer","score_opus":0.008405531065648298,"score_gpt":0.2640104945111685,"score_spread":0.2556049634455202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013573526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98917514,0.002246362,0.00005071095,0.0005379639,0.000039056024,0.0000768719,0.006185593,0.0000064097526,0.001681992],"genre_scores_gemma":[0.9920704,0.0013000576,0.00014964135,0.00025436384,0.00004886902,0.00004831212,0.0056394567,0.000008744837,0.00048011896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99574834,0.00086660567,0.00027121868,0.0006823455,0.0013351301,0.0010962923],"domain_scores_gemma":[0.98751706,0.0013120965,0.0033410753,0.00051440677,0.00469266,0.0026227778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046087606,0.0008776058,0.0013508513,0.0017356665,0.002632247,0.0016484272,0.0025464708,0.0011003902,0.001503026],"category_scores_gemma":[0.010363334,0.00051833753,0.0023234,0.0058520157,0.0011329898,0.000619407,0.0016932783,0.0014354207,0.00015601865],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013709209,0.00012838816,0.99236625,0.000068324174,0.00087912264,0.000026007825,0.0004025909,0.0001284004,0.00010145593,0.0000585735,0.0015556293,0.002914318],"study_design_scores_gemma":[0.00011063509,0.000091496055,0.99858177,0.000028189288,0.0002656905,0.000018651948,0.00040861254,0.00006773851,0.000023622946,0.000010451605,0.00037486095,0.000018262077],"about_ca_topic_score_codex":0.957371,"about_ca_topic_score_gemma":0.97165054,"teacher_disagreement_score":0.042629004,"about_ca_system_score_codex":0.021709098,"about_ca_system_score_gemma":0.033671405,"threshold_uncertainty_score":0.1575113},"labels":[],"label_agreement":null},{"id":"W2014639327","doi":"10.1016/j.urolonc.2005.07.002","title":"Active surveillance with selective delayed intervention for favorable risk prostate cancer","year":2006,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Prostate cancer; Medicine; Prostate; Biopsy; Cancer; Prostate-specific antigen; Prostate biopsy; Oncology; Urology; Internal medicine; Epidemiology; Gynecology","score_opus":0.013695895406474964,"score_gpt":0.301791084582314,"score_spread":0.28809518917583904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014639327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95661646,0.008926745,0.013915798,0.00207079,0.00066613284,0.00030328805,0.00027032092,0.0003586786,0.016871735],"genre_scores_gemma":[0.9941725,0.0010241535,0.0025532714,0.00035580242,0.00046294305,0.00004550463,0.0001283912,0.000017338845,0.001240134],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99981195,0.000042062966,0.000014540677,0.000045681998,0.00003192124,0.00005387642],"domain_scores_gemma":[0.999574,0.00015728669,0.000048060436,0.00006094001,0.00002592901,0.00013379246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042435355,0.00033817347,0.0005551079,0.0007969311,0.0005491975,0.00038285978,0.0005467432,0.0003539955,0.003611139],"category_scores_gemma":[0.001399691,0.00017314233,0.00044124367,0.00036473083,0.0003394995,0.00047598203,0.00048069505,0.00091920065,0.00025713316],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034344353,0.005173848,0.11516512,0.0006886139,0.00027602434,0.004840721,0.000260986,0.004038948,0.025952967,0.0019732234,0.0063280356,0.8009571],"study_design_scores_gemma":[0.008267869,0.081886046,0.673741,0.0005742419,0.002154233,0.070537776,0.0008469625,0.027760468,0.06629644,0.014647777,0.053072367,0.00021484891],"about_ca_topic_score_codex":0.0008519718,"about_ca_topic_score_gemma":0.0016052992,"teacher_disagreement_score":0.003611139,"about_ca_system_score_codex":0.00026895708,"about_ca_system_score_gemma":0.0007554535,"threshold_uncertainty_score":0.012080491},"labels":[],"label_agreement":null},{"id":"W2015628101","doi":"10.1016/j.urolonc.2013.09.004","title":"Optimal timing of early versus delayed adjuvant radiotherapy following radical prostatectomy for locally advanced prostate cancer","year":2013,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Radiation therapy; Propensity score matching; Urology; Salvage therapy; Hormonal therapy; Hazard ratio; Androgen deprivation therapy; Internal medicine; Adjuvant; Disease; Oncology; Cancer; Chemotherapy","score_opus":0.02822471839440619,"score_gpt":0.3353482718097515,"score_spread":0.3071235534153453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015628101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95148355,0.029953133,0.00672181,0.0020043547,0.0019050004,0.0002077561,0.0002845805,0.0001701906,0.007269659],"genre_scores_gemma":[0.9926219,0.0023962096,0.003593723,0.0002935935,0.00045032913,0.00005087916,0.00010106107,0.000033368608,0.00045896875],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99936885,0.00023939245,0.000088340945,0.00008102192,0.000118700824,0.00010369851],"domain_scores_gemma":[0.99770606,0.0011134673,0.00049886195,0.00008427277,0.0001732428,0.0004240474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013520689,0.00034224728,0.00092659885,0.0005813598,0.00029627074,0.00077553914,0.00050032826,0.00048713546,0.0025572646],"category_scores_gemma":[0.00713903,0.00031189478,0.00051350816,0.00043437415,0.00025083066,0.00074621453,0.00032999823,0.0009966538,0.00036101538],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10726045,0.0051257764,0.20180394,0.0016972856,0.0006016702,0.0012579261,0.00044193782,0.017130006,0.048163068,0.0017878037,0.0058796774,0.6088506],"study_design_scores_gemma":[0.005047898,0.09324653,0.7982884,0.0016013692,0.0028575372,0.0058315806,0.001354227,0.015672265,0.04355989,0.0043500243,0.027938409,0.00025172552],"about_ca_topic_score_codex":0.001286189,"about_ca_topic_score_gemma":0.0032436734,"teacher_disagreement_score":0.0025572646,"about_ca_system_score_codex":0.0007332357,"about_ca_system_score_gemma":0.0015181112,"threshold_uncertainty_score":0.008554935},"labels":[],"label_agreement":null},{"id":"W2016634577","doi":"10.1016/j.urolonc.2006.03.007","title":"Quality of life 2 years after salvage cryosurgery for the treatment of local recurrence of prostate cancer after radiotherapy","year":2006,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Island University; Alberta Health Services; University of Calgary; Alberta Cancer Foundation","funders":"","keywords":"Cryosurgery; Medicine; Quality of life (healthcare); Prostate cancer; Radiation therapy; Salvage therapy; Sexual function; Urinary system; Cancer; Surgery; Internal medicine; Chemotherapy; Nursing","score_opus":0.03208414961695142,"score_gpt":0.33875512580087136,"score_spread":0.3066709761839199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016634577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975284,0.0008364532,0.00010316065,0.00018265645,0.000048874896,0.000023710956,0.00046693475,0.000006861323,0.00080307055],"genre_scores_gemma":[0.99891937,0.00012366725,0.00004275807,0.00005155174,0.000022877384,0.000011044469,0.00049440935,0.0000013040755,0.0003330785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99950504,0.00015287941,0.000031554162,0.000057729292,0.00006343625,0.00018932697],"domain_scores_gemma":[0.9986009,0.00023947464,0.00045794045,0.000055118682,0.0001479774,0.0004985809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010208499,0.00043946636,0.00086023647,0.0006397049,0.00053510536,0.0006454502,0.0004629267,0.00075771887,0.0018152999],"category_scores_gemma":[0.0025497868,0.00013263723,0.0022339956,0.00052282674,0.00039349624,0.00065284735,0.00055425137,0.0010528272,0.00020836052],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02096996,0.0034226477,0.92557657,0.00018675718,0.0020282967,0.002137445,0.0008625914,0.00459642,0.0015213421,0.00017512786,0.0016338547,0.036888946],"study_design_scores_gemma":[0.00032644146,0.009103582,0.98696405,0.00002087567,0.00042741484,0.00075313775,0.0002596948,0.0011472146,0.00029146107,0.00011055242,0.00054106,0.000054503394],"about_ca_topic_score_codex":0.005595057,"about_ca_topic_score_gemma":0.0068468926,"teacher_disagreement_score":0.005595057,"about_ca_system_score_codex":0.0010449513,"about_ca_system_score_gemma":0.00047785885,"threshold_uncertainty_score":0.0111249685},"labels":[],"label_agreement":null},{"id":"W2019419180","doi":"10.1016/j.urolonc.2007.11.032","title":"Sexual intimacy in heterosexual couples after prostate cancer treatment: What we know and what we still need to learn","year":2008,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Prostate cancer; Psychosocial; Psychology; Stressor; Clinical psychology; Cancer; Medicine; Psychotherapist","score_opus":0.07678858244670908,"score_gpt":0.3765020665879972,"score_spread":0.29971348414128807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019419180","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008654669,0.99964297,0.000006312209,0.00013860094,0.00004588756,0.0000010816067,0.0000063351736,5.16652e-7,0.000071841816],"genre_scores_gemma":[0.00083708117,0.9988986,0.000034815388,0.00012378763,0.000050946146,0.000002525908,0.000006429773,2.6097987e-7,0.000045502413],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993642,0.00023607607,0.00011880662,0.000085459586,0.00015697331,0.000038500155],"domain_scores_gemma":[0.9974179,0.0019981086,0.00028453022,0.000031911386,0.00020052622,0.000067070825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019191873,0.0007046161,0.0041554486,0.0019963575,0.00046091844,0.002268444,0.0010142748,0.0017449304,0.002338472],"category_scores_gemma":[0.00385813,0.00037745183,0.0010742269,0.00324786,0.000943483,0.0018382759,0.0007154751,0.0014126397,0.00031726764],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017945204,0.000055685625,0.0019198178,0.086590335,0.0006738803,0.0003443822,0.00024441976,0.0001203631,0.00016269123,0.0007786312,0.014155351,0.8947751],"study_design_scores_gemma":[0.00023627622,0.00050950726,0.035522882,0.23650979,0.006610918,0.0070665604,0.0031696032,0.00026955863,0.00040599832,0.0026693854,0.7068374,0.00019209486],"about_ca_topic_score_codex":0.0071428292,"about_ca_topic_score_gemma":0.017865807,"teacher_disagreement_score":0.0071428292,"about_ca_system_score_codex":0.000941917,"about_ca_system_score_gemma":0.0030379202,"threshold_uncertainty_score":0.014202535},"labels":[],"label_agreement":null},{"id":"W2019758549","doi":"10.1016/j.urolonc.2013.06.001","title":"Urine markers for detection and surveillance of bladder cancer","year":2013,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cystoscopy; Urine cytology; Bladder cancer; Medicine; Cytology; Urinary system; Urine; Cancer; Urothelial carcinoma; Biomarker; Oncology; Carcinoma; Urology; Internal medicine; Pathology","score_opus":0.05582923249804399,"score_gpt":0.3699685646288457,"score_spread":0.3141393321308017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019758549","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000038204278,0.9996612,0.000034600118,0.00007653272,0.00005055114,0.0000023804737,0.000010816064,0.0000018446909,0.00012379687],"genre_scores_gemma":[0.0006215924,0.99893767,0.000113080394,0.00012270208,0.00008511045,0.0000036217555,0.000021501382,5.3956455e-7,0.00009417212],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994475,0.00012478385,0.00011018272,0.000098274446,0.00018651079,0.000032686356],"domain_scores_gemma":[0.9986467,0.0008189373,0.00023643314,0.00002617432,0.00023470599,0.00003706897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013417643,0.0010482661,0.0026373484,0.0036012738,0.00020231956,0.0009933643,0.0015415663,0.0011783509,0.0025330358],"category_scores_gemma":[0.0027496337,0.0005185048,0.001315314,0.0024293293,0.00065726804,0.0012420162,0.0007307171,0.0015474124,0.0010050031],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000088374545,0.000055595432,0.0006486442,0.039654866,0.00040627175,0.00015414589,0.000039087747,0.0002522269,0.00046821698,0.000995842,0.016344648,0.94089216],"study_design_scores_gemma":[0.00014910939,0.00036996903,0.007683312,0.047362473,0.0029180076,0.0034975177,0.00021758776,0.0003890951,0.0011423933,0.0028407553,0.93330586,0.00012390414],"about_ca_topic_score_codex":0.0030765599,"about_ca_topic_score_gemma":0.0055254535,"teacher_disagreement_score":0.0036012738,"about_ca_system_score_codex":0.0006505564,"about_ca_system_score_gemma":0.0015485237,"threshold_uncertainty_score":0.008473873},"labels":[],"label_agreement":null},{"id":"W2022935697","doi":"10.1016/j.urolonc.2006.12.019","title":"Can digital rectal examination or transrectal ultrasonography biopsy findings predict the side of nodal metastasis in prostate cancer?","year":2007,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Transrectal ultrasonography; Rectal examination; Prostate cancer; Metastasis; Biopsy; Radiology; Stage (stratigraphy); Lymph node; Prostate; Colorectal cancer; Cancer; Internal medicine","score_opus":0.024434583451715272,"score_gpt":0.30412377649688294,"score_spread":0.27968919304516765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022935697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98410404,0.008338353,0.00042347662,0.0018444831,0.00026580715,0.000013682037,0.00019821383,0.000020632344,0.0047913482],"genre_scores_gemma":[0.99609405,0.0023415587,0.0003364437,0.0002813662,0.00042354967,0.0000037599966,0.00016909646,0.0000056216777,0.0003445474],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99945205,0.0002398912,0.000054705415,0.0000470969,0.0001004387,0.00010584117],"domain_scores_gemma":[0.9956138,0.00256352,0.0005931557,0.00019663037,0.00044388018,0.00058894476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016714886,0.00070464466,0.0010764155,0.0015852088,0.00037236675,0.0011879434,0.0010536496,0.0019224361,0.0028281799],"category_scores_gemma":[0.013498873,0.00048632495,0.000867864,0.001295293,0.0009308547,0.0017381898,0.0004127271,0.0013431106,0.00090724573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048809338,0.000070491966,0.9882621,0.000038340222,0.000094347655,0.0006984991,0.000032240256,0.00014662756,0.00043917558,0.000028961866,0.00033363447,0.009367355],"study_design_scores_gemma":[0.000040217303,0.00055996893,0.990737,0.000070005364,0.000314201,0.004698623,0.00036328472,0.0016550212,0.0005099767,0.00031511323,0.0007114479,0.000025086565],"about_ca_topic_score_codex":0.0018568541,"about_ca_topic_score_gemma":0.0044856435,"teacher_disagreement_score":0.0028281799,"about_ca_system_score_codex":0.00026374552,"about_ca_system_score_gemma":0.0005246714,"threshold_uncertainty_score":0.009461224},"labels":[],"label_agreement":null},{"id":"W2026954814","doi":"10.1016/j.urolonc.2014.08.011","title":"Validation of tertiary Gleason pattern 5 in Gleason score 7 prostate cancer as an independent predictor of biochemical recurrence and development of a prognostic model","year":2014,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Biochemical recurrence; Prostatectomy; Prostate cancer; Medicine; breakpoint cluster region; Pathological; Oncology; Proportional hazards model; Nomogram; Internal medicine; Surgical margin; Adjuvant; Prostate-specific antigen; Adjuvant therapy; Clinical endpoint; Urology; Cancer; Clinical trial","score_opus":0.030918990698246076,"score_gpt":0.31108009250497615,"score_spread":0.2801611018067301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026954814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856281,0.00025673967,0.011634454,0.00032331492,0.000096678166,0.00013724997,0.00094411295,0.00011854219,0.00086081953],"genre_scores_gemma":[0.9944108,0.000077018245,0.003787793,0.000027881022,0.000037029855,0.000050141447,0.0012635172,0.000015088164,0.00033068433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982967,0.0008308525,0.00016558755,0.00025122074,0.00024775558,0.0002079244],"domain_scores_gemma":[0.9930688,0.0043542944,0.0005310889,0.00052943884,0.0011034874,0.0004129677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0099325115,0.0012084323,0.0007652653,0.0021550972,0.00067733234,0.0018444159,0.0014511592,0.0008109114,0.0020085168],"category_scores_gemma":[0.010646377,0.00039256198,0.001546376,0.0010011155,0.00048275955,0.0007520062,0.0011000774,0.0013617668,0.0007238059],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010149977,0.00042330247,0.9735531,0.000029322186,0.00048219744,0.00009250119,0.00008532782,0.008812916,0.0009412976,0.0001615012,0.0007941957,0.013609327],"study_design_scores_gemma":[0.00026916855,0.0016830699,0.4960656,0.00008395438,0.0015224728,0.0006084971,0.00039200246,0.49253315,0.0035776836,0.0013680881,0.0018288832,0.000067449524],"about_ca_topic_score_codex":0.005548236,"about_ca_topic_score_gemma":0.0055400487,"teacher_disagreement_score":0.0099325115,"about_ca_system_score_codex":0.00055956026,"about_ca_system_score_gemma":0.0026774728,"threshold_uncertainty_score":0.0525288},"labels":[],"label_agreement":null},{"id":"W2027127879","doi":"10.1016/j.urolonc.2008.03.003","title":"What is the best approach for screen-detected low volume cancers?—The case for observation","year":2008,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Prostatectomy; Medicine; Prostate cancer; Conservative management; Clinical trial; Prostate; Watchful waiting; Cancer; Intervention (counseling); Oncology; Internal medicine; Intensive care medicine; Gynecology; Surgery","score_opus":0.10674157785412987,"score_gpt":0.36511669752066983,"score_spread":0.25837511966654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027127879","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014105228,0.9931712,0.00027001227,0.005439565,0.00046764346,0.000003506015,0.000014752289,0.0000074864415,0.00048479284],"genre_scores_gemma":[0.0020450633,0.9927045,0.0006749391,0.0031354602,0.001208986,0.0000072728953,0.000021099662,0.0000038626645,0.00019889174],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993038,0.00022532631,0.00012865536,0.00011714684,0.00018355691,0.00004151539],"domain_scores_gemma":[0.99763906,0.0016696611,0.00021011388,0.000066184664,0.00033912426,0.00007574321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002316315,0.00066162716,0.0038071536,0.0014073638,0.00044782826,0.0016245618,0.0019017082,0.002253796,0.0016396341],"category_scores_gemma":[0.004877604,0.00039036974,0.0013181731,0.0014459415,0.0015548333,0.0040293518,0.00069453614,0.0045405347,0.0009681424],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016342549,0.00005931604,0.0014018498,0.020658808,0.00036513733,0.0008471055,0.00015183327,0.00042249056,0.00043690484,0.004688253,0.052562356,0.9182425],"study_design_scores_gemma":[0.00023075288,0.00029168784,0.008217122,0.069338776,0.0011558923,0.012889692,0.0009379641,0.00055987056,0.00048412808,0.018571548,0.88717145,0.00015104077],"about_ca_topic_score_codex":0.0033785498,"about_ca_topic_score_gemma":0.007017974,"teacher_disagreement_score":0.0038071536,"about_ca_system_score_codex":0.0012286825,"about_ca_system_score_gemma":0.0017197194,"threshold_uncertainty_score":0.012249947},"labels":[],"label_agreement":null},{"id":"W2029690180","doi":"10.1016/j.urolonc.2005.05.020","title":"Renal radiofrequency ablation: Technique and results","year":2005,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Percutaneous; Radiofrequency ablation; Medicine; Ablation; Radiology; Surgery; Internal medicine","score_opus":0.03225267443313697,"score_gpt":0.302567953491929,"score_spread":0.27031527905879205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029690180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6757258,0.13656773,0.15493464,0.0012815587,0.00074045453,0.00065415486,0.0021844232,0.0022573315,0.02565393],"genre_scores_gemma":[0.852144,0.040120695,0.09258517,0.0011382806,0.0016820899,0.0003202445,0.0012994441,0.0021389464,0.00857114],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.996011,0.0016666026,0.0005088981,0.0007745397,0.00078943063,0.00024950513],"domain_scores_gemma":[0.9925282,0.004699347,0.0005479183,0.0015433028,0.00045652763,0.0002248101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007056037,0.001476045,0.0017533012,0.0032162748,0.00061153463,0.001060846,0.0016395366,0.0014418048,0.002961826],"category_scores_gemma":[0.006328184,0.0008070751,0.0018603225,0.001912024,0.0016318463,0.002079651,0.00060296524,0.0020523963,0.0017529791],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018334916,0.0042062597,0.054556984,0.0031547868,0.0026661705,0.0025756822,0.0021112477,0.007029765,0.15515435,0.0013021578,0.003240834,0.74566674],"study_design_scores_gemma":[0.004051451,0.027887106,0.5219222,0.0008571962,0.008477148,0.11638923,0.0009959271,0.012403661,0.2366234,0.004013491,0.06478484,0.0015943125],"about_ca_topic_score_codex":0.001243853,"about_ca_topic_score_gemma":0.0012832792,"teacher_disagreement_score":0.007056037,"about_ca_system_score_codex":0.0007496657,"about_ca_system_score_gemma":0.00051287934,"threshold_uncertainty_score":0.037316382},"labels":[],"label_agreement":null},{"id":"W2032579945","doi":"10.1016/j.urolonc.2009.06.018","title":"BCAN Think Tank session 3: Prevention of bladder cancer","year":2010,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute","keywords":"Medicine; Bladder cancer; Cancer prevention; Cancer; Smoking cessation; Disease; Oncology; Clinical trial; Intensive care medicine; Internal medicine; Pathology","score_opus":0.030077364267431204,"score_gpt":0.35255365909833025,"score_spread":0.32247629483089907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032579945","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0055076634,0.012032374,0.0034203522,0.6009989,0.23850591,0.0017562719,0.002295857,0.00045292382,0.13502978],"genre_scores_gemma":[0.037252445,0.009822691,0.0068094255,0.20741619,0.13358471,0.001982257,0.002478172,0.0003773336,0.6002768],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984451,0.00044460196,0.00007844196,0.00021312652,0.00042578485,0.00039300532],"domain_scores_gemma":[0.9921875,0.0013408588,0.00034591046,0.0001520203,0.0019310906,0.004042538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058530564,0.00093417946,0.00079548004,0.00094271346,0.002740693,0.0018057646,0.0014849105,0.010283311,0.1585261],"category_scores_gemma":[0.006863401,0.00039393498,0.0012761962,0.00034633267,0.000430404,0.0011641007,0.002372869,0.007952547,0.023870846],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041644057,0.0003504167,0.00037791423,0.00030991124,0.000019550283,0.00014458975,0.000076474666,0.00006342597,0.00067256554,0.00037752683,0.9673024,0.029888844],"study_design_scores_gemma":[0.00038911277,0.0003832371,0.006251528,0.00048097954,0.000059324208,0.0002324558,0.00032700962,0.00018183027,0.0009575867,0.0021427795,0.98856026,0.000033948294],"about_ca_topic_score_codex":0.004432959,"about_ca_topic_score_gemma":0.0146941785,"teacher_disagreement_score":0.1585261,"about_ca_system_score_codex":0.0028842553,"about_ca_system_score_gemma":0.0073933634,"threshold_uncertainty_score":0.5303226},"labels":[],"label_agreement":null},{"id":"W2033402770","doi":"10.1016/j.urolonc.2014.05.012","title":"Patterns of referral for perioperative chemotherapy among patients with muscle-invasive bladder cancer: A population-based study","year":2014,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Cancer Care Ontario","keywords":"Medicine; Cystectomy; Bladder cancer; Referral; Chemotherapy; Cancer; Cancer registry; Perioperative; Population; Internal medicine; General surgery; Oncology; Surgery; Family medicine","score_opus":0.02195259523182697,"score_gpt":0.3102125310334676,"score_spread":0.2882599358016406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033402770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993199,0.00010557548,0.00004296258,0.000045238958,0.0000033576587,0.000007993547,0.00019141145,0.0000022380827,0.00028141274],"genre_scores_gemma":[0.9995641,0.00007910128,0.00003813832,0.000039283386,0.0000056650697,0.000008192285,0.00018489746,0.000002048628,0.000078478],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906474,0.00022522858,0.00014380302,0.00026622645,0.00013412099,0.00016593207],"domain_scores_gemma":[0.998135,0.00032573318,0.00082109147,0.00011555842,0.00019402694,0.00040851752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005652256,0.00031782922,0.0005972898,0.0013853697,0.00088116986,0.0011411264,0.0006524996,0.0010603514,0.0020978325],"category_scores_gemma":[0.002449564,0.00066499365,0.00078790163,0.0024851712,0.0005827073,0.0014338264,0.00084833463,0.0008708565,0.00032031964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000380484,0.000048823626,0.999358,0.000004105682,0.000037073198,0.00004369978,0.0001068862,0.0000113426195,0.000083545594,0.0000063093325,0.000032691813,0.00022956783],"study_design_scores_gemma":[0.0000048206693,0.00008851365,0.9985952,0.000004196354,0.000021544374,0.00023409125,0.0008752487,0.00008883229,0.000017002709,0.000011867167,0.000053233565,0.000005521061],"about_ca_topic_score_codex":0.010183165,"about_ca_topic_score_gemma":0.012260761,"teacher_disagreement_score":0.010183165,"about_ca_system_score_codex":0.00066806306,"about_ca_system_score_gemma":0.0005562768,"threshold_uncertainty_score":0.020247757},"labels":[],"label_agreement":null},{"id":"W2035993858","doi":"10.1016/j.urolonc.2011.07.014","title":"Age ≥ 80 years is independently associated with survival outcomes after radical cystectomy: Results from the Canadian Bladder Cancer Network Database","year":2011,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; University of Winnipeg; Dalhousie University; Université de Montréal; University of Alberta; Université Laval; Western University; McGill University","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Lymphovascular invasion; Proportional hazards model; Urinary diversion; Logistic regression; Internal medicine; Stage (stratigraphy); Multivariate analysis; Cancer; Database; Oncology; Urology; Metastasis","score_opus":0.05213891928180047,"score_gpt":0.30125694764124605,"score_spread":0.24911802835944558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035993858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9165059,0.003451671,0.00010502399,0.0012186302,0.00007097217,0.00007083869,0.07353362,0.000032338114,0.0050109187],"genre_scores_gemma":[0.9737405,0.0017853541,0.00019094114,0.0003190699,0.000046443987,0.000051099985,0.022873301,0.000012231128,0.0009809427],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987785,0.00009498089,0.000113139286,0.0002342908,0.00040701622,0.00037214762],"domain_scores_gemma":[0.99597305,0.0003488911,0.0011865301,0.00018518037,0.0015170004,0.0007892725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087164633,0.00057807745,0.00095078524,0.0027194072,0.001782977,0.001263634,0.0017834319,0.0009231441,0.003553564],"category_scores_gemma":[0.0046229116,0.0004835941,0.0016858854,0.007997186,0.00048248278,0.00069065404,0.0012746875,0.0011323995,0.00029510845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012072627,0.000023097795,0.99414295,0.000057753772,0.00025458477,0.00003649971,0.00010920396,0.00010125851,0.000041589756,0.0000583439,0.0037835706,0.0012704898],"study_design_scores_gemma":[0.000014470417,0.0000069216144,0.9987752,0.00002478437,0.00010546108,0.00003054114,0.00017969926,0.00012895804,0.000010809166,0.00001750261,0.00069511647,0.0000106040525],"about_ca_topic_score_codex":0.97039896,"about_ca_topic_score_gemma":0.98413336,"teacher_disagreement_score":0.97039896,"about_ca_system_score_codex":0.009935682,"about_ca_system_score_gemma":0.01974506,"threshold_uncertainty_score":0.07208872},"labels":[],"label_agreement":null},{"id":"W2036181092","doi":"10.1016/j.urolonc.2013.04.014","title":"The evolving understanding of microRNA in bladder cancer","year":2013,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Cancer Institute; Bladder Cancer Advocacy Network","keywords":"microRNA; Bladder cancer; Urothelium; Biology; Cancer research; Cancer; Suppressor; Bioinformatics; Pathology; Oncology; Medicine; Gene; Endocrinology; Genetics; Urinary system","score_opus":0.06356522632950448,"score_gpt":0.3487460202491646,"score_spread":0.2851807939196601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036181092","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007694881,0.99749494,0.00028033144,0.0010961497,0.000564545,0.0000019316592,0.00000786467,0.000007420174,0.00046990198],"genre_scores_gemma":[0.00074394624,0.99678516,0.00035096385,0.0008102684,0.00095377443,0.0000058173755,0.000012745578,0.0000028065795,0.00033441046],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99961275,0.00009155708,0.0000555434,0.00006710223,0.00013740295,0.000035735473],"domain_scores_gemma":[0.99908996,0.00059310853,0.000078503705,0.000026216574,0.00014498236,0.000067247434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015622972,0.0010105637,0.00181419,0.0017589311,0.000379496,0.0016442758,0.0010503558,0.0024290888,0.002520935],"category_scores_gemma":[0.0019253734,0.0004160112,0.0005721306,0.0025132545,0.0019565364,0.0029369867,0.0014620201,0.003779255,0.0014434184],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014832706,0.00005109038,0.00028424407,0.010464093,0.00007780656,0.000511412,0.00011907065,0.0005033995,0.004855049,0.012257354,0.048205137,0.92252314],"study_design_scores_gemma":[0.000030158484,0.00006517818,0.00063416176,0.0024637806,0.00009408124,0.0015362062,0.000115902265,0.00023649156,0.0013449674,0.0067745377,0.98666954,0.00003497471],"about_ca_topic_score_codex":0.0009133083,"about_ca_topic_score_gemma":0.0015805982,"teacher_disagreement_score":0.002520935,"about_ca_system_score_codex":0.001254812,"about_ca_system_score_gemma":0.00203546,"threshold_uncertainty_score":0.0091043115},"labels":[],"label_agreement":null},{"id":"W2036447354","doi":"10.1016/j.urolonc.2009.07.026","title":"BCAN Think Tank session 2: Molecular detection of bladder cancer: The path to progress","year":2010,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Session (web analytics); Bladder cancer; Cancer; Medicine; Cancer detection; Oncology; Internal medicine; Intensive care medicine; Computer science; World Wide Web","score_opus":0.015796232377940974,"score_gpt":0.3214644424881337,"score_spread":0.30566821011019274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036447354","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00090180273,0.013549945,0.0023806195,0.7101754,0.2560155,0.00029834267,0.00064853614,0.00021528077,0.015814645],"genre_scores_gemma":[0.013687243,0.016485367,0.0077582896,0.38035962,0.38003227,0.00081420224,0.0014076325,0.00038072123,0.19907467],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99502486,0.0016179843,0.00024080688,0.00058698875,0.0016202811,0.0009091043],"domain_scores_gemma":[0.9724089,0.0057982947,0.001098319,0.00071644946,0.008211154,0.011766764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015844833,0.0015240258,0.0012864879,0.0017489984,0.003239273,0.005447203,0.0028099366,0.018776242,0.06980729],"category_scores_gemma":[0.01947654,0.0006809793,0.0018053203,0.00068939634,0.0015039989,0.004384076,0.004449104,0.01814486,0.019467795],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020648705,0.00006464491,0.00015751821,0.00015452811,0.000012452038,0.00009058857,0.000037442624,0.000051042498,0.0004287653,0.000594961,0.984467,0.013734622],"study_design_scores_gemma":[0.00017396218,0.00013570378,0.0013018702,0.00041754745,0.00003423017,0.00026223902,0.0003050928,0.00024081947,0.0006595496,0.004142965,0.9922822,0.000043720764],"about_ca_topic_score_codex":0.004535744,"about_ca_topic_score_gemma":0.011088901,"teacher_disagreement_score":0.06980729,"about_ca_system_score_codex":0.0051887087,"about_ca_system_score_gemma":0.012805687,"threshold_uncertainty_score":0.23352867},"labels":[],"label_agreement":null},{"id":"W2036602244","doi":"10.1016/j.urolonc.2014.07.009","title":"Radical trimodality therapy for patients with locally advanced bladder cancer: The British Columbia Cancer Agency experience","year":2015,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; Ottawa Hospital; University of Ottawa; BC Cancer Agency","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Cancer; Cystoscopy; Univariate analysis; Radiation therapy; Chemotherapy; Urology; Surgery; Oncology; Internal medicine; Multivariate analysis; Urinary system","score_opus":0.034465502855273396,"score_gpt":0.329311269825086,"score_spread":0.29484576696981263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036602244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9523801,0.0052025467,0.00026220627,0.005814222,0.0000974449,0.000083831736,0.00037786644,0.000016958887,0.035764765],"genre_scores_gemma":[0.98493004,0.005188786,0.0003681964,0.0014153271,0.00004812123,0.000024576302,0.00038300353,0.000025410469,0.0076165064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997373,0.000050603943,0.000009499227,0.000021372365,0.00008448252,0.000096613636],"domain_scores_gemma":[0.99926776,0.000085746695,0.000056488454,0.000021948566,0.000121026744,0.00044709427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041563937,0.00015750804,0.00014371357,0.00025326284,0.0017306752,0.0009534291,0.00046145407,0.00039634085,0.0030150483],"category_scores_gemma":[0.0011243643,0.00014151454,0.00012651486,0.00089454534,0.0005706558,0.00036317404,0.000855112,0.000863656,0.00027353852],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017755578,0.0014439252,0.58160454,0.0003493569,0.00013461923,0.013374115,0.010176626,0.0017569726,0.006019319,0.0019502612,0.055992395,0.3254223],"study_design_scores_gemma":[0.00024157671,0.00087962364,0.88851386,0.0002901089,0.00012309021,0.009881822,0.011936498,0.0009436092,0.0009162432,0.00050125225,0.08569699,0.00007538187],"about_ca_topic_score_codex":0.6303169,"about_ca_topic_score_gemma":0.9274435,"teacher_disagreement_score":0.6303169,"about_ca_system_score_codex":0.0066995053,"about_ca_system_score_gemma":0.010645011,"threshold_uncertainty_score":0.7437204},"labels":[],"label_agreement":null},{"id":"W2038860725","doi":"10.1016/j.urolonc.2012.03.013","title":"Risk factors for biochemical recurrence following radical perineal prostatectomy in a large contemporary series: A detailed assessment of margin extent and location","year":2012,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Biochemical recurrence; Prostatectomy; Urology; Stage (stratigraphy); Neck of urinary bladder; Prostate cancer; Proportional hazards model; Cohort; Incidence (geometry); Surgical margin; Surgery; Internal medicine; Cancer; Urinary bladder","score_opus":0.03441190584894665,"score_gpt":0.34318288516360806,"score_spread":0.3087709793146614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038860725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994916,0.0002468392,0.00004295603,0.000019740664,0.0000033141514,0.0000022072168,0.000033141405,0.0000020078908,0.00015811739],"genre_scores_gemma":[0.99968004,0.00011975012,0.000045225406,0.000013109057,0.000021507578,0.0000027706826,0.00006531298,0.0000022721674,0.000050093535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996983,0.00006184995,0.00003630486,0.00007141155,0.00007536135,0.000056848687],"domain_scores_gemma":[0.99883753,0.0003486559,0.0003590912,0.00014648937,0.0000779425,0.00023020817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037294938,0.00024101371,0.00043641843,0.0008506922,0.00057481136,0.0007478594,0.0005304787,0.00047077728,0.0013028999],"category_scores_gemma":[0.0021377373,0.0004446615,0.0004505438,0.00094477297,0.0005285436,0.00081383716,0.00064573385,0.00057923427,0.00018968395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077310746,0.000023881852,0.9977724,0.0000050599724,0.000025522473,0.0006652789,0.000111836234,0.000026050942,0.00024682292,0.000010292656,0.000045137167,0.0009904249],"study_design_scores_gemma":[0.0000037233222,0.00008142118,0.99574655,0.0000029237901,0.000028200062,0.0035296062,0.00032697592,0.00011526145,0.000050584207,0.000010767534,0.00009899204,0.0000049913674],"about_ca_topic_score_codex":0.0020178938,"about_ca_topic_score_gemma":0.0034112614,"teacher_disagreement_score":0.0020178938,"about_ca_system_score_codex":0.00025259895,"about_ca_system_score_gemma":0.00038465916,"threshold_uncertainty_score":0.0043586493},"labels":[],"label_agreement":null},{"id":"W2042355566","doi":"10.1016/j.urolonc.2011.10.004","title":"The Personal Patient Profile-Prostate decision support for men with localized prostate cancer: A multi-center randomized trial","year":2011,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":113,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"National Institute of Nursing Research","keywords":"Randomized controlled trial; Medicine; Confidence interval; Prostate cancer; Intervention (counseling); Physical therapy; Family medicine; Internal medicine; Nursing; Cancer","score_opus":0.1345377187558317,"score_gpt":0.4043565022400484,"score_spread":0.2698187834842167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042355566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99186605,0.0016489766,0.00077305146,0.0009484781,0.0005936485,0.0022805193,0.0007438529,0.00006530935,0.0010801435],"genre_scores_gemma":[0.991706,0.00081646984,0.0014284656,0.0008472723,0.0005318751,0.0027800694,0.00048631054,0.0000126146915,0.0013909051],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99773186,0.0015250583,0.00011636921,0.00034277784,0.00009503513,0.00018893629],"domain_scores_gemma":[0.99664485,0.0014741357,0.00068943354,0.00022732587,0.00010186013,0.00086245046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023544782,0.0019391617,0.0034753329,0.0004730323,0.00086133886,0.0015772029,0.00113605,0.002989264,0.011037097],"category_scores_gemma":[0.004501721,0.0010344253,0.0030803164,0.00056066853,0.0015251704,0.0019840903,0.0010789514,0.00420302,0.0007528232],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.991269,0.0035287892,0.0007707184,0.00019712606,0.0012297918,0.000014475231,0.000029140525,0.00015227128,0.00020976637,0.000053217107,0.0002064719,0.0023392115],"study_design_scores_gemma":[0.9628725,0.03308391,0.001961662,0.000022550033,0.0011962707,0.000011470296,0.000035275516,0.0004355793,0.00008150543,0.00012881681,0.00015547212,0.000014988163],"about_ca_topic_score_codex":0.0013114093,"about_ca_topic_score_gemma":0.00179635,"teacher_disagreement_score":0.011037097,"about_ca_system_score_codex":0.0007720326,"about_ca_system_score_gemma":0.0013303314,"threshold_uncertainty_score":0.036922812},"labels":[],"label_agreement":null},{"id":"W2044697402","doi":"10.1016/j.urolonc.2015.03.003","title":"Reprint of: Outcomes in patients with metastatic renal cell cancer treated with individualized sunitinib therapy: Correlation with dynamic microbubble ultrasound data and review of the literature","year":2015,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Sunitinib; Medicine; Toxicity; Internal medicine; Renal cell carcinoma; Oncology; Cancer; Urology","score_opus":0.03841444750015224,"score_gpt":0.30938739513532354,"score_spread":0.2709729476351713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044697402","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5833468,0.37447378,0.00094906153,0.0062736045,0.0011375451,0.00007256834,0.012768071,0.000091623595,0.020887006],"genre_scores_gemma":[0.9122587,0.077387206,0.0007201351,0.00075094216,0.0014917001,0.00003512183,0.005097118,0.000018601315,0.0022404906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998155,0.000038846192,0.00004002491,0.000025078354,0.000065885535,0.000014649114],"domain_scores_gemma":[0.9989298,0.0004217974,0.00044283015,0.000029078326,0.00012231393,0.000054115426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039160234,0.00011395655,0.0003743669,0.0014541169,0.00012218437,0.00041713976,0.00018851791,0.0002541147,0.0033552514],"category_scores_gemma":[0.00230857,0.00004347174,0.00029971832,0.00199834,0.00016432139,0.00028136506,0.00015100017,0.00021364643,0.000554569],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015310836,0.0001427227,0.638357,0.0050283135,0.0007754708,0.0023004354,0.00023065873,0.0005416566,0.0021933685,0.0004415665,0.019343572,0.3291142],"study_design_scores_gemma":[0.00008280605,0.00037906007,0.9479107,0.0010249411,0.0010196832,0.011354399,0.0003557873,0.00053722557,0.0014905026,0.00044768717,0.035363197,0.000033984317],"about_ca_topic_score_codex":0.0005491043,"about_ca_topic_score_gemma":0.0010114344,"teacher_disagreement_score":0.0033552514,"about_ca_system_score_codex":0.00021906763,"about_ca_system_score_gemma":0.00033380344,"threshold_uncertainty_score":0.011224508},"labels":[],"label_agreement":null},{"id":"W2045154422","doi":"10.1016/j.urolonc.2012.09.011","title":"Is the performance of urinary cytology as high as reported historically? A contemporary analysis in the detection and surveillance of bladder cancer","year":2013,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Cytology; Urine cytology; Medicine; Urine; Urinary system; Bladder cancer; Urology; Cancer; Pathology; Internal medicine","score_opus":0.03111572843048829,"score_gpt":0.31079118991719906,"score_spread":0.2796754614867108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045154422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815973,0.0127738835,0.00060511107,0.0021677003,0.00012736813,0.000009992916,0.00047139986,0.000014770487,0.0022324114],"genre_scores_gemma":[0.99768686,0.0015018228,0.00011321779,0.00021034511,0.00018091562,0.0000027351857,0.00026065644,0.000005383129,0.000038035996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952951,0.0013995441,0.00069066935,0.0009396296,0.0011555487,0.00051954534],"domain_scores_gemma":[0.9731311,0.008895714,0.009915022,0.003028725,0.003931591,0.0010978802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006050237,0.0002056071,0.0006369426,0.001715498,0.00066338776,0.0029219908,0.0010614025,0.0013676911,0.00065713364],"category_scores_gemma":[0.023784572,0.00033738624,0.0007070232,0.0042213146,0.0014103055,0.0022743824,0.00090715766,0.0010030919,0.00020752265],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020093682,0.000015586842,0.9928718,0.00002570071,0.00011800406,0.000043424476,0.00010624554,0.00006613559,0.0002534903,0.00011144763,0.00022282291,0.0059644207],"study_design_scores_gemma":[0.0000050729104,0.00008840478,0.99749905,0.000028932276,0.00014442718,0.00033324468,0.0003510314,0.00028670556,0.00016327846,0.00013711373,0.00095166755,0.00001110072],"about_ca_topic_score_codex":0.004708446,"about_ca_topic_score_gemma":0.004359347,"teacher_disagreement_score":0.006050237,"about_ca_system_score_codex":0.0009836822,"about_ca_system_score_gemma":0.0009573226,"threshold_uncertainty_score":0.031997144},"labels":[],"label_agreement":null},{"id":"W2049195732","doi":"10.1016/j.urolonc.2005.07.003","title":"Expectant management for the treatment of small renal masses","year":2006,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Dalhousie University; University of Toronto; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Natural history; Medicine; Life expectancy; Intensive care medicine; Incidence (geometry); Expectant management; Clinical trial; Pathology; Internal medicine; Pregnancy; Population","score_opus":0.10407458280995156,"score_gpt":0.3619331480926299,"score_spread":0.2578585652826783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049195732","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002682365,0.9987373,0.00015364269,0.00012495171,0.00009684431,0.000002999037,0.000008037236,0.0000064699866,0.00060155836],"genre_scores_gemma":[0.0017902952,0.9972519,0.0002514698,0.00017814848,0.00021538994,0.000003934615,0.000023532593,0.0000014733506,0.00028384847],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998566,0.000030739422,0.000025144189,0.000025827758,0.000049906048,0.000011730249],"domain_scores_gemma":[0.99960154,0.00025004565,0.00007580707,0.000009536675,0.00003626605,0.0000268677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047300025,0.00066712784,0.0014321227,0.0017886882,0.00021990576,0.0005703165,0.0009822545,0.0006410185,0.002298324],"category_scores_gemma":[0.00084036874,0.00019605512,0.0004712806,0.0015243073,0.00042106264,0.00085482973,0.00037939326,0.0012721767,0.0011069234],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007173982,0.0000630574,0.0004023351,0.0096266335,0.00010936107,0.0012725014,0.000036205463,0.00025863442,0.0009810386,0.00050503126,0.012871845,0.9738017],"study_design_scores_gemma":[0.00013630844,0.00043743424,0.0074227215,0.010150119,0.0008651213,0.036447693,0.00018019005,0.0003663474,0.0016718652,0.0017859293,0.940467,0.0000692692],"about_ca_topic_score_codex":0.0006498313,"about_ca_topic_score_gemma":0.0016885567,"teacher_disagreement_score":0.002298324,"about_ca_system_score_codex":0.00034730096,"about_ca_system_score_gemma":0.0005375289,"threshold_uncertainty_score":0.0076886415},"labels":[],"label_agreement":null},{"id":"W2049382720","doi":"10.1016/j.urolonc.2014.09.010","title":"The burden of skeletal-related events in patients with prostate cancer and bone metastasis","year":2014,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bone health and treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Prostate cancer; Bone metastasis; Incidence (geometry); Spinal cord compression; Internal medicine; Odds ratio; Bone pain; Cancer; Spinal cord","score_opus":0.011680100552359312,"score_gpt":0.2875545802902652,"score_spread":0.2758744797379059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049382720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833815,0.009034446,0.00021108302,0.0014413315,0.00005837437,0.000013835818,0.0022866034,0.000012223092,0.0035606204],"genre_scores_gemma":[0.9961606,0.0023784693,0.00009172798,0.000097576434,0.00012521277,0.000004527393,0.0008376728,0.000002279527,0.000301929],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99953806,0.00014455826,0.00004464603,0.00007105504,0.0001069284,0.00009474424],"domain_scores_gemma":[0.9988991,0.00017987296,0.0005361674,0.000056977886,0.00011506151,0.00021273333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041947572,0.00022510212,0.0003863322,0.0008364848,0.00031577452,0.0007338176,0.00040308692,0.00060981157,0.0029173086],"category_scores_gemma":[0.0027559455,0.00027955216,0.0007204222,0.002029449,0.0002208048,0.0007028637,0.00067364296,0.00082658604,0.0002313809],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019056973,0.000030533927,0.9925126,0.000033344768,0.00018044654,0.0001181424,0.00003499534,0.00016692842,0.00012655239,0.00008984877,0.00033590992,0.006180194],"study_design_scores_gemma":[0.0000046001796,0.000042438558,0.99915373,0.000008360601,0.000050732033,0.00021253467,0.00008333373,0.00012588612,0.000011140428,0.00006858285,0.00023512635,0.000003547736],"about_ca_topic_score_codex":0.008346041,"about_ca_topic_score_gemma":0.011385811,"teacher_disagreement_score":0.008346041,"about_ca_system_score_codex":0.0004004608,"about_ca_system_score_gemma":0.0005393493,"threshold_uncertainty_score":0.016594946},"labels":[],"label_agreement":null},{"id":"W2051659258","doi":"10.1016/j.urolonc.2009.11.007","title":"Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy?","year":2010,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Stage (stratigraphy); Proportional hazards model; Hazard ratio; Urothelial carcinoma; Cancer; Internal medicine; Lymph node; Multivariate analysis; T-stage; Urology; Carcinoma; Disease; Oncology; Gastroenterology; Bladder cancer; Confidence interval","score_opus":0.01465563431599275,"score_gpt":0.30871165730842504,"score_spread":0.2940560229924323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051659258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99747604,0.0010341484,0.000078599434,0.00046132712,0.000076588316,0.0000047356334,0.00017215469,0.0000036206043,0.00069270184],"genre_scores_gemma":[0.9992975,0.00019901166,0.00004801334,0.00008746085,0.000073563075,0.0000019987344,0.00021814236,0.000002437279,0.000071852686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99964094,0.00011981511,0.000048028098,0.000045756933,0.000047220135,0.000098216056],"domain_scores_gemma":[0.997401,0.0009325114,0.00079366413,0.00008767648,0.00016288497,0.0006222699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000637269,0.00030163061,0.0006250893,0.0005680551,0.00040411917,0.00082556385,0.00038869202,0.00074255845,0.0017238181],"category_scores_gemma":[0.004568618,0.00014228227,0.0009234498,0.00085240783,0.00047475312,0.00077992625,0.0003860693,0.0006640108,0.00029297062],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037793137,0.000030316292,0.9967272,0.000009997997,0.000055632347,0.00011245097,0.00003422252,0.000049602,0.0001551125,0.00000865914,0.00011910106,0.0023198756],"study_design_scores_gemma":[0.000018158893,0.00025976967,0.99839467,0.000010836874,0.00010432356,0.00040060305,0.00025328406,0.00028712998,0.000058010566,0.0000494758,0.00015603814,0.000007697881],"about_ca_topic_score_codex":0.0018534209,"about_ca_topic_score_gemma":0.004622764,"teacher_disagreement_score":0.0018534209,"about_ca_system_score_codex":0.00033305932,"about_ca_system_score_gemma":0.0005612693,"threshold_uncertainty_score":0.0057667494},"labels":[],"label_agreement":null},{"id":"W2052299340","doi":"10.1016/j.urolonc.2013.08.030","title":"Local tumor destruction in renal cell carcinoma—An inpatient population-based study","year":2013,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Logistic regression; Cohort; Complication; Population; Comorbidity; Retrospective cohort study; Cohort study; Surgery; Internal medicine; Emergency medicine","score_opus":0.025147298548234005,"score_gpt":0.28133930730913903,"score_spread":0.25619200876090503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052299340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994603,0.0000982966,0.000033602206,0.000017649327,0.0000022293173,0.0000073862843,0.00015407742,0.0000018511997,0.00022458812],"genre_scores_gemma":[0.9995234,0.00010718871,0.000022566668,0.000025553274,0.000009782608,0.0000076159563,0.00021057883,0.000001680404,0.000091602524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994629,0.00013688201,0.00005994955,0.00013788232,0.0000896439,0.00011280823],"domain_scores_gemma":[0.99892116,0.00013967889,0.00044276592,0.00009706937,0.00010101149,0.00029842727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036951565,0.0003937343,0.0006592413,0.0011351889,0.0008711419,0.0010200717,0.0005538954,0.00064809434,0.0020712218],"category_scores_gemma":[0.0013869526,0.0006156849,0.00073745527,0.0019241698,0.0005542144,0.001069676,0.00083835004,0.00074515474,0.00043754687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009071262,0.00009478962,0.9990427,0.000007041201,0.000035330053,0.00010143436,0.00008479863,0.000015104936,0.00014056602,0.000005696497,0.00003307027,0.00034867896],"study_design_scores_gemma":[0.00000901817,0.00015603004,0.9987239,0.000003306339,0.0000363565,0.000324569,0.00057105435,0.00007269578,0.000034206972,0.000010521562,0.000053754236,0.0000046662935],"about_ca_topic_score_codex":0.010381664,"about_ca_topic_score_gemma":0.0128269065,"teacher_disagreement_score":0.010381664,"about_ca_system_score_codex":0.00080975203,"about_ca_system_score_gemma":0.0006003003,"threshold_uncertainty_score":0.02064246},"labels":[],"label_agreement":null},{"id":"W2052814131","doi":"10.1016/j.urolonc.2012.10.008","title":"The impact of hospital volume, residency, and fellowship training on perioperative outcomes after radical prostatectomy","year":2013,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Institutes of Health","keywords":"Medicine; Perioperative; Logistic regression; Prostatectomy; Confounding; Residency training; Teaching hospital; Complication; Emergency medicine; General surgery; Internal medicine; Surgery; Medical education; Prostate cancer; Continuing education","score_opus":0.022541623505986177,"score_gpt":0.3185868814827791,"score_spread":0.29604525797679293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052814131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99691004,0.00082336337,0.000047221733,0.000669754,0.00005329076,0.0000052463133,0.000120403354,0.000003042078,0.0013677197],"genre_scores_gemma":[0.9993753,0.000141502,0.000029181045,0.00010968224,0.00006397683,0.0000031022605,0.000106531144,0.0000035597113,0.00016722249],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979474,0.0006513412,0.00019725351,0.00014405126,0.00028224694,0.0007776999],"domain_scores_gemma":[0.9867438,0.0036497961,0.0038867071,0.00027762333,0.00074828125,0.0046939007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002000045,0.00023812383,0.0003642338,0.00056675065,0.0008058478,0.001330104,0.0008576265,0.0009273933,0.0049941195],"category_scores_gemma":[0.015600481,0.00020107317,0.00085754803,0.00091320433,0.0005825368,0.0011020215,0.0012379698,0.0012772627,0.00038008977],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076675694,0.00046874196,0.98646367,0.000026284764,0.00017957768,0.000104566185,0.0001769979,0.00022803509,0.00010659491,0.00007451147,0.0005096754,0.010894639],"study_design_scores_gemma":[0.000013055722,0.00029997135,0.9986072,0.00001761705,0.00004759553,0.00008690092,0.00048021696,0.00017361707,0.000032422246,0.000075465694,0.00015789435,0.000008011465],"about_ca_topic_score_codex":0.0042881225,"about_ca_topic_score_gemma":0.013708877,"teacher_disagreement_score":0.0049941195,"about_ca_system_score_codex":0.00097180257,"about_ca_system_score_gemma":0.002406644,"threshold_uncertainty_score":0.016707003},"labels":[],"label_agreement":null},{"id":"W2055050062","doi":"10.1016/j.urolonc.2005.07.006","title":"Surveillance programs for stage I nonseminomatous germ cell tumors of the testis","year":2006,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Retroperitoneal lymph node dissection; Stage (stratigraphy); Germ cell tumors; Radiation therapy; Medicine; Cisplatin; Chemotherapy; Germ cell; Dissection (medical); Oncology; Disease; Internal medicine; Testicular cancer; Radiology; Biology; Gene","score_opus":0.04802941256367221,"score_gpt":0.3437495059635702,"score_spread":0.29572009339989797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055050062","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00065305707,0.9986864,0.000070511705,0.00012532606,0.000055788016,0.000003874103,0.000014104976,0.0000044769786,0.000386476],"genre_scores_gemma":[0.00614931,0.9931306,0.00021620523,0.00014760025,0.00010930636,0.0000070129904,0.000044637112,8.688057e-7,0.00019442548],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998721,0.000036901918,0.000018246063,0.000025526182,0.000034859087,0.000012390041],"domain_scores_gemma":[0.99961,0.00024524645,0.00007402006,0.000005682808,0.00004409806,0.000021038539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044168092,0.00044790574,0.0010496796,0.001001355,0.00014497127,0.00033193905,0.00072433276,0.00042571087,0.0013069229],"category_scores_gemma":[0.0010368287,0.00014703615,0.00043221246,0.0008046834,0.00020787872,0.000455962,0.0002602269,0.00043780162,0.0003234997],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011642572,0.000035643377,0.0019666196,0.0110459225,0.000105620835,0.00039003257,0.000051134066,0.00022186135,0.00050359964,0.0003061681,0.0069789044,0.9782783],"study_design_scores_gemma":[0.00052407436,0.0018071368,0.059988033,0.05247578,0.00360707,0.021923058,0.00089002197,0.0008115424,0.0036138098,0.0024586997,0.8518018,0.000098938675],"about_ca_topic_score_codex":0.0023305237,"about_ca_topic_score_gemma":0.0052355253,"teacher_disagreement_score":0.0023305237,"about_ca_system_score_codex":0.0003525253,"about_ca_system_score_gemma":0.0010817456,"threshold_uncertainty_score":0.004633963},"labels":[],"label_agreement":null},{"id":"W2055691667","doi":"10.1016/j.urolonc.2013.06.013","title":"Does increasing the nodal yield improve outcomes in contemporary patients without nodal metastasis undergoing radical prostatectomy?","year":2013,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostatectomy; Interquartile range; Prostate cancer; Biochemical recurrence; Urology; Stage (stratigraphy); Prostate-specific antigen; Micrometastasis; Metastasis; T-stage; Internal medicine; Cancer","score_opus":0.030877907866676386,"score_gpt":0.3003691353558495,"score_spread":0.26949122748917315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055691667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9018679,0.05778454,0.0008427407,0.030024461,0.0014364212,0.000049885017,0.00043372446,0.00004395143,0.0075163427],"genre_scores_gemma":[0.98154116,0.013856779,0.0004352435,0.0018774729,0.0017134654,0.000014978527,0.00021018667,0.000011724691,0.0003389848],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996979,0.000098544886,0.000032705866,0.0000447952,0.00006101811,0.00006514929],"domain_scores_gemma":[0.9980855,0.000733107,0.00055193226,0.00009979064,0.00018214773,0.0003474648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011449526,0.00019732758,0.0006413791,0.00023324792,0.00031156372,0.0008256355,0.00042132198,0.000657466,0.002838775],"category_scores_gemma":[0.008367679,0.0001311423,0.0006821504,0.0005711654,0.0003990143,0.0011874111,0.0004262396,0.0009840919,0.00039061427],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057443455,0.00074421306,0.68897986,0.0004502943,0.00068512926,0.00023491865,0.00021151229,0.0009160876,0.0015023972,0.0005952887,0.0040511894,0.2958848],"study_design_scores_gemma":[0.00043651648,0.004662268,0.9806802,0.00029424427,0.0012633433,0.0005139371,0.0005839796,0.00079122715,0.000726021,0.0021119593,0.007899382,0.000036977963],"about_ca_topic_score_codex":0.0013742809,"about_ca_topic_score_gemma":0.005038879,"teacher_disagreement_score":0.002838775,"about_ca_system_score_codex":0.0005782557,"about_ca_system_score_gemma":0.00079288124,"threshold_uncertainty_score":0.009496629},"labels":[],"label_agreement":null},{"id":"W2056065461","doi":"10.1016/j.urolonc.2011.12.017","title":"Summary of the 6th annual bladder cancer think tank: New directions in urologic research","year":2012,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institutes of Health","keywords":"Bladder cancer; Medicine; Survivorship curve; Standardization; Clinical trial; Multidisciplinary approach; Cancer; Family medicine; Internal medicine; Political science","score_opus":0.12808407301072058,"score_gpt":0.42648679359404085,"score_spread":0.2984027205833203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056065461","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024512754,0.6826359,0.0004445638,0.07488632,0.23598903,0.00025414396,0.0009693799,0.00011725689,0.0044582756],"genre_scores_gemma":[0.0020744447,0.7222586,0.0018157534,0.08605483,0.15330996,0.0005389587,0.002600659,0.000101445294,0.031245327],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99677736,0.00057584845,0.00042756836,0.00033155415,0.0014324115,0.00045530303],"domain_scores_gemma":[0.9908227,0.001739538,0.0011346339,0.00015614516,0.003975208,0.0021718706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009008288,0.0024613675,0.0038549681,0.006382999,0.0016099004,0.004748169,0.0025183512,0.006935055,0.027471175],"category_scores_gemma":[0.009135301,0.0009988853,0.002646566,0.004986926,0.00081111625,0.00566397,0.004408707,0.00659127,0.013612324],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015182658,0.00004205406,0.00010387061,0.0051627704,0.000045889577,0.00006010761,0.00003779161,0.000072292765,0.0002850549,0.00033744305,0.925295,0.06840579],"study_design_scores_gemma":[0.00008820275,0.00013012419,0.000942222,0.007928942,0.00015796557,0.00016586618,0.000111643014,0.00007384143,0.00013336483,0.0009081106,0.9893232,0.00003654862],"about_ca_topic_score_codex":0.0028543102,"about_ca_topic_score_gemma":0.00855095,"teacher_disagreement_score":0.027471175,"about_ca_system_score_codex":0.0035496103,"about_ca_system_score_gemma":0.010365525,"threshold_uncertainty_score":0.09190029},"labels":[],"label_agreement":null},{"id":"W2056472977","doi":"10.1016/j.urolonc.2013.07.001","title":"Posttreatment prognostic nomogram for patients with metastatic urothelial cancer completing first-line cisplatin-based chemotherapy","year":2013,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Nomogram; Medicine; Proportional hazards model; Oncology; Internal medicine; Concordance; Chemotherapy; Confidence interval; Cisplatin; Urothelial cancer; Prognostic variable; Metastatic Urothelial Carcinoma; Cancer; Bladder cancer; Urothelial carcinoma","score_opus":0.02992241614387561,"score_gpt":0.31270409111499575,"score_spread":0.28278167497112017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056472977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99394566,0.0006025549,0.0008222447,0.0002347609,0.00006914205,0.000020931295,0.0013541075,0.000056908775,0.002893541],"genre_scores_gemma":[0.9972965,0.0001261142,0.00035209168,0.0000335872,0.00003943817,0.000014989784,0.0015759503,0.000009467887,0.00055183744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998982,0.000020244885,0.000012098345,0.000020008623,0.000016381475,0.000033219894],"domain_scores_gemma":[0.9990984,0.00026469212,0.0002134593,0.00005407689,0.00014504306,0.00022439144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039038778,0.00037187117,0.00046840683,0.0005840345,0.00036992645,0.000521111,0.00036781933,0.00052801566,0.0026851504],"category_scores_gemma":[0.0020274713,0.00010431256,0.0005696923,0.0004166144,0.00012851747,0.00045262964,0.00028626862,0.00050998805,0.0005610524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011997853,0.00005352414,0.9845509,0.000019512378,0.00004893305,0.00018186503,0.000034377685,0.000498927,0.0008225335,0.000045704626,0.0010696929,0.011474177],"study_design_scores_gemma":[0.000039287293,0.00045169255,0.99350584,0.000010681446,0.00017920251,0.0007727242,0.00012459797,0.0030255932,0.00052696816,0.00009180822,0.0012613102,0.000010274873],"about_ca_topic_score_codex":0.0014476328,"about_ca_topic_score_gemma":0.0030514083,"teacher_disagreement_score":0.0026851504,"about_ca_system_score_codex":0.00030763863,"about_ca_system_score_gemma":0.00038154787,"threshold_uncertainty_score":0.008982778},"labels":[],"label_agreement":null},{"id":"W2057400303","doi":"10.1016/j.urolonc.2012.02.008","title":"Efficacy of docetaxel-based chemotherapy following ketoconazole in metastatic castration-resistant prostate cancer: Implications for prior therapy in clinical trials","year":2012,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ontario Clinical Oncology Group","funders":"","keywords":"Docetaxel; Medicine; Prostate cancer; Ketoconazole; Oncology; Enzalutamide; Abiraterone acetate; Internal medicine; Cabazitaxel; Prednisone; Chemotherapy; Hazard ratio; Androgen deprivation therapy; Urology; Cancer; Androgen receptor; Confidence interval; Dermatology","score_opus":0.1952417861184199,"score_gpt":0.49993038371269305,"score_spread":0.30468859759427314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057400303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9379567,0.050747417,0.0006837279,0.0020883293,0.000833228,0.0010235118,0.00058132916,0.00003886467,0.0060469317],"genre_scores_gemma":[0.984297,0.011474068,0.0006526682,0.00065396726,0.00045027296,0.0002806384,0.00046847464,0.000017176322,0.0017057811],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99657625,0.0023683435,0.00028965573,0.00021549642,0.00028690783,0.0002633869],"domain_scores_gemma":[0.99179006,0.0046887207,0.001572773,0.0005647361,0.00034901715,0.0010346452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0074843527,0.0007261224,0.0028475637,0.00057144667,0.00066801504,0.0014631301,0.0007971442,0.001173815,0.0028359257],"category_scores_gemma":[0.009959022,0.00047640028,0.0021448855,0.0008613606,0.0013116365,0.0014685274,0.00043863562,0.003435179,0.0004423032],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6461816,0.013381985,0.0148901725,0.002567078,0.0037982105,0.00012247443,0.00048822296,0.0033844525,0.0032451353,0.000996618,0.00217427,0.30876973],"study_design_scores_gemma":[0.23383677,0.6214596,0.11657235,0.0011830791,0.0068516047,0.00040805916,0.00028587246,0.0023680555,0.0037866798,0.0009847172,0.012082841,0.00018042873],"about_ca_topic_score_codex":0.002822861,"about_ca_topic_score_gemma":0.015023828,"teacher_disagreement_score":0.0074843527,"about_ca_system_score_codex":0.0020638765,"about_ca_system_score_gemma":0.0019932645,"threshold_uncertainty_score":0.039581478},"labels":[],"label_agreement":null},{"id":"W2058047353","doi":"10.1016/j.urolonc.2010.06.010","title":"Advanced topics in evidence-based urologic oncology: Surrogate endpoints","year":2011,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Poznańskie Centrum Superkomputerowo-Sieciowe","keywords":"Surrogate endpoint; Clinical endpoint; Context (archaeology); Endpoint Determination; Medicine; Clinical trial; Intensive care medicine; Medical physics; Internal medicine","score_opus":0.6405611199299064,"score_gpt":0.570225369675923,"score_spread":0.07033575025398342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058047353","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012001188,0.9915747,0.005138146,0.00222015,0.00050275,0.0000233978,0.000026509237,0.00000867632,0.00038561702],"genre_scores_gemma":[0.0065244976,0.98032403,0.008768927,0.0019442427,0.0020483953,0.00013520884,0.00004884016,0.000014586965,0.00019130798],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97254735,0.021583509,0.0026338317,0.0006939298,0.0024026295,0.00013868924],"domain_scores_gemma":[0.8163537,0.17264166,0.0060838903,0.001832501,0.0026980857,0.0003901244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03237752,0.0012450692,0.0057259826,0.0037366147,0.00027626773,0.0028370009,0.00140455,0.0022560735,0.0035665215],"category_scores_gemma":[0.086663865,0.00051895576,0.0027640592,0.006322115,0.0030250307,0.0033765691,0.0016589778,0.0050442195,0.00058819156],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000368416,0.00009343441,0.0006293572,0.13117704,0.0022731149,0.00009056371,0.00011199424,0.0024766678,0.00021671283,0.05445805,0.018099656,0.7900051],"study_design_scores_gemma":[0.0009973007,0.0010081548,0.004076755,0.19723222,0.0063742297,0.002116413,0.00034724895,0.0051801833,0.0010260565,0.4124807,0.36893666,0.00022404408],"about_ca_topic_score_codex":0.0007327924,"about_ca_topic_score_gemma":0.001126796,"teacher_disagreement_score":0.03237752,"about_ca_system_score_codex":0.0017087009,"about_ca_system_score_gemma":0.004999131,"threshold_uncertainty_score":0.1712308},"labels":[],"label_agreement":null},{"id":"W2060032424","doi":"10.1016/j.urolonc.2015.01.004","title":"Multiparametric magnetic resonance imaging–targeted biopsy for the detection of prostate cancer in patients with prior negative biopsy results","year":2015,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Prostate cancer; Magnetic resonance imaging; Prostate; Biopsy; Prostate biopsy; Radiology; Odds ratio; Urology; Cancer; Internal medicine","score_opus":0.02217945990502929,"score_gpt":0.2949676933584349,"score_spread":0.27278823345340564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060032424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96741873,0.021437477,0.0016919589,0.0019360794,0.00022423117,0.00006344322,0.00021516361,0.00007796144,0.00693498],"genre_scores_gemma":[0.9957755,0.002303682,0.0009708737,0.0003353749,0.00019254298,0.000009535392,0.00012480639,0.000007632235,0.00028004125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996464,0.000105017905,0.000041918498,0.00004655872,0.0001047858,0.000055285476],"domain_scores_gemma":[0.9991912,0.0002895068,0.00017160794,0.000045163433,0.0001116145,0.00019085714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000708888,0.00042730526,0.0005736565,0.0013432334,0.00044113793,0.0008137554,0.0006768639,0.0008694192,0.0018015004],"category_scores_gemma":[0.0033720166,0.0003875166,0.00050152815,0.00057705294,0.0004052949,0.000688383,0.00039985526,0.0009465213,0.00036359858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001760331,0.00033646895,0.9261757,0.00020451368,0.00019413665,0.0037964722,0.000117320305,0.00045270583,0.0062452974,0.00012498071,0.0021122461,0.058479752],"study_design_scores_gemma":[0.00007913417,0.0009778278,0.96717495,0.00017346119,0.00042053164,0.019567227,0.0003283806,0.0042642327,0.003979431,0.00034208255,0.0026512952,0.000041337415],"about_ca_topic_score_codex":0.0022289804,"about_ca_topic_score_gemma":0.0081715,"teacher_disagreement_score":0.0022289804,"about_ca_system_score_codex":0.00027854144,"about_ca_system_score_gemma":0.0005617954,"threshold_uncertainty_score":0.006026566},"labels":[],"label_agreement":null},{"id":"W2061048203","doi":"10.1016/s1078-1439(02)00183-7","title":"Expectant management with selective delayed intervention for favorable risk prostate cancer","year":2002,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Radiation therapy; Conservative management; Expectant management; Malignancy; Stage (stratigraphy); Quality of life (healthcare); Management of prostate cancer; Cancer; Surgery; Gynecology; Internal medicine; Pregnancy","score_opus":0.023318961281136242,"score_gpt":0.30307160741469635,"score_spread":0.2797526461335601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061048203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95684385,0.010738489,0.011217211,0.004145896,0.0009865551,0.00019539538,0.00019869323,0.00038588795,0.015287994],"genre_scores_gemma":[0.98966295,0.0028106212,0.002636244,0.0008456219,0.0016595299,0.00007645669,0.00017302463,0.000026595038,0.0021088363],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99990225,0.00001993414,0.000010184654,0.000017415507,0.000018039349,0.0000322726],"domain_scores_gemma":[0.99971455,0.00007986282,0.000039732837,0.000020125291,0.00001252323,0.00013326925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023886809,0.0004423283,0.00044445533,0.0005330858,0.0006622681,0.00021099953,0.0004318225,0.00045105538,0.0025998668],"category_scores_gemma":[0.0011288363,0.00014569341,0.00038255146,0.00024106381,0.00029847762,0.00036553983,0.00041318237,0.0009767723,0.00028444824],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023132082,0.0044596163,0.18962418,0.0009021276,0.00033692239,0.08488919,0.00036829556,0.006517474,0.02796138,0.002318187,0.018055826,0.6414347],"study_design_scores_gemma":[0.003167185,0.039759822,0.5177065,0.00038438954,0.00064883585,0.34358045,0.000519234,0.014673987,0.029679645,0.008150559,0.041553304,0.00017609817],"about_ca_topic_score_codex":0.00045267062,"about_ca_topic_score_gemma":0.0008977049,"teacher_disagreement_score":0.0025998668,"about_ca_system_score_codex":0.00024104587,"about_ca_system_score_gemma":0.00059272524,"threshold_uncertainty_score":0.008697391},"labels":[],"label_agreement":null},{"id":"W2061880783","doi":"10.1016/j.urolonc.2013.10.020","title":"Genomic, pathological, and clinical heterogeneity as drivers of personalized medicine in prostate cancer","year":2014,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Prostate cancer; Medicine; Disease; Malignancy; Oncology; TMPRSS2; Precision medicine; Personalized medicine; Internal medicine; Cancer; Copy-number variation; Genomics; Bioinformatics; Pathology; Gene; Biology; Genetics; Genome","score_opus":0.11562089813087034,"score_gpt":0.46778681922508075,"score_spread":0.3521659210942104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061880783","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012967458,0.9990382,0.00006850067,0.0004751519,0.000046049434,0.00000185664,0.000011257918,0.0000016555226,0.00022759748],"genre_scores_gemma":[0.001680848,0.9977258,0.00011790303,0.00027904357,0.000096712465,0.0000029118867,0.000018042467,4.6811758e-7,0.000078341654],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999556,0.00014713201,0.00005130856,0.00008203207,0.00012682496,0.000036693167],"domain_scores_gemma":[0.9987521,0.00093275204,0.00013209575,0.000028014041,0.00012576426,0.00002928869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016230512,0.00056855445,0.0016325597,0.0017268477,0.00024371476,0.0015431135,0.00094491924,0.001010222,0.0017445341],"category_scores_gemma":[0.0028174317,0.0002636779,0.0008105067,0.002660204,0.0008420219,0.001469711,0.0008903171,0.0014949171,0.00036933075],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008479036,0.000036030364,0.0018616114,0.024421155,0.0005831501,0.00022940102,0.00013090597,0.000581265,0.00054868014,0.008979263,0.012708297,0.94983536],"study_design_scores_gemma":[0.000054941567,0.00013615687,0.010781856,0.029501043,0.0019777191,0.0028108107,0.0005089626,0.0004054179,0.0007801458,0.018251607,0.9346929,0.00009840832],"about_ca_topic_score_codex":0.00206766,"about_ca_topic_score_gemma":0.0040227207,"teacher_disagreement_score":0.00206766,"about_ca_system_score_codex":0.0010849135,"about_ca_system_score_gemma":0.0022676156,"threshold_uncertainty_score":0.008583605},"labels":[],"label_agreement":null},{"id":"W2065461989","doi":"10.1016/s1078-1439(02)00242-9","title":"A cost-outcome analysis of long-term adjuvant goserelin in addition to radiotherapy for locally advanced prostate cancer","year":2003,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Northeast Cancer Centre","funders":"","keywords":"Medicine; Prostate cancer; Goserelin; Radiation therapy; Adjuvant; Oncology; Randomized controlled trial; Cost effectiveness; Internal medicine; Cancer; Gynecology","score_opus":0.045970853083603734,"score_gpt":0.38366459222408544,"score_spread":0.33769373914048173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065461989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99539787,0.002582385,0.00034834794,0.00032409735,0.000047714177,0.00007651619,0.00059488125,0.000010770429,0.0006174285],"genre_scores_gemma":[0.99857354,0.00037793646,0.00020365455,0.00009008376,0.00004480029,0.000026478137,0.00050494476,0.0000034921238,0.00017507099],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.998382,0.0009182415,0.00011965782,0.0001460371,0.00019183659,0.00024228735],"domain_scores_gemma":[0.99636984,0.0018580715,0.00087697466,0.00016922652,0.0001667789,0.00055923825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019497167,0.0010525014,0.0014531153,0.0015166193,0.00035789324,0.0011894527,0.0010095153,0.0009899918,0.002694328],"category_scores_gemma":[0.005571824,0.00044115033,0.0039557475,0.0015557914,0.00061901775,0.001102451,0.00079442904,0.001272853,0.00022282772],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5626775,0.0044130785,0.2730793,0.0012469984,0.0141968895,0.001378899,0.00017533259,0.04233754,0.0049191387,0.0014389225,0.0019172437,0.092219114],"study_design_scores_gemma":[0.02930366,0.09802284,0.7725532,0.00029791138,0.02756816,0.0030354848,0.00071554864,0.06144669,0.0018874592,0.0023185278,0.0025340887,0.00031644554],"about_ca_topic_score_codex":0.008282511,"about_ca_topic_score_gemma":0.008809015,"teacher_disagreement_score":0.008282511,"about_ca_system_score_codex":0.004206015,"about_ca_system_score_gemma":0.0013109696,"threshold_uncertainty_score":0.030516922},"labels":[],"label_agreement":null},{"id":"W2065793218","doi":"10.1016/j.urolonc.2010.07.002","title":"Serum alkaline phosphatase changes predict survival independent of PSA changes in men with castration-resistant prostate cancer and bone metastasis receiving chemotherapy","year":2010,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bone health and treatments","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McMaster University","funders":"","keywords":"Medicine; Prostate cancer; Docetaxel; Internal medicine; Mitoxantrone; Proportional hazards model; Oncology; Chemotherapy; Urology; Hazard ratio; Alkaline phosphatase; Metastasis; Bone metastasis; Cancer; Confidence interval; Biology","score_opus":0.025374797829858006,"score_gpt":0.315692593313005,"score_spread":0.29031779548314696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065793218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99880576,0.00052246824,0.00005061285,0.000090953894,0.000013780894,0.0000030075862,0.00007355935,0.000004392151,0.00043543088],"genre_scores_gemma":[0.99956745,0.00012004534,0.000032913445,0.000023890254,0.000019235447,0.0000010723984,0.00007949919,0.0000013202457,0.00015465176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984837,0.000047292586,0.000013819863,0.000020734264,0.00003198451,0.000037803406],"domain_scores_gemma":[0.9986731,0.0005110124,0.0004362082,0.000057518315,0.000053043972,0.0002691207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003400544,0.0002847288,0.00037315086,0.0005768811,0.00029364706,0.00053475454,0.00031366787,0.0005159456,0.0016200345],"category_scores_gemma":[0.002247692,0.00034636274,0.00036953448,0.00071364536,0.0004445755,0.0003835833,0.00026702546,0.0006265297,0.00022162274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070210756,0.00004423509,0.9965083,0.0000055499186,0.00004130133,0.000092411006,0.000031625965,0.00007452463,0.00043170326,0.000009605077,0.000068275294,0.0019903427],"study_design_scores_gemma":[0.000017944036,0.00018671385,0.99882716,0.0000017757158,0.00004778623,0.00037124392,0.000054059474,0.00026645852,0.00010391408,0.000026588368,0.00009369251,0.0000026011403],"about_ca_topic_score_codex":0.0031924814,"about_ca_topic_score_gemma":0.0065773134,"teacher_disagreement_score":0.0031924814,"about_ca_system_score_codex":0.00021279257,"about_ca_system_score_gemma":0.00031763536,"threshold_uncertainty_score":0.0063477755},"labels":[],"label_agreement":null},{"id":"W2069971707","doi":"10.1016/s1078-1439(01)00130-2","title":"Identification of two genes differentially expressed upon different spatial configuration of the MGH-U3 human bladder cancer cells","year":2002,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Hôtel-Dieu de Québec","funders":"","keywords":"clone (Java method); Northern blot; Differential display; Gene; Molecular biology; Biology; Complementary DNA; Western blot; Gene expression; Messenger RNA; Growth factor; Genetics; Receptor","score_opus":0.021670452695329807,"score_gpt":0.28342180117886134,"score_spread":0.26175134848353154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069971707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99547356,0.00092908967,0.0011900442,0.00010152312,0.000030713825,0.0000139799795,0.0010528186,0.000031126732,0.0011770875],"genre_scores_gemma":[0.99310315,0.00052416883,0.0019109775,0.0001031339,0.000009403105,0.000038755516,0.0016550627,0.000011932513,0.002643523],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988043,0.000011299562,0.000007451679,0.00003314355,0.00002382828,0.000043782544],"domain_scores_gemma":[0.9999442,0.000011742616,0.000007784567,0.000008418185,0.000013180625,0.000014589023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000069108326,0.00013384153,0.0002491439,0.00032254166,0.00025609406,0.00034788696,0.00010496883,0.00023306384,0.0013740505],"category_scores_gemma":[0.00010052479,0.000107063126,0.00023787557,0.00042765224,0.00022327283,0.00012124289,0.00016064949,0.00023841596,0.00031809506],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019322606,0.000010916621,0.00074083806,0.000017026392,0.0000031829256,0.00006435241,0.000039121263,0.000022403321,0.9980197,0.000086267086,0.000039477836,0.00076338847],"study_design_scores_gemma":[0.000025304525,0.00026805716,0.061897576,0.000006514737,0.000039792183,0.0006314056,0.00034941162,0.0005316459,0.9322668,0.00008048291,0.0038916545,0.000011321191],"about_ca_topic_score_codex":0.0020726998,"about_ca_topic_score_gemma":0.0019251792,"teacher_disagreement_score":0.0020726998,"about_ca_system_score_codex":0.00022440995,"about_ca_system_score_gemma":0.00025077042,"threshold_uncertainty_score":0.004596591},"labels":[],"label_agreement":null},{"id":"W2074650678","doi":"10.1016/j.urolonc.2013.06.009","title":"Blood- and tissue-based biomarkers for prediction of outcomes in urothelial carcinoma of the bladder","year":2013,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Urothelial carcinoma; Biomarker; Bladder cancer; Oncology; Malignancy; Internal medicine; Stage (stratigraphy); Cancer; Intensive care medicine","score_opus":0.06003637401086036,"score_gpt":0.3502248774312612,"score_spread":0.2901885034204008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074650678","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000995017,0.9996445,0.00003667249,0.00006366912,0.000042377647,0.0000028206737,0.000017817774,0.0000013655714,0.000091180504],"genre_scores_gemma":[0.0012193493,0.998393,0.0001255938,0.00008866722,0.00006382679,0.000004735261,0.000035385583,4.407626e-7,0.00006893849],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996007,0.000089771085,0.00007125275,0.00007687657,0.00013318317,0.000028188064],"domain_scores_gemma":[0.9991002,0.00055174757,0.00014364775,0.000017289862,0.00016014921,0.000026984024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014347422,0.00095517345,0.0030022599,0.0020940297,0.00014700052,0.0010233466,0.0013068881,0.0009958537,0.0014321068],"category_scores_gemma":[0.0022450972,0.00031877236,0.001423338,0.0022853382,0.00042367043,0.00091430574,0.00062564865,0.0013580525,0.0005031171],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000239599,0.00007587811,0.0014967814,0.031829074,0.0010204067,0.00012284772,0.000032791944,0.00037209134,0.0005001355,0.00075847254,0.011763524,0.9517885],"study_design_scores_gemma":[0.0005285301,0.0011374702,0.030875431,0.073810324,0.011239879,0.0033522255,0.00039508718,0.0014213369,0.002602473,0.005931954,0.8684422,0.0002631665],"about_ca_topic_score_codex":0.0025054656,"about_ca_topic_score_gemma":0.0036379737,"teacher_disagreement_score":0.0030022599,"about_ca_system_score_codex":0.0005020567,"about_ca_system_score_gemma":0.0012877929,"threshold_uncertainty_score":0.007587731},"labels":[],"label_agreement":null},{"id":"W2075807787","doi":"10.1016/j.urolonc.2006.09.015","title":"Long-term outcome of radiation-based conservation therapy for invasive bladder cancer","year":2007,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Radiation therapy; Cystectomy; Bladder cancer; Chemotherapy; Oncology; Cisplatin; Cystoscopy; Urology; Surgery; Lymph node; Carcinoma; Internal medicine; Cancer; Urinary system","score_opus":0.058491059918654484,"score_gpt":0.37542339868715424,"score_spread":0.31693233876849974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075807787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99334717,0.0041780174,0.0001636984,0.00020940599,0.00007693477,0.000018451352,0.0006556078,0.000011113446,0.0013395281],"genre_scores_gemma":[0.9977463,0.0004998055,0.000026532305,0.00010200801,0.00006460544,0.000011271896,0.0009959275,0.000004644384,0.0005488598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99933475,0.00016094476,0.00007415087,0.000078014775,0.00009276437,0.00025938943],"domain_scores_gemma":[0.99683833,0.00096470705,0.00086453644,0.00024684265,0.0003383422,0.00074734207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014360736,0.0003880711,0.0010406659,0.00074069545,0.0007128807,0.0010076944,0.0006807869,0.00092618313,0.0019065592],"category_scores_gemma":[0.0032898446,0.000121430334,0.0019344315,0.0007824368,0.00072318566,0.00076399307,0.0006062918,0.0011003488,0.00046137755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.054072306,0.0043721073,0.8389385,0.00040348998,0.0025539987,0.00336111,0.0009058763,0.0029501733,0.0043917815,0.00036972846,0.0015632894,0.08611771],"study_design_scores_gemma":[0.00046404646,0.011957038,0.9817923,0.000068666144,0.0014919139,0.0014637458,0.00030370688,0.00054354547,0.0006118072,0.0003031591,0.00095023745,0.00004990573],"about_ca_topic_score_codex":0.0039447583,"about_ca_topic_score_gemma":0.0049316166,"teacher_disagreement_score":0.0039447583,"about_ca_system_score_codex":0.0009902121,"about_ca_system_score_gemma":0.0005928916,"threshold_uncertainty_score":0.007843614},"labels":[],"label_agreement":null},{"id":"W2076754230","doi":"10.1016/s1078-1439(01)00184-3","title":"Interstitial photodynamic therapy in subcutaneously implanted urologic tumors in rats after intravenous administration of 5-aminolevulinic acid","year":2002,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Photodynamic therapy; Protoporphyrin IX; Photosensitizer; Medicine; Urology; Nuclear medicine; Radionuclide therapy; Pathology; Chemistry","score_opus":0.028503785433853877,"score_gpt":0.3152713555498956,"score_spread":0.2867675701160417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076754230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921835,0.0020152333,0.00242213,0.0001755683,0.00019626578,0.000076828226,0.0004076448,0.0003223331,0.0022005653],"genre_scores_gemma":[0.99031866,0.0014905005,0.0016572721,0.000067139044,0.00006826896,0.000090065354,0.00046762472,0.00006955704,0.0057710423],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99958843,0.00004832121,0.000019895222,0.000084167346,0.000054341435,0.00020487327],"domain_scores_gemma":[0.9992729,0.0001772114,0.00018868194,0.000109455126,0.00006358733,0.00018811472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050081586,0.0012009443,0.00089922926,0.001295074,0.00053636584,0.00053312926,0.0008015522,0.0009081764,0.00235716],"category_scores_gemma":[0.00033370065,0.0006863687,0.000918684,0.00069531624,0.0011843239,0.0010866604,0.00028671164,0.001722122,0.00046906545],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006288654,0.0008953792,0.00043870177,0.00010023646,0.000035698613,0.00015167128,0.00011373985,0.00031315634,0.98715496,0.00041867484,0.00016745117,0.0039218324],"study_design_scores_gemma":[0.00009537944,0.0031594567,0.0011285724,0.0000052713754,0.0000581635,0.00007122312,0.000045384564,0.0006690432,0.99421096,0.00006618438,0.00048043454,0.000009861525],"about_ca_topic_score_codex":0.0055142874,"about_ca_topic_score_gemma":0.0047442,"teacher_disagreement_score":0.0055142874,"about_ca_system_score_codex":0.0007946611,"about_ca_system_score_gemma":0.0013704078,"threshold_uncertainty_score":0.010964394},"labels":[],"label_agreement":null},{"id":"W2079743157","doi":"10.1016/j.urolonc.2013.10.009","title":"Integrating genomics into clinical oncology: Ethical and social challenges from proponents of personalized medicine","year":2014,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Human Genome Research Institute","keywords":"Personalized medicine; Oncology; Enthusiasm; Precision medicine; Pharmacogenomics; Medicine; Internal medicine; Optimism; Reimbursement; Genomics; Health care; Bioinformatics; Psychology; Pharmacology; Genetics; Political science; Biology; Genome","score_opus":0.0652168595492476,"score_gpt":0.38560102748004704,"score_spread":0.32038416793079944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079743157","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001770947,0.0040372047,0.0031876438,0.98571163,0.0018671226,0.000012642531,0.0000067247984,0.000011996438,0.0033940852],"genre_scores_gemma":[0.16205016,0.007401036,0.008940765,0.80285805,0.015647355,0.0002135976,0.000022955935,0.000109611734,0.0027564587],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9089378,0.06088751,0.003121022,0.0042484566,0.018766746,0.0040384633],"domain_scores_gemma":[0.65608466,0.28208515,0.0073471894,0.01416394,0.020646557,0.019672517],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.19510536,0.000543218,0.0014826547,0.0018211745,0.013054568,0.020870754,0.0039588427,0.030960718,0.0034972532],"category_scores_gemma":[0.17844917,0.0011020557,0.0010145555,0.0016115883,0.087530985,0.018860439,0.020845138,0.076890826,0.000815495],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010001091,0.00028271333,0.0027661687,0.00030553617,0.00011370786,0.0006581864,0.023320306,0.0009454709,0.0007672079,0.77821034,0.12409856,0.06843178],"study_design_scores_gemma":[0.000115902694,0.0000820735,0.0013422086,0.00091237144,0.000039710114,0.00061658653,0.013799778,0.0009022022,0.00045568138,0.7807848,0.2008204,0.00012827912],"about_ca_topic_score_codex":0.0036592379,"about_ca_topic_score_gemma":0.005497436,"teacher_disagreement_score":0.19510536,"about_ca_system_score_codex":0.009953846,"about_ca_system_score_gemma":0.029574951,"threshold_uncertainty_score":0.9925784},"labels":[],"label_agreement":null},{"id":"W2080015838","doi":"10.1016/j.urolonc.2010.02.011","title":"Statistical consideration for clinical biomarker research in bladder cancer","year":2010,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute","keywords":"Overfitting; Biomarker; Biomarker discovery; Computer science; Bladder cancer; Medicine; Cancer; Bioinformatics; Machine learning; Internal medicine; Biology; Proteomics","score_opus":0.40200322786244064,"score_gpt":0.5735555181218225,"score_spread":0.17155229025938185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080015838","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00065838883,0.9744571,0.012576553,0.00830125,0.0026509513,0.00008813884,0.00029690686,0.000042551386,0.0009280477],"genre_scores_gemma":[0.06610779,0.86937743,0.031265095,0.01417401,0.016299846,0.00075385463,0.0009132213,0.00010141982,0.001007385],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.8972936,0.07705624,0.009864564,0.0038633468,0.011494873,0.0004272951],"domain_scores_gemma":[0.5916324,0.37676573,0.012720845,0.007306994,0.010920374,0.0006535668],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.10189585,0.0011801263,0.006624967,0.004207439,0.00063487416,0.0038206687,0.0038612173,0.0026287807,0.0039281338],"category_scores_gemma":[0.23938386,0.0009114631,0.0041488456,0.007315178,0.004082364,0.004138466,0.0020796005,0.004658063,0.0006261623],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008515819,0.00006800105,0.0078534465,0.06822571,0.01105519,0.00022760681,0.0002885572,0.0019380169,0.00032181028,0.029148709,0.03031038,0.849711],"study_design_scores_gemma":[0.0014286886,0.0015356058,0.032264557,0.080104075,0.024703758,0.002817785,0.00067529484,0.013564225,0.0019237965,0.32770044,0.5129112,0.0003706728],"about_ca_topic_score_codex":0.0015614571,"about_ca_topic_score_gemma":0.0021480261,"teacher_disagreement_score":0.89810413,"about_ca_system_score_codex":0.0017814365,"about_ca_system_score_gemma":0.008244542,"threshold_uncertainty_score":0.5388832},"labels":[],"label_agreement":null},{"id":"W2083871892","doi":"10.1016/j.urolonc.2006.10.008","title":"Final results of the Canadian prospective phase II trial of intermittent androgen suppression for men in biochemical recurrence after radiotherapy for locally advanced prostate cancer: Clinical parameters","year":2007,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cyproterone acetate; Prostate cancer; Medicine; Urology; Androgen suppression; Radiation therapy; Cyproterone; Prospective cohort study; Prostate; Cancer; Prostate-specific antigen; Internal medicine; Androgen; Antiandrogen; Hormone","score_opus":0.05812133756169986,"score_gpt":0.4223162492147819,"score_spread":0.36419491165308204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083871892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9206927,0.014801788,0.0012860948,0.002881489,0.00040635877,0.0044215606,0.03493472,0.00019756469,0.020377785],"genre_scores_gemma":[0.9553545,0.0028353455,0.0026552645,0.0024516291,0.00023152948,0.0015298313,0.025613585,0.00012354057,0.009204739],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9976841,0.00074059214,0.000088073175,0.0002162493,0.0007538749,0.00051695155],"domain_scores_gemma":[0.99656796,0.0005085422,0.00049960334,0.0003187293,0.0007480513,0.001357159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055099977,0.0017089946,0.0023281001,0.00048126373,0.0014863627,0.0016043504,0.0014431456,0.0014154857,0.0041732993],"category_scores_gemma":[0.0047221975,0.0004394148,0.0021476,0.0014505708,0.0013029396,0.0007240584,0.000577426,0.0023531937,0.0008224146],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.83405006,0.0049155173,0.044293262,0.0006479158,0.00445477,0.00010141944,0.00027942006,0.0025148252,0.004992992,0.00041549385,0.021364408,0.08196982],"study_design_scores_gemma":[0.27373165,0.090592764,0.5981065,0.00014320896,0.0068847667,0.00023412333,0.00029306154,0.0010522903,0.0031735653,0.0006712654,0.024907915,0.00020888331],"about_ca_topic_score_codex":0.34730455,"about_ca_topic_score_gemma":0.5869588,"teacher_disagreement_score":0.34730455,"about_ca_system_score_codex":0.008227646,"about_ca_system_score_gemma":0.017203093,"threshold_uncertainty_score":0.69056606},"labels":[],"label_agreement":null},{"id":"W2084748232","doi":"10.1016/j.urolonc.2012.09.012","title":"Is there a relationship between leapfrog volume thresholds and perioperative outcomes after radical cystectomy?","year":2013,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Fonds de Recherche du Québec - Santé","keywords":"Cystectomy; Perioperative; Volume (thermodynamics); Medicine; Urology; Internal medicine; Surgery; Bladder cancer; Physics; Thermodynamics","score_opus":0.041638716118398436,"score_gpt":0.3262084826597272,"score_spread":0.28456976654132876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084748232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925591,0.0033242756,0.0002702412,0.0016400159,0.00015293022,0.0000087547205,0.00019197962,0.000009569886,0.0018432267],"genre_scores_gemma":[0.99860674,0.00050632237,0.00015195887,0.00025790912,0.000118130534,0.000005651435,0.00016274504,0.0000055979444,0.00018503738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991086,0.0002387957,0.00011929138,0.0001283823,0.00020586321,0.00019902072],"domain_scores_gemma":[0.98712385,0.0061106887,0.004630564,0.00047301364,0.00061996677,0.0010420026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014428372,0.00012695124,0.00046292582,0.00044061508,0.0002969834,0.001223845,0.00067400833,0.00087347,0.002115661],"category_scores_gemma":[0.018576438,0.00019089323,0.00055933336,0.0007019412,0.0004918501,0.0010935757,0.00043709413,0.0016321058,0.00028101276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047803522,0.00012684484,0.98459667,0.000033012955,0.00015114828,0.000081330174,0.000090514215,0.00012360353,0.00021888269,0.00015135095,0.00039405312,0.013554604],"study_design_scores_gemma":[0.000013796961,0.0004413628,0.9977156,0.000034962235,0.00011620794,0.00020164748,0.00027159252,0.00023413434,0.00014219328,0.00040837997,0.0004071088,0.000013069467],"about_ca_topic_score_codex":0.0016086686,"about_ca_topic_score_gemma":0.002867936,"teacher_disagreement_score":0.002115661,"about_ca_system_score_codex":0.0004276545,"about_ca_system_score_gemma":0.0007854286,"threshold_uncertainty_score":0.007630527},"labels":[],"label_agreement":null},{"id":"W2085182253","doi":"10.1016/j.urolonc.2011.10.007","title":"Discharge patterns after radical prostatectomy in the United States of America","year":2011,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Logistic regression; Prostatectomy; Hospital discharge; Demography; Adverse effect; Internal medicine; Prostate cancer; Cancer","score_opus":0.033422674297207265,"score_gpt":0.2983355626603719,"score_spread":0.2649128883631647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085182253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99307644,0.0007100053,0.00005420766,0.00040243988,0.000022815215,0.0000111542,0.0036330193,0.000015987853,0.0020739287],"genre_scores_gemma":[0.99692863,0.00036409483,0.00004178245,0.00016850166,0.000015012691,0.0000066975654,0.0020590574,0.0000058894693,0.00041053258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99962485,0.00006844599,0.000060513496,0.00007158453,0.00007275053,0.00010175329],"domain_scores_gemma":[0.9981828,0.00025171676,0.0007667303,0.000044287033,0.0002931534,0.0004613037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026026534,0.00016803764,0.00025481734,0.001255235,0.00050605094,0.000678973,0.00035744364,0.00048635874,0.0019396594],"category_scores_gemma":[0.0013841038,0.00016362002,0.00041988757,0.0022561378,0.00030439382,0.00053831056,0.0006805485,0.00047846805,0.00022983125],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113671755,0.000042326454,0.99569464,0.000023134753,0.00005312178,0.000101219644,0.00022633637,0.000101971695,0.00016512224,0.000052233758,0.0013400463,0.002086129],"study_design_scores_gemma":[0.00000287912,0.000024947083,0.9987728,0.000011115701,0.0000076184283,0.00010183512,0.00058319455,0.00007491399,0.00002912193,0.000014461125,0.0003730438,0.00000411261],"about_ca_topic_score_codex":0.06723381,"about_ca_topic_score_gemma":0.13636912,"teacher_disagreement_score":0.06723381,"about_ca_system_score_codex":0.0010742934,"about_ca_system_score_gemma":0.001063365,"threshold_uncertainty_score":0.13368493},"labels":[],"label_agreement":null},{"id":"W2088360090","doi":"10.1016/j.urolonc.2006.11.003","title":"Impact of a multi-disciplinary patient education session on accrual to a difficult clinical trial: the Toronto experience with the surgical prostatectomy versus interstitial radiation intervention trial","year":2007,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Prostatectomy; Randomized controlled trial; Accrual; Prostate cancer; Brachytherapy; Specialty; Clinical trial; Radiation oncologist; Informed consent; Family medicine; Radiation therapy; General surgery; Surgery; Cancer; Alternative medicine; Internal medicine","score_opus":0.2271365830313227,"score_gpt":0.538883784542694,"score_spread":0.31174720151137136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088360090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9181407,0.0044310014,0.0018833084,0.05359756,0.00063266745,0.0021376528,0.00040881598,0.00010771107,0.01866056],"genre_scores_gemma":[0.9898463,0.00087221625,0.0024753634,0.0037979146,0.00070681126,0.0007465597,0.00016196199,0.000026221607,0.0013666507],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.97936195,0.017555833,0.00065633084,0.00049070566,0.00095003645,0.0009852444],"domain_scores_gemma":[0.8903824,0.0692779,0.009742382,0.0030520586,0.0016085396,0.02593666],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.037058663,0.00043840002,0.0010074399,0.00027260493,0.0027189818,0.0019820188,0.0010515352,0.0022683956,0.009228386],"category_scores_gemma":[0.09584359,0.00038509135,0.0011261055,0.0005840061,0.0013256321,0.0013463617,0.0029053339,0.004165095,0.00048591648],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26737332,0.02227571,0.06908018,0.0014570906,0.0020283172,0.00097600237,0.010233622,0.010413901,0.0020764205,0.0049144533,0.05280906,0.556362],"study_design_scores_gemma":[0.1589641,0.18580648,0.54985195,0.0013908998,0.002996873,0.001042018,0.00692166,0.015976012,0.0027395012,0.007565426,0.066155545,0.000589543],"about_ca_topic_score_codex":0.028147893,"about_ca_topic_score_gemma":0.090234905,"teacher_disagreement_score":0.9718521,"about_ca_system_score_codex":0.008575065,"about_ca_system_score_gemma":0.021781882,"threshold_uncertainty_score":0.19598728},"labels":[],"label_agreement":null},{"id":"W2091689720","doi":"10.1016/j.urolonc.2008.04.005","title":"Post–radical prostatectomy management options for the positive surgical margin: Argument for adjuvant radiotherapy","year":2008,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Adjuvant; Prostatectomy; Adjuvant radiotherapy; Radiation therapy; Urology; Randomized controlled trial; Prostate-specific antigen; Adjuvant therapy; Oncology; Prostate cancer; Internal medicine; Chemotherapy; Cancer","score_opus":0.04327598665435183,"score_gpt":0.36598670758854707,"score_spread":0.3227107209341952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091689720","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011403343,0.9979819,0.00004626604,0.0008426199,0.00019710482,0.000002252642,0.0000065680306,0.000002023218,0.00080713275],"genre_scores_gemma":[0.0013375145,0.997042,0.00013359834,0.0008883012,0.0003608215,0.0000028361392,0.000016759517,7.478658e-7,0.00021742303],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979,0.00006236426,0.000032366428,0.000030306674,0.00006967647,0.000015131436],"domain_scores_gemma":[0.9993838,0.00041598553,0.00009414988,0.000010688524,0.000074565665,0.000020774733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000671116,0.00045347025,0.0015598551,0.0010012654,0.00023478834,0.00066424406,0.00088443153,0.0011671097,0.002817421],"category_scores_gemma":[0.0015294336,0.00021018468,0.0005322458,0.0010272827,0.00053799455,0.00097430183,0.000394092,0.0016726579,0.00071000087],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010810136,0.000045103163,0.0006126503,0.020045454,0.00023289694,0.00071221543,0.000053107833,0.00033121317,0.0004896404,0.0023797636,0.053202394,0.9217875],"study_design_scores_gemma":[0.00014218035,0.00012059579,0.005972604,0.044921268,0.0008935083,0.008615766,0.0002522343,0.0002160641,0.00031047428,0.004476801,0.9340338,0.00004480978],"about_ca_topic_score_codex":0.0015469026,"about_ca_topic_score_gemma":0.0055538635,"teacher_disagreement_score":0.002817421,"about_ca_system_score_codex":0.0007606655,"about_ca_system_score_gemma":0.0012905434,"threshold_uncertainty_score":0.009425223},"labels":[],"label_agreement":null},{"id":"W2093323595","doi":"10.1016/s1078-1439(03)00099-1","title":"Permanent flank bulge is a consequence of flank incision for radical nephrectomy in one half of patients","year":2004,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Flank; Medicine; Nephrectomy; Flank pain; Surgery; Incidence (geometry); Renal cell carcinoma; Kidney; Anatomy; Internal medicine","score_opus":0.043113166350554795,"score_gpt":0.3070740894506124,"score_spread":0.2639609231000576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093323595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985227,0.00047721967,0.00006758868,0.00008035743,0.000015256194,0.0000031026186,0.000045027668,0.000006108472,0.0007826335],"genre_scores_gemma":[0.9994708,0.00016887885,0.00002811653,0.000043558703,0.000016463584,0.0000015224547,0.000058066056,0.0000014520606,0.00021123247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998536,0.000021075035,0.000012937971,0.00002131781,0.0000343135,0.000056634504],"domain_scores_gemma":[0.99935275,0.00014123564,0.000244248,0.000043906915,0.000023903898,0.00019394472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014104116,0.000108050386,0.000172563,0.00032892905,0.00033803983,0.0002533865,0.00018556515,0.00034186902,0.002765846],"category_scores_gemma":[0.0011453361,0.000118251824,0.00028899193,0.00030741876,0.00027252253,0.00023124415,0.00024091538,0.00046569025,0.00027043044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004414232,0.00009436104,0.96120733,0.000041430558,0.000031953958,0.022852974,0.00025728976,0.00003283565,0.0023115305,0.00008879697,0.0004224015,0.01221778],"study_design_scores_gemma":[0.00001397455,0.00038490043,0.91868186,0.000012738603,0.00002995561,0.0790035,0.0005404662,0.000080021695,0.0004960013,0.000079498524,0.00066753186,0.000009571631],"about_ca_topic_score_codex":0.0005419357,"about_ca_topic_score_gemma":0.0008796218,"teacher_disagreement_score":0.002765846,"about_ca_system_score_codex":0.00013330542,"about_ca_system_score_gemma":0.00021889184,"threshold_uncertainty_score":0.009252608},"labels":[],"label_agreement":null},{"id":"W2095617542","doi":"10.1016/j.urolonc.2010.01.001","title":"Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy","year":2010,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Concomitant; Medicine; Lymphovascular invasion; Bladder cancer; Cancer; Carcinoma in situ; Urology; Carcinoma; Internal medicine; Cohort; Stage (stratigraphy); Oncology; Metastasis; Biology","score_opus":0.010567045500921166,"score_gpt":0.26545005740970884,"score_spread":0.25488301190878765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095617542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987594,0.00031890144,0.00007615636,0.00005098653,0.000011443814,0.0000033016513,0.00006655188,0.000008234727,0.0007049887],"genre_scores_gemma":[0.9995647,0.00013284881,0.000075709344,0.00001538136,0.000042297834,0.00000189758,0.000071617236,0.000002068694,0.00009348624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99973434,0.00004031006,0.00004041044,0.000046617777,0.00008730404,0.000050910785],"domain_scores_gemma":[0.99781847,0.00049199024,0.0010419115,0.00013401425,0.000108359054,0.00040530867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025872793,0.00024806755,0.0004063639,0.0013163233,0.00046365053,0.00072122936,0.0003388754,0.000515819,0.0017374809],"category_scores_gemma":[0.0027784442,0.0002615761,0.00026255153,0.0011601648,0.00043794373,0.0006876355,0.00043441448,0.00053814094,0.0002539028],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028574953,0.000029356679,0.9920826,0.000015334748,0.000020248488,0.0019395183,0.00006769428,0.000033350607,0.003489109,0.000020403855,0.00007073843,0.0019459267],"study_design_scores_gemma":[0.0000033871895,0.00010427216,0.9923226,0.0000024594553,0.000037509602,0.0067760986,0.00017025901,0.00010364261,0.00029047285,0.000027289,0.00015729979,0.0000047145245],"about_ca_topic_score_codex":0.0010074597,"about_ca_topic_score_gemma":0.0024539323,"teacher_disagreement_score":0.0017374809,"about_ca_system_score_codex":0.00016255076,"about_ca_system_score_gemma":0.00031307692,"threshold_uncertainty_score":0.0058124065},"labels":[],"label_agreement":null},{"id":"W2096543518","doi":"10.1016/j.urolonc.2014.06.013","title":"Summary of the 8th Annual Bladder Cancer Think Tank: Collaborating to move research forward","year":2014,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institutes of Health; Bladder Cancer Advocacy Network","keywords":"Bladder cancer; Medicine; Multidisciplinary approach; Disease; Theme (computing); Cancer; Health care; Clinical trial; Quality of life (healthcare); Family medicine; Nursing; Political science; Internal medicine; Computer science","score_opus":0.0821095605138395,"score_gpt":0.4331758683550666,"score_spread":0.3510663078412271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096543518","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003891377,0.14382227,0.0011666736,0.4013202,0.4431589,0.0009841255,0.0025274546,0.00023191546,0.0063992795],"genre_scores_gemma":[0.0041483524,0.21414931,0.006756733,0.38069132,0.2952874,0.0034636229,0.0075173597,0.00044639152,0.08753956],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.987638,0.0029538965,0.0014926766,0.001119998,0.0050058975,0.00178953],"domain_scores_gemma":[0.95914847,0.006304683,0.0035714135,0.00074292877,0.019615294,0.01061727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.034084134,0.0028842401,0.0041779685,0.0061079455,0.003706272,0.007963246,0.004250185,0.01384221,0.048466966],"category_scores_gemma":[0.037692428,0.0016423505,0.004691848,0.0038470312,0.0013707953,0.0073564565,0.0089471,0.014246105,0.023984032],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014448946,0.00003292208,0.00010144922,0.0021917368,0.000050555896,0.00005287733,0.00009864081,0.000044425717,0.00020101033,0.00025279223,0.9733927,0.023436444],"study_design_scores_gemma":[0.00018509958,0.00013085868,0.0008191614,0.007860788,0.00016261895,0.00010928699,0.00037061542,0.00006835048,0.00016113924,0.0012427703,0.98883456,0.000054719607],"about_ca_topic_score_codex":0.005155058,"about_ca_topic_score_gemma":0.014567669,"teacher_disagreement_score":0.048466966,"about_ca_system_score_codex":0.0064040245,"about_ca_system_score_gemma":0.032278635,"threshold_uncertainty_score":0.18025625},"labels":[],"label_agreement":null},{"id":"W2097705796","doi":"10.1016/j.urolonc.2011.02.011","title":"Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of bladder","year":2011,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Université Laval; McGill University; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Lymph node; Urology; Lymph; Internal medicine; Oncology; Chemotherapy; Proportional hazards model; Prognostic variable; Cancer; Pathology","score_opus":0.03265623160195851,"score_gpt":0.30829055490778384,"score_spread":0.2756343233058253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097705796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9441052,0.01913562,0.020489898,0.004796404,0.0033730152,0.0027407792,0.0015299032,0.000090549496,0.003738674],"genre_scores_gemma":[0.9902714,0.00070245925,0.0064228536,0.0005277446,0.00068024034,0.00047330974,0.00043857654,0.000029869982,0.00045355762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97265685,0.016758937,0.0046500447,0.0020725229,0.0032095052,0.0006521802],"domain_scores_gemma":[0.77818906,0.14925697,0.010380054,0.014010268,0.046329197,0.0018344655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06677429,0.00072087545,0.0010989712,0.0023487392,0.0012134503,0.0015715542,0.001581134,0.0010059611,0.0013558452],"category_scores_gemma":[0.21092744,0.0004812587,0.0016761068,0.0012530629,0.0016175405,0.0012866252,0.00090946234,0.0010828958,0.00024418507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022687163,0.00031103185,0.80533904,0.0029027862,0.0044942643,0.0012820542,0.0024344665,0.0026964918,0.012728807,0.0021787025,0.009199422,0.13374583],"study_design_scores_gemma":[0.002755552,0.0065361247,0.86642545,0.0019012059,0.012385991,0.0027255171,0.0025767372,0.024209699,0.0309227,0.006947079,0.042274956,0.00033897892],"about_ca_topic_score_codex":0.0020914646,"about_ca_topic_score_gemma":0.003208279,"teacher_disagreement_score":0.06677429,"about_ca_system_score_codex":0.0020175194,"about_ca_system_score_gemma":0.0043334085,"threshold_uncertainty_score":0.3531404},"labels":[],"label_agreement":null},{"id":"W2098467164","doi":"10.1016/j.urolonc.2013.02.015","title":"Association of the Charlson comorbidity index and hypertension with survival in men with metastatic castration-resistant prostate cancer","year":2013,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Prostate cancer; Medicine; Comorbidity; Internal medicine; Oncology; Charlson comorbidity index; Cancer; Castration; Gynecology; Urology; Hormone","score_opus":0.03491996582786097,"score_gpt":0.30608319226866965,"score_spread":0.2711632264408087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098467164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99678564,0.0016210168,0.00008411829,0.00026990112,0.000050426643,0.000004145283,0.0003534961,0.000008796109,0.00082251546],"genre_scores_gemma":[0.9991912,0.00029265028,0.000040199193,0.000038557122,0.00008330277,0.000002078344,0.00016771804,0.0000015782525,0.00018266785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99967194,0.000098836346,0.000030179828,0.000055299013,0.00007067592,0.00007311],"domain_scores_gemma":[0.9984854,0.0003911217,0.00046309186,0.00010782812,0.000114063,0.0004385187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051822147,0.00027671506,0.00043825735,0.0006541029,0.0004488101,0.0005948464,0.000390174,0.00064709136,0.001602446],"category_scores_gemma":[0.002257451,0.00032474098,0.0007734782,0.0010485931,0.0002954212,0.0004759913,0.0004475065,0.0010833209,0.00013833454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032328142,0.000035986635,0.997964,0.000007665453,0.00012529212,0.000055652476,0.000020945587,0.000065470595,0.000107335174,0.00001638333,0.00010724482,0.001170783],"study_design_scores_gemma":[0.000006817033,0.00004132365,0.99951816,0.0000020113384,0.000047950765,0.00007126351,0.00003631345,0.00019100263,0.000013328012,0.000017650971,0.00005032779,0.0000038115572],"about_ca_topic_score_codex":0.010213816,"about_ca_topic_score_gemma":0.014377726,"teacher_disagreement_score":0.010213816,"about_ca_system_score_codex":0.00040030223,"about_ca_system_score_gemma":0.0006643273,"threshold_uncertainty_score":0.020308733},"labels":[],"label_agreement":null},{"id":"W2099810757","doi":"10.1016/j.urolonc.2004.10.008","title":"A prospective clinical trial of green tea for hormone refractory prostate cancer: An evaluation of the complementary/alternative therapy approach","year":2005,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Tea Polyphenols and Effects","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Ottawa Hospital","funders":"","keywords":"Medicine; Prostate cancer; Clinical endpoint; Toxicity; Refractory (planetary science); Internal medicine; Clinical trial; Hormone therapy; Cancer; Surgery; Gastroenterology","score_opus":0.14755935356850278,"score_gpt":0.4405284775318535,"score_spread":0.29296912396335073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099810757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913634,0.0028876811,0.0004565083,0.0008233619,0.0005446035,0.002036291,0.00043651942,0.00003678564,0.0014148086],"genre_scores_gemma":[0.9906872,0.0022195638,0.0013592658,0.0009775879,0.0007802075,0.0015914412,0.00041304497,0.000015987916,0.0019557716],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99795085,0.0014229675,0.00009653854,0.00024304296,0.000090395115,0.00019621068],"domain_scores_gemma":[0.99619114,0.0018145195,0.0004458323,0.00036669965,0.00019796929,0.0009838374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004666593,0.0021748089,0.003905142,0.0005874237,0.0009250159,0.0011669458,0.001090861,0.003154696,0.007545924],"category_scores_gemma":[0.0036734883,0.0009270913,0.0031298986,0.0007427283,0.002600797,0.001834094,0.0007036945,0.0038702677,0.00095408334],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98672664,0.0071794367,0.00042045035,0.00014581703,0.0004969817,0.00002501086,0.000038126498,0.00012281566,0.0007563067,0.000054920332,0.000078623685,0.003954892],"study_design_scores_gemma":[0.80798715,0.18859492,0.0015430073,0.000021064418,0.00087751495,0.000022945049,0.000034352845,0.00022260674,0.00025223158,0.00012503777,0.0003002491,0.000018927094],"about_ca_topic_score_codex":0.0010745595,"about_ca_topic_score_gemma":0.002291784,"teacher_disagreement_score":0.007545924,"about_ca_system_score_codex":0.0007805404,"about_ca_system_score_gemma":0.0017736853,"threshold_uncertainty_score":0.02524364},"labels":[],"label_agreement":null},{"id":"W2101691094","doi":"10.1016/j.urolonc.2014.04.006","title":"Risk factors for bladder cancer recurrence after nephroureterectomy for upper tract urothelial tumors: Results from the Canadian Upper Tract Collaboration","year":2014,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; University of Manitoba; University of British Columbia; McMaster University; Western University; Université de Montréal; Université Laval; University of Alberta; McGill University; Dalhousie University","funders":"McGill University Health Centre","keywords":"Medicine; Renal pelvis; Bladder cancer; Urology; Ureter; Hazard ratio; Retrospective cohort study; Cuff; Proportional hazards model; Urothelium; Cancer; Internal medicine; Surgery; Urinary bladder; Confidence interval","score_opus":0.02870974550337815,"score_gpt":0.3176958690155359,"score_spread":0.2889861235121578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101691094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9110719,0.011635318,0.00029134974,0.002243244,0.00019017143,0.00016673515,0.066612855,0.00004813017,0.0077403444],"genre_scores_gemma":[0.9731022,0.0051537883,0.00037898956,0.00042712656,0.000097086806,0.000079081554,0.01872352,0.000021345943,0.0020168219],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976821,0.00021220584,0.00016786158,0.00027105352,0.0010234171,0.0006433798],"domain_scores_gemma":[0.99303377,0.00037484986,0.0012821179,0.00018328615,0.0038256042,0.0013003177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001981323,0.00079392653,0.0010560267,0.0024323459,0.0025610256,0.0013008881,0.0021607873,0.0011120426,0.002042969],"category_scores_gemma":[0.0060107424,0.00054045185,0.0025795815,0.007775505,0.00045375674,0.0004893309,0.0015422667,0.0012010159,0.00025414355],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017126506,0.000026550893,0.9925666,0.00007175581,0.00033879388,0.000034581335,0.00023952272,0.00012355692,0.00003782362,0.00004566208,0.0032998135,0.0030441852],"study_design_scores_gemma":[0.000019017518,0.000015654981,0.99835604,0.00004003492,0.00017787266,0.00003222681,0.0003464587,0.00008502854,0.00001676668,0.000010304071,0.0008856004,0.000015026188],"about_ca_topic_score_codex":0.9897574,"about_ca_topic_score_gemma":0.99394244,"teacher_disagreement_score":0.018186858,"about_ca_system_score_codex":0.018186858,"about_ca_system_score_gemma":0.045922577,"threshold_uncertainty_score":0.1319555},"labels":[],"label_agreement":null},{"id":"W2103701043","doi":"10.1016/j.urolonc.2009.04.017","title":"Contemporary outcome and management of patients who had an aborted cystectomy due to unresectable bladder cancer","year":2009,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Concomitant; Surgery; Lymph node; Proportional hazards model; Dissection (medical); Chemotherapy; Urology; Cancer; Internal medicine","score_opus":0.044051661040566036,"score_gpt":0.3529124054344132,"score_spread":0.3088607443938472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103701043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954051,0.0017338826,0.000107654385,0.00066571374,0.00005014751,0.00000877004,0.00018358056,0.000004882115,0.0018403642],"genre_scores_gemma":[0.9987589,0.00054707634,0.00004458894,0.000114332346,0.00007217758,0.0000062394565,0.00033788345,0.0000023238827,0.000116575015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994905,0.000095061114,0.00007519832,0.00006803333,0.000090544076,0.00018067131],"domain_scores_gemma":[0.99842596,0.00028333778,0.0005594885,0.0000572206,0.00016227268,0.0005117183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004591612,0.0001905301,0.0003866533,0.0009360233,0.0010158524,0.0011550488,0.0006032389,0.0009215601,0.0010513348],"category_scores_gemma":[0.0034034941,0.0001613103,0.0006376557,0.0012079029,0.000604957,0.0006612114,0.0006606483,0.0009080376,0.00024097279],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026917772,0.00013412317,0.99061805,0.000018357716,0.00006633913,0.0022813508,0.0002628419,0.00019080532,0.00022973544,0.00008846327,0.000313338,0.005527442],"study_design_scores_gemma":[0.000016714836,0.00030722172,0.99272,0.000022556284,0.00005849427,0.004952393,0.00089927274,0.0003111513,0.00007404933,0.00015633201,0.00046631834,0.000015596486],"about_ca_topic_score_codex":0.004659208,"about_ca_topic_score_gemma":0.0066492213,"teacher_disagreement_score":0.004659208,"about_ca_system_score_codex":0.0011439817,"about_ca_system_score_gemma":0.00071727234,"threshold_uncertainty_score":0.009264171},"labels":[],"label_agreement":null},{"id":"W2108384264","doi":"10.1016/j.urolonc.2015.06.007","title":"Muscle-invasive bladder cancer is characterized by overexpression of thymidine kinase 1","year":2015,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Urothelium; Bladder cancer; Immunohistochemistry; Pathology; Cancer; Biology; Cancer research; Medicine; Internal medicine; Urinary bladder","score_opus":0.0459573828688726,"score_gpt":0.3343158383290297,"score_spread":0.28835845546015715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108384264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9443381,0.037008625,0.0021153153,0.0007717218,0.0001933078,0.000063529005,0.0011873734,0.00014820365,0.014173799],"genre_scores_gemma":[0.984706,0.008306904,0.0011114826,0.00016574535,0.000070398855,0.000022032566,0.0009150207,0.000008843735,0.004693459],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99988616,0.000013013558,0.000008903874,0.00002039136,0.00004437102,0.00002716869],"domain_scores_gemma":[0.9998672,0.000015660462,0.000061900355,0.000005899567,0.000026791724,0.000022508242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001692861,0.0003138686,0.00021460844,0.0006085934,0.00016957609,0.00045626654,0.00020035704,0.00025028124,0.0011326947],"category_scores_gemma":[0.00024543732,0.00010834547,0.00019539578,0.0007939734,0.00020892035,0.00015963237,0.00027834417,0.00031421203,0.00035041018],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065532484,0.00014929142,0.060719952,0.00055724045,0.000091078815,0.004436838,0.00017089774,0.0003198538,0.8662107,0.0009790896,0.00264207,0.06306769],"study_design_scores_gemma":[0.00007197728,0.0011848407,0.5440878,0.00011764462,0.00022464765,0.037249207,0.0005767116,0.001328938,0.3473591,0.0007635985,0.06698431,0.000051222687],"about_ca_topic_score_codex":0.00079254626,"about_ca_topic_score_gemma":0.0008846852,"teacher_disagreement_score":0.0011326947,"about_ca_system_score_codex":0.00032826333,"about_ca_system_score_gemma":0.00021861754,"threshold_uncertainty_score":0.003789246},"labels":[],"label_agreement":null},{"id":"W2109166448","doi":"10.1016/j.urolonc.2014.07.017","title":"World Urologic Oncology Federation Bladder Cancer Prevention Program: A global initiative","year":2014,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Health Sciences Centre","funders":"","keywords":"Medicine; Bladder cancer; Family medicine; Smoking cessation; Global health; Public health; Incidence (geometry); Population; Oncology; Cancer; Internal medicine; Environmental health; Nursing; Pathology","score_opus":0.09745354459747134,"score_gpt":0.43686144975296753,"score_spread":0.3394079051554962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109166448","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000117505,0.99594057,0.000058147336,0.0022948477,0.00043707102,0.000024976729,0.000082657665,0.000007123012,0.0010372356],"genre_scores_gemma":[0.0009290006,0.9970902,0.0002045135,0.001221754,0.00019160575,0.000025714087,0.00007181242,0.0000011754901,0.00026421275],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994648,0.00016029215,0.00008152321,0.00004826218,0.00017893448,0.000066138426],"domain_scores_gemma":[0.9986708,0.00048521464,0.0003258829,0.000025177562,0.0003191823,0.00017381748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002790729,0.0007373147,0.0016220965,0.0036918758,0.00036763214,0.0010302808,0.00095222617,0.001245272,0.0054664304],"category_scores_gemma":[0.002763832,0.00028762277,0.0012393177,0.0046887984,0.00040597667,0.0011967961,0.0012529955,0.0020599049,0.00080799847],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010832979,0.00015212891,0.00078665884,0.056287277,0.00038779443,0.0000786033,0.000052230916,0.00015516947,0.00019146955,0.0016559543,0.08144746,0.85869694],"study_design_scores_gemma":[0.0002197444,0.00019494303,0.0071020327,0.06391561,0.0017984429,0.0004932522,0.0001943127,0.000081256054,0.00026615866,0.000969578,0.9247392,0.000025372692],"about_ca_topic_score_codex":0.0047671273,"about_ca_topic_score_gemma":0.014721703,"teacher_disagreement_score":0.0054664304,"about_ca_system_score_codex":0.0018062424,"about_ca_system_score_gemma":0.010182121,"threshold_uncertainty_score":0.018287063},"labels":[],"label_agreement":null},{"id":"W2112366277","doi":"10.1016/j.urolonc.2013.12.005","title":"Bladder cancer: A portal into men׳s health","year":2014,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto","funders":"","keywords":"Medicine; Bladder cancer; Cancer; Internal medicine","score_opus":0.05600527733549215,"score_gpt":0.409072407161369,"score_spread":0.35306712982587685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112366277","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000055142114,0.997547,0.000027796803,0.0012505193,0.00033174688,0.0000017622418,0.000014648556,0.0000039167244,0.000767427],"genre_scores_gemma":[0.0008593622,0.9972529,0.000061615334,0.0009013733,0.0005048869,0.0000028607908,0.0000143665275,8.259413e-7,0.00040179474],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99971586,0.00009954099,0.000042406587,0.000029814404,0.00007956029,0.0000327405],"domain_scores_gemma":[0.99923503,0.00042582024,0.00014690308,0.000015879126,0.00010328562,0.00007309763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008840115,0.0006123985,0.0012370558,0.0029717304,0.0002951487,0.0014863755,0.0004907914,0.0013824386,0.009451724],"category_scores_gemma":[0.001685395,0.00025910218,0.0006515671,0.0034779017,0.00071259635,0.0021976577,0.0013364683,0.0018206475,0.0014031703],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000762902,0.00004766271,0.0003466969,0.038413584,0.00014078882,0.00014678559,0.0001355542,0.00014387321,0.00036572144,0.006333619,0.07451751,0.8793319],"study_design_scores_gemma":[0.000029445328,0.00007167847,0.0012400565,0.022544703,0.00024376663,0.0005736246,0.0001779853,0.000040130246,0.00010751237,0.0016415706,0.9733131,0.000016450285],"about_ca_topic_score_codex":0.001765514,"about_ca_topic_score_gemma":0.0045842817,"teacher_disagreement_score":0.009451724,"about_ca_system_score_codex":0.00093807845,"about_ca_system_score_gemma":0.0025660184,"threshold_uncertainty_score":0.03161913},"labels":[],"label_agreement":null},{"id":"W2113746837","doi":"10.1016/j.urolonc.2011.12.004","title":"Multifocality rather than tumor location is a prognostic factor in upper tract urothelial carcinoma","year":2013,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Manitoba; University of British Columbia; McMaster University; Université de Montréal; Université Laval; University of Alberta; Dalhousie University; McGill University; Western University","funders":"","keywords":"Renal pelvis; Medicine; Ureter; Urothelial carcinoma; Urology; Cohort; Retrospective cohort study; Ureteral neoplasm; Upper urinary tract; Carcinoma; Internal medicine; Oncology; Cancer; Urinary system; Transitional cell carcinoma; Bladder cancer","score_opus":0.031695058724388755,"score_gpt":0.3077854945877818,"score_spread":0.27609043586339305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113746837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964761,0.002354987,0.00025769972,0.00025250265,0.000030159645,0.0000041174644,0.0000872913,0.000008240841,0.0005287948],"genre_scores_gemma":[0.9992816,0.0003202458,0.000088669156,0.00001729752,0.000038011436,0.0000011655395,0.000052219893,0.000002771277,0.00019792472],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997216,0.000076793825,0.000032007363,0.00004177797,0.0000706072,0.000057266177],"domain_scores_gemma":[0.99713576,0.0009345508,0.00090456323,0.00017904691,0.00027183472,0.00057426357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009872646,0.00025300292,0.00041676758,0.00073859957,0.00035644695,0.00076332904,0.0003991461,0.00040952474,0.0020691738],"category_scores_gemma":[0.0054847966,0.00020881719,0.00031703088,0.0010146067,0.00042928336,0.00078852626,0.0005615387,0.0005442683,0.00024890553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037919468,0.000017774064,0.99065673,0.000023286648,0.000044988312,0.00019922503,0.000054725322,0.00012109889,0.001455848,0.00002631686,0.000117372176,0.0069034495],"study_design_scores_gemma":[0.000007326249,0.00014193442,0.9973316,0.000012385827,0.00008714797,0.0009061994,0.00017059245,0.00047953698,0.00037457186,0.00015638015,0.00032426772,0.000008149306],"about_ca_topic_score_codex":0.0015379164,"about_ca_topic_score_gemma":0.0032746552,"teacher_disagreement_score":0.0020691738,"about_ca_system_score_codex":0.00027222311,"about_ca_system_score_gemma":0.00036860158,"threshold_uncertainty_score":0.006922066},"labels":[],"label_agreement":null},{"id":"W2114759351","doi":"10.1016/j.urolonc.2014.06.003","title":"Population-based assessment of prostate-specific antigen testing for prostate cancer in the elderly","year":2014,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Prostate cancer; Medicine; Prostate-specific antigen; Oncology; Prostate; Cancer; Internal medicine; Population; Prostate cancer screening","score_opus":0.04422402095561237,"score_gpt":0.35280657117838127,"score_spread":0.3085825502227689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114759351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977622,0.00056299975,0.00021118914,0.00010923307,0.00001724507,0.0000134492875,0.00042136744,0.000009165637,0.0008930908],"genre_scores_gemma":[0.9992766,0.0002123995,0.00009349121,0.00007592204,0.000020395415,0.000008000438,0.00017847067,0.0000012080167,0.00013357688],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99942243,0.00023844352,0.000060138835,0.00010337348,0.000119034245,0.000056591834],"domain_scores_gemma":[0.99928856,0.0001437886,0.00022198932,0.000058993053,0.00015646839,0.00013014273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010478402,0.00017912802,0.00035492293,0.00100408,0.0003007141,0.0005396308,0.00024531264,0.00050383,0.0005784971],"category_scores_gemma":[0.0033466471,0.0002513612,0.0003945348,0.0009616695,0.000201718,0.00054272526,0.00046301918,0.0004119388,0.00023464223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006864185,0.000033201643,0.9981086,0.0000054579355,0.00004626318,0.000038117927,0.00003723322,0.000030288038,0.0000840389,0.000007610996,0.00012685174,0.0014137294],"study_design_scores_gemma":[0.0000035218443,0.00008790332,0.99938464,0.0000026083346,0.000026268986,0.00012776373,0.00011610455,0.00010759667,0.000026064634,0.000020350444,0.00009434139,0.000002769832],"about_ca_topic_score_codex":0.0071598357,"about_ca_topic_score_gemma":0.008668684,"teacher_disagreement_score":0.0071598357,"about_ca_system_score_codex":0.0003212313,"about_ca_system_score_gemma":0.00027759472,"threshold_uncertainty_score":0.014236331},"labels":[],"label_agreement":null},{"id":"W2116380170","doi":"10.1016/j.urolonc.2009.10.011","title":"BCAN Think Tank session 1: Overview of risks for and causes of bladder cancer","year":2010,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Bladder cancer; Grading (engineering); Epidemiology; Medicine; Causation; Cancer; Pathology; Internal medicine; Political science; Biology","score_opus":0.10086557556012189,"score_gpt":0.4145295704181021,"score_spread":0.31366399485798024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116380170","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002731976,0.04196796,0.005568471,0.7275613,0.15889242,0.0011394361,0.0047377544,0.0005461826,0.056854505],"genre_scores_gemma":[0.030666769,0.061175317,0.014593042,0.27027276,0.28854632,0.0021723516,0.009131909,0.0006208271,0.32282063],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985067,0.00056728785,0.00012674015,0.0001754216,0.00040572323,0.00021805103],"domain_scores_gemma":[0.9921009,0.0024494142,0.0005753747,0.0001761299,0.0026904987,0.002007721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069449167,0.0011292127,0.0009131861,0.0019757948,0.0015399114,0.0020603098,0.0012142916,0.0055172537,0.079280674],"category_scores_gemma":[0.011840332,0.0005780788,0.00127352,0.00078315963,0.00041073575,0.0021965005,0.0027499318,0.00663976,0.014556119],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013209891,0.000061722974,0.00063897774,0.0004571599,0.000021121677,0.0000857053,0.00011656198,0.00008202098,0.00026122507,0.0004377789,0.95881474,0.038890854],"study_design_scores_gemma":[0.00010520348,0.00009121245,0.006197223,0.0010193507,0.000047784863,0.00026395742,0.00055652927,0.00012006357,0.0002933645,0.003783717,0.9874824,0.000039144183],"about_ca_topic_score_codex":0.0052521406,"about_ca_topic_score_gemma":0.012537167,"teacher_disagreement_score":0.079280674,"about_ca_system_score_codex":0.0028207386,"about_ca_system_score_gemma":0.005086792,"threshold_uncertainty_score":0.26522028},"labels":[],"label_agreement":null},{"id":"W2118999469","doi":"10.1016/j.urolonc.2008.10.004","title":"The International Testicular Cancer Linkage Consortium: A clinicopathologic descriptive analysis of 461 familial malignant testicular germ cell tumor kindred","year":2009,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; National Institutes of Health; Cancer Research UK","keywords":"Cousin; Testicular Germ Cell Tumor; Testicular cancer; Seminoma; Medicine; Cancer; Genetic linkage; Oncology; Gynecology; Internal medicine; Genetics; Biology; Gene","score_opus":0.02739091710318237,"score_gpt":0.32246072670033554,"score_spread":0.2950698095971532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118999469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99874324,0.000084675856,0.00011333831,0.000015105536,0.000001780732,0.000011328661,0.00064155896,0.000004767186,0.00038425683],"genre_scores_gemma":[0.99831736,0.00007854481,0.0001791439,0.000020610163,0.0000049182395,0.000018791341,0.0011390712,0.000009891392,0.0002317419],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991454,0.00017452361,0.00010308811,0.00026307252,0.00016185573,0.00015194443],"domain_scores_gemma":[0.99855286,0.0003826212,0.00041750047,0.00019806276,0.0001723688,0.00027666296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007970522,0.0005091376,0.00050657004,0.0030355828,0.0016348134,0.00072553137,0.00056109705,0.00037104465,0.0031879747],"category_scores_gemma":[0.0030618473,0.0003593116,0.00035578985,0.0037173638,0.0005266788,0.00038950657,0.0008260714,0.00028272005,0.00038740446],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018433081,0.000054945194,0.9827641,0.000020642328,0.00007992389,0.0093423845,0.0018788263,0.00010561592,0.0023210456,0.00016408204,0.0004112296,0.0026730092],"study_design_scores_gemma":[0.000025706217,0.00010240856,0.9657229,0.000018138991,0.00016051224,0.029701052,0.0015000898,0.00023803551,0.0008056974,0.00010185396,0.0016039832,0.000019704641],"about_ca_topic_score_codex":0.01196019,"about_ca_topic_score_gemma":0.01099324,"teacher_disagreement_score":0.01196019,"about_ca_system_score_codex":0.00067337917,"about_ca_system_score_gemma":0.0006355264,"threshold_uncertainty_score":0.02378112},"labels":[],"label_agreement":null},{"id":"W2121489059","doi":"10.1016/j.urolonc.2015.06.016","title":"Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: A multi-institutional study","year":2015,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Survivin; Medicine; Lymphovascular invasion; Proportional hazards model; Pathological; Immunohistochemistry; Oncology; Internal medicine; Cohort; Lymph node; Cancer; Urology; Cancer research; Metastasis","score_opus":0.07031325358400829,"score_gpt":0.3367219696790415,"score_spread":0.2664087160950332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121489059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993198,0.0002287834,0.00006983864,0.000023421118,0.000006802803,0.0000066166963,0.000117165466,0.000002031987,0.00022555263],"genre_scores_gemma":[0.9996006,0.00006972295,0.000028327302,0.0000211261,0.000013018405,0.000004668243,0.00019151087,0.0000018560773,0.000069214475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906665,0.00029424945,0.00010629542,0.00023623637,0.000119317665,0.00017715253],"domain_scores_gemma":[0.9972355,0.000604485,0.00087685976,0.00037629736,0.0003981452,0.00050883327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010134672,0.00044419954,0.0008129013,0.0008001191,0.0010399895,0.0013575553,0.00064328086,0.0005187337,0.0019280657],"category_scores_gemma":[0.0032237968,0.00044784296,0.000869659,0.0019042025,0.000776175,0.0011627271,0.00079325994,0.0006614377,0.00033416867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004237837,0.000066763074,0.9980855,0.000008371374,0.00010375239,0.00013748025,0.000095901014,0.000024755072,0.00036830665,0.000015682086,0.00006869081,0.0006011234],"study_design_scores_gemma":[0.00005037499,0.00044536637,0.99732333,0.0000067507194,0.00022044563,0.00065367325,0.00054925174,0.00019412485,0.00015789855,0.000041039773,0.00034689202,0.000010863583],"about_ca_topic_score_codex":0.0030665991,"about_ca_topic_score_gemma":0.003105307,"teacher_disagreement_score":0.0030665991,"about_ca_system_score_codex":0.00052782166,"about_ca_system_score_gemma":0.000669466,"threshold_uncertainty_score":0.0064499974},"labels":[],"label_agreement":null},{"id":"W2123553756","doi":"10.1016/j.urolonc.2007.05.029","title":"The once and future role of cytoreductive nephrectomy","year":2008,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Nephrectomy; Renal cell carcinoma; Medicine; Randomized controlled trial; Urology; Internal medicine; Intensive care medicine; Oncology; General surgery; Kidney","score_opus":0.03543594296639664,"score_gpt":0.3268781618633462,"score_spread":0.29144221889694955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123553756","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007914366,0.9981912,0.000073738775,0.00057435373,0.00033200954,0.0000010422086,0.000004463971,0.0000028828188,0.0007411152],"genre_scores_gemma":[0.0010270895,0.99700975,0.00014898003,0.00059689104,0.00077181513,0.0000018832211,0.000010640023,9.4409455e-7,0.00043193434],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997756,0.00006492275,0.000029879606,0.000044905148,0.000067731205,0.000016990143],"domain_scores_gemma":[0.9993117,0.0004306807,0.00008655499,0.000019940384,0.000110059365,0.000041071075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000998958,0.0006591094,0.0011327281,0.0013368133,0.00030040264,0.0010832524,0.00084288284,0.0010818291,0.003323265],"category_scores_gemma":[0.0012935465,0.00021518586,0.00046347157,0.0013975372,0.0011076075,0.0020272087,0.0005182635,0.0018243352,0.0010196946],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006994012,0.000033660108,0.0003531809,0.008989615,0.00008662303,0.00056064856,0.000059728503,0.00037996407,0.0005698336,0.0036919902,0.028595285,0.9566095],"study_design_scores_gemma":[0.000028903369,0.000074888034,0.0013534179,0.0047792345,0.00017782151,0.0037340461,0.00011410657,0.00014508786,0.00026144375,0.0024900157,0.98681927,0.000021796839],"about_ca_topic_score_codex":0.001293679,"about_ca_topic_score_gemma":0.0034698595,"teacher_disagreement_score":0.003323265,"about_ca_system_score_codex":0.00081187213,"about_ca_system_score_gemma":0.0013871653,"threshold_uncertainty_score":0.011117399},"labels":[],"label_agreement":null},{"id":"W2124044133","doi":"10.1016/j.urolonc.2015.07.006","title":"Waist circumference, waist-hip ratio, body mass index, and prostate cancer risk: Results from the North-American case-control study Prostate Cancer & Environment Study","year":2015,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique; Université de Montréal","funders":"","keywords":"Waist; Body mass index; Medicine; Odds ratio; Prostate cancer; Anthropometry; Waist–hip ratio; Abdominal obesity; Population; Circumference; Obesity; Risk factor; Internal medicine; Logistic regression; Cancer; Waist-to-height ratio; Demography; Gynecology; Environmental health","score_opus":0.03701881968302579,"score_gpt":0.31361739170346975,"score_spread":0.27659857202044397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124044133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99512744,0.0015698384,0.00031296036,0.00010133878,0.00004382748,0.000037492347,0.0021886744,0.000012456118,0.00060589827],"genre_scores_gemma":[0.99586344,0.00070680346,0.000310092,0.000088221524,0.000071329734,0.00005532072,0.0023601437,0.000012431189,0.00053206494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975803,0.0011738879,0.00019697027,0.00043269267,0.0004357473,0.0001804029],"domain_scores_gemma":[0.9972216,0.00069076463,0.00063508353,0.00049153436,0.00039334042,0.0005677286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030831792,0.0009606389,0.0011454484,0.0012780823,0.0008913038,0.0012868287,0.0010852432,0.001019363,0.0014323094],"category_scores_gemma":[0.004037886,0.0016156189,0.001720434,0.003064205,0.00046311252,0.0007530205,0.0007750752,0.0012947071,0.00030285152],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019933302,0.00019168526,0.9935127,0.000048985785,0.0019395736,0.00014106419,0.00014871582,0.00008362593,0.0004135025,0.000036744925,0.0004529477,0.0010371883],"study_design_scores_gemma":[0.00011920691,0.00010741773,0.99871445,0.00000587723,0.0005303337,0.00008577411,0.00011702896,0.00008035823,0.000040444826,0.000011146133,0.00018067984,0.0000072824946],"about_ca_topic_score_codex":0.028236188,"about_ca_topic_score_gemma":0.030322548,"teacher_disagreement_score":0.028236188,"about_ca_system_score_codex":0.00051611604,"about_ca_system_score_gemma":0.0005739254,"threshold_uncertainty_score":0.05614364},"labels":[],"label_agreement":null},{"id":"W2126705382","doi":"10.1016/j.urolonc.2013.10.015","title":"Combining smoking information and molecular markers improves prognostication in patients with urothelial carcinoma of the bladder","year":2014,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Proportional hazards model; Survivin; Oncology; Lymphadenectomy; Hazard ratio; Internal medicine; Biomarker; Urology; Carcinoma; Tissue microarray; Disease; Cancer; Pathology; Confidence interval","score_opus":0.007235451908877756,"score_gpt":0.2360748174698737,"score_spread":0.22883936556099593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126705382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865682,0.009641734,0.00034352473,0.0012523765,0.00017980512,0.000014279541,0.0005410186,0.00003824765,0.0014207853],"genre_scores_gemma":[0.99639755,0.001762191,0.00032089648,0.00021756635,0.0002328348,0.0000043135447,0.0005321227,0.000007461472,0.00052494963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993917,0.00022643767,0.00006836923,0.00010150599,0.00012386727,0.0000880752],"domain_scores_gemma":[0.9978643,0.001034002,0.00042431234,0.00015657638,0.00022885382,0.00029200196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013157749,0.00054893165,0.001134584,0.0008108256,0.0003710781,0.0012230689,0.00059100863,0.0008941738,0.0016141167],"category_scores_gemma":[0.0056469804,0.00031596544,0.0008720846,0.0011832453,0.0002176799,0.000909727,0.0005786019,0.0009789389,0.00037958316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013328277,0.00017112281,0.96943206,0.00005081361,0.00035379644,0.000049717386,0.000040799954,0.00033431174,0.00060427026,0.000017534927,0.00039716257,0.027215585],"study_design_scores_gemma":[0.000058528534,0.000696603,0.993292,0.00004754381,0.00106271,0.00020131076,0.000110505134,0.0026137838,0.00073567696,0.0002721717,0.00088534295,0.000023942257],"about_ca_topic_score_codex":0.0017658586,"about_ca_topic_score_gemma":0.0050128903,"teacher_disagreement_score":0.0017658586,"about_ca_system_score_codex":0.00030401128,"about_ca_system_score_gemma":0.0004886262,"threshold_uncertainty_score":0.0069585443},"labels":[],"label_agreement":null},{"id":"W2127851117","doi":"10.1016/j.urolonc.2007.05.010","title":"Therapeutic options for hormone-refractory prostate cancer in 2007","year":2007,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Medicine; Prostate cancer; Docetaxel; Oncology; Cancer; Disease; Clinical trial; Chemotherapy; Internal medicine; Prostatectomy; Prostate; Cancer research","score_opus":0.12100402262422334,"score_gpt":0.4518026388460617,"score_spread":0.33079861622183837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127851117","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000109444416,0.9983541,0.000045127148,0.00034240744,0.00028295635,0.0000055794003,0.000015823241,0.0000032832495,0.00084126886],"genre_scores_gemma":[0.00080142386,0.9973279,0.00013679177,0.00060797075,0.0002446677,0.0000070611914,0.00003414401,0.000001011345,0.00083902245],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981266,0.00003957555,0.000039322807,0.000025773037,0.00006317849,0.000019495295],"domain_scores_gemma":[0.9997464,0.00010417073,0.000067349974,0.000007254815,0.000051885247,0.000023036017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006786023,0.0007721665,0.001366794,0.0020916099,0.00025226225,0.00087097846,0.0007255303,0.0008199657,0.0039289957],"category_scores_gemma":[0.00078526593,0.00035287804,0.00056510814,0.0022239254,0.00040652062,0.0012608514,0.000673214,0.0013933677,0.0013706851],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117337295,0.00006425741,0.00014949428,0.018981507,0.00011273342,0.00038045808,0.00005468709,0.00033410935,0.0010404766,0.0021234662,0.05285654,0.9237849],"study_design_scores_gemma":[0.000060336075,0.00012771989,0.0007761323,0.005115429,0.0002540166,0.0020831735,0.000053229538,0.00006703832,0.00038674477,0.00047071118,0.9905895,0.00001590574],"about_ca_topic_score_codex":0.0012342152,"about_ca_topic_score_gemma":0.005865458,"teacher_disagreement_score":0.0039289957,"about_ca_system_score_codex":0.0009362141,"about_ca_system_score_gemma":0.0013556159,"threshold_uncertainty_score":0.013143778},"labels":[],"label_agreement":null},{"id":"W2132768674","doi":"10.1016/j.urolonc.2015.05.030","title":"Cardiovascular risk with androgen deprivation therapy for prostate cancer: Potential mechanisms","year":2015,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Prostate cancer; Androgen deprivation therapy; Medicine; Testosterone (patch); Oncology; Internal medicine; Disease; Hormone therapy; Endocrinology; Diabetes mellitus; Cancer; Gynecology; Bioinformatics; Breast cancer; Biology","score_opus":0.06289872378817953,"score_gpt":0.3693781705458584,"score_spread":0.3064794467576789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132768674","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012742169,0.9994018,0.000021492633,0.00018585898,0.00006746263,0.000001392795,0.000014537581,0.000001238175,0.00017881404],"genre_scores_gemma":[0.0011581188,0.9983535,0.00004226657,0.00016621656,0.0001937142,0.0000027551828,0.0000143335665,2.7820758e-7,0.000068893896],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997981,0.00004806819,0.000033540684,0.000042244734,0.00005957184,0.000018559918],"domain_scores_gemma":[0.99950993,0.0003129615,0.00010198456,0.000008580343,0.00004755454,0.000018966844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065800163,0.0007337854,0.0015159877,0.001380621,0.00018867076,0.0009786302,0.00068898546,0.00075503025,0.0032920954],"category_scores_gemma":[0.0011272953,0.00026561774,0.0011110832,0.002007691,0.00039185886,0.0007737616,0.00064302003,0.0012538969,0.0004081614],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035578193,0.00010613012,0.0019970245,0.06373885,0.0017214271,0.00032190778,0.00011078959,0.0004802783,0.0010627036,0.0032501272,0.02394517,0.9029097],"study_design_scores_gemma":[0.00039655232,0.00065879454,0.02393996,0.040386397,0.008969933,0.0035237165,0.00044319392,0.0005095799,0.0009720969,0.010088884,0.9099584,0.00015246404],"about_ca_topic_score_codex":0.0010690026,"about_ca_topic_score_gemma":0.0029883632,"teacher_disagreement_score":0.0032920954,"about_ca_system_score_codex":0.00044409663,"about_ca_system_score_gemma":0.0011892341,"threshold_uncertainty_score":0.011013091},"labels":[],"label_agreement":null},{"id":"W2133571839","doi":"10.1016/j.urolonc.2014.11.018","title":"Natural history of surgically treated high-risk prostate cancer","year":2015,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Biochemical recurrence; breakpoint cluster region; Medicine; Prostate cancer; Prostatectomy; Proportional hazards model; Cancer; Oncology; Survivorship curve; Internal medicine; Urology; Surgery","score_opus":0.03295273585446662,"score_gpt":0.3010125277766605,"score_spread":0.26805979192219387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133571839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930259,0.0019773117,0.00014119517,0.00039018635,0.000020177407,0.000012779596,0.0012402019,0.000014719679,0.0031775942],"genre_scores_gemma":[0.99877053,0.00039204519,0.000030407253,0.00003533882,0.00002815877,0.000004333477,0.00046294057,0.0000023434477,0.00027369687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99969494,0.00009188205,0.00002332962,0.000062565385,0.00005439643,0.00007297216],"domain_scores_gemma":[0.99795806,0.0005874457,0.0006749109,0.00012041848,0.00013037414,0.0005288388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035766148,0.0001135395,0.00018835028,0.0010082269,0.0004197783,0.0005189523,0.00042354164,0.0004322215,0.0031829404],"category_scores_gemma":[0.002989443,0.00018932005,0.00033945823,0.00061387103,0.0003819395,0.00061590783,0.00041677448,0.0006516128,0.00030032932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031484143,0.000050856317,0.9952819,0.00001971499,0.000035122313,0.00037466016,0.000073660434,0.00012003602,0.00030313604,0.00008781613,0.0003162709,0.003021926],"study_design_scores_gemma":[0.0000041310423,0.000090751644,0.9972626,0.0000097481825,0.000020106932,0.0017836246,0.00018144332,0.00014350255,0.00006272816,0.0000865033,0.00034747217,0.000007308478],"about_ca_topic_score_codex":0.0037822798,"about_ca_topic_score_gemma":0.0042305468,"teacher_disagreement_score":0.0037822798,"about_ca_system_score_codex":0.0004557058,"about_ca_system_score_gemma":0.00045302848,"threshold_uncertainty_score":0.010648012},"labels":[],"label_agreement":null},{"id":"W2135532181","doi":"10.1016/j.urolonc.2014.06.008","title":"Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer","year":2014,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":342,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Dipstick; Urinary system; Cytology; Urology; Prospective cohort study; Bladder cancer; Urine; Gastroenterology; Internal medicine; Urine cytology; Urinalysis; Cancer; Urinary bladder; Pathology","score_opus":0.031121225003031473,"score_gpt":0.3306907502232353,"score_spread":0.2995695252202038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135532181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99834967,0.00064266316,0.00029620653,0.000024614144,0.000015954194,0.000008776436,0.00021265607,0.00000792497,0.00044151253],"genre_scores_gemma":[0.9995609,0.000047830592,0.00010058682,0.000013718117,0.00000865558,0.000003840858,0.00016949512,0.0000042137167,0.00009068959],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971746,0.0012167597,0.0002941426,0.00066792127,0.00036118279,0.000285422],"domain_scores_gemma":[0.9899767,0.0053257835,0.0016167482,0.0014134886,0.0009929795,0.0006743097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038409817,0.00051287276,0.0005575322,0.0012157566,0.00054665515,0.001369347,0.0007135546,0.001173839,0.0015954784],"category_scores_gemma":[0.011135956,0.0011988408,0.0010366584,0.0010068418,0.0007974295,0.0010899527,0.00070614676,0.00077811343,0.0006188505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094264053,0.000044272976,0.99740463,0.0000064385326,0.0001431475,0.000036276324,0.000035036574,0.00006452747,0.0005245924,0.000019318315,0.000035262874,0.0007437121],"study_design_scores_gemma":[0.000028817964,0.0003732812,0.99794227,0.0000047678714,0.00013963626,0.00026767686,0.00008077682,0.00053978653,0.00039021988,0.000038677128,0.00018591316,0.000008159095],"about_ca_topic_score_codex":0.0013319446,"about_ca_topic_score_gemma":0.0011738396,"teacher_disagreement_score":0.0038409817,"about_ca_system_score_codex":0.00032789426,"about_ca_system_score_gemma":0.0003317916,"threshold_uncertainty_score":0.020313323},"labels":[],"label_agreement":null},{"id":"W2139176803","doi":"10.1016/j.urolonc.2014.03.025","title":"Thromboembolic events in patients with urothelial carcinoma undergoing neoadjuvant chemotherapy and radical cystectomy","year":2014,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Intraperitoneal and Appendiceal Malignancies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University Medical Centre; Princess Margaret Cancer Centre; University of Toronto; Hamilton Health Sciences; Juravinski Cancer Centre; McMaster University","funders":"","keywords":"Cystectomy; Medicine; Hazard ratio; Proportional hazards model; Urology; Bladder cancer; Perioperative; Incidence (geometry); Chemotherapy; Surgery; Internal medicine; Oncology; Cancer; Confidence interval","score_opus":0.009547751566415085,"score_gpt":0.24926218203499032,"score_spread":0.23971443046857524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139176803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967558,0.0015402052,0.000053585616,0.00016025714,0.000028783865,0.000009424029,0.0001755452,0.0000035156968,0.0012729709],"genre_scores_gemma":[0.9987808,0.00058200303,0.000048298705,0.000103574646,0.00009110372,0.00000842875,0.00020507292,0.0000015299678,0.00017915289],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996952,0.000090939444,0.00004798886,0.0000402314,0.00006526434,0.00006029504],"domain_scores_gemma":[0.99859613,0.0005089671,0.00047719467,0.00006805956,0.00007011274,0.00027946816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030113125,0.00017150515,0.00042900824,0.0005330802,0.00039785774,0.0006476204,0.00020330965,0.00068102084,0.0014553567],"category_scores_gemma":[0.003398655,0.00020398556,0.00045937157,0.0010066135,0.00025669028,0.00045624503,0.00023904761,0.0006919321,0.00015382515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056216045,0.00004990084,0.99577373,0.000016727347,0.000059279737,0.001133559,0.00005468579,0.0000516979,0.00017382739,0.000025972095,0.00010215685,0.0019961982],"study_design_scores_gemma":[0.000028399263,0.00034472332,0.99507445,0.000013099446,0.00008700606,0.0036735262,0.00018314841,0.00014088821,0.00007456864,0.000048454716,0.00032476726,0.00000686357],"about_ca_topic_score_codex":0.001782562,"about_ca_topic_score_gemma":0.0027256631,"teacher_disagreement_score":0.001782562,"about_ca_system_score_codex":0.00037362412,"about_ca_system_score_gemma":0.0005078476,"threshold_uncertainty_score":0.004868686},"labels":[],"label_agreement":null},{"id":"W2144178561","doi":"10.1016/j.urolonc.2014.09.006","title":"The association between nerve sparing and a positive surgical margin during radical prostatectomy","year":2014,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; University of Ottawa; Dalhousie University; Ottawa Hospital","funders":"","keywords":"Medicine; Prostatectomy; Surgical margin; Biochemical recurrence; Surgery; Prostate cancer; Urology; Cancer; Internal medicine; Resection","score_opus":0.014663636061096358,"score_gpt":0.28416734803078153,"score_spread":0.26950371196968514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144178561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968086,0.0013525155,0.000089820234,0.00042031007,0.000068115754,0.0000045817906,0.00010126999,0.0000060314037,0.0011488419],"genre_scores_gemma":[0.99929774,0.00031231638,0.000046121793,0.000059751357,0.00012077049,0.0000016191638,0.000056439905,0.0000024294754,0.000102863116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99933124,0.00016663421,0.00010241834,0.000093593386,0.00016165565,0.00014440034],"domain_scores_gemma":[0.9923557,0.0030971093,0.0026537583,0.0003787909,0.0003479863,0.0011665834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084177766,0.00018665045,0.00027609788,0.0005534513,0.00051713735,0.00075252267,0.00066118396,0.0011958532,0.0022618533],"category_scores_gemma":[0.010216198,0.00029873953,0.00053785613,0.0007344945,0.00049834466,0.00066463,0.0003495805,0.0014831341,0.00020714823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006412751,0.0000667185,0.99470717,0.000027542917,0.00006940373,0.001166547,0.00006096461,0.0001315885,0.0005976586,0.000030647356,0.0001429211,0.0023575292],"study_design_scores_gemma":[0.0000075679027,0.00014700388,0.9960063,0.000013103463,0.000049564416,0.003087966,0.0001742732,0.00016015652,0.000107178676,0.000054346645,0.00018379554,0.0000087634035],"about_ca_topic_score_codex":0.0027952564,"about_ca_topic_score_gemma":0.005670102,"teacher_disagreement_score":0.0027952564,"about_ca_system_score_codex":0.00039212007,"about_ca_system_score_gemma":0.0008962598,"threshold_uncertainty_score":0.007566631},"labels":[],"label_agreement":null},{"id":"W2148710188","doi":"10.1016/j.urolonc.2013.07.006","title":"Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma","year":2013,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Metformin; Cystectomy; Hazard ratio; Internal medicine; Proportional hazards model; Bladder cancer; Diabetes mellitus; Cancer; Confidence interval; Gastroenterology; Urology; Lower risk; Cumulative incidence; Oncology; Surgery; Cohort; Endocrinology; Insulin","score_opus":0.01072963861945313,"score_gpt":0.25893845502060214,"score_spread":0.248208816401149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148710188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998793,0.0004886059,0.00001728743,0.00008919159,0.000021892241,0.0000037757868,0.00019845832,0.0000014972579,0.00038629063],"genre_scores_gemma":[0.9994122,0.00016350472,0.0000135677,0.000035933703,0.000032187058,0.0000031436452,0.00021620138,0.0000012184255,0.00012196125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994998,0.00014186393,0.000063524734,0.00008566704,0.00007285578,0.00013639774],"domain_scores_gemma":[0.99697816,0.0007014011,0.0012418252,0.00013029596,0.00015288636,0.0007954292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070067507,0.00023743033,0.00057388813,0.0005743566,0.00053135544,0.0010309166,0.0005233081,0.0007638329,0.0018075748],"category_scores_gemma":[0.0039831875,0.00030534485,0.0014623314,0.0010812037,0.0003774421,0.0007919193,0.00063360686,0.00145647,0.0001609497],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017399378,0.0001283192,0.99635255,0.000010153852,0.00026413013,0.00005577263,0.000029234656,0.00006584067,0.00009765604,0.000011904464,0.000055280212,0.00118925],"study_design_scores_gemma":[0.000049412178,0.00032607713,0.9989373,0.00000566859,0.00019502027,0.00006337131,0.00012338463,0.00015756876,0.000031369345,0.000027156113,0.00007597165,0.000007737108],"about_ca_topic_score_codex":0.005930147,"about_ca_topic_score_gemma":0.008341176,"teacher_disagreement_score":0.005930147,"about_ca_system_score_codex":0.000605832,"about_ca_system_score_gemma":0.00071887433,"threshold_uncertainty_score":0.011791289},"labels":[],"label_agreement":null},{"id":"W2152258370","doi":"10.1016/j.urolonc.2015.06.015","title":"Salvage ablative therapy in prostate cancer: International multidisciplinary consensus on trial design","year":2015,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Prostate cancer; Cryotherapy; Clinical trial; Prostatectomy; Salvage therapy; Medical physics; Quality of life (healthcare); Cancer; Surgery; Internal medicine","score_opus":0.10660680992827132,"score_gpt":0.3833348494028347,"score_spread":0.27672803947456337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152258370","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03579893,0.4251485,0.13849133,0.089829266,0.03597125,0.24268502,0.005789293,0.0007681246,0.02551831],"genre_scores_gemma":[0.21171123,0.08503129,0.24207348,0.06312586,0.011920155,0.37705445,0.0039149653,0.00065044395,0.004518176],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.6770117,0.26560494,0.038439818,0.0061871945,0.010298081,0.0024581817],"domain_scores_gemma":[0.81259,0.12284004,0.025492385,0.015638733,0.01726961,0.0061693224],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.29071403,0.0021736152,0.01071401,0.0019735207,0.0023822053,0.007926797,0.0045126704,0.0068447953,0.0045084013],"category_scores_gemma":[0.27612773,0.0017511911,0.00985226,0.0025697006,0.0033993074,0.0038694555,0.0053254953,0.011855679,0.0015380217],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.110176295,0.001058882,0.009689226,0.088618904,0.047302447,0.0001861799,0.0019220597,0.0042329724,0.0027356814,0.024290083,0.057848457,0.6519389],"study_design_scores_gemma":[0.31164294,0.012055195,0.02911292,0.16154177,0.064160824,0.0005310027,0.00093072286,0.011480844,0.0044358117,0.08914922,0.31425807,0.00070071843],"about_ca_topic_score_codex":0.0016412172,"about_ca_topic_score_gemma":0.0041124187,"teacher_disagreement_score":0.29071403,"about_ca_system_score_codex":0.0049246787,"about_ca_system_score_gemma":0.014086324,"threshold_uncertainty_score":0.87467587},"labels":[],"label_agreement":null},{"id":"W2152831266","doi":"10.1016/j.urolonc.2005.05.010","title":"Treatment of stage I seminoma: A 15-year review","year":2006,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Ottawa Regional Cancer Foundation; University of Ottawa","funders":"","keywords":"Medicine; Seminoma; Radiation therapy; Stage (stratigraphy); Surgery; Adjuvant; Chemotherapy; Adjuvant radiotherapy; Internal medicine","score_opus":0.06720765440953232,"score_gpt":0.3867848159972172,"score_spread":0.3195771615876849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152831266","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011703627,0.99945134,0.00004330301,0.000109620094,0.00012033777,0.0000029791295,0.0000114518425,0.000003468695,0.00014045488],"genre_scores_gemma":[0.0004642458,0.9990741,0.000092685,0.00016446877,0.000101033496,0.000002484944,0.000019663328,7.571564e-7,0.00008056729],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997098,0.000049566203,0.00007169406,0.000060612667,0.000084681684,0.00002357413],"domain_scores_gemma":[0.9993475,0.00033709995,0.00014149172,0.000011746603,0.000113880065,0.000048159833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095197547,0.00097344036,0.0027506407,0.0025278847,0.00025451044,0.0010291542,0.0016533558,0.0010189294,0.0023059445],"category_scores_gemma":[0.0012503142,0.00042467806,0.00078041846,0.0029444376,0.0005098571,0.0018552514,0.0007247239,0.0010943104,0.0008939719],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018338712,0.000088467015,0.000671659,0.051431447,0.00041139318,0.0007217514,0.00008896628,0.00045498135,0.0010581085,0.0005401017,0.032829635,0.9115202],"study_design_scores_gemma":[0.00014547454,0.00043806093,0.0051099863,0.02803098,0.002191644,0.008072606,0.00035291605,0.000271797,0.00062556996,0.0010904318,0.9535953,0.00007523183],"about_ca_topic_score_codex":0.0012463429,"about_ca_topic_score_gemma":0.0039072814,"teacher_disagreement_score":0.0027506407,"about_ca_system_score_codex":0.0005893281,"about_ca_system_score_gemma":0.0011560704,"threshold_uncertainty_score":0.007714212},"labels":[],"label_agreement":null},{"id":"W2153605569","doi":"10.1016/j.urolonc.2015.01.021","title":"Head-to-head comparison of the Montreal nomogram with the detection of primary malignant circulating prostate cells to predict prostate cancer at initial biopsy in Chilean men with suspicion of prostate cancer","year":2015,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nomogram; Medicine; Prostate cancer; Rectal examination; Urology; Biopsy; Prostate; Prostate-specific antigen; Prostate biopsy; Cancer; Prospective cohort study; Gynecology; Internal medicine","score_opus":0.03296638279800129,"score_gpt":0.32386478213087444,"score_spread":0.29089839933287315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153605569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99484295,0.0012912758,0.00019456001,0.00021070303,0.00006088234,0.000050716564,0.00083580083,0.000018134682,0.0024951345],"genre_scores_gemma":[0.99873763,0.00013798109,0.00012906332,0.000060212016,0.000026952168,0.000014848956,0.00035428652,0.000007821746,0.0005312638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989773,0.00049882376,0.000050212086,0.0001896615,0.00010842346,0.0001755915],"domain_scores_gemma":[0.99574137,0.001985115,0.0005566992,0.00037709234,0.00086599775,0.0004736821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028306677,0.00063154346,0.0006508094,0.0013217302,0.00062821043,0.0011824004,0.0008470151,0.00069871795,0.003463491],"category_scores_gemma":[0.008599926,0.0003364851,0.0010892662,0.00090015586,0.0006385284,0.00064022245,0.0011658447,0.0007244149,0.0005130229],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049956753,0.00007154087,0.9845263,0.00006583317,0.0008114513,0.00015266651,0.00027669076,0.0005519797,0.00055103615,0.000065094304,0.0007121379,0.0072196173],"study_design_scores_gemma":[0.00018530202,0.0007925795,0.9943849,0.00003381759,0.0005457596,0.00016042426,0.00084188196,0.0013969527,0.00033790898,0.000063967,0.0012250993,0.000031406955],"about_ca_topic_score_codex":0.118250854,"about_ca_topic_score_gemma":0.11915886,"teacher_disagreement_score":0.118250854,"about_ca_system_score_codex":0.002428256,"about_ca_system_score_gemma":0.0017884977,"threshold_uncertainty_score":0.23512512},"labels":[],"label_agreement":null},{"id":"W2157818081","doi":"10.1016/j.urolonc.2013.11.010","title":"Effect of ABO blood type on mortality in patients with urothelial carcinoma of the bladder treated with radical cystectomy","year":2014,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Blood groups and transfusion","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"ABO blood group system; Medicine; Cystectomy; Blood type (non-human); Internal medicine; Bladder cancer; Gastroenterology; Urothelial carcinoma; Lymphovascular invasion; Urology; Surgery; Cancer; Metastasis","score_opus":0.007672221390631207,"score_gpt":0.2485524031231271,"score_spread":0.2408801817324959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157818081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99850285,0.0007076964,0.000040780225,0.000119659526,0.000033826214,0.0000026698924,0.00010268909,0.000003035459,0.00048681305],"genre_scores_gemma":[0.9994654,0.00016908662,0.00001783078,0.00003712474,0.000049309372,0.0000020647437,0.000119852804,0.0000017869277,0.00013754185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99962234,0.00014405421,0.000029849023,0.00006214459,0.000039195078,0.0001024007],"domain_scores_gemma":[0.99806935,0.00083560817,0.00036986326,0.00010734333,0.000083756364,0.00053401344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048684323,0.00026346557,0.0006214248,0.00040610615,0.00044884562,0.0006740829,0.00038985038,0.0006533583,0.0013179453],"category_scores_gemma":[0.0031447592,0.00021605362,0.0011926163,0.0006376195,0.00035741058,0.0005461005,0.000379273,0.0012051803,0.00015426287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065135215,0.00017631766,0.9888159,0.000016888818,0.00029054208,0.00020954879,0.000058881247,0.00025478276,0.0004034508,0.000028762457,0.00012955548,0.003101744],"study_design_scores_gemma":[0.000074237054,0.0011276307,0.9974915,0.000008132909,0.0002876266,0.00016767386,0.00015625836,0.00039297383,0.00010363685,0.00006556635,0.00011305601,0.0000116791],"about_ca_topic_score_codex":0.0030506977,"about_ca_topic_score_gemma":0.0035483914,"teacher_disagreement_score":0.0030506977,"about_ca_system_score_codex":0.00041226484,"about_ca_system_score_gemma":0.0004318311,"threshold_uncertainty_score":0.0060658455},"labels":[],"label_agreement":null},{"id":"W2160379180","doi":"10.1016/j.urolonc.2013.12.012","title":"Examining the management of muscle-invasive bladder cancer by medical oncologists in the United States","year":2014,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institutes of Health; Bladder Cancer Advocacy Network","keywords":"Medicine; Gemcitabine; Bladder cancer; Carboplatin; Oncology; Internal medicine; Cisplatin; Chemotherapy; Cystectomy; Vinblastine; Lymphovascular invasion; Cancer","score_opus":0.04109061550821144,"score_gpt":0.33443319142500966,"score_spread":0.29334257591679824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160379180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917316,0.00089212006,0.000058148842,0.0045430004,0.00003444249,0.00004772718,0.00028436174,0.0000043568484,0.0024043682],"genre_scores_gemma":[0.9948997,0.0012425438,0.0002999186,0.0028999983,0.00005134596,0.00005975124,0.00023744756,0.0000021285412,0.0003072281],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974718,0.0012660361,0.00031993422,0.0001610339,0.00045158077,0.00032959707],"domain_scores_gemma":[0.98800826,0.0020333242,0.0062529934,0.00016292933,0.0014436853,0.0020988574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030951912,0.00011578909,0.00011718879,0.0007397171,0.0008756997,0.0006742175,0.0004376042,0.00078577374,0.0013582581],"category_scores_gemma":[0.0087886825,0.0002449672,0.00019962498,0.0007347209,0.00034152044,0.000758759,0.0011025817,0.00079158804,0.00017877687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003368927,0.00010827045,0.9901754,0.00006153915,0.000016955271,0.00007036187,0.0016563522,0.00002657655,0.00013565285,0.000028898055,0.0015337048,0.0061526545],"study_design_scores_gemma":[0.0000137713205,0.00019846416,0.98698425,0.00013378354,0.000017245948,0.0001871681,0.00900953,0.00014208221,0.000093169736,0.00002449162,0.0031896946,0.00000640735],"about_ca_topic_score_codex":0.020020986,"about_ca_topic_score_gemma":0.036642835,"teacher_disagreement_score":0.020020986,"about_ca_system_score_codex":0.0013743391,"about_ca_system_score_gemma":0.0031664018,"threshold_uncertainty_score":0.03980893},"labels":[],"label_agreement":null},{"id":"W2161460219","doi":"10.1016/j.urolonc.2012.12.005","title":"Short telomeres and chromosome instability prior to histologic malignant progression and cytogenetic aneuploidy in papillary urothelial neoplasms","year":2013,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute","funders":"Ministry of Education, Culture, Sports, Science and Technology","keywords":"Telomere; Anaphase; Chromosome instability; Biology; Aneuploidy; Fluorescence in situ hybridization; Chromosome; Genome instability; Molecular biology; Cancer research; Genetics; DNA damage; Gene; DNA","score_opus":0.024873176903636513,"score_gpt":0.30295728382588366,"score_spread":0.27808410692224717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161460219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971246,0.0014521972,0.00019227997,0.000078212885,0.000010286691,0.0000044645885,0.00006351971,0.000008212292,0.0010661138],"genre_scores_gemma":[0.99937207,0.0002500755,0.00005686706,0.000010411896,0.000017398073,0.0000016955119,0.00005340607,0.0000014976888,0.00023665183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998363,0.00002746127,0.000019398147,0.000025740288,0.00004378792,0.00004729003],"domain_scores_gemma":[0.9987331,0.0004072959,0.0003859434,0.000081048485,0.00015899274,0.00023363689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047698373,0.00010603452,0.00022071808,0.0019055197,0.00034016737,0.000656208,0.0002813369,0.0004888624,0.002261837],"category_scores_gemma":[0.0026370084,0.0002177264,0.0001440306,0.0006842248,0.00032972303,0.00049711374,0.0003829848,0.00046555465,0.00021448346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023885316,0.00008964548,0.9555026,0.00004458547,0.000037062015,0.005780071,0.00044325032,0.00013798564,0.023322526,0.00025916166,0.00021601688,0.011778723],"study_design_scores_gemma":[0.000008326025,0.00014990097,0.9891066,0.000009668052,0.00003054912,0.005944625,0.0005005604,0.00019022354,0.003102363,0.00027563123,0.00067300233,0.000008590813],"about_ca_topic_score_codex":0.0016549448,"about_ca_topic_score_gemma":0.0016738104,"teacher_disagreement_score":0.002261837,"about_ca_system_score_codex":0.0002706556,"about_ca_system_score_gemma":0.00038046626,"threshold_uncertainty_score":0.007566631},"labels":[],"label_agreement":null},{"id":"W2162192015","doi":"10.1016/j.urolonc.2009.08.015","title":"Clinical significance of the positive surgical margin based upon location, grade, and stage","year":2010,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Prostatectomy; Radiation therapy; Stage (stratigraphy); Adverse effect; Margin (machine learning); Disease; Prostate cancer; Clinical trial; Surgical margin; Surgery; Cancer; General surgery; Internal medicine","score_opus":0.06899239039751238,"score_gpt":0.39792617653264956,"score_spread":0.3289337861351372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162192015","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038234078,0.9987968,0.000045588597,0.00016006088,0.000078040626,0.000003632777,0.00004234741,0.0000016573908,0.0004894372],"genre_scores_gemma":[0.005763807,0.99335176,0.00018067112,0.00018520608,0.00011006342,0.000004789023,0.00008928614,9.145843e-7,0.00031358367],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997851,0.00004937734,0.000035856756,0.000046791545,0.00006956074,0.000013193807],"domain_scores_gemma":[0.9995628,0.00026216015,0.00007520282,0.000009847657,0.000077152676,0.000012859809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057637907,0.0005045439,0.0014184376,0.0015916199,0.00012528518,0.00061057863,0.0007266966,0.00040645045,0.0018626801],"category_scores_gemma":[0.0013792311,0.00018623464,0.0005729497,0.0016989108,0.00044090586,0.0004677913,0.00029038696,0.0005866829,0.000522131],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018064766,0.000021832815,0.0053736363,0.027117591,0.0004392529,0.000310336,0.000062765655,0.00026034855,0.00096275425,0.00081420434,0.019869562,0.944587],"study_design_scores_gemma":[0.00018889358,0.00043838934,0.08304338,0.04967901,0.006059748,0.014008394,0.00059993344,0.0005176363,0.0021646854,0.0033447703,0.83982426,0.00013089557],"about_ca_topic_score_codex":0.0028986933,"about_ca_topic_score_gemma":0.0069142324,"teacher_disagreement_score":0.0028986933,"about_ca_system_score_codex":0.00042981651,"about_ca_system_score_gemma":0.00087267434,"threshold_uncertainty_score":0.0062312484},"labels":[],"label_agreement":null},{"id":"W2163539852","doi":"10.1016/j.urolonc.2013.10.010","title":"Considerations on the use of urine markers in the management of patients with low-/intermediate-risk non–muscle invasive bladder cancer","year":2014,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Bladder cancer; Urine; Medicine; Cancer; Oncology; Urology; Internal medicine","score_opus":0.04851700687135616,"score_gpt":0.32036497459203694,"score_spread":0.27184796772068076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163539852","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000057663823,0.99859434,0.000053548345,0.00092895556,0.00013547002,0.0000022205224,0.0000075935895,0.0000020743787,0.00021812819],"genre_scores_gemma":[0.0010784899,0.9975074,0.00025462522,0.0007923088,0.00026332645,0.000005407856,0.00001780111,7.7288803e-7,0.00008007402],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99895084,0.0003877928,0.0002411613,0.00009776953,0.0002754821,0.000046944973],"domain_scores_gemma":[0.9967843,0.002222924,0.00035819743,0.00003254313,0.0005261625,0.0000759307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026308517,0.00063857884,0.002626515,0.0018716762,0.0003068615,0.0014472924,0.0014695387,0.0017662236,0.0015328089],"category_scores_gemma":[0.005410615,0.00030465802,0.001274282,0.0015443887,0.0006328528,0.001457895,0.0006434237,0.0028675608,0.00053446635],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017397323,0.000052353786,0.0010601511,0.031658586,0.0004039163,0.00039005876,0.000095660136,0.000327175,0.00049160264,0.0023544785,0.028116839,0.9348752],"study_design_scores_gemma":[0.00017717299,0.00027474112,0.0067695808,0.1056501,0.002122813,0.0043389755,0.0004727227,0.00044417678,0.00060451025,0.0050932234,0.8739507,0.000101258476],"about_ca_topic_score_codex":0.003335008,"about_ca_topic_score_gemma":0.008341263,"teacher_disagreement_score":0.003335008,"about_ca_system_score_codex":0.0008893577,"about_ca_system_score_gemma":0.0023859343,"threshold_uncertainty_score":0.013913393},"labels":[],"label_agreement":null},{"id":"W2165050132","doi":"10.1016/j.urolonc.2011.02.014","title":"Clinical application of a 3D ultrasound-guided prostate biopsy system","year":2011,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":239,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"DOD Prostate Cancer Research Program; National Cancer Institute; Prostate Cancer Foundation; U.S. Department of Defense","keywords":"Medicine; Prostate biopsy; Radiology; Ultrasound; Prostate; Biopsy; 3D ultrasound; Medical physics; Internal medicine; Cancer","score_opus":0.05918423511651317,"score_gpt":0.3493369825093319,"score_spread":0.2901527473928187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165050132","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46142614,0.01197601,0.49459663,0.0037556943,0.0012719813,0.00062333926,0.001032777,0.005641003,0.019676453],"genre_scores_gemma":[0.79373926,0.0014787437,0.20031056,0.0012057528,0.00024739344,0.00014940402,0.00023216718,0.00019620049,0.0024404917],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99922144,0.00024840026,0.000060763825,0.000106457475,0.0003174607,0.000045438966],"domain_scores_gemma":[0.9991672,0.0002984481,0.000055516266,0.0001552957,0.00022048996,0.00010305448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011697325,0.00034142003,0.00037911575,0.0008263911,0.00038244555,0.0009138711,0.00046281528,0.0011971929,0.0037093633],"category_scores_gemma":[0.002396683,0.00045241567,0.00054611824,0.0004087575,0.00036325454,0.0004952361,0.00088217796,0.00047468115,0.0011553509],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018450185,0.00022552635,0.03717194,0.00043430502,0.00016171344,0.004194048,0.0005747692,0.008374347,0.44893876,0.0010418074,0.0057258275,0.491312],"study_design_scores_gemma":[0.00066071947,0.0070590256,0.27235156,0.00044849105,0.0007854287,0.08853259,0.0006891184,0.2271262,0.31495327,0.002801471,0.083781496,0.0008106514],"about_ca_topic_score_codex":0.0013808616,"about_ca_topic_score_gemma":0.001980399,"teacher_disagreement_score":0.0037093633,"about_ca_system_score_codex":0.00036384977,"about_ca_system_score_gemma":0.0006651148,"threshold_uncertainty_score":0.012409091},"labels":[],"label_agreement":null},{"id":"W2170873872","doi":"10.1016/j.urolonc.2011.05.018","title":"The management of subcentimeter residual mass in NSGCT: pcRPLND vs. observation","year":2011,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Chemotherapy; Medicine; Dissection (medical); Residual; Retroperitoneal lymph node dissection; Lymph node; Radiology; Surgery; Internal medicine","score_opus":0.05467059383403067,"score_gpt":0.3010119262507773,"score_spread":0.2463413324167466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170873872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8362824,0.1033349,0.01077996,0.015469088,0.0012994169,0.00019648988,0.0002981704,0.00023267155,0.032106884],"genre_scores_gemma":[0.98074543,0.012169982,0.0024492878,0.0013010165,0.0013776771,0.000052950294,0.00020332776,0.000021105121,0.0016791532],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9997875,0.000054538297,0.000023285944,0.000029199207,0.000055334844,0.000050183316],"domain_scores_gemma":[0.9997116,0.000117097894,0.00005068866,0.000018488623,0.000016341144,0.000085788946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076195144,0.00023414922,0.0005435694,0.00043876338,0.00031120956,0.0005527892,0.0004988211,0.00044993116,0.001166304],"category_scores_gemma":[0.0012297789,0.00010742237,0.00041450042,0.0002593916,0.0006305066,0.0010171352,0.0003588724,0.0010711643,0.00023787828],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009232691,0.00060059706,0.07130305,0.00085981766,0.00016681301,0.025807066,0.00036545872,0.006584041,0.008894765,0.0023669298,0.005797071,0.8680217],"study_design_scores_gemma":[0.0031134773,0.031043002,0.5137312,0.002671806,0.0010076575,0.30909994,0.0025785035,0.021179449,0.018004414,0.0134386495,0.08387616,0.00025576813],"about_ca_topic_score_codex":0.0011391476,"about_ca_topic_score_gemma":0.0023351172,"teacher_disagreement_score":0.001166304,"about_ca_system_score_codex":0.0005242999,"about_ca_system_score_gemma":0.00074668403,"threshold_uncertainty_score":0.0040296316},"labels":[],"label_agreement":null},{"id":"W2171384261","doi":"10.1016/j.urolonc.2010.07.003","title":"Decision curve analysis to compare 3 versions of Partin Tables to predict final pathologic stage","year":2010,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Prostatectomy; Stage (stratigraphy); Prostate cancer; Nomogram; Statistics; Clinical Practice; Medicine; Mathematics; Oncology; Internal medicine; Cancer; Physical therapy","score_opus":0.04041080967512182,"score_gpt":0.3445594674241834,"score_spread":0.3041486577490616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171384261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52801466,0.012439778,0.42295435,0.002622051,0.0018400375,0.0046094675,0.015483359,0.003876977,0.008159368],"genre_scores_gemma":[0.8687926,0.0013420678,0.11394029,0.00077187817,0.00038225082,0.0033462462,0.007743304,0.0010048968,0.0026763869],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.93710804,0.048444837,0.00439257,0.003931163,0.0052748327,0.0008485719],"domain_scores_gemma":[0.5413038,0.433494,0.0066315024,0.010293331,0.0063498495,0.0019274364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0786028,0.0024136386,0.0062676924,0.005186499,0.0007219586,0.0040662987,0.0030107284,0.0027287316,0.009654731],"category_scores_gemma":[0.25467184,0.0013284702,0.007063769,0.0036676636,0.00097478007,0.0054329997,0.0022416082,0.004164227,0.0014757975],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15735503,0.0020841924,0.13711384,0.003793751,0.0343115,0.00042904905,0.0015136404,0.16048911,0.0011110695,0.010364503,0.022922572,0.4685118],"study_design_scores_gemma":[0.0065905354,0.013219996,0.04209014,0.000686591,0.007085908,0.0012757232,0.00035718235,0.89596677,0.0017936747,0.021482784,0.008918452,0.000532311],"about_ca_topic_score_codex":0.002154156,"about_ca_topic_score_gemma":0.0014055703,"teacher_disagreement_score":0.0786028,"about_ca_system_score_codex":0.0020297058,"about_ca_system_score_gemma":0.0021258965,"threshold_uncertainty_score":0.41569632},"labels":[],"label_agreement":null},{"id":"W2176677276","doi":"10.1016/j.urolonc.2015.08.019","title":"Evaluation of positive surgical margins in patients undergoing robot-assisted and open radical prostatectomy according to preoperative risk groups","year":2015,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Prostatectomy; Medicine; Urology; Surgical robot; General surgery; Robot; Prostate cancer; Internal medicine; Computer science; Artificial intelligence; Cancer","score_opus":0.06347619040299855,"score_gpt":0.36252290193104536,"score_spread":0.2990467115280468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2176677276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992761,0.00022781781,0.00004735304,0.000021572248,0.000006067001,0.0000038504563,0.000053232437,0.0000015873894,0.00036243445],"genre_scores_gemma":[0.9997625,0.00005125118,0.000026220465,0.000008074681,0.000007276939,0.0000026533578,0.000058922276,7.85821e-7,0.00008239858],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997172,0.00006695569,0.000034933553,0.000047872025,0.000053078667,0.000080030535],"domain_scores_gemma":[0.99869424,0.0004246547,0.00046007792,0.000045577264,0.00007338684,0.00030224113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035309303,0.00021465778,0.00032286224,0.0007013194,0.00027190277,0.0004838242,0.0002782646,0.0004155847,0.0015872341],"category_scores_gemma":[0.0023698695,0.00016399659,0.00054859504,0.00043203493,0.00037136863,0.0004997987,0.0004754376,0.00046266156,0.00018249951],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060522,0.00002800841,0.9977099,0.000009091672,0.000033834312,0.00007351319,0.0000621415,0.000046982575,0.00026531957,0.00001883226,0.0000247179,0.0011224797],"study_design_scores_gemma":[0.000007412722,0.00026398935,0.99864227,0.000004299218,0.000038014008,0.00031424343,0.00033687428,0.00019724597,0.00007204943,0.00004808231,0.000069898335,0.0000055809255],"about_ca_topic_score_codex":0.0008453815,"about_ca_topic_score_gemma":0.0012881383,"teacher_disagreement_score":0.0015872341,"about_ca_system_score_codex":0.00018703508,"about_ca_system_score_gemma":0.00032319943,"threshold_uncertainty_score":0.00530988},"labels":[],"label_agreement":null},{"id":"W2178723669","doi":"10.1016/j.urolonc.2015.10.005","title":"Metastatic renal cell carcinoma: Contending with a sea change in therapy","year":2015,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Renal cell carcinoma; Medicine; Oncology; Carcinoma; Internal medicine","score_opus":0.11848346988302132,"score_gpt":0.32983670514194335,"score_spread":0.21135323525892202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2178723669","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.064928174,0.0129686585,0.0024512724,0.8622853,0.009607989,0.00004139847,0.000049334216,0.00005780922,0.047610167],"genre_scores_gemma":[0.80626494,0.020240761,0.007346987,0.1306241,0.019690664,0.00006377471,0.000100886864,0.00007075332,0.015597152],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982145,0.0006401409,0.00011900643,0.00015178825,0.00045954567,0.00041508733],"domain_scores_gemma":[0.9971635,0.0007289905,0.00029753475,0.0000978006,0.00039820702,0.0013139417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027294334,0.0002382303,0.00045489075,0.0005101492,0.0035443958,0.004554888,0.0008445064,0.0070097744,0.004794937],"category_scores_gemma":[0.009704659,0.00014547184,0.0006763838,0.00053366105,0.0025589399,0.003220353,0.0021082156,0.008110115,0.0007866421],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005584101,0.0012284379,0.09791536,0.00049854984,0.00020215094,0.08970765,0.0077805505,0.0018467285,0.0044759247,0.07413882,0.29687998,0.42476746],"study_design_scores_gemma":[0.00016317872,0.00082468335,0.0433853,0.0014767374,0.00019371079,0.07295393,0.030010885,0.0035708875,0.0020104842,0.14470352,0.7005392,0.00016755129],"about_ca_topic_score_codex":0.001562606,"about_ca_topic_score_gemma":0.004872217,"teacher_disagreement_score":0.0070097744,"about_ca_system_score_codex":0.0024665336,"about_ca_system_score_gemma":0.0052385335,"threshold_uncertainty_score":0.017895997},"labels":[],"label_agreement":null},{"id":"W2187726566","doi":"10.1016/s1078-1439(00)00129-0","title":"Surveillance for stage I testicular seminoma","year":2001,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Seminoma; Medicine; Stage (stratigraphy); Radiation therapy; Psychosocial; Intensive care medicine; Quality of life (healthcare); General surgery; Surgery; Chemotherapy; Nursing; Psychiatry","score_opus":0.03458588083172499,"score_gpt":0.32918507879331643,"score_spread":0.29459919796159145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2187726566","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97438407,0.01127977,0.0007438676,0.00089208834,0.00013473158,0.000043854885,0.00052277185,0.00009523907,0.0119035505],"genre_scores_gemma":[0.995252,0.0023330043,0.0005572768,0.00027480937,0.000145876,0.00000993586,0.00033224956,0.000009005419,0.00108581],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99990404,0.000019364728,0.00000803042,0.000017186592,0.00001919956,0.00003225567],"domain_scores_gemma":[0.99966526,0.00009916642,0.00007371595,0.00001610182,0.000030498704,0.00011525601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023863498,0.00014539834,0.0003293206,0.0007413331,0.00034214955,0.00030397333,0.00023937762,0.0002611074,0.001682555],"category_scores_gemma":[0.0006791416,0.00009857764,0.00028258207,0.00044787608,0.0001510719,0.0002664545,0.00020408303,0.000331791,0.00018109646],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002019011,0.00020436286,0.81167865,0.00022109416,0.00007891659,0.006371378,0.00044135962,0.0006864627,0.008665591,0.00019937006,0.003882937,0.16555083],"study_design_scores_gemma":[0.00015382147,0.0033896137,0.94139206,0.00021543127,0.00041763717,0.029416906,0.00072961167,0.0019477505,0.009176227,0.0005947854,0.012543307,0.000022927366],"about_ca_topic_score_codex":0.0027419028,"about_ca_topic_score_gemma":0.0060216603,"teacher_disagreement_score":0.0027419028,"about_ca_system_score_codex":0.00029547952,"about_ca_system_score_gemma":0.00051943527,"threshold_uncertainty_score":0.005628705},"labels":[],"label_agreement":null},{"id":"W2192988598","doi":"10.1016/j.urolonc.2015.09.012","title":"Five-year biochemical recurrence-free and overall survival following high-dose-rate brachytherapy with additional external beam or radical prostatectomy in patients with clinically localized prostate cancer","year":2015,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Prostate cancer; Medicine; Brachytherapy; Prostatectomy; Biochemical recurrence; Urology; Cohort; Androgen deprivation therapy; Proportional hazards model; Propensity score matching; Hazard ratio; Internal medicine; Radiation therapy; Oncology; Cancer; Confidence interval","score_opus":0.025056147692931737,"score_gpt":0.30868317554904523,"score_spread":0.2836270278561135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2192988598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982022,0.0010710595,0.00007532058,0.000058653965,0.000018195155,0.0000056142303,0.00011019582,0.000004816535,0.0004539225],"genre_scores_gemma":[0.99948007,0.00013255209,0.000021969357,0.000029131133,0.000015333075,0.000002553851,0.0001712504,0.0000011499104,0.00014590341],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997516,0.00006422361,0.000018713876,0.000042180858,0.000037290916,0.00008594871],"domain_scores_gemma":[0.9994336,0.00013961772,0.00017499099,0.000037983154,0.00003206174,0.00018178474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049720495,0.00024328759,0.0004642823,0.00038831925,0.0002876587,0.0004900542,0.0003733994,0.00043956336,0.0009953893],"category_scores_gemma":[0.0013020155,0.0001481379,0.0012742322,0.00037199064,0.0003213526,0.00047301536,0.00039993855,0.00051015994,0.00013923587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017920459,0.00056263455,0.9507218,0.00012119486,0.0008460414,0.0012211333,0.00031309266,0.0022684296,0.002675633,0.00008138796,0.00046954316,0.022798542],"study_design_scores_gemma":[0.00012989389,0.002535765,0.9952153,0.0000114199565,0.00041340588,0.0005596876,0.00011880784,0.000500782,0.00019096205,0.000054362554,0.00025249773,0.000017231554],"about_ca_topic_score_codex":0.0035563887,"about_ca_topic_score_gemma":0.006733202,"teacher_disagreement_score":0.0035563887,"about_ca_system_score_codex":0.0006276587,"about_ca_system_score_gemma":0.0004354564,"threshold_uncertainty_score":0.007071376},"labels":[],"label_agreement":null},{"id":"W2197865895","doi":"10.1016/j.urolonc.2015.09.016","title":"The experience of patients with early-stage testicular cancer during the transition from active treatment to follow-up surveillance","year":2015,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Stage (stratigraphy); Transition (genetics); Testicular cancer; Cancer; Medicine; Oncology; Internal medicine; Biology","score_opus":0.02268818828409049,"score_gpt":0.29458134806534536,"score_spread":0.2718931597812549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2197865895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998024,0.00038725382,0.000050226976,0.00041543817,0.000017038616,0.000006275591,0.00004353445,0.0000023830999,0.0010539267],"genre_scores_gemma":[0.99942917,0.000204693,0.00002435738,0.00010355129,0.000011907825,0.0000035734715,0.000044839053,0.0000012567054,0.00017655957],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9995408,0.00014924334,0.000023243017,0.000032979082,0.000051786985,0.0002018833],"domain_scores_gemma":[0.9984281,0.00041498063,0.00029373175,0.000024514942,0.00011629459,0.0007224364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006324283,0.000099779776,0.00024517116,0.00023993655,0.0012508789,0.0015096198,0.0002683485,0.00054023555,0.0014430261],"category_scores_gemma":[0.0044717537,0.000098479555,0.00027477148,0.00040049021,0.0004258355,0.00089488714,0.0009317474,0.0010397191,0.00011994486],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011081821,0.00040695452,0.9361835,0.00008213693,0.000039627983,0.008104318,0.023932371,0.0002711195,0.0010498309,0.00051703147,0.0019059922,0.026398838],"study_design_scores_gemma":[0.00006170412,0.0020939556,0.8914203,0.00013883402,0.00007319521,0.020957308,0.07626803,0.0005451889,0.00059323903,0.0004972924,0.007283085,0.00006788128],"about_ca_topic_score_codex":0.005277007,"about_ca_topic_score_gemma":0.0060917046,"teacher_disagreement_score":0.005277007,"about_ca_system_score_codex":0.0007230761,"about_ca_system_score_gemma":0.000808948,"threshold_uncertainty_score":0.010492563},"labels":[],"label_agreement":null},{"id":"W2206481743","doi":"10.1016/j.urolonc.2015.11.018","title":"Very long-term survival patterns of young patients treated with radical prostatectomy for high-risk prostate cancer","year":2015,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Urology; Proportional hazards model; Cumulative incidence; Surgical margin; Stage (stratigraphy); Cohort; Prostate-specific antigen; Cancer; Internal medicine; Oncology; Gynecology","score_opus":0.027459105312952602,"score_gpt":0.30338178581907704,"score_spread":0.27592268050612445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2206481743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99890685,0.00031199004,0.00003648133,0.000054696226,0.0000066131925,0.0000026880887,0.000294371,0.0000020402213,0.00038428567],"genre_scores_gemma":[0.9995202,0.00008881525,0.000011885332,0.00002015662,0.0000073441183,0.0000016936847,0.00022997172,0.0000010979097,0.00011881746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997857,0.00003732685,0.000027577953,0.000039938837,0.000030571577,0.00007889029],"domain_scores_gemma":[0.99848205,0.00030761154,0.0005089303,0.00003503133,0.00009586879,0.0005705013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021806319,0.00011854017,0.00025644028,0.0007210362,0.0004008307,0.00045127707,0.00024923775,0.0004962599,0.0020100868],"category_scores_gemma":[0.0015926537,0.00013658081,0.0004846735,0.00068434776,0.00025122176,0.0004927569,0.00044282657,0.00045619762,0.00026645654],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010401691,0.000016671855,0.99858344,0.0000056836843,0.00002276598,0.00011995735,0.000089856934,0.000021237718,0.00017828395,0.0000103528455,0.000048491842,0.0007991946],"study_design_scores_gemma":[0.0000017109853,0.00006722705,0.99931395,0.0000032431071,0.000011733793,0.00027560748,0.0001986751,0.000026436788,0.000019358933,0.000012763018,0.000066185166,0.0000031081584],"about_ca_topic_score_codex":0.0038352828,"about_ca_topic_score_gemma":0.006113399,"teacher_disagreement_score":0.0038352828,"about_ca_system_score_codex":0.00023809067,"about_ca_system_score_gemma":0.00028645562,"threshold_uncertainty_score":0.0076259375},"labels":[],"label_agreement":null},{"id":"W2221909862","doi":"10.1016/j.urolonc.2015.05.010","title":"Re: Herr et al.: BCG-refractory vs. BCG-relapsing non–muscle-invasive bladder cancer: A prospective cohort outcomes study (Urol Oncol 2015; 33: 108.el-108.e4)","year":2015,"lang":"en","type":"letter","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Telesta Therapeutics (Canada); Campbell Scientific (Canada); Queen's University","funders":"","keywords":"Medicine; Prospective cohort study; Bladder cancer; Cohort; Refractory (planetary science); Oncology; Internal medicine; Cancer","score_opus":0.03602959298876951,"score_gpt":0.36498020033081774,"score_spread":0.32895060734204823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2221909862","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017602314,0.0034444733,0.00010871939,0.96744084,0.021433484,0.000025537804,0.0009797893,0.00006398943,0.0047429013],"genre_scores_gemma":[0.016480641,0.002936083,0.00016744468,0.90096843,0.059456564,0.00007454544,0.0005466687,0.00005733482,0.01931223],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985819,0.00048130352,0.00021161356,0.00021917601,0.0003329317,0.000173013],"domain_scores_gemma":[0.99376476,0.0032042256,0.00044274027,0.00022943974,0.0014435527,0.0009153473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025449113,0.0006069576,0.0014544126,0.0008535681,0.001568371,0.001974432,0.0015303143,0.013713037,0.01681792],"category_scores_gemma":[0.021086195,0.0004578254,0.0006987259,0.00082028646,0.00070508535,0.001997337,0.00077444094,0.011403729,0.018106353],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014920498,0.000033773667,0.0025752739,0.000033640074,0.000026671374,0.0007737306,0.000037487935,0.000018118353,0.00008179447,0.00029280578,0.98948026,0.0064972034],"study_design_scores_gemma":[0.0017059622,0.00030909874,0.025367364,0.0016099424,0.00023945101,0.008996008,0.00078709086,0.0012988349,0.0010142035,0.009908296,0.948522,0.00024180338],"about_ca_topic_score_codex":0.0075294506,"about_ca_topic_score_gemma":0.009960112,"teacher_disagreement_score":0.01681792,"about_ca_system_score_codex":0.0021585638,"about_ca_system_score_gemma":0.0017335297,"threshold_uncertainty_score":0.0562616},"labels":[],"label_agreement":null},{"id":"W2237583211","doi":"10.1016/j.urolonc.2015.11.015","title":"SPINK1 expression in relation to PTEN and ERG in matched primary and lymph node metastatic prostate cancer: Implications for biomarker development","year":2015,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; Hôpital du Sacré-Cœur de Montréal; University of Calgary","funders":"","keywords":"Erg; PTEN; Prostate cancer; Lymph node; Biomarker; Immunohistochemistry; Prostate; Pathology; Phenotype; Metastasis; Biology; Cancer research; Medicine; Cancer; Internal medicine; Gene; PI3K/AKT/mTOR pathway; Signal transduction; Genetics","score_opus":0.07500170282839905,"score_gpt":0.37393877484945,"score_spread":0.2989370720210509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2237583211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987619,0.00034615968,0.00012466127,0.000017338109,0.000005036298,0.0000042684455,0.00019081518,0.0000073162137,0.00054260006],"genre_scores_gemma":[0.9995061,0.000076131204,0.000060207913,0.000007872069,0.0000022477905,0.0000033182416,0.00013071293,0.0000019483734,0.00021151693],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998534,0.000018206943,0.000010873272,0.000039999788,0.000030983163,0.00004660501],"domain_scores_gemma":[0.99969614,0.000091749156,0.000083297746,0.000023249067,0.000036579582,0.00006904895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023798832,0.000109909466,0.00025606062,0.00088283804,0.00024657985,0.00060366245,0.00021684737,0.00022598145,0.0016432091],"category_scores_gemma":[0.0008704288,0.0001115002,0.0001617343,0.00061957317,0.0003095569,0.00021979991,0.00026739945,0.0002563303,0.00023909229],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049035377,0.00008514836,0.8854714,0.000082186176,0.00011076426,0.00082717766,0.00027760913,0.0004445729,0.09625834,0.00020824108,0.00022201019,0.011109051],"study_design_scores_gemma":[0.000011206263,0.00022003042,0.9847186,0.0000045174565,0.00006979231,0.001289747,0.0003150654,0.0004762943,0.012348698,0.00012358028,0.00041616845,0.0000063786724],"about_ca_topic_score_codex":0.0024209726,"about_ca_topic_score_gemma":0.002504235,"teacher_disagreement_score":0.0024209726,"about_ca_system_score_codex":0.0003868918,"about_ca_system_score_gemma":0.00021677728,"threshold_uncertainty_score":0.005497098},"labels":[],"label_agreement":null},{"id":"W2293265043","doi":"10.1016/j.urolonc.2015.10.013","title":"Validation of lymphovascular invasion is an independent prognostic factor for biochemical recurrence after radical prostatectomy","year":2016,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Lymphovascular invasion; Biochemical recurrence; Medicine; Interquartile range; Urology; Prostate cancer; Prostatectomy; Hazard ratio; Surgical margin; Proportional hazards model; Retrospective cohort study; Internal medicine; Oncology; Cancer; Metastasis; Confidence interval","score_opus":0.03665235512303948,"score_gpt":0.3134032490215131,"score_spread":0.2767508938984736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2293265043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970233,0.0010434542,0.0004816006,0.00012588057,0.00006590423,0.000013865832,0.00019165338,0.000015110386,0.0010392256],"genre_scores_gemma":[0.9989483,0.00016050584,0.00029688515,0.00003192221,0.00004934495,0.0000069711714,0.00022877731,0.0000045804377,0.00027284666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982889,0.000630048,0.0001986929,0.00020967028,0.00045554317,0.00021701443],"domain_scores_gemma":[0.99129254,0.0038834175,0.0016640562,0.00091845694,0.0016745664,0.0005668333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038728346,0.00034511846,0.0003445218,0.0010725172,0.0004166734,0.0012721567,0.0008035926,0.00048242693,0.0015039652],"category_scores_gemma":[0.01229596,0.00030619986,0.00040273066,0.0008395755,0.0006924536,0.0007960166,0.000625968,0.0006664066,0.0003826545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020697505,0.00003061617,0.9944383,0.0000189663,0.00006408988,0.000039980976,0.000049804174,0.00007894098,0.0011634554,0.00001812029,0.00010690304,0.003783861],"study_design_scores_gemma":[0.000010707745,0.00022047952,0.99568415,0.000017764236,0.00012311882,0.0003497165,0.00015114424,0.0009778449,0.0017490329,0.000070519774,0.0006364363,0.000009128874],"about_ca_topic_score_codex":0.0017073626,"about_ca_topic_score_gemma":0.0031430272,"teacher_disagreement_score":0.0038728346,"about_ca_system_score_codex":0.0003330358,"about_ca_system_score_gemma":0.00080923556,"threshold_uncertainty_score":0.020481765},"labels":[],"label_agreement":null},{"id":"W2299315051","doi":"10.1016/j.urolonc.2016.02.016","title":"Disease volume and distribution as drivers of treatment decisions in metastatic prostate cancer: From chemohormonal therapy to stereotactic ablative radiotherapy of oligometastases","year":2016,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; McMaster University; University of Toronto","funders":"Joseph and Silvana Melara Cancer Research Fund","keywords":"SABR volatility model; Prostate cancer; Medicine; Radiation therapy; Ablative case; Oncology; Androgen deprivation therapy; Prostate; Prostatectomy; Cancer; Internal medicine","score_opus":0.0718110862801678,"score_gpt":0.40692022173480086,"score_spread":0.33510913545463306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2299315051","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030829833,0.9992455,0.000024946825,0.00022594535,0.000029806202,0.0000011148088,0.0000108542845,6.7788443e-7,0.00015297532],"genre_scores_gemma":[0.0052243853,0.99428093,0.00009726757,0.00019344484,0.000106943626,0.0000025144616,0.000021145122,6.3158814e-7,0.00007283497],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99970263,0.00010291098,0.000048315072,0.000048604565,0.00007812847,0.000019379653],"domain_scores_gemma":[0.99870014,0.0009789581,0.0001967537,0.000012311352,0.0000900969,0.000021614309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010029074,0.00040066816,0.0012979988,0.0008746352,0.00012209958,0.0008745077,0.00061531557,0.00054188893,0.0016734925],"category_scores_gemma":[0.002805579,0.0001974245,0.00087361864,0.0015523346,0.00036313786,0.0007540312,0.00032921202,0.000816052,0.00021712853],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020142469,0.000042801457,0.0037791342,0.027609097,0.0012056696,0.0000898632,0.00009634977,0.00067709835,0.00021171788,0.0018929011,0.009057821,0.955136],"study_design_scores_gemma":[0.0003461249,0.0006877462,0.06079215,0.07645383,0.011490149,0.003151437,0.0007827195,0.0011475033,0.0007259418,0.01075334,0.8334952,0.00017385416],"about_ca_topic_score_codex":0.0033076876,"about_ca_topic_score_gemma":0.0076031997,"teacher_disagreement_score":0.0033076876,"about_ca_system_score_codex":0.0007658642,"about_ca_system_score_gemma":0.0012921435,"threshold_uncertainty_score":0.0065768957},"labels":[],"label_agreement":null},{"id":"W2423517989","doi":"10.1016/j.urolonc.2016.05.012","title":"Using the neoadjuvant chemotherapy paradigm to develop precision therapy for muscle-invasive bladder cancer","year":2016,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bladder cancer; Chemotherapy; Medicine; Cancer; Oncology; Neoadjuvant therapy; Internal medicine; Urology; Breast cancer","score_opus":0.1261711172978729,"score_gpt":0.42594511324257484,"score_spread":0.29977399594470194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2423517989","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015005114,0.99882835,0.00008158731,0.0001959716,0.000081946404,0.000005694156,0.000010879916,0.0000020505313,0.0006434844],"genre_scores_gemma":[0.0013747027,0.9978288,0.00018971592,0.00024739915,0.00006347183,0.000006775896,0.000021380158,8.664845e-7,0.00026691286],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983394,0.000044216133,0.00003138295,0.000027212935,0.000050546227,0.000012659173],"domain_scores_gemma":[0.99975985,0.00015762678,0.000033327626,0.000005984952,0.0000353484,0.000007749344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055596296,0.00049557775,0.0009917312,0.001332815,0.00017038762,0.0008171332,0.0005535062,0.0005575462,0.00280312],"category_scores_gemma":[0.00087680464,0.00017122149,0.0006421629,0.0011906787,0.0003574944,0.0008679665,0.00050424895,0.00121645,0.00068942655],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000092232964,0.00006685078,0.00022686334,0.041084737,0.00027746218,0.0001532942,0.000058522877,0.00040746512,0.0014937395,0.0039648125,0.010628076,0.9415461],"study_design_scores_gemma":[0.000093034796,0.0002501958,0.0017986117,0.017900983,0.00089942804,0.0015567201,0.00010416869,0.00019621283,0.0013081748,0.0029586551,0.97289366,0.000040156126],"about_ca_topic_score_codex":0.00093127653,"about_ca_topic_score_gemma":0.0028213973,"teacher_disagreement_score":0.00280312,"about_ca_system_score_codex":0.0004934563,"about_ca_system_score_gemma":0.0010132703,"threshold_uncertainty_score":0.00937736},"labels":[],"label_agreement":null},{"id":"W2463222779","doi":"10.1016/j.urolonc.2016.06.007","title":"Statin use and kidney cancer outcomes: A propensity score analysis","year":2016,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University Health Network; University of Toronto; Health Sciences Centre","funders":"","keywords":"Propensity score matching; Medicine; Hazard ratio; Statin; Internal medicine; Interquartile range; Kidney cancer; Proportional hazards model; Renal cell carcinoma; Retrospective cohort study; Cancer; Confounding; Oncology; Kidney disease; Population; Nephrectomy; Surgery; Confidence interval; Kidney","score_opus":0.04567850455468814,"score_gpt":0.30560478799120955,"score_spread":0.2599262834365214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2463222779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969861,0.00043789844,0.001395342,0.00007926923,0.000031599244,0.00002390426,0.0006036869,0.000015953614,0.00042619885],"genre_scores_gemma":[0.9988105,0.00010281541,0.0002702282,0.000026380916,0.00002845773,0.00001805669,0.00043963647,0.00000859256,0.00029524285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983235,0.0005994803,0.00021553812,0.00041216004,0.00022540645,0.00022395303],"domain_scores_gemma":[0.997063,0.0007523928,0.00094155857,0.00074843597,0.00020817923,0.00028642942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023898988,0.00046628236,0.00089861127,0.0013347116,0.0006327409,0.0011870769,0.0006505536,0.0008197133,0.0027150216],"category_scores_gemma":[0.004155879,0.0005180639,0.0028326928,0.00270001,0.0004236951,0.00077765534,0.0008437989,0.0010692567,0.00039548127],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026838426,0.000103991544,0.9907362,0.000022002028,0.002165239,0.00008499726,0.000042672673,0.00047958072,0.0005031876,0.00012579907,0.0002956297,0.0027568608],"study_design_scores_gemma":[0.00029335934,0.00072601007,0.9875151,0.0000147144965,0.0023535439,0.00042269376,0.000157251,0.006941035,0.00034427445,0.0004514337,0.00074771256,0.00003282946],"about_ca_topic_score_codex":0.0032346651,"about_ca_topic_score_gemma":0.0032934474,"teacher_disagreement_score":0.0032346651,"about_ca_system_score_codex":0.0004198532,"about_ca_system_score_gemma":0.00079401047,"threshold_uncertainty_score":0.012639105},"labels":[],"label_agreement":null},{"id":"W2463254470","doi":"10.1016/j.urolonc.2016.05.025","title":"The natural history of renal function after surgical management of renal cell carcinoma: Results from the Canadian Kidney Cancer Information System","year":2016,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Princess Margaret Cancer Centre; University of Calgary; McGill University; University Health Network; Dalhousie University; University of Toronto; McMaster University; University of Alberta; Université Laval; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Nephrectomy; Medicine; Renal cell carcinoma; Renal function; Kidney disease; Urology; Kidney cancer; Kidney; Cancer; Surgery; Internal medicine","score_opus":0.017241106684029207,"score_gpt":0.23423773477561097,"score_spread":0.21699662809158177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2463254470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9485551,0.0012528002,0.00008354666,0.0009963027,0.000029616598,0.00008746952,0.042424027,0.000029165365,0.0065419558],"genre_scores_gemma":[0.9858015,0.0005706423,0.00012780279,0.00017417203,0.00001613541,0.000022753205,0.012371147,0.000009148863,0.0009067594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977088,0.00020491028,0.00018056798,0.00020932373,0.0011361979,0.0005602034],"domain_scores_gemma":[0.9923137,0.00072338583,0.0018039362,0.00019307865,0.0034986644,0.0014673047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015435301,0.00035768465,0.00044175584,0.0030949942,0.0019074978,0.001259681,0.0014592014,0.0006646988,0.0027367545],"category_scores_gemma":[0.008866259,0.00025325245,0.0009353301,0.0075910306,0.00059275853,0.0007407167,0.0014179724,0.00087042834,0.00035822572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008760784,0.000027801796,0.99604815,0.000028629822,0.00004746116,0.000023623717,0.00020119359,0.00009265975,0.000024109464,0.000030388293,0.001269206,0.002119171],"study_design_scores_gemma":[0.00000337346,0.000012600633,0.99911505,0.000010585529,0.000017793991,0.00001526194,0.0002249722,0.00010013183,0.00001658195,0.0000060441894,0.0004707626,0.0000068070485],"about_ca_topic_score_codex":0.98369366,"about_ca_topic_score_gemma":0.98812205,"teacher_disagreement_score":0.019256633,"about_ca_system_score_codex":0.019256633,"about_ca_system_score_gemma":0.02548211,"threshold_uncertainty_score":0.13971734},"labels":[],"label_agreement":null},{"id":"W2469385908","doi":"10.1016/j.urolonc.2016.05.034","title":"Disease progression and kidney function after partial vs. radical nephrectomy for T1 renal cancer","year":2016,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Princess Margaret Cancer Centre; University of Calgary; McGill University; University of Ottawa; Université Laval; University of Alberta; McMaster University; University Health Network; Dalhousie University; Western University; University of Toronto; University of Manitoba; University of British Columbia","funders":"","keywords":"Renal function; Medicine; Nephrectomy; Urology; Proportional hazards model; Confounding; Hazard ratio; Cancer; Kidney cancer; Kidney disease; Population; Internal medicine; Kidney; Oncology; Confidence interval","score_opus":0.02551865439055036,"score_gpt":0.3169906949751495,"score_spread":0.29147204058459913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2469385908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99845994,0.0008659304,0.000027768245,0.000072750074,0.000025031266,0.0000036448614,0.00007870788,0.000003360812,0.00046289747],"genre_scores_gemma":[0.9993674,0.0001407131,0.000011568956,0.000033560787,0.000026925449,0.0000022010174,0.00017051182,0.0000015186157,0.0002456347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997538,0.000058449623,0.000018006147,0.000036369183,0.000049193663,0.00008414427],"domain_scores_gemma":[0.999079,0.0003021382,0.00017190987,0.00004420563,0.000043004526,0.00035985518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006764605,0.00016359225,0.00062239595,0.0003037789,0.00023417667,0.0005830453,0.00030267055,0.00034648526,0.001568899],"category_scores_gemma":[0.0016697922,0.00008440586,0.00094649836,0.00028775693,0.0002937221,0.00070786965,0.00032691666,0.00092680997,0.00015455367],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.122797236,0.0025549093,0.7580415,0.0003800265,0.0017329687,0.0012053692,0.0005994362,0.0028343447,0.012514891,0.00028260326,0.001601236,0.09545542],"study_design_scores_gemma":[0.00026366848,0.010560312,0.9860715,0.000015511725,0.0003995667,0.00044896847,0.00019335524,0.0005124125,0.0007980957,0.00016787049,0.00054906326,0.000019600095],"about_ca_topic_score_codex":0.0016457324,"about_ca_topic_score_gemma":0.003597557,"teacher_disagreement_score":0.0016457324,"about_ca_system_score_codex":0.0005685033,"about_ca_system_score_gemma":0.0005715948,"threshold_uncertainty_score":0.0052485466},"labels":[],"label_agreement":null},{"id":"W2470797207","doi":"10.1016/j.urolonc.2016.04.015","title":"Acute and late urinary toxicity following radiation in men with an intact prostate gland or after a radical prostatectomy: A secondary analysis of RTOG 94-08 and 96-01","year":2016,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Hôpital Notre-Dame; Juravinski Cancer Centre; Hamilton Health Sciences","funders":"National Cancer Institute","keywords":"Medicine; Urology; Prostatectomy; Prostate cancer; Radiation therapy; Prostate; Toxicity; Urinary system; Acute toxicity; Internal medicine; Cancer","score_opus":0.009160155699212153,"score_gpt":0.28654540887267255,"score_spread":0.2773852531734604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2470797207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984479,0.00044196905,0.000043519478,0.000014837487,0.0000050943972,0.000022061538,0.00069583504,0.0000035183418,0.00032520888],"genre_scores_gemma":[0.99783784,0.0002329891,0.000039774375,0.000052394586,0.000022546774,0.000018609917,0.0012394486,0.000006022536,0.000550365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993892,0.00019348014,0.00005931589,0.000097866556,0.000114253045,0.00014592981],"domain_scores_gemma":[0.9986879,0.00031020137,0.000491404,0.000097352335,0.00010743905,0.00030568033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007386355,0.0004609621,0.0007103731,0.0012033352,0.00028768094,0.00070353015,0.0005075734,0.00047537984,0.0021221319],"category_scores_gemma":[0.0013678272,0.00027010782,0.0019326904,0.0012226147,0.0002682935,0.0004004553,0.00064240745,0.000703565,0.00032354752],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057355994,0.00031470179,0.9881251,0.000073843716,0.0006192025,0.00017666088,0.00007367229,0.00016780046,0.0015693584,0.000018048715,0.00018727119,0.0029387656],"study_design_scores_gemma":[0.00008380964,0.001206658,0.9978617,0.00000524177,0.00017820421,0.0001716693,0.000089889065,0.000062965795,0.00017481392,0.000008177974,0.00015141311,0.000005478334],"about_ca_topic_score_codex":0.0063234246,"about_ca_topic_score_gemma":0.009102267,"teacher_disagreement_score":0.0063234246,"about_ca_system_score_codex":0.000518178,"about_ca_system_score_gemma":0.00057253864,"threshold_uncertainty_score":0.012573242},"labels":[],"label_agreement":null},{"id":"W2471359461","doi":"10.1016/j.urolonc.2016.05.028","title":"Follow-up in non–muscle-invasive bladder cancer—International Bladder Cancer Network recommendations","year":2016,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Cystoscopy; Medicine; Bladder cancer; Urine cytology; Cytology; Cancer; Urinary system; Urology; Oncology; Radiology; Internal medicine; Pathology","score_opus":0.061535952180295284,"score_gpt":0.3924444408448101,"score_spread":0.33090848866451483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2471359461","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00052208704,0.9677958,0.00067003624,0.021440653,0.0043823323,0.00023502175,0.0012519351,0.000041052466,0.003661129],"genre_scores_gemma":[0.005928022,0.9660049,0.004360869,0.01657248,0.0021576588,0.0005607806,0.0019467,0.000014570587,0.0024539612],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99805045,0.00064686144,0.00063790625,0.00018683627,0.0003545729,0.00012339048],"domain_scores_gemma":[0.9951609,0.0019466674,0.0011399932,0.00010420127,0.001313108,0.00033519827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055785654,0.000788911,0.0024173856,0.0025853023,0.00048226255,0.0011928952,0.002538212,0.0023308252,0.0070203627],"category_scores_gemma":[0.012968836,0.00043627096,0.0035395136,0.0021115367,0.00047597676,0.0020027698,0.0013678701,0.0031627964,0.0014951142],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033390356,0.000110830726,0.0032370654,0.0741379,0.0008977953,0.00021696335,0.00016497078,0.0004683464,0.00027295251,0.002126887,0.22235806,0.69567436],"study_design_scores_gemma":[0.0004459387,0.00017869397,0.01122358,0.3130943,0.0034575262,0.00061776274,0.00035959066,0.00023694854,0.00022742004,0.003466953,0.6666223,0.00006909709],"about_ca_topic_score_codex":0.016834099,"about_ca_topic_score_gemma":0.04391848,"teacher_disagreement_score":0.016834099,"about_ca_system_score_codex":0.0019268079,"about_ca_system_score_gemma":0.0076940237,"threshold_uncertainty_score":0.03347224},"labels":[],"label_agreement":null},{"id":"W2514830499","doi":"10.1016/j.urolonc.2016.07.021","title":"Malignant urachal neoplasms: A population-based study and systematic review of literature","year":2016,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Urinary and Genital Oncology Studies","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Systematic review; Medicine; Biology; MEDLINE","score_opus":0.03749937689450253,"score_gpt":0.36007564416657234,"score_spread":0.3225762672720698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2514830499","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015458343,0.9826325,0.00012816674,0.00019121355,0.000040492087,0.00013991269,0.0011876054,0.000004376149,0.00021736335],"genre_scores_gemma":[0.1380663,0.85938495,0.000779688,0.00058674737,0.000072051575,0.0003174567,0.00067211833,0.000004321659,0.00011627098],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9962584,0.00085300056,0.0017916417,0.0005173567,0.00043803558,0.00014160373],"domain_scores_gemma":[0.99201787,0.0051466087,0.002098627,0.00015846668,0.0004472741,0.00013118933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025525228,0.0008421699,0.0038680956,0.0071905977,0.0005250471,0.0014666301,0.0009614176,0.0010176911,0.0026864351],"category_scores_gemma":[0.012694038,0.0007489156,0.005105146,0.010940945,0.00063129846,0.0016804266,0.0013229764,0.0006704112,0.00015301778],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066817744,0.00007096846,0.056985833,0.8401202,0.054653153,0.0011097117,0.0009430746,0.00016646278,0.00045312647,0.0002745735,0.002533088,0.04202164],"study_design_scores_gemma":[0.0007574656,0.00046256694,0.16516258,0.3650397,0.4327873,0.0062662344,0.0033816856,0.00017088017,0.00034654903,0.00074136833,0.024726387,0.00015723675],"about_ca_topic_score_codex":0.0040976712,"about_ca_topic_score_gemma":0.018680075,"teacher_disagreement_score":0.0071905977,"about_ca_system_score_codex":0.0011059432,"about_ca_system_score_gemma":0.0031411634,"threshold_uncertainty_score":0.0134992},"labels":[],"label_agreement":null},{"id":"W2519041701","doi":"10.1016/j.urolonc.2016.05.030","title":"Microhematuria assessment an IBCN consensus—Based upon a critical review of current guidelines","year":2016,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Urodynamic testing; Cystoscopy; Context (archaeology); Microhematuria; Urine cytology; Bladder cancer; Medical physics; Intensive care medicine; Gynecology; Cancer; Pathology; Internal medicine; Alternative medicine","score_opus":0.1876702843046566,"score_gpt":0.5009867709406035,"score_spread":0.3133164866359469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2519041701","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00073775504,0.95992094,0.0031863146,0.023556054,0.0049766465,0.00080880744,0.00093023316,0.00007227586,0.005810981],"genre_scores_gemma":[0.009202584,0.9539779,0.01615706,0.013472277,0.0022019946,0.0010929458,0.0018564624,0.000036003134,0.0020028218],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9921491,0.001971269,0.0032121097,0.0005525778,0.0018434796,0.00027147715],"domain_scores_gemma":[0.98388267,0.0055884216,0.0029182727,0.00038638106,0.0066283913,0.00059586175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013987275,0.0011780699,0.0043447763,0.008652117,0.001087346,0.0034277304,0.004348575,0.0033522025,0.0057315943],"category_scores_gemma":[0.02931094,0.0007118464,0.0036946693,0.0046512275,0.0011722144,0.0034143508,0.0032040684,0.003267631,0.0021689495],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002887661,0.00009956115,0.0020643375,0.116946556,0.0014830895,0.0005778187,0.0005142234,0.0004432925,0.0008289672,0.005383452,0.15924366,0.71212626],"study_design_scores_gemma":[0.00029921014,0.00012156283,0.0036586071,0.33336353,0.004037353,0.0015012883,0.00062492973,0.00036171678,0.0005989007,0.0072832913,0.64802057,0.00012901763],"about_ca_topic_score_codex":0.0044795703,"about_ca_topic_score_gemma":0.0090822,"teacher_disagreement_score":0.013987275,"about_ca_system_score_codex":0.0028628935,"about_ca_system_score_gemma":0.014762698,"threshold_uncertainty_score":0.07397264},"labels":[],"label_agreement":null},{"id":"W2519423603","doi":"10.1016/j.urolonc.2016.05.013","title":"Prognostic significance of markers of systemic inflammatory response in patients with non–muscle-invasive bladder cancer","year":2016,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Bladder cancer; Internal medicine; Gastroenterology; Disease; C-reactive protein; Neutrophil to lymphocyte ratio; Cancer; Oncology; Inflammation; Urology; Lymphocyte","score_opus":0.010970311764732657,"score_gpt":0.2600904078632036,"score_spread":0.24912009609847094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2519423603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99772555,0.001121044,0.00012033396,0.00010576137,0.000023781324,0.000003962201,0.00023944164,0.0000062031077,0.00065390475],"genre_scores_gemma":[0.99941087,0.00014608252,0.00006521698,0.00002572141,0.000034006705,0.0000036930637,0.00017687553,0.000001238889,0.00013638403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997615,0.00006435668,0.00003517316,0.000039825445,0.000034889854,0.00006424421],"domain_scores_gemma":[0.9990125,0.00025760624,0.00037943714,0.00005336802,0.00010135238,0.00019577476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037020745,0.00027741137,0.0004335517,0.00054158067,0.00028157223,0.0005786979,0.0002342964,0.0004625608,0.0012120953],"category_scores_gemma":[0.0017347927,0.00014357836,0.00039971256,0.0009639169,0.00025978166,0.00045469526,0.00038904455,0.00061856094,0.00018125902],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037843394,0.000018674484,0.997436,0.00001314794,0.000043126183,0.000082128245,0.000021200654,0.00004491227,0.00038551626,0.000012501267,0.00006558159,0.0014987141],"study_design_scores_gemma":[0.000009155185,0.00013291814,0.99866045,0.0000063225043,0.00006381321,0.00031234766,0.00010857488,0.00028804934,0.0001685015,0.000046093257,0.0001990155,0.0000047811686],"about_ca_topic_score_codex":0.00065872853,"about_ca_topic_score_gemma":0.0010562087,"teacher_disagreement_score":0.0012120953,"about_ca_system_score_codex":0.00017172916,"about_ca_system_score_gemma":0.00025149665,"threshold_uncertainty_score":0.0040548444},"labels":[],"label_agreement":null},{"id":"W2521421870","doi":"10.1016/j.urolonc.2016.06.004","title":"Microfluidic enrichment of circulating tumor cells in patients with clinically localized prostate cancer","year":2016,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Prostate cancer; Circulating tumor cell; Medicine; Prostate; Prostatectomy; Lymph node; Cancer; Prostate-specific antigen; Pathology; Androgen receptor; Antigen; Urology; Internal medicine; Oncology; Metastasis; Immunology","score_opus":0.018015097491583965,"score_gpt":0.29862258095747796,"score_spread":0.280607483465894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521421870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99281114,0.0033230132,0.0017104681,0.00035388087,0.00009739387,0.000033412485,0.00024923348,0.00008683946,0.0013346839],"genre_scores_gemma":[0.99749255,0.00037914215,0.000975084,0.00016863125,0.00006376697,0.00002321132,0.00016268257,0.0000083432,0.0007266319],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997626,0.000055005894,0.000010349583,0.00006462108,0.000054334057,0.000053063974],"domain_scores_gemma":[0.99977094,0.00009434465,0.000046159388,0.000012001683,0.0000253532,0.000051157556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021345688,0.00018792406,0.00037703756,0.00029049022,0.00030683633,0.00075310125,0.00018643292,0.00034090155,0.0016953417],"category_scores_gemma":[0.00072020735,0.00015940574,0.00016728723,0.00021510811,0.00019792945,0.00020604768,0.00025373485,0.00046459198,0.00027010008],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008897493,0.000863857,0.33386448,0.0006846535,0.0001968191,0.002480203,0.001003988,0.0013691654,0.5172457,0.0008556096,0.0061179656,0.12641998],"study_design_scores_gemma":[0.0002583479,0.0051239817,0.72439754,0.000096612064,0.0004809479,0.005391585,0.0010565841,0.014555631,0.23535985,0.00062093226,0.012579751,0.00007825884],"about_ca_topic_score_codex":0.0012661441,"about_ca_topic_score_gemma":0.0017594838,"teacher_disagreement_score":0.0016953417,"about_ca_system_score_codex":0.00046973172,"about_ca_system_score_gemma":0.00047140973,"threshold_uncertainty_score":0.0056714416},"labels":[],"label_agreement":null},{"id":"W2521599253","doi":"10.1016/j.urolonc.2016.07.006","title":"The effect of HER2 status on oncological outcomes of patients with invasive bladder cancer","year":2016,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Interquartile range; Oncology; Bladder cancer; Internal medicine; Lymph node; Retrospective cohort study; Immunohistochemistry; Cancer","score_opus":0.015134288671178974,"score_gpt":0.306970386741322,"score_spread":0.291836098070143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521599253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975714,0.0007153812,0.000025916679,0.00020922726,0.000016981876,0.0000028226168,0.00024946,0.000001826645,0.0012069698],"genre_scores_gemma":[0.9992223,0.00017177014,0.000009977019,0.00005429144,0.000028293716,0.0000017978074,0.00027170533,0.0000015353049,0.00023820349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99957603,0.00012796113,0.000037536145,0.000056888373,0.000060440063,0.00014120227],"domain_scores_gemma":[0.998221,0.0006103925,0.000546935,0.00007576817,0.00011390703,0.0004320143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066926976,0.0001675011,0.0002756744,0.00041070406,0.00029138062,0.00076575804,0.00033430537,0.00037199847,0.0022594065],"category_scores_gemma":[0.0035725236,0.00011768073,0.0006085583,0.00066945795,0.0003248797,0.00081369805,0.00064783375,0.00075536495,0.00023497759],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009981642,0.000085181906,0.99376374,0.000014454094,0.0001156693,0.0000864448,0.000058806603,0.00011163065,0.0001763531,0.000030317471,0.00016286944,0.0043964335],"study_design_scores_gemma":[0.0000120818195,0.000160111,0.9992125,0.000004778459,0.000055237662,0.00008268867,0.00012850529,0.00010295552,0.000035119232,0.000056867953,0.00014543196,0.0000037148366],"about_ca_topic_score_codex":0.002248749,"about_ca_topic_score_gemma":0.00430251,"teacher_disagreement_score":0.0022594065,"about_ca_system_score_codex":0.0004316284,"about_ca_system_score_gemma":0.0003050274,"threshold_uncertainty_score":0.007558465},"labels":[],"label_agreement":null},{"id":"W2523653648","doi":"10.1016/j.urolonc.2016.03.004","title":"Taking the next step—Advancing bladder cancer management","year":2016,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bladder cancer; Cancer; Medicine; Internal medicine","score_opus":0.04637663941155458,"score_gpt":0.3391658116760182,"score_spread":0.29278917226446366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523653648","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0066700964,0.16721854,0.0076777576,0.7715045,0.024716645,0.000097329284,0.000129538,0.00032576383,0.021659797],"genre_scores_gemma":[0.16766752,0.34249607,0.06647796,0.31782955,0.08822643,0.00025243286,0.0005771262,0.00024384879,0.016229115],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99663395,0.0012639326,0.00035776943,0.00028561812,0.0010172811,0.00044153185],"domain_scores_gemma":[0.9875802,0.0030477028,0.0011816443,0.00042027823,0.002815423,0.004954847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059329392,0.00068486156,0.0011419898,0.0017983768,0.0028674204,0.007055185,0.0019358728,0.0054012695,0.009375675],"category_scores_gemma":[0.019772211,0.00042695913,0.0011113187,0.00071857916,0.0020160703,0.0077908286,0.006314056,0.01211953,0.0028318712],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016452628,0.00080780964,0.015193341,0.0020101531,0.0001510877,0.0010127575,0.0010693404,0.0006226513,0.0020717273,0.011999984,0.25670934,0.7081873],"study_design_scores_gemma":[0.00011630181,0.0007051072,0.020760246,0.011135146,0.00034846182,0.0035167213,0.0069314255,0.0011437468,0.0020500356,0.05828582,0.89480597,0.0002009264],"about_ca_topic_score_codex":0.003039609,"about_ca_topic_score_gemma":0.008659077,"teacher_disagreement_score":0.009375675,"about_ca_system_score_codex":0.0023664944,"about_ca_system_score_gemma":0.0135470005,"threshold_uncertainty_score":0.03137678},"labels":[],"label_agreement":null},{"id":"W2527573802","doi":"10.1016/j.urolonc.2016.07.003","title":"New Gleason grading system: Statement from the editors of 6 journals","year":2016,"lang":"en","type":"letter","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Grading (engineering); Statement (logic); Computer science; Library science; Philosophy; Engineering; Epistemology","score_opus":0.04118877760117581,"score_gpt":0.32112458150619716,"score_spread":0.2799358039050214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2527573802","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005642779,0.001216458,0.00012084052,0.92711765,0.068233125,0.000015898015,0.00008509428,0.000018066994,0.0026286996],"genre_scores_gemma":[0.0066820853,0.00231233,0.0004358958,0.77415484,0.20648542,0.000048950697,0.00010949915,0.000037859005,0.009733198],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99574846,0.0007741052,0.00084682315,0.0005372036,0.0014671105,0.0006262609],"domain_scores_gemma":[0.9889627,0.0031155804,0.0017169898,0.0003145879,0.003470592,0.002419615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033218486,0.0009643266,0.0013907817,0.0010243478,0.0024947324,0.0037946054,0.0015348368,0.0342321,0.006580439],"category_scores_gemma":[0.03472748,0.00081715646,0.0015080615,0.0012198264,0.0014944702,0.0027904795,0.0012967162,0.024102798,0.006507632],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004650731,0.000030267589,0.0012746241,0.000047793026,0.000015115251,0.0027184228,0.000072025956,0.000070727554,0.00015533071,0.000711663,0.98879904,0.0060585225],"study_design_scores_gemma":[0.00018953634,0.00008918396,0.00425413,0.0007762497,0.000077844554,0.00937866,0.0005258639,0.0008514227,0.00046876215,0.0039384784,0.9793347,0.00011522358],"about_ca_topic_score_codex":0.0026950534,"about_ca_topic_score_gemma":0.0048403423,"teacher_disagreement_score":0.0342321,"about_ca_system_score_codex":0.003887171,"about_ca_system_score_gemma":0.004246954,"threshold_uncertainty_score":0.028203547},"labels":[],"label_agreement":null},{"id":"W2538113786","doi":"10.1016/j.urolonc.2016.09.004","title":"Emerging role of checkpoint inhibition in localized bladder cancer","year":2016,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"G2-M DNA damage checkpoint; Cancer research; Bladder cancer; Cancer; Cell cycle checkpoint; Medicine; Internal medicine; Cell cycle","score_opus":0.04110599783235761,"score_gpt":0.3729253368420641,"score_spread":0.33181933900970645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2538113786","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000106230946,0.9992847,0.000041198717,0.00013903427,0.00007201592,0.0000024157457,0.000010723799,0.0000023686525,0.00034134972],"genre_scores_gemma":[0.0010613904,0.9983891,0.00008080305,0.00021399788,0.000089783774,0.0000030363265,0.000017042736,6.3347113e-7,0.00014422295],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999814,0.00004125538,0.000034047524,0.000036147747,0.000053909218,0.000020644131],"domain_scores_gemma":[0.99964786,0.00021283636,0.00006279328,0.000008511245,0.00005056464,0.000017455168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007970329,0.0006647422,0.0015623916,0.001435351,0.000183992,0.001009937,0.0008114196,0.0008041334,0.0035128486],"category_scores_gemma":[0.00095830404,0.00023832642,0.0008790352,0.0014852654,0.00044151823,0.0011048611,0.0006324828,0.0016806936,0.000805725],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020222919,0.00009166136,0.0003145154,0.039796963,0.0003157536,0.00022735311,0.000054406984,0.00040353547,0.0014102901,0.0020361433,0.014190523,0.9409566],"study_design_scores_gemma":[0.00020673107,0.00050071714,0.0027445648,0.017725203,0.00159544,0.0018872491,0.00012936765,0.00026541884,0.0011233911,0.0027034536,0.9710726,0.000045831122],"about_ca_topic_score_codex":0.0008496746,"about_ca_topic_score_gemma":0.002274445,"teacher_disagreement_score":0.0035128486,"about_ca_system_score_codex":0.00045763626,"about_ca_system_score_gemma":0.0011020965,"threshold_uncertainty_score":0.011751711},"labels":[],"label_agreement":null},{"id":"W2548002414","doi":"10.1016/j.urolonc.2016.07.022","title":"External validation of the pathological nodal staging score in upper tract urothelial carcinoma: A population-based study","year":2016,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Interquartile range; Lymph node; Cohort; Lymphadenectomy; Pathological; Stage (stratigraphy); Dissection (medical); Pathological staging; T-stage; Urology; Radiology; Surgery; Oncology; Internal medicine; Cancer","score_opus":0.03588254356410598,"score_gpt":0.3159358956159071,"score_spread":0.28005335205180115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548002414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978695,0.00015926862,0.0007265586,0.000034726825,0.000031159278,0.00008251495,0.0004283069,0.000008545788,0.00065943087],"genre_scores_gemma":[0.99826556,0.000054771313,0.00024997068,0.000054441203,0.000030381216,0.00009876896,0.0010397473,0.000015978781,0.00019038489],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9896465,0.005679507,0.00077253295,0.0020919996,0.001314087,0.0004953468],"domain_scores_gemma":[0.9822297,0.0060997093,0.002261829,0.00515157,0.0034757582,0.0007814347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012002186,0.0008596511,0.0009903569,0.0011007278,0.0012266284,0.0016279775,0.0015892,0.0016664126,0.0015572195],"category_scores_gemma":[0.023588467,0.0007363991,0.0014037545,0.0013947263,0.0020097184,0.0010395512,0.001692918,0.0010819843,0.0008619156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087443454,0.00025316153,0.9949536,0.000028803592,0.00046061733,0.0000797973,0.00038506632,0.00013078813,0.0008690573,0.000063790125,0.00030959636,0.0015913259],"study_design_scores_gemma":[0.00017609932,0.00077777356,0.99579763,0.000017549784,0.00044007934,0.00031148404,0.00036356976,0.000570602,0.00029097567,0.000101593076,0.0011358928,0.000016691956],"about_ca_topic_score_codex":0.0024191914,"about_ca_topic_score_gemma":0.0027649296,"teacher_disagreement_score":0.012002186,"about_ca_system_score_codex":0.00069737516,"about_ca_system_score_gemma":0.00085355964,"threshold_uncertainty_score":0.06347436},"labels":[],"label_agreement":null},{"id":"W2558970092","doi":"10.1016/j.urolonc.2016.10.021","title":"Preoperative anemia is associated with disease recurrence and progression in patients with non–muscle-invasive bladder cancer","year":2016,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Interquartile range; Bladder cancer; Anemia; Proportional hazards model; Internal medicine; Cancer; Cohort; Retrospective cohort study; Disease; Urology; Oncology; Surgery","score_opus":0.016629097210813865,"score_gpt":0.3002979414051745,"score_spread":0.28366884419436067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558970092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99764496,0.0015151766,0.00008112899,0.00014959206,0.000023717483,0.0000034201526,0.00013985863,0.000005873182,0.00043630096],"genre_scores_gemma":[0.99942386,0.00018800395,0.000045482684,0.000028160668,0.000028768938,0.0000020206883,0.00013627284,0.0000013758807,0.0001460677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99970704,0.00008236471,0.000047385212,0.00004368666,0.000056853358,0.00006255565],"domain_scores_gemma":[0.99804074,0.00042111665,0.0010253615,0.00011254537,0.00014752417,0.00025277617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003319647,0.00017907133,0.00034799447,0.0005584893,0.00031785315,0.0005528105,0.00037000212,0.00045885978,0.0015040225],"category_scores_gemma":[0.0028217137,0.0002087907,0.00047507658,0.0010282221,0.00022829567,0.00043351823,0.00034007576,0.00090105867,0.00012653839],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018572068,0.00002023293,0.99773186,0.000014543411,0.000058970458,0.000082310704,0.000028811228,0.000029875313,0.00015177796,0.00000957514,0.00007681382,0.0016095457],"study_design_scores_gemma":[0.0000036354845,0.000060802227,0.99921715,0.0000059413487,0.00006682182,0.000242602,0.00006983726,0.00014492837,0.00004322372,0.00001955067,0.00012206079,0.0000034196344],"about_ca_topic_score_codex":0.0024299393,"about_ca_topic_score_gemma":0.0035070763,"teacher_disagreement_score":0.0024299393,"about_ca_system_score_codex":0.00021975214,"about_ca_system_score_gemma":0.0003202995,"threshold_uncertainty_score":0.0050314665},"labels":[],"label_agreement":null},{"id":"W2560681959","doi":"10.1016/j.urolonc.2016.10.018","title":"Dynamics of three-dimensional telomere profiles of circulating tumor cells in patients with high-risk prostate cancer who are undergoing androgen deprivation and radiation therapies","year":2016,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Prostate cancer; Medicine; Circulating tumor cell; Androgen deprivation therapy; Telomere; Oncology; Prostate; Radiation therapy; Blood sampling; Internal medicine; Cancer; Prostate-specific antigen; Androgen; Fluorescence in situ hybridization; Metastasis; Biology; Hormone; Gene","score_opus":0.010614793123314668,"score_gpt":0.23986946803667855,"score_spread":0.22925467491336388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560681959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991333,0.00018461343,0.00041676944,0.000014300397,0.000001722379,0.0000027106516,0.000081220576,0.000008529887,0.00015695652],"genre_scores_gemma":[0.99930954,0.00006366212,0.00034886642,0.000011585665,0.0000025497213,0.000004556676,0.00012902114,0.0000019564575,0.00012827567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999961,0.000006479409,0.0000023203909,0.00001225773,0.0000103084085,0.000007685571],"domain_scores_gemma":[0.9998654,0.000034282963,0.000046930363,0.000007804291,0.000017308617,0.00002823258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007920244,0.00007268744,0.00014683284,0.00029178202,0.0001334209,0.00025476242,0.000079393154,0.00018231044,0.0007191508],"category_scores_gemma":[0.00034768687,0.00006459978,0.00009297714,0.00025441314,0.000077630735,0.00010390296,0.000109318076,0.00020080284,0.00012448007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020459571,0.00011502777,0.7444437,0.000061255414,0.00005761607,0.0006043266,0.00080617075,0.000966939,0.21093982,0.00009591481,0.00036182202,0.039501373],"study_design_scores_gemma":[0.000018561273,0.00040222966,0.9845142,0.0000037560494,0.000028058592,0.0010955514,0.0002056617,0.0023358345,0.010654418,0.000074479976,0.00065672427,0.000010520908],"about_ca_topic_score_codex":0.0010025378,"about_ca_topic_score_gemma":0.0010686391,"teacher_disagreement_score":0.0010025378,"about_ca_system_score_codex":0.00014760942,"about_ca_system_score_gemma":0.000076441196,"threshold_uncertainty_score":0.0024058223},"labels":[],"label_agreement":null},{"id":"W2567749076","doi":"10.1016/j.urolonc.2016.12.001","title":"Does teaching of robotic partial nephrectomy affect renal function and perioperative outcomes?","year":2017,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; McGill University Health Centre","funders":"","keywords":"Medicine; Nephrectomy; Affect (linguistics); Perioperative; Renal function; Urology; Surgery; Internal medicine; Kidney","score_opus":0.03543236616639452,"score_gpt":0.3281480225520905,"score_spread":0.292715656385696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567749076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858439,0.004329164,0.0002963309,0.0036675287,0.0003884057,0.000017134826,0.00026386042,0.000011820161,0.0051817955],"genre_scores_gemma":[0.9967338,0.001421346,0.0001888865,0.00051665376,0.0003793445,0.000008311306,0.00015127948,0.0000074394507,0.0005928754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992472,0.00020143959,0.00008050199,0.000097869255,0.00016173135,0.00021125189],"domain_scores_gemma":[0.99518836,0.0013574567,0.001849363,0.00017726958,0.00040949442,0.001017972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010659574,0.00012026817,0.00031052108,0.00024118059,0.0005939119,0.0009351439,0.0005199002,0.0008229536,0.0066025048],"category_scores_gemma":[0.008950297,0.00012704472,0.0010050745,0.00045029735,0.00042563013,0.001057956,0.00033879382,0.0008554889,0.0006126133],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017665554,0.0011665282,0.93108565,0.00023388297,0.0005349587,0.00033762498,0.0004313184,0.00030105838,0.0006638182,0.0004952291,0.0019270511,0.061056327],"study_design_scores_gemma":[0.00007919073,0.0010839741,0.9922672,0.00015016015,0.00042305424,0.0005737992,0.0010194125,0.00036754517,0.00031332075,0.0007180069,0.0029745747,0.000029750725],"about_ca_topic_score_codex":0.0031839968,"about_ca_topic_score_gemma":0.0065386333,"teacher_disagreement_score":0.0066025048,"about_ca_system_score_codex":0.0007855461,"about_ca_system_score_gemma":0.0015570957,"threshold_uncertainty_score":0.022087574},"labels":[],"label_agreement":null},{"id":"W2570494786","doi":"10.1016/j.urolonc.2016.12.003","title":"Quality indicators in the management of bladder cancer: A modified Delphi study","year":2017,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Dalhousie University; Université Laval; University of Alberta; McGill University; McGill University Health Centre; University of Ottawa; University of Manitoba; University of Calgary; Princess Margaret Cancer Centre; Western University; University of Toronto; University Health Network; Université de Montréal; Queen's University; University of British Columbia","funders":"Bladder Cancer Canada","keywords":"Benchmarking; Medicine; Delphi method; Bladder cancer; Delphi; Quality management; Best practice; Quality (philosophy); Medical physics; Operations management; Cancer; Management system; Computer science; Artificial intelligence; Management","score_opus":0.08052186606323836,"score_gpt":0.40997048396774216,"score_spread":0.3294486179045038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570494786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99147004,0.0003518611,0.0019279909,0.0008641937,0.00003816039,0.0029090093,0.00018715933,0.0000058477895,0.002245715],"genre_scores_gemma":[0.9904274,0.00033525215,0.0034093556,0.00030013916,0.000015887039,0.0051797368,0.000109089015,0.0000061543924,0.00021705577],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9104672,0.0724776,0.0072649918,0.0010607657,0.005248438,0.0034809706],"domain_scores_gemma":[0.8922487,0.078883454,0.007653876,0.0025432913,0.015884373,0.0027863495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08510454,0.0005474464,0.0009833529,0.0029537573,0.0025679718,0.0019910177,0.0009490625,0.00096469786,0.0016034517],"category_scores_gemma":[0.11581074,0.0006381816,0.0020039272,0.0035314301,0.0020689513,0.0024712568,0.005254685,0.0018514944,0.00019483338],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003906007,0.0041189156,0.46513203,0.0051371385,0.0010518897,0.00051628664,0.3561816,0.0018255827,0.0017654451,0.0050291964,0.0034736998,0.1518622],"study_design_scores_gemma":[0.0010632441,0.0081258975,0.554108,0.0033492297,0.00073632435,0.00056139583,0.40979004,0.0056881486,0.0018448744,0.0027597055,0.011661446,0.00031166268],"about_ca_topic_score_codex":0.0048116865,"about_ca_topic_score_gemma":0.0050599743,"teacher_disagreement_score":0.08510454,"about_ca_system_score_codex":0.0068727448,"about_ca_system_score_gemma":0.008459338,"threshold_uncertainty_score":0.45008123},"labels":[],"label_agreement":null},{"id":"W2585727728","doi":"10.1016/j.urolonc.2016.12.014","title":"Radical prostatectomy neutralizes obesity-driven risk of prostate cancer progression","year":2017,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Prostate cancer; Prostatectomy; Medicine; Obesity; Cancer; Urology; Oncology; Internal medicine","score_opus":0.02799499225316246,"score_gpt":0.3545464086482542,"score_spread":0.3265514163950918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585727728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764025,0.010053571,0.002682235,0.0022964873,0.00061215163,0.00010571571,0.00029678296,0.0004013521,0.0071492307],"genre_scores_gemma":[0.99560815,0.0016443771,0.0005138813,0.00035373305,0.00019469054,0.000017196648,0.0001327259,0.000021684022,0.0015136495],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9997856,0.000050067396,0.0000076053093,0.000034880217,0.000051727005,0.00007005528],"domain_scores_gemma":[0.9995777,0.000105095845,0.00008542806,0.00004785581,0.00002552317,0.00015846646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005059328,0.00024228827,0.00047583887,0.00023761352,0.00019986591,0.0005663702,0.00042984393,0.00030518477,0.0050872797],"category_scores_gemma":[0.0010571711,0.00021227158,0.00039723696,0.00012503765,0.00050742127,0.0003866295,0.00041341854,0.0012299733,0.00032779144],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05746389,0.008149383,0.022520928,0.0013416278,0.0014047592,0.0004836979,0.00018893855,0.0036890348,0.41339165,0.008268572,0.008653233,0.4744442],"study_design_scores_gemma":[0.012284725,0.20789477,0.5069855,0.00043394565,0.0025609597,0.004884653,0.0007655079,0.009312145,0.18545716,0.014267889,0.05480093,0.00035181257],"about_ca_topic_score_codex":0.0005003504,"about_ca_topic_score_gemma":0.0009691243,"teacher_disagreement_score":0.0050872797,"about_ca_system_score_codex":0.00015776718,"about_ca_system_score_gemma":0.0009355542,"threshold_uncertainty_score":0.017018676},"labels":[],"label_agreement":null},{"id":"W2586086234","doi":"10.1016/j.urolonc.2016.12.009","title":"Effect of statins as a secondary chemopreventive agent among individuals with non–muscle-invasive bladder cancer: A population-based analysis","year":2017,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Princess Margaret Cancer Centre; University Health Network; University of Toronto; Sunnybrook Health Science Centre; Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Interquartile range; Bladder cancer; Statin; Internal medicine; Population; Cohort; Proportional hazards model; Concomitant; Cancer; Retrospective cohort study; Oncology","score_opus":0.008534691662882045,"score_gpt":0.29906497106027713,"score_spread":0.29053027939739506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586086234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998946,0.000525071,0.00010160529,0.000024651406,0.000009260928,0.000008926674,0.00018148945,0.0000046869163,0.0001982445],"genre_scores_gemma":[0.99943084,0.00012495635,0.000063557,0.00002684805,0.0000104870605,0.000007109441,0.00015214854,0.000002515443,0.00018154221],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990017,0.0003465981,0.000107143285,0.00029993703,0.000102842634,0.00014175943],"domain_scores_gemma":[0.99921656,0.00020201805,0.0002135157,0.000121212746,0.00010622715,0.00014040624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008914826,0.0005230273,0.00095598423,0.0006054467,0.0005211614,0.0007365106,0.00038468005,0.0011338779,0.0014306036],"category_scores_gemma":[0.0015764199,0.0006425606,0.002725484,0.0010382407,0.00037709234,0.0005365972,0.0005314998,0.00095636817,0.00022490518],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010433518,0.00043244017,0.9802965,0.000058243706,0.003049192,0.0001536909,0.00012589236,0.00009848494,0.0023758006,0.000028993094,0.00010600905,0.0028412815],"study_design_scores_gemma":[0.00015758643,0.0018162717,0.9950955,0.0000070614624,0.002006412,0.00012636693,0.00014709598,0.00027936604,0.00017318182,0.000028591425,0.00015160446,0.0000110193605],"about_ca_topic_score_codex":0.006009258,"about_ca_topic_score_gemma":0.007653845,"teacher_disagreement_score":0.006009258,"about_ca_system_score_codex":0.00033617794,"about_ca_system_score_gemma":0.00038162174,"threshold_uncertainty_score":0.011948526},"labels":[],"label_agreement":null},{"id":"W2588087814","doi":"10.1016/j.urolonc.2017.01.012","title":"Prognostic role of N-cadherin expression in patients with non–muscle-invasive bladder cancer","year":2017,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Interquartile range; Internal medicine; Bladder cancer; Proportional hazards model; Immunohistochemistry; Oncology; Pathological; Adjuvant therapy; Biomarker; Cadherin; Stage (stratigraphy); Cancer; Urology; Adjuvant; Gastroenterology; Biology","score_opus":0.01764593332350883,"score_gpt":0.2994738744372035,"score_spread":0.2818279411136947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588087814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99767464,0.0008647754,0.00007769756,0.00011167202,0.000021239406,0.000003033034,0.00019365468,0.0000057764014,0.0010474336],"genre_scores_gemma":[0.99935716,0.00014473873,0.00003814971,0.000020467325,0.000019126284,0.0000021089727,0.00018382425,0.0000011671849,0.00023325931],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997913,0.00004867428,0.000024201545,0.00003759622,0.000032070522,0.00006612111],"domain_scores_gemma":[0.999383,0.00018531107,0.00017407932,0.000035170608,0.000084067746,0.00013840273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034623232,0.00022761992,0.00030642326,0.0005536434,0.00034634935,0.00059703423,0.00036100778,0.00052276143,0.0018167391],"category_scores_gemma":[0.0017015176,0.00016191375,0.00034804703,0.0008308795,0.00037330046,0.00061312673,0.00041545753,0.00048047167,0.0002406151],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026135796,0.000017783615,0.99622774,0.000014791073,0.00004174575,0.00016322968,0.000038648224,0.00007194978,0.00070644054,0.000023892318,0.00016447148,0.0022680338],"study_design_scores_gemma":[0.000004747754,0.000055835695,0.9985061,0.0000052751084,0.000045799632,0.00041639106,0.00011108671,0.00033341922,0.00015225296,0.000042130152,0.00032282984,0.0000041395247],"about_ca_topic_score_codex":0.0017761498,"about_ca_topic_score_gemma":0.0038154598,"teacher_disagreement_score":0.0018167391,"about_ca_system_score_codex":0.00030130154,"about_ca_system_score_gemma":0.00025428366,"threshold_uncertainty_score":0.006077647},"labels":[],"label_agreement":null},{"id":"W2588114211","doi":"10.1016/j.urolonc.2017.01.018","title":"Erratum to “The natural history of renal function after surgical management of renal cell carcinoma: Results from the Canadian Kidney Cancer Information System” [Urol Oncol 34(11) (2016) 486.e1–486.e7]","year":2017,"lang":"en","type":"erratum","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; McGill University; University of Ottawa; Princess Margaret Cancer Centre; University of Calgary; University Health Network; Dalhousie University; University of Toronto; McMaster University; University of Alberta; Université Laval; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Natural history; Renal cell carcinoma; Cancer; Kidney cancer; Renal function; Kidney; Function (biology); Urology; General surgery; Oncology; Internal medicine; Biology","score_opus":0.0218521363317264,"score_gpt":0.2539814095709124,"score_spread":0.23212927323918603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588114211","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008087204,0.0023544938,0.0003576454,0.21540782,0.7409897,0.00013581758,0.019539602,0.0003769988,0.02002917],"genre_scores_gemma":[0.019007936,0.014725382,0.0036764988,0.39064088,0.21256195,0.00045143926,0.04363562,0.0012551042,0.31404528],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948485,0.00046877086,0.0013000641,0.0002737152,0.0026499867,0.0004589891],"domain_scores_gemma":[0.95896494,0.0085385535,0.0018493072,0.0010011023,0.028198447,0.00144758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037053283,0.0011699103,0.0013825175,0.004111321,0.0035371012,0.002286503,0.0021872325,0.004649634,0.035993684],"category_scores_gemma":[0.049672715,0.00075419183,0.0017546469,0.0037208302,0.0012994912,0.0013347028,0.0013536775,0.00649831,0.021206427],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011964617,0.0000050123135,0.00020174222,0.00003213286,0.0000035224148,0.000076503806,0.00001174546,0.000013745787,0.0000057650677,0.00011779028,0.99769515,0.001824817],"study_design_scores_gemma":[0.000091660906,0.000024092371,0.0058893366,0.0007887247,0.00005602659,0.00032526904,0.00021729132,0.00014600316,0.00017553779,0.00039996416,0.99182653,0.00005955872],"about_ca_topic_score_codex":0.32898924,"about_ca_topic_score_gemma":0.338413,"teacher_disagreement_score":0.67101073,"about_ca_system_score_codex":0.0077727763,"about_ca_system_score_gemma":0.022785759,"threshold_uncertainty_score":0.6541486},"labels":[],"label_agreement":null},{"id":"W2588238299","doi":"10.1016/j.urolonc.2017.01.015","title":"Current guidelines do not sufficiently discriminate venous thromboembolism risk in urology","year":2017,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Venous thromboembolism; Cystectomy; Logistic regression; Risk factor; Nephrectomy; Risk assessment; Surgery; Bladder cancer; Internal medicine; Cancer; Thrombosis","score_opus":0.06788541423691669,"score_gpt":0.37719137026453253,"score_spread":0.30930595602761585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588238299","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31682995,0.17912598,0.04193061,0.26735336,0.014919749,0.0010456833,0.007881967,0.0013726214,0.16953997],"genre_scores_gemma":[0.8436957,0.032314155,0.054156832,0.053615835,0.005619755,0.0005976137,0.00525974,0.0003608486,0.004379494],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9739014,0.00986251,0.0075388993,0.0011891742,0.0063065724,0.0012014617],"domain_scores_gemma":[0.9162407,0.04847204,0.010764349,0.0021798972,0.019210203,0.003132785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018813727,0.00049450237,0.0014419532,0.004651097,0.0012288428,0.0037494474,0.0022720245,0.0023638187,0.0026061262],"category_scores_gemma":[0.0898158,0.0005140812,0.001094631,0.00507929,0.0011816651,0.0025426901,0.0014833142,0.0028565722,0.0016029908],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019604666,0.00045949628,0.4946151,0.0032806164,0.0007280645,0.00050658867,0.001083793,0.0013306264,0.00051845046,0.0056739296,0.11817252,0.37343472],"study_design_scores_gemma":[0.000267559,0.0007641242,0.6207422,0.023817819,0.0023503967,0.005656224,0.0055418634,0.0091314735,0.0026606533,0.023481328,0.30532742,0.0002589456],"about_ca_topic_score_codex":0.006227197,"about_ca_topic_score_gemma":0.018615639,"teacher_disagreement_score":0.018813727,"about_ca_system_score_codex":0.0016252131,"about_ca_system_score_gemma":0.0042146174,"threshold_uncertainty_score":0.099497676},"labels":[],"label_agreement":null},{"id":"W2588429189","doi":"10.1016/j.urolonc.2016.12.008","title":"Filtration-based enrichment of circulating tumor cells from all prostate cancer risk groups","year":2017,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba; Research Manitoba","funders":"Mitacs; Movember Foundation","keywords":"Prostate cancer; Circulating tumor cell; Cytokeratin; Androgen receptor; Prostate; Immunohistochemistry; Cancer; Internal medicine; Oncology; Medicine; Urology; Pathology; Biology; Cancer research; Metastasis","score_opus":0.033005164103334025,"score_gpt":0.323000796736851,"score_spread":0.28999563263351696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588429189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9609121,0.0026324303,0.033555686,0.00014452357,0.000039408114,0.00024033808,0.0005273705,0.0002766752,0.0016714222],"genre_scores_gemma":[0.970471,0.0005465991,0.026062597,0.00015285802,0.000056914636,0.00012026774,0.0012487835,0.00004666421,0.0012942523],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996456,0.00004976868,0.000020718695,0.00008533093,0.00013161373,0.000067057736],"domain_scores_gemma":[0.9997613,0.000069720794,0.000034160734,0.000023675448,0.00006340648,0.000047751433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045112954,0.000300066,0.00047637784,0.0010202883,0.00024399563,0.0005724634,0.00023503472,0.0002771166,0.001326501],"category_scores_gemma":[0.0007775438,0.00011547661,0.00023966767,0.0004695173,0.00019145594,0.00021605055,0.00034400978,0.00030681325,0.00034710814],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005261345,0.00011978912,0.04258938,0.000100747944,0.000058387344,0.00012408505,0.00011420605,0.0002367542,0.92602956,0.00013020617,0.0003762352,0.029594624],"study_design_scores_gemma":[0.00015376047,0.0019356336,0.36352074,0.000054494543,0.00036683367,0.0035855682,0.00015679268,0.0119743785,0.6073084,0.00036855682,0.010526623,0.000048316433],"about_ca_topic_score_codex":0.0014498995,"about_ca_topic_score_gemma":0.002171809,"teacher_disagreement_score":0.0014498995,"about_ca_system_score_codex":0.00023110617,"about_ca_system_score_gemma":0.00030068515,"threshold_uncertainty_score":0.004437566},"labels":[],"label_agreement":null},{"id":"W2591863070","doi":"10.1016/j.urolonc.2017.01.024","title":"Is The Cancer Genome Atlas (TCGA) bladder cancer cohort representative of invasive bladder cancer?","year":2017,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cystectomy; Bladder cancer; Cohort; Medicine; Oncology; Concordance; Internal medicine; Cancer; Lymph node; Nomogram; Disease; Stage (stratigraphy); Biology","score_opus":0.057552263672976625,"score_gpt":0.38292398158697494,"score_spread":0.3253717179139983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591863070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94798166,0.009934831,0.003699876,0.011947943,0.00082374195,0.0000729311,0.019321863,0.000097225195,0.006120083],"genre_scores_gemma":[0.9869912,0.0018985881,0.00072106894,0.002615388,0.0003544296,0.00005970006,0.0066855834,0.00005374925,0.00062039064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99684566,0.0008584593,0.00031653678,0.0009862359,0.00042084232,0.0005722087],"domain_scores_gemma":[0.9957094,0.0011108369,0.0009123936,0.0012725438,0.00063605804,0.00035867194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004165392,0.00023525151,0.0011612937,0.0013936609,0.0009137936,0.002176286,0.0011693687,0.0011686026,0.0020498615],"category_scores_gemma":[0.014576482,0.00046196306,0.0011631448,0.0025213738,0.00060084753,0.0015260421,0.0011542074,0.0010535858,0.00064839795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036639263,0.000032902284,0.96775883,0.00013000764,0.0011715214,0.00020158937,0.0004387055,0.00020533378,0.0025908977,0.00082785904,0.008011677,0.01826428],"study_design_scores_gemma":[0.000023825787,0.00006293551,0.9839061,0.000065255364,0.0005683199,0.00071633776,0.0007011569,0.0002979796,0.00047730122,0.0013619511,0.011791584,0.000027221478],"about_ca_topic_score_codex":0.012571624,"about_ca_topic_score_gemma":0.019030312,"teacher_disagreement_score":0.012571624,"about_ca_system_score_codex":0.0005865029,"about_ca_system_score_gemma":0.0012965649,"threshold_uncertainty_score":0.024996936},"labels":[],"label_agreement":null},{"id":"W2593839194","doi":"10.1016/j.urolonc.2017.01.017","title":"Nivolumab treatment for advanced renal cell carcinoma: Considerations for clinical practice","year":2017,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Centre for Applied Research in Cancer Control","keywords":"Nivolumab; Renal cell carcinoma; Clinical Practice; Medicine; Intensive care medicine; Oncology; Cancer research; Internal medicine; Immunotherapy; Cancer; Nursing","score_opus":0.25299152889040166,"score_gpt":0.4905502424194859,"score_spread":0.23755871352908425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593839194","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000075069955,0.9963648,0.00008935146,0.0025095227,0.00041594412,0.0000030640674,0.000011263666,0.0000054913626,0.0005255472],"genre_scores_gemma":[0.0015901204,0.99422175,0.00042245473,0.0025890127,0.0008285413,0.000009419921,0.000025510843,0.000002520977,0.00031066444],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99948525,0.0001568412,0.0001077334,0.00006642372,0.00014383049,0.00003993815],"domain_scores_gemma":[0.9984907,0.00082324265,0.0001997639,0.000025382215,0.00037467454,0.000086221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021063706,0.00053446356,0.0019935472,0.0013589555,0.00034428327,0.0020701303,0.0012518096,0.0017499761,0.002811412],"category_scores_gemma":[0.0031381412,0.00025545855,0.00092693267,0.0012522527,0.0006797473,0.002108056,0.00084022933,0.003468984,0.00095268764],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012941354,0.000041630497,0.00041820065,0.016756784,0.00018728017,0.0002682396,0.000063563915,0.0003765865,0.00043747816,0.003612306,0.05654537,0.92116326],"study_design_scores_gemma":[0.00009884358,0.00013104841,0.0011726189,0.022060035,0.0004946328,0.0014023179,0.00015713292,0.00026514576,0.00019183305,0.004007974,0.9699791,0.000039259296],"about_ca_topic_score_codex":0.0015722795,"about_ca_topic_score_gemma":0.006881542,"teacher_disagreement_score":0.002811412,"about_ca_system_score_codex":0.0013246118,"about_ca_system_score_gemma":0.0028940483,"threshold_uncertainty_score":0.011139691},"labels":[],"label_agreement":null},{"id":"W2596675526","doi":"10.1016/j.urolonc.2017.01.025","title":"The potential role of follicle-stimulating hormone in the cardiovascular, metabolic, skeletal, and cognitive effects associated with androgen deprivation therapy","year":2017,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University","funders":"","keywords":"Androgen deprivation therapy; Prostate cancer; Medicine; Internal medicine; Follicle-stimulating hormone; Androgen; Pathological; Bone metastasis; Bioinformatics; Endocrinology; Oncology; Bone remodeling; Hormone; Cancer; Luteinizing hormone","score_opus":0.06364099203906712,"score_gpt":0.3691253156940628,"score_spread":0.30548432365499567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596675526","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012092712,0.98400396,0.00017526947,0.0014681048,0.0001477266,0.000021340855,0.00016984265,0.0000032566916,0.0019177814],"genre_scores_gemma":[0.17165042,0.82459426,0.0006339133,0.0015023091,0.00088602595,0.00005276511,0.0001841434,0.0000030176668,0.0004930746],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99920875,0.0003620991,0.00014704948,0.00005212832,0.00019208153,0.00003783659],"domain_scores_gemma":[0.9979481,0.0013637014,0.00050159305,0.000020887406,0.0001293837,0.00003635921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011260627,0.00021360365,0.0005701586,0.0011945923,0.0002204436,0.0007551397,0.000275192,0.00042033632,0.0016387617],"category_scores_gemma":[0.0033141267,0.00010056382,0.0008722234,0.0012361588,0.000362078,0.00043722687,0.00030905707,0.00043598952,0.00011409191],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028840122,0.00023081899,0.07505279,0.09483812,0.003938167,0.004481132,0.0006892369,0.0006321724,0.008313721,0.004045236,0.009723192,0.79517144],"study_design_scores_gemma":[0.000923141,0.0042846194,0.5161542,0.06569487,0.018449191,0.02688292,0.003217117,0.0012500059,0.0100888545,0.011406039,0.3414685,0.00018053559],"about_ca_topic_score_codex":0.002093144,"about_ca_topic_score_gemma":0.0039172154,"teacher_disagreement_score":0.002093144,"about_ca_system_score_codex":0.00050392584,"about_ca_system_score_gemma":0.0011004306,"threshold_uncertainty_score":0.005955279},"labels":[],"label_agreement":null},{"id":"W2602580763","doi":"10.1016/j.urolonc.2017.02.009","title":"Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancer","year":2017,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Caveolin-1 and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cystectomy; Bladder cancer; Medicine; Interquartile range; Hazard ratio; Proportional hazards model; Internal medicine; Oncology; Lymphovascular invasion; Biochemical recurrence; Tissue microarray; Survival analysis; Caveolin 1; Cancer; Urology; Pathology; Prostate cancer; Metastasis; Prostatectomy; Confidence interval","score_opus":0.018223776635531246,"score_gpt":0.29768250725198503,"score_spread":0.27945873061645377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602580763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99896085,0.00066825305,0.000033668057,0.00005784166,0.000015543363,0.0000017621666,0.00006931943,0.0000030119484,0.00018970398],"genre_scores_gemma":[0.99964666,0.00011669298,0.000018773417,0.000016430513,0.00002102615,0.0000016046708,0.00008912705,9.969568e-7,0.00008883039],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998641,0.000027579561,0.000012589328,0.000028269938,0.00002328031,0.0000441829],"domain_scores_gemma":[0.99952877,0.00012462772,0.00013404795,0.00002577496,0.0000412008,0.00014554335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028726406,0.00014500403,0.00038064562,0.0004390619,0.00038915733,0.0005017701,0.00037619023,0.00044395108,0.0008918857],"category_scores_gemma":[0.0014545462,0.00016261991,0.00039278078,0.0006446092,0.00030337228,0.00035036544,0.00029893641,0.00048751404,0.00007942518],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004281791,0.0000298878,0.99636,0.0000133413205,0.000066891225,0.00013658007,0.00006997735,0.00007824621,0.00062199985,0.000016221784,0.000101931495,0.00207682],"study_design_scores_gemma":[0.000010137069,0.000091939706,0.9988752,0.0000033577398,0.000092910785,0.0002929712,0.00009814691,0.00023925959,0.00010859844,0.000030645122,0.00015188757,0.0000050022163],"about_ca_topic_score_codex":0.0032867112,"about_ca_topic_score_gemma":0.004443002,"teacher_disagreement_score":0.0032867112,"about_ca_system_score_codex":0.00032212373,"about_ca_system_score_gemma":0.0004693918,"threshold_uncertainty_score":0.0065351725},"labels":[],"label_agreement":null},{"id":"W2609301236","doi":"10.1016/j.urolonc.2017.01.022","title":"Obesity is associated with biochemical recurrence after radical prostatectomy: A multi-institutional extended validation study","year":2017,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Biochemical recurrence; Prostatectomy; Prostate cancer; Body mass index; Interquartile range; Overweight; Hazard ratio; Urology; Proportional hazards model; Obesity; Internal medicine; Cohort; Oncology; Cancer; Confidence interval","score_opus":0.041362077110012184,"score_gpt":0.33764064623054274,"score_spread":0.2962785691205306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2609301236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99946696,0.00007275638,0.00008728893,0.000015315163,0.000008100921,0.000016071106,0.00022854295,0.0000023615662,0.00010260755],"genre_scores_gemma":[0.99873537,0.0000482907,0.00014197867,0.00004182079,0.000016729153,0.000031895474,0.0007763965,0.0000069236626,0.00020052126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827194,0.00076699036,0.00013085219,0.00040382764,0.00017515486,0.0002511884],"domain_scores_gemma":[0.9944648,0.0010066713,0.0020165113,0.0011359097,0.00059037947,0.00078570965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024930194,0.00096542557,0.0006874386,0.0008489932,0.0015145743,0.0014288069,0.0011366328,0.00097167795,0.001593872],"category_scores_gemma":[0.0046236506,0.00091583055,0.0017681733,0.001422271,0.0010107062,0.0009885003,0.0014933087,0.001497297,0.00043103367],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055621035,0.00020760251,0.9976223,0.000010457018,0.00038644802,0.000049837763,0.00018569603,0.000035394536,0.00032670988,0.000015646401,0.00009193778,0.0005117836],"study_design_scores_gemma":[0.000033760676,0.00025588917,0.9989071,0.000004900721,0.00014966437,0.00011023263,0.00023101465,0.00008703494,0.000057658617,0.000012386077,0.0001411032,0.00000915033],"about_ca_topic_score_codex":0.007149437,"about_ca_topic_score_gemma":0.009417753,"teacher_disagreement_score":0.007149437,"about_ca_system_score_codex":0.00054070255,"about_ca_system_score_gemma":0.0008500532,"threshold_uncertainty_score":0.014215648},"labels":[],"label_agreement":null},{"id":"W2610237020","doi":"10.1016/j.urolonc.2017.04.005","title":"Health care services utilization during the last 6 months of life among patients with bladder cancer who underwent radical cystectomy in Quebec, Canada","year":2017,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Cystectomy; Bladder cancer; Cohort; Retrospective cohort study; Health care; Radiation therapy; Urinary system; Cancer; Emergency medicine; Surgery; Internal medicine","score_opus":0.015227017950246755,"score_gpt":0.2880855705536628,"score_spread":0.272858552603416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610237020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98476255,0.0015848775,0.00008308148,0.00083370035,0.000052670228,0.00004469915,0.008995802,0.000014018905,0.0036285212],"genre_scores_gemma":[0.99588025,0.0006542359,0.00008305287,0.0002331231,0.000013993909,0.000019351452,0.0019802332,0.000004557191,0.0011310922],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99937147,0.00006270735,0.00006338229,0.000095251424,0.00013644449,0.00027081245],"domain_scores_gemma":[0.9980209,0.00011709757,0.00043805875,0.00003622577,0.0007714412,0.0006163477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038790872,0.0003699365,0.0004444441,0.0012263932,0.0021099327,0.001244461,0.0013622988,0.0007909973,0.0034308985],"category_scores_gemma":[0.001543107,0.00033512898,0.0010399206,0.00368064,0.0005691756,0.0006040558,0.00068045635,0.0011252417,0.000275733],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043174765,0.000033537654,0.9966378,0.000023671406,0.00007666435,0.00008676123,0.00030686104,0.0001284398,0.00009071434,0.000051480958,0.0011135476,0.0014072395],"study_design_scores_gemma":[0.000005739079,0.000016282922,0.9980743,0.000038822236,0.000025782065,0.00003478606,0.0010254248,0.0002206472,0.000017535875,0.0000076020438,0.00052320986,0.000010045297],"about_ca_topic_score_codex":0.99465346,"about_ca_topic_score_gemma":0.99694026,"teacher_disagreement_score":0.024314445,"about_ca_system_score_codex":0.024314445,"about_ca_system_score_gemma":0.019584838,"threshold_uncertainty_score":0.17641449},"labels":[],"label_agreement":null},{"id":"W2611625034","doi":"10.1016/j.urolonc.2013.03.011","title":"Commentary on “Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience.” Yafi FA, Aprikian AG, Fradet Y, Chin JL, Izawa J, Rendon R, Estey E, Fairey A, Cagiannos I, Lacombe L, Lattouf JB, Bell D, Saad F, Drachenberg D, Kassouf W. Department of Surgery (Urology), McGill University, Quebec, Canada","year":2013,"lang":"en","type":"letter","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Dissection (medical); Lymph node; Cancer; Urinary diversion; Disease; Cohort; Regimen; Urology; Surgery; General surgery; Oncology; Internal medicine","score_opus":0.036880496608188804,"score_gpt":0.2948694637530366,"score_spread":0.25798896714484776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611625034","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020095617,0.00057130307,0.000042409007,0.982788,0.015241922,0.000014255518,0.00016277109,0.0000237221,0.00095467234],"genre_scores_gemma":[0.001424121,0.00043623798,0.00008937826,0.9754077,0.020825466,0.000036603782,0.0000821377,0.000017609293,0.0016808299],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99282795,0.0020886136,0.0011701544,0.0007666511,0.0022776686,0.0008689391],"domain_scores_gemma":[0.97943455,0.0096042855,0.0015654779,0.0003511291,0.0065253605,0.0025192173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0063640075,0.0011155466,0.0019355447,0.0016060781,0.004508136,0.0028444915,0.003628516,0.050481476,0.006194907],"category_scores_gemma":[0.04335433,0.0011441986,0.002084703,0.0022645579,0.002805343,0.0037870295,0.0014076635,0.034774296,0.006324057],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028084352,0.000008265018,0.00029051735,0.000024030871,0.000006161047,0.00026954486,0.0000559049,0.00002613048,0.000029699619,0.00024810786,0.9973116,0.0017019295],"study_design_scores_gemma":[0.00019662599,0.00006146162,0.00370608,0.0008304167,0.0000770337,0.001695951,0.0005506057,0.00054526003,0.0002976786,0.0027030378,0.98918253,0.00015331981],"about_ca_topic_score_codex":0.07400717,"about_ca_topic_score_gemma":0.08880416,"teacher_disagreement_score":0.9875095,"about_ca_system_score_codex":0.012490481,"about_ca_system_score_gemma":0.013681343,"threshold_uncertainty_score":0.14715278},"labels":[],"label_agreement":null},{"id":"W2612425293","doi":"10.1016/j.urolonc.2017.04.013","title":"Oncological and functional outcomes of sexual function–preserving cystectomy compared with standard radical cystectomy in men: A systematic review","year":2017,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Cystectomy; Medicine; Sexual function; Bladder cancer; Urology; Urinary diversion; Confounding; Surgery; Internal medicine; Cancer","score_opus":0.0956517045637671,"score_gpt":0.3825237011726574,"score_spread":0.2868719966088903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612425293","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0040353145,0.9952814,0.00006467222,0.00007197059,0.000069186586,0.000075857366,0.00028370638,0.0000050221515,0.00011289635],"genre_scores_gemma":[0.08776848,0.9104114,0.00043505218,0.00065782067,0.00012267547,0.00016451461,0.00028974228,0.000006858405,0.00014351697],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9975981,0.00070088677,0.0009152452,0.00035046393,0.00031423205,0.00012116007],"domain_scores_gemma":[0.99296874,0.005043011,0.0014124098,0.000104380466,0.00034547853,0.00012591096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028831486,0.0011545956,0.007949109,0.0025903855,0.00039794078,0.001664005,0.0014997334,0.0015296079,0.0042008054],"category_scores_gemma":[0.013683961,0.00090584776,0.0116893565,0.0038272005,0.00069608534,0.0012985651,0.0011638058,0.0015547555,0.0002042415],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018691643,0.000047171277,0.004818094,0.85358673,0.1127015,0.00009751203,0.00017860667,0.00017274161,0.00019551597,0.000101826714,0.00091749197,0.025313599],"study_design_scores_gemma":[0.0024776931,0.00077992893,0.01912285,0.20225383,0.76700526,0.00034844855,0.00039185677,0.00015230228,0.00018174888,0.00029461438,0.0069054756,0.000085960484],"about_ca_topic_score_codex":0.009396837,"about_ca_topic_score_gemma":0.03231974,"teacher_disagreement_score":0.009396837,"about_ca_system_score_codex":0.0017552953,"about_ca_system_score_gemma":0.0031656343,"threshold_uncertainty_score":0.018684328},"labels":[],"label_agreement":null},{"id":"W2665457297","doi":"10.1016/j.urolonc.2017.05.004","title":"Prognostic role of Ki-67 score in localized prostate cancer: A systematic review and meta-analysis","year":2017,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Queen's University; University Health Network","funders":"","keywords":"Medicine; Meta-analysis; Prostate cancer; Internal medicine; Odds ratio; Publication bias; Oncology; Ki-67; Disease; MEDLINE; Cancer; Immunohistochemistry","score_opus":0.1302690526630754,"score_gpt":0.4109729012274499,"score_spread":0.28070384856437447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2665457297","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00637813,0.9925789,0.00024265348,0.00011532599,0.000100219404,0.000055802106,0.00037281172,0.000015333027,0.00014073927],"genre_scores_gemma":[0.23461051,0.7609561,0.0015143225,0.0011438138,0.00028692445,0.00025864743,0.0007528316,0.000029961322,0.00044692014],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9967002,0.0011241523,0.0010370744,0.00060028554,0.00035364335,0.00018464308],"domain_scores_gemma":[0.992997,0.005005901,0.0011318388,0.00031019983,0.00042276786,0.0001323644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005035846,0.0023437333,0.011219856,0.0034667102,0.0005435841,0.0022162304,0.0020151993,0.0021604656,0.0038694793],"category_scores_gemma":[0.014484712,0.0015054101,0.02650667,0.005338428,0.00066267693,0.001788467,0.0016094391,0.0018585701,0.00038079332],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023613689,0.000051367697,0.01738013,0.2851937,0.67629397,0.00023051207,0.00014276238,0.00051258644,0.00036703327,0.00012396256,0.0010869395,0.016255645],"study_design_scores_gemma":[0.0003725533,0.00012559647,0.007780882,0.008543056,0.9814487,0.000102304344,0.00006024777,0.00011757474,0.00006655128,0.00013141024,0.0012203507,0.000030786458],"about_ca_topic_score_codex":0.00789421,"about_ca_topic_score_gemma":0.025997316,"teacher_disagreement_score":0.011219856,"about_ca_system_score_codex":0.0012672625,"about_ca_system_score_gemma":0.0022777673,"threshold_uncertainty_score":0.026632428},"labels":[],"label_agreement":null},{"id":"W2735496645","doi":"10.1016/j.urolonc.2017.06.060","title":"Metastatic renal cell carcinoma: Patterns and predictors of metastases—A contemporary population-based series","year":2017,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Chromophobe cell; Oncology; Odds ratio; Epidemiology; Disease; Hazard ratio; Kidney cancer; Logistic regression; Lung cancer; Population; Performance status; Cancer; Clear cell; Confidence interval","score_opus":0.04462623261756779,"score_gpt":0.29821327858660135,"score_spread":0.2535870459690336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735496645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99882394,0.0003992166,0.0001155566,0.00003980419,0.000004885735,0.0000042380775,0.00023889667,0.000004606536,0.00036881733],"genre_scores_gemma":[0.999313,0.0002864479,0.000040562532,0.000019054074,0.000015067409,0.0000038237454,0.00025353782,0.0000028846966,0.00006567706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994537,0.00009090048,0.000062632666,0.00023593425,0.00008691638,0.00006983455],"domain_scores_gemma":[0.99925715,0.00013228285,0.00023585185,0.00009750207,0.00010638963,0.00017076638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038342972,0.00027138196,0.00061923964,0.0011774169,0.0006951271,0.00084054004,0.00043666168,0.0005248081,0.001960048],"category_scores_gemma":[0.0012931753,0.00042828196,0.00056779204,0.0020955058,0.00055790663,0.0014322673,0.0006994668,0.0006082991,0.0004051935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052773456,0.000030070443,0.9981844,0.000005949625,0.000047183177,0.00016692399,0.000118588185,0.000025650113,0.00019973768,0.000016420894,0.000082141436,0.0010700979],"study_design_scores_gemma":[0.000004007777,0.000051988714,0.9978794,0.0000036307351,0.000031591655,0.0010975474,0.0005501387,0.000130976,0.000030829746,0.0000309849,0.00018311583,0.0000058562764],"about_ca_topic_score_codex":0.004607468,"about_ca_topic_score_gemma":0.005426297,"teacher_disagreement_score":0.004607468,"about_ca_system_score_codex":0.0003647479,"about_ca_system_score_gemma":0.0004323812,"threshold_uncertainty_score":0.0091612935},"labels":[],"label_agreement":null},{"id":"W2737880734","doi":"10.1016/j.urolonc.2017.06.048","title":"Identifying intermediate-risk candidates for active surveillance of prostate cancer","year":2017,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Prostate cancer; Cancer; Medicine; Oncology; Internal medicine","score_opus":0.09921041288774915,"score_gpt":0.4275026429449954,"score_spread":0.3282922300572463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2737880734","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018019218,0.9992518,0.00005013376,0.00014506975,0.00006754217,0.0000037875604,0.000019885201,0.0000014870485,0.00028016872],"genre_scores_gemma":[0.002595245,0.99666303,0.00019477418,0.00024154104,0.00012715324,0.000004755633,0.00006190958,7.039246e-7,0.00011085216],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99970704,0.00007118235,0.0000605142,0.00006190519,0.00007752554,0.000021702002],"domain_scores_gemma":[0.99918085,0.0005676337,0.00012176791,0.000011905048,0.00009338522,0.000024496157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065022625,0.00060224533,0.0012559857,0.0014391895,0.00015534367,0.00093608524,0.0009495722,0.0007717012,0.0025767733],"category_scores_gemma":[0.003024516,0.00022360368,0.0011545467,0.0010449437,0.0002412689,0.0008064305,0.00050911016,0.0009435464,0.00041937098],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000101884,0.000044226163,0.0031740074,0.043197393,0.00050417124,0.0001985886,0.00004052109,0.00023841225,0.000289179,0.0006945935,0.010863488,0.9406535],"study_design_scores_gemma":[0.00027804723,0.0004132214,0.038519114,0.18077515,0.010545479,0.0075181653,0.000577383,0.0006689908,0.001038375,0.005111879,0.75440335,0.00015085452],"about_ca_topic_score_codex":0.002494864,"about_ca_topic_score_gemma":0.006360056,"teacher_disagreement_score":0.0025767733,"about_ca_system_score_codex":0.0003858502,"about_ca_system_score_gemma":0.0012306876,"threshold_uncertainty_score":0.008620143},"labels":[],"label_agreement":null},{"id":"W2738752481","doi":"10.1016/j.urolonc.2017.07.004","title":"Hospitalization before surgery and subsequent risk of infective complications after radical cystectomy: A population-based analysis","year":2017,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cystectomy; Medicine; General surgery; Surgery; Bladder cancer; Internal medicine; Cancer","score_opus":0.02013023970879372,"score_gpt":0.31173808250322815,"score_spread":0.2916078427944344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2738752481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99888366,0.00033044186,0.00007948686,0.000035277397,0.000011445523,0.000006973267,0.00034336327,0.0000056633303,0.0003037263],"genre_scores_gemma":[0.9993449,0.00012142594,0.000037316688,0.000025569012,0.000018356019,0.0000072789376,0.00033032187,0.0000035053527,0.000111346395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900085,0.00022638193,0.00011564145,0.00032494118,0.00011406334,0.00021809923],"domain_scores_gemma":[0.99738127,0.00053881976,0.0010182254,0.0003351628,0.00014351348,0.00058301166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008279139,0.00056540983,0.0008356227,0.0012589769,0.0007136732,0.0012214704,0.0008933877,0.0016416672,0.0029158664],"category_scores_gemma":[0.0025540786,0.00096588884,0.0028246953,0.0019088227,0.0006134693,0.0013725817,0.0008991037,0.0017519839,0.0003573818],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051136035,0.000112619295,0.9979365,0.000013201854,0.0005513473,0.00008487098,0.000051520514,0.000075265496,0.0001492894,0.000018351313,0.000083139625,0.0004126117],"study_design_scores_gemma":[0.000019967085,0.00021907825,0.9988412,0.0000045525085,0.00014585954,0.00015613933,0.00025632101,0.00024639265,0.000020785625,0.000025011925,0.00005357568,0.000011072575],"about_ca_topic_score_codex":0.0075962474,"about_ca_topic_score_gemma":0.0063468018,"teacher_disagreement_score":0.0075962474,"about_ca_system_score_codex":0.0005407716,"about_ca_system_score_gemma":0.000510988,"threshold_uncertainty_score":0.015104055},"labels":[],"label_agreement":null},{"id":"W2743885869","doi":"10.1016/j.urolonc.2017.06.044","title":"Creation and internal validation of a biopsy avoidance prediction tool to aid in the choice of diagnostic approach in patients with prostate cancer suspicion","year":2017,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Mount Sinai Hospital; University of Toronto; University Health Network","funders":"","keywords":"Rectal examination; Medicine; Biopsy; Prostate cancer; Prostate biopsy; Prostate; Intraepithelial neoplasia; High-grade prostatic intraepithelial neoplasia; Urology; Prostate-specific antigen; Receiver operating characteristic; Logistic regression; Cancer; Radiology; Internal medicine","score_opus":0.02065637297110281,"score_gpt":0.30854047784406274,"score_spread":0.28788410487295996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2743885869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9320979,0.0008478211,0.053054657,0.0012034051,0.0003604917,0.00077813945,0.0029979714,0.0011824622,0.0074772765],"genre_scores_gemma":[0.95554703,0.00013824562,0.040822435,0.0002456725,0.000110493915,0.00038417493,0.0019753654,0.00009924524,0.0006772657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99376065,0.0023006676,0.0008017447,0.00094644545,0.0017430563,0.0004473251],"domain_scores_gemma":[0.9608429,0.023008537,0.004231042,0.0029733034,0.0080786245,0.0008656257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015047631,0.0008159178,0.0008311257,0.003143293,0.00077327766,0.0034184046,0.001203924,0.001319707,0.0023508787],"category_scores_gemma":[0.051972177,0.0005028002,0.0009283747,0.0016650908,0.000707069,0.0011205417,0.0015647828,0.0012026386,0.0009723975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007910071,0.00027492858,0.91449016,0.00013297936,0.0002684303,0.00018709365,0.00058501575,0.0028698898,0.0022240593,0.0010653273,0.0039154557,0.07319581],"study_design_scores_gemma":[0.00021679439,0.00090627186,0.7990778,0.00054341316,0.0010821897,0.0026103964,0.0012536997,0.14906421,0.023973938,0.0041962154,0.016927874,0.00014720783],"about_ca_topic_score_codex":0.0016715958,"about_ca_topic_score_gemma":0.0022175417,"teacher_disagreement_score":0.015047631,"about_ca_system_score_codex":0.00079112925,"about_ca_system_score_gemma":0.0019183873,"threshold_uncertainty_score":0.079580426},"labels":[],"label_agreement":null},{"id":"W2745944691","doi":"10.1016/j.urolonc.2017.07.031","title":"Mitomycin-C and urethral dilatation: A safe, effective, and minimally invasive procedure for recurrent vesicourethral anastomotic stenoses","year":2017,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Urological Disorders and Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec; Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"","keywords":"Medicine; Cystoscopy; Surgery; Prostatectomy; Anastomosis; Mitomycin C; Interquartile range; Urology; Stenosis; Urethra; Internal medicine; Prostate; Urinary system","score_opus":0.030238595218029508,"score_gpt":0.3328615068064946,"score_spread":0.3026229115884651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2745944691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9283614,0.049896125,0.009086933,0.0039849496,0.0006857731,0.00010198893,0.000064867185,0.0003798928,0.007437919],"genre_scores_gemma":[0.98295295,0.009792322,0.0033526728,0.00055343774,0.0015220504,0.000025056319,0.00004414867,0.00002654052,0.0017308154],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.999843,0.000036753652,0.000015912077,0.000020560383,0.000044551853,0.000039059378],"domain_scores_gemma":[0.99979573,0.000047630278,0.0000405405,0.000018227749,0.000009630206,0.0000882298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022150888,0.00038279843,0.0005036754,0.00064167345,0.0005674733,0.00024835343,0.00028909,0.00080444803,0.00094343047],"category_scores_gemma":[0.0007096643,0.0001411321,0.0005162634,0.00020575615,0.0004287834,0.00043491897,0.00032340197,0.0009333196,0.00028146888],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006902589,0.0017695932,0.07548671,0.00085804507,0.0004735205,0.11740759,0.00039079564,0.0012973566,0.12529704,0.0018752672,0.0076270965,0.6606144],"study_design_scores_gemma":[0.0015309833,0.017111896,0.2904511,0.00040291494,0.00091206573,0.5865421,0.00030888777,0.0042337687,0.051562592,0.0016735843,0.04504654,0.000223616],"about_ca_topic_score_codex":0.00046914443,"about_ca_topic_score_gemma":0.0015315389,"teacher_disagreement_score":0.00094343047,"about_ca_system_score_codex":0.00016532945,"about_ca_system_score_gemma":0.00040873513,"threshold_uncertainty_score":0.003156066},"labels":[],"label_agreement":null},{"id":"W2755217671","doi":"10.1016/j.urolonc.2017.08.023","title":"Lymphadenectomy in Gleason 7 prostate cancer: Adherence to guidelines and effect on clinical outcomes","year":2017,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Nomogram; Prostate cancer; Prostatectomy; Lymphadenectomy; Oncology; Internal medicine; Cancer; Biochemical recurrence; Urology; Prostate; Population","score_opus":0.10957873176005241,"score_gpt":0.45761983859298305,"score_spread":0.34804110683293066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755217671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99081814,0.004828829,0.00010004945,0.0016812136,0.000069724054,0.000013574341,0.00025907997,0.000007209622,0.0022221564],"genre_scores_gemma":[0.9982468,0.0008723115,0.00007934033,0.00027134482,0.000045410234,0.0000054681323,0.0002576935,0.0000038546273,0.00021781035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817157,0.0008137554,0.00024699324,0.00015785407,0.0003219897,0.0002877851],"domain_scores_gemma":[0.98924935,0.0046048122,0.0039885226,0.0004123002,0.00063117157,0.0011138896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023834738,0.000108476655,0.00032555594,0.00046787361,0.00032314737,0.0006598365,0.00046003854,0.0006220974,0.0014209909],"category_scores_gemma":[0.018950827,0.00013178814,0.000593075,0.0011085543,0.0002929201,0.00067057606,0.0006515333,0.0010028267,0.00012351113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000887318,0.00038126545,0.9635123,0.00009017042,0.00034590226,0.000055998877,0.0002244865,0.00040385072,0.00007783153,0.000104607,0.0008002653,0.03311616],"study_design_scores_gemma":[0.00004858973,0.0004365296,0.99813735,0.00005828599,0.00014645635,0.000050610197,0.00022169892,0.00026928482,0.00003508559,0.00015431199,0.00043359373,0.000008271695],"about_ca_topic_score_codex":0.011337257,"about_ca_topic_score_gemma":0.020072239,"teacher_disagreement_score":0.011337257,"about_ca_system_score_codex":0.0006391698,"about_ca_system_score_gemma":0.0010362826,"threshold_uncertainty_score":0.022542536},"labels":[],"label_agreement":null},{"id":"W2759094161","doi":"10.1016/j.urolonc.2017.09.007","title":"Decreasing suicide risk among patients with prostate cancer: Implications for depression, erectile dysfunction, and suicidal ideation screening","year":2017,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Cancer survivorship and care","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Prostate cancer; Medicine; Depression (economics); Erectile dysfunction; Suicidal ideation; Cancer; Internal medicine; Androgen deprivation therapy; Oncology; Psychiatry; Gynecology; Poison control; Suicide prevention; Emergency medicine","score_opus":0.059499973695838565,"score_gpt":0.371890890216891,"score_spread":0.31239091652105244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2759094161","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030920305,0.99923754,0.00001845261,0.00021689027,0.000055465556,0.0000054858297,0.000027483875,0.000001755545,0.00012773726],"genre_scores_gemma":[0.003535235,0.9958813,0.00010636482,0.0002776303,0.000085053,0.000011194232,0.000039453524,5.679828e-7,0.00006321325],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997003,0.000092662114,0.0000708051,0.00004049247,0.00007795301,0.000017848393],"domain_scores_gemma":[0.9991948,0.0005209867,0.0001390097,0.000010727068,0.00010109776,0.00003341238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008820351,0.00061379414,0.0022057078,0.001193297,0.00020221117,0.00069287507,0.0009113815,0.0008516249,0.0025912873],"category_scores_gemma":[0.002893073,0.00024298739,0.0014992086,0.0011400393,0.00022329754,0.00055501127,0.00041190622,0.0012630065,0.000279392],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030851807,0.00011598925,0.0032923222,0.10087769,0.0026790306,0.00011224912,0.00009047071,0.00020254441,0.00015333039,0.00069462194,0.011902374,0.87957096],"study_design_scores_gemma":[0.0023365847,0.0019828277,0.07416665,0.36750168,0.042066287,0.0035642767,0.0011530367,0.0009463056,0.0006355207,0.0050400198,0.5003833,0.00022345691],"about_ca_topic_score_codex":0.004098977,"about_ca_topic_score_gemma":0.011903581,"teacher_disagreement_score":0.004098977,"about_ca_system_score_codex":0.0005016943,"about_ca_system_score_gemma":0.0014135131,"threshold_uncertainty_score":0.008668721},"labels":[],"label_agreement":null},{"id":"W2760139092","doi":"10.1016/j.urolonc.2017.08.027","title":"Comparison of the EORTC tables and the EAU categories for risk stratification of patients with nonmuscle-invasive bladder cancer","year":2017,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Interquartile range; Bladder cancer; Proportional hazards model; Internal medicine; Risk stratification; Disease; Cystectomy; Adjuvant; Lower risk; Oncology; Cancer; Urology; Confidence interval","score_opus":0.03197959785697537,"score_gpt":0.34013693470499823,"score_spread":0.3081573368480229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2760139092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98133427,0.002775188,0.0025355963,0.0004360734,0.00017646838,0.0000743959,0.0081124995,0.00008035596,0.0044752266],"genre_scores_gemma":[0.9952034,0.00031737896,0.0012850644,0.00008869519,0.000059130292,0.000042851185,0.0024515383,0.000032900858,0.0005191008],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975858,0.0012419091,0.00028648123,0.00032513635,0.00035162325,0.00020905136],"domain_scores_gemma":[0.9868019,0.009817723,0.0014098313,0.00078074465,0.0007198404,0.00046987185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031318031,0.00054164807,0.0010796475,0.0021486937,0.0002521437,0.0014657484,0.00071211817,0.00066864723,0.004489228],"category_scores_gemma":[0.017976712,0.0002463897,0.0020020409,0.001989793,0.00023568125,0.0015078282,0.0008966407,0.0007401789,0.0005297041],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013045655,0.00012157636,0.94072294,0.00019668597,0.0024094,0.000108525666,0.0001961506,0.002162762,0.00063083007,0.0008078079,0.003062049,0.036535595],"study_design_scores_gemma":[0.00050843856,0.0014628757,0.9684741,0.000121859404,0.002042793,0.00040260862,0.0010360834,0.02019223,0.0005759754,0.0024840701,0.0026218828,0.000077051496],"about_ca_topic_score_codex":0.002918811,"about_ca_topic_score_gemma":0.004763916,"teacher_disagreement_score":0.004489228,"about_ca_system_score_codex":0.00046654334,"about_ca_system_score_gemma":0.0005648093,"threshold_uncertainty_score":0.01656276},"labels":[],"label_agreement":null},{"id":"W2760650159","doi":"10.1016/j.urolonc.2017.09.004","title":"Sunitinib dose-escalation after disease progression in metastatic renal cell carcinoma","year":2017,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Sunitinib; Medicine; Renal cell carcinoma; Toxicity; Internal medicine; Oncology; Progression-free survival; Retrospective cohort study; Urology; Progressive disease; Dosing; Surgery; Overall survival; Disease","score_opus":0.044977480753712495,"score_gpt":0.33666559523442724,"score_spread":0.29168811448071474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2760650159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877814,0.006790294,0.0007555607,0.0004830152,0.00020575705,0.00018401898,0.0001810838,0.00016967245,0.0034492917],"genre_scores_gemma":[0.99713266,0.0010418732,0.00042203796,0.00011992939,0.000052698048,0.000051757095,0.00014888775,0.000022635166,0.0010075417],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9995995,0.000106666586,0.000041568124,0.00006447476,0.0000870452,0.00010073537],"domain_scores_gemma":[0.9996673,0.000108765744,0.00007881027,0.00003818903,0.000029811647,0.0000772063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010046168,0.00025964298,0.0013960114,0.00057843426,0.00037546616,0.00062922976,0.00036272005,0.00034628218,0.002243662],"category_scores_gemma":[0.0012383107,0.00014998877,0.00086857704,0.00040474418,0.00021133556,0.00051307934,0.00021787136,0.0011962183,0.0003353517],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049279127,0.005482383,0.020090578,0.0008998346,0.0012256748,0.00056097825,0.00051334075,0.013251833,0.034075774,0.0008085208,0.005494791,0.86831725],"study_design_scores_gemma":[0.033455636,0.2613869,0.49330673,0.00044618786,0.0029727283,0.0056610554,0.00061419443,0.033583224,0.105525486,0.0035798855,0.059199367,0.0002687227],"about_ca_topic_score_codex":0.0007779759,"about_ca_topic_score_gemma":0.0027637926,"teacher_disagreement_score":0.002243662,"about_ca_system_score_codex":0.001077047,"about_ca_system_score_gemma":0.0005389058,"threshold_uncertainty_score":0.007814527},"labels":[],"label_agreement":null},{"id":"W2766530906","doi":"10.1016/j.urolonc.2017.06.034","title":"Plasticity in muscle-invasive bladder cancer before and after cisplatin-based neoadjuvant chemotherapy","year":2017,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia; University of British Columbia","funders":"","keywords":"Cisplatin; Bladder cancer; Chemotherapy; Medicine; Oncology; Neoadjuvant therapy; Urology; Internal medicine; Cancer","score_opus":0.02364812231578766,"score_gpt":0.32528145425208527,"score_spread":0.3016333319362976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766530906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980326,0.0007191273,0.00009225688,0.00006110073,0.000022689153,0.000008886962,0.00008181391,0.0000068083623,0.0009746374],"genre_scores_gemma":[0.99932754,0.00020548873,0.000028425306,0.000021251071,0.000010189493,0.000007902333,0.0000645389,0.0000024691471,0.0003321945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998116,0.00003964705,0.0000073914603,0.000032328135,0.000031004038,0.00007808193],"domain_scores_gemma":[0.9996013,0.00011849632,0.00008117714,0.000032976866,0.0000580784,0.00010804998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019189091,0.000094208575,0.00036650273,0.00032228316,0.00028573387,0.0005618064,0.0002216162,0.00025063418,0.002015555],"category_scores_gemma":[0.0016407219,0.00010114594,0.00034502236,0.0003305108,0.00033682626,0.00040985883,0.0003859076,0.00047974676,0.00027767255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0334377,0.0018230269,0.5287772,0.0004723335,0.00037254638,0.0031730437,0.0022871322,0.0025662333,0.20459217,0.000712408,0.0023904645,0.2193958],"study_design_scores_gemma":[0.000027878747,0.0018180994,0.98782873,0.000022934617,0.0000713442,0.0006349368,0.000562022,0.0007725518,0.0069184825,0.0003112578,0.0010130143,0.000018729508],"about_ca_topic_score_codex":0.002011232,"about_ca_topic_score_gemma":0.0022758932,"teacher_disagreement_score":0.002015555,"about_ca_system_score_codex":0.0004422775,"about_ca_system_score_gemma":0.0004642252,"threshold_uncertainty_score":0.006742716},"labels":[],"label_agreement":null},{"id":"W2767847180","doi":"10.1016/j.urolonc.2017.10.014","title":"Neoadjuvant treatment for muscle-invasive bladder cancer: The past, the present, and the future","year":2017,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University Health Centre","funders":"Cancer Research UK","keywords":"Medicine; Cystectomy; Bladder cancer; Regimen; Oncology; Immunotherapy; Radiation therapy; Internal medicine; Clinical trial; Cisplatin; Biomarker; Chemotherapy; Cancer","score_opus":0.09999600311254865,"score_gpt":0.40669450208148555,"score_spread":0.3066984989689369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767847180","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000049198596,0.99952126,0.000016016484,0.00016481265,0.00007129222,8.990478e-7,0.000006448665,0.0000010244376,0.00016896115],"genre_scores_gemma":[0.00044545592,0.9991381,0.000042516647,0.00018615297,0.000083769315,0.0000016040274,0.000010082912,4.3784846e-7,0.00009185794],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979025,0.00005750879,0.00003879982,0.000034322784,0.00006136767,0.00001767832],"domain_scores_gemma":[0.9995178,0.00030861123,0.00008197974,0.000008034985,0.000060491784,0.000023067922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067196076,0.0005012933,0.0014671716,0.0011258541,0.00019033563,0.0009720493,0.00082511443,0.00081806927,0.003278134],"category_scores_gemma":[0.0011271907,0.0001975034,0.000625156,0.0015171662,0.00040448073,0.001259387,0.0004899582,0.0015266589,0.00066154706],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012364479,0.000047346864,0.00028153945,0.04062361,0.00021084522,0.00012803932,0.000057898058,0.00028150564,0.00072580803,0.0018073485,0.02262652,0.933086],"study_design_scores_gemma":[0.000072700364,0.0001920889,0.002162521,0.031704947,0.00086355564,0.001636736,0.0001742528,0.00016530194,0.00034690386,0.0021785642,0.9604636,0.00003892135],"about_ca_topic_score_codex":0.00095515384,"about_ca_topic_score_gemma":0.0037237194,"teacher_disagreement_score":0.003278134,"about_ca_system_score_codex":0.00050085457,"about_ca_system_score_gemma":0.0010588862,"threshold_uncertainty_score":0.01096648},"labels":[],"label_agreement":null},{"id":"W2769387619","doi":"10.1016/j.urolonc.2017.10.025","title":"The impact of readmission hospital on failure-to-rescue rates following major urologic cancer surgery","year":2017,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Logistic regression; Emergency medicine; Complication; Retrospective cohort study; Odds ratio; Sepsis; Cohort; Intensive care medicine; Surgery; General surgery; Internal medicine","score_opus":0.03424858509455961,"score_gpt":0.36890815552577877,"score_spread":0.3346595704312192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769387619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99551046,0.0013492826,0.00009518386,0.0008326276,0.00009541335,0.000009980935,0.00058741774,0.000009455691,0.0015100711],"genre_scores_gemma":[0.9989298,0.00020109849,0.00004134756,0.00011595336,0.00009553585,0.0000040304303,0.0003873529,0.000004344738,0.00022053221],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981217,0.0006716919,0.00025895747,0.0001902763,0.0002748828,0.0004826142],"domain_scores_gemma":[0.9830593,0.005156752,0.006725262,0.0007426934,0.0012349853,0.0030810528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019515258,0.0003048062,0.0005761643,0.0008022781,0.00054732326,0.0014230893,0.0008621263,0.0010826673,0.004464301],"category_scores_gemma":[0.018906616,0.00026273084,0.0019090044,0.0008222418,0.00034741106,0.0011190238,0.0013198126,0.0020691247,0.0005107669],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041812778,0.00011590046,0.9941234,0.000032142496,0.0002496305,0.0000911204,0.000083303494,0.00018823,0.000032487627,0.000044857552,0.00052773673,0.0040930267],"study_design_scores_gemma":[0.0000072845473,0.0001413822,0.99891305,0.000020430407,0.00006806818,0.00006775374,0.00032335435,0.0002947192,0.000017354216,0.000040653547,0.00009807736,0.000007790525],"about_ca_topic_score_codex":0.008875646,"about_ca_topic_score_gemma":0.014796956,"teacher_disagreement_score":0.008875646,"about_ca_system_score_codex":0.00095445797,"about_ca_system_score_gemma":0.0011390651,"threshold_uncertainty_score":0.017647982},"labels":[],"label_agreement":null},{"id":"W2771131151","doi":"10.1016/j.urolonc.2017.11.010","title":"Impact of age on outcomes of patients with non–muscle-invasive bladder cancer treated with immediate postoperative instillation of mitomycin C","year":2017,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Mitomycin C; Proportional hazards model; Bladder cancer; Cohort; Surgery; Pathological; Disease; Urology; Cancer; Internal medicine","score_opus":0.02377074411454563,"score_gpt":0.3297511915495603,"score_spread":0.3059804474350147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2771131151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99765426,0.00094087695,0.00004644091,0.00016937779,0.000040905197,0.000004404875,0.00017897488,0.0000024667954,0.00096241746],"genre_scores_gemma":[0.9993173,0.00019189733,0.00001712123,0.000059611088,0.000032420623,0.0000029986732,0.00019308247,0.0000012298059,0.00018432757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997106,0.00006214415,0.000028973562,0.00004046073,0.000041763848,0.000116036914],"domain_scores_gemma":[0.99888843,0.00031414136,0.00042902137,0.000042530024,0.00007320564,0.00025262128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036826055,0.00015993556,0.00035638918,0.00022574779,0.00024850242,0.00052879634,0.00021090177,0.0003661643,0.0019993873],"category_scores_gemma":[0.0021775176,0.00008595629,0.001007715,0.0003140012,0.00021134704,0.0005043975,0.00041744087,0.0007409066,0.00017028431],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005845221,0.0002903882,0.9783492,0.000048777158,0.00039389732,0.00036061762,0.00010398889,0.00031743126,0.00077114213,0.000070379654,0.00039184562,0.013057025],"study_design_scores_gemma":[0.000046558092,0.0014547657,0.99682933,0.000017756738,0.000280328,0.00026086217,0.00016314472,0.00023946645,0.00020278608,0.00006971623,0.0004263255,0.000008987887],"about_ca_topic_score_codex":0.0014443445,"about_ca_topic_score_gemma":0.0025566856,"teacher_disagreement_score":0.0019993873,"about_ca_system_score_codex":0.00039074835,"about_ca_system_score_gemma":0.00035395482,"threshold_uncertainty_score":0.006688595},"labels":[],"label_agreement":null},{"id":"W2771514333","doi":"10.1016/j.urolonc.2017.10.022","title":"Adherence to pelvic lymph node dissection recommendations according to the National Comprehensive Cancer Network pelvic lymph node dissection guideline and the D'Amico lymph node invasion risk stratification","year":2017,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Nomogram; Medicine; Lymph node; Guideline; Prostate cancer; Prostatectomy; Dissection (medical); Stage (stratigraphy); Population; Radiology; Cancer; Internal medicine; Pathology","score_opus":0.06236181102325685,"score_gpt":0.3685785812146616,"score_spread":0.30621677019140475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2771514333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.48949856,0.03994393,0.0325317,0.1341001,0.0068683303,0.0052620173,0.042214315,0.0006798437,0.24890119],"genre_scores_gemma":[0.8745112,0.01383851,0.0515166,0.022041153,0.0007193253,0.002453524,0.022834577,0.00011620809,0.011968845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.993768,0.0017861364,0.0014965923,0.00035041512,0.0021360982,0.00046287585],"domain_scores_gemma":[0.9927205,0.001836052,0.0022366873,0.00033678135,0.0021710226,0.00069909875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067296857,0.00015188089,0.00048778942,0.0013223176,0.00039574358,0.0007484376,0.0008974967,0.0010267792,0.0019464466],"category_scores_gemma":[0.020415448,0.00014810993,0.0007236424,0.0015834188,0.0002396535,0.000491199,0.0008035846,0.0014480161,0.0004740682],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002614938,0.0004112789,0.5639056,0.0013570191,0.0004946823,0.00016843475,0.0008112061,0.0020524838,0.0007130497,0.002896758,0.16600811,0.2609199],"study_design_scores_gemma":[0.00020134619,0.00034980397,0.8768777,0.0036288744,0.00034961122,0.0005456105,0.0011021639,0.0033490881,0.0006621914,0.002002036,0.110850446,0.000081035294],"about_ca_topic_score_codex":0.025736535,"about_ca_topic_score_gemma":0.044800118,"teacher_disagreement_score":0.025736535,"about_ca_system_score_codex":0.0012190134,"about_ca_system_score_gemma":0.004519846,"threshold_uncertainty_score":0.05117345},"labels":[],"label_agreement":null},{"id":"W2773177438","doi":"10.1016/j.urolonc.2017.11.015","title":"Perioperative chemotherapy for bladder cancer in the general population: Are practice patterns finally changing?","year":2017,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canadian Cancer Society Research Institute; Institute for Clinical Evaluative Sciences; Cancer Care Ontario; Cancer Research Institute","keywords":"Medicine; Bladder cancer; Cystectomy; Referral; Perioperative; Population; Chemotherapy; Internal medicine; Cancer; Oncology; General surgery; Surgery; Family medicine","score_opus":0.044216247731591454,"score_gpt":0.38817271314940316,"score_spread":0.3439564654178117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2773177438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9239985,0.012281951,0.00071861583,0.054538656,0.00037814368,0.000041189316,0.00060300657,0.00003747702,0.0074025574],"genre_scores_gemma":[0.9882521,0.0058531417,0.00050427165,0.0044668904,0.00024782322,0.000018230856,0.00025503532,0.000012426483,0.00039011159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998268,0.0006238838,0.0002558853,0.00027798637,0.00033817277,0.00023603761],"domain_scores_gemma":[0.98901397,0.0027434812,0.004265057,0.00041642628,0.001962028,0.0015990318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020683215,0.00007838323,0.00026651777,0.00075979944,0.00032648933,0.0011845445,0.0004969067,0.0007794132,0.0023250487],"category_scores_gemma":[0.012961208,0.00015172268,0.00021025464,0.0021189728,0.0005249432,0.0017391448,0.00044457446,0.00082928175,0.00025247832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001229397,0.00012053126,0.9057852,0.00019198745,0.0000684551,0.0001287746,0.0019876387,0.000087236345,0.00047216454,0.00067169644,0.0053620967,0.0850013],"study_design_scores_gemma":[0.0000130817125,0.00008509629,0.98870975,0.00019447385,0.000025006218,0.0002490145,0.0053577586,0.00021401633,0.00008626286,0.00035311634,0.0047003403,0.000012092863],"about_ca_topic_score_codex":0.015805822,"about_ca_topic_score_gemma":0.03307658,"teacher_disagreement_score":0.015805822,"about_ca_system_score_codex":0.0011698116,"about_ca_system_score_gemma":0.0018401064,"threshold_uncertainty_score":0.03142762},"labels":[],"label_agreement":null},{"id":"W2774426427","doi":"10.1016/j.urolonc.2017.11.017","title":"Predicting therapy response and resistance in metastatic prostate cancer with circulating tumor DNA","year":2017,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Prostate cancer; Androgen receptor; Medicine; Precision medicine; Oncology; Liquid biopsy; Circulating tumor cell; Internal medicine; Disease; Cell-free fetal DNA; Bioinformatics; Cancer; Cancer research; Metastasis; Biology; Pathology","score_opus":0.057053904801318805,"score_gpt":0.36045871273121133,"score_spread":0.30340480792989255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774426427","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001876383,0.9985575,0.00018401063,0.0004414011,0.00019792697,0.0000038377816,0.00002457547,0.000006020411,0.00039703902],"genre_scores_gemma":[0.003826126,0.99336433,0.0006253676,0.0009135517,0.00070384535,0.000013639473,0.00008823594,0.0000031562631,0.00046181362],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99961424,0.0000938703,0.000048815986,0.00008989944,0.00012294255,0.000030182146],"domain_scores_gemma":[0.999047,0.0006394219,0.00009779191,0.000018877758,0.00016040615,0.00003650848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012832645,0.0007433872,0.0016424888,0.0013585556,0.0001292455,0.0012360665,0.00090231426,0.0010224052,0.0011746516],"category_scores_gemma":[0.0026878626,0.00030966196,0.0006629011,0.0010655208,0.00053718884,0.0008466234,0.00061078207,0.0020120314,0.0007797145],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010809537,0.00003929749,0.0017974692,0.006246072,0.0001809696,0.00016278015,0.000026294068,0.00037514884,0.00055669906,0.001321111,0.01806133,0.9711247],"study_design_scores_gemma":[0.00015320128,0.00034018277,0.011126504,0.013117248,0.0015381483,0.004179099,0.00017584223,0.0010647499,0.0020988006,0.005784081,0.96030885,0.0001132496],"about_ca_topic_score_codex":0.0013559292,"about_ca_topic_score_gemma":0.0025509838,"teacher_disagreement_score":0.0016424888,"about_ca_system_score_codex":0.00067329255,"about_ca_system_score_gemma":0.0010546433,"threshold_uncertainty_score":0.006786585},"labels":[],"label_agreement":null},{"id":"W2777810775","doi":"10.1016/j.urolonc.2017.12.003","title":"Tertiary Gleason pattern in radical prostatectomy specimens is associated with worse outcomes than the next higher Gleason score group in localized prostate cancer","year":2017,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Interquartile range; Prostatectomy; Prostate cancer; Lymphovascular invasion; Biochemical recurrence; Urology; Internal medicine; Prostate-specific antigen; Gastroenterology; Cancer; Oncology; Metastasis","score_opus":0.04251752342725025,"score_gpt":0.3200482004236059,"score_spread":0.27753067699635564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2777810775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987639,0.0003150262,0.00006651956,0.00011458813,0.000024879528,0.0000029478763,0.00009419095,0.000010217931,0.00060769374],"genre_scores_gemma":[0.99943763,0.00007942597,0.000034066306,0.000039076767,0.00002038406,0.0000010530372,0.00010424616,0.0000037037014,0.0002803604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997086,0.000065780485,0.00003280862,0.00005115876,0.00005828523,0.000083365136],"domain_scores_gemma":[0.99819535,0.00025268755,0.00053635304,0.00014286899,0.00013281012,0.0007400062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036061753,0.00024585798,0.0003434383,0.0007604586,0.00050718506,0.00081595004,0.00046512636,0.00055102113,0.006059032],"category_scores_gemma":[0.0022062925,0.00022929587,0.0005505883,0.0007215105,0.0004700119,0.00045316105,0.00063388405,0.0007987604,0.0005240636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018055431,0.0000311012,0.9965816,0.000009491574,0.000047145437,0.00010649424,0.00003937076,0.000044479773,0.00077210926,0.000013982573,0.0001367897,0.0020369492],"study_design_scores_gemma":[0.0000024011426,0.000055970817,0.9992029,0.0000029592074,0.000022047418,0.00028870485,0.00011213605,0.00006623381,0.00013155997,0.000038505175,0.00007393378,0.000002585232],"about_ca_topic_score_codex":0.0034744316,"about_ca_topic_score_gemma":0.007150703,"teacher_disagreement_score":0.006059032,"about_ca_system_score_codex":0.0003068539,"about_ca_system_score_gemma":0.00062590063,"threshold_uncertainty_score":0.020269454},"labels":[],"label_agreement":null},{"id":"W2790686747","doi":"10.1016/j.urolonc.2017.11.006","title":"Editorial: Managing locally advanced bladder cancer. Third International Bladder Cancer Network seminars series","year":2018,"lang":"en","type":"editorial","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bladder cancer; Cancer; Series (stratigraphy); Medicine; Internal medicine; Biology","score_opus":0.014709881811839704,"score_gpt":0.3270386121538218,"score_spread":0.3123287303419821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790686747","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002312743,0.0023779273,0.000054705855,0.023359492,0.97286224,0.000014412845,0.000038313745,0.00003612658,0.0012336499],"genre_scores_gemma":[0.0002708754,0.0024424098,0.00005461988,0.015003796,0.9756419,0.00002137595,0.000031884112,0.000021927615,0.006511158],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963672,0.00067191245,0.00051412306,0.00043271048,0.0017436619,0.00027035753],"domain_scores_gemma":[0.9838012,0.006092981,0.0012547901,0.00033637666,0.005659546,0.0028552613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004895089,0.0039702854,0.0033911078,0.0034631207,0.0028498757,0.0055099926,0.0037800379,0.012371997,0.02512541],"category_scores_gemma":[0.023885649,0.0010542108,0.002894673,0.0012609912,0.0017457595,0.0052725584,0.0014824428,0.01842991,0.019522347],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024894958,0.000011110432,0.000014110701,0.000103835395,0.0000070923425,0.000080356236,0.0000045692623,0.00002038787,0.00002384038,0.00008448692,0.99682945,0.002795902],"study_design_scores_gemma":[0.000142391,0.000048875867,0.00035479656,0.0007707413,0.00006114888,0.00050367997,0.000037979495,0.00019864016,0.00013813465,0.00092882034,0.9967931,0.000021675673],"about_ca_topic_score_codex":0.0014429394,"about_ca_topic_score_gemma":0.003643966,"teacher_disagreement_score":0.02512541,"about_ca_system_score_codex":0.0033749312,"about_ca_system_score_gemma":0.003145287,"threshold_uncertainty_score":0.08405286},"labels":[],"label_agreement":null},{"id":"W2791194794","doi":"10.1016/j.urolonc.2018.01.018","title":"Accurate prediction of progression to muscle-invasive disease in patients with pT1G3 bladder cancer: A clinical decision-making tool","year":2018,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"European Association of Urology; World Health Organization","keywords":"Nomogram; Medicine; Bladder cancer; Lymphovascular invasion; Internal medicine; Retrospective cohort study; Oncology; Proportional hazards model; Cystectomy; Urology; Disease; Cohort; Cancer; Metastasis","score_opus":0.030298481486270658,"score_gpt":0.3754081287208728,"score_spread":0.34510964723460213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791194794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815734,0.0031562808,0.0054629394,0.002447403,0.00019079482,0.00013121129,0.0014025159,0.00010732853,0.005528028],"genre_scores_gemma":[0.99456537,0.00038273702,0.0035995406,0.00018765988,0.00011708207,0.000030237818,0.00077390287,0.000010000402,0.0003333453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989982,0.00041405263,0.00014343843,0.00013397656,0.0001851156,0.000125339],"domain_scores_gemma":[0.99605656,0.0022577094,0.000517228,0.00013940818,0.00052831863,0.00050077576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002368223,0.000654342,0.0010391868,0.0020952777,0.00047890973,0.0019332801,0.0007726303,0.0012045193,0.001952427],"category_scores_gemma":[0.008748783,0.00027301977,0.0007598063,0.0010285847,0.00033906248,0.0011701699,0.00097443315,0.001154918,0.0006583278],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015864937,0.00021960434,0.9270902,0.00008317676,0.00016005745,0.0003988515,0.00010480699,0.0032193714,0.00096353434,0.00025678388,0.0031522776,0.06276481],"study_design_scores_gemma":[0.00039733504,0.0019785063,0.8392946,0.00035288365,0.00096598925,0.0039735,0.00078299845,0.13530093,0.0042087687,0.004993141,0.0076158857,0.00013545014],"about_ca_topic_score_codex":0.0012237348,"about_ca_topic_score_gemma":0.0025276297,"teacher_disagreement_score":0.002368223,"about_ca_system_score_codex":0.00053279725,"about_ca_system_score_gemma":0.0006368552,"threshold_uncertainty_score":0.012524545},"labels":[],"label_agreement":null},{"id":"W2793460136","doi":"10.1016/j.urolonc.2018.01.004","title":"External beam radiotherapy with or without androgen deprivation therapy in elderly patients with high metastatic risk prostate cancer","year":2018,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Androgen deprivation therapy; Prostate cancer; Comorbidity; Radiation therapy; Internal medicine; Confounding; Oncology; Surveillance, Epidemiology, and End Results; Cancer; Epidemiology; Randomized controlled trial; Clinical trial; Combination therapy; Cancer registry","score_opus":0.027180621844176606,"score_gpt":0.33229612939569414,"score_spread":0.3051155075515175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793460136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865311,0.011439049,0.00009710703,0.00028236688,0.00006821415,0.000021385074,0.00011199881,0.0000060080424,0.0014428038],"genre_scores_gemma":[0.996197,0.0030425272,0.00010277489,0.00018354606,0.00009498092,0.000011489968,0.00007942494,0.0000024412652,0.00028583533],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998468,0.000066083994,0.00001541246,0.000018857787,0.000017879718,0.00003498283],"domain_scores_gemma":[0.9998047,0.000079396355,0.00005031798,0.000008625591,0.000010484363,0.000046489637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045638005,0.00015726582,0.0005416044,0.00018067234,0.00018837686,0.00025306732,0.00013631902,0.00023126685,0.0012240275],"category_scores_gemma":[0.0013183256,0.000079364465,0.0004635522,0.00032488097,0.00015131987,0.00027034123,0.00020669504,0.00023275848,0.00012044043],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18223706,0.0016738056,0.5349466,0.0011393253,0.001497965,0.0014626598,0.00058177667,0.0023350234,0.009582204,0.00022545879,0.0029180527,0.26140007],"study_design_scores_gemma":[0.003582558,0.02562954,0.9618901,0.00015830429,0.0016616164,0.0012903458,0.00046851777,0.00063458644,0.00083629525,0.00022813477,0.0035966055,0.00002327434],"about_ca_topic_score_codex":0.0013908665,"about_ca_topic_score_gemma":0.0041838665,"teacher_disagreement_score":0.0013908665,"about_ca_system_score_codex":0.00027992795,"about_ca_system_score_gemma":0.00039749173,"threshold_uncertainty_score":0.004094839},"labels":[],"label_agreement":null},{"id":"W2793467041","doi":"10.1016/j.urolonc.2018.02.001","title":"Null association between androgen-deprivation therapy and nonprostate cancer mortality among older men with nonmetastatic prostate cancer","year":2018,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; University Health Network; Health Sciences Centre","funders":"Canadian Institutes of Health Research; Government of Ontario; Johns Hopkins University","keywords":"Cancer; Prostate cancer; Androgen deprivation therapy; Medicine; Oncology; Null (SQL); Internal medicine; Gerontology","score_opus":0.045676979912590523,"score_gpt":0.3573562732017739,"score_spread":0.31167929328918337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793467041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965911,0.0012490952,0.00014673756,0.00026292077,0.00004891487,0.0000033944746,0.00061842956,0.000010819299,0.0010684669],"genre_scores_gemma":[0.99918157,0.00010019141,0.000029576166,0.00005462998,0.000040622654,0.0000019886486,0.00022737586,0.000002275522,0.00036179015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994622,0.00015581693,0.000064173124,0.00013062521,0.000095818046,0.000091374946],"domain_scores_gemma":[0.99645823,0.0013031778,0.0008883468,0.000453263,0.0002502879,0.00064675405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096645043,0.00026149405,0.00029951098,0.0005207607,0.00024380215,0.00072213716,0.0005384869,0.00040269765,0.0034885677],"category_scores_gemma":[0.0047887517,0.0002276642,0.0008296015,0.00050292077,0.00034980892,0.00042598794,0.0005341913,0.00067895395,0.00022981239],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012213913,0.00003303115,0.9954476,0.00002028145,0.00023938096,0.00012262043,0.000047180347,0.000030738014,0.0007643924,0.00004583643,0.00012705366,0.0019004301],"study_design_scores_gemma":[0.000015578269,0.00014349014,0.99900764,0.0000036431275,0.00014519124,0.00023191163,0.00007325489,0.00008346781,0.00007527066,0.000054407268,0.00016356906,0.00000270898],"about_ca_topic_score_codex":0.0036559799,"about_ca_topic_score_gemma":0.00370454,"teacher_disagreement_score":0.0036559799,"about_ca_system_score_codex":0.00021097316,"about_ca_system_score_gemma":0.0003436823,"threshold_uncertainty_score":0.011670411},"labels":[],"label_agreement":null},{"id":"W2793834563","doi":"10.1016/j.urolonc.2018.01.011","title":"Understanding how prostate cancer patients value the current treatment options for metastatic castration resistant prostate cancer","year":2018,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Prostate cancer; Medicine; Willingness to pay; Government (linguistics); Cancer; Family medicine; Oncology; Demographics; Internal medicine; Docetaxel; Gynecology; Demography","score_opus":0.15795684390010298,"score_gpt":0.4037151549053187,"score_spread":0.2457583110052157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793834563","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2204501,0.12646009,0.004214139,0.58465207,0.0028278637,0.000071746814,0.0006037213,0.00005875456,0.060661532],"genre_scores_gemma":[0.8965274,0.05951523,0.0031621656,0.034625333,0.0018735981,0.000034425873,0.00021569156,0.000030720792,0.0040153265],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9983557,0.00100501,0.00006216223,0.00009038213,0.00028738123,0.00019930763],"domain_scores_gemma":[0.9963232,0.0020774931,0.00049197755,0.0000901823,0.0005244131,0.00049281016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028602292,0.00020604159,0.00034546768,0.0004724089,0.00064312824,0.0037124644,0.000655166,0.0012978282,0.0056235874],"category_scores_gemma":[0.013581287,0.00016063095,0.0004800871,0.00040328005,0.0015734739,0.0033686052,0.00091302686,0.0040793796,0.00057328946],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001044036,0.0007504639,0.08413757,0.0015932932,0.00080886966,0.00070109405,0.0049931514,0.002601286,0.0022042755,0.042763136,0.09507938,0.7633234],"study_design_scores_gemma":[0.00044861002,0.0016329512,0.1860029,0.006037603,0.0016573019,0.0031896015,0.03772171,0.0063393125,0.0032614842,0.32082447,0.43255067,0.00033335734],"about_ca_topic_score_codex":0.0038806777,"about_ca_topic_score_gemma":0.01102231,"teacher_disagreement_score":0.0056235874,"about_ca_system_score_codex":0.0020597305,"about_ca_system_score_gemma":0.0030987584,"threshold_uncertainty_score":0.018812776},"labels":[],"label_agreement":null},{"id":"W2796945520","doi":"10.1016/j.urolonc.2018.03.015","title":"Monopolar vs. bipolar transurethral resection for non–muscle invasive bladder carcinoma: A post-hoc analysis from a randomized controlled trial","year":2018,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Cystoscopy; Bladder cancer; Perforation; Randomized controlled trial; Perioperative; Surgery; Incidence (geometry); Urology; Cancer; Urinary system; Internal medicine","score_opus":0.022346264565417197,"score_gpt":0.30980139577893673,"score_spread":0.2874551312135195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2796945520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96188074,0.02196024,0.0033615045,0.0010350717,0.0033463384,0.0043249386,0.0013112864,0.00022067422,0.002559064],"genre_scores_gemma":[0.9866425,0.0039114244,0.002218905,0.0010125111,0.0009921805,0.0025563037,0.0006169208,0.000048551705,0.0020007049],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9963146,0.0022819263,0.00035659524,0.0005365477,0.00016254533,0.00034778073],"domain_scores_gemma":[0.99459475,0.0035105515,0.00084264285,0.00034567664,0.0002482926,0.00045815794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048767366,0.0026557029,0.007011255,0.00052147993,0.00049478124,0.001991356,0.0014408056,0.0022297874,0.008820851],"category_scores_gemma":[0.007969931,0.00088883383,0.0062966323,0.00068313244,0.0015472871,0.0022916126,0.00078069174,0.003999959,0.0009645729],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99223256,0.0004809289,0.00015638168,0.0007613102,0.003370546,0.000016226599,0.00001915702,0.00010656618,0.00035442438,0.00004478859,0.00014713216,0.002309921],"study_design_scores_gemma":[0.9615193,0.02840736,0.0012804567,0.00009988057,0.00742874,0.000018401437,0.0000458679,0.00047418664,0.00019088967,0.00025582328,0.00024940717,0.000029673121],"about_ca_topic_score_codex":0.000985442,"about_ca_topic_score_gemma":0.0017491515,"teacher_disagreement_score":0.008820851,"about_ca_system_score_codex":0.0009803011,"about_ca_system_score_gemma":0.001011182,"threshold_uncertainty_score":0.02950871},"labels":[],"label_agreement":null},{"id":"W2797459972","doi":"10.1016/j.urolonc.2018.03.016","title":"Mechanistic target of rapamycin (MTOR) protein expression in the tumor and its microenvironment correlates with more aggressive pathology at cystectomy","year":2018,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia; University of British Columbia","funders":"National Cancer Institute; National Institutes of Health; Burroughs Wellcome Fund","keywords":"PI3K/AKT/mTOR pathway; Cystectomy; Stroma; Immunohistochemistry; Cancer research; Protein kinase B; Pathology; Medicine; Tumor microenvironment; Bladder cancer; Biology; Cancer; Internal medicine; Phosphorylation; Signal transduction; Tumor cells; Cell biology","score_opus":0.010049616633221889,"score_gpt":0.2533141758185196,"score_spread":0.2432645591852977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2797459972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995915,0.00011934585,0.00008090237,0.0000069139464,0.000001028596,0.0000028596944,0.000061224535,0.0000031754162,0.00013292512],"genre_scores_gemma":[0.99967885,0.000035878602,0.000089390735,0.0000049731784,0.0000022839288,0.0000047982553,0.00009703532,0.0000015930016,0.00008529268],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998466,0.000024652483,0.000019280034,0.00004883208,0.00003287075,0.000027752394],"domain_scores_gemma":[0.999383,0.0001018402,0.00030634733,0.000042230335,0.00006020549,0.0001065276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002010059,0.00011886513,0.00019552586,0.00043785374,0.0002078932,0.0003124433,0.00014888674,0.00018507728,0.0013214968],"category_scores_gemma":[0.0005943898,0.000111937705,0.00016528925,0.00026942932,0.00027320857,0.00016580669,0.0001952628,0.00023233233,0.00018484378],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004390652,0.000022429042,0.9648301,0.000019122106,0.000035854293,0.0002453369,0.00005047627,0.00007474436,0.032298263,0.000014094338,0.000057220837,0.001913192],"study_design_scores_gemma":[0.0000028232087,0.00014425276,0.9937588,0.0000019561746,0.000021806944,0.0014930288,0.00007557355,0.00013114024,0.004204319,0.000009130018,0.00015555654,0.0000016727852],"about_ca_topic_score_codex":0.00046300484,"about_ca_topic_score_gemma":0.00072724256,"teacher_disagreement_score":0.0013214968,"about_ca_system_score_codex":0.00020755749,"about_ca_system_score_gemma":0.00013986848,"threshold_uncertainty_score":0.004420817},"labels":[],"label_agreement":null},{"id":"W2805670171","doi":"10.1016/j.urolonc.2018.05.004","title":"Contemporary outcomes of palliative transurethral resection of the prostate in patients with locally advanced prostate cancer","year":2018,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Université Laval","funders":"","keywords":"Medicine; Prostate cancer; Perioperative; Urology; Prostate; Bladder cancer; Cystectomy; Bladder outlet obstruction; Transurethral resection of the prostate; Cancer; Internal medicine; Oncology; Surgery","score_opus":0.030951936058997192,"score_gpt":0.33956325014926064,"score_spread":0.30861131409026343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805670171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97509,0.017179538,0.00034947827,0.0021600423,0.0001030523,0.000010206674,0.00091915583,0.000008802161,0.0041796425],"genre_scores_gemma":[0.99671364,0.0020115892,0.0000536085,0.00014671279,0.00010889218,0.0000045069987,0.0008360008,0.0000040264313,0.00012105542],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993338,0.00014944714,0.00009404501,0.00010726725,0.00016240258,0.00015313714],"domain_scores_gemma":[0.9968118,0.00061828695,0.0013882841,0.00009163366,0.0004053997,0.0006844948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068932935,0.00014121462,0.00034052704,0.00078288314,0.0004422699,0.001240422,0.00050883583,0.00046792845,0.0015441175],"category_scores_gemma":[0.005353931,0.00011275135,0.00060781866,0.0016830805,0.00064631016,0.00105538,0.00088989263,0.00071400526,0.00019803876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042355654,0.000052736676,0.97456586,0.00012287374,0.00023529751,0.00027290097,0.00043613027,0.00047169384,0.00018094077,0.0003768913,0.0010058095,0.021855222],"study_design_scores_gemma":[0.000010287166,0.0001532559,0.99625444,0.000054918466,0.00010669041,0.00078222924,0.0009067314,0.00021919611,0.000051059364,0.00033583396,0.0011125304,0.00001278698],"about_ca_topic_score_codex":0.0028462086,"about_ca_topic_score_gemma":0.006493832,"teacher_disagreement_score":0.0028462086,"about_ca_system_score_codex":0.0011199686,"about_ca_system_score_gemma":0.000569312,"threshold_uncertainty_score":0.00812602},"labels":[],"label_agreement":null},{"id":"W2806018284","doi":"10.1016/j.urolonc.2018.05.019","title":"Increasing rate of lymph node invasion in patients with prostate cancer treated with radical prostatectomy and lymph node dissection","year":2018,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Prostatectomy; Prostate cancer; Medicine; Lymph node; Dissection (medical); Stage (stratigraphy); Logistic regression; Urology; Biochemical recurrence; Lymph; Prostate-specific antigen; Epidemiology; Pathological; Surgery; Cancer; Radiology; Internal medicine; Pathology","score_opus":0.014138287044229874,"score_gpt":0.27585497317421914,"score_spread":0.2617166861299893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806018284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965366,0.0013232676,0.00014388768,0.00016121127,0.000025552345,0.000004853811,0.00035753325,0.000013919398,0.0014331094],"genre_scores_gemma":[0.99882704,0.00040490757,0.00007168515,0.000059068243,0.000040747935,0.000002890777,0.00020324675,0.0000034009581,0.00038701214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979585,0.000044806427,0.000019138806,0.000045310127,0.000050107697,0.000044777207],"domain_scores_gemma":[0.9989133,0.0002929469,0.00043237102,0.00005995311,0.00008171152,0.00021971887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023622409,0.0001392457,0.00024824502,0.00056329026,0.00025607526,0.00041512738,0.00027492188,0.0003919566,0.003090623],"category_scores_gemma":[0.001789367,0.00016955151,0.00037351207,0.00081704627,0.00021037678,0.00047532594,0.00030361244,0.00066319597,0.00030980844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012135965,0.000016084696,0.99743336,0.000013861696,0.000026491576,0.00017562116,0.00003907286,0.000038327904,0.0002850515,0.000015471096,0.00012330618,0.0017119816],"study_design_scores_gemma":[0.0000028442644,0.00004828036,0.9985262,0.000004336729,0.000030377238,0.0008586765,0.000119944314,0.00008963516,0.000056409994,0.000021427997,0.00023911512,0.0000026979671],"about_ca_topic_score_codex":0.0019999954,"about_ca_topic_score_gemma":0.0033155316,"teacher_disagreement_score":0.003090623,"about_ca_system_score_codex":0.00019892746,"about_ca_system_score_gemma":0.00036454125,"threshold_uncertainty_score":0.010339141},"labels":[],"label_agreement":null},{"id":"W2807307046","doi":"10.1016/j.urolonc.2018.05.007","title":"Metric substage according to micro and extensive lamina propria invasion improves prognostics in T1 bladder cancer","year":2018,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Erasmus+; University Health Network","keywords":"Interquartile range; Perineural invasion; Medicine; Carcinoma in situ; Bladder cancer; Hazard ratio; Cancer; Internal medicine; Oncology; Retrospective cohort study; Adjuvant therapy; Urology","score_opus":0.03432888449356644,"score_gpt":0.33620665978230285,"score_spread":0.3018777752887364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807307046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928792,0.0029651334,0.0013460455,0.00039610837,0.00009721738,0.000023850855,0.00050402223,0.00006776454,0.0017207082],"genre_scores_gemma":[0.9978467,0.0003640201,0.0006664076,0.000049697457,0.000058699876,0.00000976806,0.0004775016,0.000013063882,0.00051409606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996315,0.00011687064,0.000041006402,0.00008230101,0.000064867476,0.000063429885],"domain_scores_gemma":[0.99899215,0.00019254696,0.00034554463,0.00009789393,0.00016388802,0.0002079296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070147484,0.00040821024,0.0006657474,0.0006046676,0.00037127922,0.00095162983,0.0003397383,0.00036331097,0.0020112665],"category_scores_gemma":[0.0024028632,0.0001617903,0.0004497611,0.0006953365,0.00028472472,0.0008837437,0.00084687636,0.000529714,0.00046008066],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028561852,0.00009140372,0.9080407,0.0001571496,0.00024625516,0.0000855443,0.00018081978,0.0011914503,0.005237778,0.000105850726,0.0014784121,0.08032847],"study_design_scores_gemma":[0.00005240179,0.0014165598,0.9861085,0.00006271901,0.0004865882,0.00035963586,0.00044715125,0.0055629564,0.0023639507,0.00080391875,0.0023023325,0.00003330441],"about_ca_topic_score_codex":0.0015492786,"about_ca_topic_score_gemma":0.0045348117,"teacher_disagreement_score":0.0020112665,"about_ca_system_score_codex":0.00034849576,"about_ca_system_score_gemma":0.00030153603,"threshold_uncertainty_score":0.006728351},"labels":[],"label_agreement":null},{"id":"W2884217060","doi":"10.1016/j.urolonc.2018.05.023","title":"Female radical cystectomy patients have a higher risk of surgical site infections","year":2018,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Cystectomy; Surgical site infection; Medicine; General surgery; Surgery; Bladder cancer; Internal medicine; Cancer","score_opus":0.02060501496152117,"score_gpt":0.31017183520950414,"score_spread":0.28956682024798297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884217060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835804,0.0059515266,0.00037253948,0.00070583436,0.00014208388,0.000016186297,0.0010440762,0.000025470446,0.008161826],"genre_scores_gemma":[0.9927182,0.0022556523,0.00022643092,0.0003057498,0.00012528551,0.000011036123,0.00057613966,0.000013882855,0.0037675393],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998661,0.000015988428,0.000010557582,0.000023094386,0.00004214684,0.000041964355],"domain_scores_gemma":[0.9993038,0.000104396255,0.00034774368,0.00003147833,0.000057092864,0.00015554031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010996115,0.0001669854,0.00030147078,0.0003999391,0.00046291304,0.0004539923,0.00012187985,0.0002846422,0.012429491],"category_scores_gemma":[0.00091857516,0.00010230882,0.00037443795,0.00068642583,0.00012031349,0.00022923794,0.00019851251,0.0006366243,0.0009086503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015651537,0.000088198634,0.9791373,0.00008482004,0.000089235655,0.00054386316,0.00012269027,0.000030550917,0.0015817006,0.00008342941,0.0014803279,0.016601473],"study_design_scores_gemma":[0.000004754421,0.00008633732,0.99396604,0.000026361799,0.000055142387,0.0022918736,0.00028559286,0.000027195212,0.00023674085,0.000081265585,0.0029321087,0.00000666572],"about_ca_topic_score_codex":0.001293952,"about_ca_topic_score_gemma":0.001926875,"teacher_disagreement_score":0.012429491,"about_ca_system_score_codex":0.00012531529,"about_ca_system_score_gemma":0.00033131434,"threshold_uncertainty_score":0.041580856},"labels":[],"label_agreement":null},{"id":"W2896633866","doi":"10.1016/j.urolonc.2018.09.001","title":"Post-translational modifications in bladder cancer: Expanding the tumor target repertoire","year":2018,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"SUMO protein; Proteome; Epitope; Antigen; Computational biology; Glycosylation; Biology; Bladder cancer; Tumor antigen; Cancer; Cancer research; Bioinformatics; Immunotherapy; Ubiquitin; Immunology; Gene; Genetics","score_opus":0.06425938409968128,"score_gpt":0.3812216493640114,"score_spread":0.3169622652643301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896633866","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002886187,0.9981659,0.00013802551,0.00045687394,0.00019230426,0.0000033808012,0.000024115881,0.0000061233286,0.0007247516],"genre_scores_gemma":[0.002540619,0.99626535,0.00018505885,0.0003593369,0.00021901567,0.000004249075,0.00003567788,0.0000017031632,0.00038892584],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998054,0.00004765609,0.000024149089,0.000034109664,0.00006165733,0.000027098236],"domain_scores_gemma":[0.9995821,0.00025148783,0.00006217019,0.000015525422,0.00006638621,0.000022276328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079121365,0.0005214877,0.0009298287,0.0010955747,0.0001850016,0.0010525023,0.0006777453,0.0008686433,0.0039987564],"category_scores_gemma":[0.0010020268,0.00018144994,0.0005709167,0.0011182165,0.0005145616,0.0013150821,0.00072420744,0.0013996583,0.0010459293],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015494267,0.00006308218,0.0004300369,0.020829085,0.00018819897,0.00035952264,0.00010064616,0.00039425783,0.0044998894,0.005116984,0.01654611,0.95131713],"study_design_scores_gemma":[0.000029117671,0.00015979203,0.0016326378,0.005504724,0.00033125342,0.0017784276,0.00011629387,0.00014353284,0.0025605143,0.004393871,0.9833188,0.000031009316],"about_ca_topic_score_codex":0.000536074,"about_ca_topic_score_gemma":0.0011015487,"teacher_disagreement_score":0.0039987564,"about_ca_system_score_codex":0.00044284196,"about_ca_system_score_gemma":0.0010620514,"threshold_uncertainty_score":0.01337719},"labels":[],"label_agreement":null},{"id":"W2900528353","doi":"10.1016/j.urolonc.2018.11.006","title":"Age-related variations in gene expression patterns of renal cell carcinoma","year":2018,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Montreal Children's Hospital; McGill University and Génome Québec Innovation Centre","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Biology; Renal cell carcinoma; Gene; Gene expression; Clear cell renal cell carcinoma; Cancer; Kidney cancer; Cancer research; Genetics; Medicine; Pathology","score_opus":0.026141905998626758,"score_gpt":0.29087402588112,"score_spread":0.26473211988249323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900528353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987344,0.00052289723,0.00011948485,0.000019680183,0.000007740983,0.0000012644232,0.00025235815,0.000003215997,0.00033892514],"genre_scores_gemma":[0.9989723,0.00025693496,0.00008883677,0.000013667845,0.000011643884,0.0000019158701,0.00019712551,0.0000029315254,0.00045471717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998921,0.00001860991,0.000013678891,0.000035948287,0.0000184966,0.000021130629],"domain_scores_gemma":[0.99973613,0.000074380274,0.00009525383,0.000023825385,0.00003845051,0.000031895936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017625559,0.00008227561,0.00019189146,0.0006212057,0.00013890886,0.00023187847,0.00009087828,0.00014536647,0.0012214449],"category_scores_gemma":[0.0005045369,0.000063020314,0.00017576083,0.00072687847,0.000106718195,0.00017657502,0.00012995435,0.00013649176,0.00020032973],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012439961,0.000046103265,0.90392894,0.000050140596,0.00014422633,0.00048650493,0.0003323038,0.0001901505,0.08023766,0.00012509551,0.00020630153,0.013008577],"study_design_scores_gemma":[0.0000014908862,0.000051268868,0.9972627,0.0000017012659,0.000019813035,0.00031862647,0.00007735686,0.00008777124,0.0017853164,0.0000502759,0.0003411111,0.000002538885],"about_ca_topic_score_codex":0.00073351903,"about_ca_topic_score_gemma":0.0008071854,"teacher_disagreement_score":0.0012214449,"about_ca_system_score_codex":0.000117924705,"about_ca_system_score_gemma":0.0000680889,"threshold_uncertainty_score":0.004086137},"labels":[],"label_agreement":null},{"id":"W2900862175","doi":"10.1016/j.urolonc.2018.09.015","title":"Clinical value of cholinesterase in the prediction of biochemical recurrence after radical prostatectomy","year":2018,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostatectomy; Urology; Biochemical recurrence; Cholinesterase; Value (mathematics); Predictive value; Prostate cancer; Internal medicine; Cancer; Statistics","score_opus":0.04613411504467641,"score_gpt":0.3696100236209258,"score_spread":0.3234759085762494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900862175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99088544,0.0067753606,0.00025108433,0.00033750266,0.000083893,0.000015296551,0.00021101118,0.000020735171,0.0014196882],"genre_scores_gemma":[0.9987463,0.0006253353,0.0001411603,0.00004503161,0.00008857163,0.0000042072725,0.00013656319,0.0000027019714,0.0002100612],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993544,0.00024981343,0.000083780425,0.00007941534,0.00016033989,0.00007228332],"domain_scores_gemma":[0.9965699,0.001612189,0.00063858146,0.00018108383,0.0004496394,0.0005486599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016735173,0.00046776456,0.000861418,0.0014728233,0.00035885806,0.00095737196,0.00074805366,0.0008107361,0.0009736824],"category_scores_gemma":[0.0071809124,0.00026787558,0.0005541045,0.0008737689,0.00042402357,0.0005502722,0.00046286822,0.00100497,0.00031091596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010983247,0.00006583638,0.9910188,0.00003071429,0.0001575486,0.00014219314,0.000039110204,0.00023892625,0.0003933762,0.000020726216,0.00012270424,0.006671773],"study_design_scores_gemma":[0.00003347245,0.0005066875,0.99476373,0.000029747858,0.00028008054,0.0007322119,0.00015565578,0.0025176508,0.0004609935,0.00010979507,0.00038419038,0.000025618858],"about_ca_topic_score_codex":0.0028737425,"about_ca_topic_score_gemma":0.0035078228,"teacher_disagreement_score":0.0028737425,"about_ca_system_score_codex":0.00038451873,"about_ca_system_score_gemma":0.0005067683,"threshold_uncertainty_score":0.008850515},"labels":[],"label_agreement":null},{"id":"W2900982922","doi":"10.1016/j.urolonc.2018.10.013","title":"Implications of micropapillary urothelial carcinoma variant on prognosis following radical cystectomy: A multi-institutional investigation","year":2018,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cystectomy; Lymphovascular invasion; Medicine; Stage (stratigraphy); Histology; Bladder cancer; Urothelial carcinoma; Internal medicine; Oncology; Urology; Proportional hazards model; Carcinoma; Cancer; Gastroenterology; Metastasis; Biology","score_opus":0.040835047969700326,"score_gpt":0.3191051004624758,"score_spread":0.2782700524927755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900982922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99944836,0.00015047929,0.000039740895,0.000035842557,0.000004654934,0.0000059071594,0.000089501904,0.000001380861,0.00022405619],"genre_scores_gemma":[0.9997286,0.00006642641,0.000029551662,0.000014847779,0.000014062557,0.0000026386324,0.0000953481,0.0000010166858,0.00004746122],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992078,0.00019158612,0.000098545526,0.00017705931,0.000099549805,0.0002254908],"domain_scores_gemma":[0.9973144,0.000526349,0.00090363534,0.0003276957,0.00047496552,0.00045289076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009226661,0.00025121027,0.0004332755,0.0016547999,0.0012767786,0.001042973,0.0006145656,0.0004596712,0.0015626187],"category_scores_gemma":[0.0031264026,0.00024341125,0.00059191335,0.0018843611,0.00068128016,0.0009838134,0.001043897,0.00045075253,0.00022996144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049901966,0.000022506612,0.99854845,0.000003819108,0.00002379429,0.00046822,0.00011791947,0.000012601561,0.00010835625,0.000012607463,0.00003648174,0.000595343],"study_design_scores_gemma":[0.0000027296176,0.00008811285,0.99650806,0.000006346727,0.000067269284,0.0019416402,0.000995044,0.00009953149,0.000073788404,0.00004403666,0.00016506577,0.000008380636],"about_ca_topic_score_codex":0.0033121333,"about_ca_topic_score_gemma":0.004603094,"teacher_disagreement_score":0.0033121333,"about_ca_system_score_codex":0.00048402642,"about_ca_system_score_gemma":0.00058716844,"threshold_uncertainty_score":0.006585717},"labels":[],"label_agreement":null},{"id":"W2901062149","doi":"10.1016/j.urolonc.2018.10.012","title":"Propensity-score-matched comparison of soft tissue surgical margins status between open and robotic-assisted radical cystectomy","year":2018,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Cystectomy; Propensity score matching; Medicine; Bladder cancer; Cohort; Logistic regression; Urology; Surgery; Internal medicine; Cancer","score_opus":0.09781590432359291,"score_gpt":0.3827681028913831,"score_spread":0.2849521985677902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901062149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99839276,0.00027965146,0.00047720328,0.000026017367,0.000056114823,0.000033347977,0.00028826614,0.000005825802,0.00044086954],"genre_scores_gemma":[0.99923086,0.000060408653,0.00012750698,0.000031170173,0.000026893416,0.000017049655,0.00030319823,0.0000026490197,0.00020026023],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99903095,0.00021612553,0.00014293514,0.00030819126,0.00013227537,0.00016958274],"domain_scores_gemma":[0.9986449,0.00042078848,0.00045029016,0.00025185972,0.00010911264,0.00012305898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010214258,0.00022312174,0.0007066783,0.0003871333,0.0002308571,0.00061027583,0.0004760031,0.00041661997,0.0024068078],"category_scores_gemma":[0.003517363,0.0002595727,0.001274129,0.0006009847,0.00043666497,0.00056302,0.00045257958,0.00045735147,0.00029899142],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15313195,0.0011026016,0.7698106,0.00053804123,0.0065902364,0.0005082729,0.00050823967,0.0021603266,0.013711216,0.0009516117,0.0026820397,0.048304804],"study_design_scores_gemma":[0.0022649944,0.008136594,0.9808154,0.000038239177,0.0014889507,0.00039232327,0.00038818156,0.0027890152,0.0010798721,0.0009938647,0.0015690036,0.00004358218],"about_ca_topic_score_codex":0.0009522934,"about_ca_topic_score_gemma":0.0014431792,"teacher_disagreement_score":0.0024068078,"about_ca_system_score_codex":0.000273176,"about_ca_system_score_gemma":0.00035649064,"threshold_uncertainty_score":0.008051574},"labels":[],"label_agreement":null},{"id":"W2901456761","doi":"10.1016/j.urolonc.2018.10.025","title":"Delivery of chemotherapy for testicular cancer in routine practice: A population-based study","year":2018,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Queen's University; University of Calgary","funders":"Southeastern Ontario Academic Medical Organization; Ontario Ministry of Health and Long-Term Care; Cancer Care Ontario","keywords":"Testicular cancer; Medicine; Chemotherapy; Cancer chemotherapy; Oncology; Gynecology; Internal medicine","score_opus":0.025882364793642903,"score_gpt":0.3706795355009358,"score_spread":0.3447971707072929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901456761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990095,0.0002846735,0.000057985093,0.000085113,0.0000047094563,0.000013261982,0.00019292711,0.000002052512,0.00034969504],"genre_scores_gemma":[0.9994037,0.00017766071,0.000054513304,0.00008547585,0.000009823747,0.000011937152,0.00014965599,0.0000025596148,0.0001047244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982311,0.0006091612,0.00024260032,0.00039483432,0.00025735717,0.00026489902],"domain_scores_gemma":[0.9949464,0.0011372395,0.0024023273,0.00026148648,0.00039058918,0.00086193124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008068337,0.00027160405,0.0006297871,0.0012658401,0.0010060243,0.0013552513,0.0007275996,0.001180332,0.002852639],"category_scores_gemma":[0.0056584002,0.0007606061,0.00076862535,0.0034155014,0.0006678276,0.0014754471,0.00090405555,0.0011387098,0.00039596664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060494618,0.00013144528,0.99871564,0.000012712582,0.000060695776,0.000060232687,0.0002535719,0.000015024248,0.000056200894,0.000013220455,0.000059740305,0.0005609835],"study_design_scores_gemma":[0.000013849058,0.0002572137,0.9980914,0.000013565582,0.000045758305,0.00021767845,0.0011329236,0.00009235536,0.000011681221,0.00001794945,0.000097866316,0.000007658555],"about_ca_topic_score_codex":0.016757984,"about_ca_topic_score_gemma":0.016903419,"teacher_disagreement_score":0.016757984,"about_ca_system_score_codex":0.0010071837,"about_ca_system_score_gemma":0.0009736013,"threshold_uncertainty_score":0.033320904},"labels":[],"label_agreement":null},{"id":"W2901919971","doi":"10.1016/j.urolonc.2018.08.010","title":"Radical prostatectomy after previous TUR-P: Oncological, surgical, and functional outcomes","year":2018,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostatectomy; Propensity score matching; Biochemical recurrence; Urology; Confidence interval; Prostate cancer; Logistic regression; Surgery; Odds ratio; Proportional hazards model; Retrospective cohort study; Internal medicine; Cancer","score_opus":0.029416844000878697,"score_gpt":0.31708596089965796,"score_spread":0.2876691168987793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901919971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951094,0.002407232,0.00006067754,0.00031759968,0.00007434112,0.0000083083805,0.00037906214,0.000009016073,0.0016343268],"genre_scores_gemma":[0.9991492,0.0002662708,0.000014348425,0.000047172427,0.000044091183,0.0000017040469,0.00029262315,0.0000014801797,0.0001831416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995697,0.00007817523,0.00002444738,0.00007220408,0.00008799484,0.0001675836],"domain_scores_gemma":[0.9982315,0.00023533177,0.00053306593,0.00008555556,0.00012311837,0.0007914101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043855573,0.00025195,0.000387137,0.0005600565,0.000549595,0.0008488165,0.0006870971,0.0006757588,0.0031867477],"category_scores_gemma":[0.0030064604,0.0001591893,0.0009362092,0.0007696611,0.0004264261,0.0010667457,0.0009902597,0.0012876703,0.0002831862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000468016,0.00018774554,0.9895327,0.00003996891,0.00026227618,0.00037146045,0.00011613975,0.00018726772,0.0001647425,0.00006671393,0.0005053199,0.008097491],"study_design_scores_gemma":[0.0000073104975,0.0001986518,0.99870896,0.000014059378,0.000064956235,0.0004860237,0.00015360213,0.00009803404,0.000023518098,0.00006929435,0.00016673052,0.000008843466],"about_ca_topic_score_codex":0.005303778,"about_ca_topic_score_gemma":0.009548349,"teacher_disagreement_score":0.005303778,"about_ca_system_score_codex":0.0005545936,"about_ca_system_score_gemma":0.0007846895,"threshold_uncertainty_score":0.010660768},"labels":[],"label_agreement":null},{"id":"W2902402532","doi":"10.1016/j.urolonc.2018.11.012","title":"Proton therapy for prostate cancer: A review of the rationale, evidence, and current state","year":2018,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Infection and Immunity; National Cancer Institute; Massachusetts General Hospital; Prostate Cancer Foundation","keywords":"Prostate cancer; Proton therapy; Context (archaeology); Medicine; Clinical trial; Radiation therapy; Medical physics; Cancer; Prospective cohort study; Evidence-based practice; Oncology; Internal medicine; Alternative medicine; Pathology","score_opus":0.12181013220419787,"score_gpt":0.43120386444484965,"score_spread":0.3093937322406518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902402532","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000030471896,0.99968994,0.00001458434,0.00013920171,0.000033752673,0.0000034104698,0.000013811152,8.456492e-7,0.00007398054],"genre_scores_gemma":[0.0003235234,0.9993961,0.000059470818,0.00014460197,0.000042068892,0.000003688873,0.000008923579,3.0476681e-7,0.000021332087],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99903727,0.00026592784,0.00025204426,0.00013823707,0.000264603,0.000041933083],"domain_scores_gemma":[0.9961306,0.0029487626,0.0005357982,0.000047182202,0.00027478664,0.000062833846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027440994,0.0011796509,0.0034833068,0.002995444,0.0003286369,0.0015642495,0.001751572,0.0014675754,0.0038937351],"category_scores_gemma":[0.005867719,0.00051533565,0.0021463404,0.004056079,0.00083734083,0.0018781144,0.0009908128,0.0019891236,0.0005413758],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028171617,0.00006319965,0.00041621175,0.36701098,0.0014641659,0.00015734257,0.00012628177,0.00035247699,0.000532348,0.0024428251,0.017288614,0.6098639],"study_design_scores_gemma":[0.0002522758,0.0004263293,0.004474547,0.2796904,0.009489408,0.001984281,0.00035443992,0.00026274382,0.0004971847,0.0047243536,0.69773936,0.00010473847],"about_ca_topic_score_codex":0.0027307225,"about_ca_topic_score_gemma":0.0075436234,"teacher_disagreement_score":0.0038937351,"about_ca_system_score_codex":0.0011963276,"about_ca_system_score_gemma":0.0031594636,"threshold_uncertainty_score":0.0145123005},"labels":[],"label_agreement":null},{"id":"W2902972217","doi":"10.1016/j.urolonc.2018.11.013","title":"Role of serum cholinesterase in patients treated with salvage radical prostatectomy","year":2018,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostatectomy; Interquartile range; Biochemical recurrence; Hazard ratio; Prostate cancer; Internal medicine; Urology; Gastroenterology; Metastasis; Confidence interval; Body mass index; Surgery; Cancer","score_opus":0.016989031232288045,"score_gpt":0.30934868894041084,"score_spread":0.2923596577081228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902972217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870024,0.009621181,0.000076851895,0.0006997742,0.0000826594,0.000007208027,0.00025877848,0.000013830539,0.0022373337],"genre_scores_gemma":[0.99804676,0.0012923816,0.0000484521,0.00009116892,0.00008441957,0.0000024619244,0.00017696475,0.0000022470442,0.00025505683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998287,0.000049886246,0.000017367025,0.00002581367,0.000035400833,0.00004282333],"domain_scores_gemma":[0.9992587,0.0002775623,0.00018684298,0.00003247293,0.000055013363,0.0001893426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025938838,0.00031511558,0.0006925222,0.000630695,0.00037855885,0.000809666,0.00044949044,0.00068210304,0.0018365285],"category_scores_gemma":[0.0028078358,0.00016496507,0.0006608063,0.0007371833,0.00026798595,0.00048678502,0.00027243994,0.0007641576,0.00019387956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012221466,0.00007287087,0.98830414,0.000036364498,0.00015914324,0.00071929995,0.000054751257,0.00014911008,0.0003231466,0.000042391857,0.0002524406,0.008664086],"study_design_scores_gemma":[0.000037352194,0.00034336958,0.99636745,0.00003777256,0.00025946755,0.0013043017,0.00027970393,0.00061510364,0.00017458429,0.0001271736,0.00044423377,0.000009425821],"about_ca_topic_score_codex":0.0038786891,"about_ca_topic_score_gemma":0.0046806405,"teacher_disagreement_score":0.0038786891,"about_ca_system_score_codex":0.00047306606,"about_ca_system_score_gemma":0.0006829792,"threshold_uncertainty_score":0.0077121854},"labels":[],"label_agreement":null},{"id":"W2904493400","doi":"10.1016/j.urolonc.2018.11.021","title":"Reducing unnecessary biopsies while detecting clinically significant prostate cancer including cribriform growth with the ERSPC Rotterdam risk calculator and 4Kscore","year":2018,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Overdiagnosis; Medicine; Prostate cancer; Biopsy; Grading (engineering); Prostate-specific antigen; Urology; Receiver operating characteristic; Internal medicine; Oncology; Prostate; Cohort; Prostate biopsy; Cancer; Radiology","score_opus":0.03852594861989619,"score_gpt":0.3287136019899408,"score_spread":0.29018765337004465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904493400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8460217,0.03498006,0.018972063,0.019908953,0.0010997216,0.0008098665,0.0056308727,0.0024381946,0.070138544],"genre_scores_gemma":[0.9529962,0.00499896,0.029907748,0.0025005243,0.0006082268,0.0001883033,0.0024299787,0.00026604426,0.0061040823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898773,0.00035406544,0.00007453669,0.0001411668,0.00034459942,0.00009781772],"domain_scores_gemma":[0.9982805,0.00045095966,0.0006074312,0.000085059495,0.00036409273,0.00021209654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010689761,0.0006276682,0.00066975824,0.0013214357,0.00037193534,0.0009201523,0.0006531902,0.00049537205,0.0039065117],"category_scores_gemma":[0.008401831,0.00033842906,0.000794616,0.00090760156,0.00015004042,0.00063955766,0.0008213088,0.0009682526,0.0009103141],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023499117,0.00067809183,0.5534834,0.00045917093,0.0009195114,0.0002175952,0.00012085786,0.004601656,0.0011398162,0.0006784243,0.041548897,0.39380267],"study_design_scores_gemma":[0.0005442903,0.0011495525,0.94607794,0.0005737004,0.0014362537,0.0010318304,0.00021285898,0.016637746,0.001619436,0.002484494,0.028150976,0.000080933896],"about_ca_topic_score_codex":0.01077141,"about_ca_topic_score_gemma":0.025707508,"teacher_disagreement_score":0.01077141,"about_ca_system_score_codex":0.0006694637,"about_ca_system_score_gemma":0.0014401932,"threshold_uncertainty_score":0.021417439},"labels":[],"label_agreement":null},{"id":"W2904495714","doi":"10.1016/j.urolonc.2018.11.015","title":"Molecular tumor heterogeneity in muscle invasive bladder cancer: Biomarkers, subtypes, and implications for therapy","year":2018,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; University of British Columbia","funders":"","keywords":"Subtyping; Bladder cancer; Biomarker; Immunotherapy; Medicine; Targeted therapy; Tumor heterogeneity; Biomarker discovery; Precision medicine; Circulating tumor cell; Oncology; Genetic heterogeneity; Computational biology; Bioinformatics; Cancer; Internal medicine; Phenotype; Biology; Pathology; Proteomics; Gene; Genetics; Metastasis","score_opus":0.07521439352814811,"score_gpt":0.3891175472210551,"score_spread":0.313903153692907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904495714","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008551324,0.9994586,0.000031623127,0.0002162995,0.000052153788,0.0000016171542,0.000017537386,0.0000011251097,0.00013547351],"genre_scores_gemma":[0.00073929044,0.99886024,0.00006431492,0.00015150278,0.000086129134,0.0000023641965,0.000021440255,3.7250243e-7,0.00007442326],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996972,0.00006596915,0.00004983646,0.00006426398,0.00009502791,0.000027808861],"domain_scores_gemma":[0.9992594,0.00046037915,0.0001247768,0.0000141113605,0.00011323802,0.000028029395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011889056,0.000605509,0.0017085081,0.0021747055,0.00019634003,0.0012736546,0.0008750157,0.00081979885,0.0018605331],"category_scores_gemma":[0.001881207,0.00026111215,0.0007547713,0.0025792683,0.0005610553,0.0013595718,0.00079297763,0.0013070736,0.00049695076],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012643769,0.00003497803,0.001283699,0.03400869,0.00036674776,0.00016368106,0.00008898743,0.00038928914,0.0007115794,0.0030963118,0.020194998,0.93953454],"study_design_scores_gemma":[0.000056216213,0.0001646209,0.0062648472,0.027661635,0.0013874539,0.0024894022,0.00033988876,0.00019586089,0.00051533175,0.0051327352,0.95572865,0.00006327247],"about_ca_topic_score_codex":0.001608817,"about_ca_topic_score_gemma":0.003224499,"teacher_disagreement_score":0.0021747055,"about_ca_system_score_codex":0.0007258931,"about_ca_system_score_gemma":0.001762732,"threshold_uncertainty_score":0.006287575},"labels":[],"label_agreement":null},{"id":"W2905750639","doi":"10.1016/j.urolonc.2018.11.005","title":"Prognostic value of modified Glasgow Prognostic Score in non–muscle-invasive bladder cancer","year":2018,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Bladder cancer; Medicine; Internal medicine; Oncology; Urology; Cancer","score_opus":0.029427839136757443,"score_gpt":0.314112132081601,"score_spread":0.28468429294484354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905750639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942062,0.002466903,0.00029402284,0.00047506514,0.00012166335,0.000014103368,0.0007530452,0.00002253241,0.0016463172],"genre_scores_gemma":[0.9987373,0.00026295934,0.00013388602,0.000042675696,0.000077615594,0.0000069552107,0.0005047911,0.0000035704495,0.00023021954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996257,0.000104161125,0.000042592517,0.00005475574,0.00006667087,0.00010618818],"domain_scores_gemma":[0.99864537,0.00029636946,0.0004406559,0.00008588752,0.00021156768,0.00032007857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007838233,0.00047278748,0.0005184771,0.00090747356,0.00030009204,0.0008539704,0.0005141603,0.00060419086,0.0015767952],"category_scores_gemma":[0.0037851913,0.00013153555,0.00054666895,0.0012285472,0.0004172841,0.00066006585,0.00082270027,0.00074010954,0.00027066827],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008062751,0.000029628225,0.99065745,0.000039843286,0.0001315573,0.00013075417,0.00004071648,0.00029487102,0.00031460452,0.000061458006,0.0005477974,0.006944967],"study_design_scores_gemma":[0.000023888862,0.00022086203,0.99635917,0.000019996169,0.00017188667,0.00029527422,0.00015686949,0.0014888368,0.00016573574,0.00035878862,0.0007210769,0.000017523094],"about_ca_topic_score_codex":0.0025504162,"about_ca_topic_score_gemma":0.003175563,"teacher_disagreement_score":0.0025504162,"about_ca_system_score_codex":0.00046058153,"about_ca_system_score_gemma":0.0006096654,"threshold_uncertainty_score":0.0052748322},"labels":[],"label_agreement":null},{"id":"W2909864962","doi":"10.1016/j.urolonc.2018.12.020","title":"Depression and prostate cancer: A focused review for the clinician","year":2019,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Cancer survivorship and care","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; McMaster University; Hamilton Health Sciences; Impact; Queen's University","funders":"","keywords":"Medicine; Prostate cancer; Depression (economics); Cancer; Population; Androgen deprivation therapy; Suicidal ideation; Psychiatry; Oncology; Internal medicine; Poison control; Suicide prevention","score_opus":0.10061199390978122,"score_gpt":0.42206263651450193,"score_spread":0.3214506426047207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909864962","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021239228,0.9990507,0.000013617913,0.00049772207,0.00031019037,0.000003020824,0.000012543436,0.0000017586683,0.00008927547],"genre_scores_gemma":[0.0002203479,0.99838626,0.000055203986,0.0008009919,0.000402591,0.0000048432707,0.000012659881,5.6286234e-7,0.00011654251],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99950016,0.00012230303,0.00010497921,0.0000824657,0.00015685953,0.00003324622],"domain_scores_gemma":[0.9981376,0.0011792824,0.00028498954,0.000028340279,0.00026732692,0.00010243629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009726968,0.0011440946,0.002580849,0.0030982785,0.0003894789,0.0018585136,0.00121034,0.0022100327,0.005459676],"category_scores_gemma":[0.0029780439,0.0004901229,0.0010892312,0.0033457424,0.0005912238,0.001965546,0.0013062853,0.0024500045,0.0010602772],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018972732,0.00008163689,0.000504713,0.11249249,0.00055142917,0.00033999936,0.00012982453,0.00020372965,0.00061872,0.0013959123,0.14089203,0.7425997],"study_design_scores_gemma":[0.00014678274,0.00023304265,0.003908825,0.11911419,0.0016190456,0.001957624,0.0003478744,0.0001484099,0.0001397278,0.0022173142,0.8700872,0.0000800061],"about_ca_topic_score_codex":0.0032978426,"about_ca_topic_score_gemma":0.009338634,"teacher_disagreement_score":0.005459676,"about_ca_system_score_codex":0.0010221516,"about_ca_system_score_gemma":0.002700855,"threshold_uncertainty_score":0.018264413},"labels":[],"label_agreement":null},{"id":"W2911363133","doi":"10.1016/j.urolonc.2019.01.031","title":"Combining urinary DNA methylation and cell-free microRNA biomarkers for improved monitoring of prostate cancer patients on active surveillance","year":2019,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Sinai Health System; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"Institute of Cancer Research; Prostate Cancer Canada","keywords":"Prostate cancer; DNA methylation; Medicine; Receiver operating characteristic; Oncology; Urinary system; Urine; Internal medicine; Odds ratio; Methylation; Cell-free fetal DNA; Logistic regression; Confidence interval; Cancer; Biomarker; Area under the curve; microRNA; Prostate biopsy; DNA; Biology; Gene; Gene expression; Genetics","score_opus":0.019198366040732284,"score_gpt":0.29890172514144026,"score_spread":0.279703359100708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911363133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.969023,0.018674515,0.006232753,0.0008653344,0.0002735318,0.00009143987,0.0013034573,0.0003292661,0.0032067737],"genre_scores_gemma":[0.9914875,0.0017483351,0.0048565096,0.00032467511,0.00015473798,0.000039671613,0.0005038132,0.000019813318,0.0008649114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994773,0.0001553137,0.000036419584,0.000127292,0.00014542195,0.000058116908],"domain_scores_gemma":[0.99940825,0.00019483126,0.00015392224,0.000036544327,0.0001285497,0.00007793959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007269609,0.00052691385,0.0010784417,0.0010601797,0.00029170385,0.0012558779,0.0004438192,0.00077959674,0.0008490466],"category_scores_gemma":[0.001637433,0.00029047747,0.00044829724,0.0009036086,0.00020371386,0.0005820101,0.00045377036,0.0007902853,0.0002531967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021258565,0.0003081998,0.82044286,0.00030052746,0.00053220865,0.0002380945,0.00024276663,0.0009516303,0.038412746,0.000215783,0.0019928706,0.1342365],"study_design_scores_gemma":[0.00012553128,0.002974975,0.91811424,0.00019016238,0.001173426,0.002043792,0.00049757946,0.015867984,0.049291827,0.0011488434,0.008467708,0.000103827806],"about_ca_topic_score_codex":0.0007617467,"about_ca_topic_score_gemma":0.0019903982,"teacher_disagreement_score":0.0012558779,"about_ca_system_score_codex":0.00026201713,"about_ca_system_score_gemma":0.00032450576,"threshold_uncertainty_score":0.0038446188},"labels":[],"label_agreement":null},{"id":"W2912079315","doi":"10.1016/j.urolonc.2019.01.003","title":"Editorial: Basic research in bladder cancer – refining the tools. 3rd IBCN seminars series1","year":2019,"lang":"en","type":"editorial","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Translational research; Bladder cancer; Cancer; Cancer research; Basic research; Urothelial cancer; Organoid; Ex vivo; Medicine; Computational biology; Oncology; Bioinformatics; Biology; Neuroscience; In vivo; Computer science; Pathology; Internal medicine; Library science; Biotechnology","score_opus":0.07443235410740094,"score_gpt":0.39945151020432523,"score_spread":0.3250191560969243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912079315","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000015026519,0.0030972818,0.00005438143,0.031749938,0.96418285,0.000015532267,0.000056948928,0.000036385736,0.0007916509],"genre_scores_gemma":[0.0002127569,0.0028305906,0.00006386573,0.02599629,0.964527,0.000022390732,0.000036790465,0.000031600608,0.006278867],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927411,0.0015950281,0.00080852985,0.0008131381,0.0035397252,0.0005024836],"domain_scores_gemma":[0.96784145,0.0154117355,0.0018793932,0.0006382747,0.010008354,0.004220861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010599158,0.004782867,0.004366323,0.005276053,0.0036053704,0.0077321134,0.005218264,0.01575756,0.025679976],"category_scores_gemma":[0.03923064,0.0014383806,0.0037767678,0.0017439772,0.003002053,0.006287834,0.0019462912,0.021970626,0.020358514],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034521396,0.000007017977,0.000009466208,0.0001156691,0.000009144251,0.0000368796,0.000004794104,0.000012323889,0.00002258112,0.00011606391,0.9980749,0.0015566248],"study_design_scores_gemma":[0.00019074256,0.000057700403,0.00029749633,0.00096786645,0.00009056795,0.000281917,0.000044409135,0.00019283441,0.00014419193,0.0016784483,0.99602246,0.000031276824],"about_ca_topic_score_codex":0.0021134717,"about_ca_topic_score_gemma":0.0057010534,"teacher_disagreement_score":0.025679976,"about_ca_system_score_codex":0.0046318304,"about_ca_system_score_gemma":0.005002368,"threshold_uncertainty_score":0.085908055},"labels":[],"label_agreement":null},{"id":"W2912319693","doi":"10.1016/j.urolonc.2019.01.018","title":"Perioperative blood transfusion affects oncologic outcomes after nephrectomy for renal cell carcinoma: A systematic review and meta-analysis","year":2019,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Blood transfusion and management","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Meta-analysis; Perioperative; Hazard ratio; Internal medicine; Subgroup analysis; Cochrane Library; Kidney cancer; Retrospective cohort study; Proportional hazards model; Blood transfusion; Surgery; Kidney; Confidence interval","score_opus":0.07203731200593386,"score_gpt":0.35459222539892404,"score_spread":0.2825549133929902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912319693","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008297151,0.9903938,0.00020609099,0.00018103315,0.00013243266,0.00007278773,0.00052063336,0.000014660993,0.00018122782],"genre_scores_gemma":[0.23970675,0.7555981,0.0012948578,0.0016465544,0.00030959785,0.0002602951,0.0007058639,0.00002969701,0.00044826482],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9966402,0.0010818333,0.0012276893,0.0005115521,0.00034026054,0.0001985309],"domain_scores_gemma":[0.99075025,0.006206303,0.0020994912,0.00030426786,0.00048534168,0.00015447376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044286554,0.0017469933,0.007578582,0.002921306,0.0005127882,0.0020678185,0.0016401246,0.0020962998,0.0046227667],"category_scores_gemma":[0.016134508,0.0012522718,0.023336723,0.004561097,0.0006605715,0.0014257731,0.0015104121,0.0018171394,0.0003742144],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019020468,0.00005172891,0.01745061,0.35119936,0.6105646,0.00019014192,0.00019724887,0.00034090798,0.0002963127,0.00011646667,0.0012477498,0.016442863],"study_design_scores_gemma":[0.00049692736,0.00015491401,0.010054045,0.018137885,0.96882844,0.00011883437,0.00008901021,0.00008761779,0.00006423185,0.00014164258,0.0017920334,0.000034330897],"about_ca_topic_score_codex":0.007867772,"about_ca_topic_score_gemma":0.02954441,"teacher_disagreement_score":0.007867772,"about_ca_system_score_codex":0.001337178,"about_ca_system_score_gemma":0.0025847994,"threshold_uncertainty_score":0.023421228},"labels":[],"label_agreement":null},{"id":"W2914092773","doi":"10.1016/j.urolonc.2019.01.030","title":"Population-based outcomes of men with a single negative prostate biopsy: Importance of continued follow-up among older patients","year":2019,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Institute for Work & Health; Institute for Clinical Evaluative Sciences; Public Health Ontario; Toronto Rehabilitation Institute; University of Toronto; University Health Network","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Prostate cancer; Cumulative incidence; Prostate biopsy; Proportional hazards model; Biopsy; Population; Cohort; Prostatectomy; Gynecology; Cancer; Internal medicine; Oncology","score_opus":0.014013818694420263,"score_gpt":0.2717969145318967,"score_spread":0.25778309583747644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914092773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956533,0.001569003,0.00019921466,0.0005870537,0.000044555036,0.000013354941,0.00082235754,0.000010537731,0.0011005935],"genre_scores_gemma":[0.9990042,0.00028703632,0.00009029054,0.00008171685,0.000042736345,0.0000066711796,0.00039169026,0.000002874368,0.00009271219],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911207,0.00026619996,0.00012732147,0.00016203396,0.00014860043,0.00018369558],"domain_scores_gemma":[0.9967673,0.0006744239,0.0013585235,0.00027312236,0.00044786598,0.00047881313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015183345,0.00029511153,0.0007931303,0.0009818638,0.00064740906,0.0011659698,0.000581554,0.00096071616,0.0009863639],"category_scores_gemma":[0.0073719257,0.00023195343,0.0009110959,0.0015518425,0.00019043566,0.0018150546,0.00079027744,0.001271992,0.00014659669],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008434616,0.000033371536,0.9972313,0.000009190441,0.00008197861,0.000038556027,0.000046172023,0.000049251637,0.00003994625,0.0000132868445,0.00013731295,0.0022353753],"study_design_scores_gemma":[0.000002146041,0.00004830225,0.99938965,0.000008361482,0.00004875975,0.00006423055,0.00015303341,0.0001414908,0.00001585519,0.000035919773,0.00008780137,0.00000445533],"about_ca_topic_score_codex":0.011687672,"about_ca_topic_score_gemma":0.016935557,"teacher_disagreement_score":0.011687672,"about_ca_system_score_codex":0.0004362558,"about_ca_system_score_gemma":0.00049114827,"threshold_uncertainty_score":0.023239255},"labels":[],"label_agreement":null},{"id":"W2920206705","doi":"10.1016/j.urolonc.2019.02.006","title":"The prognostic significance of nodal disease burden in patients with lymph node metastases from renal cell carcinoma","year":2019,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Hospital; Juravinski Cancer Centre","funders":"National Cancer Institute; Sidney Kimmel Center for Prostate and Urologic Cancers","keywords":"Medicine; Interquartile range; Renal cell carcinoma; Nephrectomy; Proportional hazards model; Internal medicine; Lymph node; Clear cell; Urology; Cancer; Oncology; Carcinoma; Gastroenterology; Surgery; Kidney","score_opus":0.013544364732218329,"score_gpt":0.24231533526287527,"score_spread":0.22877097053065695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920206705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99660945,0.0013227902,0.00007113077,0.0002291007,0.00002069775,0.0000028092095,0.00024289505,0.00000479411,0.0014965135],"genre_scores_gemma":[0.99931026,0.00024369525,0.000027272343,0.000022119162,0.00004533198,0.0000016208743,0.00017787906,0.000002263393,0.00016946651],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985766,0.000036557103,0.000014424176,0.000021317164,0.000029956387,0.000040062267],"domain_scores_gemma":[0.99922466,0.00022773354,0.00022062549,0.000038785416,0.0000638802,0.00022436905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003071671,0.00020539844,0.00026283707,0.00050497765,0.00027630353,0.00055310456,0.00033030857,0.00032144543,0.0018838797],"category_scores_gemma":[0.002326456,0.0001402412,0.00022647755,0.0006973482,0.0002588481,0.00048785782,0.00044276303,0.00045840573,0.00022691394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028388426,0.000013475169,0.9958305,0.000010812145,0.000029653898,0.00014416249,0.000036011657,0.00012795471,0.00043036422,0.00002992164,0.00013761265,0.0029257622],"study_design_scores_gemma":[0.000006399652,0.000047355035,0.9989666,0.0000045014126,0.000033823017,0.0002886784,0.0000891015,0.00021468516,0.0000641309,0.00006183186,0.00021944055,0.0000034532884],"about_ca_topic_score_codex":0.0030228775,"about_ca_topic_score_gemma":0.005266812,"teacher_disagreement_score":0.0030228775,"about_ca_system_score_codex":0.0003414044,"about_ca_system_score_gemma":0.00029157512,"threshold_uncertainty_score":0.0063022375},"labels":[],"label_agreement":null},{"id":"W2920739957","doi":"10.1016/j.urolonc.2019.02.004","title":"Endocavitary treatment for upper tract urothelial carcinoma: A meta-analysis of the current literature","year":2019,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Urothelial carcinoma; Meta-analysis; Oncology; Carcinoma; Internal medicine; Cancer; Bladder cancer","score_opus":0.16526443577367167,"score_gpt":0.41447866170771147,"score_spread":0.2492142259340398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920739957","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021616323,0.9973521,0.00008401846,0.000059192556,0.00004528878,0.00001593219,0.00016266106,0.0000036633655,0.00011543024],"genre_scores_gemma":[0.054626603,0.9439095,0.00037474485,0.0004403118,0.00012200145,0.000038276354,0.0003355631,0.0000083827545,0.00014455985],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.998135,0.0005928177,0.0005464262,0.00035362763,0.00027880922,0.00009338751],"domain_scores_gemma":[0.9959686,0.002827612,0.00077230507,0.000112469585,0.00023921063,0.00007980592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032567126,0.0013328798,0.0071725477,0.0028800552,0.00033460415,0.0016557958,0.0012712217,0.0010447626,0.0030167487],"category_scores_gemma":[0.00659226,0.0006605702,0.015376326,0.004712839,0.00041842496,0.0011407194,0.00095513347,0.001238329,0.00022481299],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034336497,0.000073253555,0.014162732,0.4309819,0.46609366,0.00022348457,0.00016663349,0.0007471649,0.0007859612,0.00020135491,0.002236447,0.0808937],"study_design_scores_gemma":[0.00057014014,0.00033627814,0.01793473,0.03431475,0.93792975,0.00029760558,0.00013087573,0.00015668257,0.00021218708,0.0003341028,0.0077388245,0.000044182754],"about_ca_topic_score_codex":0.0031903533,"about_ca_topic_score_gemma":0.011518997,"teacher_disagreement_score":0.0071725477,"about_ca_system_score_codex":0.0008361676,"about_ca_system_score_gemma":0.0014466647,"threshold_uncertainty_score":0.017223299},"labels":[],"label_agreement":null},{"id":"W2921034390","doi":"10.1016/j.urolonc.2019.01.017","title":"Use and duration of antibiotic prophylaxis and the rate of urinary tract infection after radical cystectomy for bladder cancer: Results of a multicentric series","year":2019,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Cystectomy; Urinary system; Antibiotics; Odds ratio; Antibiotic prophylaxis; Internal medicine; Logistic regression; Perioperative; Bladder cancer; Confidence interval; Urinary diversion; Cohort; Surgery; Urology; Cancer","score_opus":0.022046408063709607,"score_gpt":0.2953727078975592,"score_spread":0.2733262998338496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921034390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99941635,0.0002566107,0.00004289774,0.000006628768,0.000004039868,0.000007695404,0.00011434314,0.0000017131478,0.0001497104],"genre_scores_gemma":[0.9991886,0.0002528724,0.00007222751,0.000020919892,0.00002194729,0.000011866714,0.00022387471,0.0000047393687,0.00020294025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987085,0.00045663427,0.00019072619,0.00027906895,0.00020574525,0.00015934827],"domain_scores_gemma":[0.99679345,0.0009608482,0.0011349677,0.0003607666,0.00035477633,0.0003951446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013870278,0.000564208,0.00081186317,0.0018830801,0.00063761673,0.00076658133,0.000630698,0.0008650993,0.0016060186],"category_scores_gemma":[0.0028842608,0.0006271994,0.0013806623,0.0024388386,0.00086845335,0.0010552986,0.0006565192,0.0005119963,0.00040152812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023283588,0.00045955763,0.99238014,0.000029033083,0.0003140514,0.0002682527,0.00045278788,0.0000988824,0.00062248757,0.000009638636,0.000080035345,0.002956865],"study_design_scores_gemma":[0.000050932147,0.0009294418,0.9977569,0.000005193548,0.00011618217,0.0004392992,0.00034149972,0.000087545144,0.00012815213,0.000007132315,0.00012068736,0.000017147871],"about_ca_topic_score_codex":0.0040086405,"about_ca_topic_score_gemma":0.0032397443,"teacher_disagreement_score":0.0040086405,"about_ca_system_score_codex":0.0006057996,"about_ca_system_score_gemma":0.00042989478,"threshold_uncertainty_score":0.007970631},"labels":[],"label_agreement":null},{"id":"W2921705093","doi":"10.1016/j.urolonc.2018.12.014","title":"New horizons in bladder cancer research","year":2019,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bladder cancer; Identification (biology); Subtyping; Translational research; Medicine; Cancer; Library science; Oncology; Internal medicine; Pathology; Biology; Computer science","score_opus":0.18594623414356412,"score_gpt":0.47233861367372104,"score_spread":0.28639237953015695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921705093","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000017689525,0.99867946,0.000030698226,0.0005577468,0.00042214233,0.0000014334904,0.000008512956,0.0000035433984,0.00027877433],"genre_scores_gemma":[0.00032660767,0.9977925,0.00009292113,0.00082132337,0.0006887443,0.0000025183344,0.000013628419,9.737753e-7,0.00026087527],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992454,0.00023453202,0.000106123494,0.00009751607,0.00024054943,0.00007599262],"domain_scores_gemma":[0.9976915,0.0014036633,0.00023539386,0.00005740164,0.00044599627,0.00016610476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00270849,0.001111485,0.0024325554,0.0044545033,0.00041708432,0.002618179,0.0011446499,0.0023554594,0.009813282],"category_scores_gemma":[0.0033397647,0.00045857838,0.0009992426,0.0048793983,0.0013646777,0.0045874533,0.0016755867,0.003801759,0.0027130095],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013546713,0.000075664466,0.0002467088,0.04704877,0.00018796595,0.00020763675,0.00014389848,0.0003591253,0.00089132425,0.0078243865,0.08695375,0.8559253],"study_design_scores_gemma":[0.000049609385,0.00010269956,0.00071785407,0.016606126,0.0002721144,0.0005393696,0.00018530684,0.000111632515,0.00011733782,0.0061630704,0.9751027,0.000032143937],"about_ca_topic_score_codex":0.0018755008,"about_ca_topic_score_gemma":0.0045485464,"teacher_disagreement_score":0.009813282,"about_ca_system_score_codex":0.0014804673,"about_ca_system_score_gemma":0.0039123455,"threshold_uncertainty_score":0.03282869},"labels":[],"label_agreement":null},{"id":"W2922190478","doi":"10.1016/j.urolonc.2019.01.006","title":"Impact of the estimated blood loss during radical prostatectomy on functional outcomes","year":2019,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Prostatectomy; Erectile dysfunction; Medicine; Logistic regression; Prostate cancer; Urology; Odds ratio; Internal medicine; Cancer","score_opus":0.025988098976350377,"score_gpt":0.32094822102455384,"score_spread":0.29496012204820343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922190478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98395556,0.008112571,0.00029517183,0.0016279079,0.00023393209,0.00001223676,0.0016128897,0.000014908755,0.0041348743],"genre_scores_gemma":[0.9980679,0.00071142305,0.00006795386,0.000114366296,0.00009660688,0.0000035539563,0.0005037658,0.0000046980367,0.00042973034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992642,0.00026990782,0.00005606432,0.00008488588,0.0001538968,0.00017095203],"domain_scores_gemma":[0.9962753,0.0015312493,0.001146995,0.00011846889,0.00027024368,0.00065778807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009729846,0.0002355507,0.00040991962,0.00039946797,0.00025760994,0.00085267995,0.00046619924,0.00042100184,0.0031583328],"category_scores_gemma":[0.0075439666,0.00015108472,0.0014875777,0.00051065616,0.00023726873,0.0006682296,0.00063271885,0.0015661571,0.0002766594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002129213,0.00032486566,0.9617626,0.00015362063,0.0011554712,0.0001383082,0.00007565334,0.0020841728,0.00021742671,0.0001581267,0.0009275506,0.03087293],"study_design_scores_gemma":[0.00001524803,0.0004400121,0.99807405,0.000032098134,0.0001984708,0.00009397359,0.000078301775,0.0005991248,0.000047613055,0.00008973259,0.00032089124,0.000010501218],"about_ca_topic_score_codex":0.0077538895,"about_ca_topic_score_gemma":0.009642614,"teacher_disagreement_score":0.0077538895,"about_ca_system_score_codex":0.00074979075,"about_ca_system_score_gemma":0.0008409988,"threshold_uncertainty_score":0.015417516},"labels":[],"label_agreement":null},{"id":"W2942756034","doi":"10.1016/j.urolonc.2019.04.009","title":"The current state of randomized clinical trial evidence for prostate brachytherapy","year":2019,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Prostate Cancer Foundation","keywords":"Brachytherapy; Randomized controlled trial; Prostate cancer; Medicine; Medical physics; Prostate brachytherapy; Prostate; Presentation (obstetrics); Clinical trial; Quality of life (healthcare); Intensive care medicine; Radiation therapy; Cancer; Internal medicine; Surgery","score_opus":0.24638696444802674,"score_gpt":0.5058475815207233,"score_spread":0.2594606170726965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942756034","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032027974,0.9976629,0.00022694239,0.0007122356,0.0003473977,0.0000766699,0.00024570967,0.000013389199,0.00039452495],"genre_scores_gemma":[0.011910808,0.98011214,0.0015301199,0.004853086,0.00070505333,0.00019647671,0.00037804848,0.000025575844,0.0002885785],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9896568,0.0045412374,0.0030515858,0.0013210858,0.0011454725,0.00028394442],"domain_scores_gemma":[0.9329793,0.05932636,0.004863643,0.00083680893,0.0015845442,0.00040932727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019661827,0.0014064822,0.012681954,0.002064518,0.00046022647,0.003949918,0.0037301022,0.0034981936,0.014033187],"category_scores_gemma":[0.06528633,0.000955507,0.008652563,0.0032898134,0.0016759711,0.0029131824,0.0014917552,0.003704591,0.0011859433],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052441396,0.000083874664,0.0006726231,0.70203537,0.026511759,0.000062726554,0.00011233821,0.00039705203,0.00042549756,0.0016845986,0.009656102,0.25311399],"study_design_scores_gemma":[0.015051612,0.0024123995,0.005487588,0.5207954,0.22836861,0.00043982166,0.00036056433,0.0005001113,0.00061680924,0.01000143,0.21582216,0.00014355284],"about_ca_topic_score_codex":0.0027509534,"about_ca_topic_score_gemma":0.0077339574,"teacher_disagreement_score":0.019661827,"about_ca_system_score_codex":0.0019164528,"about_ca_system_score_gemma":0.004178931,"threshold_uncertainty_score":0.103982925},"labels":[],"label_agreement":null},{"id":"W2945314703","doi":"10.1016/j.urolonc.2019.05.001","title":"Contemporary clinicopathological characteristics of pT0 prostate cancer at radical prostatectomy: A population-based study","year":2019,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); McGill University Health Centre; Université de Montréal","funders":"","keywords":"Prostatectomy; Prostate cancer; Urology; Medicine; Prostate; Population; Oncology; Cancer; Internal medicine; Environmental health","score_opus":0.0383324612901228,"score_gpt":0.3433728178215954,"score_spread":0.3050403565314726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945314703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990177,0.00024293484,0.00006879478,0.000022113278,0.0000042721945,0.000005277454,0.00023836902,0.000003060079,0.0003974086],"genre_scores_gemma":[0.9995215,0.00008776683,0.000025603184,0.000017410337,0.000011072427,0.0000044142475,0.00025425424,0.0000020975244,0.0000758857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99943286,0.0001216513,0.00005359801,0.00020436333,0.00009594663,0.00009163275],"domain_scores_gemma":[0.99900717,0.00015766667,0.00033857554,0.000103587256,0.000105093866,0.00028802434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054377876,0.00030716124,0.0005537687,0.0012415029,0.00069726486,0.0008965467,0.00053238124,0.000746344,0.0018246728],"category_scores_gemma":[0.0014119382,0.0004995017,0.000672531,0.0021280453,0.000663359,0.0012199862,0.00067033805,0.00065341004,0.00035454414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009514516,0.000033122462,0.9988784,0.0000049356395,0.00005231709,0.00007701585,0.00008706265,0.000022152028,0.0002022386,0.000012932776,0.000048727514,0.00048590434],"study_design_scores_gemma":[0.0000026873042,0.000057859936,0.9993394,0.0000011846154,0.000018006167,0.00022540912,0.00021828365,0.00003849355,0.00001259492,0.000015829419,0.000067154106,0.0000030939975],"about_ca_topic_score_codex":0.003880169,"about_ca_topic_score_gemma":0.003649926,"teacher_disagreement_score":0.003880169,"about_ca_system_score_codex":0.0004480996,"about_ca_system_score_gemma":0.00036851375,"threshold_uncertainty_score":0.0077151656},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W2946200001","doi":"10.1016/j.urolonc.2019.04.023","title":"Contemporary analysis of the effect of marital status on survival of prostate cancer patients across all stages: A population-based study","year":2019,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Cancer survivorship and care","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Marital status; Hazard ratio; Demography; Medicine; Prostate cancer; Population; Epidemiology; Subgroup analysis; Incidence (geometry); Proportional hazards model; Cohort; Cancer; Internal medicine; Oncology; Gynecology; Gerontology; Confidence interval; Environmental health","score_opus":0.020680106156984214,"score_gpt":0.3337875330225225,"score_spread":0.3131074268655383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946200001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998054,0.00094260817,0.00012056153,0.000083149105,0.0000067429924,0.0000042784495,0.00036112728,0.0000023419832,0.00042508077],"genre_scores_gemma":[0.9992686,0.00029166258,0.00003768911,0.000033469765,0.000014366078,0.00000380864,0.0002924712,0.0000016333241,0.000056219247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987197,0.0005767436,0.000100403304,0.00030777048,0.00015443501,0.00014106517],"domain_scores_gemma":[0.99753016,0.00082801003,0.00060523016,0.0003719289,0.0003022201,0.0003624729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015740208,0.00020845076,0.0005396802,0.0012786003,0.0008101117,0.00085653085,0.000631318,0.0005388121,0.0012465769],"category_scores_gemma":[0.004007666,0.0002595972,0.0008262678,0.002955801,0.0006429511,0.0008160543,0.0008535888,0.0006583846,0.00015573834],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016390298,0.00002517828,0.9977779,0.000009592125,0.00021737548,0.000032009542,0.00013891587,0.000025400865,0.000118283206,0.00002747919,0.00006891008,0.0013951551],"study_design_scores_gemma":[0.0000036849888,0.00006233714,0.9993487,0.0000027917858,0.00006951439,0.00005682545,0.0002457034,0.00004841224,0.000013040383,0.000018859973,0.00012770724,0.000002408371],"about_ca_topic_score_codex":0.013809262,"about_ca_topic_score_gemma":0.016243108,"teacher_disagreement_score":0.013809262,"about_ca_system_score_codex":0.0004434152,"about_ca_system_score_gemma":0.00044704348,"threshold_uncertainty_score":0.027457774},"labels":[],"label_agreement":null},{"id":"W2947781721","doi":"10.1016/j.urolonc.2019.01.013","title":"Prognostic performance of the 1973 and 2004 WHO grading classification in upper tract urothelial carcinoma","year":2019,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Natural Science Foundation of Beijing Municipality; Capital Health","keywords":"Medicine; Grading (engineering); Univariate analysis; Urothelial carcinoma; Internal medicine; Multivariate analysis; Ureteral neoplasm; Gastroenterology; Oncology; Cancer; Bladder cancer; Transitional cell carcinoma","score_opus":0.02583108560197167,"score_gpt":0.2865401860522031,"score_spread":0.26070910045023143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947781721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866982,0.002898184,0.00034577528,0.00049305364,0.00027155672,0.000022925175,0.002130006,0.000024480738,0.007115892],"genre_scores_gemma":[0.9968274,0.00034076895,0.0001269406,0.000056907513,0.000059797683,0.0000059438603,0.0014297136,0.000009849794,0.0011426333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994228,0.00015566258,0.000057052686,0.00007206305,0.00010683004,0.00018552288],"domain_scores_gemma":[0.9970366,0.0006515329,0.00087475235,0.00020171367,0.00074183353,0.00049360766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011921682,0.00038409137,0.00032378017,0.0025115376,0.00040057307,0.001269298,0.00062184304,0.0008835925,0.0020878213],"category_scores_gemma":[0.005766006,0.0001565529,0.00078288204,0.002016051,0.00046024975,0.0008498844,0.0005337946,0.00052089675,0.00061849057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029887812,0.000021650845,0.9926468,0.000013618485,0.00006462188,0.00005215548,0.000046586927,0.000291308,0.00018396691,0.00006911976,0.0007568514,0.0055542835],"study_design_scores_gemma":[0.000010398629,0.00008012631,0.9973546,0.00001960722,0.00006616478,0.000121699486,0.00017547238,0.0006976185,0.0001197813,0.00010574403,0.0012399565,0.000008860791],"about_ca_topic_score_codex":0.023852391,"about_ca_topic_score_gemma":0.03657593,"teacher_disagreement_score":0.023852391,"about_ca_system_score_codex":0.0012120496,"about_ca_system_score_gemma":0.00092962355,"threshold_uncertainty_score":0.04742706},"labels":[],"label_agreement":null},{"id":"W2951604609","doi":"10.1016/j.urolonc.2019.05.009","title":"Morphologic subtyping as a prognostic predictor for survival in papillary renal cell carcinoma: Type 1 vs. type 2","year":2019,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of British Columbia; McMaster University; Muscular Dystrophy Canada; University of Ottawa","funders":"","keywords":"Medicine; Hazard ratio; Renal cell carcinoma; Nephrectomy; Papillary renal cell carcinomas; Cohort; Internal medicine; Urology; Lymph node; Clear cell; Confidence interval; Kidney cancer; Gastroenterology; Oncology; Kidney","score_opus":0.03180586596165426,"score_gpt":0.28880818324214075,"score_spread":0.2570023172804865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951604609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99940956,0.00015498328,0.000056826797,0.000024733954,0.0000058968667,0.0000047222193,0.00015895015,0.0000019364745,0.00018246661],"genre_scores_gemma":[0.99961865,0.00004299867,0.00004650635,0.00000891944,0.0000076237316,0.0000020063908,0.00021833049,0.000001240259,0.000053770895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996941,0.00004473731,0.00002329563,0.00007559339,0.00009491577,0.000067485584],"domain_scores_gemma":[0.9990689,0.00011455581,0.00043407996,0.000068879126,0.00013968571,0.000173811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050804706,0.00020891994,0.00023655112,0.00062216946,0.00039532126,0.00045831356,0.0004177803,0.0002342066,0.0009272361],"category_scores_gemma":[0.001826142,0.00014444982,0.00038356154,0.00073866436,0.0003502534,0.0002546262,0.00034365102,0.000281057,0.000100017445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006987304,0.000004640695,0.9991248,0.0000018251762,0.000016922439,0.000028557177,0.000012843918,0.00001996672,0.00014885337,0.000005063991,0.00003795343,0.0005286443],"study_design_scores_gemma":[0.0000061967908,0.000048956575,0.99924976,0.000002644027,0.000027994127,0.00022422004,0.00005932798,0.0001921671,0.00007891593,0.000016154238,0.00009109904,0.0000024292265],"about_ca_topic_score_codex":0.0254748,"about_ca_topic_score_gemma":0.056679036,"teacher_disagreement_score":0.0254748,"about_ca_system_score_codex":0.0007816733,"about_ca_system_score_gemma":0.0013156121,"threshold_uncertainty_score":0.05065304},"labels":[],"label_agreement":null},{"id":"W2955007835","doi":"10.1016/j.urolonc.2019.05.019","title":"Prognostic role of the urokinase plasminogen activator (uPA) system in patients with nonmuscle invasive bladder cancer","year":2019,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Urokinase receptor; Interquartile range; Medicine; Bladder cancer; Hazard ratio; Plasminogen activator; Proportional hazards model; SuPAR; Internal medicine; Plasminogen activator inhibitor-1; Biomarker; Urokinase; Adjuvant; Cancer; Oncology; Adjuvant therapy; Urology; Biology","score_opus":0.010315779000670813,"score_gpt":0.24918202695293418,"score_spread":0.23886624795226336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955007835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970241,0.0015673164,0.00007729949,0.00015305913,0.00003086525,0.0000035351475,0.00033301106,0.0000060919156,0.00080463925],"genre_scores_gemma":[0.9993112,0.00021745762,0.000042932064,0.000025820294,0.0000341808,0.0000022551003,0.00019360495,0.0000013431805,0.00017113022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975175,0.00006599754,0.000026458409,0.000040723236,0.000044176213,0.000070805574],"domain_scores_gemma":[0.9990165,0.00031545165,0.0003285842,0.000048668204,0.000088567554,0.0002021875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037764965,0.00023423138,0.00032857675,0.00079790904,0.00036161006,0.0008176655,0.00032318835,0.00050859357,0.0017561995],"category_scores_gemma":[0.0022672608,0.00015962005,0.0004117352,0.0011416472,0.00031442236,0.0005376506,0.0004748946,0.0006650286,0.00025496777],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017920037,0.000014174043,0.9978029,0.00000752411,0.000036815018,0.000079224694,0.000019062385,0.00003886372,0.00021244721,0.000014936334,0.00007684494,0.0015180549],"study_design_scores_gemma":[0.000006181875,0.00005707812,0.9989467,0.0000053229073,0.0000493718,0.00029848696,0.00008528551,0.00021243894,0.00009881223,0.00004445444,0.00019210004,0.0000038207295],"about_ca_topic_score_codex":0.001710866,"about_ca_topic_score_gemma":0.0020956434,"teacher_disagreement_score":0.0017561995,"about_ca_system_score_codex":0.00026604073,"about_ca_system_score_gemma":0.00033589648,"threshold_uncertainty_score":0.005875051},"labels":[],"label_agreement":null},{"id":"W2955659266","doi":"10.1016/j.urolonc.2019.05.021","title":"The role of adjuvant radiotherapy after surgery for upper and lower urinary tract urothelial carcinoma: A systematic review","year":2019,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Urothelial carcinoma; Medicine; Upper urinary tract; Adjuvant radiotherapy; Adjuvant; Urology; Radiation therapy; Urinary system; Carcinoma; Oncology; General surgery; Internal medicine; Cancer; Bladder cancer","score_opus":0.03762698539632905,"score_gpt":0.33983755501991086,"score_spread":0.30221056962358184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955659266","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000570408,0.99906975,0.000033209435,0.00006580601,0.000050475523,0.000026709817,0.00009974121,0.000002345816,0.00008162096],"genre_scores_gemma":[0.012665467,0.9864277,0.00019408014,0.00044830603,0.000059023514,0.00004714245,0.00008637703,0.000002800928,0.000069117305],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9979869,0.00066883716,0.00072365656,0.00026166823,0.00026537527,0.000093514645],"domain_scores_gemma":[0.99199235,0.005807662,0.0016093479,0.00010989802,0.00036050912,0.000120111676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031964155,0.00093902054,0.00519524,0.0033222875,0.00025535774,0.0014775314,0.001282532,0.0016405876,0.00410274],"category_scores_gemma":[0.013272463,0.000721743,0.006825348,0.00399994,0.0006304249,0.00139654,0.0009750716,0.0012976262,0.00026417614],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006259638,0.00002794895,0.0016405775,0.91745335,0.027953556,0.000073356714,0.00011541137,0.00018910097,0.00022476606,0.0001512,0.0016688062,0.049876012],"study_design_scores_gemma":[0.001260273,0.00062288437,0.013152495,0.5951818,0.35726675,0.00041956952,0.00029405384,0.0001594269,0.00022279366,0.00041610477,0.030922864,0.00008105664],"about_ca_topic_score_codex":0.008307124,"about_ca_topic_score_gemma":0.028268429,"teacher_disagreement_score":0.008307124,"about_ca_system_score_codex":0.0015523828,"about_ca_system_score_gemma":0.0037242256,"threshold_uncertainty_score":0.016904473},"labels":[],"label_agreement":null},{"id":"W2955956858","doi":"10.1016/j.urolonc.2019.06.006","title":"Diabetes and kidney cancer survival in patients undergoing nephrectomy: A Canadian multi-center, propensity score analysis","year":2019,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Université Laval; University of Alberta; University of Calgary; McGill University; University of British Columbia; University of Toronto; Dalhousie University; University of Ottawa; McMaster University","funders":"","keywords":"Medicine; Hazard ratio; Propensity score matching; Kidney cancer; Nephrectomy; Confidence interval; Cancer; Proportional hazards model; Diabetes mellitus; Interquartile range; Internal medicine; Population; Cancer registry; Oncology; Surgery; Kidney; Endocrinology","score_opus":0.029112550064496694,"score_gpt":0.27187891371456546,"score_spread":0.24276636365006876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955956858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965733,0.00045408553,0.00016814246,0.00019090413,0.000020311261,0.000017936409,0.0017288966,0.000010241117,0.00083626225],"genre_scores_gemma":[0.9978156,0.00029266096,0.00017462806,0.000058605307,0.000017466464,0.000009891608,0.0012942342,0.000008572875,0.00032830625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991116,0.000090363996,0.000058634323,0.00022825372,0.00024849686,0.0002626716],"domain_scores_gemma":[0.99749917,0.00021994204,0.00065345224,0.00023566853,0.0007577085,0.0006340604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011527148,0.0006263968,0.00073158287,0.002270057,0.002434405,0.0013355362,0.0014587145,0.0009229189,0.0020388803],"category_scores_gemma":[0.0028354053,0.00058031763,0.00171973,0.0054803165,0.00077242224,0.0005736552,0.0010109392,0.0013186911,0.00020903432],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002046227,0.00002248002,0.9971879,0.0000067549036,0.0002396129,0.000056928795,0.000072086186,0.00020062669,0.00013607575,0.00007146009,0.0004931391,0.0013084131],"study_design_scores_gemma":[0.000030227591,0.000028374538,0.9980422,0.000008322901,0.00016221419,0.000112532885,0.00019251106,0.00088414544,0.000033922166,0.000051976225,0.00043483794,0.000018578065],"about_ca_topic_score_codex":0.90067834,"about_ca_topic_score_gemma":0.9186433,"teacher_disagreement_score":0.09932166,"about_ca_system_score_codex":0.008800363,"about_ca_system_score_gemma":0.011871252,"threshold_uncertainty_score":0.19981313},"labels":[],"label_agreement":null},{"id":"W2959343983","doi":"10.1016/j.urolonc.2019.05.020","title":"How cancer-specific mortality changes over time after radical cystectomy: Conditional survival of patients with nonmetastatic urothelial carcinoma of the urinary bladder","year":2019,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal; Surgical Specialties (Canada)","funders":"","keywords":"Cystectomy; Medicine; Proportional hazards model; Hazard ratio; Bladder cancer; Urology; Internal medicine; Cohort; Oncology; Cancer; Confidence interval","score_opus":0.01861578946876259,"score_gpt":0.2690129087415232,"score_spread":0.25039711927276065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2959343983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966641,0.00088129425,0.00021849008,0.00046085427,0.000037051803,0.0000043174155,0.0009231957,0.00001759208,0.00079310127],"genre_scores_gemma":[0.9989795,0.0001401831,0.000039142462,0.00004721545,0.000034289555,0.0000019375138,0.00055069104,0.0000050883627,0.00020181785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993975,0.00016397939,0.000042614887,0.00016859258,0.00004581019,0.00018143129],"domain_scores_gemma":[0.99636555,0.0011355412,0.0012166747,0.0004389668,0.00024043031,0.0006028997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013041532,0.00028034832,0.00037469863,0.00064009335,0.00030612806,0.0009978281,0.0005427188,0.00086593145,0.0030771364],"category_scores_gemma":[0.0069943937,0.00024907407,0.0013276164,0.00096092536,0.0004348462,0.0011994878,0.0007911164,0.001060701,0.0003686687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006398026,0.00003747916,0.9930882,0.000024456021,0.0003284623,0.000056100587,0.000068478155,0.00058296096,0.00026983992,0.000086260654,0.0003132249,0.004504805],"study_design_scores_gemma":[0.0000055200326,0.0001021532,0.9983901,0.000005077834,0.000138609,0.00007471379,0.00008647681,0.0008118954,0.00007075385,0.00015298843,0.00015175228,0.000010040534],"about_ca_topic_score_codex":0.008300802,"about_ca_topic_score_gemma":0.010690071,"teacher_disagreement_score":0.008300802,"about_ca_system_score_codex":0.0004299882,"about_ca_system_score_gemma":0.00057062047,"threshold_uncertainty_score":0.016505003},"labels":[],"label_agreement":null},{"id":"W2961503121","doi":"10.1016/j.urolonc.2019.05.024","title":"Adherence to guideline recommendations for lymph node dissection in squamous cell carcinoma of the penis: Effect on survival and complication rates","year":2019,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Genital Health and Disease","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Penile cancer; Lymphadenectomy; Lymph node; Complication; Epidemiology; Urology; Dissection (medical); Cohort; Odds ratio; Penis; Surgery; Cancer; Internal medicine; Oncology","score_opus":0.03872716762247207,"score_gpt":0.3597510906586294,"score_spread":0.32102392303615734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2961503121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8147332,0.05648158,0.004860903,0.07375955,0.0022478956,0.00093635527,0.009404963,0.00020547106,0.037370123],"genre_scores_gemma":[0.9675509,0.009074872,0.0061112377,0.011170377,0.00027804152,0.00032207335,0.004154203,0.000048151054,0.0012900503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9916346,0.003540627,0.0015870145,0.00048159526,0.0023203075,0.00043585835],"domain_scores_gemma":[0.97204685,0.014025145,0.0076985247,0.0007438621,0.0044511477,0.0010344335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006566853,0.00013969095,0.0005248524,0.0008524887,0.00039410836,0.0009419632,0.00074732007,0.0015430769,0.001185044],"category_scores_gemma":[0.048565075,0.00014305333,0.0010981278,0.0016645739,0.0002295971,0.0005752389,0.0004576325,0.0015496291,0.00015051989],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006559032,0.00072553416,0.7358526,0.001997075,0.0016450922,0.00025350173,0.00066749967,0.002938482,0.00032249588,0.0007572141,0.034373872,0.21981074],"study_design_scores_gemma":[0.00034117248,0.0006190193,0.97191703,0.0034856137,0.0011966433,0.00051670056,0.0010908921,0.003271764,0.00024479747,0.0009811961,0.016278757,0.000056480618],"about_ca_topic_score_codex":0.03009232,"about_ca_topic_score_gemma":0.049565196,"teacher_disagreement_score":0.03009232,"about_ca_system_score_codex":0.0013533622,"about_ca_system_score_gemma":0.0035829556,"threshold_uncertainty_score":0.05983436},"labels":[],"label_agreement":null},{"id":"W2961781424","doi":"10.1016/j.urolonc.2019.06.007","title":"Oncological safety of testosterone replacement therapy in prostate cancer survivors after definitive local therapy: A systematic literature review and meta-analysis","year":2019,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Meta-analysis; Prostate cancer; Cryotherapy; Radiation therapy; Systematic review; Brachytherapy; Subgroup analysis; Extracorporeal shockwave therapy; Internal medicine; Cochrane Library; Androgen deprivation therapy; Prostatectomy; Biochemical recurrence; Oncology; Cancer; MEDLINE; Surgery","score_opus":0.11895687250595288,"score_gpt":0.4086968276717142,"score_spread":0.28973995516576134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2961781424","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0052358727,0.9938653,0.00020283762,0.00008807156,0.00009012537,0.00005786669,0.0003042132,0.000009814842,0.00014593289],"genre_scores_gemma":[0.21252847,0.78396237,0.0010065036,0.0010488023,0.0002565512,0.00020075077,0.00064291456,0.000022000659,0.00033168736],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99568886,0.0014677797,0.001526042,0.00065366866,0.00048157517,0.00018201456],"domain_scores_gemma":[0.9889749,0.0078966245,0.0020878762,0.00038755574,0.0005114099,0.00014155793],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.006260236,0.001636942,0.0098967785,0.0030274664,0.00045129625,0.0023188242,0.0016783192,0.0019527142,0.0037825059],"category_scores_gemma":[0.017405601,0.0011265422,0.025809288,0.0044953935,0.0006972446,0.0014011093,0.0013561106,0.0018631429,0.0002923933],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027986208,0.000040944626,0.010655716,0.34112215,0.62574565,0.00014218104,0.00012930062,0.00038472487,0.00024909707,0.00011803534,0.00072573806,0.0178878],"study_design_scores_gemma":[0.0005578426,0.00022009859,0.0076860497,0.01602515,0.9734634,0.000095066265,0.00007022045,0.000095767304,0.000077498764,0.00014852235,0.0015293629,0.000030974366],"about_ca_topic_score_codex":0.0060583744,"about_ca_topic_score_gemma":0.018771933,"teacher_disagreement_score":0.99010324,"about_ca_system_score_codex":0.0014954212,"about_ca_system_score_gemma":0.0022668573,"threshold_uncertainty_score":0.03310764},"labels":[],"label_agreement":null},{"id":"W2964363953","doi":"10.1016/j.urolonc.2019.06.025","title":"Editorial: Bladder cancer within the focus of basic and clinical research. Sixth IBCN Seminars Series","year":2019,"lang":"en","type":"editorial","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Series (stratigraphy); Focus (optics); Medicine; Geology; Physics","score_opus":0.052414555709831,"score_gpt":0.4061191334540965,"score_spread":0.3537045777442655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964363953","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001538932,0.002264662,0.00004117547,0.022718279,0.97355574,0.000014629155,0.000058036494,0.00003800653,0.0012941236],"genre_scores_gemma":[0.00023505889,0.0024170058,0.0000565755,0.018897785,0.96683705,0.000024368279,0.00004660978,0.000033259465,0.011452378],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99519354,0.000883714,0.0005245268,0.0005454783,0.0025209484,0.00033183774],"domain_scores_gemma":[0.979185,0.008372476,0.0014374176,0.0004548487,0.0069997674,0.0035504673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006983185,0.004229904,0.0040800096,0.004591318,0.0035267265,0.0073174285,0.004261977,0.013168498,0.034689568],"category_scores_gemma":[0.026214164,0.0013245739,0.0030835413,0.0015382724,0.002142768,0.0050173015,0.0016998021,0.01837312,0.02916507],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028869268,0.000006847995,0.0000075877206,0.00008715961,0.0000061038972,0.00003854928,0.0000034661612,0.000011280673,0.00002078721,0.00008272388,0.9981756,0.0015309664],"study_design_scores_gemma":[0.00016636263,0.00004874401,0.00030388922,0.00071262056,0.000060863626,0.00024771702,0.00003540626,0.00015421829,0.00011737467,0.0011703075,0.99695873,0.00002376878],"about_ca_topic_score_codex":0.0020468817,"about_ca_topic_score_gemma":0.00591874,"teacher_disagreement_score":0.034689568,"about_ca_system_score_codex":0.004100356,"about_ca_system_score_gemma":0.004240246,"threshold_uncertainty_score":0.11604822},"labels":[],"label_agreement":null},{"id":"W2964559192","doi":"10.1016/j.urolonc.2019.06.021","title":"Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer","year":2019,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia; University of British Columbia","funders":"","keywords":"Urothelial cancer; Bladder cancer; Cancer; Biology; Pathology; Cancer research; Medicine; Genetics","score_opus":0.018139160072410038,"score_gpt":0.29046182176507557,"score_spread":0.2723226616926655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964559192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99405575,0.0013786145,0.0012540964,0.00017916205,0.000011975461,0.000030034502,0.0005815611,0.00004717885,0.002461663],"genre_scores_gemma":[0.99782264,0.0004013761,0.0006275941,0.00006110594,0.000008968145,0.000014441087,0.00047499235,0.000009744844,0.0005792491],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99976474,0.000029165758,0.0000251012,0.00006131468,0.00006565852,0.00005393788],"domain_scores_gemma":[0.99960274,0.00008186015,0.00010345753,0.00004393093,0.00010418516,0.00006390376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028707896,0.00011153476,0.00016862864,0.0012554779,0.00029816476,0.0007024418,0.00021778331,0.0003255463,0.0018603161],"category_scores_gemma":[0.0008211941,0.00013225494,0.00016639316,0.0006197214,0.000282843,0.00033633402,0.0004600574,0.0002880303,0.00029172417],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086700224,0.000116907475,0.520627,0.00021852745,0.00011148997,0.0016671529,0.00078874215,0.0007621079,0.42902562,0.0011023022,0.00069921016,0.04401395],"study_design_scores_gemma":[0.000015729876,0.00025303924,0.942512,0.000026024416,0.00009228286,0.004371115,0.0011851621,0.001354477,0.04421316,0.0006475648,0.0053196363,0.000009905696],"about_ca_topic_score_codex":0.00092543074,"about_ca_topic_score_gemma":0.0011502337,"teacher_disagreement_score":0.0018603161,"about_ca_system_score_codex":0.00021652508,"about_ca_system_score_gemma":0.0002390116,"threshold_uncertainty_score":0.0062233806},"labels":[],"label_agreement":null},{"id":"W2966631918","doi":"10.1016/j.urolonc.2019.07.010","title":"Developing an effective strategy to improve the detection of significant prostate cancer by combining the 4Kscore and multiparametric MRI","year":2019,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Regional Hospital; Western University","funders":"National Institutes of Health; Sidney Kimmel Foundation for Cancer Research; National Cancer Institute; Foundation for the National Institutes of Health","keywords":"Medicine; Prostate cancer; Biopsy; Magnetic resonance imaging; Prospective cohort study; Prostate biopsy; Multiparametric MRI; Prostate; Cancer; Radiology; Oncology; Internal medicine","score_opus":0.02230511198765285,"score_gpt":0.3197477759900001,"score_spread":0.29744266400234726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966631918","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22863701,0.12603544,0.53146416,0.054526195,0.004393712,0.0027788125,0.0015113675,0.0054391664,0.045214098],"genre_scores_gemma":[0.6003582,0.034295853,0.33361328,0.015664227,0.0043373755,0.0008258038,0.0012963499,0.00038170634,0.009227231],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99922645,0.00028937156,0.00004985448,0.00014612368,0.0001889858,0.000099142744],"domain_scores_gemma":[0.99894565,0.00035641962,0.00014644822,0.00006656506,0.0003375675,0.00014727584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020216722,0.0009354081,0.0014881203,0.002554347,0.000422695,0.0015820083,0.0009267816,0.0010375595,0.0031693066],"category_scores_gemma":[0.0037484074,0.00035879304,0.0008841905,0.0006799482,0.00040010692,0.0018900855,0.001062974,0.0015514658,0.001120714],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004525809,0.000978653,0.05125397,0.0010333315,0.00038880992,0.00049705716,0.00010745177,0.0034247038,0.03160222,0.0018208006,0.022532314,0.8859082],"study_design_scores_gemma":[0.0007815856,0.006718129,0.45156503,0.0035086977,0.00394565,0.012718343,0.0016048102,0.12164558,0.10600335,0.030050991,0.26065594,0.0008018696],"about_ca_topic_score_codex":0.0020172591,"about_ca_topic_score_gemma":0.0039609773,"teacher_disagreement_score":0.0031693066,"about_ca_system_score_codex":0.0005322278,"about_ca_system_score_gemma":0.0018775844,"threshold_uncertainty_score":0.010691762},"labels":[],"label_agreement":null},{"id":"W2972841675","doi":"10.1016/j.urolonc.2019.08.004","title":"Anesthetic technique and oncological outcomes in urology: A clinical practice review","year":2019,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Anesthetic; Perioperative; Prostate cancer; Narrative review; Bladder cancer; Anesthesiology; Prostatectomy; Anesthesia; Cancer; Surgery; Intensive care medicine; Internal medicine","score_opus":0.10112210366671671,"score_gpt":0.4588600929836709,"score_spread":0.3577379893169542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972841675","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001016474,0.99961734,0.000016063716,0.00010974595,0.000045047855,0.0000026801215,0.000018225086,0.0000010861446,0.00008817486],"genre_scores_gemma":[0.0008200316,0.99890983,0.00005362066,0.000115219445,0.00005831775,0.000003138244,0.000015067263,3.6135384e-7,0.000024355195],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993228,0.00014115492,0.00020554438,0.00013378474,0.00015830266,0.000038464135],"domain_scores_gemma":[0.99638027,0.0026110737,0.0005423699,0.000037744026,0.00035550905,0.0000730494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016139898,0.00064427144,0.0021638935,0.003611678,0.00031697677,0.0015688302,0.0011802291,0.0012496642,0.0034522996],"category_scores_gemma":[0.0052201357,0.00039480758,0.0015949468,0.005893496,0.00058611756,0.0012607276,0.0007980346,0.0012798961,0.00038149153],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020636262,0.00011278638,0.0032618798,0.21263702,0.0017268062,0.00015029688,0.00020951223,0.00035960737,0.0002674027,0.0014737068,0.021078575,0.7585159],"study_design_scores_gemma":[0.00021337003,0.0004817043,0.03125726,0.38995674,0.017178701,0.0028870576,0.0010425745,0.0003922691,0.00032490026,0.0031904485,0.5528889,0.0001860704],"about_ca_topic_score_codex":0.0041395626,"about_ca_topic_score_gemma":0.010358342,"teacher_disagreement_score":0.0041395626,"about_ca_system_score_codex":0.0008923699,"about_ca_system_score_gemma":0.0031367706,"threshold_uncertainty_score":0.011549115},"labels":[],"label_agreement":null},{"id":"W2973597900","doi":"10.1016/j.urolonc.2019.08.014","title":"Development and acceptability testing of a patient decision aid for individuals with localized renal masses considering surgical removal with partial or radical nephrectomy","year":2019,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Ottawa Hospital; Princess Margaret Cancer Centre; University of Ottawa","funders":"","keywords":"Nephrectomy; Medicine; Decision aids; Decision analysis; Kidney cancer; Intensive care medicine; Surgery; General surgery; Kidney disease; Kidney; Internal medicine; Alternative medicine","score_opus":0.09368297663922938,"score_gpt":0.3812102200725703,"score_spread":0.28752724343334096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973597900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4591864,0.0018358303,0.29827663,0.04909143,0.0023316056,0.020645166,0.0071490677,0.010567375,0.15091649],"genre_scores_gemma":[0.37405062,0.00077394507,0.59166956,0.0057120277,0.00031820472,0.006258848,0.002842524,0.00036625421,0.01800805],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9912253,0.005553041,0.00086273876,0.00061889744,0.0013596184,0.0003804742],"domain_scores_gemma":[0.95931095,0.026023122,0.0021338651,0.0014300907,0.008942051,0.0021600216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014352637,0.00054078014,0.00046502418,0.001293567,0.000877781,0.002394159,0.0016610879,0.0010281056,0.01616046],"category_scores_gemma":[0.053471424,0.0002934162,0.0006965695,0.0005101237,0.0005129111,0.0017032794,0.0019603278,0.0014208035,0.004435218],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019972955,0.0037027982,0.20100829,0.00074936816,0.00015899996,0.002271549,0.006174913,0.0030399088,0.0030646075,0.007064708,0.104191534,0.66657597],"study_design_scores_gemma":[0.0016047842,0.005978077,0.12861033,0.0035514487,0.00079323456,0.009341513,0.02303616,0.10137001,0.028822323,0.03281217,0.66359997,0.00048009667],"about_ca_topic_score_codex":0.0020344153,"about_ca_topic_score_gemma":0.0031706672,"teacher_disagreement_score":0.01616046,"about_ca_system_score_codex":0.0012144268,"about_ca_system_score_gemma":0.0049005365,"threshold_uncertainty_score":0.075904906},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2975501952","doi":"10.1016/j.urolonc.2019.08.017","title":"An integrative DNA methylation model for improved prognostication of postsurgery recurrence and therapy in prostate cancer patients","year":2019,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"Prostate Cancer Canada","keywords":"Medicine; Biochemical recurrence; Cohort; Prostate cancer; Hazard ratio; Oncology; Internal medicine; Proportional hazards model; Nomogram; Cancer; Prostatectomy; Confidence interval","score_opus":0.027093828777981152,"score_gpt":0.3370569242346323,"score_spread":0.3099630954566511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975501952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.898219,0.0029906568,0.08706138,0.0024486985,0.00012413057,0.0001256604,0.0035972344,0.0005559513,0.004877327],"genre_scores_gemma":[0.98932135,0.0003238935,0.007150221,0.00015831938,0.00006532432,0.000048567043,0.0013971317,0.000033243196,0.0015019779],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99951553,0.00020529564,0.000016629667,0.00015193797,0.000050782113,0.000059845028],"domain_scores_gemma":[0.99935335,0.00035366308,0.000087637905,0.000068319154,0.00008482742,0.00005220089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017612762,0.0007866893,0.0010455915,0.0010523184,0.00034257825,0.001135827,0.0009652954,0.0004790734,0.0024861903],"category_scores_gemma":[0.002539823,0.00024190464,0.0014542976,0.0008156209,0.0003317976,0.0006211231,0.00084016455,0.00090231426,0.000551315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026816605,0.0009599601,0.53114974,0.00029854427,0.0047566155,0.00043068177,0.00048707225,0.23707569,0.0089994725,0.0070217047,0.005235751,0.2009032],"study_design_scores_gemma":[0.0001147353,0.0007585284,0.11758943,0.00005931519,0.0013872617,0.0002963119,0.00017767907,0.86007893,0.0014298997,0.015860435,0.002188438,0.000058962247],"about_ca_topic_score_codex":0.0092909,"about_ca_topic_score_gemma":0.011637907,"teacher_disagreement_score":0.0092909,"about_ca_system_score_codex":0.00057552266,"about_ca_system_score_gemma":0.0010517776,"threshold_uncertainty_score":0.018473625},"labels":[],"label_agreement":null},{"id":"W2977703368","doi":"10.1016/j.urolonc.2019.09.004","title":"Efficacy and toxicity outcomes of elderly castrate-resistant prostate cancer patients treated with docetaxel—A pooled analysis of 3 randomized studies","year":2019,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Internal medicine; Prostate cancer; Docetaxel; Proportional hazards model; Hazard ratio; Adverse effect; Survival analysis; Incidence (geometry); Cancer; Confidence interval","score_opus":0.027363252507344043,"score_gpt":0.3475226745891153,"score_spread":0.3201594220817712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977703368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7004624,0.29283074,0.0012830925,0.000290897,0.00036627593,0.0006123029,0.002581721,0.00005924343,0.001513484],"genre_scores_gemma":[0.9778888,0.019074183,0.00047494555,0.00037801356,0.0002683674,0.00022236221,0.0013646828,0.000015569367,0.00031300285],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99292713,0.0040482003,0.0013228632,0.00088006596,0.0005578534,0.00026389214],"domain_scores_gemma":[0.99325985,0.0032449905,0.0023502207,0.00052877463,0.00035733296,0.00025873302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008207162,0.0016329266,0.006370322,0.0016673806,0.00036300582,0.001738803,0.000740451,0.0012400693,0.0012795513],"category_scores_gemma":[0.0094648935,0.00081191235,0.01761107,0.0017871547,0.0007057549,0.0009969928,0.0008325501,0.0013131972,0.00014338108],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32985908,0.0003236737,0.052356858,0.012070237,0.57661754,0.00015647442,0.00010004588,0.0020510792,0.0012033859,0.0001132336,0.0007694096,0.02437909],"study_design_scores_gemma":[0.080646515,0.015669473,0.1367556,0.0012917111,0.76058495,0.00030660076,0.00014869573,0.0010786343,0.00059854874,0.0005133494,0.0022758532,0.00013010875],"about_ca_topic_score_codex":0.0017240642,"about_ca_topic_score_gemma":0.0036987155,"teacher_disagreement_score":0.008207162,"about_ca_system_score_codex":0.0009985836,"about_ca_system_score_gemma":0.00067918625,"threshold_uncertainty_score":0.043404102},"labels":[],"label_agreement":null},{"id":"W2980397102","doi":"10.1016/j.urolonc.2019.08.008","title":"The miR-200 family as prognostic markers in clear cell renal cell carcinoma","year":2019,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Kidney Foundation of Canada","keywords":"microRNA; Clear cell renal cell carcinoma; Renal cell carcinoma; Metastasis; Biology; Cancer; Oncology; Cancer research; Disease; Proportional hazards model; Medicine; Internal medicine; Gene; Genetics","score_opus":0.008787517364165665,"score_gpt":0.24237672696937593,"score_spread":0.23358920960521026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980397102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93246996,0.050719924,0.0047326144,0.0009542144,0.00028302075,0.00003956218,0.0007845809,0.00020696902,0.009809231],"genre_scores_gemma":[0.9905832,0.004622914,0.0026987717,0.00015734725,0.00015374205,0.00002986947,0.00032122232,0.000024575416,0.0014084764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997632,0.0000765147,0.00002065356,0.000040132432,0.00007082961,0.000028782439],"domain_scores_gemma":[0.9996081,0.00016663127,0.00007160122,0.000019783489,0.00008284789,0.000051045092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086878485,0.00029035678,0.00038318438,0.0016585893,0.00033190296,0.0010540105,0.00020672797,0.00034288346,0.001006625],"category_scores_gemma":[0.0016117394,0.00016579863,0.0002035791,0.001177888,0.00026681295,0.0004014556,0.0002488552,0.00035454804,0.0003443438],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070250216,0.0002455406,0.52720267,0.00041674363,0.00037109945,0.002283753,0.00051164516,0.0019576568,0.16225936,0.0026184882,0.004663688,0.2904444],"study_design_scores_gemma":[0.00017541599,0.0013809028,0.825462,0.00014240846,0.0008460712,0.0072110347,0.00069307745,0.020206751,0.090520024,0.004616633,0.04862659,0.000119110024],"about_ca_topic_score_codex":0.00064944226,"about_ca_topic_score_gemma":0.0005948444,"teacher_disagreement_score":0.0016585893,"about_ca_system_score_codex":0.0003935895,"about_ca_system_score_gemma":0.0003063009,"threshold_uncertainty_score":0.004594624},"labels":[],"label_agreement":null},{"id":"W2981440294","doi":"10.1016/j.urolonc.2019.09.015","title":"Survival outcomes of radical prostatectomy vs. external beam radiation therapy in prostate cancer patients with Gleason Score 9-10 at biopsy: A population-based analysis","year":2019,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); McGill University Health Centre; Université de Montréal","funders":"","keywords":"Prostatectomy; Prostate cancer; Medicine; External beam radiation; Urology; Radiation therapy; Biopsy; External beam radiotherapy; Oncology; Internal medicine; Cancer","score_opus":0.01489544668136936,"score_gpt":0.29195568512780323,"score_spread":0.27706023844643385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981440294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99847585,0.00061648584,0.00008734886,0.000053124306,0.000013576866,0.0000050357535,0.00043414367,0.000005275009,0.0003092321],"genre_scores_gemma":[0.9992761,0.00011589294,0.000016627999,0.000032301086,0.000018317263,0.000004386277,0.00040290967,0.0000029013147,0.00013060636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99920183,0.00022207425,0.000054189048,0.0002537215,0.0000813346,0.00018682415],"domain_scores_gemma":[0.99889755,0.00038690717,0.00034954067,0.00008986926,0.00006187773,0.00021421305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082116324,0.0003607685,0.00082962005,0.00069016253,0.0003456782,0.00075597997,0.0005349057,0.0010174036,0.002355735],"category_scores_gemma":[0.0019793522,0.00040922285,0.0021698487,0.0009973927,0.0003993785,0.0009447302,0.0007345445,0.0010294596,0.000318136],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053990143,0.0001897806,0.9876423,0.00004536968,0.0016412697,0.00014360463,0.000106196065,0.0005733655,0.00053078996,0.00006492805,0.0003900512,0.0032734252],"study_design_scores_gemma":[0.00012600288,0.0010017504,0.99646,0.000009625739,0.00058921997,0.00026670028,0.00027702362,0.0008540752,0.00007089893,0.00012722048,0.0001963635,0.00002113681],"about_ca_topic_score_codex":0.0033445342,"about_ca_topic_score_gemma":0.0038819811,"teacher_disagreement_score":0.0033445342,"about_ca_system_score_codex":0.00038496658,"about_ca_system_score_gemma":0.00030397504,"threshold_uncertainty_score":0.007880688},"labels":[],"label_agreement":null},{"id":"W2984768217","doi":"10.1016/j.urolonc.2019.10.002","title":"Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?","year":2019,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Pathological; Concordance; Proportional hazards model; Pathology; Internal medicine","score_opus":0.01707292954371076,"score_gpt":0.2806001909357846,"score_spread":0.26352726139207383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984768217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41726828,0.1778554,0.008513189,0.29672524,0.039390158,0.00018713981,0.008601493,0.00040999125,0.051049035],"genre_scores_gemma":[0.89470536,0.04401034,0.008913135,0.02588616,0.009006847,0.000076408156,0.0058552325,0.00011483948,0.011431652],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996388,0.000063746775,0.00005950903,0.00005091194,0.00010615626,0.00008085166],"domain_scores_gemma":[0.9985605,0.00016333704,0.00020210138,0.00007534265,0.00062245666,0.00037630793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012559509,0.00020620039,0.0003989953,0.00064671284,0.0004704002,0.0013515005,0.00044730157,0.00071248,0.004014131],"category_scores_gemma":[0.0039450545,0.0001298955,0.00028007154,0.0010562274,0.0005741767,0.0018559298,0.000708681,0.0016170248,0.0013344302],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011516532,0.0001252777,0.29383522,0.0007368064,0.000050856706,0.0014236124,0.00025154217,0.00022579446,0.0054425444,0.0068982127,0.097420976,0.5924375],"study_design_scores_gemma":[0.00018034958,0.0008449245,0.46198997,0.0025893971,0.0004459453,0.010031922,0.0047457167,0.002664267,0.0033764893,0.016612746,0.4963798,0.00013856885],"about_ca_topic_score_codex":0.0058635427,"about_ca_topic_score_gemma":0.011442235,"teacher_disagreement_score":0.0058635427,"about_ca_system_score_codex":0.00069676066,"about_ca_system_score_gemma":0.002097099,"threshold_uncertainty_score":0.013428628},"labels":[],"label_agreement":null},{"id":"W2985290258","doi":"10.1016/j.urolonc.2019.10.006","title":"Improving research for prostate cancer survivorship: A statement from the Survivorship Research in Prostate Cancer (SuRECaP) working group","year":2019,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Survivorship curve; Prostate cancer; Medicine; Disease; Cancer survivorship; Cancer; Oncology; Prostate; Quality of life (healthcare); Gynecology; Internal medicine; Nursing","score_opus":0.354657451780228,"score_gpt":0.5029034638587878,"score_spread":0.1482460120785598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985290258","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008842362,0.9009183,0.00025627326,0.0803535,0.01663212,0.00015857436,0.00041152365,0.000032425785,0.0011487989],"genre_scores_gemma":[0.000573577,0.9415316,0.0014077125,0.048254956,0.0062396424,0.00023842619,0.00047217237,0.000017078131,0.0012648907],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937972,0.0019337949,0.0012567037,0.00046316607,0.0019972103,0.0005519434],"domain_scores_gemma":[0.9656525,0.019151725,0.00320916,0.0006778851,0.008575881,0.0027328178],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.030215692,0.0018910574,0.0040757065,0.005180106,0.0010098587,0.003396083,0.0025901317,0.008728486,0.0035836468],"category_scores_gemma":[0.025372144,0.0011645682,0.0035896283,0.0058011296,0.0014117149,0.0046652798,0.0038758733,0.012331342,0.0019934364],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017825041,0.000111675785,0.0003928132,0.03273449,0.0005178648,0.00006757039,0.00016248328,0.00014009712,0.0006052251,0.0030167964,0.5861053,0.37596744],"study_design_scores_gemma":[0.0001794212,0.00010101148,0.0011588851,0.04165979,0.00076234125,0.000100994424,0.00011454334,0.000058521597,0.00019445014,0.0017738205,0.9538601,0.000036220426],"about_ca_topic_score_codex":0.008549478,"about_ca_topic_score_gemma":0.019972678,"teacher_disagreement_score":0.9697843,"about_ca_system_score_codex":0.0039894334,"about_ca_system_score_gemma":0.030866794,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W2986112591","doi":"10.1016/j.urolonc.2019.09.023","title":"The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy","year":2019,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University Health Centre; University of Alberta; University of British Columbia","funders":"","keywords":"Cystectomy; Bladder cancer; Medicine; Lymphovascular invasion; Internal medicine; Oncology; Neutrophil to lymphocyte ratio; Odds ratio; Chemotherapy; Logistic regression; Cancer; Proportional hazards model; Retrospective cohort study; Lymphocyte; Gastroenterology; Urology; Metastasis","score_opus":0.006163280652825639,"score_gpt":0.2401902713463832,"score_spread":0.23402699069355756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986112591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997389,0.0015994238,0.000083315485,0.00014853357,0.000030871946,0.0000048924376,0.00011253025,0.000004185091,0.00062715623],"genre_scores_gemma":[0.9994049,0.00020993089,0.000061202365,0.00003807197,0.00004208949,0.000005187051,0.00013765463,0.0000014267072,0.0000995404],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997732,0.00007619985,0.000035430614,0.000034831384,0.0000381159,0.000042282212],"domain_scores_gemma":[0.9988846,0.0004220803,0.00033369707,0.000042864773,0.000091114496,0.00022567836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041317428,0.00023502017,0.00048380476,0.0005765315,0.00028638708,0.0005593198,0.00027525498,0.0004764752,0.00076314464],"category_scores_gemma":[0.0025468052,0.00016017487,0.00026421418,0.0007490533,0.0003064157,0.000507713,0.00028436226,0.00058318453,0.00015083411],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076610176,0.000024118142,0.9963972,0.000010487044,0.000045602894,0.00013923446,0.000023477627,0.000080907295,0.00039375,0.000012938773,0.000058932583,0.0020472123],"study_design_scores_gemma":[0.00002433293,0.0002974899,0.9973278,0.000009031537,0.00012295834,0.00073934934,0.00013983525,0.0006837254,0.00025195684,0.00006901155,0.00032598453,0.000008501255],"about_ca_topic_score_codex":0.0008483656,"about_ca_topic_score_gemma":0.0012941739,"teacher_disagreement_score":0.0008483656,"about_ca_system_score_codex":0.0003124889,"about_ca_system_score_gemma":0.0003905253,"threshold_uncertainty_score":0.0025529861},"labels":[],"label_agreement":null},{"id":"W2988892807","doi":"10.1016/j.urolonc.2019.09.030","title":"Evaluation of individual and cumulative sites of extrarenal tumor invasion in pT3a clear cell renal cell carcinoma","year":2019,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Renal cell carcinoma; Clear cell renal cell carcinoma; Cell; Cancer research; Biology; Medicine; Pathology","score_opus":0.06227888323747924,"score_gpt":0.3135551663548787,"score_spread":0.25127628311739947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988892807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978237,0.0006093349,0.0005622269,0.000009099294,0.0000025369773,0.000006083582,0.00008128115,0.000010715659,0.00089510967],"genre_scores_gemma":[0.99911875,0.00017889557,0.0003873076,0.000003732228,0.0000039791125,0.0000037914576,0.000053362346,0.000004399804,0.0002458435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997352,0.000058005633,0.000024244307,0.000044736335,0.000087477376,0.00005039319],"domain_scores_gemma":[0.9993488,0.00020010327,0.00015808696,0.000047294838,0.00011129227,0.00013446166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006596479,0.00022982073,0.00028341307,0.0012101163,0.00020918982,0.00059725734,0.00021661159,0.00028303155,0.0010423403],"category_scores_gemma":[0.0009608851,0.00019826433,0.00041856058,0.0007016162,0.00026723096,0.00053221564,0.00040653397,0.00026208136,0.00015055636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010422941,0.0000430622,0.96745,0.000052398864,0.000083407016,0.00062456465,0.00014610299,0.0007012556,0.013916551,0.000053606997,0.00003952061,0.015847221],"study_design_scores_gemma":[0.0000034999898,0.0001715765,0.99308926,0.000004588201,0.00008685054,0.001647751,0.00020448952,0.0015877549,0.0028789653,0.000041139498,0.00027731463,0.000006864257],"about_ca_topic_score_codex":0.0019552202,"about_ca_topic_score_gemma":0.0039692144,"teacher_disagreement_score":0.0019552202,"about_ca_system_score_codex":0.00031306647,"about_ca_system_score_gemma":0.0002502347,"threshold_uncertainty_score":0.0038876534},"labels":[],"label_agreement":null},{"id":"W2991380951","doi":"10.1016/j.urolonc.2019.10.018","title":"Unmarried men have worse oncologic outcomes after radical cystectomy for nonmetastatic urothelial bladder cancer","year":2019,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); Université de Montréal","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Marital status; Logistic regression; Urothelial cancer; Epidemiology; Incidence (geometry); Proportional hazards model; Internal medicine; Urology; Oncology; Demography; Gynecology; Cancer; Population","score_opus":0.02520090591740231,"score_gpt":0.3361745134918298,"score_spread":0.3109736075744275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991380951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995423,0.0017236006,0.00004931894,0.0006533608,0.0001612149,0.0000053761414,0.00038471125,0.0000051276465,0.0015941687],"genre_scores_gemma":[0.9979011,0.00074245164,0.000025494772,0.00019455026,0.00016928437,0.0000034366087,0.00019894802,0.0000027370227,0.000761893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981374,0.000036530717,0.000014184158,0.000027835851,0.00003137044,0.00007643862],"domain_scores_gemma":[0.99860376,0.00016974495,0.00071643264,0.000049385646,0.00006892392,0.00039183733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028455674,0.00019721361,0.00024812788,0.00035297815,0.00059748656,0.0007425316,0.00026869538,0.0004013165,0.0049905833],"category_scores_gemma":[0.0025919606,0.00021476751,0.0005047036,0.0006358354,0.00025077784,0.00060720317,0.00055312837,0.00095838134,0.00036742454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030934345,0.00010397273,0.9925815,0.00003861341,0.000116879055,0.00017193615,0.00020973226,0.000054345983,0.0001464913,0.000047371264,0.00067249185,0.0055472804],"study_design_scores_gemma":[0.000008243236,0.000069567,0.99882406,0.000011743834,0.000045861907,0.00012733212,0.00037068434,0.00005618636,0.00002881269,0.000055885976,0.0003968113,0.0000048647667],"about_ca_topic_score_codex":0.003505895,"about_ca_topic_score_gemma":0.0064732037,"teacher_disagreement_score":0.0049905833,"about_ca_system_score_codex":0.00019286125,"about_ca_system_score_gemma":0.00031516695,"threshold_uncertainty_score":0.016695142},"labels":[],"label_agreement":null},{"id":"W2992712678","doi":"10.1016/j.urolonc.2019.11.004","title":"Validation of a neuroendocrine-like classifier confirms poor outcomes in patients with bladder cancer treated with cisplatin-based neoadjuvant chemotherapy","year":2019,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Decipher Biosciences (Canada); University of Calgary","funders":"National Cancer Institute","keywords":"Cystectomy; Bladder cancer; Medicine; Cisplatin; Chemotherapy; Oncology; Neuroendocrine tumors; Carcinoma; Internal medicine; Cohort; Pathology; Cancer","score_opus":0.015945987217303743,"score_gpt":0.2848942911665937,"score_spread":0.26894830394929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992712678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966524,0.0005343952,0.00069213315,0.00029742057,0.00007510337,0.00002605756,0.0004575375,0.000027065254,0.0012379041],"genre_scores_gemma":[0.9980102,0.00014632755,0.00053823506,0.00013807231,0.000036242418,0.000015405583,0.00086234644,0.000008405429,0.00024470597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992112,0.00019501273,0.00009867074,0.00020320009,0.00017224229,0.000119758464],"domain_scores_gemma":[0.9978567,0.00075713656,0.00040504595,0.00018967871,0.0004538967,0.00033750996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016357243,0.00031591454,0.00057331787,0.00080685207,0.00045567082,0.0014410828,0.00050605414,0.00070749706,0.001403737],"category_scores_gemma":[0.0052001174,0.00017154602,0.00041487417,0.00058175414,0.00047380486,0.00061996625,0.00070190616,0.00066854426,0.0005302335],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057568663,0.000060002567,0.9821516,0.000039354058,0.00009454703,0.000236842,0.000051497747,0.00041506736,0.0047131875,0.00005251175,0.0006536699,0.010956044],"study_design_scores_gemma":[0.00008098684,0.0007710368,0.97783124,0.000059307265,0.00037752712,0.002804377,0.0003928612,0.007568451,0.0062882886,0.00045552474,0.0033451964,0.000025289666],"about_ca_topic_score_codex":0.0009527926,"about_ca_topic_score_gemma":0.0018719496,"teacher_disagreement_score":0.0016357243,"about_ca_system_score_codex":0.00034798382,"about_ca_system_score_gemma":0.00049250573,"threshold_uncertainty_score":0.0086506605},"labels":[],"label_agreement":null},{"id":"W2999559745","doi":"10.1016/j.urolonc.2019.12.024","title":"Upstaging to pT3a disease in patients undergoing robotic partial nephrectomy for cT1 kidney cancer: Outcomes and predictors from a multi-institutional dataset","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Nephrectomy; Logistic regression; Kidney cancer; Proportional hazards model; Urology; Internal medicine; Cohort; Stage (stratigraphy); Pathological; Kidney disease; Cancer; Oncology; Kidney; Surgery","score_opus":0.04937847680332095,"score_gpt":0.3190912112984793,"score_spread":0.2697127344951583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999559745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870761,0.00058567146,0.00016202738,0.00014207793,0.000025353784,0.000012653647,0.011366777,0.000015089073,0.0006142349],"genre_scores_gemma":[0.9865095,0.00024328132,0.00013317438,0.000089195884,0.00002588626,0.000017378217,0.012741968,0.000013752849,0.00022585342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999008,0.000120222576,0.00014346445,0.00036967912,0.00011162735,0.00024707578],"domain_scores_gemma":[0.9968299,0.00042159972,0.0015542754,0.0003964884,0.00029663186,0.000501069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088474585,0.00036285116,0.0005134039,0.0011711591,0.000511684,0.0011673566,0.00096542697,0.00069467246,0.0026971367],"category_scores_gemma":[0.003928783,0.0003363549,0.0015318729,0.0023534321,0.00039018967,0.0010927916,0.0017655191,0.0010750613,0.00046028197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014747294,0.00001744601,0.997795,0.00002036638,0.00019478389,0.000035324985,0.000039459424,0.000109839944,0.000081326805,0.000022487078,0.0006310646,0.00090550235],"study_design_scores_gemma":[0.000012877274,0.00004043072,0.99822253,0.000016335114,0.000112747235,0.00027604864,0.00024963426,0.0003479868,0.000060634866,0.00005655889,0.0005918416,0.000012265687],"about_ca_topic_score_codex":0.009612248,"about_ca_topic_score_gemma":0.019935906,"teacher_disagreement_score":0.009612248,"about_ca_system_score_codex":0.00061713805,"about_ca_system_score_gemma":0.00090234954,"threshold_uncertainty_score":0.019112647},"labels":[],"label_agreement":null},{"id":"W2999639531","doi":"10.1016/j.urolonc.2019.11.005","title":"Development of a prognostic model for survival time prediction in castration-resistant prostate cancer patients","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Docetaxel; Medicine; Nomogram; Prostate cancer; Internal medicine; Proportional hazards model; Oncology; Hazard ratio; Neutrophil to lymphocyte ratio; Prostate-specific antigen; Chemotherapy; Cancer; Lymphocyte; Confidence interval","score_opus":0.040454875163654175,"score_gpt":0.30207554906886747,"score_spread":0.26162067390521326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999639531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7486419,0.0016698532,0.23570228,0.0026672473,0.00052236486,0.00042346874,0.005678876,0.002295803,0.002398263],"genre_scores_gemma":[0.9556782,0.00044685745,0.03809726,0.00014627738,0.00015065397,0.00023852395,0.0039270595,0.00004444816,0.0012707314],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9996588,0.00010743658,0.000040477586,0.00008348861,0.00005778676,0.000051927924],"domain_scores_gemma":[0.99868613,0.0007752976,0.00009934812,0.00005431978,0.0002971922,0.00008779297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021319392,0.0009150203,0.0010167016,0.001504276,0.00041367617,0.0013284613,0.00080859935,0.00060639234,0.001733249],"category_scores_gemma":[0.004029702,0.00030429167,0.0010997338,0.0006392917,0.00012980758,0.0005509544,0.00055135816,0.0010424108,0.0006108013],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020539085,0.0011263123,0.5142802,0.0001769377,0.001311296,0.00044412786,0.000116057505,0.2219925,0.002899861,0.0011626716,0.010581265,0.24385494],"study_design_scores_gemma":[0.000053112504,0.00025239462,0.019625144,0.000027451119,0.00028414506,0.00012452745,0.000034512912,0.9769642,0.00080137973,0.00086313765,0.0009472343,0.000022694641],"about_ca_topic_score_codex":0.0075653386,"about_ca_topic_score_gemma":0.0049422253,"teacher_disagreement_score":0.0075653386,"about_ca_system_score_codex":0.000636489,"about_ca_system_score_gemma":0.0016648592,"threshold_uncertainty_score":0.015042603},"labels":[],"label_agreement":null},{"id":"W3000573294","doi":"10.1016/j.urolonc.2019.12.014","title":"Definition of high-risk prostate cancer impacts oncological outcomes after radical prostatectomy","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Prostatectomy; Prostate cancer; Medicine; Urology; Hazard ratio; Biochemical recurrence; Proportional hazards model; Population; Internal medicine; Cancer; Oncology; Prostate-specific antigen; Lower risk; Biopsy; Stage (stratigraphy); Metastasis; Gynecology; Confidence interval","score_opus":0.0333654611799859,"score_gpt":0.31288996411923525,"score_spread":0.27952450293924935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000573294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95976985,0.011052467,0.0019704683,0.012058121,0.00052968826,0.000066355184,0.0012196373,0.000038083323,0.01329531],"genre_scores_gemma":[0.99659157,0.0009366423,0.0005492341,0.00072032807,0.00028403976,0.000014949961,0.00046397035,0.000022520182,0.0004167037],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99474686,0.002609161,0.00048544016,0.00051322236,0.0010791675,0.0005660722],"domain_scores_gemma":[0.9821087,0.0062239068,0.0070341583,0.0007297402,0.0015694761,0.002333916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051417206,0.00033822487,0.00051899115,0.0011876363,0.00089545693,0.0038376718,0.001394087,0.0007841453,0.006364593],"category_scores_gemma":[0.034984976,0.00026768615,0.0013827572,0.0017329628,0.0010282525,0.0022011045,0.002928561,0.0024957233,0.00044307043],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030365275,0.00012927823,0.9698721,0.00014414272,0.00031878488,0.000046024714,0.00040955807,0.0003879362,0.00014859198,0.0011626288,0.0017882416,0.025289027],"study_design_scores_gemma":[0.000012810045,0.00016892231,0.99299777,0.00017352954,0.00016836358,0.00019478175,0.0010745602,0.00038133832,0.00021028897,0.0019997237,0.0025791042,0.000038693757],"about_ca_topic_score_codex":0.004122261,"about_ca_topic_score_gemma":0.0072515677,"teacher_disagreement_score":0.006364593,"about_ca_system_score_codex":0.0017321183,"about_ca_system_score_gemma":0.0023335535,"threshold_uncertainty_score":0.027192354},"labels":[],"label_agreement":null},{"id":"W3003383600","doi":"10.1016/j.urolonc.2019.12.027","title":"The impact of very high initial PSA on oncological outcomes after radical prostatectomy for clinically localized prostate cancer","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostate cancer; Urology; Prostatectomy; Hazard ratio; Biochemical recurrence; Proportional hazards model; Internal medicine; Prostate-specific antigen; Cancer; Confidence interval","score_opus":0.04661965357703723,"score_gpt":0.39318487910538996,"score_spread":0.3465652255283527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003383600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909718,0.0043837763,0.00014030437,0.0011863596,0.00017125932,0.0000094874,0.00024860477,0.000012308617,0.0028760915],"genre_scores_gemma":[0.9990625,0.00031871634,0.000033513064,0.00015746967,0.00010965136,0.000002049522,0.00014489848,0.000004998547,0.00016629383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986927,0.00051025907,0.00009301366,0.000095986725,0.00027065355,0.00033747364],"domain_scores_gemma":[0.989925,0.0050324434,0.0022890356,0.00035259192,0.000497892,0.001903049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013429079,0.00018914738,0.0003890848,0.0005701657,0.0005216982,0.0012947916,0.00062011345,0.00073509774,0.0020970132],"category_scores_gemma":[0.015008551,0.00017936766,0.0010712974,0.00079958397,0.00064868754,0.0008308795,0.00087825576,0.001768547,0.00025033328],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022343807,0.0003081527,0.971584,0.00007000518,0.00033693723,0.00030733418,0.00012544832,0.00042961398,0.00033982864,0.00011760606,0.0008202951,0.023326408],"study_design_scores_gemma":[0.000012374097,0.00042950892,0.9985312,0.000014883794,0.000102624654,0.00021920439,0.00015096576,0.0001413531,0.00006741942,0.00013633784,0.00018317658,0.0000110168285],"about_ca_topic_score_codex":0.0036106536,"about_ca_topic_score_gemma":0.0083615845,"teacher_disagreement_score":0.0036106536,"about_ca_system_score_codex":0.0009663159,"about_ca_system_score_gemma":0.00112019,"threshold_uncertainty_score":0.0071792603},"labels":[],"label_agreement":null},{"id":"W3005297699","doi":"10.1016/j.urolonc.2020.01.004","title":"Prognostic value of the systemic inflammation modified Glasgow prognostic score in patients with upper tract urothelial carcinoma (UTUC) treated with radical nephroureterectomy: Results from a large multicenter international collaboration","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Proportional hazards model; Cohort; Internal medicine; Retrospective cohort study; Oncology; Logistic regression; Perioperative; Cancer; Urology; Surgery","score_opus":0.013891971068228204,"score_gpt":0.2453229369827587,"score_spread":0.2314309659145305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005297699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99841404,0.00066372403,0.00006176684,0.00009358001,0.00001300578,0.000012695199,0.0005214872,0.0000023549244,0.00021742821],"genre_scores_gemma":[0.99888915,0.00019602408,0.0000845887,0.00004409392,0.000026513193,0.000012308715,0.0006931,0.0000018352047,0.000052427535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897265,0.000448286,0.00010186832,0.00022311536,0.00015078842,0.00010336747],"domain_scores_gemma":[0.99723935,0.0005374325,0.0012867352,0.00019216166,0.0003456209,0.0003987405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019469592,0.00039792145,0.00064195273,0.0007604499,0.0004018678,0.0009964848,0.0004941344,0.00055462075,0.00037523088],"category_scores_gemma":[0.0040869727,0.00019517922,0.0006883092,0.0017387028,0.00043729,0.00045779726,0.0007723056,0.0004890197,0.0000857818],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079568656,0.000053688356,0.9965377,0.000019086481,0.00035393168,0.000022085831,0.000076991615,0.00008053377,0.00022789204,0.000010145109,0.00017950988,0.0016426812],"study_design_scores_gemma":[0.000092101705,0.00016569755,0.9989066,0.0000071926397,0.0002261088,0.00006547584,0.00012284462,0.00015195405,0.00007766725,0.00001775174,0.00015962265,0.0000070850397],"about_ca_topic_score_codex":0.0035988449,"about_ca_topic_score_gemma":0.0052222232,"teacher_disagreement_score":0.0035988449,"about_ca_system_score_codex":0.0004693253,"about_ca_system_score_gemma":0.00063442346,"threshold_uncertainty_score":0.010296583},"labels":[],"label_agreement":null},{"id":"W3006222801","doi":"10.1016/j.urolonc.2020.01.010","title":"Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancer","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University Health Centre; University of Alberta; University of British Columbia","funders":"","keywords":"Hazard ratio; Medicine; Confidence interval; Bladder cancer; Proportional hazards model; Internal medicine; Logistic regression; Cystectomy; Oncology; Menopause; Stage (stratigraphy); Odds ratio; Cancer; Chemotherapy; Gynecology; Biology","score_opus":0.023471895500540445,"score_gpt":0.3305486323638788,"score_spread":0.30707673686333836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006222801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922915,0.0045920233,0.000037275073,0.0007371984,0.00009849317,0.0000065534523,0.00020836336,0.00000381211,0.0020247134],"genre_scores_gemma":[0.9982293,0.00082330825,0.000030468345,0.00024517227,0.00008452355,0.000003981045,0.00019052962,0.0000036777524,0.00038907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996469,0.00017250024,0.000032845477,0.000032963497,0.000050844905,0.000063840744],"domain_scores_gemma":[0.9984047,0.00078000134,0.000426097,0.000047346413,0.0000706528,0.0002712462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005051632,0.000129038,0.00032236706,0.00023134117,0.00018579088,0.000564506,0.00015614739,0.0003008529,0.0017772373],"category_scores_gemma":[0.004373786,0.00008106792,0.00058299914,0.00038410694,0.00021679897,0.00034218788,0.00025183064,0.0005851171,0.00016978578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072975415,0.00019459208,0.9630106,0.00006315444,0.00034771152,0.0001810331,0.00008880759,0.00025396442,0.00066336343,0.00004481375,0.00041137415,0.027443068],"study_design_scores_gemma":[0.000080202444,0.001115284,0.9972861,0.000021800526,0.00017253327,0.00018637581,0.0001503875,0.00019654333,0.00013342539,0.00006931696,0.0005816518,0.0000064210035],"about_ca_topic_score_codex":0.0009193448,"about_ca_topic_score_gemma":0.0027179732,"teacher_disagreement_score":0.0017772373,"about_ca_system_score_codex":0.00033130485,"about_ca_system_score_gemma":0.0004016309,"threshold_uncertainty_score":0.005945444},"labels":[],"label_agreement":null},{"id":"W3008502333","doi":"10.1016/j.urolonc.2020.01.013","title":"Histotype predicts the rate of lymph node invasion at nephrectomy in patients with nonmetastatic renal cell carcinoma","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Surgical Specialties (Canada)","funders":"","keywords":"Nephrectomy; Renal cell carcinoma; Medicine; Lymph node; Oncology; Urology; Internal medicine; Kidney","score_opus":0.023906186737125454,"score_gpt":0.23805755520731697,"score_spread":0.2141513684701915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008502333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986424,0.00024556348,0.00009976664,0.00006544679,0.000012905082,0.0000029661906,0.00012326492,0.0000038507856,0.0008039106],"genre_scores_gemma":[0.9995134,0.00008778101,0.00004625695,0.000018289576,0.000014812411,0.0000016505783,0.000096873366,0.0000026577864,0.0002184012],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998142,0.000054902863,0.000021308493,0.000028767634,0.00003728614,0.00004347969],"domain_scores_gemma":[0.9986265,0.0004479162,0.000419201,0.00009174717,0.00012055041,0.00029412008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003837488,0.00021629232,0.00022791962,0.00058147893,0.00029880134,0.00060266623,0.00034353213,0.00043791137,0.002475935],"category_scores_gemma":[0.0022976387,0.0002017957,0.00035284925,0.0006029141,0.00029624533,0.00052312756,0.00034394814,0.00053865,0.0003661638],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000072126226,0.000007735221,0.99897087,0.0000023665204,0.00001321288,0.00007154453,0.0000113537835,0.000043836637,0.00023375782,0.0000075574976,0.000027679343,0.0005379943],"study_design_scores_gemma":[0.000002484836,0.000036334113,0.9988135,0.0000020581554,0.000022312375,0.00047288105,0.000114506096,0.0003038924,0.000117313684,0.00003047984,0.00008145517,0.000002703643],"about_ca_topic_score_codex":0.0015798752,"about_ca_topic_score_gemma":0.002506076,"teacher_disagreement_score":0.002475935,"about_ca_system_score_codex":0.00020588408,"about_ca_system_score_gemma":0.0002624777,"threshold_uncertainty_score":0.00828284},"labels":[],"label_agreement":null},{"id":"W3008517425","doi":"10.1016/j.urolonc.2020.02.008","title":"Prognostic role of preoperative De Ritis ratio in upper tract urothelial carcinoma treated with nephroureterectomy","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Proportional hazards model; Urology; Odds ratio; Metastatic Urothelial Carcinoma; Internal medicine; Bladder cancer; Urothelial carcinoma; Oncology; Gastroenterology; Cancer","score_opus":0.02105563623263535,"score_gpt":0.2806656774549817,"score_spread":0.2596100412223464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008517425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970999,0.0013316678,0.0001498991,0.00013071501,0.000038992875,0.0000034179288,0.0001660384,0.000012624352,0.0010667982],"genre_scores_gemma":[0.9994029,0.00015958975,0.000051229956,0.000020923899,0.00003662735,0.0000019898157,0.00014396518,0.0000023202815,0.0001806124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979085,0.00004650638,0.000028227485,0.000037294016,0.000038181184,0.0000589597],"domain_scores_gemma":[0.998808,0.00035997003,0.0003901625,0.00006916158,0.000071989605,0.0003006667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032808658,0.00023354031,0.000322097,0.0006134254,0.0002452497,0.00064691104,0.0002761379,0.00043374085,0.0017611695],"category_scores_gemma":[0.0023350513,0.00016448899,0.00048769457,0.0005037227,0.00035921385,0.00043541947,0.0003296539,0.00055015157,0.0002096353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046836847,0.000024021927,0.9955419,0.000012435497,0.000066544744,0.00020314899,0.000024859792,0.00012534148,0.00076565775,0.0000267186,0.00009237766,0.0026487515],"study_design_scores_gemma":[0.000007180802,0.00012788113,0.9977648,0.0000055694213,0.00009586262,0.00071306987,0.00011899185,0.00046391474,0.0003456499,0.000053832806,0.00029677278,0.0000065696213],"about_ca_topic_score_codex":0.0011318814,"about_ca_topic_score_gemma":0.0018730182,"teacher_disagreement_score":0.0017611695,"about_ca_system_score_codex":0.00025965215,"about_ca_system_score_gemma":0.0003369602,"threshold_uncertainty_score":0.0058916807},"labels":[],"label_agreement":null},{"id":"W3008645455","doi":"10.1016/j.urolonc.2020.01.007","title":"A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Capital District Health Authority; University Health Network; University of Toronto; Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Canadian Urological Association","keywords":"Medicine; Bladder cancer; Urine; Receiver operating characteristic; Biomarker; Cancer; Urinary system; Methylation; Logistic regression; Internal medicine; Oncology; Urology; Area under the curve; DNA methylation; Gene; Biology; Gene expression; Genetics","score_opus":0.09088514481609229,"score_gpt":0.35365624715395694,"score_spread":0.26277110233786466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008645455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93606234,0.010100032,0.035615925,0.0018170672,0.00047446348,0.00035601752,0.0056951037,0.0011126422,0.008766281],"genre_scores_gemma":[0.9712337,0.0016742143,0.016673889,0.0008924086,0.00021409044,0.0001810405,0.0023254983,0.00006774234,0.006737336],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99947447,0.00011647166,0.000031064126,0.00013089854,0.0001908408,0.000056241985],"domain_scores_gemma":[0.99956316,0.00010639744,0.00006808248,0.000035281202,0.00016594426,0.000061166655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006805521,0.0006344328,0.0007269463,0.0015542568,0.00034831092,0.0010127824,0.0003839272,0.0008953097,0.0017261452],"category_scores_gemma":[0.0016061937,0.0003377826,0.0004511665,0.00080495176,0.00022841216,0.00046191903,0.00049005955,0.0008942228,0.000749829],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018746566,0.00072492735,0.47584993,0.00033268452,0.0004527718,0.00045698904,0.00024598013,0.001509194,0.293033,0.00052036764,0.0065388903,0.21846071],"study_design_scores_gemma":[0.00019283727,0.00406816,0.7120733,0.00021525871,0.00085712195,0.005025347,0.00042956162,0.025281442,0.23256803,0.0022020293,0.016928932,0.00015802916],"about_ca_topic_score_codex":0.0013029595,"about_ca_topic_score_gemma":0.0029177316,"teacher_disagreement_score":0.0017261452,"about_ca_system_score_codex":0.0002959543,"about_ca_system_score_gemma":0.00051894883,"threshold_uncertainty_score":0.0057745576},"labels":[],"label_agreement":null},{"id":"W3010242400","doi":"10.1016/j.urolonc.2020.02.004","title":"Effect of stage and grade migration on cancer specific mortality in renal cell carcinoma patients, according to clear cell vs. non-clear cell histology: A contemporary population-based analysis","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); Université de Montréal","funders":"","keywords":"Clear cell renal cell carcinoma; Medicine; Stage (stratigraphy); Clear cell; Internal medicine; Chromophobe cell; Oncology; Renal cell carcinoma; Biology","score_opus":0.035142799633973806,"score_gpt":0.29997750649717486,"score_spread":0.26483470686320104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010242400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990735,0.00032816074,0.000065253,0.000033269887,0.000010537177,0.0000021929413,0.0002610862,0.000003552716,0.00022246731],"genre_scores_gemma":[0.9994784,0.000095503216,0.000022313372,0.000012659536,0.000015345087,0.0000024990827,0.00026812547,0.000002704793,0.000102407335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993697,0.00017911856,0.00005320555,0.00022416699,0.000056213084,0.00011757855],"domain_scores_gemma":[0.99870276,0.0003987521,0.00037149002,0.00015953864,0.000092439,0.00027503862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007064177,0.00037386123,0.00064623257,0.00078741414,0.00041469192,0.0008148631,0.00050647755,0.0008262678,0.0020891768],"category_scores_gemma":[0.0022647833,0.00038352716,0.0018062735,0.0012653605,0.00041975174,0.0008294663,0.00056405395,0.00090290635,0.00025965934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084228616,0.000033643748,0.9973869,0.000009960877,0.00032792805,0.00005010514,0.00005378399,0.00008569392,0.00015238035,0.00001925345,0.000083256375,0.0009549219],"study_design_scores_gemma":[0.000015519048,0.00017077116,0.99886405,0.0000025519362,0.00016205384,0.00008461884,0.00018121618,0.000383009,0.000025706015,0.000034636316,0.00006893189,0.0000069598755],"about_ca_topic_score_codex":0.00649111,"about_ca_topic_score_gemma":0.007822907,"teacher_disagreement_score":0.00649111,"about_ca_system_score_codex":0.00038354966,"about_ca_system_score_gemma":0.00036555147,"threshold_uncertainty_score":0.012906671},"labels":[],"label_agreement":null},{"id":"W3012148626","doi":"10.1016/j.urolonc.2020.02.011","title":"Prognostic value of the SPOP mutant genomic subclass in prostate cancer","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"Weill Cornell Medical College","keywords":"Subclass; Mutant; Prostate cancer; Cancer; Prostate; Value (mathematics); Biology; Computational biology; Genetics; Cancer research; Oncology; Medicine; Gene; Mathematics; Statistics","score_opus":0.028910402481300827,"score_gpt":0.29992129546162694,"score_spread":0.2710108929803261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012148626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956553,0.0007296435,0.00030542305,0.00017641399,0.000018558485,0.0000052226637,0.0003115037,0.000025529745,0.002772411],"genre_scores_gemma":[0.9992556,0.00013785489,0.00011376387,0.000022459704,0.000020598354,0.0000017633658,0.00016271432,0.000007585158,0.00027765593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998872,0.000019206493,0.0000083251125,0.000025525229,0.000028502538,0.000031204454],"domain_scores_gemma":[0.9992933,0.00016514586,0.00018868849,0.00007136765,0.00008307422,0.00019836563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000239429,0.00027698695,0.00021728738,0.00093200576,0.00036426037,0.00075366156,0.0003648474,0.00039865388,0.004095378],"category_scores_gemma":[0.0015503081,0.00012965358,0.0001794253,0.00045085954,0.00034501284,0.00037614646,0.00046417743,0.0004633355,0.0004343468],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078877935,0.000030804025,0.974441,0.000020144556,0.000057742516,0.000456576,0.00004464524,0.00043539205,0.010288476,0.0002884049,0.0003608085,0.012787228],"study_design_scores_gemma":[0.000013214186,0.00016522201,0.987855,0.000016998545,0.000112600836,0.00368807,0.00031137472,0.0017339037,0.0035715569,0.0011018483,0.0014179411,0.000012207241],"about_ca_topic_score_codex":0.0011971188,"about_ca_topic_score_gemma":0.0014776229,"teacher_disagreement_score":0.004095378,"about_ca_system_score_codex":0.00024628686,"about_ca_system_score_gemma":0.0002194521,"threshold_uncertainty_score":0.013700426},"labels":[],"label_agreement":null},{"id":"W3012590719","doi":"10.1016/j.urolonc.2020.02.002","title":"The prognostic value of the urokinase-plasminogen activator system (uPA) in bladder cancer patients treated with radical cystectomy (RC)","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Lymphovascular invasion; Medicine; Urokinase receptor; Cystectomy; Bladder cancer; Plasminogen activator; Proportional hazards model; Hazard ratio; Metastasis; Internal medicine; Lymph node; Cancer; Urokinase; Oncology; SuPAR; Pathology; Confidence interval","score_opus":0.018933880395659696,"score_gpt":0.2715359821409866,"score_spread":0.25260210174532693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012590719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969649,0.0020015186,0.000064708,0.00014820317,0.000036017114,0.000004102504,0.0001926588,0.000004060559,0.000583738],"genre_scores_gemma":[0.9993212,0.00029196628,0.00003689077,0.00003260617,0.000044764874,0.0000022098773,0.0001455474,0.0000010680808,0.00012380292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998111,0.00005415801,0.000018775789,0.000029017181,0.000035030524,0.000051829156],"domain_scores_gemma":[0.99931014,0.0002474998,0.00019779977,0.000029394734,0.000054752443,0.00016037973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030787452,0.00015792582,0.00028144955,0.00054442754,0.00030048768,0.0006449663,0.0002245782,0.00041039486,0.0010972196],"category_scores_gemma":[0.0019359188,0.00012350947,0.00038725475,0.00075102324,0.00028586303,0.00035410654,0.00029285304,0.0006636885,0.00015121976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005245082,0.000031448242,0.9946121,0.000013921311,0.00007560801,0.00008407844,0.000027850176,0.00006340717,0.00036267246,0.000016226808,0.000092272814,0.004095982],"study_design_scores_gemma":[0.000014586723,0.00017330649,0.99865735,0.0000065924633,0.00011379035,0.00024089853,0.0000918471,0.00024330876,0.00015929817,0.00005065052,0.00024351676,0.000004753344],"about_ca_topic_score_codex":0.001859771,"about_ca_topic_score_gemma":0.0022534216,"teacher_disagreement_score":0.001859771,"about_ca_system_score_codex":0.00028660832,"about_ca_system_score_gemma":0.00038738138,"threshold_uncertainty_score":0.0036979318},"labels":[],"label_agreement":null},{"id":"W3014683097","doi":"10.1016/j.urolonc.2020.02.015","title":"Psychological distress associated with active surveillance in patients younger than 70 with a small renal mass","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Malignancy; Anxiety; Biopsy; Distress; Depression (economics); Internal medicine; Psychological distress; Disease; Renal mass; Surgery; Clinical psychology; Kidney; Psychiatry; Nephrectomy","score_opus":0.03811115136379088,"score_gpt":0.2789579145751844,"score_spread":0.24084676321139348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014683097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984347,0.00046763296,0.000020084159,0.00028533846,0.000026759055,0.000005650871,0.00007673288,0.0000015443716,0.0006815735],"genre_scores_gemma":[0.9994702,0.00025895317,0.000020991129,0.00007708706,0.000038483053,0.0000028788095,0.00007184701,5.0177533e-7,0.000059080296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975306,0.00007103142,0.000024682451,0.000023317096,0.000043367625,0.00008448336],"domain_scores_gemma":[0.99815,0.0004283973,0.0007344249,0.000031896518,0.00010201824,0.0005533937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026566433,0.00017964748,0.0003445095,0.00059432583,0.0005509555,0.0006104818,0.0001686198,0.00044058613,0.0013101471],"category_scores_gemma":[0.0042812056,0.00012002781,0.000456275,0.00083841383,0.00028871212,0.00042488865,0.00047794494,0.0009081465,0.000087030494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018546848,0.000064534,0.99595994,0.000017147757,0.000043185206,0.00052377785,0.00024980112,0.000029205696,0.00010348039,0.0000115849725,0.00014678175,0.0026652056],"study_design_scores_gemma":[0.0000059923523,0.00015018503,0.99789447,0.000011274453,0.00003730331,0.0008057742,0.00084625516,0.00006559959,0.00002069406,0.000022197082,0.00013517833,0.000005102024],"about_ca_topic_score_codex":0.0038046604,"about_ca_topic_score_gemma":0.005834853,"teacher_disagreement_score":0.0038046604,"about_ca_system_score_codex":0.00030079295,"about_ca_system_score_gemma":0.00036264572,"threshold_uncertainty_score":0.0075650215},"labels":[],"label_agreement":null},{"id":"W3015870540","doi":"10.1016/j.urolonc.2020.03.012","title":"Partial orchiectomy: The Princess Margaret cancer centre experience","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Princess Margaret Cancer Foundation","keywords":"Medicine; Lesion; Orchiectomy; Histology; Surgery; Surgical margin; Radiology; Pathology","score_opus":0.04084133019379415,"score_gpt":0.3330053213715313,"score_spread":0.29216399117773717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015870540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97672164,0.004051743,0.00015357429,0.0033331986,0.00013028884,0.000054030497,0.00020140808,0.000012960074,0.015341205],"genre_scores_gemma":[0.993298,0.0025555885,0.00022463864,0.00078547443,0.0001479521,0.000016235997,0.00014389862,0.000015768377,0.002812593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994991,0.000100883684,0.00002867531,0.00004643693,0.000112601105,0.0002122789],"domain_scores_gemma":[0.9988901,0.0001400332,0.00011587148,0.000039683186,0.00007029409,0.00074404024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041866777,0.00035153292,0.00027820969,0.0003850387,0.0027071536,0.0013039359,0.00044238797,0.0010580422,0.004246645],"category_scores_gemma":[0.0017923956,0.0003763156,0.000287111,0.0011880497,0.0008053922,0.0006885169,0.0013388289,0.00093833945,0.00044217083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088558515,0.0012712769,0.45894623,0.000469383,0.00016942235,0.4307484,0.015513457,0.0010663773,0.0028230299,0.0024469062,0.020475822,0.06518396],"study_design_scores_gemma":[0.00013043023,0.0014040242,0.4785592,0.00020646086,0.000059417132,0.48247924,0.012123592,0.00042688678,0.00055656995,0.0004831982,0.02349838,0.00007273631],"about_ca_topic_score_codex":0.008437014,"about_ca_topic_score_gemma":0.037579246,"teacher_disagreement_score":0.008437014,"about_ca_system_score_codex":0.0018906803,"about_ca_system_score_gemma":0.0019379744,"threshold_uncertainty_score":0.016775787},"labels":[],"label_agreement":null},{"id":"W3021629923","doi":"10.1016/j.urolonc.2020.03.030","title":"The expression of urokinase-type plasminogen activator system in upper tract urothelial carcinoma and its prognostic value after radical nephroureterectomy","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Urokinase receptor; Lymphovascular invasion; Medicine; Hazard ratio; Lymph node; Immunohistochemistry; Plasminogen activator; Cancer; Oncology; Stage (stratigraphy); Internal medicine; Plasminogen activator inhibitor-1; Urology; Pathology; Confidence interval; Metastasis; Biology","score_opus":0.026213661176739535,"score_gpt":0.28464493734980706,"score_spread":0.25843127617306755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021629923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968786,0.0021404002,0.00011069178,0.00006366334,0.000020754302,0.0000033035649,0.00009813512,0.0000053358876,0.00067901606],"genre_scores_gemma":[0.99927515,0.00032317895,0.000051760875,0.00001157303,0.000023301372,0.0000018861956,0.000088235836,0.000001033205,0.00022384351],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983704,0.00003780637,0.000016272897,0.00002152058,0.0000391101,0.000048123726],"domain_scores_gemma":[0.99933964,0.00020995001,0.00018542289,0.00003651242,0.00009418137,0.00013426924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041286307,0.00013072579,0.00021485578,0.00079336116,0.00022682591,0.0005807373,0.00021579854,0.00027602498,0.0008272353],"category_scores_gemma":[0.0017042495,0.00009425117,0.00026354846,0.00070545706,0.0003849772,0.00038006908,0.00021610328,0.0003678744,0.00017066111],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000686078,0.000029498291,0.9849819,0.00003112623,0.00006991603,0.00039437067,0.00009799709,0.00012758576,0.0049421056,0.00004225201,0.000104076375,0.008493065],"study_design_scores_gemma":[0.0000042835763,0.00011486104,0.99756193,0.000004199635,0.00006137822,0.00049331976,0.000107047454,0.00025211956,0.0009997156,0.0000526854,0.00034289042,0.000005648204],"about_ca_topic_score_codex":0.0013410259,"about_ca_topic_score_gemma":0.001805963,"teacher_disagreement_score":0.0013410259,"about_ca_system_score_codex":0.00027133178,"about_ca_system_score_gemma":0.00026548354,"threshold_uncertainty_score":0.0027673244},"labels":[],"label_agreement":null},{"id":"W3025146952","doi":"10.1016/j.urolonc.2020.04.016","title":"A novel prevention bundle to reduce incisional infections after radical cystectomy","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Cystectomy; Surgery; Surgical site infection; Cohort; Bladder cancer; Internal medicine; Cancer","score_opus":0.043439840515320696,"score_gpt":0.33974015162747684,"score_spread":0.29630031111215616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025146952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80387783,0.015681688,0.119060345,0.020266071,0.004992828,0.002064449,0.0006199271,0.0027303495,0.030706562],"genre_scores_gemma":[0.83339095,0.006701109,0.1318049,0.006050083,0.0028150731,0.0014348207,0.0006566012,0.00017994443,0.016966632],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9994894,0.00013617447,0.000039411894,0.00008914873,0.00016153867,0.0000842626],"domain_scores_gemma":[0.9991365,0.00016186247,0.0002329524,0.000053492768,0.00017868388,0.00023655115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007596195,0.000356389,0.0005247276,0.0005503149,0.00059131876,0.0005916415,0.00073553954,0.0006247834,0.007540737],"category_scores_gemma":[0.002229097,0.00020293742,0.000734096,0.00032690636,0.00020497329,0.00091213954,0.0007146084,0.0011268905,0.0010432439],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035157858,0.014029789,0.011904957,0.0012420927,0.0003065232,0.00032003535,0.0004506463,0.00087991933,0.011337218,0.0018592344,0.02067648,0.9334774],"study_design_scores_gemma":[0.021509126,0.10343716,0.51722544,0.0051957024,0.005326374,0.008864972,0.0033975216,0.048067745,0.03742905,0.020882294,0.22817834,0.00048629413],"about_ca_topic_score_codex":0.0005473663,"about_ca_topic_score_gemma":0.0012071985,"teacher_disagreement_score":0.007540737,"about_ca_system_score_codex":0.00031266917,"about_ca_system_score_gemma":0.0013642235,"threshold_uncertainty_score":0.025226235},"labels":[],"label_agreement":null},{"id":"W3035505613","doi":"10.1016/j.urolonc.2020.04.019","title":"Use of combined androgen deprivation therapy with postoperative radiation treatment for prostate cancer: Impact of randomized trials on clinical practice","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Prostate cancer; Androgen deprivation therapy; Prostatectomy; Radiation therapy; Logistic regression; Port (circuit theory); Cancer; Epidemiology; Urology; Internal medicine; Surveillance, Epidemiology, and End Results; Oncology; Gynecology; Surgery; Cancer registry","score_opus":0.1760198785500329,"score_gpt":0.4501077258025158,"score_spread":0.2740878472524829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035505613","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35414004,0.60324544,0.0043253317,0.017618079,0.008347953,0.0040049255,0.0013307214,0.00012505065,0.006862518],"genre_scores_gemma":[0.9027625,0.075368255,0.0066649565,0.00856152,0.003219285,0.0017342295,0.0009071573,0.00006288254,0.00071922917],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9353207,0.0501053,0.0074244053,0.0033461018,0.0029995362,0.000803949],"domain_scores_gemma":[0.8862455,0.085844636,0.018048061,0.0040362845,0.0031439788,0.0026814702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04954065,0.0010420529,0.0065633263,0.00096450717,0.0006223183,0.003377606,0.0019359243,0.0044108923,0.004795902],"category_scores_gemma":[0.10200691,0.0009768687,0.00767265,0.0019648147,0.0035766214,0.004350626,0.0016093901,0.0048124855,0.00043480392],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.75242263,0.0021640752,0.01553885,0.022716573,0.06077134,0.00005353701,0.00024206312,0.0011527896,0.0011582492,0.0012342593,0.0020041394,0.14054158],"study_design_scores_gemma":[0.7690153,0.07568432,0.034191575,0.011179755,0.090893574,0.00015498752,0.0003361785,0.0017526874,0.0007860819,0.0040954263,0.0117263775,0.0001837795],"about_ca_topic_score_codex":0.0017542787,"about_ca_topic_score_gemma":0.0030982855,"teacher_disagreement_score":0.04954065,"about_ca_system_score_codex":0.0022509957,"about_ca_system_score_gemma":0.0034313174,"threshold_uncertainty_score":0.26199913},"labels":[],"label_agreement":null},{"id":"W3039488352","doi":"10.1016/j.urolonc.2020.06.002","title":"Down-regulation of ADRB2 expression is associated with small cell neuroendocrine prostate cancer and adverse clinical outcomes in castration-resistant prostate cancer","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Prostate cancer; Medicine; Hazard ratio; Neuroendocrine differentiation; Proportional hazards model; Internal medicine; Biochemical recurrence; Cancer; Oncology; Quartile; Prostatectomy","score_opus":0.03882649213395672,"score_gpt":0.3212878862549093,"score_spread":0.28246139412095256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3039488352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966377,0.002204188,0.00020261605,0.000105295214,0.000030319005,0.0000040081723,0.00021192143,0.000014614604,0.000589356],"genre_scores_gemma":[0.9988625,0.00037863126,0.00010882825,0.000051554558,0.000029982933,0.0000042664706,0.0002032565,0.000004508797,0.0003565453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998895,0.000027482458,0.000008909511,0.000026157206,0.000023576593,0.000024316572],"domain_scores_gemma":[0.99962723,0.00004796537,0.00019119825,0.00002408699,0.00003614827,0.000073403084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018474669,0.00020475958,0.00030128114,0.00032202576,0.00020650573,0.00052997406,0.00019813016,0.00026134527,0.0011358692],"category_scores_gemma":[0.000519005,0.0001386623,0.00024787226,0.00044933773,0.00028875892,0.00014944216,0.00016556797,0.00041234918,0.00018882805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002697118,0.0001583646,0.9206335,0.000097659155,0.00031285116,0.00090021,0.0001384645,0.00020106256,0.062041596,0.00013796626,0.0005939783,0.012087299],"study_design_scores_gemma":[0.000012522022,0.000115553325,0.9968335,0.000006935097,0.00008542148,0.00065413216,0.00008638004,0.00021256752,0.001302029,0.00007306153,0.0006107978,0.000007100716],"about_ca_topic_score_codex":0.0010073411,"about_ca_topic_score_gemma":0.0012192432,"teacher_disagreement_score":0.0011358692,"about_ca_system_score_codex":0.00017177699,"about_ca_system_score_gemma":0.0001331173,"threshold_uncertainty_score":0.003799796},"labels":[],"label_agreement":null},{"id":"W3041324089","doi":"10.1016/j.urolonc.2020.06.009","title":"Bladder cancer incidence rates and trends in young adults aged 20-39 years","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Bladder cancer; Incidence (geometry); Medicine; Stage (stratigraphy); Epidemiology; Cohort; Demography; Cancer; Internal medicine; Biology","score_opus":0.03202457868522956,"score_gpt":0.33099694156752374,"score_spread":0.2989723628822942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041324089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98434687,0.0018254302,0.00007059487,0.00017656856,0.000030309706,0.000019315066,0.011479132,0.000015021746,0.0020366749],"genre_scores_gemma":[0.9896828,0.0023873074,0.000101562095,0.00013266978,0.00004306069,0.00003181768,0.006096926,0.0000044547755,0.0015192952],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998274,0.000015856689,0.00003482324,0.00003562978,0.000030268751,0.000056022087],"domain_scores_gemma":[0.9993678,0.000058594796,0.00029211718,0.000014752808,0.0001183337,0.00014850711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002997818,0.00017450689,0.00024869893,0.0016763901,0.00027415078,0.0004860619,0.00019245839,0.0004179446,0.0022157854],"category_scores_gemma":[0.0010415487,0.00019768899,0.0006407837,0.002044876,0.00011084156,0.0007403952,0.00041443837,0.00039358647,0.0005797562],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006723558,0.000020186397,0.99693155,0.000032685515,0.000034326888,0.000045231707,0.00015008304,0.000025844933,0.00007595147,0.000017292294,0.00042068554,0.0021788643],"study_design_scores_gemma":[0.0000022578577,0.000034956094,0.998917,0.000012627328,0.000016525464,0.00011842671,0.00035302114,0.00002784666,0.00001892494,0.000007094843,0.0004894401,0.0000017928224],"about_ca_topic_score_codex":0.029190779,"about_ca_topic_score_gemma":0.037107103,"teacher_disagreement_score":0.029190779,"about_ca_system_score_codex":0.0003572951,"about_ca_system_score_gemma":0.0004723073,"threshold_uncertainty_score":0.05804175},"labels":[],"label_agreement":null},{"id":"W3041863946","doi":"10.1016/j.urolonc.2020.06.013","title":"Low compliance to guidelines in nonmuscle-invasive bladder carcinoma: A systematic review","year":2020,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Compliance (psychology); Systematic review; Medicine; Oncology; Urology; MEDLINE; Psychology; Biology","score_opus":0.11931002928046197,"score_gpt":0.4102799463984164,"score_spread":0.29096991711795445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041863946","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034945551,0.9951703,0.00011239959,0.00041688973,0.00013047513,0.00009613597,0.0003822565,0.000007465627,0.00018960552],"genre_scores_gemma":[0.115536444,0.88053095,0.0008298437,0.0022152446,0.0001336308,0.00022691273,0.00039785838,0.0000116367755,0.0001174205],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.988815,0.0043848357,0.0042263307,0.0010339419,0.001211702,0.00032832276],"domain_scores_gemma":[0.9590837,0.030107109,0.0080444915,0.0005673526,0.0017777947,0.00041960616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009776243,0.0009005947,0.007040189,0.003722964,0.00045947253,0.0022825697,0.001595009,0.002582982,0.0034537076],"category_scores_gemma":[0.062288024,0.0012420682,0.00813721,0.0060767015,0.0010491352,0.0026621227,0.0016522502,0.0022920487,0.0001911342],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066481833,0.00004252916,0.012017566,0.8717577,0.07146639,0.00012305575,0.00050850597,0.00016694822,0.00010587168,0.0002286665,0.0027549635,0.04016303],"study_design_scores_gemma":[0.0013849894,0.00031481838,0.03318496,0.59859437,0.3532887,0.0003744084,0.00080593687,0.00021036674,0.00015033926,0.000635762,0.010946105,0.00010927916],"about_ca_topic_score_codex":0.014760527,"about_ca_topic_score_gemma":0.05086684,"teacher_disagreement_score":0.014760527,"about_ca_system_score_codex":0.0025818641,"about_ca_system_score_gemma":0.006683167,"threshold_uncertainty_score":0.05170238},"labels":[],"label_agreement":null},{"id":"W3042127423","doi":"10.1016/j.urolonc.2020.04.028","title":"Androgen deprivation therapy for prostate cancer and the risk of bladder cancer: A systematic review of observational studies","year":2020,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Queen's University; Montreal General Hospital; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Androgen deprivation therapy; Prostate cancer; Observational study; Medicine; Bladder cancer; Oncology; Internal medicine; Systematic review; Cancer therapy; Cancer; MEDLINE; Biology","score_opus":0.12348586428019602,"score_gpt":0.4168290380878311,"score_spread":0.2933431738076351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042127423","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019506139,0.9973972,0.000089475434,0.000055641347,0.00004639632,0.000035787496,0.00035647445,0.0000039996607,0.00006442922],"genre_scores_gemma":[0.03430361,0.9644404,0.00035710522,0.0003015237,0.00007065369,0.000086139866,0.00036492653,0.000004866733,0.00007078885],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9964103,0.0010592635,0.0013869471,0.00054699666,0.00045515053,0.00014139738],"domain_scores_gemma":[0.98504376,0.011150234,0.0028030989,0.00031122976,0.00053352263,0.00015818844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043213526,0.0011987054,0.006658705,0.0034950834,0.00038894592,0.0016307568,0.0015174095,0.0015310555,0.0030518873],"category_scores_gemma":[0.017817484,0.0010260195,0.011139748,0.006471971,0.0006063626,0.001273175,0.0012160706,0.0013097478,0.00023991826],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010878928,0.0000338843,0.012369753,0.77800494,0.17807363,0.00017213364,0.00014065293,0.00028640486,0.00032351207,0.00017405544,0.0015465894,0.027786642],"study_design_scores_gemma":[0.0009238641,0.00029729257,0.039601944,0.15883741,0.78871006,0.00050543353,0.00025097295,0.00017539009,0.00022195207,0.0005509211,0.009831773,0.00009298212],"about_ca_topic_score_codex":0.009848522,"about_ca_topic_score_gemma":0.022899777,"teacher_disagreement_score":0.009848522,"about_ca_system_score_codex":0.001375086,"about_ca_system_score_gemma":0.0030426118,"threshold_uncertainty_score":0.022853792},"labels":[],"label_agreement":null},{"id":"W3042556618","doi":"10.1016/j.urolonc.2020.06.025","title":"Organ preserving radiation strategies for penile cancer","year":2020,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Genital Health and Disease","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia, Okanagan Campus; Interior Health","funders":"","keywords":"Brachytherapy; Penile cancer; Medicine; Radiation therapy; External beam radiotherapy; External beam radiation; Cancer; Surgery; Radiation treatment planning; Stage (stratigraphy); Penis; General surgery; Internal medicine","score_opus":0.08903756193998258,"score_gpt":0.4231450591462405,"score_spread":0.33410749720625793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042556618","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000036697587,0.9995782,0.000026332043,0.00007504742,0.00006574463,0.0000016737082,0.000006941934,0.0000018004264,0.00020753239],"genre_scores_gemma":[0.0004847463,0.9990132,0.000060442508,0.00018040945,0.00010418748,0.0000023542666,0.000012971505,8.180694e-7,0.00014075609],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983835,0.000042049556,0.00002861559,0.000036529458,0.00003746355,0.0000170211],"domain_scores_gemma":[0.99954623,0.0003271739,0.000056211866,0.0000110038745,0.000041976902,0.000017385548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067973306,0.0007931499,0.0014612615,0.0019865336,0.00023773295,0.00091452047,0.0008813483,0.00081339374,0.0053398204],"category_scores_gemma":[0.0012518198,0.00030701805,0.0008731825,0.0017296548,0.00050138595,0.0011102621,0.0006394876,0.0016702248,0.00090944715],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010185544,0.000045777288,0.000154548,0.04173948,0.00024800102,0.00015441145,0.000050015304,0.0004813587,0.0006149474,0.0016586354,0.021592164,0.9331588],"study_design_scores_gemma":[0.00012687316,0.00033776846,0.0022233778,0.03550939,0.0015200558,0.0027811578,0.0001247481,0.00017509314,0.00051754346,0.0024138268,0.95422107,0.00004902006],"about_ca_topic_score_codex":0.0016000903,"about_ca_topic_score_gemma":0.0043471535,"teacher_disagreement_score":0.0053398204,"about_ca_system_score_codex":0.0006705061,"about_ca_system_score_gemma":0.0010583063,"threshold_uncertainty_score":0.017863512},"labels":[],"label_agreement":null},{"id":"W3042649051","doi":"10.1016/j.urolonc.2020.06.001","title":"Does renal tumor biopsies for small renal carcinoma increase the risk of upstaging on final surgery pathology report and the risk of recurrence?","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Capital District Health Authority; Alberta Health Services; Juravinski Hospital; Centre hospitalier universitaire de Québec; Ottawa Hospital; University Health Network; St. Joseph’s Healthcare Hamilton; McGill University Health Centre; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Nephrectomy; Odds ratio; Confidence interval; Kidney cancer; Cohort; Pathological; Biopsy; Surgery; Urology; Renal cell carcinoma; Cancer; Kidney; Internal medicine","score_opus":0.04797432769682929,"score_gpt":0.2797521764391201,"score_spread":0.2317778487422908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042649051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974115,0.012481942,0.0009329139,0.0037371402,0.00033875584,0.000021762984,0.00040496833,0.000031497224,0.007935953],"genre_scores_gemma":[0.99567693,0.0023089068,0.00042310372,0.00050133094,0.0005103673,0.000003985921,0.00015400855,0.000010179649,0.00041116247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845827,0.0006026804,0.0001516777,0.00015961248,0.00043990306,0.00018788877],"domain_scores_gemma":[0.9884992,0.004420481,0.0045497566,0.0008761681,0.00096668355,0.0006877941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024078875,0.00029388568,0.00057623594,0.00091873267,0.000310007,0.0009329733,0.0005540237,0.001490422,0.0029533724],"category_scores_gemma":[0.016700404,0.00031893316,0.00084350596,0.0012811689,0.00049750245,0.0012874459,0.0003013952,0.0011347412,0.0006576217],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002587358,0.000046405858,0.98777455,0.000036626403,0.00012515024,0.00037385253,0.00003502871,0.000053885356,0.00021513583,0.000055721608,0.0003394599,0.010685564],"study_design_scores_gemma":[0.000010537989,0.000232559,0.99408746,0.00006668667,0.00021564077,0.0030460916,0.00022299659,0.0004761779,0.0003099688,0.00031635532,0.0010030767,0.000012476229],"about_ca_topic_score_codex":0.0019127867,"about_ca_topic_score_gemma":0.003152016,"teacher_disagreement_score":0.0029533724,"about_ca_system_score_codex":0.00026159853,"about_ca_system_score_gemma":0.00037635578,"threshold_uncertainty_score":0.012734294},"labels":[],"label_agreement":null},{"id":"W3043081582","doi":"10.1016/j.urolonc.2020.06.020","title":"Obesity is associated with adverse short-term perioperative outcomes in patients treated with open and robot-assisted radical cystectomy for bladder cancer","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cystectomy; Medicine; Perioperative; Odds ratio; Bladder cancer; Confidence interval; Body mass index; Obesity; Logistic regression; Adverse effect; Internal medicine; Surgery; Urology; Cancer","score_opus":0.04354730382898404,"score_gpt":0.32737037243718786,"score_spread":0.28382306860820383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043081582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99848866,0.00090555864,0.000051733557,0.00009967464,0.000037037596,0.0000031853203,0.00012052883,0.0000014096864,0.000292166],"genre_scores_gemma":[0.9990651,0.0004205789,0.00004766379,0.0000611223,0.000050694984,0.000004040629,0.0002036872,0.0000017188615,0.00014544962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997564,0.000057296085,0.0000361962,0.00004296184,0.000036676975,0.00007042131],"domain_scores_gemma":[0.9988293,0.00018367144,0.00064060633,0.000046175322,0.000055909244,0.00024424228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031143188,0.00020307387,0.00030850802,0.0003553688,0.0002766325,0.0006008032,0.00028362256,0.00043806795,0.0013271177],"category_scores_gemma":[0.0018990563,0.00019326217,0.00094705936,0.0006679587,0.00025645568,0.00038314675,0.0004532315,0.00091243285,0.00011513015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005210085,0.00004988429,0.9969446,0.00002169119,0.00021411724,0.00007227922,0.00003204619,0.000037164944,0.00021095936,0.00001835522,0.000077727156,0.0018000766],"study_design_scores_gemma":[0.000008473037,0.00009134297,0.9993316,0.00000729433,0.000101766236,0.00011486054,0.00010981444,0.00009984026,0.000018572873,0.000029925925,0.000082044004,0.0000045052825],"about_ca_topic_score_codex":0.0022750013,"about_ca_topic_score_gemma":0.003693346,"teacher_disagreement_score":0.0022750013,"about_ca_system_score_codex":0.00019691579,"about_ca_system_score_gemma":0.0003796009,"threshold_uncertainty_score":0.0045235157},"labels":[],"label_agreement":null},{"id":"W3044322824","doi":"10.1016/j.urolonc.2020.06.031","title":"Sequential administration of Bacillus Calmette-Guerin (BCG) and Electromotive Drug Administration (EMDA) of mitomycin C (MMC) for the treatment of high-grade nonmuscle invasive bladder cancer after BCG failure","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; Sinai Health System; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Mitomycin C; Bladder cancer; Urology; Internal medicine; Carcinoma in situ; Surgery; Confidence interval; Cancer; Gastroenterology","score_opus":0.03296514392094393,"score_gpt":0.3126456104444776,"score_spread":0.2796804665235337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044322824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904235,0.005816188,0.0013176886,0.00012956788,0.00020555778,0.00031291696,0.000083755425,0.00006813919,0.0016426933],"genre_scores_gemma":[0.9971234,0.00093135174,0.0008785667,0.000059990132,0.000069785696,0.000078531266,0.000069923866,0.000004240015,0.00078424765],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99989307,0.000025326617,0.000010128256,0.000020710446,0.0000125776805,0.00003811502],"domain_scores_gemma":[0.9998535,0.000033008284,0.000027964757,0.000016483244,0.000010335216,0.000058630707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025323458,0.0003879398,0.0008791521,0.0003343809,0.00024426286,0.00020098059,0.00030781908,0.0003428635,0.0010543957],"category_scores_gemma":[0.00044138482,0.00014345096,0.0003413484,0.00032435544,0.00023557004,0.00018911654,0.00022594223,0.0006601004,0.00017445066],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20900676,0.016884381,0.011506472,0.0008157575,0.00048242373,0.0019955863,0.00020967075,0.0025415362,0.19670789,0.0009621074,0.0016984344,0.55718905],"study_design_scores_gemma":[0.03548987,0.6495751,0.15932745,0.00019822513,0.00087776163,0.004525068,0.00015300144,0.0079613635,0.11796576,0.00067954,0.023158325,0.000088489665],"about_ca_topic_score_codex":0.0010572104,"about_ca_topic_score_gemma":0.0026514388,"teacher_disagreement_score":0.0010572104,"about_ca_system_score_codex":0.00024089147,"about_ca_system_score_gemma":0.00045359173,"threshold_uncertainty_score":0.0035273433},"labels":[],"label_agreement":null},{"id":"W3045937352","doi":"10.1016/j.urolonc.2020.06.034","title":"Impact of tumor size on the oncological outcome of high-grade nonmuscle invasive bladder cancer – examining the utility of classifying Ta bladder cancer based on size","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Bladder cancer; Medicine; Cancer; Bladder tumor; Oncology; Outcome (game theory); Internal medicine; Urology; Mathematics","score_opus":0.11145792447127204,"score_gpt":0.36938070171749277,"score_spread":0.2579227772462207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045937352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99741805,0.0007265853,0.00018217441,0.00042518787,0.000068924724,0.000008802211,0.0001586272,0.000004274581,0.0010073276],"genre_scores_gemma":[0.9992415,0.00011455047,0.000078548415,0.0000834403,0.00007721059,0.0000047361723,0.00013510273,0.0000061583282,0.0002586864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99807763,0.001179823,0.00010946588,0.00020657602,0.00026475982,0.00016181805],"domain_scores_gemma":[0.9898874,0.0059319874,0.001998008,0.00063256035,0.00054969825,0.0010003315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004208648,0.00031329726,0.0003846377,0.0006363334,0.00026343844,0.0010314466,0.00063981616,0.00059488666,0.002289663],"category_scores_gemma":[0.0117966,0.00016428066,0.0013618531,0.000594193,0.0007039037,0.0012285443,0.00060368265,0.0009157918,0.00041187438],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048896526,0.00018700726,0.97768867,0.00002977715,0.00049822184,0.000065889886,0.0000979103,0.00038187517,0.00077353214,0.00006567189,0.00033106867,0.014990716],"study_design_scores_gemma":[0.000040196144,0.002188527,0.99452,0.000017021837,0.00035781413,0.00014467516,0.000293863,0.0013055752,0.0003836884,0.00020018898,0.0005352266,0.000013179488],"about_ca_topic_score_codex":0.0016323801,"about_ca_topic_score_gemma":0.0032863973,"teacher_disagreement_score":0.004208648,"about_ca_system_score_codex":0.0005403336,"about_ca_system_score_gemma":0.00051023334,"threshold_uncertainty_score":0.022257745},"labels":[],"label_agreement":null},{"id":"W3048080988","doi":"10.1016/j.urolonc.2020.07.021","title":"Outcomes of complete metastasectomy in metastatic renal cell carcinoma patients: The Canadian Kidney Cancer information system experience","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Juravinski Cancer Centre; McMaster University; Centre hospitalier universitaire de Québec; Princess Margaret Cancer Centre; BC Cancer Agency; University of Toronto; University of Alberta; Queen Elizabeth II Health Sciences Centre; University of Calgary; Centre Hospitalier de l’Université de Montréal; McGill University","funders":"Faculty of Medicine, McGill University","keywords":"Metastasectomy; Medicine; Hazard ratio; Renal cell carcinoma; Proportional hazards model; Cohort; Metastasis; Confidence interval; Kidney cancer; Internal medicine; Oncology; Surgery; Cancer; Urology","score_opus":0.04598665495310941,"score_gpt":0.2851413074170707,"score_spread":0.2391546524639613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048080988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96203274,0.0024776293,0.0001295857,0.0062111923,0.000075868105,0.00006523694,0.008291586,0.000019915202,0.020696227],"genre_scores_gemma":[0.995083,0.00081651774,0.000104302075,0.00042232173,0.000024373716,0.000011584445,0.0026643742,0.00000929832,0.0008642606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99802303,0.00016493216,0.00007514098,0.00014934123,0.000829367,0.00075816136],"domain_scores_gemma":[0.9961265,0.00027126525,0.0006166509,0.000064932516,0.001175438,0.0017452367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011797139,0.00023279266,0.00037209157,0.0008277131,0.002461721,0.0018281989,0.0008717788,0.00049120164,0.0033069332],"category_scores_gemma":[0.006261996,0.00016574172,0.00040435503,0.0033659216,0.0006604748,0.0007263335,0.0014011846,0.0009179281,0.00017835053],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002170062,0.00009174926,0.97000676,0.000045141423,0.00008209304,0.00024775654,0.0013371233,0.0003702006,0.00014550654,0.0005172362,0.01061567,0.016323833],"study_design_scores_gemma":[0.000014504189,0.000042167612,0.9934169,0.00003802833,0.000034969216,0.0002023866,0.0020524715,0.00029204265,0.00004961149,0.00008802661,0.0037459652,0.000022853312],"about_ca_topic_score_codex":0.9649385,"about_ca_topic_score_gemma":0.98604614,"teacher_disagreement_score":0.03506148,"about_ca_system_score_codex":0.03472644,"about_ca_system_score_gemma":0.034892287,"threshold_uncertainty_score":0.25195915},"labels":[],"label_agreement":null},{"id":"W3048109011","doi":"10.1016/j.urolonc.2020.07.017","title":"Primary Ta high grade bladder tumors: Determination of the risk of progression","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary; Université de Montréal","funders":"","keywords":"Medicine; Bladder cancer; Concomitant; Internal medicine; Tumor progression; Proportional hazards model; Carcinoma in situ; Stage (stratigraphy); Disease; Lower risk; Cancer; Oncology; Gastroenterology; Urology; Confidence interval","score_opus":0.026999872523391658,"score_gpt":0.30548152352513847,"score_spread":0.2784816510017468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048109011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98831695,0.0040883077,0.0013508489,0.00019630691,0.00004114271,0.00003210082,0.0006679756,0.000043817203,0.00526262],"genre_scores_gemma":[0.9979578,0.00059151376,0.0005173277,0.000021046111,0.000039195318,0.000007737796,0.00020688873,0.0000052623514,0.000653237],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996736,0.00009734142,0.000035219,0.000057194986,0.000091940914,0.0000445531],"domain_scores_gemma":[0.99857855,0.0004388123,0.00049214176,0.0001004894,0.00019106637,0.00019899104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077076536,0.00022322494,0.00039266396,0.0010495676,0.00027565626,0.0009078758,0.0002778452,0.0004606037,0.001818394],"category_scores_gemma":[0.0023268103,0.00019022552,0.00042229547,0.001027943,0.00020919902,0.00047064156,0.00037703986,0.00061992434,0.0003537612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059092476,0.000031846637,0.9878929,0.000032894553,0.000074343894,0.00018291622,0.000046114183,0.00019804346,0.001166185,0.000058892525,0.00016308736,0.009561708],"study_design_scores_gemma":[0.000005707858,0.00034419968,0.9957337,0.000013291179,0.0001085801,0.0013473353,0.00010853372,0.0009228846,0.0006325746,0.00014717164,0.00062759797,0.000008532712],"about_ca_topic_score_codex":0.0012225365,"about_ca_topic_score_gemma":0.0015704257,"teacher_disagreement_score":0.001818394,"about_ca_system_score_codex":0.0003270856,"about_ca_system_score_gemma":0.00035825252,"threshold_uncertainty_score":0.006083131},"labels":[],"label_agreement":null},{"id":"W3086030493","doi":"10.1016/j.urolonc.2020.08.027","title":"Practice patterns related to prostate cancer grading: results of a 2019 Genitourinary Pathology Society clinician survey","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Calgary Laboratory Services; Université de Montréal; McGill University Health Centre; University of Calgary","funders":"National Cancer Institute","keywords":"Grading (engineering); Medicine; Prostate cancer; Genitourinary system; Biopsy; Prostate; Cribriform; Terminology; Radiology; Carcinoma; Gynecology; Pathology; Cancer; Internal medicine","score_opus":0.05662426004315956,"score_gpt":0.37113229882654486,"score_spread":0.3145080387833853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3086030493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98679525,0.0005803758,0.0001935987,0.0007785694,0.000016977978,0.00006544148,0.009714583,0.000018400673,0.0018368614],"genre_scores_gemma":[0.99062306,0.000570125,0.00034365035,0.000418321,0.000031659914,0.00010262743,0.006909311,0.000015512198,0.0009857605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977653,0.00059310364,0.00046000388,0.00038707553,0.00050960854,0.0002850156],"domain_scores_gemma":[0.98639256,0.0020314595,0.00697807,0.00027655563,0.002793217,0.0015280903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001719811,0.00021489941,0.00029912256,0.002489255,0.00048778785,0.0009236641,0.00067747885,0.00076073216,0.002873976],"category_scores_gemma":[0.008395516,0.00035743395,0.0005435557,0.004683823,0.00026629298,0.0014798992,0.0015687556,0.0005548801,0.00088031765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037495436,0.00004927526,0.99668914,0.00003877054,0.00002944954,0.000026669228,0.0004264473,0.000038755385,0.00007920293,0.000010638944,0.00083302887,0.0017411424],"study_design_scores_gemma":[0.00000371037,0.000029098139,0.99856997,0.000017560771,0.000007096546,0.00006040048,0.0007799288,0.00013653674,0.000027363367,0.000005538789,0.00035834117,0.000004395551],"about_ca_topic_score_codex":0.049089514,"about_ca_topic_score_gemma":0.07438255,"teacher_disagreement_score":0.049089514,"about_ca_system_score_codex":0.0019092952,"about_ca_system_score_gemma":0.0017028667,"threshold_uncertainty_score":0.09760755},"labels":[],"label_agreement":null},{"id":"W3087207786","doi":"10.1016/j.urolonc.2020.08.032","title":"The suggested chemopreventive association of metformin with prostate cancer in diabetic patients","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; University Health Network; Princess Margaret Cancer Centre; Institute for Clinical Evaluative Sciences","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Metformin; Medicine; Prostate cancer; Internal medicine; Interquartile range; Androgen deprivation therapy; Proportional hazards model; Hazard ratio; Diabetes mellitus; Population; Cohort; Comorbidity; Cancer; Oncology; Endocrinology; Insulin; Confidence interval","score_opus":0.008165616279768346,"score_gpt":0.25188240204449636,"score_spread":0.24371678576472802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087207786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9545242,0.03373345,0.0013813175,0.002107978,0.000426121,0.000028247445,0.0006117206,0.000043838627,0.0071431636],"genre_scores_gemma":[0.9911821,0.0054976037,0.001065863,0.00053448556,0.00032062942,0.00000876483,0.00018666316,0.0000061598575,0.001197758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974686,0.00010643628,0.000022947008,0.000053788463,0.000041093743,0.000028813633],"domain_scores_gemma":[0.9988827,0.0004737968,0.00030659078,0.00009962054,0.00011723837,0.00011993519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072125404,0.0002551998,0.00022026588,0.0008747389,0.00027874042,0.0006506702,0.00027430634,0.00046812344,0.0031440896],"category_scores_gemma":[0.0028440023,0.00019055408,0.0005732141,0.0012288633,0.00018475004,0.00020595046,0.00018375933,0.0007885529,0.00015716927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018764675,0.00022737772,0.9629277,0.00023521353,0.00045130492,0.0005357743,0.000061682455,0.00010470567,0.004793101,0.0006409267,0.00045928513,0.02768659],"study_design_scores_gemma":[0.000050056293,0.0004402239,0.9936579,0.00004877951,0.00056387874,0.0006981497,0.00006809441,0.00024774027,0.0016015563,0.0003272109,0.0022874046,0.000008880537],"about_ca_topic_score_codex":0.0018285278,"about_ca_topic_score_gemma":0.0026994632,"teacher_disagreement_score":0.0031440896,"about_ca_system_score_codex":0.0002391543,"about_ca_system_score_gemma":0.00040093414,"threshold_uncertainty_score":0.010518014},"labels":[],"label_agreement":null},{"id":"W3087255447","doi":"10.1016/j.urolonc.2020.08.012","title":"Comparison of Mexican-American vs Caucasian prostate cancer active surveillance candidates","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Demography; Logistic regression; Ethnic group; Prostate cancer; Epidemiology; Internal medicine; Relative risk; Surveillance, Epidemiology, and End Results; Cancer; Confidence interval; Cancer registry","score_opus":0.038696805411728714,"score_gpt":0.36801316104880766,"score_spread":0.32931635563707895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087255447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987198,0.00020295958,0.000023840737,0.000051016177,0.000013498217,0.000007361944,0.00012463403,0.0000014764313,0.0008555285],"genre_scores_gemma":[0.999501,0.00007464044,0.000012142655,0.000043984517,0.000014286043,0.0000050523395,0.00013853991,0.0000014629156,0.00020881668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996612,0.000093690294,0.000026805677,0.000065799955,0.000039794155,0.00011267974],"domain_scores_gemma":[0.99911267,0.00023164577,0.00026377742,0.000031529748,0.00007642466,0.00028383677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043813494,0.00018667163,0.0003804773,0.00061838,0.00041115217,0.0006485679,0.00031945843,0.00039980665,0.0048078676],"category_scores_gemma":[0.0021759372,0.00016048444,0.0005203997,0.00061345904,0.00019559002,0.00050736323,0.0003733526,0.00032585714,0.00039269167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016370375,0.0007190277,0.9690099,0.000078859906,0.00036760542,0.0003642264,0.00045593214,0.00010095632,0.0021498983,0.00014287802,0.0006308702,0.009609514],"study_design_scores_gemma":[0.00022724217,0.0019727615,0.9946943,0.000017925515,0.00018256425,0.00021218359,0.0017048342,0.00020344481,0.00012730535,0.000047049067,0.0006017211,0.000008617539],"about_ca_topic_score_codex":0.0039834296,"about_ca_topic_score_gemma":0.004292284,"teacher_disagreement_score":0.0048078676,"about_ca_system_score_codex":0.0002368296,"about_ca_system_score_gemma":0.00026873843,"threshold_uncertainty_score":0.016083896},"labels":[],"label_agreement":null},{"id":"W3087397625","doi":"10.1016/j.urolonc.2020.08.013","title":"Association of preoperative serum De Ritis ratio with oncological outcomes in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); Université de Montréal","funders":"","keywords":"Medicine; Hazard ratio; Renal cell carcinoma; Confidence interval; Proportional hazards model; Internal medicine; Nephrectomy; Urology; Concordance; Gastroenterology; Population; Carcinoma; Oncology; Surgery; Kidney","score_opus":0.0250208082716316,"score_gpt":0.2748793186329744,"score_spread":0.24985851036134277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087397625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992951,0.00038950323,0.00008078148,0.000039011327,0.000004048418,0.0000024430726,0.000047861307,0.0000025034806,0.00013869748],"genre_scores_gemma":[0.9998265,0.00004834438,0.000035634337,0.0000067365354,0.0000057145417,0.0000013632616,0.00004994673,4.4794638e-7,0.00002536191],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968445,0.00009622637,0.000039642386,0.000054922235,0.00007461037,0.000050148006],"domain_scores_gemma":[0.9983669,0.00045530443,0.0008603944,0.00007194834,0.000070030896,0.00017555217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005926566,0.00018038214,0.00027288342,0.00036615613,0.0001677383,0.00037719446,0.00020184516,0.0003335884,0.00072934345],"category_scores_gemma":[0.0027454984,0.00013580175,0.00034271384,0.00041011444,0.0002909753,0.00023235184,0.00025893177,0.00044602042,0.00009166079],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021841515,0.000017721879,0.998431,0.000006422113,0.000035394725,0.00004953359,0.000013220797,0.00007653154,0.00017033158,0.00000723973,0.000025961235,0.0009481339],"study_design_scores_gemma":[0.000009142382,0.00014941006,0.9985544,0.0000047551202,0.000044146494,0.00032918007,0.00005088854,0.00062142266,0.00012375736,0.000028835007,0.000081244696,0.000002681774],"about_ca_topic_score_codex":0.0010451803,"about_ca_topic_score_gemma":0.0013664933,"teacher_disagreement_score":0.0010451803,"about_ca_system_score_codex":0.00025014978,"about_ca_system_score_gemma":0.00025051375,"threshold_uncertainty_score":0.0031343699},"labels":[],"label_agreement":null},{"id":"W3091682715","doi":"10.1016/j.urolonc.2020.09.001","title":"Setting the stage for bladder preservation","year":2020,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cystectomy; Bladder cancer; Medicine; Clinical trial; Radiation therapy; Quality of life (healthcare); Stage (stratigraphy); Cancer; Intensive care medicine; Surgery; Internal medicine","score_opus":0.09653550182880465,"score_gpt":0.3971286896372959,"score_spread":0.30059318780849126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091682715","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007475391,0.97024214,0.0018722326,0.016008276,0.0048716157,0.00006866922,0.00011411841,0.000043736734,0.006031584],"genre_scores_gemma":[0.015973872,0.9386254,0.004586059,0.03183871,0.0048845117,0.00010668657,0.00016330776,0.00002362188,0.0037979102],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992956,0.0002480437,0.000108424705,0.00012482,0.00013308907,0.00009008153],"domain_scores_gemma":[0.9991715,0.00043584153,0.00014532644,0.000030972165,0.00012457557,0.000091839895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019639574,0.0007641969,0.0018150787,0.0009948129,0.0007094628,0.0019856177,0.0014804143,0.0026856395,0.011320818],"category_scores_gemma":[0.0029061865,0.00029535673,0.0011679506,0.00044306534,0.0011928679,0.0051098224,0.0024930905,0.005965535,0.0023030217],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031639953,0.000098137316,0.00089130574,0.022673167,0.00018322893,0.00061503676,0.00018315154,0.0007240448,0.0011385692,0.024480425,0.0729867,0.8757098],"study_design_scores_gemma":[0.0002835123,0.00032053314,0.0028642577,0.053098343,0.00037898033,0.0035344772,0.0007770919,0.00047784083,0.0009742599,0.03797421,0.8992222,0.0000942996],"about_ca_topic_score_codex":0.0018258664,"about_ca_topic_score_gemma":0.0057187336,"teacher_disagreement_score":0.011320818,"about_ca_system_score_codex":0.0011695231,"about_ca_system_score_gemma":0.004623945,"threshold_uncertainty_score":0.037871957},"labels":[],"label_agreement":null},{"id":"W3091844070","doi":"10.1016/j.urolonc.2020.09.004","title":"The effect of sex on disease stage and survival after radical cystectomy: a population-based analysis","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Odds ratio; Logistic regression; Confidence interval; Internal medicine; Epidemiology; Cohort; Cancer; Population; Incidence (geometry); Oncology; Gynecology; Demography","score_opus":0.016878558551475357,"score_gpt":0.30555131479473396,"score_spread":0.2886727562432586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091844070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99878937,0.000403739,0.00012611714,0.00003894383,0.000011268582,0.0000050807275,0.00035792618,0.0000054954153,0.00026211797],"genre_scores_gemma":[0.9992525,0.00012560426,0.00004312371,0.000023226876,0.000017474693,0.0000061977776,0.0003488728,0.0000047996687,0.0001780485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867105,0.0005111159,0.000103314684,0.0003738981,0.00012977784,0.00021081018],"domain_scores_gemma":[0.9978557,0.0008327029,0.00047708626,0.0003717063,0.00012105067,0.00034163828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014803451,0.0005575486,0.0008203975,0.0010103504,0.0004647415,0.0009241421,0.0007327438,0.001079773,0.002935605],"category_scores_gemma":[0.0030409212,0.0006939989,0.0032861927,0.0015975793,0.00053453335,0.0010002794,0.00071562146,0.0012012292,0.0003116053],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001685608,0.000103415994,0.9947641,0.0000145239555,0.0015516565,0.00013129081,0.000060861614,0.000097448385,0.00030595655,0.000023192111,0.000105682426,0.0011563319],"study_design_scores_gemma":[0.00004631206,0.0003912049,0.99826884,0.0000031325565,0.0005013716,0.00015697813,0.00015359055,0.00031536346,0.000032223044,0.00003363909,0.00008792181,0.000009358706],"about_ca_topic_score_codex":0.0054656444,"about_ca_topic_score_gemma":0.0057411403,"teacher_disagreement_score":0.0054656444,"about_ca_system_score_codex":0.00032411155,"about_ca_system_score_gemma":0.00034578468,"threshold_uncertainty_score":0.010867715},"labels":[],"label_agreement":null},{"id":"W3092348947","doi":"10.1016/j.urolonc.2020.09.015","title":"Trends in urologic oncology clinical practice and medical education under COVID-19 pandemic: An international survey of senior clinical and academic urologists","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Pandemic; Family medicine; Attendance; Cystectomy; Prostate cancer; Bladder cancer; Coronavirus disease 2019 (COVID-19); Urology; Internal medicine; General surgery; Gynecology; Disease; Cancer","score_opus":0.3429068473975451,"score_gpt":0.5751949433908835,"score_spread":0.23228809599333838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092348947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98372126,0.002408513,0.000098163866,0.0042629894,0.00009308977,0.000041396277,0.0040566176,0.000015617303,0.00530228],"genre_scores_gemma":[0.99317497,0.0019334846,0.00017158443,0.0012998591,0.00011168545,0.00004441998,0.0020434544,0.000009984907,0.0012106352],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983668,0.00025912334,0.0002735899,0.00023136492,0.00029872736,0.00057037565],"domain_scores_gemma":[0.98838484,0.0009992514,0.0046465406,0.0001628707,0.001397089,0.0044094673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010595461,0.00012917255,0.00022667932,0.0021539181,0.0007471759,0.0013008434,0.00051364035,0.00083168154,0.004006406],"category_scores_gemma":[0.005635834,0.00021134764,0.00032895853,0.0045848493,0.00038372612,0.001334197,0.0015940663,0.0010605544,0.0005370836],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025086669,0.000050159248,0.9925701,0.000053644697,0.000015985432,0.00005003336,0.001116647,0.000019374682,0.00010402143,0.00010142028,0.0015668818,0.0043267654],"study_design_scores_gemma":[0.0000018538404,0.000034117493,0.9924022,0.000051391686,0.0000044895664,0.00010703482,0.004890001,0.00004733959,0.00003114778,0.000016903035,0.0024078656,0.0000057480283],"about_ca_topic_score_codex":0.02423608,"about_ca_topic_score_gemma":0.036956243,"teacher_disagreement_score":0.02423608,"about_ca_system_score_codex":0.0011301726,"about_ca_system_score_gemma":0.0034819231,"threshold_uncertainty_score":0.048189998},"labels":[],"label_agreement":null},{"id":"W3093499426","doi":"10.1016/j.urolonc.2020.10.010","title":"Oncological outcomes of pathologically organ-confined, lymph node-positive prostate cancer after radical prostatectomy","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Biochemical recurrence; Hazard ratio; Lymph node; Urology; Proportional hazards model; Stage (stratigraphy); Lymph; Internal medicine; Oncology; Cancer; Pathology; Confidence interval","score_opus":0.023130720269543412,"score_gpt":0.30448747321377506,"score_spread":0.2813567529442316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093499426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960418,0.0010513521,0.000075428696,0.00015671637,0.000032514854,0.000008113704,0.0009019767,0.0000053172616,0.0017268518],"genre_scores_gemma":[0.9989543,0.00011888718,0.000010886082,0.00002613608,0.000026615375,0.0000018824888,0.00065088423,0.0000017115003,0.00020871978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956244,0.000096373326,0.000037257276,0.00006867565,0.000090019945,0.00014521218],"domain_scores_gemma":[0.99818665,0.0004008698,0.00062484515,0.00007940254,0.00015949117,0.0005488235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051014364,0.00019802459,0.00032268808,0.0007552771,0.00037802674,0.00075994607,0.00056221563,0.0004034698,0.0026263325],"category_scores_gemma":[0.0031631782,0.00012759908,0.00083309977,0.00078983925,0.00041177566,0.0007423073,0.00082471984,0.0006883456,0.00023823009],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009935371,0.00008261338,0.9912341,0.000038888495,0.00018927496,0.0002023807,0.00011883037,0.0005562952,0.00026021613,0.0000880536,0.00044017864,0.0057956125],"study_design_scores_gemma":[0.0000074166696,0.00014776073,0.9990702,0.0000054346965,0.00006318464,0.00015841593,0.00013167039,0.00011952936,0.000040274557,0.00008317013,0.00016594153,0.0000069864655],"about_ca_topic_score_codex":0.00483073,"about_ca_topic_score_gemma":0.009897985,"teacher_disagreement_score":0.00483073,"about_ca_system_score_codex":0.0007378429,"about_ca_system_score_gemma":0.00053204875,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W3093554611","doi":"10.1016/j.urolonc.2020.10.001","title":"Refining assessment of response to radiation-based therapy for muscle-invasive bladder cancer: Is post-treatment tumor bed biopsy always necessary?","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Urine cytology; Bladder cancer; Cystoscopy; Cystectomy; Biopsy; Lymphovascular invasion; Urology; Interquartile range; Hazard ratio; Population; Cancer; Radiology; Internal medicine; Urinary system; Confidence interval; Metastasis","score_opus":0.04787274848590643,"score_gpt":0.36433957875137035,"score_spread":0.3164668302654639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093554611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90054953,0.044936128,0.022460764,0.012249019,0.0016773539,0.0004039993,0.00075115374,0.00057125423,0.016400747],"genre_scores_gemma":[0.9685394,0.006003253,0.020538118,0.002430395,0.00056304096,0.00013415825,0.00043888707,0.00009602892,0.0012566318],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99633706,0.0017038115,0.0005823845,0.00030024425,0.0007985794,0.00027797965],"domain_scores_gemma":[0.9888103,0.0049820407,0.0014716082,0.000734931,0.0036183144,0.0003828618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010563204,0.0005890314,0.0015393081,0.0011483342,0.00046107834,0.0017360424,0.0011286583,0.0013461135,0.0012666121],"category_scores_gemma":[0.028092222,0.00035436236,0.00080882927,0.0007283138,0.00072594045,0.0014944196,0.0006366076,0.0014876002,0.0009034334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026580018,0.0002868771,0.6999084,0.00083657115,0.00039945036,0.00067572604,0.0009353021,0.0020598765,0.014215266,0.00040923574,0.0060401955,0.27157503],"study_design_scores_gemma":[0.00013038437,0.0037501669,0.9319495,0.0012002657,0.00095739216,0.0033432492,0.0031976437,0.00982191,0.018220652,0.0018414652,0.025446171,0.00014118147],"about_ca_topic_score_codex":0.0045224857,"about_ca_topic_score_gemma":0.0077030645,"teacher_disagreement_score":0.010563204,"about_ca_system_score_codex":0.0006992662,"about_ca_system_score_gemma":0.0009040548,"threshold_uncertainty_score":0.055864275},"labels":[],"label_agreement":null},{"id":"W3095069291","doi":"10.1016/j.urolonc.2020.10.013","title":"Management of urologic cancers during the pandemic and potential impact of treatment deferrals on outcomes","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Pandemic; Context (archaeology); Triage; Intensive care medicine; Adverse effect; Health care; Disease; General surgery; Medical emergency; Coronavirus disease 2019 (COVID-19); Internal medicine; Infectious disease (medical specialty)","score_opus":0.08728387866296372,"score_gpt":0.4032034186392693,"score_spread":0.31591953997630556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095069291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45815894,0.06644855,0.0010759857,0.39227933,0.0027184081,0.00012589058,0.002971362,0.00005286256,0.076168716],"genre_scores_gemma":[0.9612606,0.025858928,0.00076103443,0.008114176,0.0016924833,0.00005993894,0.0008263937,0.000024389079,0.001401969],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99704343,0.0012217293,0.00014564005,0.00014745648,0.0005553175,0.0008865244],"domain_scores_gemma":[0.99307233,0.0019866643,0.0019144459,0.00014792103,0.0010010189,0.0018775854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031917242,0.00012981416,0.00028669412,0.0006428966,0.001141652,0.0021812017,0.0007578643,0.00070929003,0.0058733793],"category_scores_gemma":[0.023229642,0.00013925525,0.00047165542,0.001263977,0.00061355927,0.0014855306,0.0019537068,0.0022389211,0.00030759582],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053064735,0.00071467576,0.52084875,0.001272538,0.00021916567,0.001429428,0.0060197813,0.0023141322,0.00037636998,0.020679368,0.07667563,0.36891955],"study_design_scores_gemma":[0.000114796094,0.000720685,0.81377876,0.0052585206,0.00019444925,0.0022494115,0.037876654,0.0017360087,0.00055947603,0.02091079,0.11645797,0.00014244363],"about_ca_topic_score_codex":0.026615817,"about_ca_topic_score_gemma":0.036757458,"teacher_disagreement_score":0.026615817,"about_ca_system_score_codex":0.0034532496,"about_ca_system_score_gemma":0.00851658,"threshold_uncertainty_score":0.05292183},"labels":[],"label_agreement":null},{"id":"W3099977035","doi":"10.1016/j.urolonc.2020.10.011","title":"External beam radiation therapy improves survival in elderly metastatic prostate cancer patients with low PSA","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostate cancer; Proportional hazards model; Urology; External beam radiotherapy; Prostate-specific antigen; Radiation therapy; Internal medicine; Hazard ratio; Oncology; Cancer; Confidence interval","score_opus":0.02171346201538671,"score_gpt":0.29368099489607186,"score_spread":0.27196753288068515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3099977035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801271,0.015576376,0.00012753224,0.00074065715,0.0001332933,0.000015369871,0.00031152111,0.000024493056,0.0029435428],"genre_scores_gemma":[0.99325305,0.004499284,0.00015246813,0.0004761257,0.00018870643,0.000007109457,0.0003370811,0.0000043878485,0.0010817226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99994063,0.000019262072,0.0000062291288,0.000007056495,0.00001396829,0.000012852002],"domain_scores_gemma":[0.9997682,0.00006575769,0.00008235907,0.000008532028,0.000025346793,0.00004978143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025420196,0.00015302683,0.00039465743,0.00019030515,0.00013617911,0.00023030439,0.00010642684,0.00017300817,0.002087696],"category_scores_gemma":[0.0011938154,0.00006418982,0.0003494939,0.00025129385,0.00007349421,0.0001829785,0.00016495169,0.00021228637,0.000313291],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018472109,0.0011470838,0.62562007,0.0005920345,0.00098581,0.0007652068,0.00035073704,0.0006993396,0.008318252,0.00009332685,0.007749863,0.3352061],"study_design_scores_gemma":[0.000394513,0.0032268749,0.99122417,0.000046429206,0.00048604776,0.0006339766,0.00015303596,0.0001656082,0.00041418918,0.000085086904,0.0031612774,0.000008828307],"about_ca_topic_score_codex":0.0010241527,"about_ca_topic_score_gemma":0.0027549395,"teacher_disagreement_score":0.002087696,"about_ca_system_score_codex":0.00012922195,"about_ca_system_score_gemma":0.00020336917,"threshold_uncertainty_score":0.0069839954},"labels":[],"label_agreement":null},{"id":"W3103876657","doi":"10.1016/j.urolonc.2020.11.005","title":"Impact of preoperative serum albumin-globulin ratio on disease outcome after radical cystectomy for urothelial carcinoma of the bladder","year":2020,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"European Association of Urology","keywords":"Medicine; Cystectomy; Confidence interval; Internal medicine; Odds ratio; Bladder cancer; Logistic regression; Urology; Proportional hazards model; Receiver operating characteristic; Gastroenterology; Retrospective cohort study; Albumin; Surgery; Oncology; Cancer","score_opus":0.049237439794161494,"score_gpt":0.3717106869188211,"score_spread":0.3224732471246596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3103876657","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99924433,0.00041573,0.000065641354,0.000030252802,0.000004430194,0.000002143904,0.000103743056,0.0000034935201,0.00013033222],"genre_scores_gemma":[0.9997925,0.000044827906,0.000030388885,0.0000053797257,0.0000059466865,0.0000013587919,0.000095144984,8.449354e-7,0.000023548731],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994221,0.00021397344,0.00006683999,0.00010640921,0.00011108071,0.00007969628],"domain_scores_gemma":[0.9964005,0.0014094579,0.0013969364,0.00020189973,0.00021324618,0.0003779917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014075716,0.0002561268,0.00029118068,0.0006291116,0.0002069751,0.00058349426,0.00032725403,0.00031383033,0.0009245886],"category_scores_gemma":[0.0045473548,0.00013442297,0.00042721545,0.000634487,0.00036583177,0.00039659636,0.0003773369,0.00042073225,0.00013969907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015326255,0.000011989188,0.99868447,0.0000060223997,0.00004117232,0.00003171789,0.000010537966,0.00006266986,0.0000756851,0.0000046896284,0.000023351691,0.00089440413],"study_design_scores_gemma":[0.000004052355,0.00009346193,0.9989837,0.000004709636,0.000048824473,0.00021413247,0.000033668704,0.00047238663,0.00006937624,0.000020922644,0.00005200963,0.000002692],"about_ca_topic_score_codex":0.0012759805,"about_ca_topic_score_gemma":0.0013657635,"teacher_disagreement_score":0.0014075716,"about_ca_system_score_codex":0.00028637532,"about_ca_system_score_gemma":0.00034512632,"threshold_uncertainty_score":0.0074440837},"labels":[],"label_agreement":null},{"id":"W3105237244","doi":"10.1016/j.urolonc.2020.10.009","title":"At a time of global BCG shortage, attempts at optimizing BCG dose and schedule is no longer the answer","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Immune responses and vaccinations","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Economic shortage; Schedule; Medicine; Computer science","score_opus":0.022579920996437623,"score_gpt":0.28004082086280246,"score_spread":0.25746089986636483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3105237244","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0150614735,0.21050906,0.016939953,0.73075724,0.017193032,0.00006994966,0.00040490687,0.00034198505,0.008722386],"genre_scores_gemma":[0.293073,0.23178777,0.04487865,0.3525463,0.05435745,0.00020017056,0.000963942,0.00063798076,0.021554766],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99807775,0.0007179849,0.00017365065,0.00033327713,0.0003754014,0.00032200335],"domain_scores_gemma":[0.9880001,0.0057578823,0.0016295634,0.0007713797,0.0018598932,0.0019811802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007243399,0.00060677045,0.0018495709,0.00043561394,0.0007711466,0.0031806838,0.0010887816,0.0037567108,0.012082716],"category_scores_gemma":[0.013525606,0.0002570655,0.0006010068,0.0005356143,0.0029305946,0.003656932,0.0015175432,0.012152481,0.0046484713],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003074807,0.0010520353,0.014858679,0.0040291976,0.0005199677,0.00075339136,0.0005911962,0.0037434443,0.026602892,0.07484919,0.25712192,0.6128033],"study_design_scores_gemma":[0.0003766611,0.0025434508,0.015993178,0.0034440926,0.00038594726,0.001940934,0.0033102678,0.0020824226,0.008695014,0.0891967,0.871804,0.00022736017],"about_ca_topic_score_codex":0.0020393536,"about_ca_topic_score_gemma":0.0022799845,"teacher_disagreement_score":0.012082716,"about_ca_system_score_codex":0.002011455,"about_ca_system_score_gemma":0.003317666,"threshold_uncertainty_score":0.04042077},"labels":[],"label_agreement":null},{"id":"W3105853448","doi":"10.1016/j.urolonc.2020.10.006","title":"Systemic therapy in bladder preservation","year":2020,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Chemotherapy; Context (archaeology); Oncology; Neoadjuvant therapy; Cisplatin; Pathological; Disease; Internal medicine; Urology; Cancer","score_opus":0.09249236188668081,"score_gpt":0.37967331609766786,"score_spread":0.28718095421098705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3105853448","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000072758565,0.9990414,0.00003851922,0.00016110204,0.00014466333,0.0000027813617,0.0000063957873,0.0000022292395,0.00053029007],"genre_scores_gemma":[0.00073744036,0.9985832,0.000077037155,0.00022222647,0.00011586693,0.000004676826,0.000014472341,9.964367e-7,0.00024420963],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997732,0.000065833876,0.00003681044,0.000034264893,0.00007346185,0.000016491984],"domain_scores_gemma":[0.9997193,0.00017653742,0.000040433235,0.000008480667,0.000042281106,0.000012951937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052229525,0.0005432014,0.001076634,0.0013246704,0.000222968,0.0007456299,0.0006302636,0.0009217397,0.0037925404],"category_scores_gemma":[0.00081800064,0.00017800769,0.0006750678,0.0012884493,0.000485715,0.0009034933,0.0005918728,0.0015827474,0.0011925867],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000070518196,0.000041060666,0.00012563221,0.02767292,0.00014114061,0.00013083383,0.00006154855,0.0002616246,0.00060916157,0.0032147602,0.019419447,0.94825137],"study_design_scores_gemma":[0.00004214938,0.00011900616,0.0010336018,0.01514508,0.00024107081,0.0018749107,0.00006189374,0.0000900583,0.0003635606,0.0021821365,0.9788304,0.000016164651],"about_ca_topic_score_codex":0.0008991941,"about_ca_topic_score_gemma":0.0017949338,"teacher_disagreement_score":0.0037925404,"about_ca_system_score_codex":0.0006121942,"about_ca_system_score_gemma":0.0010822234,"threshold_uncertainty_score":0.012687385},"labels":[],"label_agreement":null},{"id":"W3108115836","doi":"10.1016/j.urolonc.2020.07.028","title":"A polymeric paste-drug formulation for local treatment of upper tract urothelial carcinoma","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Gemcitabine; Medicine; Urology; Renal pelvis; Upper urinary tract; Pharmacokinetics; Urinary system; Bladder cancer; Urine; Cmax; Ureter; Cancer; Internal medicine","score_opus":0.04201112083085735,"score_gpt":0.3156303040649413,"score_spread":0.27361918323408396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108115836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9538236,0.02223929,0.014314354,0.0005551325,0.0005016695,0.00041596981,0.00015524308,0.00026842178,0.0077262097],"genre_scores_gemma":[0.984761,0.004339109,0.0073234728,0.00015879622,0.00009293487,0.000066866,0.00008119417,0.000034705834,0.0031418991],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999521,0.000012592117,0.0000031662453,0.000011000535,0.000014053016,0.0000070677083],"domain_scores_gemma":[0.999944,0.000019134286,0.000010230395,0.000003462996,0.0000068754007,0.000016248243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019323418,0.00016590743,0.0002566105,0.00031077815,0.00015025045,0.0001600889,0.0002449931,0.00028438994,0.0024498014],"category_scores_gemma":[0.00021032341,0.0000900236,0.00021365519,0.00016652094,0.00014372425,0.00026598977,0.00017230207,0.0005194039,0.00038096853],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022065295,0.001418681,0.00031416456,0.0007473952,0.000037553073,0.0008106572,0.00007719313,0.00053722336,0.7555765,0.00053384545,0.0010074422,0.23673289],"study_design_scores_gemma":[0.0034899693,0.073085785,0.01717623,0.0001881928,0.00050662056,0.0062165814,0.00017873199,0.006633651,0.84299195,0.0004933763,0.048968837,0.00007006899],"about_ca_topic_score_codex":0.0002279796,"about_ca_topic_score_gemma":0.0005029181,"teacher_disagreement_score":0.0024498014,"about_ca_system_score_codex":0.000083506944,"about_ca_system_score_gemma":0.0001253748,"threshold_uncertainty_score":0.00819546},"labels":[],"label_agreement":null},{"id":"W3110787147","doi":"10.1016/j.urolonc.2020.11.031","title":"The effect of race/ethnicity on histological subtype distribution, stage at presentation and cancer specific survival in urethral cancer","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Urinary and Genital Oncology Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Stage (stratigraphy); Cancer; Hazard ratio; Epidemiology; Ethnic group; Internal medicine; Adenocarcinoma; Incidence (geometry); Proportional hazards model; Demography; Oncology; Gynecology; Confidence interval","score_opus":0.04864423327473306,"score_gpt":0.34981237097133244,"score_spread":0.3011681376965994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110787147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99835336,0.0004947655,0.000049020397,0.00013485424,0.000021279044,0.0000019856648,0.00015582661,0.000002002701,0.0007869325],"genre_scores_gemma":[0.99921143,0.0001483647,0.00003296334,0.0000447265,0.00002500619,0.0000019636823,0.00011003763,0.0000055448795,0.00041989423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990669,0.00043397932,0.000060478334,0.00013635946,0.000064795844,0.00023748286],"domain_scores_gemma":[0.99723524,0.0011121344,0.00054164615,0.00026984574,0.00017409977,0.0006670783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012654087,0.00020275098,0.00034474782,0.00054917054,0.0006398884,0.0008437652,0.00050201913,0.0005048068,0.004176576],"category_scores_gemma":[0.004384126,0.00028868899,0.0010791986,0.0007577351,0.00043475212,0.0007615812,0.00062928314,0.0008226881,0.00038876222],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048683083,0.000055576827,0.9966968,0.0000074075515,0.00012939707,0.00008296147,0.00008736436,0.000038438102,0.00024464115,0.00003387298,0.00008783779,0.0020490077],"study_design_scores_gemma":[0.000005483032,0.000097275675,0.9991147,0.0000053673893,0.00006731538,0.00010363033,0.0002725093,0.000120191275,0.000042716012,0.00004174393,0.00012535253,0.000003727674],"about_ca_topic_score_codex":0.008798758,"about_ca_topic_score_gemma":0.016655384,"teacher_disagreement_score":0.008798758,"about_ca_system_score_codex":0.00034152874,"about_ca_system_score_gemma":0.00062091387,"threshold_uncertainty_score":0.017495096},"labels":[],"label_agreement":null},{"id":"W3110798720","doi":"10.1016/j.urolonc.2020.10.048","title":"FBXW7 loss of function contributes to worse overall survival and is associated with accumulation of MYC in muscle invasive bladder cancer","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Biology; Bladder cancer; Downregulation and upregulation; Cancer research; Ubiquitin ligase; Suppressor; Gene; Cancer; Ubiquitin; Genetics","score_opus":0.06418824028544855,"score_gpt":0.33735431776999364,"score_spread":0.2731660774845451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110798720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957541,0.0024104381,0.00037977178,0.00015785788,0.000025471652,0.00000467293,0.00044869713,0.000030823554,0.0007881845],"genre_scores_gemma":[0.99708194,0.00077334355,0.00019959871,0.000068260284,0.000024036359,0.00000530223,0.00055322214,0.000011255801,0.0012830235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998871,0.000014152323,0.000008724358,0.000025111334,0.000036402977,0.000028587634],"domain_scores_gemma":[0.99958247,0.00004816684,0.00022340874,0.000024361068,0.00003720682,0.000084450665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022366893,0.00031861162,0.00030391564,0.0007952845,0.00023973783,0.0006435571,0.00030238472,0.00054059795,0.0023111447],"category_scores_gemma":[0.0005322942,0.00021625211,0.0002892094,0.0005889337,0.00033021442,0.0002662478,0.00034018877,0.00051210413,0.00038673586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036754608,0.00019992463,0.69059247,0.00022214917,0.00047946733,0.003380395,0.00015273754,0.0007460485,0.26623762,0.0005668514,0.0021399003,0.03160707],"study_design_scores_gemma":[0.000024815354,0.00017199399,0.97743875,0.000026186079,0.00014942528,0.0035034462,0.00016710995,0.0009610608,0.014839117,0.0003371959,0.0023666965,0.000014209113],"about_ca_topic_score_codex":0.0011048849,"about_ca_topic_score_gemma":0.0011190787,"teacher_disagreement_score":0.0023111447,"about_ca_system_score_codex":0.0002431014,"about_ca_system_score_gemma":0.00020664284,"threshold_uncertainty_score":0.007731557},"labels":[],"label_agreement":null},{"id":"W3111048201","doi":"10.1016/j.urolonc.2020.10.067","title":"Organotypic & in vitro monolayer modeling of urothelial carcinoma gives different cellular responses to proteinase activated receptor (PAR) agonism/antagonism","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Cell biology; Cell culture; Proteases; Biology; Autocrine signalling; Paracrine signalling; Receptor; Cell migration; Cell growth; Apoptosis; Chemistry; Cancer research; Biochemistry","score_opus":0.04893705349364525,"score_gpt":0.28969790967068587,"score_spread":0.24076085617704063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111048201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9201634,0.0059493356,0.039155107,0.00091789453,0.0007942079,0.0002549414,0.0061951415,0.0004480202,0.0261219],"genre_scores_gemma":[0.9660872,0.0024587256,0.018067833,0.0003008335,0.000064836946,0.00019824217,0.0023573777,0.00006828549,0.010396503],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993117,0.00012192085,0.000062337094,0.00012606413,0.00020682848,0.00017123805],"domain_scores_gemma":[0.99959165,0.00011812623,0.00005419168,0.00011570719,0.000067585184,0.00005274534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004420358,0.00042299327,0.00042271437,0.00030090252,0.00043765496,0.0007486281,0.000383869,0.0005721892,0.0034898059],"category_scores_gemma":[0.00024656174,0.00031165106,0.0006500844,0.00039046872,0.00029703864,0.00055220095,0.00037314196,0.0012010908,0.0017385681],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036637927,0.00015966667,0.00072338537,0.0001823694,0.000029742298,0.00043858722,0.00017903591,0.00054288143,0.99358904,0.00057260384,0.00045760957,0.0027587325],"study_design_scores_gemma":[0.000021862135,0.00062133255,0.009439237,0.00001794027,0.00005069374,0.0004975291,0.00024674216,0.0027707068,0.97739834,0.00012922416,0.008788915,0.000017566836],"about_ca_topic_score_codex":0.0024731737,"about_ca_topic_score_gemma":0.0038719885,"teacher_disagreement_score":0.0034898059,"about_ca_system_score_codex":0.0003285495,"about_ca_system_score_gemma":0.0002813216,"threshold_uncertainty_score":0.011674523},"labels":[],"label_agreement":null},{"id":"W3111074218","doi":"10.1016/j.urolonc.2020.10.060","title":"Investigating sexual dimorphism in the tumour immune microenvironment of non-muscle invasive bladder cancer","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Immune system; Bladder cancer; Immune checkpoint; Cytotoxic T cell; Biology; CD163; Tissue microarray; Tumor microenvironment; CD8; Stromal cell; Cancer research; Immunotherapy; Immunology; Cancer; Pathology; Immunohistochemistry; Phenotype; Medicine; Gene","score_opus":0.03695989515403326,"score_gpt":0.3048531442562163,"score_spread":0.26789324910218304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111074218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948679,0.0022577944,0.00039500973,0.000121617275,0.000024504852,0.000015784371,0.00022777657,0.0000039496545,0.0020856059],"genre_scores_gemma":[0.99651504,0.0011046873,0.00027374996,0.00016538112,0.000033975273,0.000021344884,0.00019397122,0.0000059437434,0.0016859658],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998419,0.00005609588,0.00000813411,0.000027611713,0.000035267956,0.00003097108],"domain_scores_gemma":[0.9997589,0.00007988533,0.00005516134,0.000025230991,0.000033541673,0.00004730152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044105592,0.000067706045,0.00013268137,0.00028816515,0.00011684668,0.0003938019,0.00015507847,0.00014564923,0.0025440557],"category_scores_gemma":[0.00062709214,0.000057856087,0.00012676786,0.0003276152,0.00019637318,0.00018944826,0.00021999009,0.00030764772,0.00019846483],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002654676,0.0004975163,0.41998652,0.0003786403,0.00015578525,0.0010205964,0.0016247468,0.00033245026,0.45949057,0.0023224414,0.0013082458,0.11022781],"study_design_scores_gemma":[0.000025045441,0.0009346721,0.96005255,0.000034659126,0.000044829954,0.0014710102,0.0011761842,0.00038617488,0.028996387,0.0006932948,0.0061690393,0.000016095393],"about_ca_topic_score_codex":0.00040028928,"about_ca_topic_score_gemma":0.0005103885,"teacher_disagreement_score":0.0025440557,"about_ca_system_score_codex":0.00014642821,"about_ca_system_score_gemma":0.00019607175,"threshold_uncertainty_score":0.008510709},"labels":[],"label_agreement":null},{"id":"W3112393379","doi":"10.1016/j.urolonc.2020.08.028","title":"Creation of a primary tumor tissue expression biomarker-augmented prognostic model for patients with metastatic renal cell carcinoma","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Calgary","funders":"","keywords":"Medicine; Hazard ratio; Renal cell carcinoma; Biomarker; Clear cell renal cell carcinoma; Oncology; Nephrectomy; Survivin; Internal medicine; Proportional hazards model; Immunohistochemistry; Cancer; Cohort; Confidence interval; Pathology; Kidney","score_opus":0.04092772972940268,"score_gpt":0.28401058310950333,"score_spread":0.24308285338010066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112393379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7749778,0.00088918634,0.21370213,0.0015711193,0.00017803344,0.0001781705,0.0058251764,0.0009435319,0.0017348133],"genre_scores_gemma":[0.981952,0.00021963916,0.013701108,0.0000991106,0.00005290069,0.00008440891,0.002854664,0.000028933631,0.0010072328],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9997731,0.000056495086,0.000011482052,0.00008627174,0.000029558754,0.00004312524],"domain_scores_gemma":[0.9995529,0.00021747474,0.000058061687,0.00004007042,0.000080794154,0.00005069309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010798573,0.00077739044,0.0007096816,0.0006314053,0.00029189637,0.0010986333,0.00075391086,0.0005035249,0.0010409966],"category_scores_gemma":[0.0016859946,0.0002820717,0.0011037352,0.00044189315,0.00020521734,0.00041851692,0.00062124955,0.0008869049,0.00034579178],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001455268,0.00062575884,0.21636178,0.00013246891,0.0010153287,0.0007517633,0.00012734941,0.6709538,0.0061793206,0.0021864972,0.0048672585,0.09534346],"study_design_scores_gemma":[0.000026354965,0.0001541571,0.009486364,0.000008267184,0.00018052928,0.00013881702,0.00001918332,0.9870253,0.0007245778,0.0014081092,0.0008130294,0.0000152307],"about_ca_topic_score_codex":0.009095642,"about_ca_topic_score_gemma":0.0070836092,"teacher_disagreement_score":0.009095642,"about_ca_system_score_codex":0.0005116713,"about_ca_system_score_gemma":0.0013972897,"threshold_uncertainty_score":0.01808542},"labels":[],"label_agreement":null},{"id":"W3112713442","doi":"10.1016/j.urolonc.2020.10.051","title":"Regulation of PPARγ expression in luminal muscle invasive bladder cancer","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Transcription factor; Biology; Peroxisome proliferator-activated receptor; Nuclear receptor; Cell biology; Regulation of gene expression; Gene expression; Cancer research; Chromatin; RNA interference; Receptor; Computational biology; Gene; Genetics; RNA","score_opus":0.02429646227349081,"score_gpt":0.28543941177485926,"score_spread":0.26114294950136846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112713442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98811615,0.0062275315,0.0010184437,0.00043002045,0.000070787115,0.000012860628,0.0004390437,0.000057903162,0.0036272823],"genre_scores_gemma":[0.98512,0.0038181834,0.00058369397,0.0001818418,0.00003449229,0.000024652363,0.0006706622,0.000013552576,0.009552876],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988365,0.000018858555,0.000007270246,0.000020995385,0.000031283984,0.000037993374],"domain_scores_gemma":[0.9999523,0.000009487318,0.000007964975,0.000006210049,0.000011972854,0.000012053554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002063418,0.00013376753,0.00020896336,0.00037819814,0.0003030482,0.00056191057,0.00015445657,0.0002413653,0.0018693747],"category_scores_gemma":[0.00015274298,0.00014575427,0.00021968385,0.00043624995,0.00027519854,0.00016750062,0.00024956305,0.00048024184,0.00039248285],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008759367,0.00004230539,0.0035979357,0.00012517866,0.000014534298,0.00024454694,0.0002253534,0.00009770983,0.9874422,0.00030183667,0.0002777501,0.006754766],"study_design_scores_gemma":[0.00006598974,0.00077340874,0.2223221,0.00006844958,0.0001318614,0.0015294448,0.0022211552,0.0010989577,0.7490494,0.00049564807,0.022212787,0.00003081101],"about_ca_topic_score_codex":0.0017544843,"about_ca_topic_score_gemma":0.0020854096,"teacher_disagreement_score":0.0018693747,"about_ca_system_score_codex":0.00044918206,"about_ca_system_score_gemma":0.00029579687,"threshold_uncertainty_score":0.0062537193},"labels":[],"label_agreement":null},{"id":"W3112926203","doi":"10.1016/j.urolonc.2020.10.054","title":"Predictive and Prognostic Performance of IHC3 Immunohistochemistry-based Molecular Subtyping in Muscle-Invasive Bladder Cancer","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Subtyping; Immunohistochemistry; Tissue microarray; Bladder cancer; Cystectomy; Oncology; Pathology; Internal medicine; Medicine; Cancer; Biology","score_opus":0.02257981178748856,"score_gpt":0.29852312217719856,"score_spread":0.27594331038971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112926203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99644357,0.00094736036,0.0004280358,0.00022818301,0.000070921844,0.0000090722315,0.00026518456,0.000019727744,0.0015879044],"genre_scores_gemma":[0.9993048,0.00013671698,0.000117349555,0.000027277682,0.000032839434,0.0000024847047,0.00017864873,0.0000046597816,0.00019510838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956447,0.000117866,0.000041714993,0.00008283076,0.000076807606,0.000116298994],"domain_scores_gemma":[0.9983315,0.00057231693,0.00034560484,0.00013663646,0.00028870156,0.000325264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015442285,0.0004953499,0.00038204415,0.00074896525,0.00039956547,0.0010157189,0.00052220887,0.00069449545,0.0027347174],"category_scores_gemma":[0.0036903415,0.00020824595,0.00068952976,0.0007156139,0.000518846,0.00073276693,0.00058832276,0.00069279387,0.0005074266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006398542,0.000033423123,0.9907527,0.000017644925,0.00007881841,0.000085359425,0.000043888507,0.0004831172,0.0012931483,0.00004529364,0.00031344665,0.006213256],"study_design_scores_gemma":[0.000024840778,0.00030100875,0.9885246,0.000028734743,0.00037308605,0.0006449045,0.00039192598,0.0067631803,0.0013078928,0.00054760836,0.0010716479,0.000020534892],"about_ca_topic_score_codex":0.0023984006,"about_ca_topic_score_gemma":0.004488093,"teacher_disagreement_score":0.0027347174,"about_ca_system_score_codex":0.00037009327,"about_ca_system_score_gemma":0.0003781805,"threshold_uncertainty_score":0.009148538},"labels":[],"label_agreement":null},{"id":"W3113031067","doi":"10.1016/j.urolonc.2020.10.050","title":"Genome-wide CRISPR screen reveals SLFN11 as a potent mediator of cisplatin sensitivity in muscle-invasive bladder cancer","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bladder cancer; Cisplatin; Cystectomy; CRISPR; Cancer research; Cancer; Context (archaeology); Biology; Bioinformatics; Medicine; Oncology; Internal medicine; Chemotherapy; Gene; Genetics","score_opus":0.036363836388605394,"score_gpt":0.3192518160607323,"score_spread":0.28288797967212687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113031067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9589147,0.0035170163,0.0196815,0.0008931718,0.00043277367,0.00015120498,0.00485081,0.0014628388,0.010096018],"genre_scores_gemma":[0.9864544,0.0010497686,0.0039758408,0.00029133863,0.000011576615,0.000045727793,0.002093115,0.000088812594,0.00598945],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99971586,0.00003016527,0.000025021629,0.0000673528,0.000113689995,0.000047922986],"domain_scores_gemma":[0.9998838,0.000033860208,0.000022002683,0.000016835455,0.0000135950495,0.000029890876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025095532,0.0004098422,0.00048758538,0.00028197974,0.00028690905,0.0005521265,0.00045022072,0.0006583883,0.00338328],"category_scores_gemma":[0.0002714019,0.00022288742,0.00057566917,0.00019294769,0.0003351165,0.0001600808,0.0003965238,0.0009489322,0.000992885],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015824105,0.00006028804,0.00077458343,0.00012776788,0.000036606423,0.00032789746,0.000028335635,0.00054203434,0.9918296,0.0003070217,0.00080085703,0.0050067795],"study_design_scores_gemma":[0.000077929035,0.00041927458,0.0098305065,0.000035081714,0.00018855187,0.0011645333,0.00012123091,0.00724417,0.95845234,0.00019149063,0.02223508,0.000039827697],"about_ca_topic_score_codex":0.0021037923,"about_ca_topic_score_gemma":0.004137959,"teacher_disagreement_score":0.00338328,"about_ca_system_score_codex":0.0004314939,"about_ca_system_score_gemma":0.0004117201,"threshold_uncertainty_score":0.011318207},"labels":[],"label_agreement":null},{"id":"W3122929327","doi":"10.1016/j.urolonc.2020.12.006","title":"Defining oligometastatic hormone sensitive prostate cancer and clinically significant outcomes: Implications on clinical trials?","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Prostate cancer; Hormone therapy; Clinical trial; Androgen deprivation therapy; Oncology; Clinical Practice; Internal medicine; Medical physics; Cancer; Family medicine; Breast cancer","score_opus":0.15644910506767903,"score_gpt":0.48406610435500197,"score_spread":0.3276169992873229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3122929327","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.059035227,0.6307948,0.006455424,0.2629542,0.019145701,0.0016416453,0.0021130932,0.00006158663,0.017798247],"genre_scores_gemma":[0.5889273,0.18120001,0.033351272,0.14243028,0.042977177,0.0043214574,0.003642521,0.00016404896,0.0029858933],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.92844146,0.05555696,0.007444535,0.0032540779,0.0039604884,0.001342464],"domain_scores_gemma":[0.70278823,0.2396694,0.021153541,0.0095430175,0.018755674,0.008090114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.18100885,0.0015761685,0.011693406,0.0013755523,0.0021062936,0.00951469,0.0048535788,0.0057061315,0.009873458],"category_scores_gemma":[0.23853958,0.0009408824,0.0033606917,0.004840712,0.007522964,0.013260092,0.004503732,0.011594783,0.00152812],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057742868,0.0028335343,0.15394644,0.03454151,0.018175874,0.0002895286,0.0022472912,0.0019041508,0.0017682055,0.05016435,0.060376655,0.6160096],"study_design_scores_gemma":[0.05356586,0.033439025,0.2724504,0.055425,0.032737006,0.001394809,0.0108013805,0.004665179,0.0020050954,0.22145723,0.31084448,0.0012146484],"about_ca_topic_score_codex":0.0035182007,"about_ca_topic_score_gemma":0.008786793,"teacher_disagreement_score":0.18100885,"about_ca_system_score_codex":0.0028282339,"about_ca_system_score_gemma":0.010306476,"threshold_uncertainty_score":0.9572777},"labels":[],"label_agreement":null},{"id":"W3127046624","doi":"10.1016/j.urolonc.2021.01.021","title":"Prognostic markers in pT3 bladder cancer: A study from the international bladder cancer tissue microarray project","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Tissue microarray; Bladder cancer; Immunohistochemistry; Medicine; Oncology; Cancer; Internal medicine; Proportional hazards model; Pathology","score_opus":0.03897733067201524,"score_gpt":0.35611397639569925,"score_spread":0.317136645723684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127046624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99675804,0.0002386892,0.00031567246,0.000068958376,0.000005082691,0.000027291011,0.0021053846,0.000004901878,0.00047603247],"genre_scores_gemma":[0.9950488,0.00020735113,0.00033467347,0.00009706792,0.000011959643,0.000054536435,0.003770364,0.0000088588395,0.00046633364],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99958485,0.000110136716,0.000030211351,0.000092616334,0.00009332129,0.00008880397],"domain_scores_gemma":[0.9992679,0.00016740363,0.00017031672,0.00013663007,0.0001266876,0.00013105272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087988324,0.0002472845,0.0004144344,0.00054746465,0.0007109132,0.0006461685,0.0003986491,0.00036729127,0.0012775303],"category_scores_gemma":[0.0015316432,0.00023423428,0.00039390233,0.0018566508,0.00023892023,0.0002837608,0.0006657042,0.00047767378,0.00038000933],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002272319,0.00020802066,0.9776839,0.000051874893,0.0001950284,0.00021208265,0.00052927784,0.000115726514,0.0052668015,0.000055295684,0.001460473,0.011949178],"study_design_scores_gemma":[0.000021488207,0.00012505944,0.99776113,0.000005203674,0.00010330051,0.00027389,0.00017364242,0.00010366803,0.0004111686,0.000025819045,0.0009900562,0.0000055463015],"about_ca_topic_score_codex":0.0051128245,"about_ca_topic_score_gemma":0.0063099554,"teacher_disagreement_score":0.0051128245,"about_ca_system_score_codex":0.0003007247,"about_ca_system_score_gemma":0.000543968,"threshold_uncertainty_score":0.010166109},"labels":[],"label_agreement":null},{"id":"W3129240410","doi":"10.1016/j.urolonc.2021.01.003","title":"Comparison between small renal masses 0-2 cm vs. 2.1-4 cm in size: A population-based study","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Université de Montréal","funders":"","keywords":"Chromophobe cell; Histology; Clear cell; Renal cell carcinoma; Nephrectomy; Medicine; Population; Urology; Stage (stratigraphy); Pathology; Internal medicine; Kidney; Biology","score_opus":0.06800168052362313,"score_gpt":0.3508501710381261,"score_spread":0.282848490514503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129240410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99890745,0.00046875095,0.00012562449,0.000027246795,0.000017337063,0.000015555552,0.00016334598,0.0000022747677,0.00027228965],"genre_scores_gemma":[0.99937004,0.00013720161,0.0000485857,0.000044847482,0.000031834792,0.000017716635,0.00022163744,0.0000036291606,0.00012462234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998295,0.0006769011,0.0001749938,0.0005117895,0.00017051803,0.00017085156],"domain_scores_gemma":[0.9978194,0.00094264495,0.00060128985,0.00019503271,0.00013548111,0.00030608632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015148966,0.00072839635,0.0012712864,0.0012441819,0.0005461411,0.0010850312,0.0007951693,0.0015682268,0.0033967285],"category_scores_gemma":[0.004473928,0.00063216157,0.0019645744,0.0016727009,0.0007567577,0.0013982874,0.00072541833,0.000891387,0.00046363304],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009656761,0.0004718522,0.9840771,0.000103447455,0.0017758394,0.00030191627,0.00019908078,0.00008764539,0.0010607798,0.000074347154,0.00014512123,0.0020460642],"study_design_scores_gemma":[0.00057149696,0.0031065308,0.9934934,0.000019081092,0.0010013946,0.00044589312,0.0005294998,0.00031874477,0.0000920012,0.00014825849,0.00024943546,0.000024207591],"about_ca_topic_score_codex":0.0016259506,"about_ca_topic_score_gemma":0.0016771724,"teacher_disagreement_score":0.0033967285,"about_ca_system_score_codex":0.00035946665,"about_ca_system_score_gemma":0.00026579938,"threshold_uncertainty_score":0.011363149},"labels":[],"label_agreement":null},{"id":"W3131276948","doi":"10.1016/j.urolonc.2021.01.013","title":"Surgical challenges and considerations in Tri-modal therapy for muscle invasive bladder cancer","year":2021,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Princess Margaret Cancer Centre; University of British Columbia; University Health Network","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Cystoscopy; Lymphovascular invasion; Urology; Carcinoma in situ; Cancer; Surgery; Internal medicine; Metastasis; Urinary system","score_opus":0.14545758760256003,"score_gpt":0.4112418099487047,"score_spread":0.2657842223461446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131276948","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005167669,0.99886644,0.000056910205,0.00049001776,0.00015994995,0.0000014092021,0.0000064140772,0.0000017580522,0.0003654086],"genre_scores_gemma":[0.0005871665,0.99836653,0.00014299818,0.00043459694,0.0002901141,0.0000029780026,0.000012262134,8.6710617e-7,0.00016245194],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997141,0.00008252199,0.00005022301,0.00003701832,0.00009098454,0.000025291964],"domain_scores_gemma":[0.9991917,0.0005554895,0.000097505064,0.000011212307,0.00011494505,0.000029122923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012268061,0.00040850605,0.0010037452,0.0012652008,0.000247864,0.001197514,0.00064521586,0.0008398955,0.0028747646],"category_scores_gemma":[0.002021629,0.00019762057,0.00069126283,0.0013563682,0.00055757386,0.0012917473,0.00061474607,0.0018738875,0.0008461072],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000069915695,0.000030386984,0.0002940856,0.023183502,0.00012710386,0.00025114513,0.00007292692,0.00044214827,0.00047301032,0.0039647017,0.03014036,0.94095063],"study_design_scores_gemma":[0.00003977161,0.00014567997,0.0016330598,0.028381076,0.00040719486,0.0026243483,0.00023513426,0.00022504857,0.00023603834,0.0044749193,0.96155536,0.00004228255],"about_ca_topic_score_codex":0.0012157231,"about_ca_topic_score_gemma":0.0041961665,"teacher_disagreement_score":0.0028747646,"about_ca_system_score_codex":0.0005764109,"about_ca_system_score_gemma":0.0015527355,"threshold_uncertainty_score":0.009617031},"labels":[],"label_agreement":null},{"id":"W3133339845","doi":"10.1016/j.urolonc.2021.02.006","title":"Liposomal bupivacaine for open urological surgery: Friend or foe?","year":2021,"lang":"en","type":"letter","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Anesthesia and Pain Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Hospital Edmonton; University of Alberta Hospital","funders":"","keywords":"Bupivacaine; Medicine; Analgesic; Catheter; Anesthesia; Surgery","score_opus":0.09120725525332049,"score_gpt":0.34183390340481085,"score_spread":0.2506266481514904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133339845","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006702081,0.0016496876,0.000073338575,0.9861231,0.008096609,0.0000067869432,0.00001717096,0.000008658896,0.003354388],"genre_scores_gemma":[0.012316239,0.0033910368,0.00044946477,0.92310035,0.04785559,0.00003031043,0.000026807033,0.000028092618,0.012802228],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99777716,0.0007397682,0.00026490414,0.00024968307,0.0005661291,0.00040230664],"domain_scores_gemma":[0.99588686,0.0019143302,0.00036253763,0.000111667905,0.0006233793,0.0011011383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002265904,0.0005366049,0.0010024065,0.0005744685,0.0040784148,0.0035229633,0.0011432944,0.047829553,0.0071098604],"category_scores_gemma":[0.018931316,0.00049891975,0.0009820997,0.00056386663,0.0023587504,0.0047741253,0.0013095926,0.02812591,0.0041580442],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010296643,0.00008739289,0.001314935,0.000101586666,0.000034424826,0.01709077,0.00036854148,0.00008081781,0.0002799214,0.0051702387,0.95933735,0.016031025],"study_design_scores_gemma":[0.00019737387,0.00017606585,0.002051977,0.0008165467,0.000056071585,0.02617043,0.0022293327,0.00075146405,0.00027224296,0.01629474,0.9508873,0.00009636331],"about_ca_topic_score_codex":0.0052143596,"about_ca_topic_score_gemma":0.009837684,"teacher_disagreement_score":0.047829553,"about_ca_system_score_codex":0.004591557,"about_ca_system_score_gemma":0.0046910993,"threshold_uncertainty_score":0.033314228},"labels":[],"label_agreement":null},{"id":"W3134970731","doi":"10.1016/j.urolonc.2021.02.014","title":"Expression of programmed death ligand-1 (PD-L1) in metastatic and postchemotherapy viable testicular germ cell tumors","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Dalhousie University; Université Laval","funders":"Bristol-Myers Squibb Canada","keywords":"Germ cell tumors; Chemotherapy; Medicine; Seminoma; Teratoma; Oncology; Internal medicine; Pathology","score_opus":0.02366865629153438,"score_gpt":0.30649745881820545,"score_spread":0.2828288025266711,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134970731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985474,0.00053319323,0.00020572226,0.00002069244,0.000005997434,0.000004181126,0.00009537249,0.000007431404,0.0005800293],"genre_scores_gemma":[0.99871814,0.0001469533,0.00012234038,0.00000708348,0.0000033247002,0.000003773139,0.0001372139,0.0000018879401,0.0008593643],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999224,0.000010430771,0.0000036529862,0.000014569129,0.000023648368,0.000025288504],"domain_scores_gemma":[0.999913,0.000022232016,0.000016055263,0.000004440936,0.000015181187,0.000029154564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009768428,0.00006154663,0.000120469835,0.00037728186,0.00016989135,0.0003682544,0.00012340106,0.00016546996,0.0014337676],"category_scores_gemma":[0.00018772366,0.00008495626,0.000096726304,0.0001964447,0.00021750067,0.00019183931,0.00010586085,0.00026787253,0.00013269769],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016089326,0.00017725427,0.016525965,0.0000710159,0.000019273431,0.0005039214,0.00025204231,0.00046654567,0.97140414,0.0007356879,0.00018111024,0.008054213],"study_design_scores_gemma":[0.00016126494,0.004820551,0.2621592,0.000017230243,0.000098487944,0.0047720047,0.0015245669,0.006963869,0.7122952,0.0005346626,0.006629001,0.000023907682],"about_ca_topic_score_codex":0.0011190226,"about_ca_topic_score_gemma":0.0009141746,"teacher_disagreement_score":0.0014337676,"about_ca_system_score_codex":0.00039575432,"about_ca_system_score_gemma":0.0002294531,"threshold_uncertainty_score":0.0047963858},"labels":[],"label_agreement":null},{"id":"W3135481067","doi":"10.1016/j.urolonc.2021.01.027","title":"Utilization of focal therapy for patients discontinuing active surveillance of prostate cancer: Recommendations of an international Delphi consensus","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; Israel National Road Safety Authority","keywords":"Medicine; Consensus conference; Prostate cancer; Delphi method; Respondent; Family medicine; Medical physics; Cancer; Internal medicine; Political science","score_opus":0.04836550147418722,"score_gpt":0.3678946050771812,"score_spread":0.31952910360299397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135481067","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20398954,0.032593075,0.114724964,0.5334021,0.0086402055,0.029485054,0.0027633845,0.00054572296,0.07385595],"genre_scores_gemma":[0.586346,0.015070134,0.3246011,0.04525439,0.00095207774,0.021327373,0.002315314,0.00027956383,0.003854088],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.8648369,0.08630651,0.029834503,0.0032581312,0.0102211,0.0055429204],"domain_scores_gemma":[0.7947101,0.11016891,0.011890141,0.0058878157,0.06829493,0.009048088],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.19262286,0.0009221797,0.0015868149,0.0045555257,0.005547802,0.0050185206,0.004345729,0.0046262215,0.0028946109],"category_scores_gemma":[0.1630871,0.0009838458,0.0046678865,0.0030055873,0.003884065,0.004034997,0.007952637,0.0063999477,0.00076019997],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009823646,0.00092443737,0.1412699,0.023168573,0.0020243183,0.0013172139,0.1106819,0.0032703325,0.0055319727,0.0341487,0.14784478,0.5288356],"study_design_scores_gemma":[0.0011182526,0.0012471697,0.15851673,0.09128209,0.0027260662,0.0030137273,0.25208887,0.013202009,0.0057559777,0.052541677,0.41730124,0.0012060986],"about_ca_topic_score_codex":0.0143600935,"about_ca_topic_score_gemma":0.016936628,"teacher_disagreement_score":0.19262286,"about_ca_system_score_codex":0.010415949,"about_ca_system_score_gemma":0.05683247,"threshold_uncertainty_score":0.99563974},"labels":[],"label_agreement":null},{"id":"W3137275704","doi":"10.1016/j.urolonc.2021.01.031","title":"Impact of high-intensity local treatment on overall survival in stage IV upper tract urothelial carcinoma","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Stage (stratigraphy); Proportional hazards model; Internal medicine; Survival analysis; Intensity (physics); T-stage; Urology; Subgroup analysis; Carcinoma; Overall survival; Oncology; Hazard ratio; Urothelial carcinoma; Gastroenterology; Cancer; Confidence interval; Bladder cancer","score_opus":0.037108879440190076,"score_gpt":0.3307959744362352,"score_spread":0.2936870949960451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137275704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911602,0.0057051084,0.00012313995,0.0004993267,0.000055778066,0.000013552778,0.00011352548,0.000007468861,0.0023218177],"genre_scores_gemma":[0.99842525,0.00073199824,0.000049432598,0.00011891082,0.000055996526,0.0000063309453,0.00012313016,0.000003302064,0.00048570614],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99975044,0.00012242224,0.00001295444,0.000021429383,0.000031490923,0.00006130632],"domain_scores_gemma":[0.99952614,0.00021179709,0.0000945844,0.000024646228,0.000028153265,0.00011473553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006516715,0.000121894605,0.00030928018,0.00014486445,0.0001507546,0.00035194724,0.00020530699,0.00019118123,0.0018086496],"category_scores_gemma":[0.0012472526,0.000044369714,0.00065513107,0.00018198168,0.00025481905,0.00027182163,0.00032950655,0.0003919661,0.00008353705],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051656306,0.003559741,0.40725005,0.0007052618,0.0017804435,0.00028900208,0.00030000377,0.009243398,0.0103419535,0.0004377352,0.002165049,0.512271],"study_design_scores_gemma":[0.00050040655,0.013101966,0.9818996,0.000056724723,0.0008175978,0.00012865743,0.00023886624,0.000896872,0.0008232154,0.00025326596,0.0012725666,0.00001016928],"about_ca_topic_score_codex":0.0019378786,"about_ca_topic_score_gemma":0.005507302,"teacher_disagreement_score":0.0019378786,"about_ca_system_score_codex":0.00044651856,"about_ca_system_score_gemma":0.00039382308,"threshold_uncertainty_score":0.006050527},"labels":[],"label_agreement":null},{"id":"W3144606368","doi":"10.1016/j.urolonc.2021.02.025","title":"Lymph node dissection during radical nephrectomy: A Canadian multi-institutional analysis","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; Université de Montréal; University of Alberta; Université Laval; Princess Margaret Cancer Centre; University of Calgary; University of Ottawa; McGill University; University of British Columbia; University of Toronto; McMaster University; University of Manitoba","funders":"","keywords":"Propensity score matching; Medicine; Nephrectomy; Renal cell carcinoma; Lymph node; Proportional hazards model; Kidney cancer; Dissection (medical); Urology; Cohort; Oncology; Internal medicine; Survival analysis; Surgery; Kidney","score_opus":0.029137943384666243,"score_gpt":0.2930300634981475,"score_spread":0.26389212011348123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3144606368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873132,0.0022816698,0.00022921851,0.0004091844,0.000025352352,0.00012299701,0.005918793,0.000013692752,0.0036859186],"genre_scores_gemma":[0.992784,0.0021028572,0.00029751196,0.00035364935,0.00003178276,0.00003623079,0.0035259295,0.000028788187,0.0008392723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99657226,0.0003595892,0.0002435057,0.0005479929,0.001195651,0.0010809834],"domain_scores_gemma":[0.99032986,0.0012401171,0.0024240518,0.000546559,0.0035811411,0.0018782574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00207094,0.0010011642,0.0009504764,0.0039132694,0.004090398,0.002555329,0.0030158053,0.0011672276,0.003980695],"category_scores_gemma":[0.00811048,0.0009785673,0.0018414177,0.014428589,0.0013298576,0.0008628823,0.0017517912,0.0019348456,0.0004145609],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043574226,0.000071261056,0.9926623,0.000080152975,0.0002466725,0.0002490576,0.00055316446,0.00019408374,0.00019523269,0.00015263502,0.0010590425,0.004100525],"study_design_scores_gemma":[0.000047650126,0.0000553507,0.99680233,0.000059286725,0.00020404365,0.00026883747,0.0010405328,0.00020311368,0.000046754874,0.000030051266,0.0012079304,0.00003402476],"about_ca_topic_score_codex":0.9791003,"about_ca_topic_score_gemma":0.9887552,"teacher_disagreement_score":0.9791003,"about_ca_system_score_codex":0.031129273,"about_ca_system_score_gemma":0.046618264,"threshold_uncertainty_score":0.2258597},"labels":[],"label_agreement":null},{"id":"W3155792441","doi":"10.1016/j.urolonc.2021.03.005","title":"Prognostic blood-based biomarkers in patients treated with neoadjuvant chemotherapy for urothelial carcinoma of the bladder: A systematic review","year":2021,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Internal medicine; Oncology; Lymphocyte; Bladder cancer; Chemotherapy; Gastroenterology; CD8; Cancer; Immunology; Immune system","score_opus":0.02872018240957009,"score_gpt":0.31512440863428437,"score_spread":0.2864042262247143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155792441","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031376053,0.99555796,0.00010728859,0.0001468569,0.000061189465,0.00018097021,0.0006563607,0.0000063063744,0.00014547467],"genre_scores_gemma":[0.044455744,0.9530077,0.0006015434,0.00047525158,0.00008845979,0.0006066535,0.00065327936,0.0000059219506,0.00010555232],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99618113,0.0010278791,0.0018021114,0.0003877311,0.0004702622,0.00013086636],"domain_scores_gemma":[0.98416996,0.010609594,0.0037100671,0.00022851491,0.0010873735,0.00019448668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036568828,0.0012105296,0.008677376,0.007822256,0.00046105045,0.0017300105,0.001566756,0.0015472147,0.0026870484],"category_scores_gemma":[0.018669894,0.0007314863,0.0072854934,0.010088796,0.00064224773,0.0015806961,0.0009594145,0.00072240323,0.00018227064],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003912678,0.000018650222,0.003997287,0.95780224,0.017338164,0.000105970896,0.000109478766,0.00009147591,0.00017669795,0.0000882781,0.0007162904,0.019164274],"study_design_scores_gemma":[0.00054293894,0.0005114094,0.021733275,0.69900626,0.26312515,0.0006813722,0.0003239275,0.00018167985,0.00026049514,0.00024283363,0.013321572,0.00006915507],"about_ca_topic_score_codex":0.0060541155,"about_ca_topic_score_gemma":0.016877329,"teacher_disagreement_score":0.008677376,"about_ca_system_score_codex":0.0017364465,"about_ca_system_score_gemma":0.0062831487,"threshold_uncertainty_score":0.01933968},"labels":[],"label_agreement":null},{"id":"W3162590777","doi":"10.1016/j.urolonc.2021.04.004","title":"The effect of race/ethnicity on active treatment rates among septuagenarian or older low risk prostate cancer patients","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Brachytherapy; Prostate cancer; Prostatectomy; Logistic regression; Socioeconomic status; Ethnic group; Epidemiology; Cohort; Stage (stratigraphy); Cancer; Internal medicine; Oncology; Radiation therapy; Demography; Population","score_opus":0.015069455428494121,"score_gpt":0.3207780785865922,"score_spread":0.30570862315809805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162590777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997894,0.00019567908,0.00002229226,0.0001861211,0.000017433218,0.0000021419874,0.0003021136,0.0000019630468,0.0013782424],"genre_scores_gemma":[0.999305,0.00006818808,0.0000124840635,0.00005863511,0.000018274171,0.0000016030489,0.00010965737,0.0000025677919,0.0004236091],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996445,0.00011026394,0.000034016277,0.000057443514,0.00004074781,0.00011307972],"domain_scores_gemma":[0.9981025,0.00046825796,0.0007183322,0.00007841968,0.00011492448,0.0005176344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004657648,0.00014401384,0.00021892942,0.0004343505,0.00043569162,0.0007511971,0.0003084089,0.00037740957,0.0057351715],"category_scores_gemma":[0.0026495745,0.00016245316,0.00070149486,0.0004947138,0.00023693981,0.0003965302,0.00042054395,0.0005982484,0.00044131055],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065786525,0.000054343887,0.9969754,0.000008845696,0.0000906546,0.00006447991,0.0001329874,0.000029504248,0.00018763084,0.000033602744,0.00017005876,0.0015945625],"study_design_scores_gemma":[0.000009381905,0.000073779345,0.99903274,0.000005653334,0.000043078595,0.00007040443,0.00046645923,0.000090256275,0.00003343998,0.000017137687,0.00015416037,0.0000036413192],"about_ca_topic_score_codex":0.024308447,"about_ca_topic_score_gemma":0.039606877,"teacher_disagreement_score":0.024308447,"about_ca_system_score_codex":0.00036849864,"about_ca_system_score_gemma":0.0005548629,"threshold_uncertainty_score":0.048333883},"labels":[],"label_agreement":null},{"id":"W3164402145","doi":"10.1016/j.urolonc.2021.04.011","title":"Evaluation of carbonic anhydrase IX as a potential therapeutic target in urothelial carcinoma","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Enzyme function and inhibition","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Decipher Biosciences (Canada); University of British Columbia","funders":"","keywords":"Gene silencing; Cancer research; Biology; Bladder cancer; Pathology; Urothelial Cell; Cell growth; Cystectomy; Urothelium; Cell culture; Cancer; Small interfering RNA; Medicine; Transfection; Internal medicine; Urinary bladder; Gene","score_opus":0.023740734080079595,"score_gpt":0.2991380258558943,"score_spread":0.2753972917758147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164402145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84788954,0.1256151,0.0050108847,0.0018700894,0.0003210918,0.00032289344,0.0003248755,0.00010274178,0.018542781],"genre_scores_gemma":[0.9653908,0.027291067,0.0016189013,0.00019835068,0.0001264511,0.000057616537,0.00026187112,0.000019749628,0.0050351494],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998179,0.000059451337,0.000010696776,0.000018163115,0.000054306343,0.00003936954],"domain_scores_gemma":[0.9999089,0.000026430916,0.000009884305,0.000007978169,0.000027570883,0.000019238661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074271025,0.00028608498,0.0004635407,0.00024614154,0.00023648054,0.0005545095,0.00034870097,0.00041730484,0.0016182222],"category_scores_gemma":[0.0003056364,0.00008857794,0.00030169333,0.00028372914,0.00025862953,0.00022759475,0.00014980597,0.00044756,0.00026662502],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053421427,0.00066899805,0.0038271786,0.0006812674,0.00013317143,0.0007274129,0.00011377121,0.0015895402,0.87955177,0.0017835482,0.0011414522,0.104439735],"study_design_scores_gemma":[0.0005416647,0.011897582,0.009251533,0.000052147876,0.00031831567,0.0011909825,0.000116191586,0.0020843693,0.93730325,0.00043943292,0.03678863,0.000015882015],"about_ca_topic_score_codex":0.001330683,"about_ca_topic_score_gemma":0.0015557626,"teacher_disagreement_score":0.0016182222,"about_ca_system_score_codex":0.0007364341,"about_ca_system_score_gemma":0.00056327845,"threshold_uncertainty_score":0.0054135323},"labels":[],"label_agreement":null},{"id":"W3165426308","doi":"10.1016/j.urolonc.2021.04.007","title":"Leibovich score is the optimal clinico-pathological system associated with recurrence of non-metastatic clear cell renal cell carcinoma","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Proportional hazards model; Oncology","score_opus":0.0439392193209567,"score_gpt":0.2981296363804599,"score_spread":0.25419041705950324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165426308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917326,0.0016282692,0.00046507482,0.00043270024,0.000057530782,0.000011899079,0.00047587563,0.000023132772,0.005172889],"genre_scores_gemma":[0.99929225,0.00012224785,0.00010170635,0.00001933226,0.000030812298,0.0000030548863,0.00022051083,0.000003330573,0.0002067156],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999445,0.000108651475,0.00007730008,0.00007945049,0.00015360836,0.00013598154],"domain_scores_gemma":[0.9978346,0.00043510983,0.0007411024,0.00011351935,0.0003632079,0.0005125708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008019097,0.00034831857,0.000571503,0.0019422938,0.00050966395,0.0011309604,0.0005015145,0.00046447752,0.0029534341],"category_scores_gemma":[0.006043476,0.0001304307,0.0007101477,0.0013518519,0.0006193745,0.00073256163,0.000661951,0.0005196589,0.00038630492],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016956383,0.000013627416,0.9951599,0.000015505619,0.000060520993,0.00021643988,0.000019920244,0.00020872588,0.00017300418,0.00009976417,0.0003098,0.0035532378],"study_design_scores_gemma":[0.000011003534,0.00009428211,0.99561274,0.000019538289,0.0001378263,0.0012664626,0.00018020823,0.0011632633,0.00022719054,0.00067223655,0.00059887365,0.000016408701],"about_ca_topic_score_codex":0.0028970565,"about_ca_topic_score_gemma":0.0029321793,"teacher_disagreement_score":0.0029534341,"about_ca_system_score_codex":0.0006062577,"about_ca_system_score_gemma":0.0011140014,"threshold_uncertainty_score":0.009880245},"labels":[],"label_agreement":null},{"id":"W3167276022","doi":"10.1016/j.urolonc.2021.03.024","title":"Intravesical sequential gemcitabine and docetaxel versus bacillus calmette-guerin (BCG) plus interferon in patients with recurrent non-muscle invasive bladder cancer following a single induction course of BCG","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Docetaxel; Gemcitabine; Internal medicine; Proportional hazards model; Oncology; Bladder cancer; BCG vaccine; Logistic regression; Hazard ratio; Cancer; Confidence interval; Tuberculosis; Pathology","score_opus":0.03321787774255678,"score_gpt":0.3082676663313635,"score_spread":0.2750497885888067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167276022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99641776,0.0026215455,0.00007300306,0.00018330295,0.0001059485,0.00006645837,0.000051985044,0.00001165921,0.00046831853],"genre_scores_gemma":[0.99817395,0.0009838758,0.00014286565,0.00011922378,0.00009658425,0.000049142025,0.00009824024,0.0000037589864,0.00033240268],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999665,0.00013244279,0.000032224045,0.00005793843,0.000020292211,0.000092142545],"domain_scores_gemma":[0.99924123,0.00022632479,0.00013128889,0.000042007534,0.000022758304,0.0003364161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007877275,0.00048637288,0.0021759071,0.00026575656,0.00025624307,0.0007384201,0.000501651,0.00066139956,0.0014797202],"category_scores_gemma":[0.0016203892,0.00027813436,0.0011196225,0.000418415,0.00035667367,0.0006250353,0.00025371189,0.0017523742,0.00026926445],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8218334,0.008578591,0.017100753,0.00051363994,0.001290523,0.0003347799,0.00027775162,0.0036441807,0.008101509,0.00018758295,0.0007951724,0.13734204],"study_design_scores_gemma":[0.15679835,0.6585965,0.16637081,0.00025373773,0.004094848,0.0007593599,0.00034250968,0.0056990515,0.004157304,0.00040028474,0.0024465425,0.00008076697],"about_ca_topic_score_codex":0.00174078,"about_ca_topic_score_gemma":0.0056646657,"teacher_disagreement_score":0.0021759071,"about_ca_system_score_codex":0.0008329723,"about_ca_system_score_gemma":0.0010193071,"threshold_uncertainty_score":0.0060436726},"labels":[],"label_agreement":null},{"id":"W3168770254","doi":"10.1016/j.urolonc.2021.04.040","title":"Contemporary analysis of the effect of marital status on survival in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: A population-based study","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Cancer survivorship and care","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Hazard ratio; Proportional hazards model; Confidence interval; Marital status; Internal medicine; Epidemiology; Population; Cancer; Demography; Urology; Oncology; Gynecology","score_opus":0.016982044882655183,"score_gpt":0.2851996668785632,"score_spread":0.268217621995908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168770254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99875677,0.00062970637,0.000056348435,0.000046779674,0.000005756119,0.0000028472039,0.00021014478,0.0000016531933,0.00029000585],"genre_scores_gemma":[0.9995141,0.00019825606,0.000018013612,0.00001875849,0.000013829967,0.0000025213228,0.00019327656,0.0000011777095,0.000040177187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992287,0.0003158239,0.00007524941,0.00017119394,0.0001089018,0.00010012642],"domain_scores_gemma":[0.99820423,0.00064562645,0.0004923971,0.00018965702,0.00018677633,0.00028128867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010102282,0.00017626869,0.00048568263,0.0010006035,0.00060569023,0.0008057718,0.00047636326,0.0005406322,0.0012870015],"category_scores_gemma":[0.0031794126,0.00022427177,0.00074244203,0.0023153906,0.0005545764,0.0007003042,0.00052590907,0.0005271683,0.00017257979],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002277634,0.00002984943,0.9982784,0.0000073627543,0.00013001588,0.00003532043,0.00008155809,0.00002146487,0.00010588296,0.000012537254,0.000041190408,0.0010287733],"study_design_scores_gemma":[0.000005047637,0.0000877685,0.9994481,0.000001942629,0.000054788998,0.00006565056,0.00017731772,0.000050942635,0.000013894796,0.000011832612,0.00008049307,0.000002170471],"about_ca_topic_score_codex":0.0066998797,"about_ca_topic_score_gemma":0.0067581288,"teacher_disagreement_score":0.0066998797,"about_ca_system_score_codex":0.0004012792,"about_ca_system_score_gemma":0.00036321869,"threshold_uncertainty_score":0.013321757},"labels":[],"label_agreement":null},{"id":"W3170537322","doi":"10.1016/j.urolonc.2021.04.031","title":"Radical prostatectomy for localized prostate cancer: 20-year oncological outcomes from a German high-volume center","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostate cancer; Prostatectomy; Urology; Biochemical recurrence; Proportional hazards model; Cancer; breakpoint cluster region; Internal medicine; Oncology","score_opus":0.02804162559137328,"score_gpt":0.33417231667220376,"score_spread":0.30613069108083046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170537322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997384,0.00048102744,0.000032476553,0.00019920216,0.000013115058,0.000006534415,0.0011154606,0.0000054789916,0.00076269195],"genre_scores_gemma":[0.9980415,0.00024143171,0.000021003163,0.00009486222,0.000020335056,0.0000033437832,0.0013244174,0.00000359258,0.0002495271],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940276,0.00009818124,0.00004316122,0.000116824835,0.000090961585,0.0002482144],"domain_scores_gemma":[0.999032,0.000075957694,0.000320957,0.000045862707,0.000117250864,0.00040790185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052277464,0.0004711326,0.00040418585,0.0015107407,0.0006951109,0.0012829303,0.00059559435,0.0007661234,0.0020206538],"category_scores_gemma":[0.0011863743,0.00029350293,0.0006531327,0.002139243,0.00047207688,0.0009960942,0.0013440332,0.0005312868,0.00038033607],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002111529,0.000108783766,0.9946906,0.000020973048,0.0001476295,0.00036363726,0.00026030227,0.00024261796,0.0001152139,0.000052669653,0.0009841801,0.0028023385],"study_design_scores_gemma":[0.000009956259,0.00007295192,0.9988117,0.000010603136,0.000037128382,0.00019303006,0.00047336702,0.00008508577,0.000022965172,0.00002011051,0.00025246578,0.000010684453],"about_ca_topic_score_codex":0.030490654,"about_ca_topic_score_gemma":0.04566286,"teacher_disagreement_score":0.030490654,"about_ca_system_score_codex":0.001800542,"about_ca_system_score_gemma":0.0011372187,"threshold_uncertainty_score":0.060626388},"labels":[],"label_agreement":null},{"id":"W3170759998","doi":"10.1016/j.urolonc.2021.05.008","title":"Characterization and management of NMIBC recurrences after TMT: a matched cohort analysis","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Cohort; Bladder cancer; Cystectomy; Radiation therapy; Urology; Oncology; Stage (stratigraphy); Proportional hazards model; Internal medicine; Cancer","score_opus":0.021050079404503905,"score_gpt":0.3062340415336144,"score_spread":0.28518396212911046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170759998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99888545,0.00024101287,0.00014828304,0.000016108495,0.000010680962,0.00001755443,0.00043595218,0.000002682914,0.00024236445],"genre_scores_gemma":[0.99898523,0.00007199139,0.000070612696,0.000024771645,0.00001412119,0.000016089729,0.00058990245,0.000004486064,0.00022280349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915755,0.00012938518,0.000081768994,0.00032788614,0.00010719833,0.00019620059],"domain_scores_gemma":[0.9991062,0.00010317022,0.00036073723,0.00020240824,0.00009664081,0.00013078083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006148917,0.00026228683,0.00046795502,0.00075443875,0.00064448913,0.00067463785,0.00052467233,0.00050902984,0.0024928784],"category_scores_gemma":[0.0018192078,0.00036851532,0.001134892,0.0010400108,0.0002358885,0.000580548,0.00060956716,0.0005969202,0.00036557973],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015870085,0.00014562646,0.99345386,0.000018851817,0.00047063967,0.00015994943,0.00010136624,0.00007384156,0.00075543596,0.000043267046,0.0002611181,0.0029290428],"study_design_scores_gemma":[0.0000538533,0.00042346542,0.99772877,0.00000734117,0.00023611763,0.0003852385,0.00023768534,0.00026261387,0.00012363288,0.000039909806,0.0004936463,0.000007917587],"about_ca_topic_score_codex":0.005104899,"about_ca_topic_score_gemma":0.0064485637,"teacher_disagreement_score":0.005104899,"about_ca_system_score_codex":0.0005475255,"about_ca_system_score_gemma":0.0006113747,"threshold_uncertainty_score":0.010150373},"labels":[],"label_agreement":null},{"id":"W3172342781","doi":"10.1016/j.urolonc.2021.05.002","title":"Impact of systemic Immune–inflammation Index on oncologic outcomes in patients treated with radical prostatectomy for clinically nonmetastatic prostate cancer","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"Department of Local Government, Sport and Cultural Industries Office of Multicultural Interests; European Association of Urology; Open Society Foundations","keywords":"Medicine; Prostatectomy; Prostate cancer; Receiver operating characteristic; Nomogram; Hazard ratio; Logistic regression; Proportional hazards model; Internal medicine; Youden's J statistic; Urology; Biochemical recurrence; Cancer; Cohort; Oncology; Surgery; Confidence interval","score_opus":0.01904863852613846,"score_gpt":0.3368209184100082,"score_spread":0.31777227988386975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172342781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979493,0.0010184721,0.00006108211,0.0001502228,0.00003754438,0.000004511704,0.0001713587,0.0000035104197,0.0006039421],"genre_scores_gemma":[0.99945575,0.00013195015,0.000029407402,0.00004375706,0.000042060292,0.000002591819,0.00014621703,0.0000010582036,0.00014731016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997404,0.00007878034,0.000023164095,0.000050514856,0.000043551092,0.00006363498],"domain_scores_gemma":[0.99933076,0.00016500706,0.00024329734,0.000025728206,0.000055293793,0.00017995929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003440373,0.00021479004,0.00047467643,0.0002924828,0.0002734924,0.0006227019,0.00021049395,0.0003381636,0.0013597762],"category_scores_gemma":[0.0015209834,0.00012277382,0.00067907356,0.00053660723,0.00024371593,0.00036633434,0.00040720397,0.00075486157,0.00013618247],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079182326,0.00006910774,0.9955635,0.000014838129,0.00016812161,0.000050002665,0.00002327046,0.00008008308,0.00022831677,0.000013330592,0.00011933596,0.0028783071],"study_design_scores_gemma":[0.000017450786,0.00034151558,0.9988243,0.000004780699,0.0001567735,0.00008216572,0.00007478322,0.00025328362,0.00006788633,0.00003953039,0.00013242733,0.00000515587],"about_ca_topic_score_codex":0.0015104242,"about_ca_topic_score_gemma":0.0029776178,"teacher_disagreement_score":0.0015104242,"about_ca_system_score_codex":0.00030561397,"about_ca_system_score_gemma":0.0004300823,"threshold_uncertainty_score":0.004548967},"labels":[],"label_agreement":null},{"id":"W3175301954","doi":"10.1016/j.urolonc.2021.04.032","title":"An economic analysis comparing health care resource use and cost of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin versus gemcitabine and cisplatin as neoadjuvant therapy for muscle invasive bladder cancer","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Gemcitabine; Cisplatin; Internal medicine; Bladder cancer; Vinblastine; Chemotherapy; Regimen; Cystectomy; Oncology; Urology; Cancer; Surgery","score_opus":0.06448005431455607,"score_gpt":0.376689990809975,"score_spread":0.31220993649541895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3175301954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830269,0.0074249124,0.0017647203,0.0015976724,0.00029071947,0.0007797331,0.0016043056,0.000032333264,0.0034788216],"genre_scores_gemma":[0.997511,0.00074840285,0.0005646812,0.00021661218,0.00004788492,0.00015420749,0.00037202734,0.0000065868053,0.00037851004],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99476516,0.00396822,0.00021363284,0.00023834013,0.0003006435,0.0005139332],"domain_scores_gemma":[0.99026066,0.0077379523,0.00083867257,0.00021472687,0.00025445517,0.00069351285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048023947,0.0016851239,0.002342739,0.0019689878,0.00049955765,0.0026214435,0.0017795763,0.0018548251,0.006103466],"category_scores_gemma":[0.017836822,0.0011303648,0.0074970936,0.0019080616,0.0011242598,0.0018471781,0.001203248,0.0028193078,0.00022689924],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.56235296,0.009382551,0.036593743,0.0030724118,0.026599254,0.0009754992,0.00020095243,0.29556894,0.0024382912,0.005653974,0.003135244,0.0540262],"study_design_scores_gemma":[0.12208676,0.083766334,0.13171919,0.0017800789,0.05556416,0.001971862,0.002255247,0.5805899,0.0027826603,0.010576674,0.006262857,0.0006442575],"about_ca_topic_score_codex":0.01839017,"about_ca_topic_score_gemma":0.010192363,"teacher_disagreement_score":0.01839017,"about_ca_system_score_codex":0.009930299,"about_ca_system_score_gemma":0.0031970718,"threshold_uncertainty_score":0.07204968},"labels":[],"label_agreement":null},{"id":"W3177107741","doi":"10.1016/j.urolonc.2021.05.026","title":"The increasing use of renal tumor biopsy amongst Canadian urologists: When is biopsy most utilized?","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; University of Alberta; Queen Elizabeth II Health Sciences Centre; St. Joseph’s Healthcare Hamilton; McMaster University; University of Calgary; Princess Margaret Cancer Centre; Ottawa Hospital; University of Ottawa; McGill University Health Centre; University of British Columbia; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Logistic regression; Biopsy; Surgery; General surgery; Internal medicine","score_opus":0.0469239435373554,"score_gpt":0.28924066317403635,"score_spread":0.24231671963668094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177107741","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.36733466,0.10045753,0.0014197915,0.47545093,0.0031635724,0.00013703037,0.0048371945,0.0002250327,0.046974253],"genre_scores_gemma":[0.90981144,0.04161248,0.00274406,0.040777527,0.0016530234,0.00003826211,0.0013777817,0.0001114316,0.0018739955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9899019,0.0011304294,0.0007249435,0.00076575315,0.0048636347,0.0026134427],"domain_scores_gemma":[0.93312126,0.010672281,0.0129739465,0.000908769,0.029914558,0.01240914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005337666,0.00028877793,0.0006129325,0.004228446,0.0043170527,0.0040741465,0.0028043748,0.0027562734,0.008501128],"category_scores_gemma":[0.04885833,0.00044732078,0.0007832518,0.008809619,0.0021703732,0.0022770998,0.0011998266,0.0031772677,0.0005887785],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027876763,0.00009622234,0.78917986,0.0009850913,0.00015079674,0.00096665905,0.0040005413,0.00038253167,0.0007389922,0.0021049196,0.07821099,0.12290462],"study_design_scores_gemma":[0.000024568104,0.00006435061,0.9186602,0.0028906565,0.00019468482,0.0016206919,0.020201474,0.0006588754,0.0003687123,0.0006381205,0.054554027,0.00012356146],"about_ca_topic_score_codex":0.9416205,"about_ca_topic_score_gemma":0.9745334,"teacher_disagreement_score":0.05837947,"about_ca_system_score_codex":0.046316136,"about_ca_system_score_gemma":0.078212254,"threshold_uncertainty_score":0.3360486},"labels":[],"label_agreement":null},{"id":"W3179635546","doi":"10.1016/j.urolonc.2021.06.003","title":"Applicant perceptions of virtual interviews for society of urologic oncology fellowships during the COVID-19 pandemic","year":2021,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Likert scale; Thematic analysis; Medical education; Descriptive statistics; Pandemic; Medicine; Coronavirus disease 2019 (COVID-19); Qualitative research; Family medicine; Psychology; Sociology","score_opus":0.2325565624231125,"score_gpt":0.47752235132934684,"score_spread":0.24496578890623433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179635546","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.055277545,0.91839814,0.00017358497,0.015749788,0.001350736,0.00018211266,0.00036489198,0.0000061331284,0.008497074],"genre_scores_gemma":[0.23735416,0.75178677,0.00071619125,0.007081945,0.0004923151,0.0004019113,0.0002852836,0.0000079166575,0.0018736038],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9924402,0.005119373,0.00053751795,0.00029526843,0.001104265,0.0005033095],"domain_scores_gemma":[0.9779027,0.014941682,0.0032037734,0.00015713453,0.002329739,0.0014650148],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.014795837,0.00025395173,0.0007421995,0.001153281,0.0009545398,0.0024476827,0.0008444835,0.0012219393,0.00450164],"category_scores_gemma":[0.0343482,0.0002542565,0.00071718346,0.0025059222,0.0006133415,0.0021609724,0.0026448069,0.0018910626,0.0002959159],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008009681,0.00043652952,0.027066883,0.10034489,0.0010067889,0.00066958374,0.06396453,0.00019861742,0.00034891866,0.0036045355,0.037615053,0.7639427],"study_design_scores_gemma":[0.000194812,0.00088932854,0.13767952,0.17359127,0.0012238838,0.00087905093,0.21908794,0.000087307475,0.000352776,0.00085127976,0.46499518,0.00016754877],"about_ca_topic_score_codex":0.008861077,"about_ca_topic_score_gemma":0.03785087,"teacher_disagreement_score":0.98520416,"about_ca_system_score_codex":0.002866304,"about_ca_system_score_gemma":0.008597788,"threshold_uncertainty_score":0.0782488},"labels":[],"label_agreement":null},{"id":"W3184777509","doi":"10.1016/j.urolonc.2021.06.023","title":"Post-prostatectomy adjuvant androgen deprivation therapy— Current opinions and practices of Canadian urologists","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Prostatectomy; Androgen deprivation therapy; Adjuvant; Prostate cancer; Clinical trial; Adjuvant therapy; Randomized controlled trial; Family medicine; Oncology; Internal medicine; Cancer","score_opus":0.05948973763045701,"score_gpt":0.3573178426695828,"score_spread":0.29782810503912577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3184777509","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.082567774,0.22899507,0.0004018095,0.6074203,0.0039812406,0.00008189447,0.0016862609,0.000040877723,0.07482477],"genre_scores_gemma":[0.59767133,0.3214343,0.002519814,0.0628914,0.0034710278,0.00006910156,0.0012096335,0.000059845202,0.010673492],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99488986,0.0007979558,0.00047386598,0.00035508932,0.0022386566,0.0012445629],"domain_scores_gemma":[0.9679409,0.0045170086,0.0028282197,0.0002743172,0.017364983,0.00707439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006464825,0.00022361093,0.00035814545,0.0026402473,0.004753905,0.0035911652,0.0020380167,0.00161182,0.006376437],"category_scores_gemma":[0.02592089,0.00029068167,0.00049052783,0.0064245067,0.0022036228,0.0012409058,0.0012402589,0.0022762355,0.00048779082],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040363296,0.00014453652,0.20453355,0.0031336942,0.00013641965,0.00081655546,0.014187019,0.0004195936,0.0005777209,0.0055976477,0.3483438,0.4217058],"study_design_scores_gemma":[0.000099095436,0.00010857545,0.3789553,0.011216553,0.00024704673,0.001157533,0.054853924,0.00031433502,0.00024985682,0.0013435292,0.5512716,0.00018257495],"about_ca_topic_score_codex":0.9430057,"about_ca_topic_score_gemma":0.9804223,"teacher_disagreement_score":0.05699432,"about_ca_system_score_codex":0.037746076,"about_ca_system_score_gemma":0.09820037,"threshold_uncertainty_score":0.2738682},"labels":[],"label_agreement":null},{"id":"W3184874576","doi":"10.1016/j.urolonc.2021.07.001","title":"The effect of race on stage at presentation and survival in upper tract urothelial carcinoma","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Propensity score matching; Hazard ratio; Stage (stratigraphy); Lymph node; Cohort; Incidence (geometry); Ethnic group; Proportional hazards model; Epidemiology; Internal medicine; Oncology; Urology; Demography; Confidence interval; Biology","score_opus":0.021556916846751956,"score_gpt":0.32374356141886157,"score_spread":0.30218664457210964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3184874576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99728096,0.0011386975,0.000064962034,0.00028876244,0.000053034928,0.0000029445155,0.00018734035,0.0000042020692,0.0009791455],"genre_scores_gemma":[0.9989969,0.00025430118,0.000034356435,0.00005562588,0.00006280172,0.0000023009234,0.00012689565,0.000006477188,0.0004604169],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921274,0.0003689192,0.000045611192,0.00010037817,0.00006550403,0.0002067727],"domain_scores_gemma":[0.9957997,0.0017634942,0.0007891999,0.0002775329,0.00025029623,0.001119796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012593565,0.00022992372,0.00050911936,0.00050540984,0.00046748176,0.00089094846,0.0005127733,0.0006901382,0.0030424325],"category_scores_gemma":[0.006390815,0.00024566584,0.0011486126,0.00084996613,0.00042697074,0.000740621,0.00068888016,0.0009536631,0.00036225302],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013698993,0.00008392598,0.99335325,0.000011633376,0.00013561765,0.00008998012,0.00008571866,0.00009186024,0.00040726192,0.000028654193,0.00015352608,0.004188647],"study_design_scores_gemma":[0.000009166341,0.00016130866,0.99913293,0.0000059408935,0.000078953526,0.00007885968,0.00012920803,0.00016466537,0.000052270963,0.000041166302,0.00014049762,0.0000048949805],"about_ca_topic_score_codex":0.005959916,"about_ca_topic_score_gemma":0.00866637,"teacher_disagreement_score":0.005959916,"about_ca_system_score_codex":0.00043260923,"about_ca_system_score_gemma":0.000570862,"threshold_uncertainty_score":0.011850476},"labels":[],"label_agreement":null},{"id":"W3185158984","doi":"10.1016/j.urolonc.2021.06.025","title":"The impact of time to prostate specific antigen nadir on biochemical recurrence and mortality rates after radiation therapy for localized prostate cancer","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Prostate cancer; Nadir; Medicine; Biochemical recurrence; Proportional hazards model; Urology; Prostate-specific antigen; Radiation therapy; Brachytherapy; Internal medicine; Hazard ratio; Survival analysis; Oncology; Overall survival; Cancer; Prostatectomy; Confidence interval","score_opus":0.03019834636300711,"score_gpt":0.3621893434135096,"score_spread":0.3319909970505025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185158984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933635,0.0039048858,0.00014480321,0.00043710318,0.00007216658,0.000007451077,0.00037485152,0.000011770236,0.0016835134],"genre_scores_gemma":[0.99896693,0.0003401315,0.000037137906,0.00005907038,0.0000464451,0.000002595267,0.00021550103,0.000006018866,0.0003262106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989862,0.00041776255,0.000080603015,0.00012956103,0.00016997797,0.00021589398],"domain_scores_gemma":[0.9928925,0.0040645176,0.0014898464,0.00035584165,0.00035451437,0.0008428372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002116242,0.00022420334,0.00042861074,0.000492973,0.00033240614,0.0010202656,0.00077573804,0.0006639991,0.0028431665],"category_scores_gemma":[0.0124254925,0.00021068328,0.0015858632,0.000734667,0.0003431186,0.00078610965,0.00055409264,0.001110452,0.00030515454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004091578,0.00024464008,0.98111206,0.00005046311,0.0005090793,0.00012046035,0.00008342477,0.000850055,0.00025498515,0.00008366148,0.00031915787,0.012280536],"study_design_scores_gemma":[0.000019399446,0.00047050562,0.9983911,0.000009161325,0.00021682665,0.00008710155,0.00008749676,0.00042295663,0.000073816314,0.000049153976,0.00016362143,0.000008822098],"about_ca_topic_score_codex":0.009154857,"about_ca_topic_score_gemma":0.012711674,"teacher_disagreement_score":0.009154857,"about_ca_system_score_codex":0.0007384542,"about_ca_system_score_gemma":0.0008737568,"threshold_uncertainty_score":0.01820314},"labels":[],"label_agreement":null},{"id":"W3190572377","doi":"10.1016/j.urolonc.2021.06.008","title":"PSMA PET predicts metastasis-free survival in the setting of salvage radiotherapy after radical prostatectomy","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Positron emission tomography; Glutamate carboxypeptidase II; Biochemical recurrence; Proportional hazards model; Propensity score matching; Hazard ratio; Nuclear medicine; Internal medicine; Oncology; Urology; PET-CT; Cancer; Confidence interval","score_opus":0.028680241360428023,"score_gpt":0.3342595366078746,"score_spread":0.3055792952474466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190572377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99654335,0.0012995533,0.00011609919,0.00022308365,0.000039093877,0.0000051331776,0.00013473125,0.000013238305,0.0016257659],"genre_scores_gemma":[0.99939334,0.00015723381,0.000037823884,0.000038547973,0.000030621835,0.0000017184165,0.00009318656,0.0000018599978,0.000245679],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998217,0.00004135978,0.000013965429,0.000032835123,0.000032160355,0.00005793779],"domain_scores_gemma":[0.99902487,0.00029405873,0.000294458,0.00005837494,0.000078745725,0.0002495099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033871375,0.00028221132,0.00039779308,0.00043525075,0.0003119183,0.0007627866,0.00041803328,0.0006362139,0.0026356282],"category_scores_gemma":[0.0028238748,0.00020765964,0.00039385745,0.00036317922,0.0004426415,0.0004959012,0.0002985835,0.00065299013,0.0004623428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008802144,0.000077102595,0.9853753,0.000031651925,0.000073435825,0.0008139651,0.00009319909,0.0006171423,0.0013778026,0.000053706302,0.00068723515,0.009919232],"study_design_scores_gemma":[0.000009264208,0.00029413542,0.99552345,0.00001362661,0.00010076886,0.0017846283,0.00018438957,0.0010868517,0.00040164456,0.00018224014,0.00040839458,0.000010516109],"about_ca_topic_score_codex":0.0021313233,"about_ca_topic_score_gemma":0.004363708,"teacher_disagreement_score":0.0026356282,"about_ca_system_score_codex":0.00042925408,"about_ca_system_score_gemma":0.0003967393,"threshold_uncertainty_score":0.008817077},"labels":[],"label_agreement":null},{"id":"W3193767906","doi":"10.1016/j.urolonc.2021.07.022","title":"Adjuvant therapy with tyrosine kinase inhibitors for localized and locally advanced renal cell carcinoma: an updated systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Internal medicine; Placebo; Meta-analysis; Oncology; Renal cell carcinoma; Adjuvant therapy; Adjuvant; Adverse effect; Randomized controlled trial; Clinical endpoint; Forest plot; Cochrane Library; Chemotherapy; Pathology","score_opus":0.0710168210008935,"score_gpt":0.3466635522659927,"score_spread":0.2756467312650992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193767906","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033680883,0.995057,0.0003369715,0.00015900037,0.0001075604,0.0001655526,0.00057860155,0.00001785887,0.00020935733],"genre_scores_gemma":[0.1304437,0.8642712,0.0017651849,0.001040761,0.00026347482,0.00078195217,0.0010791819,0.00003050556,0.00032393294],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9933547,0.0029720853,0.0019963258,0.0006849036,0.0007550394,0.00023698839],"domain_scores_gemma":[0.9862953,0.0096642645,0.0024036625,0.00037443716,0.0010875263,0.0001747747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010216858,0.0022366513,0.018488053,0.006045782,0.00048206447,0.0023636657,0.0017156206,0.00179726,0.0036734096],"category_scores_gemma":[0.022272179,0.0011770804,0.031918917,0.007614732,0.00051411253,0.0015073488,0.0011128729,0.0016395107,0.00027634858],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019537213,0.000026458107,0.0030379852,0.45699084,0.5236444,0.00012680564,0.00006350978,0.00062891544,0.0002711843,0.00012376392,0.0008635934,0.012268923],"study_design_scores_gemma":[0.00049034524,0.00014091699,0.0030198896,0.024324866,0.9700161,0.00008748634,0.00002351974,0.00014310444,0.00008166406,0.000115730465,0.0015381782,0.000018151384],"about_ca_topic_score_codex":0.007191738,"about_ca_topic_score_gemma":0.016483018,"teacher_disagreement_score":0.018488053,"about_ca_system_score_codex":0.002227529,"about_ca_system_score_gemma":0.003216935,"threshold_uncertainty_score":0.054032564},"labels":[],"label_agreement":null},{"id":"W3198582500","doi":"10.1016/j.urolonc.2021.08.007","title":"A machine learning approach to predict progression on active surveillance for prostate cancer","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Random forest; Prostate cancer; Machine learning; Artificial intelligence; Logistic regression; Support vector machine; Cohort; Artificial neural network; Medicine; Test set; Oncology; Cancer; Computer science; Internal medicine","score_opus":0.03209663178769579,"score_gpt":0.34076012082320745,"score_spread":0.30866348903551166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198582500","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4409113,0.003162842,0.5417856,0.0036506406,0.0005891815,0.0002521278,0.0016179193,0.0013641746,0.0066660424],"genre_scores_gemma":[0.94488746,0.00036183491,0.050294053,0.00024535754,0.00034854436,0.00010313721,0.0009788213,0.000028492132,0.0027523697],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9994505,0.0001999115,0.00005515353,0.00013577584,0.00009000446,0.000068695204],"domain_scores_gemma":[0.99757236,0.0018244585,0.00012133884,0.00008446623,0.00032600726,0.000071466304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017065266,0.00055593863,0.00081074913,0.001810416,0.000526523,0.0011782174,0.0009908528,0.0011027892,0.0013775653],"category_scores_gemma":[0.004765232,0.00023545034,0.00093591487,0.00087322504,0.00026733827,0.00070509943,0.0005274088,0.0015003027,0.0004036083],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062609016,0.0012276383,0.062275425,0.00009927872,0.00040819665,0.00023206002,0.000091773414,0.38050693,0.001811619,0.003322227,0.0056768428,0.543722],"study_design_scores_gemma":[0.000013202533,0.000074519194,0.0030340136,0.00000827212,0.000028531425,0.000038632003,0.000013714212,0.9936923,0.00027314664,0.002511187,0.0003046317,0.0000079958445],"about_ca_topic_score_codex":0.0066460376,"about_ca_topic_score_gemma":0.0052404176,"teacher_disagreement_score":0.0066460376,"about_ca_system_score_codex":0.00069890276,"about_ca_system_score_gemma":0.00089271594,"threshold_uncertainty_score":0.013214707},"labels":[],"label_agreement":null},{"id":"W3198886682","doi":"10.1016/j.urolonc.2021.07.028","title":"Feasibility and outcome of radical prostatectomy following inductive neoadjuvant therapy in patients with suspicion of rectal infiltration","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Rectum; Prostatectomy; Prostate cancer; Surgery; Urology; Neoadjuvant therapy; Prostate; Internal medicine; Cancer","score_opus":0.03644382450356771,"score_gpt":0.32062846646528964,"score_spread":0.28418464196172194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198886682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99712867,0.00069725927,0.00016449435,0.00018338181,0.000020447935,0.000013523087,0.00010833641,0.000005944931,0.0016780256],"genre_scores_gemma":[0.999315,0.00016038434,0.00008523627,0.000037366248,0.00004952537,0.0000067613187,0.00020111215,0.0000020008827,0.00014243645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960035,0.0001337961,0.000033360786,0.000051993615,0.0000571189,0.0001234518],"domain_scores_gemma":[0.99794096,0.0011028877,0.00033906708,0.00007651039,0.000096288226,0.0004443152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007041349,0.00024804627,0.00030965195,0.0006360033,0.00044857015,0.0006232419,0.00038383386,0.0005559964,0.0019108587],"category_scores_gemma":[0.0043379744,0.00017803129,0.0005448566,0.00034177903,0.00052541227,0.00059791206,0.0004965485,0.00052572414,0.00030223627],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004317689,0.0002741933,0.97539234,0.000049440605,0.00004833425,0.004037546,0.00013228506,0.00076487707,0.0015649644,0.00011580992,0.00024923575,0.01305336],"study_design_scores_gemma":[0.00004613785,0.002274281,0.9890525,0.00001913126,0.00007272311,0.0062729944,0.0003030084,0.0009528346,0.0005056892,0.000142332,0.00033935846,0.000019052404],"about_ca_topic_score_codex":0.0014358446,"about_ca_topic_score_gemma":0.002386722,"teacher_disagreement_score":0.0019108587,"about_ca_system_score_codex":0.00048585833,"about_ca_system_score_gemma":0.0006216381,"threshold_uncertainty_score":0.006392479},"labels":[],"label_agreement":null},{"id":"W3200262534","doi":"10.1016/j.urolonc.2021.07.027","title":"Combination MRI-targeted and systematic prostate biopsy may overestimate gleason grade on final surgical pathology and impact risk stratification","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Biopsy; Downgrade; Concordance; Prostate biopsy; Radiology; Prostate cancer; Internal medicine; Cancer","score_opus":0.031565781806074916,"score_gpt":0.33073538435162336,"score_spread":0.2991696025455485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200262534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8954417,0.046301775,0.025576439,0.0059219766,0.0015700441,0.00019073935,0.0012377899,0.00091488863,0.022844749],"genre_scores_gemma":[0.983603,0.0027019945,0.01015455,0.0012145798,0.0006195527,0.00001977936,0.00050987053,0.00009876879,0.0010779089],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99714154,0.0010657436,0.00031717235,0.00048008887,0.00076839677,0.00022710495],"domain_scores_gemma":[0.9948855,0.0020391315,0.0011833392,0.00043947206,0.0010724032,0.00038006232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031344425,0.001236906,0.0015028587,0.002212619,0.0005322247,0.0017049513,0.000761656,0.0008769997,0.0026650806],"category_scores_gemma":[0.014087126,0.0006717962,0.0010468235,0.001249819,0.0005050508,0.0012958741,0.00094098103,0.000857642,0.0010422723],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016590956,0.00019110073,0.83624953,0.00062279776,0.0012306186,0.00090352836,0.000117455624,0.002634253,0.01398711,0.00039290942,0.0043915566,0.13762003],"study_design_scores_gemma":[0.00009567586,0.001463937,0.9539017,0.0004336737,0.0019570556,0.009469563,0.00025895776,0.0147215035,0.008893011,0.0021486296,0.0065484457,0.00010778568],"about_ca_topic_score_codex":0.0038641875,"about_ca_topic_score_gemma":0.014913465,"teacher_disagreement_score":0.0038641875,"about_ca_system_score_codex":0.0005188944,"about_ca_system_score_gemma":0.0009794352,"threshold_uncertainty_score":0.016576707},"labels":[],"label_agreement":null},{"id":"W3200324071","doi":"10.1016/j.urolonc.2021.08.013","title":"Subpathologies and genomic classifier for treatment individualization of post-prostatectomy radiotherapy","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Internal medicine; Cohort; Radiation therapy; Biochemical recurrence; Metastasis; Oncology; Gastroenterology; Cancer; Urology; Surgery","score_opus":0.04216608076412808,"score_gpt":0.33246388720108516,"score_spread":0.2902978064369571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200324071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9504402,0.0053112675,0.031846967,0.001342948,0.00025884842,0.00014670502,0.0048672953,0.00080203934,0.0049836864],"genre_scores_gemma":[0.983011,0.0007163177,0.010673551,0.0002763967,0.00018651458,0.000061466046,0.0038738803,0.00009288232,0.001107913],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999432,0.000119073426,0.00004972114,0.00019290824,0.00011209855,0.00009412533],"domain_scores_gemma":[0.9985953,0.0006346331,0.00025534525,0.00013917401,0.0002542043,0.000121430014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010406843,0.00042174052,0.0007281774,0.0021455614,0.00047573983,0.0010653858,0.0004991148,0.00059752556,0.002381188],"category_scores_gemma":[0.00385017,0.00015149688,0.00085604587,0.0011655738,0.0002693646,0.00051762414,0.0006785997,0.00079161144,0.00077906204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010696606,0.00017894314,0.77487755,0.00016367229,0.0004920573,0.00051531714,0.00016317684,0.004955568,0.0133675225,0.000705393,0.004202893,0.19930819],"study_design_scores_gemma":[0.0000958929,0.00069684145,0.8906838,0.00016128934,0.0020487795,0.0029158904,0.0005024448,0.07156285,0.011557167,0.008905579,0.010802731,0.00006675214],"about_ca_topic_score_codex":0.001704355,"about_ca_topic_score_gemma":0.0024678914,"teacher_disagreement_score":0.002381188,"about_ca_system_score_codex":0.00034344877,"about_ca_system_score_gemma":0.0005955086,"threshold_uncertainty_score":0.007965803},"labels":[],"label_agreement":null},{"id":"W3200904978","doi":"10.1016/j.urolonc.2021.08.016","title":"Prognostic significance of extent of venous tumor thrombus in patients with non-metastatic renal cell carcinoma: Results from a Canadian multi-institutional collaborative","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; University of Toronto; McMaster University; University of Calgary; University of Ottawa; McGill University; University of British Columbia; University of Manitoba; Ottawa Hospital; University of Alberta; Université de Montréal; Université Laval","funders":"","keywords":"Medicine; Renal cell carcinoma; Interquartile range; Cohort; Internal medicine; Thrombus; Cancer; Statistical significance; Carcinoma; Kidney cancer; Oncology; Surgery","score_opus":0.019694132130670793,"score_gpt":0.2568181782263729,"score_spread":0.2371240460957021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200904978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99531496,0.0003121992,0.00007981822,0.00019421823,0.000009752239,0.000046704885,0.002774699,0.0000049023074,0.001262818],"genre_scores_gemma":[0.9968035,0.0003110218,0.00017501785,0.00006949637,0.000017286875,0.000018651754,0.0022288912,0.0000048717243,0.00037130868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867284,0.00017758243,0.000077404795,0.0002271641,0.00051100785,0.00033411666],"domain_scores_gemma":[0.9960975,0.00031821989,0.0006101707,0.00016277017,0.0019321438,0.0008791874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014765391,0.00044604272,0.0005753214,0.0014727217,0.002200221,0.0011993062,0.0013370005,0.00064940075,0.0010752374],"category_scores_gemma":[0.0047955764,0.000285989,0.0006003421,0.00402592,0.00057469006,0.00041777868,0.0010628373,0.000708937,0.00016282396],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012945855,0.000035800826,0.99718946,0.000010202992,0.000063675776,0.000042383006,0.0002915311,0.00007676854,0.00013732881,0.000020372316,0.00039707005,0.0016060672],"study_design_scores_gemma":[0.000015123196,0.000030053014,0.99904734,0.0000053762487,0.000040704326,0.000051830182,0.00037361137,0.00009978883,0.000036684498,0.000008552702,0.0002841345,0.000006775946],"about_ca_topic_score_codex":0.9037192,"about_ca_topic_score_gemma":0.9439052,"teacher_disagreement_score":0.09628081,"about_ca_system_score_codex":0.009192157,"about_ca_system_score_gemma":0.013434693,"threshold_uncertainty_score":0.1936956},"labels":[],"label_agreement":null},{"id":"W3206770087","doi":"10.1016/j.urolonc.2021.09.008","title":"Survival benefit of chemotherapy in a contemporary cohort of metastatic urachal carcinoma","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Urinary and Genital Oncology Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Proportional hazards model; Chemotherapy; Internal medicine; Propensity score matching; Cohort; Incidence (geometry); Cystectomy; Epidemiology; Cumulative incidence; Oncology; Cancer; Surgery; Bladder cancer","score_opus":0.06077762158476715,"score_gpt":0.33366941525075156,"score_spread":0.27289179366598443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206770087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99902225,0.00034844843,0.000042557716,0.00007641221,0.0000059668528,0.0000022002928,0.00013087351,0.000002352719,0.0003689391],"genre_scores_gemma":[0.99947613,0.00015149271,0.000020144567,0.00003096991,0.000022182856,0.0000017888805,0.00018424526,0.0000017221912,0.000111440175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985266,0.000024431785,0.00000765553,0.000055780878,0.000017684986,0.000041892774],"domain_scores_gemma":[0.9996909,0.00008195352,0.00007585709,0.000037178575,0.000026131618,0.00008803909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021738186,0.00013276325,0.0003043358,0.0003215521,0.00045613543,0.00058115483,0.00019726927,0.0003128812,0.0015731016],"category_scores_gemma":[0.0010199731,0.000114855364,0.0002772493,0.00045050276,0.00027282775,0.00038792926,0.00032582978,0.00038211938,0.00019740286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00201889,0.00010055646,0.9832925,0.000017731267,0.00012762264,0.0006833139,0.00017105573,0.0004488219,0.0023499525,0.00015335719,0.00046792228,0.010168238],"study_design_scores_gemma":[0.00004643596,0.00055400433,0.99570507,0.0000067131064,0.00013870966,0.0012278188,0.0002267354,0.000694524,0.0001870989,0.0002065702,0.0009982506,0.000008155553],"about_ca_topic_score_codex":0.0026139913,"about_ca_topic_score_gemma":0.0034702586,"teacher_disagreement_score":0.0026139913,"about_ca_system_score_codex":0.0004338601,"about_ca_system_score_gemma":0.00022301583,"threshold_uncertainty_score":0.0052626133},"labels":[],"label_agreement":null},{"id":"W3216917116","doi":"10.1016/j.urolonc.2021.11.002","title":"Impact of sarcopenia on outcomes of patients treated with trimodal therapy for muscle invasive bladder cancer","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McGill University Health Centre","funders":"","keywords":"Sarcopenia; Medicine; Internal medicine; Bladder cancer; Urology; Quartile; Sarcopenic obesity; Body mass index; Incidence (geometry); Cystectomy; Retrospective cohort study; Cancer; Gastroenterology; Oncology; Confidence interval","score_opus":0.055132979760921234,"score_gpt":0.38626517195497545,"score_spread":0.3311321921940542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216917116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964103,0.0019266068,0.000041985393,0.0003966514,0.00004520017,0.000006074791,0.0002793526,0.0000028515994,0.0008910213],"genre_scores_gemma":[0.99891734,0.00045405736,0.000026569578,0.00010473075,0.00004895084,0.000006376686,0.0003009308,0.0000012796769,0.0001398283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996799,0.00009866715,0.000031868967,0.000045826062,0.000048629885,0.00009510135],"domain_scores_gemma":[0.9990508,0.00013756493,0.0004461301,0.000029856292,0.000089870366,0.0002457464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050391955,0.00016215448,0.00045289745,0.00026634452,0.00031351988,0.0006089328,0.00020602763,0.0003531902,0.0014668417],"category_scores_gemma":[0.0022470057,0.00009309017,0.0008771444,0.00058338215,0.00016836803,0.00037253965,0.00050132547,0.00075960177,0.00012821476],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036627767,0.00033945226,0.96409434,0.00011570895,0.0009038439,0.0000951952,0.000102985345,0.00040713258,0.00036747602,0.000057587637,0.0007139725,0.029139506],"study_design_scores_gemma":[0.00006259247,0.000877167,0.99787366,0.000038171478,0.000345083,0.00006125184,0.000112736205,0.00023582853,0.00004778621,0.00007685039,0.0002625188,0.000006319307],"about_ca_topic_score_codex":0.0027686437,"about_ca_topic_score_gemma":0.005379121,"teacher_disagreement_score":0.0027686437,"about_ca_system_score_codex":0.00042254452,"about_ca_system_score_gemma":0.00047034398,"threshold_uncertainty_score":0.0055050254},"labels":[],"label_agreement":null},{"id":"W4200135951","doi":"10.1016/j.urolonc.2021.10.010","title":"Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"KWF Kankerbestrijding; University of Toronto","keywords":"Cystectomy; Medicine; Bladder cancer; Immunohistochemistry; Stage (stratigraphy); Lymph node; Internal medicine; Ki-67; Gastroenterology; Single Center; Oncology; Pathology; Cancer; Urology; Biology","score_opus":0.030364975677093516,"score_gpt":0.328080711827127,"score_spread":0.2977157361500335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200135951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997265,0.000089784946,0.000031786036,0.00001129305,0.000002074482,0.000001930512,0.00008640894,0.000001214526,0.000048947903],"genre_scores_gemma":[0.9996716,0.000032655822,0.000034403514,0.000011273201,0.000005993059,0.0000026579964,0.00017336226,0.0000012025827,0.00006691785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996394,0.00008652327,0.000036036636,0.00011348416,0.000047616744,0.00007695437],"domain_scores_gemma":[0.9994174,0.000146354,0.00019068946,0.000052016683,0.00006089584,0.00013258905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004697494,0.00031030504,0.00052336743,0.000715393,0.00046152296,0.000715573,0.00035480672,0.00042762147,0.0008800208],"category_scores_gemma":[0.0010068767,0.0003445494,0.00052660634,0.0009598205,0.00025468593,0.00044235296,0.0004907996,0.00040286142,0.00017125103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003319784,0.000043607262,0.99770737,0.0000044704193,0.00009307354,0.00010402928,0.00006415093,0.00005064125,0.000528243,0.0000054500315,0.00005929965,0.0010077336],"study_design_scores_gemma":[0.000015857575,0.00015469693,0.99879104,0.00000193903,0.000084426705,0.00032964893,0.00019777041,0.00020619521,0.00011179475,0.000009416239,0.000092219016,0.0000049723453],"about_ca_topic_score_codex":0.0021596137,"about_ca_topic_score_gemma":0.0031243644,"teacher_disagreement_score":0.0021596137,"about_ca_system_score_codex":0.00032128766,"about_ca_system_score_gemma":0.0002806505,"threshold_uncertainty_score":0.004294038},"labels":[],"label_agreement":null},{"id":"W4210479555","doi":"10.1016/j.urolonc.2021.12.010","title":"Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Chromophobe cell; Interquartile range; Renal cell carcinoma; Clear cell renal cell carcinoma; Internal medicine; Clear cell; Oncology; Stage (stratigraphy); Nephrectomy; Radiology; Urology; Kidney","score_opus":0.06039941112047952,"score_gpt":0.3299964613434211,"score_spread":0.26959705022294156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210479555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.942882,0.03271994,0.003748898,0.0011491177,0.0024384018,0.00058744836,0.011808312,0.00016282762,0.0045031095],"genre_scores_gemma":[0.9857751,0.0029426953,0.00081752334,0.00086877675,0.0008855951,0.00024756536,0.006757174,0.00009392292,0.0016116446],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9960503,0.0022351863,0.00023850356,0.0007041864,0.00031517196,0.00045671896],"domain_scores_gemma":[0.9888016,0.008320003,0.0008129924,0.00079503015,0.0006459242,0.0006244091],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.009417485,0.0023668658,0.0050668423,0.0014618824,0.00056355365,0.0019696914,0.001333062,0.001368615,0.0051415595],"category_scores_gemma":[0.012823296,0.0005286489,0.013112376,0.001053211,0.00070202124,0.0023565465,0.0017637486,0.003013459,0.0009629907],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48760206,0.0014552921,0.23517187,0.003921139,0.16693231,0.0003127384,0.00048289954,0.008109968,0.0016689096,0.0007535217,0.01376859,0.07982066],"study_design_scores_gemma":[0.059544165,0.09189737,0.59502405,0.0018036385,0.2057474,0.0009573549,0.0027441657,0.020261494,0.0027351247,0.005378291,0.013343964,0.0005630869],"about_ca_topic_score_codex":0.004351334,"about_ca_topic_score_gemma":0.009161585,"teacher_disagreement_score":0.9949331,"about_ca_system_score_codex":0.00094802363,"about_ca_system_score_gemma":0.0013758831,"threshold_uncertainty_score":0.049805045},"labels":[],"label_agreement":null},{"id":"W4210741025","doi":"10.1016/j.urolonc.2021.12.006","title":"Uptake of re-resection in T1 bladder cancer: An interrupted population-based time series analysis among different groups of surgeons","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Institute for Work & Health; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Interrupted Time Series Analysis; Resection; Guideline; Bladder cancer; Poisson regression; Population; Autoregressive integrated moving average; Interrupted time series; Cohort; Surgery; Cancer; General surgery; Psychological intervention; Internal medicine; Time series; Pathology; Nursing","score_opus":0.024068480904417638,"score_gpt":0.31044619646088084,"score_spread":0.2863777155564632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210741025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982529,0.00036414328,0.000102257385,0.000056500176,0.000008902939,0.000005025414,0.000947156,0.0000050674616,0.00025791465],"genre_scores_gemma":[0.99875057,0.000111177185,0.000034735414,0.000020127161,0.000010222142,0.0000062413087,0.00090984453,0.000004335127,0.00015260848],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859065,0.00035508026,0.00017274842,0.00043564528,0.00012880444,0.0003171151],"domain_scores_gemma":[0.99429566,0.0012732797,0.0027327642,0.0007092528,0.0004314132,0.0005575506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015124889,0.00028506643,0.00049289665,0.0011263925,0.0003236669,0.0010290974,0.00083955267,0.00079360127,0.0025256383],"category_scores_gemma":[0.0058107576,0.00045937463,0.0016398926,0.0021312635,0.00034836258,0.00092604116,0.00080148614,0.0010664206,0.00036464864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031031884,0.00002964537,0.9983469,0.000013866918,0.0002847086,0.000039383554,0.00009047343,0.00009968472,0.00007532072,0.000022070082,0.00009219129,0.0005953248],"study_design_scores_gemma":[0.000007069054,0.00007720647,0.9988232,0.0000055647743,0.00010056024,0.00008458134,0.0002544947,0.00051659177,0.000023070474,0.000016857839,0.00008514153,0.0000056288727],"about_ca_topic_score_codex":0.016646499,"about_ca_topic_score_gemma":0.011013878,"teacher_disagreement_score":0.016646499,"about_ca_system_score_codex":0.00063935533,"about_ca_system_score_gemma":0.00047240302,"threshold_uncertainty_score":0.033099234},"labels":[],"label_agreement":null},{"id":"W4210826013","doi":"10.1016/j.urolonc.2021.12.018","title":"Stereotactic ablative radiation therapy for renal cell carcinoma with inferior vena cava tumor thrombus","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"National Cancer Institute","keywords":"SABR volatility model; Medicine; Renal cell carcinoma; Inferior vena cava; Surgery; Radiation therapy; Radiology; Internal medicine","score_opus":0.030381952682203686,"score_gpt":0.28678817229217696,"score_spread":0.2564062196099733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210826013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90147334,0.03197415,0.0072868373,0.00642815,0.0010848811,0.00034431726,0.0004407452,0.0003347942,0.050632708],"genre_scores_gemma":[0.9888103,0.0052785696,0.0015277959,0.0007093753,0.000594793,0.000025139274,0.00015363294,0.000026817643,0.0028735963],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9999,0.000013938048,0.000008143649,0.000012497216,0.000032452772,0.00003299915],"domain_scores_gemma":[0.9998692,0.000044731496,0.00002902778,0.00001838794,0.000010047674,0.000028541846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020862771,0.00020226034,0.00033714928,0.0007735382,0.000387056,0.00034807858,0.00039627077,0.0006462452,0.0022667968],"category_scores_gemma":[0.00065607956,0.00016177687,0.00046235515,0.0006074868,0.00039408018,0.00036865746,0.00018761164,0.0007303196,0.00048913294],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019519432,0.00077738694,0.057512585,0.000751803,0.0003646776,0.69350195,0.00047092282,0.00272618,0.04953208,0.004882127,0.014753764,0.17277458],"study_design_scores_gemma":[0.00082347536,0.002972761,0.16766208,0.00015021679,0.00057996635,0.7472592,0.00018074783,0.0052782674,0.032516565,0.0027642061,0.039751105,0.00006141137],"about_ca_topic_score_codex":0.0017388304,"about_ca_topic_score_gemma":0.0027020255,"teacher_disagreement_score":0.0022667968,"about_ca_system_score_codex":0.00081207405,"about_ca_system_score_gemma":0.00089366233,"threshold_uncertainty_score":0.007583201},"labels":[],"label_agreement":null},{"id":"W4212945456","doi":"10.1016/j.urolonc.2022.01.005","title":"Outcomes following cytoreductive nephrectomy without immediate postoperative systemic therapy for patients with synchronous metastatic renal cell carcinoma","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Systemic therapy; Metastasectomy; Renal cell carcinoma; Nephrectomy; Surgery; Internal medicine; Metastasis; Cancer; Kidney; Breast cancer","score_opus":0.02036302867564935,"score_gpt":0.2809911818542471,"score_spread":0.2606281531785977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212945456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99639964,0.0013210186,0.00014623109,0.00027400372,0.00007174209,0.000011137991,0.00029536505,0.0000048222973,0.001475918],"genre_scores_gemma":[0.9987198,0.00031897123,0.000039106653,0.00007572575,0.000050987575,0.000005239653,0.0006086741,0.0000022865518,0.00017924808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996252,0.00006644399,0.000037668273,0.00006359677,0.00007836664,0.00012864286],"domain_scores_gemma":[0.99907696,0.00015646391,0.00031347817,0.00004092655,0.00006836159,0.00034378935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033723898,0.0002157934,0.0004350303,0.00037486723,0.00057777116,0.000790471,0.0004194483,0.00038256898,0.0014030575],"category_scores_gemma":[0.0022882377,0.00012972827,0.0010365533,0.0005274254,0.0003865064,0.00054056186,0.00083627005,0.00066249695,0.00015509754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018772461,0.00025461343,0.9710008,0.00008974876,0.0004599172,0.0020728027,0.00024840952,0.0010751497,0.0006142449,0.00016776792,0.0011005476,0.02103866],"study_design_scores_gemma":[0.00006423703,0.0010753775,0.99361044,0.00004306875,0.00028103858,0.0025034854,0.0006323667,0.0005836782,0.00017438718,0.00033969607,0.00067222473,0.00002005528],"about_ca_topic_score_codex":0.0033572405,"about_ca_topic_score_gemma":0.009166816,"teacher_disagreement_score":0.0033572405,"about_ca_system_score_codex":0.001194334,"about_ca_system_score_gemma":0.00062813447,"threshold_uncertainty_score":0.008665502},"labels":[],"label_agreement":null},{"id":"W4214547776","doi":"10.1016/j.urolonc.2022.01.009","title":"Real-world use of systemic therapies in men with metastatic castration resistant prostate cancer (mCRPC) in Canada","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Queen Elizabeth II Health Sciences Centre; Dalhousie University; University of British Columbia; BC Cancer Agency; London Health Sciences Centre; University of Alberta; Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Calgary; University of Ottawa; McGill University; Western University; University of Toronto; Ottawa Hospital; Jewish General Hospital; McMaster University; Juravinski Cancer Centre; St. Joseph’s Healthcare Hamilton","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Prostate cancer; Oncology; Taxane; Docetaxel; Internal medicine; Cabazitaxel; Population; Proportional hazards model; Systemic therapy; Cohort; Cancer; Androgen deprivation therapy; Breast cancer","score_opus":0.048954909469585695,"score_gpt":0.3267261583704557,"score_spread":0.27777124890087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214547776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97306323,0.0020722449,0.00023373375,0.0012517957,0.000019466903,0.00011680354,0.020722745,0.000023874149,0.0024960744],"genre_scores_gemma":[0.99425066,0.00092989544,0.00027382583,0.00024152281,0.000011998457,0.000031718177,0.0037723174,0.0000053197664,0.00048271933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864036,0.00011586881,0.00011665491,0.00022230895,0.0005074629,0.00039728335],"domain_scores_gemma":[0.9963701,0.00025316462,0.0013867907,0.00010518325,0.0011623703,0.0007223498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077109114,0.0002422063,0.00042086237,0.0011050513,0.0018847839,0.0011833187,0.001143328,0.0004196109,0.0018311371],"category_scores_gemma":[0.0028426514,0.00032252597,0.0006340614,0.0047168224,0.00073651277,0.00040786093,0.0008459364,0.0008011776,0.00015064927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000092018134,0.000031632262,0.9931352,0.00010420171,0.000074414515,0.000112561414,0.00044466686,0.00035745377,0.00010133044,0.00016122339,0.0017597629,0.0036255121],"study_design_scores_gemma":[0.00001948754,0.000039159375,0.9956079,0.00007795678,0.00004318699,0.0001330367,0.0011045277,0.0007963992,0.00007881872,0.00005133867,0.0020269782,0.000021186474],"about_ca_topic_score_codex":0.9944807,"about_ca_topic_score_gemma":0.9964818,"teacher_disagreement_score":0.04583782,"about_ca_system_score_codex":0.04583782,"about_ca_system_score_gemma":0.050546017,"threshold_uncertainty_score":0.33257824},"labels":[],"label_agreement":null},{"id":"W4223999413","doi":"10.1016/j.urolonc.2022.03.011","title":"Variability in testosterone measurement between radioimmunoassay (RIA), chemiluminescence assay (CLIA) and liquid chromatography-tandem mass spectrometry (MS) among prostate cancer patients on androgen deprivation therapy (ADT)","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Princess Margaret Cancer Centre; University of Toronto","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Radioimmunoassay; Prostate cancer; Androgen deprivation therapy; Concordance; Medicine; Testosterone (patch); Internal medicine; Cancer","score_opus":0.038061561165329195,"score_gpt":0.30414934970652113,"score_spread":0.2660877885411919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223999413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954476,0.0009613512,0.0024689622,0.000070035196,0.000058284182,0.0000119768565,0.00022953542,0.00004548042,0.0007067734],"genre_scores_gemma":[0.9992256,0.00006347243,0.00034436112,0.00005152561,0.000020694293,0.000004643053,0.00015581334,0.000006883683,0.00012696271],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99586177,0.001617551,0.00036039174,0.00082156545,0.0011814223,0.0001572554],"domain_scores_gemma":[0.9918252,0.0054853656,0.0009203349,0.0007012963,0.00084967713,0.0002180718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038030394,0.00022484794,0.00036191478,0.0006584379,0.0002468287,0.00092589244,0.0003332327,0.0003488564,0.00027495832],"category_scores_gemma":[0.009330208,0.00017741733,0.0003386093,0.0007902989,0.00032393672,0.00023739364,0.0003419019,0.00051314343,0.0001793066],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019759366,0.000117763164,0.95500606,0.000052007115,0.00047510074,0.00013156176,0.0007645553,0.00062125846,0.01358305,0.00012505222,0.0003225397,0.026825106],"study_design_scores_gemma":[0.000026936415,0.0008505552,0.9888158,0.00001020511,0.00015718414,0.0007063812,0.000180814,0.00232816,0.006016997,0.00013273978,0.0007539329,0.000020240854],"about_ca_topic_score_codex":0.0019993524,"about_ca_topic_score_gemma":0.0018877524,"teacher_disagreement_score":0.0038030394,"about_ca_system_score_codex":0.00044117784,"about_ca_system_score_gemma":0.00029554317,"threshold_uncertainty_score":0.020112634},"labels":[],"label_agreement":null},{"id":"W4224067951","doi":"10.1016/j.urolonc.2022.03.014","title":"Survival trends in chemotherapy exposed metastatic bladder cancer patients and chemotherapy effect across different age, sex, and race/ethnicity","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Chemotherapy; Race (biology); Medicine; Oncology; Ethnic group; Bladder cancer; Internal medicine; Overall survival; Cancer; Biology","score_opus":0.03306754418097076,"score_gpt":0.3492049090228632,"score_spread":0.3161373648418925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224067951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957254,0.00043411614,0.00008814085,0.000096214375,0.000012194104,0.0000039559136,0.0022206013,0.000008212289,0.0014112727],"genre_scores_gemma":[0.9973774,0.00021448085,0.000038865823,0.00004629882,0.000012294131,0.0000056566673,0.0013578645,0.0000047467215,0.00094247365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998454,0.000021647022,0.000015977352,0.000048718386,0.000014701881,0.000053650823],"domain_scores_gemma":[0.99950933,0.00008837392,0.00019095486,0.00003034964,0.00007152945,0.00010946411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024259754,0.000099823264,0.00019757176,0.00040117843,0.00022599306,0.00035522826,0.00018284786,0.00023865659,0.004161957],"category_scores_gemma":[0.0010899195,0.000104538,0.0005589659,0.00067780085,0.00010683753,0.0004420992,0.00025245352,0.00045733814,0.00032053317],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055251276,0.000042568336,0.9941064,0.000018501627,0.000120917255,0.000058928676,0.00009204911,0.00012966678,0.00050530734,0.00006676323,0.00039628492,0.0039099758],"study_design_scores_gemma":[0.000005488366,0.00011717411,0.9987313,0.000005902263,0.00005332609,0.00010235587,0.00024373647,0.00018526019,0.00009078247,0.00003829026,0.0004224055,0.0000039148617],"about_ca_topic_score_codex":0.007902068,"about_ca_topic_score_gemma":0.013152335,"teacher_disagreement_score":0.007902068,"about_ca_system_score_codex":0.0002424602,"about_ca_system_score_gemma":0.00032163365,"threshold_uncertainty_score":0.015712142},"labels":[],"label_agreement":null},{"id":"W4226302670","doi":"10.1016/j.urolonc.2022.02.021","title":"The prognostic value of urinary cytology after trimodal therapy (TMT) for muscle-invasive bladder cancer","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Cytology; Medicine; Cystoscopy; Bladder cancer; Urine cytology; Urinary system; Internal medicine; Cancer; Urology; Pathology","score_opus":0.030104106422192228,"score_gpt":0.3265574076720914,"score_spread":0.29645330124989916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226302670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99316424,0.00486171,0.00015430854,0.00036302715,0.00011314437,0.000008123431,0.00019366553,0.000015203743,0.0011264905],"genre_scores_gemma":[0.9991393,0.0003810596,0.00005446625,0.00004781425,0.000078716825,0.000001836165,0.0001392987,0.0000031064953,0.00015440679],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961424,0.00010798915,0.000044957756,0.000058750044,0.000083862,0.00009018522],"domain_scores_gemma":[0.99611986,0.0017521578,0.000867352,0.00018823391,0.0004482487,0.0006242014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082329515,0.00022811485,0.00036114547,0.00060752005,0.0003173475,0.00087113155,0.00040591494,0.00062902947,0.0012074979],"category_scores_gemma":[0.0075600273,0.00012428816,0.00039921483,0.00073730137,0.00038366666,0.00072364457,0.00038309104,0.0006572956,0.00025592957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020065776,0.0000626401,0.97574526,0.000038008653,0.000102568956,0.00024109191,0.00004604827,0.0002946453,0.00093149586,0.000023610215,0.00030676913,0.020201225],"study_design_scores_gemma":[0.000014494076,0.0003869121,0.99728084,0.000016461354,0.00014524566,0.00038710315,0.00010994417,0.0007376103,0.00040554485,0.00005776509,0.00044935508,0.0000086785285],"about_ca_topic_score_codex":0.0021498546,"about_ca_topic_score_gemma":0.0031889796,"teacher_disagreement_score":0.0021498546,"about_ca_system_score_codex":0.00045477,"about_ca_system_score_gemma":0.00048594098,"threshold_uncertainty_score":0.004354},"labels":[],"label_agreement":null},{"id":"W4229364404","doi":"10.1016/j.urolonc.2022.03.019","title":"Salvage partial gland ablation for recurrent prostate cancer following primary partial gland ablation: Functional and oncological outcomes","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Prostate gland; Ablation; Prostate cancer; Cancer; Prostate; Medicine; Oncology; Internal medicine","score_opus":0.04243989265858021,"score_gpt":0.32864826765516775,"score_spread":0.2862083749965875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229364404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99150896,0.004712636,0.00032720147,0.00026177493,0.00007183195,0.000018557479,0.00045601832,0.000018371704,0.0026246675],"genre_scores_gemma":[0.99797076,0.00066218514,0.00008961051,0.00012385004,0.00008933934,0.000006279812,0.0005963194,0.0000040622617,0.000457514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99972504,0.00005867497,0.000022157317,0.000036477137,0.00007198015,0.00008569656],"domain_scores_gemma":[0.99912924,0.00016333471,0.00029179134,0.000055558594,0.00007664052,0.0002834411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042145295,0.00022069702,0.0005415832,0.00040688174,0.00031431927,0.00073049153,0.0003799579,0.0004134014,0.0021735737],"category_scores_gemma":[0.0015748484,0.00006933374,0.0010755227,0.0004436143,0.00028453203,0.0005568166,0.0003953439,0.0004643892,0.0003666862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004299479,0.0008760128,0.8210824,0.0002806259,0.0008653458,0.0030340455,0.00043624904,0.0011692832,0.0021628581,0.0002866728,0.0023430444,0.16316403],"study_design_scores_gemma":[0.00006128288,0.0029024673,0.98905444,0.000073177696,0.0004076374,0.0047542453,0.00029185868,0.00059671386,0.0003507686,0.00036993856,0.0011163104,0.000021199512],"about_ca_topic_score_codex":0.0012352337,"about_ca_topic_score_gemma":0.0032420333,"teacher_disagreement_score":0.0021735737,"about_ca_system_score_codex":0.0005436196,"about_ca_system_score_gemma":0.00035541912,"threshold_uncertainty_score":0.0072713494},"labels":[],"label_agreement":null},{"id":"W4229769653","doi":"10.1016/j.urolonc.2013.10.004","title":"Outcomes in patients with metastatic renal cell cancer treated with individualized sunitinib therapy: Correlation with dynamic microbubble ultrasound data and review of the literature","year":2013,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Sunitinib; Medicine; Toxicity; Internal medicine; Oncology; Cancer; Renal cell carcinoma; Urology","score_opus":0.022585551828201714,"score_gpt":0.2871025089758623,"score_spread":0.2645169571476606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229769653","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.48316258,0.510416,0.0005737099,0.0009796107,0.00011482036,0.000022806082,0.0009535137,0.000018054365,0.0037589613],"genre_scores_gemma":[0.87639403,0.12174059,0.00043972972,0.00019069301,0.00026342098,0.000016628741,0.0007481699,0.000004869061,0.00020196919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997074,0.0000605834,0.00006349643,0.000049941023,0.00009837446,0.000020180383],"domain_scores_gemma":[0.9990478,0.00041077405,0.00037958755,0.000016572722,0.00010501029,0.000040172235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042066904,0.00013223021,0.0008178338,0.001290056,0.0001698426,0.00055289693,0.00024111115,0.00023965328,0.0004478176],"category_scores_gemma":[0.0023008566,0.00006737281,0.0005130495,0.0019396233,0.00020276025,0.00036019288,0.00019951195,0.00022801917,0.00006519351],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007607971,0.000068153095,0.8129632,0.0030786567,0.0010031355,0.0016269444,0.00021591446,0.00044325826,0.00096199167,0.00024761423,0.0013462378,0.17728408],"study_design_scores_gemma":[0.000035866637,0.00029911406,0.9779158,0.0009833225,0.0022950652,0.008728974,0.00050074316,0.000476481,0.0005184473,0.0002850206,0.0079265125,0.000034621928],"about_ca_topic_score_codex":0.0010020336,"about_ca_topic_score_gemma":0.0017227394,"teacher_disagreement_score":0.001290056,"about_ca_system_score_codex":0.00044210846,"about_ca_system_score_gemma":0.00041656775,"threshold_uncertainty_score":0.0032076836},"labels":[],"label_agreement":null},{"id":"W4229911199","doi":"10.1016/j.urolonc.2011.11.013","title":"Commentary on “International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: Long-term results of the BA06 30894 trial.” Griffiths G, Hall R, Sylvester R, Raghavan D, Parmar MK, and the International Collaboration of Trialists; Medical Research Council Advanced Bladder Cancer Working Party (now the National Cancer Research Institute Bladder Cancer Clinical Studies Group); European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group; Australian Bladder Cancer Study Group; National Cancer Institute of Canada Clinical Trials Group; Finnbladder; Norwegian Bladder Cancer Study Group; Club Urologico Espanol de Tratamiento Oncologico Group. Medical Research Council Clinical Trials Unit, London, United Kingdom","year":2012,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Vinblastine; Cisplatin; Methotrexate; Medicine; Bladder cancer; Chemotherapy; Urothelial cancer; Oncology; Internal medicine; Cancer","score_opus":0.5719069345010497,"score_gpt":0.5827083789599501,"score_spread":0.010801444458900411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229911199","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018846782,0.0022922878,0.00011519653,0.9298808,0.06617034,0.00004156661,0.00044184935,0.00004925563,0.00082028774],"genre_scores_gemma":[0.0009249014,0.0008995058,0.00015123514,0.9563387,0.039345555,0.00010157642,0.0000989823,0.000027021575,0.0021125057],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.988974,0.0042892518,0.0014269452,0.0014850049,0.003036967,0.0007878127],"domain_scores_gemma":[0.9488578,0.035461005,0.0026331004,0.0010524805,0.009035078,0.0029604614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015841413,0.0018550466,0.0036545973,0.0015492088,0.003523303,0.0031670793,0.007391719,0.054735992,0.0073218215],"category_scores_gemma":[0.07099305,0.0015809436,0.0040072375,0.002410685,0.004019381,0.0047007254,0.0018239375,0.05996409,0.008189962],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015194145,0.000007884223,0.00004866113,0.0001345775,0.00002489488,0.000070737544,0.000032554028,0.000029206301,0.0000541719,0.0004159364,0.9970193,0.0020101597],"study_design_scores_gemma":[0.0009049561,0.00018180325,0.0014752651,0.0017798956,0.00029701597,0.00045118472,0.00023424928,0.00040197375,0.0006302865,0.0053986534,0.9881052,0.00013949364],"about_ca_topic_score_codex":0.012877894,"about_ca_topic_score_gemma":0.016574148,"teacher_disagreement_score":0.054735992,"about_ca_system_score_codex":0.0069894674,"about_ca_system_score_gemma":0.0093141915,"threshold_uncertainty_score":0.08377838},"labels":[],"label_agreement":null},{"id":"W4230724877","doi":"10.1016/j.urolonc.2019.09.025","title":"Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer","year":2019,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia; University of British Columbia","funders":"","keywords":"Biology; Transcriptome; Phenotype; Bladder cancer; Pathology; Cancer research; Sarcoma; Cancer; Genetics; Gene; Gene expression; Medicine","score_opus":0.018139160072410038,"score_gpt":0.29046182176507557,"score_spread":0.2723226616926655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230724877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99405575,0.0013786145,0.0012540964,0.00017916205,0.000011975461,0.000030034502,0.0005815611,0.00004717885,0.002461663],"genre_scores_gemma":[0.99782264,0.0004013761,0.0006275941,0.00006110594,0.000008968145,0.000014441087,0.00047499235,0.000009744844,0.0005792491],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99976474,0.000029165758,0.0000251012,0.00006131468,0.00006565852,0.00005393788],"domain_scores_gemma":[0.99960274,0.00008186015,0.00010345753,0.00004393093,0.00010418516,0.00006390376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028707896,0.00011153476,0.00016862864,0.0012554779,0.00029816476,0.0007024418,0.00021778331,0.0003255463,0.0018603161],"category_scores_gemma":[0.0008211941,0.00013225494,0.00016639316,0.0006197214,0.000282843,0.00033633402,0.0004600574,0.0002880303,0.00029172417],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086700224,0.000116907475,0.520627,0.00021852745,0.00011148997,0.0016671529,0.00078874215,0.0007621079,0.42902562,0.0011023022,0.00069921016,0.04401395],"study_design_scores_gemma":[0.000015729876,0.00025303924,0.942512,0.000026024416,0.00009228286,0.004371115,0.0011851621,0.001354477,0.04421316,0.0006475648,0.0053196363,0.000009905696],"about_ca_topic_score_codex":0.00092543074,"about_ca_topic_score_gemma":0.0011502337,"teacher_disagreement_score":0.0018603161,"about_ca_system_score_codex":0.00021652508,"about_ca_system_score_gemma":0.0002390116,"threshold_uncertainty_score":0.0062233806},"labels":[],"label_agreement":null},{"id":"W4230810821","doi":"10.1016/j.urolonc.2021.05.036","title":"A 25-year perspective on advances in an understanding of the biology, evaluation, treatment and future directions/challenges of urothelial cancer","year":2021,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bladder cancer; Urothelial cancer; Cystectomy; Medicine; Clinical trial; Cancer; Immunotherapy; Oncology; Internal medicine","score_opus":0.1315954276886505,"score_gpt":0.4401467663277732,"score_spread":0.3085513386391227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230810821","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003313414,0.9942363,0.000079162935,0.0028807886,0.0022091365,0.0000030130318,0.000027444998,0.000007965658,0.0005232006],"genre_scores_gemma":[0.0003076713,0.9941964,0.00017477332,0.0024197144,0.002341897,0.000005066961,0.00004626472,0.000002168174,0.0005059721],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991689,0.00023229727,0.00011361804,0.00010581199,0.0002728658,0.000106576],"domain_scores_gemma":[0.99645835,0.0019982622,0.00032163886,0.00006229137,0.00084600615,0.00031344916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030296738,0.0012811322,0.0026095146,0.003151406,0.00045874278,0.002482122,0.0014454419,0.0029521917,0.008420053],"category_scores_gemma":[0.0046886136,0.00039329543,0.0012063684,0.0032298814,0.0009792374,0.0052339956,0.001795696,0.005046082,0.0030499524],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025974214,0.00010467093,0.0002960467,0.02525334,0.00016945673,0.00030117613,0.00013617711,0.00049868366,0.001479578,0.01037279,0.26753378,0.69359463],"study_design_scores_gemma":[0.000028136703,0.00014435635,0.0006192567,0.0074833124,0.00015451325,0.0005225547,0.00011319082,0.0000909023,0.0000912324,0.0036878544,0.9870346,0.000030052135],"about_ca_topic_score_codex":0.0017625651,"about_ca_topic_score_gemma":0.005029268,"teacher_disagreement_score":0.008420053,"about_ca_system_score_codex":0.0015299844,"about_ca_system_score_gemma":0.0036171852,"threshold_uncertainty_score":0.028167903},"labels":[],"label_agreement":null},{"id":"W4247927392","doi":"10.1016/j.urolonc.2016.12.021","title":"Chemohormonal therapy in metastatic hormone-sensitive prostate cancer. Sweeney CJ, Chen YH, Carducci M, Liu G, Jarrard DF, Eisenberger M, Wong YN, Hahn N, Kohli M, Cooney MM, Dreicer R, Vogelzang NJ, Picus J, Shevrin D, Hussain M, Garcia JA, DiPaola RS. Department of Medicine; Department of Biostatistics and Computational Biology; Dana-Farber Cancer Institute, Boston; Harvard Medical School, Boston; Johns Hopkins University, Baltimore; University of Wisconsin Carbone Cancer Center; School of Medicine and Public Health; Madison; Fox Chase Cancer Center, Temple University Health System, Philadelphia; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis; Mayo Clinic, Rochester, MN; University Hospitals Case Medical Center, Seidman Cancer Center; Cleveland Clinic Taussig Cancer Institute; Both in Cleveland; University of Virginia Cancer Center, Charlottesville; Comprehensive Cancer Centers of Nevada, Las Vegas; Siteman Cancer Center, Washington University School of Medicine, St. Louis; NorthShore University Health System, Evanston, IL; University of Michigan Comprehensive Cancer Center, Ann Arbor; Rutgers Cancer Institute of New Jersey, New Brunswick.N Engl J Med. 2015 Aug 20;373(8):737-46. [Epub 2015 Aug 5]. doi: 10.1056/NEJMoa1503747.","year":2017,"lang":"en","type":"letter","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Docetaxel; Androgen deprivation therapy; Medicine; Prostate cancer; Hazard ratio; Urology; Internal medicine; Combination therapy; Cancer; Oncology; Confidence interval; Surgery","score_opus":0.05452041160486256,"score_gpt":0.33954735402472885,"score_spread":0.2850269424198663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247927392","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034334306,0.6618522,0.0010307456,0.09407127,0.013832186,0.00050708005,0.004453848,0.00033029795,0.18958807],"genre_scores_gemma":[0.3328521,0.5190021,0.002810867,0.029906997,0.02159135,0.00049502857,0.004408293,0.00011122895,0.088822104],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999762,0.00007707501,0.00002163529,0.000021501732,0.00007975982,0.0000379693],"domain_scores_gemma":[0.99949026,0.00023510194,0.000051408533,0.00003084487,0.00007040202,0.0001219873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007652004,0.00019702809,0.00042037942,0.00058770453,0.0003992542,0.0005906083,0.000380978,0.0004917622,0.024298385],"category_scores_gemma":[0.001908276,0.00013088618,0.00045946552,0.00064357027,0.00026797317,0.0003885327,0.00039132804,0.0010470244,0.0023853933],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011913569,0.00039960697,0.006829126,0.0014122297,0.00012311233,0.0007820553,0.0000907634,0.000496301,0.0013153496,0.0020198382,0.35392687,0.63141334],"study_design_scores_gemma":[0.0015232331,0.0019250549,0.055850897,0.0028603373,0.0003932124,0.0037105798,0.00019723317,0.0007933509,0.0019693724,0.007402041,0.9233279,0.00004672651],"about_ca_topic_score_codex":0.0020273149,"about_ca_topic_score_gemma":0.007808781,"teacher_disagreement_score":0.024298385,"about_ca_system_score_codex":0.0007281878,"about_ca_system_score_gemma":0.0011619045,"threshold_uncertainty_score":0.08128625},"labels":[],"label_agreement":null},{"id":"W4255597075","doi":"10.1016/s1078-1439(03)00080-2","title":"Interstitial photodynamic therapy in subcutaneously implanted urologic tumors in rats after intravenous administration of 5-aminolevulinic acid","year":2003,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Photodynamic therapy; Intravenous therapy; Urology; Pharmacology; Internal medicine; Chemistry","score_opus":0.022588322305023435,"score_gpt":0.3213904358901353,"score_spread":0.29880211358511183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255597075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919939,0.0020398607,0.0025430226,0.00017925088,0.00020143074,0.00007788787,0.0004125118,0.0003323909,0.0022198162],"genre_scores_gemma":[0.9901731,0.0014815648,0.001703546,0.000067099034,0.00006839863,0.00009161498,0.00047146692,0.0000705144,0.0058727576],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995845,0.000048614624,0.0000203043,0.00008575522,0.000055023113,0.00020577907],"domain_scores_gemma":[0.99926144,0.00018056428,0.00019355801,0.00011062733,0.00006502968,0.00018880128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005073603,0.0012167861,0.0009058094,0.0012998626,0.00053215167,0.0005366376,0.00080907333,0.0009118984,0.002342537],"category_scores_gemma":[0.00033302436,0.000686212,0.00093774655,0.0006983681,0.0011833163,0.0011038445,0.00029121037,0.0017506684,0.00046427545],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006320394,0.0008848558,0.00044674685,0.00010103062,0.000036589223,0.00015140812,0.00011528468,0.0003261131,0.9870825,0.0004243939,0.0001692159,0.0039415476],"study_design_scores_gemma":[0.00009297375,0.00313065,0.0010879585,0.0000052847704,0.000057735866,0.000069887334,0.000045061624,0.0006809108,0.99427843,0.00006543978,0.0004759055,0.0000097908505],"about_ca_topic_score_codex":0.0056796535,"about_ca_topic_score_gemma":0.0048500057,"teacher_disagreement_score":0.0056796535,"about_ca_system_score_codex":0.00080451777,"about_ca_system_score_gemma":0.0013927494,"threshold_uncertainty_score":0.011293232},"labels":[],"label_agreement":null},{"id":"W4256418686","doi":"10.1016/j.urolonc.2010.07.012","title":"Re: Clinical significance of the positive surgical margin based upon location, grade and stage","year":2010,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Stage (stratigraphy); Margin (machine learning); Clinical significance; Medicine; Geology; Computer science; Internal medicine; Paleontology; Machine learning","score_opus":0.037721799938541745,"score_gpt":0.3523478381595695,"score_spread":0.31462603822102775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256418686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87790537,0.010665028,0.0071389084,0.0034092793,0.0014660498,0.00030542823,0.016705373,0.0007419507,0.08166259],"genre_scores_gemma":[0.992203,0.00029603913,0.0015904424,0.0002783742,0.0003555537,0.000039966082,0.0015566482,0.00007015704,0.0036098945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911255,0.00023352826,0.00012054009,0.00013122855,0.00023229702,0.00016989089],"domain_scores_gemma":[0.9946103,0.0024356102,0.0014733376,0.00037128545,0.0006247956,0.0004846448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016836638,0.00064632,0.0005193739,0.0018641736,0.00025559377,0.00081696967,0.0009996078,0.00088328106,0.015578397],"category_scores_gemma":[0.010973893,0.00011105644,0.00083530997,0.0006617211,0.0006566269,0.0010391101,0.000715884,0.0009994174,0.0025740124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005772838,0.00013560368,0.89192516,0.00056636945,0.00053209596,0.0010951725,0.00012473848,0.0008026422,0.0063675535,0.0006759156,0.012249622,0.07975239],"study_design_scores_gemma":[0.00015231172,0.0010914078,0.9697788,0.00014859738,0.0006122506,0.00896192,0.00059070875,0.0023885553,0.0035194422,0.0015030047,0.011185831,0.000067093286],"about_ca_topic_score_codex":0.00083808287,"about_ca_topic_score_gemma":0.002050449,"teacher_disagreement_score":0.015578397,"about_ca_system_score_codex":0.00033018956,"about_ca_system_score_gemma":0.00031877478,"threshold_uncertainty_score":0.052114904},"labels":[],"label_agreement":null},{"id":"W4280597367","doi":"10.1016/j.urolonc.2022.04.006","title":"Venous thromboembolism risk in patients receiving neoadjuvant chemotherapy for bladder cancer","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Toronto; University of Ottawa","funders":"","keywords":"Medicine; Cystectomy; Chemotherapy; Bladder cancer; Retrospective cohort study; Incidence (geometry); Internal medicine; Neoadjuvant therapy; Surgery; Oncology; Cancer; Breast cancer","score_opus":0.019075713025839765,"score_gpt":0.3036513108270406,"score_spread":0.28457559780120084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280597367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99629897,0.001759935,0.00007141328,0.00032401012,0.000026931779,0.000005447266,0.00015219439,0.000002845427,0.0013581896],"genre_scores_gemma":[0.99890244,0.00057979155,0.00006258295,0.000086955304,0.000041263702,0.0000042720603,0.000122010715,0.0000012834319,0.00019936259],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984384,0.000049200677,0.00002098406,0.00001793753,0.000037049118,0.000030922325],"domain_scores_gemma":[0.99932814,0.00022647102,0.000258203,0.0000201131,0.00004042335,0.00012671275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017530056,0.00009585146,0.00018179559,0.0003083019,0.00021921557,0.0004380506,0.00010388859,0.0003398259,0.0011096115],"category_scores_gemma":[0.0023510107,0.00012232404,0.0001917925,0.00056504866,0.00012612063,0.0002281675,0.00015986634,0.00046153393,0.000101095415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029534684,0.000034078883,0.99479914,0.000015373951,0.000029156525,0.00024161319,0.000037380563,0.00005304066,0.00024439764,0.00002219199,0.00015765266,0.0040707523],"study_design_scores_gemma":[0.000010536192,0.00016424718,0.9979565,0.000014551778,0.000047670736,0.000895502,0.00013428969,0.00019705921,0.00011145989,0.000046790003,0.0004174659,0.0000039742526],"about_ca_topic_score_codex":0.0016058849,"about_ca_topic_score_gemma":0.0029634896,"teacher_disagreement_score":0.0016058849,"about_ca_system_score_codex":0.00029587926,"about_ca_system_score_gemma":0.00033541358,"threshold_uncertainty_score":0.0037119985},"labels":[],"label_agreement":null},{"id":"W4281986020","doi":"10.1016/j.urolonc.2022.05.011","title":"Corrigendum to: Mechanistic target of rapamycin (mTOR) protein expression in the tumor and its microenvironment correlates with more aggressive pathology at cystectomy","year":2022,"lang":"en","type":"erratum","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia; University of British Columbia","funders":"","keywords":"PI3K/AKT/mTOR pathway; Protein expression; Cystectomy; Cancer research; Tumor microenvironment; Expression (computer science); Medicine; Pathology; Biology; Internal medicine; Cell biology; Tumor cells; Bladder cancer; Computer science; Signal transduction; Cancer; Genetics; Gene","score_opus":0.017948223881097597,"score_gpt":0.2705275158684314,"score_spread":0.25257929198733375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281986020","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007499731,0.0018177145,0.00012521523,0.031569764,0.96342665,0.000023878998,0.00026455385,0.00008665675,0.0026105163],"genre_scores_gemma":[0.004873441,0.012311535,0.0013845399,0.08561424,0.68627053,0.00016570558,0.0012694049,0.00034398807,0.20776667],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979532,0.00029211765,0.00035547683,0.00034096412,0.0008012895,0.00025700842],"domain_scores_gemma":[0.98819715,0.0026982508,0.00062581536,0.00069733296,0.006830095,0.00095144653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021261466,0.0021189163,0.0024220494,0.004344234,0.0023126826,0.003436957,0.0025757367,0.007321163,0.06298734],"category_scores_gemma":[0.021448838,0.001214549,0.0020443022,0.002210042,0.001809744,0.001579958,0.0013253733,0.008527523,0.0391531],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029467163,0.00001087611,0.00007950613,0.00008803128,0.00001005121,0.00021684055,0.0000065414265,0.000022274866,0.000039903418,0.00014576255,0.9947285,0.004622358],"study_design_scores_gemma":[0.00009353085,0.000058897538,0.0027109669,0.00039590386,0.00010478965,0.0012286012,0.000062770945,0.0002315284,0.00045576625,0.00062878284,0.9939839,0.000044513476],"about_ca_topic_score_codex":0.01566062,"about_ca_topic_score_gemma":0.023640526,"teacher_disagreement_score":0.06298734,"about_ca_system_score_codex":0.0038325433,"about_ca_system_score_gemma":0.0038291607,"threshold_uncertainty_score":0.21071362},"labels":[],"label_agreement":null},{"id":"W4284965889","doi":"10.1016/j.urolonc.2022.06.003","title":"Treatment patterns and rates of upgrading and upstaging in prostate cancer patients with single GGG1 positive biopsy core","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Prostatectomy; Medicine; Prostate cancer; Biopsy; Urology; Stage (stratigraphy); Logistic regression; Odds ratio; Prostate biopsy; Prostate-specific antigen; Cancer; Internal medicine; Radiology; Oncology","score_opus":0.02856705733864892,"score_gpt":0.3072886228718262,"score_spread":0.2787215655331773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4284965889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982687,0.00053630164,0.00007794233,0.000049054022,0.0000065689783,0.0000036250576,0.000273764,0.000007522541,0.00077647384],"genre_scores_gemma":[0.9994873,0.00009505011,0.000025200283,0.000020333562,0.0000059320605,0.0000016234342,0.00016931267,0.0000040659947,0.00019106288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996106,0.00007907011,0.00004185524,0.00009793062,0.000057638455,0.000112962385],"domain_scores_gemma":[0.9986327,0.00036248085,0.0005527307,0.00011257864,0.00008694111,0.00025254427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036114032,0.00017843032,0.0002824673,0.00070157513,0.0002461162,0.0004928065,0.00036408106,0.00043931452,0.0026909078],"category_scores_gemma":[0.0024185486,0.00022155767,0.0005732701,0.00079627155,0.0002450819,0.00059600204,0.0003920285,0.0005699022,0.0003155816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028811264,0.00002297184,0.9961344,0.000007961413,0.00004131211,0.00005403908,0.000045725938,0.000121666686,0.00034120216,0.000021819626,0.000093354596,0.0028274881],"study_design_scores_gemma":[0.0000024764943,0.00006972947,0.9990707,0.000004182886,0.000021564874,0.00028292654,0.00013665693,0.00019793258,0.00007241789,0.00003697841,0.000100534424,0.000003988134],"about_ca_topic_score_codex":0.0032849885,"about_ca_topic_score_gemma":0.004444295,"teacher_disagreement_score":0.0032849885,"about_ca_system_score_codex":0.00024583688,"about_ca_system_score_gemma":0.0002395032,"threshold_uncertainty_score":0.00900197},"labels":[],"label_agreement":null},{"id":"W4285606368","doi":"10.1016/j.urolonc.2022.06.008","title":"Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high–grade non-muscle-invasive urothelial bladder cancer","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Bladder cancer; Concordance; Cohort; Oncology; Internal medicine; Retrospective cohort study; Area under the curve; Risk stratification; Risk assessment; Cancer","score_opus":0.02816320204084686,"score_gpt":0.3112616326000677,"score_spread":0.2830984305592208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285606368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9466223,0.0056399065,0.00755575,0.0015897328,0.0005864874,0.0001539629,0.028248226,0.0004383118,0.009165395],"genre_scores_gemma":[0.9763491,0.0007255505,0.0028479882,0.00020059933,0.00012091143,0.000081323626,0.017881757,0.000086048836,0.0017067831],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980769,0.0007630712,0.00020958317,0.00031345928,0.00046496815,0.00017201132],"domain_scores_gemma":[0.98783106,0.007846707,0.0013135653,0.0007738451,0.001552283,0.00068251457],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0075273803,0.0011942084,0.001145024,0.0028520662,0.0004208004,0.0022144648,0.0010221301,0.0010073358,0.003480023],"category_scores_gemma":[0.031377807,0.00026443618,0.0018662856,0.0015076079,0.00035610338,0.0011580786,0.0012781693,0.000788796,0.0012812054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002703172,0.00013233934,0.9062035,0.00021029549,0.0013989969,0.00007009879,0.00010451256,0.015554716,0.00024997393,0.0006189897,0.013105744,0.059647728],"study_design_scores_gemma":[0.00048103882,0.0011697435,0.7534825,0.0004808815,0.0020825816,0.00063694356,0.0004633428,0.22566076,0.0010919202,0.0044195787,0.009812055,0.00021870583],"about_ca_topic_score_codex":0.013455218,"about_ca_topic_score_gemma":0.013270734,"teacher_disagreement_score":0.99247265,"about_ca_system_score_codex":0.00095453614,"about_ca_system_score_gemma":0.0014948309,"threshold_uncertainty_score":0.03980905},"labels":[],"label_agreement":null},{"id":"W4287844217","doi":"10.1016/j.urolonc.2022.06.009","title":"Impact of the primary tumor location on secondary sites and overall mortality in patients with metastatic upper tract urothelial carcinoma","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Renal pelvis; Medicine; Urology; Proportional hazards model; Odds ratio; Internal medicine; Lung; Logistic regression; Urothelial carcinoma; Ureter; Oncology; Gastroenterology; Cancer; Bladder cancer","score_opus":0.021627920050810556,"score_gpt":0.2944742899734875,"score_spread":0.27284636992267697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4287844217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99750024,0.0010361638,0.000054856828,0.00017809668,0.000025559597,0.0000028137001,0.00017214064,0.0000041901426,0.0010259573],"genre_scores_gemma":[0.99938786,0.00017885366,0.00002165431,0.000043395794,0.00003310663,0.0000013490428,0.00013563561,0.0000024012343,0.00019573368],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977094,0.00007520829,0.000018388133,0.00003347021,0.000038446135,0.000063582935],"domain_scores_gemma":[0.9992322,0.00021107029,0.00020446106,0.00003895927,0.000068518355,0.0002449217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031627706,0.00021620408,0.00040792566,0.00031270762,0.00028938038,0.0006397058,0.00026217257,0.00031544865,0.0023214966],"category_scores_gemma":[0.0020538657,0.0001423732,0.00071756635,0.0005121942,0.00021847566,0.00042985214,0.00057489873,0.00064766273,0.00025102182],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006973317,0.000043095275,0.9932681,0.000016787983,0.00011673191,0.00019734472,0.00003655182,0.00017959294,0.00035811323,0.000017838975,0.00019952611,0.004868937],"study_design_scores_gemma":[0.000012261307,0.00016462765,0.99884975,0.0000060420375,0.000095499956,0.00029169276,0.00012474491,0.00022282724,0.0000598793,0.000042375745,0.0001261783,0.0000040499804],"about_ca_topic_score_codex":0.002413634,"about_ca_topic_score_gemma":0.0050054137,"teacher_disagreement_score":0.002413634,"about_ca_system_score_codex":0.00036213183,"about_ca_system_score_gemma":0.0003359501,"threshold_uncertainty_score":0.007766247},"labels":[],"label_agreement":null},{"id":"W4288056283","doi":"10.1016/j.urolonc.2022.06.022","title":"Other-cause mortality and access to care in metastatic renal cell carcinoma according to race/ethnicity","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Poisson regression; Logistic regression; Ethnic group; Internal medicine; Epidemiology; Incidence (geometry); Race (biology); Cancer; Demography; Oncology; Population","score_opus":0.0968063485757463,"score_gpt":0.37149616811598796,"score_spread":0.27468981954024163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288056283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971879,0.00032911164,0.00007051718,0.00015847992,0.000015600826,0.000004243526,0.0007997364,0.0000052868672,0.0014291038],"genre_scores_gemma":[0.99884915,0.00012007388,0.000025590254,0.00004645783,0.000020527,0.0000037456102,0.00041638178,0.0000044390936,0.000513626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99950004,0.00010176048,0.000044066386,0.000104901424,0.0000537414,0.00019547973],"domain_scores_gemma":[0.99875355,0.0002343522,0.00046162642,0.000074949196,0.00010490069,0.00037070696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053614756,0.0002258886,0.000367002,0.00082769105,0.0005082347,0.0007750154,0.000477263,0.00042322278,0.006490793],"category_scores_gemma":[0.0022357213,0.00025804923,0.0013090227,0.0011151503,0.00030099493,0.00086270063,0.00091208005,0.0007759121,0.0004522344],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021727926,0.00006824221,0.9977291,0.000010627055,0.00014399916,0.00006270396,0.000092961585,0.00011957137,0.00014436655,0.000060408413,0.00020158042,0.0011490916],"study_design_scores_gemma":[0.0000060637954,0.000046300407,0.9987852,0.000008039032,0.00004920139,0.000086524065,0.00041745228,0.00032656518,0.00003798781,0.00007678631,0.0001538951,0.000006016274],"about_ca_topic_score_codex":0.023024019,"about_ca_topic_score_gemma":0.028721346,"teacher_disagreement_score":0.023024019,"about_ca_system_score_codex":0.00048004367,"about_ca_system_score_gemma":0.00055003806,"threshold_uncertainty_score":0.045780003},"labels":[],"label_agreement":null},{"id":"W4291035494","doi":"10.1016/j.urolonc.2022.06.018","title":"Sequencing impact and prognostic factors in metastatic castration-resistant prostate cancer patients treated with cabazitaxel: A systematic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cabazitaxel; Medicine; Docetaxel; Prostate cancer; Hazard ratio; Meta-analysis; Internal medicine; Oncology; Confidence interval; Subgroup analysis; Cancer; Androgen deprivation therapy","score_opus":0.1436887576997822,"score_gpt":0.41327638703670366,"score_spread":0.2695876293369215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291035494","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0052275592,0.99317294,0.00042343335,0.00017523294,0.00010871769,0.0001641142,0.0005044156,0.000020191503,0.00020337015],"genre_scores_gemma":[0.23380244,0.7605869,0.0019758218,0.00092973106,0.00026643998,0.00086574064,0.0011888318,0.00003924683,0.00034488318],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99307936,0.003167886,0.0020033193,0.0007876364,0.00069490774,0.00026691036],"domain_scores_gemma":[0.985044,0.010741819,0.0023726134,0.00047557193,0.0011443704,0.00022169786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011560563,0.0025292449,0.015912812,0.0063742255,0.0005813656,0.002790007,0.0019326858,0.002089115,0.002967042],"category_scores_gemma":[0.023348412,0.0014369574,0.041941557,0.007347437,0.0006533331,0.0013594604,0.0012736637,0.0015497584,0.00028702096],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001683,0.00002561636,0.005063833,0.2907768,0.6924563,0.00013082814,0.00007729004,0.00053134374,0.00024335855,0.000098786106,0.00044685465,0.00846605],"study_design_scores_gemma":[0.00025277844,0.00011011472,0.0029341225,0.012891837,0.9826037,0.000062380816,0.000026245087,0.00012623522,0.00006330229,0.00010747337,0.00080587127,0.0000159737],"about_ca_topic_score_codex":0.0075206254,"about_ca_topic_score_gemma":0.015341862,"teacher_disagreement_score":0.015912812,"about_ca_system_score_codex":0.0020454223,"about_ca_system_score_gemma":0.003362449,"threshold_uncertainty_score":0.06113881},"labels":[],"label_agreement":null},{"id":"W4291285686","doi":"10.1016/j.urolonc.2022.07.005","title":"Patients’ perceptions on active surveillance for the treatment of small renal masses","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Ottawa Hospital; Université Laval; University of Ottawa; Centre Hospitalier Universitaire de Sherbrooke; McGill University Health Centre; Université de Sherbrooke","funders":"Canadian Urological Association Scholarship Fund","keywords":"Medicine; Focus group; Thematic analysis; Watchful waiting; Perception; Active monitoring; Family medicine; Qualitative research; Psychology; Internal medicine","score_opus":0.047544422483143015,"score_gpt":0.3040212992789343,"score_spread":0.2564768767957913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291285686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9710976,0.0011657331,0.00023958612,0.013488204,0.0001772247,0.000021050882,0.00011883165,0.000008254878,0.013683468],"genre_scores_gemma":[0.99758196,0.00032154645,0.00008015664,0.0015691897,0.000051006038,0.0000058533474,0.00002971957,0.0000029206608,0.00035765136],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99604404,0.0022441861,0.0002517746,0.00016317671,0.0007715843,0.0005252851],"domain_scores_gemma":[0.9811297,0.008483784,0.004331699,0.000272115,0.001744662,0.004038007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044290717,0.0001423607,0.00022425978,0.0005186811,0.0014925401,0.0022547278,0.00033024212,0.000902064,0.004573786],"category_scores_gemma":[0.027585449,0.00014949433,0.00036416698,0.0003544982,0.0014889898,0.0013241142,0.0014538282,0.002028801,0.00023561787],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008886602,0.0005170904,0.7706084,0.0004363533,0.00027273147,0.0018099212,0.13785408,0.00046164417,0.002047513,0.003677543,0.012479153,0.06894692],"study_design_scores_gemma":[0.00011092388,0.0011123681,0.63773364,0.0005906182,0.00020370528,0.0044153198,0.31128135,0.0006935493,0.00074285525,0.002549199,0.04035889,0.00020762792],"about_ca_topic_score_codex":0.003708102,"about_ca_topic_score_gemma":0.004637453,"teacher_disagreement_score":0.004573786,"about_ca_system_score_codex":0.0012290424,"about_ca_system_score_gemma":0.0014346985,"threshold_uncertainty_score":0.023423433},"labels":[],"label_agreement":null},{"id":"W4294940243","doi":"10.1016/j.urolonc.2022.08.004","title":"Meningeal metastases in prostate cancer: Institutional series and comprehensive systematic review","year":2022,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre; University of Toronto","funders":"","keywords":"Medicine; Prostate cancer; Observational study; Cancer; Prostate; Radiation therapy; Internal medicine; Incidence (geometry); Oncology; Surgery","score_opus":0.08051859959011262,"score_gpt":0.38107412912952626,"score_spread":0.30055552953941367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294940243","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031288874,0.9943263,0.000104840634,0.00017873188,0.00007194694,0.000101152575,0.0019295102,0.000009963454,0.00014864084],"genre_scores_gemma":[0.07527919,0.9213324,0.0006166158,0.00109034,0.000102359656,0.00031877807,0.0010971226,0.000013979455,0.00014923554],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9937582,0.0015776242,0.0027728728,0.00083548966,0.0007041986,0.00035160655],"domain_scores_gemma":[0.979479,0.012600493,0.0060294587,0.0005168784,0.0010128994,0.00036133066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049577337,0.001162302,0.005912176,0.010653608,0.0003941722,0.002050645,0.0012901132,0.0014258614,0.004324959],"category_scores_gemma":[0.025619969,0.0010291096,0.008709388,0.01487263,0.0009296187,0.0020192687,0.0022718129,0.0012387577,0.0003148363],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047455987,0.00003137292,0.019826721,0.85638416,0.09118167,0.00023104339,0.00036695442,0.00021271907,0.00026148505,0.00023190229,0.0046459683,0.026151419],"study_design_scores_gemma":[0.00072820514,0.00022387564,0.058829527,0.48487952,0.4309894,0.0008103632,0.00082708057,0.00013127577,0.00017881565,0.00042279012,0.02184557,0.00013351635],"about_ca_topic_score_codex":0.014996072,"about_ca_topic_score_gemma":0.056112,"teacher_disagreement_score":0.014996072,"about_ca_system_score_codex":0.0026137973,"about_ca_system_score_gemma":0.0073658153,"threshold_uncertainty_score":0.029817581},"labels":[],"label_agreement":null},{"id":"W4306683141","doi":"10.1016/j.urolonc.2022.09.012","title":"Biology of BCG response in non-muscle invasive bladder cancer - 2021 IBCN Updates Part III","year":2022,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Deutsche Forschungsgemeinschaft; Merck","keywords":"Medicine; Bladder cancer; Context (archaeology); Urothelial cancer; Cancer; Oncology; Internal medicine; Intensive care medicine; Immunology","score_opus":0.06396467059731958,"score_gpt":0.380894958434083,"score_spread":0.3169302878367634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306683141","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010964119,0.9986926,0.000043707267,0.00032849205,0.00023229019,0.0000069491575,0.00004227117,0.000003300291,0.0005407723],"genre_scores_gemma":[0.0012087881,0.997086,0.00010499775,0.00053984846,0.00030095893,0.000011991182,0.00009161403,0.0000018232697,0.0006540586],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998042,0.000051813724,0.000035378096,0.000033378914,0.000052210296,0.000023023204],"domain_scores_gemma":[0.9995615,0.00026643684,0.00006615151,0.000010315243,0.000074552765,0.000020961814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008304323,0.0005076061,0.001263569,0.0011301651,0.00011366147,0.0010497851,0.0005202095,0.0006265918,0.0039649997],"category_scores_gemma":[0.0014357263,0.00026505385,0.0007600091,0.0010194343,0.00027186106,0.0007237062,0.00054813246,0.0011960805,0.0013613364],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020993831,0.00004700857,0.0004501065,0.03775261,0.00023037872,0.00007101068,0.000049805793,0.00035292056,0.0012155224,0.0021364754,0.03918751,0.9182967],"study_design_scores_gemma":[0.000075281125,0.00030831218,0.0037161985,0.02534475,0.00083969586,0.0007059356,0.000051762116,0.00016595326,0.00063195586,0.0014136785,0.96671927,0.000027286449],"about_ca_topic_score_codex":0.0019165393,"about_ca_topic_score_gemma":0.0040880092,"teacher_disagreement_score":0.0039649997,"about_ca_system_score_codex":0.0009995074,"about_ca_system_score_gemma":0.0017027111,"threshold_uncertainty_score":0.013264239},"labels":[],"label_agreement":null},{"id":"W4306932585","doi":"10.1016/j.urolonc.2022.09.010","title":"UnCHAARTED territory: The role of docetaxel rechallenge following chemohormonal therapy for metastatic castration-sensitive prostate cancer","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; London Health Sciences Centre; Western University; Sunnybrook Health Science Centre; Health Sciences Centre; Ottawa Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"Joseph and Silvana Melara Cancer Research Fund","keywords":"Docetaxel; Medicine; Prostate cancer; Cabazitaxel; Androgen deprivation therapy; Oncology; Internal medicine; Prostate-specific antigen; Cancer; Urology","score_opus":0.051539667060191724,"score_gpt":0.35441702149511206,"score_spread":0.30287735443492037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306932585","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4071934,0.46713617,0.0031215404,0.043451797,0.008345171,0.00024174487,0.0010143016,0.00024954765,0.06924635],"genre_scores_gemma":[0.92860645,0.053247407,0.001264941,0.0056552053,0.00405905,0.000047017664,0.00036746883,0.000056329158,0.006696115],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996257,0.00018171307,0.00003725885,0.000040933337,0.000055397268,0.00005899686],"domain_scores_gemma":[0.9989256,0.0005212858,0.00015385276,0.00006666702,0.000094707226,0.00023786971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010032166,0.00025301112,0.0007688653,0.00027100704,0.0004019442,0.001353624,0.0004820277,0.0006334151,0.004349806],"category_scores_gemma":[0.0028190853,0.000094725016,0.0006307151,0.00037057148,0.0005026176,0.00074607204,0.0002712027,0.0016897051,0.0005446712],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017303128,0.0008109617,0.016805118,0.0006391346,0.00048079516,0.0017508204,0.00013678886,0.0018230601,0.0031569907,0.00231081,0.012548526,0.94223386],"study_design_scores_gemma":[0.008982185,0.036425944,0.3256035,0.002859332,0.0049100313,0.01580298,0.0014662567,0.007965368,0.008479952,0.013508245,0.5736729,0.00032334015],"about_ca_topic_score_codex":0.0031781602,"about_ca_topic_score_gemma":0.016522635,"teacher_disagreement_score":0.004349806,"about_ca_system_score_codex":0.0007560242,"about_ca_system_score_gemma":0.001735793,"threshold_uncertainty_score":0.01455152},"labels":[],"label_agreement":null},{"id":"W4306955464","doi":"10.1016/j.urolonc.2022.09.024","title":"Analysis of sex-based differences to Bacillus Calmette-Guérin for non-muscle invasive bladder cancer","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Bladder cancer; Tolerability; Carcinoma in situ; Internal medicine; Medical record; Retrospective cohort study; Cystectomy; Urology; Incidence (geometry); Cancer; Stage (stratigraphy); Oncology; Gynecology; Adverse effect","score_opus":0.0404708845401386,"score_gpt":0.3321718331945408,"score_spread":0.2917009486544022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306955464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99876404,0.00035297617,0.000066922425,0.000039439594,0.00001571509,0.0000035280655,0.00018849362,0.0000032427881,0.0005656418],"genre_scores_gemma":[0.9995042,0.000055109802,0.000025718931,0.000019374571,0.000010270657,0.0000023595965,0.00012569032,0.0000035526816,0.0002537097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999496,0.00017617071,0.000037704875,0.00010436536,0.00007541928,0.00011041486],"domain_scores_gemma":[0.9983631,0.00077588396,0.00032885,0.00012622245,0.00012633108,0.00027971677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006828842,0.00021509313,0.0003474256,0.0005075652,0.00015057459,0.00041543477,0.000313571,0.00032363329,0.002590861],"category_scores_gemma":[0.0030399498,0.000120163975,0.000945097,0.0005323011,0.00019283312,0.00023762259,0.0002554179,0.00043972238,0.00029803062],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007001044,0.00010986492,0.9814936,0.000021107528,0.000529547,0.00015487027,0.000066578454,0.00013813609,0.002056913,0.000045058645,0.00016183803,0.008221502],"study_design_scores_gemma":[0.000041967178,0.0010126121,0.9978263,0.000003378407,0.000120274046,0.0001365457,0.00009467412,0.00022502575,0.00028107894,0.000038884948,0.00021539051,0.0000038136245],"about_ca_topic_score_codex":0.0013474136,"about_ca_topic_score_gemma":0.001547114,"teacher_disagreement_score":0.002590861,"about_ca_system_score_codex":0.00027648825,"about_ca_system_score_gemma":0.00028168448,"threshold_uncertainty_score":0.00866729},"labels":[],"label_agreement":null},{"id":"W4307810833","doi":"10.1016/j.urolonc.2022.09.004","title":"5α-reductase inhibitors and the risk of bladder cancer in a large, population-based cohort","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Institute for Clinical Evaluative Sciences; Western University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Dutasteride; Bladder cancer; Hazard ratio; Population; Confidence interval; Internal medicine; Gynecology; Demography; Cancer; Prostate cancer","score_opus":0.01339895178721554,"score_gpt":0.3009816262695392,"score_spread":0.28758267448232366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307810833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984086,0.00032228956,0.0001302883,0.00007386549,0.000012083917,0.000009023477,0.0006359675,0.0000069901066,0.00040084],"genre_scores_gemma":[0.99876356,0.00023346004,0.0000731676,0.00006621182,0.00002376127,0.000012907645,0.00047682837,0.000004956911,0.00034512914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994764,0.00011413679,0.00003581746,0.00019059743,0.00009481413,0.00008819202],"domain_scores_gemma":[0.9993413,0.000102977625,0.00016834933,0.00013733433,0.00007603921,0.00017401349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055022363,0.00041650582,0.00059301365,0.0008073378,0.00098251,0.0011232343,0.0004530302,0.0007738527,0.0019579625],"category_scores_gemma":[0.0012872436,0.00083159044,0.0012029564,0.001349052,0.00040251284,0.00059678475,0.0004942929,0.0014196329,0.00043191365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002980487,0.00008331298,0.99760544,0.000008153153,0.00034636664,0.00013372573,0.00008597,0.000038387232,0.0005667063,0.000020257028,0.00019567212,0.0006179315],"study_design_scores_gemma":[0.000026834305,0.00013566198,0.9985133,0.0000043459095,0.00020374873,0.00039598424,0.00022227938,0.00017480602,0.00004952553,0.000027813938,0.00023796526,0.000007863394],"about_ca_topic_score_codex":0.013069855,"about_ca_topic_score_gemma":0.01117858,"teacher_disagreement_score":0.013069855,"about_ca_system_score_codex":0.00039672473,"about_ca_system_score_gemma":0.0005575582,"threshold_uncertainty_score":0.025987566},"labels":[],"label_agreement":null},{"id":"W4307927336","doi":"10.1016/j.urolonc.2022.09.021","title":"Deferred cytoreductive nephrectomy in the management of metastatic renal cell carcinoma: A systematic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services; University of Toronto","funders":"","keywords":"Medicine; Renal cell carcinoma; Hazard ratio; Perioperative; Nephrectomy; Meta-analysis; Systemic therapy; Internal medicine; Oncology; Surgery; Cancer; Kidney; Confidence interval","score_opus":0.1376613381637201,"score_gpt":0.36722988709193227,"score_spread":0.22956854892821218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307927336","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028846632,0.9963766,0.00014557039,0.00008762612,0.00006870982,0.000042294374,0.00026022203,0.000006208554,0.00012818346],"genre_scores_gemma":[0.085339285,0.9123032,0.0006721918,0.0007321433,0.00016472541,0.00014289607,0.00043014056,0.000010887813,0.00020452174],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9976248,0.000810509,0.0007708005,0.0003924095,0.00028185986,0.00011970399],"domain_scores_gemma":[0.99442434,0.0039716414,0.0010714594,0.00012606042,0.00031461098,0.00009191132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036208064,0.0014679471,0.009329631,0.002629656,0.0004014064,0.001741443,0.0014840297,0.0015755593,0.0036247943],"category_scores_gemma":[0.01020919,0.00080781296,0.015901646,0.004172653,0.0005005522,0.0013672216,0.0010120629,0.0014949156,0.00027114584],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027604487,0.000055389224,0.0075235944,0.5650017,0.39114714,0.00016625447,0.00014301733,0.0005915883,0.00041732163,0.00017997065,0.0014801603,0.03053344],"study_design_scores_gemma":[0.0009303261,0.00023190511,0.008945938,0.04187558,0.9438271,0.00014302882,0.00010102288,0.00017164572,0.0001073472,0.00024661486,0.0033740306,0.00004547894],"about_ca_topic_score_codex":0.006065425,"about_ca_topic_score_gemma":0.023269713,"teacher_disagreement_score":0.009329631,"about_ca_system_score_codex":0.0012423611,"about_ca_system_score_gemma":0.0019651514,"threshold_uncertainty_score":0.019148886},"labels":[],"label_agreement":null},{"id":"W4308736447","doi":"10.1016/j.urolonc.2022.10.008","title":"A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy—A large, retrospective, single-center study","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Frailty in Older Adults","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nephrectomy; Medicine; Center (category theory); Retrospective cohort study; Single Center; General surgery; Surgery; Internal medicine; Kidney","score_opus":0.04271215697743528,"score_gpt":0.3272179421273574,"score_spread":0.2845057851499221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308736447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995005,0.00023253821,0.0000423831,0.000010325509,0.0000029931025,0.000006395517,0.00011709583,6.639053e-7,0.00008711887],"genre_scores_gemma":[0.9996146,0.00008674098,0.00003943078,0.000020603868,0.000009053248,0.000005854717,0.00019635643,5.3243053e-7,0.000026868101],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961406,0.000094083596,0.000056578505,0.00010458254,0.00006287913,0.00006773615],"domain_scores_gemma":[0.9991026,0.00012327953,0.0003623525,0.000093829774,0.00007310942,0.00024490702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088920904,0.00032967023,0.00062832213,0.00076883053,0.0005426102,0.00065771886,0.0003179647,0.00045661724,0.0006269027],"category_scores_gemma":[0.0015008363,0.00026999915,0.0008245874,0.0011916126,0.0004120835,0.0007318081,0.00064776116,0.00053409487,0.00009484333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017849046,0.000050791245,0.9986319,0.0000102648255,0.00014752023,0.00002898702,0.000050798128,0.000019119148,0.00011334902,0.000007852884,0.000036730813,0.0007240683],"study_design_scores_gemma":[0.000013648317,0.00019500121,0.999316,0.0000066692464,0.00007189816,0.000111623965,0.00011776412,0.00006469313,0.000022920038,0.000011439039,0.00006421332,0.000004030989],"about_ca_topic_score_codex":0.0036959525,"about_ca_topic_score_gemma":0.005733459,"teacher_disagreement_score":0.0036959525,"about_ca_system_score_codex":0.00036205418,"about_ca_system_score_gemma":0.0004919007,"threshold_uncertainty_score":0.007348895},"labels":[],"label_agreement":null},{"id":"W4308887302","doi":"10.1016/j.urolonc.2022.10.006","title":"Predicting short- and long-term renal function following partial and radical nephrectomy","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Nephrectomy; Renal function; Urology; Receiver operating characteristic; Retrospective cohort study; Cohort; Surgery; Internal medicine; Kidney","score_opus":0.03383944163855581,"score_gpt":0.29698958180393265,"score_spread":0.26315014016537686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308887302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985207,0.00048723468,0.00009532902,0.000063832034,0.000022715103,0.0000041835665,0.000109287656,0.0000038192566,0.00069289806],"genre_scores_gemma":[0.99933463,0.00014204408,0.000051313447,0.00002091481,0.000025130392,0.000002260588,0.00019124222,0.0000011616929,0.00023122442],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99967694,0.00007055061,0.000036324414,0.00004738035,0.00007541352,0.00009340521],"domain_scores_gemma":[0.99792933,0.0006058565,0.00045956645,0.00008046639,0.00019414262,0.0007306191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079214346,0.00027055782,0.00046884417,0.0006615168,0.00035210548,0.00075187825,0.00035172483,0.0005422785,0.0010359194],"category_scores_gemma":[0.0030200605,0.00011327964,0.00062308717,0.0005658209,0.00040540233,0.0005702826,0.0004871515,0.0007183193,0.00019727378],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005766275,0.00006829315,0.99526715,0.000009853199,0.00005028255,0.0001258859,0.00003118496,0.00019333244,0.00026836354,0.000012477808,0.00006492651,0.003331653],"study_design_scores_gemma":[0.0000037924747,0.00039954367,0.99821895,0.0000048582137,0.00005132351,0.00032647752,0.00012653857,0.00040724664,0.00021254449,0.000051818577,0.00018968804,0.0000072488447],"about_ca_topic_score_codex":0.0020568166,"about_ca_topic_score_gemma":0.0037659467,"teacher_disagreement_score":0.0020568166,"about_ca_system_score_codex":0.00045303584,"about_ca_system_score_gemma":0.00054716493,"threshold_uncertainty_score":0.0041893125},"labels":[],"label_agreement":null},{"id":"W4309574459","doi":"10.1016/j.urolonc.2022.10.027","title":"Conditional survival after radical cystectomy for non-metastatic muscle-invasive squamous cell carcinoma of the urinary bladder: A population-based analysis","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cystectomy; Urology; Basal cell; Medicine; Urinary bladder; Oncology; Population; Internal medicine; Bladder cancer; Cancer","score_opus":0.019735400549731642,"score_gpt":0.2885209937949807,"score_spread":0.26878559324524903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309574459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99827754,0.00034595467,0.00020861221,0.000044324108,0.0000117074915,0.000005488897,0.00079550984,0.000013918486,0.00029689074],"genre_scores_gemma":[0.9987691,0.00011487683,0.000040201183,0.000016425436,0.000017853277,0.0000058497817,0.0008658628,0.0000072989965,0.00016252765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989355,0.00031734598,0.00007302194,0.0003979926,0.00008030836,0.00019591562],"domain_scores_gemma":[0.99699414,0.0010648464,0.0007377587,0.0005827131,0.00015294917,0.00046767422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018420228,0.0005805041,0.0008046914,0.00086089404,0.00046110144,0.0010553926,0.000905969,0.0010840782,0.0031470186],"category_scores_gemma":[0.0037281304,0.0005660715,0.00275386,0.001096117,0.0005568274,0.00089486747,0.0009545298,0.0016046483,0.0003630278],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002331737,0.000101371894,0.9920067,0.00003357411,0.0019609341,0.0002448608,0.00007408496,0.0006924737,0.0005384929,0.00010084465,0.00034816645,0.0015668612],"study_design_scores_gemma":[0.000054688575,0.00042182708,0.9959603,0.0000064047667,0.00084860425,0.0003390845,0.00016827541,0.001770334,0.00006385035,0.00013610758,0.00020824332,0.000022296472],"about_ca_topic_score_codex":0.007080903,"about_ca_topic_score_gemma":0.005820669,"teacher_disagreement_score":0.007080903,"about_ca_system_score_codex":0.0003892499,"about_ca_system_score_gemma":0.00041647902,"threshold_uncertainty_score":0.014079392},"labels":[],"label_agreement":null},{"id":"W4309575387","doi":"10.1016/j.urolonc.2022.09.015","title":"Nephron-sparing surgery for renal cell carcinoma in children and young adults: A systematic review","year":2022,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Meta-analysis; Confounding; Kidney cancer; MEDLINE; Systematic review; Population; Incidence (geometry); Surgery; Internal medicine; Kidney","score_opus":0.04616795877088565,"score_gpt":0.3087822264354913,"score_spread":0.26261426766460566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309575387","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00071401236,0.9986959,0.00004176366,0.00009493401,0.000055361317,0.000044883825,0.00023091077,0.00000449002,0.00011772226],"genre_scores_gemma":[0.010400375,0.98874414,0.00017410566,0.00041413138,0.00003594193,0.0000574449,0.000104086954,0.0000025467727,0.00006732323],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99872595,0.0002737687,0.0005516895,0.00018404835,0.0001827666,0.00008180503],"domain_scores_gemma":[0.9954639,0.0028949513,0.0012656046,0.00005186252,0.00023132337,0.00009239431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015748349,0.0010254517,0.0053270184,0.0046889293,0.0002820171,0.001370482,0.0009822934,0.0012046839,0.004661694],"category_scores_gemma":[0.008333626,0.00073385565,0.0059316345,0.0057997108,0.00055968453,0.0013479706,0.0010517226,0.0009470969,0.000251228],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002746315,0.000021388492,0.0018732062,0.9350188,0.018099744,0.00013600393,0.00014071944,0.00014985164,0.0002570942,0.00013429437,0.002748188,0.04114607],"study_design_scores_gemma":[0.0009682176,0.0003571806,0.012700786,0.69656855,0.25226197,0.0009727926,0.00036879742,0.00010451475,0.00022842473,0.0003317455,0.03505445,0.00008254995],"about_ca_topic_score_codex":0.008614082,"about_ca_topic_score_gemma":0.03631788,"teacher_disagreement_score":0.008614082,"about_ca_system_score_codex":0.0017285412,"about_ca_system_score_gemma":0.0041915164,"threshold_uncertainty_score":0.017127931},"labels":[],"label_agreement":null},{"id":"W4309731124","doi":"10.1016/j.urolonc.2022.09.028","title":"Should grade group 1 prostate cancer be reclassified as “non-cancer”? A pathology community perspective","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Rockyview General Hospital","funders":"","keywords":"Overdiagnosis; Prostate cancer; Medicine; Prostatectomy; Cancer; Gynecology; Internal medicine; Family medicine; Oncology","score_opus":0.11459962503718452,"score_gpt":0.4104762455651094,"score_spread":0.2958766205279249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309731124","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010004185,0.0052129366,0.00048741818,0.96988374,0.003784686,0.0000133016365,0.00008257933,0.000025847718,0.01050526],"genre_scores_gemma":[0.42552868,0.03223311,0.0029540698,0.48069772,0.050645065,0.000065367385,0.00044922432,0.00011087135,0.007315814],"study_design_codex":"not_applicable","study_design_gemma":"qualitative","domain_scores_codex":[0.9942887,0.002451664,0.00047259295,0.0006078332,0.0014796662,0.000699555],"domain_scores_gemma":[0.95913684,0.012057324,0.0040659914,0.0011515969,0.014868319,0.0087199155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013646749,0.00025834906,0.0005907574,0.002353954,0.0030581148,0.0061570057,0.002412493,0.006953377,0.009349603],"category_scores_gemma":[0.056181643,0.00037668206,0.0005508846,0.0017602335,0.004513303,0.004870474,0.0028293517,0.007913975,0.0016878126],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021474167,0.0005446309,0.10206785,0.0008656029,0.00014635768,0.0020835341,0.0046842783,0.00042851942,0.0013598158,0.038116362,0.51621115,0.3332772],"study_design_scores_gemma":[0.00023446529,0.00060672517,0.15280013,0.005456529,0.00033749544,0.006456426,0.042689938,0.0009838749,0.0011629516,0.0920278,0.6969557,0.0002879726],"about_ca_topic_score_codex":0.013199748,"about_ca_topic_score_gemma":0.02372038,"teacher_disagreement_score":0.013646749,"about_ca_system_score_codex":0.0024270006,"about_ca_system_score_gemma":0.011586178,"threshold_uncertainty_score":0.07217181},"labels":[],"label_agreement":null},{"id":"W4309947242","doi":"10.1016/j.urolonc.2022.11.008","title":"IBCN Seminar Series 2021: Circulating tumor DNA in bladder cancer","year":2022,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Series (stratigraphy); Virology; Cancer; Oncology; Internal medicine; Biology","score_opus":0.0409542778204986,"score_gpt":0.33400634327336937,"score_spread":0.29305206545287077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309947242","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005650665,0.9908455,0.0001268643,0.001980135,0.0045113736,0.000010838851,0.0000947259,0.00001865292,0.0023553737],"genre_scores_gemma":[0.0005178075,0.9897461,0.00019484728,0.0023901926,0.003736461,0.000013422106,0.00019603623,0.0000066272296,0.0031985196],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997117,0.000060885774,0.000029125436,0.000042983855,0.00012043628,0.00003489504],"domain_scores_gemma":[0.999275,0.00026837506,0.00007114752,0.000018574532,0.0002450923,0.000121867204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012492328,0.00082632096,0.0012924641,0.002200889,0.00023503025,0.0012116,0.0010109878,0.0017050959,0.010709105],"category_scores_gemma":[0.0020348132,0.00026246495,0.00058506266,0.0015961645,0.00041000437,0.0011501011,0.00111643,0.0024044618,0.0069160173],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011785129,0.00004294131,0.00012224013,0.009371627,0.000062810155,0.00016105657,0.000022658021,0.00013671053,0.00082005444,0.001757703,0.3289906,0.6583937],"study_design_scores_gemma":[0.000032227726,0.00006023523,0.00039925353,0.0039144484,0.00008272311,0.0005279758,0.00001280302,0.000030285519,0.00025259133,0.00075181643,0.9939242,0.000011348365],"about_ca_topic_score_codex":0.0013935413,"about_ca_topic_score_gemma":0.0022480525,"teacher_disagreement_score":0.010709105,"about_ca_system_score_codex":0.0010644333,"about_ca_system_score_gemma":0.0021898889,"threshold_uncertainty_score":0.03582555},"labels":[],"label_agreement":null},{"id":"W4309947504","doi":"10.1016/j.urolonc.2022.10.031","title":"25 years International Bladder Cancer Network (IBCN): The past, the present, and the future","year":2022,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Multidisciplinary approach; Bladder cancer; Pandemic; Coronavirus disease 2019 (COVID-19); Work (physics); Cancer; Medical education; Family medicine; Pathology; Disease; Internal medicine; Social science; Sociology; Engineering","score_opus":0.045583978504341864,"score_gpt":0.3597876445404012,"score_spread":0.3142036660360593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309947504","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000033608743,0.99721515,0.000016003853,0.0013204616,0.0009029252,0.0000019748677,0.00002893425,0.0000037333325,0.00047717142],"genre_scores_gemma":[0.00039884832,0.99726844,0.000060864422,0.0011719875,0.0005269811,0.0000035255384,0.000040775594,0.0000012139536,0.00052735844],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996138,0.000094749164,0.000054759996,0.000054175725,0.00012569463,0.00005670825],"domain_scores_gemma":[0.99906415,0.0003029029,0.00016135849,0.000019115025,0.0002869802,0.00016547134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014948494,0.0007984932,0.001485873,0.0029772993,0.00041955512,0.0018130454,0.0010389655,0.0017166964,0.007912792],"category_scores_gemma":[0.001959438,0.00026155938,0.00078024145,0.0046467725,0.0006463564,0.0025698044,0.00138127,0.0024365867,0.0018332424],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001162241,0.000040095594,0.00031866838,0.023873921,0.00011472663,0.00010228911,0.00008594791,0.00026431037,0.00029014258,0.0050851484,0.19063081,0.77907765],"study_design_scores_gemma":[0.000018662342,0.000042142034,0.000840325,0.010896508,0.00013916446,0.0002697997,0.00010016816,0.000042341846,0.00004314338,0.0011696323,0.9864231,0.00001505363],"about_ca_topic_score_codex":0.006204052,"about_ca_topic_score_gemma":0.01755006,"teacher_disagreement_score":0.007912792,"about_ca_system_score_codex":0.0020290695,"about_ca_system_score_gemma":0.0058244914,"threshold_uncertainty_score":0.0264709},"labels":[],"label_agreement":null},{"id":"W4310104772","doi":"10.1016/j.urolonc.2022.11.009","title":"Collecting duct carcinoma: Epidemiology, clinical characteristics and survival","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Université de Montréal","funders":"","keywords":"Medicine; Proportional hazards model; Hazard ratio; Epidemiology; Internal medicine; Cohort; Stage (stratigraphy); Nephrectomy; Surveillance, Epidemiology, and End Results; Survival analysis; Population; Oncology; Surgery; Cancer registry; Confidence interval; Kidney; Biology","score_opus":0.13099492023472173,"score_gpt":0.3852238586296991,"score_spread":0.2542289383949774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310104772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99505913,0.002514193,0.00013815156,0.00021561391,0.000013024032,0.000005573075,0.00078019616,0.000009436616,0.0012645954],"genre_scores_gemma":[0.9983468,0.0007870726,0.000056133114,0.000028187278,0.000036412406,0.000004131419,0.0005037142,0.0000025609247,0.00023501377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99969745,0.00007058618,0.000037103586,0.00007204113,0.000054777844,0.000068058966],"domain_scores_gemma":[0.99898237,0.00020773352,0.00039483726,0.00006445197,0.00011077008,0.00023983221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049148453,0.00015135306,0.00034047302,0.0012616664,0.0003546819,0.0006255082,0.0002477461,0.00040934223,0.0018612355],"category_scores_gemma":[0.0015772892,0.00019231203,0.0004187532,0.0023860058,0.00030629244,0.0007247795,0.00037808335,0.0004962355,0.000314954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007352131,0.000022265302,0.99749076,0.000009205554,0.000034268178,0.000069946356,0.000028807452,0.000049421622,0.00013634533,0.000028976023,0.0001309351,0.0019256376],"study_design_scores_gemma":[0.0000033605704,0.000056407465,0.9987091,0.000005130243,0.000018662404,0.000542048,0.00016823015,0.000113518974,0.00003522877,0.00005307336,0.0002911009,0.0000042149386],"about_ca_topic_score_codex":0.0023836214,"about_ca_topic_score_gemma":0.0018449902,"teacher_disagreement_score":0.0023836214,"about_ca_system_score_codex":0.00030035453,"about_ca_system_score_gemma":0.00040923728,"threshold_uncertainty_score":0.00622648},"labels":[],"label_agreement":null},{"id":"W4312140743","doi":"10.1016/j.urolonc.2022.10.033","title":"Detection and resection of carcinoma in situ of the bladder: Implications for clinical trial design","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bladder cancer; Concordance; Medicine; Cystectomy; Cystoscopy; Carcinoma in situ; Urology; Biopsy; Carcinoma; Radiology; Internal medicine; Cancer; Urinary system","score_opus":0.12152041395633523,"score_gpt":0.3948277263792842,"score_spread":0.273307312422949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312140743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.58614105,0.1923959,0.07345306,0.064742,0.024534725,0.026268125,0.0019391301,0.00025053616,0.03027545],"genre_scores_gemma":[0.9489748,0.005643047,0.017335042,0.012011286,0.0038743708,0.010113238,0.00041957304,0.00005728638,0.0015713528],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.7121609,0.26323077,0.01167766,0.0074683833,0.004159813,0.0013024792],"domain_scores_gemma":[0.71700966,0.24617401,0.019859696,0.009342391,0.0035288222,0.0040854537],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.20465897,0.0012438543,0.0051994366,0.00074417534,0.0013346284,0.005416445,0.00229317,0.0059314067,0.004766999],"category_scores_gemma":[0.27353963,0.0009895576,0.004939546,0.0018665842,0.004230412,0.005388392,0.0019843064,0.006177622,0.00055222725],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6435396,0.0030304263,0.07578339,0.017472852,0.04476767,0.00042870815,0.0012640294,0.005327544,0.002022669,0.021477781,0.005402554,0.17948285],"study_design_scores_gemma":[0.4304683,0.14213997,0.12314574,0.009953583,0.06651074,0.0010902474,0.0017361996,0.029193262,0.003297936,0.14682339,0.044894625,0.00074599765],"about_ca_topic_score_codex":0.000497373,"about_ca_topic_score_gemma":0.0009588832,"teacher_disagreement_score":0.20465897,"about_ca_system_score_codex":0.0017160198,"about_ca_system_score_gemma":0.0034135932,"threshold_uncertainty_score":0.9807971},"labels":[],"label_agreement":null},{"id":"W4313557964","doi":"10.1016/j.urolonc.2022.11.022","title":"Comparative real-world survival outcomes of metastatic papillary and clear cell renal cell carcinoma treated with immunotherapy, targeted therapy, and combination therapy","year":2023,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Internal medicine; Oncology; Clear cell renal cell carcinoma; Proportional hazards model; Renal cell carcinoma; Exact test; Immunotherapy; Cancer","score_opus":0.05975180963272117,"score_gpt":0.3126910654585206,"score_spread":0.25293925582579946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313557964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99493885,0.0014632765,0.00011487737,0.00007230523,0.00002026552,0.000011593962,0.0026105521,0.000005417924,0.00076282595],"genre_scores_gemma":[0.9974886,0.0002154355,0.00003304542,0.000021436088,0.000020361758,0.000010777827,0.0021058419,0.0000025258619,0.00010199811],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99916685,0.00028597587,0.00009137295,0.00019610926,0.00010090788,0.00015890047],"domain_scores_gemma":[0.9977464,0.0007186449,0.00081927184,0.00014306128,0.00028442018,0.00028819742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012025802,0.00027013253,0.0006537445,0.0007166072,0.00027189346,0.0008095318,0.00042847183,0.0006168919,0.0025100925],"category_scores_gemma":[0.0031663915,0.00011596135,0.0016606118,0.0012722688,0.00038672384,0.0008242779,0.00051110756,0.00059217017,0.00028596743],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025188677,0.00031123386,0.9462237,0.00029253028,0.0030148362,0.00027975076,0.00031187685,0.003090256,0.0008140772,0.00025739326,0.001441404,0.01877429],"study_design_scores_gemma":[0.0002562564,0.0023450744,0.99281996,0.000034618777,0.0010471586,0.0004215482,0.0003640249,0.0013161722,0.0001724401,0.00019401018,0.0009975876,0.000031096446],"about_ca_topic_score_codex":0.0041160877,"about_ca_topic_score_gemma":0.0055359313,"teacher_disagreement_score":0.0041160877,"about_ca_system_score_codex":0.0011566211,"about_ca_system_score_gemma":0.00041652884,"threshold_uncertainty_score":0.008397102},"labels":[],"label_agreement":null},{"id":"W4315641281","doi":"10.1016/j.urolonc.2022.12.003","title":"Validating the total cancer location density metric for stratifying patients with low-risk localized prostate cancer at higher risk of grade group reclassification while on active surveillance","year":2023,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Prostate cancer; Prostatectomy; Cohort; Proportional hazards model; Internal medicine; Biopsy; Urology; Prostate; Prostate biopsy; Cancer; Oncology; Gynecology","score_opus":0.03752426127442013,"score_gpt":0.31558088846024596,"score_spread":0.2780566271858258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315641281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843174,0.0003697812,0.008989716,0.00046213836,0.00012925238,0.00009034877,0.0035272571,0.00024338676,0.0018706787],"genre_scores_gemma":[0.991467,0.00007000124,0.0055958317,0.00007091914,0.00004002951,0.000033539978,0.0023234435,0.000025091407,0.0003741562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984648,0.00052209944,0.00012916411,0.000355418,0.00035408672,0.00017444234],"domain_scores_gemma":[0.993753,0.0025672375,0.0008242795,0.0008075933,0.0015420371,0.0005057763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037115335,0.00047447375,0.0006399296,0.0016213654,0.00044522097,0.0020203162,0.00087258994,0.0007804307,0.0018557089],"category_scores_gemma":[0.0202002,0.0002147151,0.0007889332,0.0011223326,0.00036305827,0.000975101,0.0011930293,0.00081820885,0.0010392442],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004992146,0.000116728814,0.9645649,0.000027095457,0.0001836127,0.000029168432,0.000096386495,0.0037525012,0.00057279936,0.00023412594,0.0021525796,0.027770843],"study_design_scores_gemma":[0.00013864806,0.0012240657,0.82070637,0.00008644749,0.00039424602,0.0006707003,0.0011187115,0.16567014,0.0027057233,0.0026054927,0.004571097,0.00010829912],"about_ca_topic_score_codex":0.010630637,"about_ca_topic_score_gemma":0.012815935,"teacher_disagreement_score":0.010630637,"about_ca_system_score_codex":0.00059973216,"about_ca_system_score_gemma":0.0011494155,"threshold_uncertainty_score":0.021137536},"labels":[],"label_agreement":null},{"id":"W4315703068","doi":"10.1016/j.urolonc.2022.11.019","title":"A real-world retrospective analysis of the management of metastatic castrate-resistant prostate cancer in Ontario, Canada from 2010 – 2018","year":2023,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; Sunnybrook Health Science Centre; AstraZeneca (Canada)","funders":"","keywords":"Enzalutamide; Medicine; Prostate cancer; Retrospective cohort study; Internal medicine; Cancer; Oncology; Cancer registry; Cohort; Abiraterone; Survival analysis; Clinical trial; Docetaxel; Androgen receptor","score_opus":0.03914345252339676,"score_gpt":0.33293876066128486,"score_spread":0.2937953081378881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315703068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95131594,0.0041338527,0.00028194967,0.0009694795,0.00007180099,0.00016989179,0.03828335,0.000036691883,0.004737077],"genre_scores_gemma":[0.9853098,0.0016432197,0.00030281988,0.0004268279,0.000033356362,0.00005896438,0.010797881,0.000017911576,0.001409251],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99791807,0.000108775756,0.00025017597,0.00032994774,0.00069967145,0.00069332874],"domain_scores_gemma":[0.99451894,0.00019084556,0.0014863044,0.00018968138,0.0026964801,0.00091778825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007781131,0.0005803674,0.0006989604,0.0019561984,0.0025116547,0.0016520874,0.0018646828,0.00080418895,0.0019623488],"category_scores_gemma":[0.0034822922,0.0006962562,0.00086468284,0.007356606,0.000923489,0.00054972124,0.0013844802,0.0009823312,0.00029487672],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015876546,0.00002567677,0.99080396,0.00015370284,0.00015155227,0.00034263785,0.00081451255,0.00018623284,0.00015088831,0.00012297001,0.0040890407,0.0030000028],"study_design_scores_gemma":[0.000010871185,0.000025570285,0.9944944,0.000099251396,0.00006926644,0.00026366088,0.0013154688,0.00019430996,0.000045695168,0.000017068134,0.0034459187,0.000018600187],"about_ca_topic_score_codex":0.9937972,"about_ca_topic_score_gemma":0.99666035,"teacher_disagreement_score":0.04535156,"about_ca_system_score_codex":0.04535156,"about_ca_system_score_gemma":0.06604339,"threshold_uncertainty_score":0.32905018},"labels":[],"label_agreement":null},{"id":"W4316038182","doi":"10.1016/j.urolonc.2022.12.013","title":"Editorial: Cutting edge basic and clinical bladder cancer research – the IBCN updates","year":2023,"lang":"en","type":"editorial","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Urothelial cancer; Cancer; Library science; General surgery; Internal medicine","score_opus":0.08336077993712795,"score_gpt":0.4499190736971997,"score_spread":0.36655829376007176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4316038182","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001562793,0.00457797,0.00004996571,0.025955332,0.9679043,0.000021329986,0.000054053846,0.00004059972,0.0013807038],"genre_scores_gemma":[0.00018059334,0.0030338143,0.00006133431,0.020198755,0.9708929,0.000025919264,0.000044416127,0.000035357967,0.00552691],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9892545,0.002164714,0.0011013981,0.0010642456,0.0055735316,0.00084154075],"domain_scores_gemma":[0.9619779,0.0116028255,0.003634098,0.0009848232,0.013809782,0.007990469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013505116,0.0053781667,0.0061484217,0.006515998,0.0038895796,0.012848734,0.005115374,0.022912653,0.028704032],"category_scores_gemma":[0.039263465,0.0017619821,0.0043000104,0.0022409663,0.0028874674,0.0055288714,0.0032291305,0.021957878,0.024555573],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003455751,0.000009533398,0.000014568394,0.0001424703,0.000012448049,0.00004090431,0.0000052054806,0.000012529205,0.000027452403,0.00008582129,0.9970715,0.0025430191],"study_design_scores_gemma":[0.00018241102,0.000041926294,0.0002245749,0.000908486,0.00009431294,0.00017146213,0.000035849527,0.000118233016,0.00007482737,0.0007169707,0.9974049,0.00002588111],"about_ca_topic_score_codex":0.0023748768,"about_ca_topic_score_gemma":0.007656717,"teacher_disagreement_score":0.028704032,"about_ca_system_score_codex":0.005525645,"about_ca_system_score_gemma":0.0065679043,"threshold_uncertainty_score":0.09602451},"labels":[],"label_agreement":null},{"id":"W4317936530","doi":"10.1016/j.urolonc.2022.10.032","title":"Age related differences in primary testicular lymphoma: A population based cohort study","year":2023,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Interquartile range; Incidence (geometry); Malignancy; Lymphoma; Internal medicine; Cohort; Seminoma; Population; Diffuse large B-cell lymphoma; Pathological; Chemotherapy","score_opus":0.027681491698843493,"score_gpt":0.2947032491944229,"score_spread":0.26702175749557944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317936530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991654,0.00018528682,0.000068049674,0.000023324312,0.0000064729697,0.000005092635,0.00024002376,0.0000024193303,0.00030414504],"genre_scores_gemma":[0.99959606,0.00007563493,0.000023543636,0.000015949727,0.000007943549,0.0000030348986,0.00012800703,0.0000020351615,0.0001477397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993622,0.00015123225,0.000059448612,0.00019750114,0.000076225355,0.00015336146],"domain_scores_gemma":[0.9989484,0.00014226027,0.00038003243,0.00015250863,0.00012274577,0.00025404716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004687915,0.00022681143,0.00036813662,0.00089549914,0.00062814757,0.00073860766,0.00034485728,0.00048823626,0.002360433],"category_scores_gemma":[0.0014562217,0.00046084437,0.0005949484,0.001481046,0.00029410294,0.00077579747,0.0004590818,0.00061164104,0.00033494818],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009443279,0.000040435327,0.99870276,0.0000040297373,0.00007763489,0.00014876552,0.00012602181,0.000015075077,0.00024907952,0.000014987419,0.00005483765,0.0004719186],"study_design_scores_gemma":[0.0000030212132,0.00007359339,0.9992261,0.0000013887,0.000030287383,0.000279412,0.00022707155,0.000035827925,0.00002115679,0.000011439645,0.00008831148,0.0000025042125],"about_ca_topic_score_codex":0.008267195,"about_ca_topic_score_gemma":0.008453257,"teacher_disagreement_score":0.008267195,"about_ca_system_score_codex":0.00036385932,"about_ca_system_score_gemma":0.00031920604,"threshold_uncertainty_score":0.016438127},"labels":[],"label_agreement":null},{"id":"W4317936583","doi":"10.1016/j.urolonc.2023.01.001","title":"Bladder preservation after neoadjuvant therapy – 2021 IBCN updates part 1","year":2023,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Neoadjuvant therapy; Cisplatin; Oncology; Clinical trial; Stage (stratigraphy); Urology; Internal medicine; Chemotherapy; Cancer","score_opus":0.10551008056200276,"score_gpt":0.3862761928058856,"score_spread":0.2807661122438828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317936583","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018972455,0.99252045,0.000096357384,0.0010404907,0.0016352333,0.000032609703,0.00024793646,0.000015308762,0.0042219358],"genre_scores_gemma":[0.0009081258,0.99417096,0.00019461096,0.0013400842,0.001013502,0.000029345314,0.0003682123,0.0000072413627,0.0019679167],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99970406,0.0000761481,0.00006468944,0.0000362832,0.00008061133,0.000038221733],"domain_scores_gemma":[0.9991215,0.00038691383,0.00018784188,0.000026730311,0.0002138379,0.00006329215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001120172,0.0006667153,0.00112135,0.0025622037,0.00022337248,0.0011885138,0.00057587196,0.00074670574,0.01635255],"category_scores_gemma":[0.0024089862,0.0002833904,0.00080400927,0.0019082422,0.00030167663,0.0010791934,0.0009761359,0.0012623371,0.0032637753],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016104589,0.000041249,0.00014102213,0.032328144,0.00011665396,0.000059446724,0.000032950044,0.00018170013,0.00081517396,0.0010806378,0.1105407,0.85450125],"study_design_scores_gemma":[0.000057554393,0.00014860037,0.0010645051,0.024901958,0.00038499187,0.00046735085,0.00002245345,0.00004101483,0.00030093742,0.0005689428,0.97202796,0.000013764267],"about_ca_topic_score_codex":0.0018845488,"about_ca_topic_score_gemma":0.006266178,"teacher_disagreement_score":0.01635255,"about_ca_system_score_codex":0.0009835135,"about_ca_system_score_gemma":0.002403205,"threshold_uncertainty_score":0.054704785},"labels":[],"label_agreement":null},{"id":"W4319337718","doi":"10.1016/j.urolonc.2023.01.011","title":"Access to definitive treatment and survival for intermediate-risk and high-risk prostate cancer at hospital systems serving health disparity populations","year":2023,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto","funders":"Pfizer; American Cancer Society","keywords":"Medicine; Underinsured; Prostate cancer; Socioeconomic status; Cancer; Odds ratio; Quartile; Odds; Retrospective cohort study; Emergency medicine; Health care; Demography; Internal medicine; Logistic regression; Environmental health; Population; Confidence interval; Health insurance","score_opus":0.06483367269311235,"score_gpt":0.3726518988323701,"score_spread":0.30781822613925774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319337718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99740905,0.00035556487,0.0000782637,0.00088810164,0.000013423682,0.0000094474335,0.00035609712,0.0000039963033,0.0008859889],"genre_scores_gemma":[0.9995047,0.00007234785,0.00002391962,0.00009951465,0.000013060716,0.0000028488848,0.00014370069,0.0000014002824,0.00013842327],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990157,0.00022420814,0.000058662365,0.000109962886,0.00007047451,0.0005209283],"domain_scores_gemma":[0.9974285,0.00040142747,0.0008760974,0.000068008834,0.00020947077,0.0010165389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005241577,0.0001778109,0.00028268984,0.00078829064,0.0010887639,0.0014409237,0.0007481962,0.0006161406,0.006799377],"category_scores_gemma":[0.00518736,0.0002592477,0.00056697434,0.0011794419,0.0005344827,0.001480537,0.0024376567,0.0012644611,0.00024285697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006559009,0.00007657911,0.9960026,0.000013107427,0.0000386344,0.000056154422,0.00038151318,0.00010310704,0.000043599102,0.00018602736,0.0004038987,0.0026291932],"study_design_scores_gemma":[0.000008706815,0.00008961333,0.9942174,0.000028276529,0.000028088363,0.000118623975,0.0044768113,0.000364216,0.000036164227,0.0003114801,0.00030991682,0.000010596693],"about_ca_topic_score_codex":0.059599392,"about_ca_topic_score_gemma":0.07627106,"teacher_disagreement_score":0.059599392,"about_ca_system_score_codex":0.0014602183,"about_ca_system_score_gemma":0.0017117221,"threshold_uncertainty_score":0.118505},"labels":[],"label_agreement":null},{"id":"W4321350071","doi":"10.1016/j.urolonc.2023.01.003","title":"Morbidity and mortality of multivisceral resection with radical nephrectomy for locally advanced renal cell carcinoma: An analysis of the National Surgical Quality Improvement Program (NSQIP) database","year":2023,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Propensity score matching; Renal cell carcinoma; Odds ratio; Confidence interval; Database; Nephrectomy; Retrospective cohort study; Surgery; Cohort; Internal medicine; Kidney","score_opus":0.067057038859862,"score_gpt":0.381023893112357,"score_spread":0.31396685425249504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321350071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938141,0.00068814243,0.00007345549,0.000090920556,0.000009704122,0.000013013172,0.0049694846,0.000006175838,0.00033496786],"genre_scores_gemma":[0.99563485,0.00032080623,0.000077469515,0.000055943274,0.000018832618,0.000017052464,0.0037758166,0.0000043534296,0.00009486578],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853003,0.00038075857,0.0002667021,0.00035712565,0.0002830138,0.00018224519],"domain_scores_gemma":[0.9961046,0.0007607531,0.0021200764,0.00026911238,0.0002895098,0.0004560048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012837743,0.0003125282,0.00058718526,0.0016642966,0.00036457684,0.0008815297,0.0007770131,0.00068356714,0.0012026116],"category_scores_gemma":[0.0036090948,0.00040534747,0.0015721066,0.003096738,0.00034584338,0.00089220784,0.0009926405,0.00079955277,0.00017522152],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015465493,0.000022143147,0.9987476,0.000017438864,0.00020776849,0.000023639355,0.000019877803,0.00010455889,0.000037758367,0.000013039003,0.00017092837,0.00048056486],"study_design_scores_gemma":[0.000009153898,0.00002468775,0.99947757,0.000004610834,0.00005471025,0.0000602599,0.00008552098,0.00018556083,0.00001657114,0.0000097505845,0.00006832505,0.0000033818364],"about_ca_topic_score_codex":0.016329203,"about_ca_topic_score_gemma":0.02248689,"teacher_disagreement_score":0.016329203,"about_ca_system_score_codex":0.0012949962,"about_ca_system_score_gemma":0.0009780341,"threshold_uncertainty_score":0.03246832},"labels":[],"label_agreement":null},{"id":"W4323267818","doi":"10.1016/j.urolonc.2023.01.015","title":"Adenocarcinoma of the Bladder: Assessment of Survival Advantage Associated With Radical Cystectomy and Comparison With Urothelial Bladder Cancer","year":2023,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cystectomy; Bladder cancer; Urothelial cancer; Urology; Medicine; Oncology; Adenocarcinoma; Cancer; Internal medicine","score_opus":0.03327128359324958,"score_gpt":0.34343645907069204,"score_spread":0.31016517547744243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323267818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974738,0.001558592,0.00011058318,0.000050026993,0.000025118808,0.0000065281015,0.00027656727,0.0000031970728,0.0004956538],"genre_scores_gemma":[0.99936706,0.00021607518,0.000044651464,0.000016380067,0.00003943572,0.0000031127731,0.00017779556,0.0000017576841,0.00013374396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993537,0.00027210906,0.00006194177,0.0001409266,0.000080120626,0.00009112478],"domain_scores_gemma":[0.99844664,0.00074125006,0.00037348538,0.00013160001,0.00007673599,0.00023031655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013178507,0.0003068694,0.0005813828,0.0007775412,0.0001867051,0.00060785055,0.00037589323,0.00048576665,0.001906581],"category_scores_gemma":[0.003752489,0.00010212402,0.0013889393,0.0007672028,0.0003278783,0.00063700206,0.0006090016,0.000438464,0.00015164254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022208853,0.00021089475,0.9621292,0.00015364458,0.0015191135,0.00013163441,0.00009272429,0.00047247153,0.0019419801,0.00011387426,0.00012720711,0.010898551],"study_design_scores_gemma":[0.00013285717,0.0033494388,0.9936879,0.000011127219,0.00084126944,0.00024942312,0.00019993928,0.0006204889,0.00032556543,0.00019933404,0.00036635355,0.000016244698],"about_ca_topic_score_codex":0.0012464249,"about_ca_topic_score_gemma":0.0018175608,"teacher_disagreement_score":0.001906581,"about_ca_system_score_codex":0.00030665414,"about_ca_system_score_gemma":0.0002763752,"threshold_uncertainty_score":0.0069695115},"labels":[],"label_agreement":null},{"id":"W4360612889","doi":"10.1016/j.urolonc.2023.02.007","title":"Surgeon-level versus hospital-level quality variance in kidney cancer surgery","year":2023,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Public Health Ontario; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Kidney cancer; Kidney disease; Cohort; Cancer; Veterans Affairs; Cancer surgery; Variance (accounting); Analysis of variance; Surgery; Internal medicine","score_opus":0.15209557813202887,"score_gpt":0.37194008499688574,"score_spread":0.21984450686485688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360612889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912254,0.0010235838,0.00432956,0.00081593177,0.000042838612,0.000040986273,0.0016636675,0.000027237906,0.00083066325],"genre_scores_gemma":[0.9985807,0.0000855371,0.00036857827,0.00006371562,0.000025569912,0.000016717278,0.00078499503,0.000005606389,0.000068524496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9920637,0.0032508369,0.00078159414,0.0010837301,0.0021548015,0.0006653584],"domain_scores_gemma":[0.95717925,0.01956533,0.016358461,0.002035881,0.0032804464,0.0015806248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009438408,0.00018916829,0.0004289653,0.0013545157,0.00023887148,0.00086917484,0.00047071668,0.00027862616,0.0011948632],"category_scores_gemma":[0.04106518,0.000121069716,0.00088245585,0.0027076812,0.0005073255,0.0005173943,0.0010403488,0.0005235453,0.00011600681],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006217152,0.00001709996,0.9955413,0.000029633331,0.00019118754,0.000009540451,0.00010819922,0.0005566696,0.000059113714,0.00014139495,0.00022265561,0.0030610098],"study_design_scores_gemma":[0.0000074436425,0.00007426762,0.9970091,0.00002013294,0.000041333282,0.000031366533,0.0001458324,0.0019398849,0.00012117633,0.00026518002,0.0003371847,0.0000071079908],"about_ca_topic_score_codex":0.00966503,"about_ca_topic_score_gemma":0.00890466,"teacher_disagreement_score":0.00966503,"about_ca_system_score_codex":0.0017131966,"about_ca_system_score_gemma":0.0016539736,"threshold_uncertainty_score":0.04991567},"labels":[],"label_agreement":null},{"id":"W4360992653","doi":"10.1016/j.urolonc.2023.02.009","title":"Small Testicular Masses: Contemporary Diagnostic and Treatment Strategies, Future Directions, and Knowledge Gaps","year":2023,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Malignancy; Testicular cancer; Medicine; Dilemma; Intervention (counseling); Narrative review; Narrative; Intensive care medicine; Set (abstract data type); General surgery; Gynecology; Cancer; Medical physics; Pathology; Internal medicine; Computer science; Epistemology","score_opus":0.10666658741661335,"score_gpt":0.3729667038880825,"score_spread":0.2663001164714692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360992653","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007083474,0.9984282,0.000071205635,0.0009640104,0.00013459504,0.000002413832,0.000013564286,0.0000038199046,0.00031137903],"genre_scores_gemma":[0.0006110363,0.99855417,0.00016313363,0.0003415572,0.00023993275,0.0000040021428,0.000018710705,0.0000011093102,0.00006626186],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995459,0.00013159408,0.00011384696,0.000065820794,0.0001061222,0.000036743186],"domain_scores_gemma":[0.99705136,0.0020458084,0.00031922467,0.000053735297,0.00044334074,0.00008643888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018345253,0.0006037174,0.0015202465,0.002579996,0.00036196253,0.001601353,0.0010361691,0.0012289463,0.004045525],"category_scores_gemma":[0.0044803,0.00030387627,0.00077395444,0.0024194391,0.00094417727,0.0022314345,0.00070502784,0.0017343797,0.0010482995],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010253679,0.000047591446,0.00058278156,0.04786089,0.00017546887,0.00045115242,0.00019685515,0.00048912945,0.00038616205,0.0060510156,0.029440718,0.91421574],"study_design_scores_gemma":[0.000031769792,0.00013846863,0.0019348335,0.054362986,0.0005851493,0.004410131,0.00052972866,0.00021546197,0.00024022402,0.008624691,0.92887604,0.000050529274],"about_ca_topic_score_codex":0.0019286181,"about_ca_topic_score_gemma":0.003790944,"teacher_disagreement_score":0.004045525,"about_ca_system_score_codex":0.0009456673,"about_ca_system_score_gemma":0.0027339256,"threshold_uncertainty_score":0.013533592},"labels":[],"label_agreement":null},{"id":"W4365450907","doi":"10.1016/j.urolonc.2023.03.003","title":"Attainment of early, deep prostate-specific antigen response in metastatic castration-sensitive prostate cancer: A comparison of patients initiated on apalutamide or enzalutamide","year":2023,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Enzalutamide; Prostate cancer; Medicine; Urology; Oncology; Prostate-specific antigen; Internal medicine; Proportional hazards model; Hazard ratio; Cancer; Androgen receptor; Confidence interval","score_opus":0.09863561196560236,"score_gpt":0.4006963273397584,"score_spread":0.302060715374156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365450907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995796,0.0001635195,0.0000129799,0.00000763193,0.0000022101958,0.000007921162,0.000078780584,6.899304e-7,0.00014654746],"genre_scores_gemma":[0.9996008,0.000069542206,0.00001888817,0.000020388574,0.0000051222933,0.0000064503715,0.00022150118,6.1754866e-7,0.000056771365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995548,0.0001253598,0.00005671864,0.00009455843,0.000078578145,0.00009006211],"domain_scores_gemma":[0.9983693,0.00034178884,0.0005990458,0.000047763686,0.00011439789,0.0005278396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005083881,0.00020868024,0.00045855957,0.0005590879,0.0002906085,0.00059231214,0.00026100784,0.00039119675,0.0010306843],"category_scores_gemma":[0.0013864329,0.00015032911,0.0006295713,0.0005435699,0.00024207262,0.0005033831,0.00045860675,0.0005321936,0.00014410727],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006649153,0.00037311495,0.9878732,0.000039125513,0.000273439,0.00008164402,0.00016241206,0.00010750496,0.0007117945,0.000023650371,0.00007436112,0.003630728],"study_design_scores_gemma":[0.00020536238,0.004079562,0.99461454,0.00000857481,0.00008437327,0.0001764191,0.0002779528,0.00021477463,0.00012356968,0.000017565264,0.00019056544,0.00000680224],"about_ca_topic_score_codex":0.004023592,"about_ca_topic_score_gemma":0.0067469548,"teacher_disagreement_score":0.004023592,"about_ca_system_score_codex":0.0005847296,"about_ca_system_score_gemma":0.0004663359,"threshold_uncertainty_score":0.008000314},"labels":[],"label_agreement":null},{"id":"W4366416287","doi":"10.1016/j.urolonc.2023.03.013","title":"Comparison of prostate-specific antigen response in patients with metastatic castration-sensitive prostate cancer initiated on apalutamide or abiraterone acetate: A retrospective cohort study","year":2023,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Abiraterone acetate; Medicine; Prostate cancer; Urology; Oncology; Proportional hazards model; Prostate-specific antigen; Internal medicine; Hazard ratio; Enzalutamide; Biochemical recurrence; Cohort; Androgen deprivation therapy; Cancer; Androgen receptor; Prostatectomy; Confidence interval","score_opus":0.0770773440475049,"score_gpt":0.3936441231716296,"score_spread":0.31656677912412473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366416287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993655,0.0001536228,0.00005089118,0.000008000402,0.0000031478874,0.000012729603,0.0003006412,0.0000015503334,0.000103903774],"genre_scores_gemma":[0.9994085,0.000066686654,0.000050164148,0.000010836164,0.0000055448413,0.000010823584,0.0003959567,0.0000016100806,0.000049843882],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998579,0.0003627776,0.00017218717,0.00046256854,0.0002581387,0.00016533957],"domain_scores_gemma":[0.99690264,0.0005021786,0.0015436647,0.00032548993,0.00026534926,0.00046061893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013438936,0.0003401377,0.00055329787,0.0009370119,0.00046224368,0.00079525466,0.0005613027,0.00045257722,0.00095506565],"category_scores_gemma":[0.003206695,0.0004108873,0.0008925199,0.0011860573,0.00030266913,0.0004916506,0.00053939095,0.0005717891,0.00022722615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004530041,0.00003146852,0.99867046,0.000006951821,0.00011740667,0.00005129142,0.000045295135,0.00003150419,0.00011942548,0.0000067381284,0.000025769852,0.00044088552],"study_design_scores_gemma":[0.00004522719,0.00050541386,0.9983209,0.0000058893197,0.00009579455,0.0003724496,0.00015975606,0.00021369387,0.00008684601,0.000012340571,0.00017527759,0.000006345273],"about_ca_topic_score_codex":0.0068522715,"about_ca_topic_score_gemma":0.00577033,"teacher_disagreement_score":0.0068522715,"about_ca_system_score_codex":0.0006630382,"about_ca_system_score_gemma":0.0006475365,"threshold_uncertainty_score":0.013624787},"labels":[],"label_agreement":null},{"id":"W4376649495","doi":"10.1016/j.urolonc.2023.04.015","title":"Comparison of patients with renal cell carcinoma in adjuvant therapy trials to a real-world population","year":2023,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; Health Sciences Centre; Sunnybrook Health Science Centre; Université de Montréal; University of Manitoba; University of Ottawa; McGill University; University of Calgary; University of British Columbia; University of Toronto; Dalhousie University; University of Alberta; Université Laval; Queen Elizabeth II Health Sciences Centre; McMaster University","funders":"","keywords":"Medicine; Internal medicine; Renal cell carcinoma; Clinical trial; Adjuvant therapy; Adjuvant; Population; Gastroenterology; Cancer; Surgery","score_opus":0.08879285853470481,"score_gpt":0.37520187823230194,"score_spread":0.28640901969759713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376649495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951983,0.0027319174,0.00028853034,0.00024641823,0.000058603073,0.000098737524,0.0003560434,0.0000045776314,0.0010169431],"genre_scores_gemma":[0.99807477,0.000524129,0.00009310444,0.00021707674,0.00007127531,0.0001336871,0.0007100188,0.0000033097442,0.0001726837],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99511683,0.0033959926,0.00048287248,0.00051249505,0.00023674793,0.0002549946],"domain_scores_gemma":[0.9951498,0.0031152628,0.00086196355,0.0002463933,0.00026810425,0.00035854455],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0041207797,0.000361694,0.0013834119,0.00057949516,0.00040935632,0.0010451847,0.0003969358,0.0008896802,0.0022688587],"category_scores_gemma":[0.015110206,0.00016525063,0.0012515396,0.00079227745,0.00042191925,0.0010888698,0.0006594964,0.00067401095,0.00026208436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2892775,0.0024017422,0.6503545,0.000948314,0.010133279,0.00068991375,0.0005571969,0.0021747155,0.004152671,0.00078976207,0.0019469238,0.036573526],"study_design_scores_gemma":[0.032268737,0.07278672,0.872661,0.0001698809,0.006878934,0.0010426971,0.0017133892,0.0033751167,0.0011991732,0.0014169838,0.006414987,0.00007252975],"about_ca_topic_score_codex":0.00049392553,"about_ca_topic_score_gemma":0.0007132324,"teacher_disagreement_score":0.99587923,"about_ca_system_score_codex":0.00048397706,"about_ca_system_score_gemma":0.0004889796,"threshold_uncertainty_score":0.021793067},"labels":[],"label_agreement":null},{"id":"W4377141282","doi":"10.1016/j.urolonc.2023.03.006","title":"Conditional survival of patients with low-risk prostate cancer: Temporal changes in active surveillance permanence over time","year":2023,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Proportional hazards model; Prostate cancer; Risk stratification; Internal medicine; Demography; Cancer; Oncology","score_opus":0.013211601541704109,"score_gpt":0.2875371737868317,"score_spread":0.2743255722451276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377141282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940175,0.0011736767,0.0005844549,0.00040308762,0.000018704748,0.000007836683,0.0024325456,0.000030730556,0.0013314747],"genre_scores_gemma":[0.9985776,0.00013057234,0.00006970988,0.000022222997,0.000013252848,0.0000040081686,0.0009014266,0.0000058208493,0.00027551627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994523,0.000107063286,0.000048716003,0.0001841569,0.000054717948,0.00015305309],"domain_scores_gemma":[0.9924281,0.002913316,0.0028461101,0.00063403515,0.00051765493,0.0006606397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015934904,0.00012591334,0.0003128663,0.0006478118,0.00023108655,0.00080090895,0.00050828175,0.00042671137,0.004944827],"category_scores_gemma":[0.012937414,0.00019765693,0.00063048914,0.000983657,0.00022689361,0.001289065,0.00067144417,0.00082083774,0.00033703106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096506503,0.000034973877,0.9899912,0.000043573462,0.00023888939,0.000061293445,0.00014394012,0.0007098166,0.00033754247,0.00040831426,0.0003284457,0.0067369286],"study_design_scores_gemma":[0.000005790232,0.00009850648,0.9974679,0.0000089253235,0.00008582683,0.0001564694,0.00012239168,0.0013903969,0.000094012044,0.00029780302,0.00026365826,0.000008437145],"about_ca_topic_score_codex":0.0073038046,"about_ca_topic_score_gemma":0.0073796026,"teacher_disagreement_score":0.0073038046,"about_ca_system_score_codex":0.00035407432,"about_ca_system_score_gemma":0.00046651353,"threshold_uncertainty_score":0.016542137},"labels":[],"label_agreement":null},{"id":"W4377826546","doi":"10.1016/j.urolonc.2023.04.008","title":"Stimulated Raman histology as a method to determine the adequacy of renal mass biopsy and identify malignant subtypes of renal cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; H&E stain; Biopsy; Renal cell carcinoma; Chromophobe cell; Histology; Oncocytoma; Pathology; Nephrectomy; Renal biopsy; Radiology; Clear cell; Kidney; Urology; Nuclear medicine; Staining; Internal medicine","score_opus":0.045302296344314964,"score_gpt":0.33872146118865754,"score_spread":0.29341916484434255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377826546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9276978,0.004752025,0.054367706,0.0005586298,0.0001716067,0.0001761391,0.00018787588,0.0005395997,0.011548598],"genre_scores_gemma":[0.9589822,0.0012011336,0.03800356,0.000103243096,0.000039855724,0.000029426863,0.00007163918,0.000059959733,0.001508879],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982692,0.00073049025,0.000111688394,0.00011168754,0.00069018715,0.00008661324],"domain_scores_gemma":[0.9972607,0.0010940811,0.00018858521,0.0002997303,0.0010445934,0.00011230479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004072591,0.00036255445,0.00026359342,0.002819694,0.0004040354,0.0008587165,0.0006237571,0.00053255435,0.0009352459],"category_scores_gemma":[0.0046737655,0.00046341767,0.00030864278,0.00050778367,0.00062707363,0.00067233265,0.00041850854,0.0005995187,0.00046192633],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019770341,0.00020795947,0.33388707,0.000291425,0.0002725996,0.0016547678,0.0011267189,0.0020709073,0.51789904,0.0014157085,0.0007826367,0.13841419],"study_design_scores_gemma":[0.0000740706,0.0016945077,0.39985582,0.00017614305,0.0007892862,0.022292638,0.0030421426,0.068282485,0.49455014,0.002183312,0.0068916343,0.0001678025],"about_ca_topic_score_codex":0.0017117228,"about_ca_topic_score_gemma":0.0042016753,"teacher_disagreement_score":0.004072591,"about_ca_system_score_codex":0.0002898697,"about_ca_system_score_gemma":0.00056648813,"threshold_uncertainty_score":0.021538198},"labels":[],"label_agreement":null},{"id":"W4385618112","doi":"10.1016/j.urolonc.2023.06.005","title":"Conditional survival of stage III non-seminoma testis cancer patients","year":2023,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Seminoma; Proportional hazards model; Medicine; Stage (stratigraphy); Cancer; Internal medicine; Confidence interval; Disease; Testicular cancer; Survival analysis; Surgery; Oncology; Chemotherapy; Biology","score_opus":0.030960713030763917,"score_gpt":0.3315075205866964,"score_spread":0.3005468075559325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385618112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957527,0.00035682978,0.000112807174,0.00015277928,0.000023251454,0.0000028716188,0.0015103476,0.000014441728,0.0020740058],"genre_scores_gemma":[0.99857545,0.000076337405,0.000015542522,0.000027131755,0.000013537014,0.0000019153865,0.0008401705,0.0000036293266,0.00044631225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998667,0.000022857668,0.000006682704,0.000028782235,0.0000125556335,0.00006240694],"domain_scores_gemma":[0.9993875,0.0001381392,0.00016156165,0.00004050594,0.000042646665,0.00022960395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002028115,0.00011898737,0.00016917025,0.00020270787,0.00019888404,0.00038408462,0.00015441049,0.00021076929,0.004850482],"category_scores_gemma":[0.0010863986,0.00006486305,0.00036633995,0.0002926284,0.0001430884,0.0002662785,0.0003111366,0.0003901047,0.00041027847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015135786,0.0000400052,0.9889503,0.000022858429,0.000082772625,0.00021084526,0.00005828905,0.00034393772,0.0009529856,0.00017416888,0.00091658445,0.006733701],"study_design_scores_gemma":[0.000016352318,0.0002594129,0.9974704,0.000005475982,0.00009393825,0.00044612307,0.00009682261,0.00040712208,0.00022079608,0.00025945914,0.00071788,0.000006398946],"about_ca_topic_score_codex":0.0028653706,"about_ca_topic_score_gemma":0.004379211,"teacher_disagreement_score":0.004850482,"about_ca_system_score_codex":0.0002352569,"about_ca_system_score_gemma":0.0003772835,"threshold_uncertainty_score":0.01622647},"labels":[],"label_agreement":null},{"id":"W4387117731","doi":"10.1016/j.urolonc.2023.08.014","title":"Survival of patients with clear cell renal carcinoma according to number and location of organ-specific metastatic sites","year":2023,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Lung; Renal cell carcinoma; Proportional hazards model; Metastatic carcinoma; Hazard ratio; Kidney; Internal medicine; Oncology; Pathology; Carcinoma; Confidence interval","score_opus":0.03733585232672881,"score_gpt":0.28734114617499185,"score_spread":0.25000529384826303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387117731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997054,0.00050662516,0.00013765588,0.000092285416,0.0000165927,0.0000035023834,0.0010847235,0.000010119977,0.0010945702],"genre_scores_gemma":[0.99866176,0.000114473965,0.000017390517,0.000027639051,0.000014174086,0.000002952121,0.0007600047,0.0000027503463,0.00039880857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99972564,0.000036158515,0.000017336311,0.000076448516,0.000024397923,0.000119969336],"domain_scores_gemma":[0.9991013,0.0002863902,0.00022285317,0.000057286503,0.00006752453,0.0002646977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004116946,0.00026128,0.0004516924,0.0006861616,0.00030248016,0.00045965475,0.0003280803,0.0005943261,0.0035666383],"category_scores_gemma":[0.0014194491,0.00019180584,0.000907464,0.0007321774,0.00029088074,0.0007385732,0.00060001743,0.00057907554,0.0004048227],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029547242,0.00004895651,0.9893545,0.000022346178,0.00021284647,0.00018798994,0.0001287227,0.0008581739,0.0006022167,0.00009239472,0.0005000698,0.0050370693],"study_design_scores_gemma":[0.000028391838,0.00037784406,0.9978083,0.000005323752,0.000101317135,0.000297455,0.0001748346,0.00070993893,0.00007661397,0.00013221834,0.00027607227,0.000011683099],"about_ca_topic_score_codex":0.0039803074,"about_ca_topic_score_gemma":0.0040756133,"teacher_disagreement_score":0.0039803074,"about_ca_system_score_codex":0.0003367614,"about_ca_system_score_gemma":0.00030755124,"threshold_uncertainty_score":0.011931658},"labels":[],"label_agreement":null},{"id":"W4387796853","doi":"10.1016/j.urolonc.2023.09.005","title":"Characterization of the metabolomic profile of renal cell carcinoma by high resolution magic angle spinning proton magnetic resonance spectroscopy","year":2023,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institutes of Health","keywords":"Renal cell carcinoma; Phosphocholine; Chromophobe cell; Pathology; Taurine; Chemistry; Metabolomics; Oncocytoma; Medicine; Nuclear magnetic resonance; Clear cell; Biochemistry; Amino acid; Chromatography","score_opus":0.010602915996240544,"score_gpt":0.24394095125964874,"score_spread":0.23333803526340818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387796853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993515,0.0018811276,0.0029564262,0.00017073758,0.000016976686,0.000024032444,0.00073044037,0.000033761593,0.000671392],"genre_scores_gemma":[0.9929315,0.0012506441,0.003964166,0.00009881994,0.000018492596,0.000025988464,0.00090872863,0.000013573411,0.0007880705],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999392,0.000007957454,0.0000042236165,0.000014086419,0.000022229036,0.0000124606095],"domain_scores_gemma":[0.9999211,0.000014180865,0.000011891959,0.00000658309,0.000031258827,0.000015053676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013018356,0.00017683044,0.0002399354,0.0005156081,0.00021493057,0.0002733146,0.00010025818,0.00022153169,0.00052635337],"category_scores_gemma":[0.00023839984,0.00008544048,0.00015284891,0.00047063257,0.00009232301,0.00018855045,0.00013628758,0.00029504937,0.00015523707],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042265165,0.00003750946,0.009229329,0.000036668032,0.00002992258,0.00015899168,0.000036450852,0.00010715208,0.98296607,0.000031595715,0.0000899029,0.006853771],"study_design_scores_gemma":[0.000026500269,0.0006440733,0.29264718,0.000008701173,0.00013290455,0.0017786316,0.0002835531,0.0049260026,0.6967206,0.00022720132,0.0025650098,0.000039622893],"about_ca_topic_score_codex":0.001814386,"about_ca_topic_score_gemma":0.00141207,"teacher_disagreement_score":0.001814386,"about_ca_system_score_codex":0.00011496495,"about_ca_system_score_gemma":0.00019358899,"threshold_uncertainty_score":0.0036076307},"labels":[],"label_agreement":null},{"id":"W4388657135","doi":"10.1016/j.urolonc.2023.10.004","title":"Optimizing outcomes for high-risk, non-muscle-invasive bladder cancer: The evolving role of PD-(L)1 inhibition","year":2023,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Pfizer","keywords":"Medicine; Bladder cancer; Immunotherapy; Clinical trial; Adverse effect; Oncology; Internal medicine; Cancer","score_opus":0.053086448714973825,"score_gpt":0.3638037370371719,"score_spread":0.3107172883221981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388657135","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002733045,0.98869765,0.0005406686,0.0061931945,0.00019803738,0.000017321336,0.00013713397,0.000016269702,0.0014667688],"genre_scores_gemma":[0.05244862,0.93988943,0.0017610769,0.0040598665,0.0009612202,0.00008208969,0.00032925585,0.000019127321,0.00044931404],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99882036,0.00052748615,0.00021738895,0.00012185929,0.00022928661,0.000083555446],"domain_scores_gemma":[0.99555284,0.002705905,0.00092021737,0.000059338865,0.0005466414,0.00021497949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027609435,0.00032900463,0.0015116386,0.0010353413,0.00022124333,0.0014199201,0.0005971461,0.0008108693,0.002520405],"category_scores_gemma":[0.007961551,0.00008590648,0.0013252704,0.0011013724,0.00034464235,0.0013670594,0.00071267283,0.0014566033,0.00042350125],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006478426,0.000109882436,0.0037332145,0.036067985,0.00083069445,0.00016075314,0.0001440648,0.0005980894,0.0005103553,0.0038764772,0.017249586,0.93607104],"study_design_scores_gemma":[0.0011421172,0.0037423533,0.04652915,0.14838937,0.0065227766,0.004069881,0.0016090828,0.0021162606,0.002164251,0.032905784,0.7506246,0.00018433538],"about_ca_topic_score_codex":0.00078362954,"about_ca_topic_score_gemma":0.0014913135,"teacher_disagreement_score":0.0027609435,"about_ca_system_score_codex":0.0011632667,"about_ca_system_score_gemma":0.0018977299,"threshold_uncertainty_score":0.014601469},"labels":[],"label_agreement":null},{"id":"W4389719567","doi":"10.1016/j.urolonc.2023.10.013","title":"Contemporary sex-specific analysis of the association of marital status with cancer-specific mortality in primary urethral carcinoma patients","year":2023,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Marital status; Hazard ratio; Proportional hazards model; Cohort; Internal medicine; Epidemiology; Cancer; Gynecology; Demography; Oncology; Confidence interval; Population","score_opus":0.03739399016885166,"score_gpt":0.30028848708957606,"score_spread":0.2628944969207244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389719567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963013,0.001909121,0.00012652331,0.00013367603,0.000016501159,0.0000026527441,0.0007042312,0.000006545249,0.0007994175],"genre_scores_gemma":[0.9990075,0.00037075471,0.000038009926,0.000028559409,0.000024040168,0.0000021618268,0.00040252088,0.0000020487062,0.00012443996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996,0.0001246794,0.0000446356,0.000098964585,0.000061293875,0.000070502814],"domain_scores_gemma":[0.9985654,0.00047863022,0.00041291563,0.00018402225,0.00018744143,0.00017157555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007247532,0.00012852544,0.00031057556,0.0010014895,0.0004389031,0.00069601665,0.00036514798,0.00032725531,0.0020200643],"category_scores_gemma":[0.0026644634,0.00013600806,0.00067780603,0.002055567,0.00027225012,0.00042689402,0.00039209484,0.00046735254,0.00018947589],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016462803,0.00000822532,0.9972844,0.000007447608,0.00010389734,0.000023731442,0.000041349034,0.000022382928,0.00011470277,0.000020684822,0.00009209572,0.002116366],"study_design_scores_gemma":[0.0000026090815,0.000034688703,0.9993783,0.0000025046588,0.00005129514,0.0000674175,0.00011792544,0.000084957224,0.00003253795,0.000021332584,0.0002045177,0.000001806486],"about_ca_topic_score_codex":0.005319664,"about_ca_topic_score_gemma":0.0074668783,"teacher_disagreement_score":0.005319664,"about_ca_system_score_codex":0.00028573905,"about_ca_system_score_gemma":0.00032231756,"threshold_uncertainty_score":0.010577381},"labels":[],"label_agreement":null},{"id":"W4390451997","doi":"10.1016/j.urolonc.2023.11.022","title":"A systematic review of nanocarriers for treatment of urologic cancers","year":2023,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada; Deutsche Forschungsgemeinschaft","keywords":"Medicine; Clinical trial; Prostate cancer; Bladder cancer; Cancer; Kidney cancer; Urologic disease; Intensive care medicine; Oncology; Internal medicine; Urinary system","score_opus":0.1198387692680881,"score_gpt":0.43646663794154794,"score_spread":0.3166278686734598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390451997","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003199865,0.999081,0.00006108563,0.000085034146,0.00007132847,0.000090443995,0.00013077504,0.0000047063186,0.00015572246],"genre_scores_gemma":[0.0038002871,0.995355,0.00024162327,0.00033154298,0.00003809017,0.000069987356,0.00006459169,0.0000024181988,0.00009641625],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99755317,0.0008242034,0.0008382796,0.0002255145,0.00046161588,0.00009729932],"domain_scores_gemma":[0.9945345,0.0037580738,0.0010964251,0.00008386327,0.00044044043,0.000086662134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031814806,0.0012739459,0.0068602166,0.0050746463,0.0003904032,0.0018431471,0.0015089521,0.0014699433,0.004967762],"category_scores_gemma":[0.011749156,0.00067755574,0.0061398316,0.0051615643,0.0006786728,0.0012909356,0.001064384,0.0011211326,0.00033132822],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003532491,0.00001856651,0.00019367757,0.9368674,0.010361991,0.000069628164,0.0000663895,0.00011702211,0.00026880414,0.0001961251,0.002188618,0.049298514],"study_design_scores_gemma":[0.0009906177,0.00061640854,0.0036239831,0.7545126,0.16859563,0.0006118753,0.00021033768,0.00016687023,0.00038796864,0.00069151935,0.069521196,0.000071045826],"about_ca_topic_score_codex":0.0072867596,"about_ca_topic_score_gemma":0.023931602,"teacher_disagreement_score":0.0072867596,"about_ca_system_score_codex":0.0018929833,"about_ca_system_score_gemma":0.004846371,"threshold_uncertainty_score":0.016825497},"labels":[],"label_agreement":null},{"id":"W4391509936","doi":"10.1016/j.urolonc.2024.01.015","title":"Germline variants in early and late-onset Brazilian prostate cancer patients","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Fundação Oswaldo Cruz; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior","keywords":"Germline; Prostate cancer; Epigenetics; Biology; Genetics; Germline mutation; Cancer; Disease; Gene; Population; Oncology; Mutation; Medicine; Internal medicine","score_opus":0.01710158968764387,"score_gpt":0.3117981940437426,"score_spread":0.29469660435609873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391509936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953902,0.001111384,0.00010779937,0.00024306428,0.000020132422,0.000013018379,0.00076202466,0.0000059930335,0.0023463452],"genre_scores_gemma":[0.9982772,0.0007134293,0.00007078613,0.00008554389,0.000010674519,0.000007786665,0.00036628282,0.0000073908295,0.00046093503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99972504,0.0000439402,0.000025055337,0.000076909164,0.000051844865,0.00007716564],"domain_scores_gemma":[0.9994653,0.000120837285,0.0001663182,0.000040798008,0.000108950015,0.00009784974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034715232,0.00031738624,0.00034197167,0.00094973546,0.00061929243,0.00056033063,0.00031920936,0.000364392,0.0039445073],"category_scores_gemma":[0.0029044212,0.00023809931,0.0003793594,0.0011776665,0.000378776,0.00018197684,0.0003453393,0.00042825702,0.00033159775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029943028,0.00004941521,0.9830277,0.00009075769,0.00009271363,0.0024762498,0.002075101,0.00005478802,0.0022131403,0.00028076317,0.0007551872,0.008584722],"study_design_scores_gemma":[0.000022008464,0.00008795289,0.98631454,0.00009033148,0.0001357747,0.0072456375,0.0024661468,0.00010182504,0.00025360414,0.0002778685,0.0029860365,0.000018246095],"about_ca_topic_score_codex":0.04856233,"about_ca_topic_score_gemma":0.050405,"teacher_disagreement_score":0.04856233,"about_ca_system_score_codex":0.0005329034,"about_ca_system_score_gemma":0.0005791404,"threshold_uncertainty_score":0.096559286},"labels":[],"label_agreement":null},{"id":"W4391541159","doi":"10.1016/j.urolonc.2024.01.022","title":"Unmarried status effect on stage at presentation and treatment patterns in primary urethral carcinoma patients","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Cohort; Logistic regression; Stage (stratigraphy); Epidemiology; Internal medicine; Odds ratio; Marital status; Presentation (obstetrics); Cancer; Cohort study; Oncology; Gynecology; Surgery; Population","score_opus":0.022504163406704,"score_gpt":0.3154587156865671,"score_spread":0.29295455227986306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391541159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99915624,0.00025700332,0.000013885957,0.000068782545,0.000008742651,0.0000017471633,0.000105351006,0.0000011618234,0.00038713048],"genre_scores_gemma":[0.99963903,0.00006609018,0.000008301626,0.000018010778,0.0000068636095,6.5849844e-7,0.000061721425,9.639697e-7,0.00019825873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99976844,0.000059796548,0.000022398144,0.000033548902,0.00002410618,0.000091785456],"domain_scores_gemma":[0.9988133,0.00028213242,0.00042095737,0.000042213025,0.0000526903,0.00038876245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027099747,0.00013003183,0.00023306896,0.00035316797,0.00038949263,0.0005816832,0.00022002531,0.0002818666,0.004354949],"category_scores_gemma":[0.0025363017,0.00014847249,0.00051212654,0.00053555303,0.00018859217,0.00043399044,0.0004524653,0.00051265286,0.0002472932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005061716,0.000087896246,0.99579006,0.000011000687,0.00005605021,0.0001409207,0.00016903647,0.00004888003,0.00017763712,0.000020313868,0.0000893702,0.0029025618],"study_design_scores_gemma":[0.000006507309,0.00017327268,0.9988387,0.0000073372216,0.000025673586,0.0001573484,0.0004941835,0.0001080176,0.00003487338,0.00003022187,0.000119593555,0.0000044058215],"about_ca_topic_score_codex":0.0039768587,"about_ca_topic_score_gemma":0.0057111527,"teacher_disagreement_score":0.004354949,"about_ca_system_score_codex":0.00022745396,"about_ca_system_score_gemma":0.00029877826,"threshold_uncertainty_score":0.014568746},"labels":[],"label_agreement":null},{"id":"W4391671329","doi":"10.1016/j.urolonc.2024.01.019","title":"Standardization of the evaluation and surveillance of patients with BCG unresponsive high grade non-muscle invasive bladder cancer clinical trials","year":2024,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"CAPS Research","keywords":"Medicine; Clinical trial; Cystoscopy; Bladder cancer; Context (archaeology); Guideline; Intensive care medicine; Clinical study design; Medical physics; Cancer; Internal medicine; Pathology; Urinary system","score_opus":0.13509189851081152,"score_gpt":0.46451999889989753,"score_spread":0.329428100389086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391671329","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008912903,0.99459285,0.00076891464,0.0020341466,0.0004511579,0.00025747603,0.00020043326,0.000014153028,0.00078955066],"genre_scores_gemma":[0.029275816,0.95776844,0.005828706,0.0044331863,0.0007670272,0.00094664516,0.0006073943,0.000013342715,0.00035951968],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9867533,0.007912694,0.0030250056,0.0007068122,0.0013353782,0.00026680678],"domain_scores_gemma":[0.9618848,0.026286053,0.0058469865,0.001082592,0.004326013,0.00057357445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.029493954,0.00074413995,0.005573989,0.0016752589,0.00024884002,0.0023299195,0.0021186005,0.0018538894,0.0017396549],"category_scores_gemma":[0.05490378,0.00042801295,0.0025166783,0.0018319146,0.0007378426,0.0017315692,0.00094254775,0.0018020733,0.00037412217],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013236499,0.000094779985,0.003586209,0.10605372,0.00258018,0.00006830192,0.00020339813,0.00074139546,0.00079408434,0.0028599647,0.01431228,0.86738205],"study_design_scores_gemma":[0.0045276536,0.0027009926,0.04128538,0.3889679,0.022522258,0.0011813736,0.0005284639,0.0017994052,0.002037509,0.008514022,0.5257703,0.00016465291],"about_ca_topic_score_codex":0.002208994,"about_ca_topic_score_gemma":0.0055204593,"teacher_disagreement_score":0.029493954,"about_ca_system_score_codex":0.0016906052,"about_ca_system_score_gemma":0.006613654,"threshold_uncertainty_score":0.15598083},"labels":[],"label_agreement":null},{"id":"W4391691849","doi":"10.1016/j.urolonc.2024.01.034","title":"Regional differences in upper tract urothelial carcinoma patients across the United States","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Renal pelvis; Hazard ratio; Proportional hazards model; Internal medicine; Epidemiology; Stage (stratigraphy); Urology; Ethnic group; Pelvis; Oncology; Surgery; Urinary system; Confidence interval; Biology","score_opus":0.040543153344487055,"score_gpt":0.3270166415059276,"score_spread":0.2864734881614405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391691849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957918,0.0007717182,0.00007014385,0.0003315518,0.000018086179,0.000009409977,0.0016351535,0.0000059295317,0.0013661738],"genre_scores_gemma":[0.99868745,0.0002507027,0.000029410534,0.00010927422,0.000012503184,0.0000056285367,0.0007280177,0.0000031279815,0.00017387758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994387,0.0001527885,0.00006839455,0.00013741376,0.0000684215,0.00013428],"domain_scores_gemma":[0.998667,0.00021195396,0.0006012798,0.00006684774,0.00018108872,0.00027182122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048027158,0.000143978,0.00032455497,0.0008916784,0.00037417267,0.00067798625,0.00041214656,0.00035118457,0.0022459175],"category_scores_gemma":[0.0016996267,0.00018969516,0.00049815944,0.0019904615,0.00030665385,0.0004680257,0.0007195004,0.0004278017,0.00026521058],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073277624,0.000016434507,0.99789584,0.000013305084,0.00007990111,0.000045167984,0.00015902861,0.000060721017,0.00017934786,0.000032085336,0.0003044326,0.0011405132],"study_design_scores_gemma":[0.0000020174386,0.000015508333,0.99911255,0.000006127348,0.000019426598,0.000053842123,0.0005031857,0.00004640348,0.000026287016,0.00001239574,0.00019938892,0.0000027685103],"about_ca_topic_score_codex":0.04223179,"about_ca_topic_score_gemma":0.075592235,"teacher_disagreement_score":0.04223179,"about_ca_system_score_codex":0.0006728281,"about_ca_system_score_gemma":0.0005726577,"threshold_uncertainty_score":0.08397198},"labels":[],"label_agreement":null},{"id":"W4392703546","doi":"10.1016/j.urolonc.2024.01.027","title":"Alignment of molecular subtypes across multiple bladder cancer subtyping classifiers","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia","funders":"René Vogels Stichting; Deutsche Forschungsgemeinschaft","keywords":"Subtyping; Bladder cancer; Medicine; Cystectomy; Oncology; Internal medicine; Concordance; Cancer","score_opus":0.034280975956934974,"score_gpt":0.3505061778678021,"score_spread":0.3162252019108671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392703546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8345661,0.0057347883,0.05745288,0.0026595131,0.0008574065,0.000563075,0.07908401,0.0055309334,0.013551267],"genre_scores_gemma":[0.7695024,0.0014493807,0.057432465,0.0007767703,0.0003122964,0.00025724398,0.16581689,0.00074218685,0.0037104036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816906,0.0002553721,0.00023539696,0.0006625688,0.0003626776,0.0003149695],"domain_scores_gemma":[0.9959417,0.0014060009,0.00044979714,0.0006463707,0.0012383498,0.00031775652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015314907,0.0007406958,0.0011040816,0.004224565,0.0011067241,0.0023553642,0.0007982129,0.00088391505,0.0038887297],"category_scores_gemma":[0.007386805,0.00034693576,0.001540661,0.0031632385,0.00029872786,0.00084166456,0.0013684538,0.001182661,0.0032134678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003009197,0.00049186277,0.42554623,0.0011870947,0.0015990126,0.0015227823,0.00068698206,0.015816644,0.08944624,0.0023753694,0.061292097,0.39702657],"study_design_scores_gemma":[0.0004937238,0.0011021344,0.56207085,0.0006768623,0.004283331,0.005533435,0.0021905466,0.18774219,0.063073404,0.02118291,0.15147112,0.00017945108],"about_ca_topic_score_codex":0.0065365825,"about_ca_topic_score_gemma":0.010184049,"teacher_disagreement_score":0.0065365825,"about_ca_system_score_codex":0.00078642956,"about_ca_system_score_gemma":0.0020308595,"threshold_uncertainty_score":0.013009071},"labels":[],"label_agreement":null},{"id":"W4392807463","doi":"10.1016/j.urolonc.2024.01.280","title":"URINARY EXTRACELLULAR VESICLE PROTEINS AS SIGNATURES FOR CRIBRIFORM AND INTRADUCTAL PROSTATE CARCINOMA","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cribriform; Prostate carcinoma; Extracellular vesicle; Extracellular vesicles; Carcinoma; Prostate; Pathology; Urology; Medicine; Biology; Internal medicine; Cancer; Cell biology; Microvesicles; Biochemistry; Gene","score_opus":0.01254289224577429,"score_gpt":0.28042647874009974,"score_spread":0.2678835864943254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392807463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878864,0.0067492197,0.0013572049,0.00013214967,0.000039881263,0.000037560745,0.00018699896,0.000039130853,0.0035713143],"genre_scores_gemma":[0.9975739,0.0009327398,0.0006904623,0.000027807655,0.000023928733,0.000008516339,0.0001276661,0.000009974609,0.000604935],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9996847,0.000051614956,0.0000318036,0.000052554977,0.00009073163,0.00008861141],"domain_scores_gemma":[0.999506,0.00011731925,0.00011623365,0.00004769028,0.00010523794,0.00010753076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074486644,0.00031887816,0.0003683694,0.0022263392,0.00035136388,0.0014904048,0.00046421614,0.00060602865,0.0014957557],"category_scores_gemma":[0.0014436913,0.00020527586,0.0002981207,0.0013332799,0.00065702526,0.0007172962,0.00095021067,0.00045518638,0.00026737037],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034034112,0.000100416764,0.38879004,0.00045635496,0.00023071727,0.008979681,0.0010539431,0.0005795899,0.5501158,0.0026069675,0.0007297903,0.042953342],"study_design_scores_gemma":[0.00006161818,0.0004382652,0.7898219,0.00010437964,0.00021986495,0.027075471,0.0018623953,0.003915142,0.16103232,0.0016626425,0.01373966,0.00006641484],"about_ca_topic_score_codex":0.0010237298,"about_ca_topic_score_gemma":0.0006386501,"teacher_disagreement_score":0.0022263392,"about_ca_system_score_codex":0.00042686597,"about_ca_system_score_gemma":0.00026626632,"threshold_uncertainty_score":0.0050037503},"labels":[],"label_agreement":null},{"id":"W4392807493","doi":"10.1016/j.urolonc.2024.01.287","title":"PROPENSITY-MATCHED ANALYSIS OF OPEN VERSUS ROBOTIC PRIMARY RETROPERITONEAL LYMPH NODE DISSECTION FOR CS II TESTICULAR CANCER","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Retroperitoneal lymph node dissection; Lymph node; Dissection (medical); Medicine; Testicular cancer; Propensity score matching; Surgery; Cancer; Radiology; Internal medicine","score_opus":0.05819044358936207,"score_gpt":0.36745900415771054,"score_spread":0.3092685605683485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392807493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99617434,0.0006900008,0.0018736356,0.00003957356,0.00009877208,0.0000970824,0.0004068914,0.000011521637,0.00060815865],"genre_scores_gemma":[0.99880016,0.00010300837,0.00040732135,0.00004782141,0.000038954615,0.00004153877,0.000312263,0.0000052791684,0.00024358874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99807847,0.000739104,0.00022370428,0.00053050317,0.00020122778,0.00022700639],"domain_scores_gemma":[0.9976986,0.000943051,0.00057320873,0.00051728997,0.00010181721,0.00016600206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019176423,0.00032383204,0.00091288675,0.00028941626,0.00023447158,0.0007660482,0.0006553208,0.00041452984,0.0030037658],"category_scores_gemma":[0.005361043,0.00034695677,0.0020887642,0.000538609,0.00039771,0.0005766304,0.00046136082,0.00062236545,0.00029438065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28395858,0.0012665797,0.59324443,0.0009823296,0.016109303,0.0006370257,0.0005304957,0.0073970137,0.010907414,0.0017242165,0.0034841294,0.07975859],"study_design_scores_gemma":[0.012778997,0.026050316,0.9096891,0.00013855023,0.009920056,0.001028326,0.000825032,0.027879415,0.0025960822,0.003859705,0.0051017595,0.00013265783],"about_ca_topic_score_codex":0.00095581746,"about_ca_topic_score_gemma":0.0019073534,"teacher_disagreement_score":0.0030037658,"about_ca_system_score_codex":0.00047634603,"about_ca_system_score_gemma":0.0005835554,"threshold_uncertainty_score":0.010141611},"labels":[],"label_agreement":null},{"id":"W4392807521","doi":"10.1016/j.urolonc.2024.01.288","title":"LONG-TERM OUTCOMES OF SURVEILLANCE OF CLINICAL STAGE I PURE TERATOMA OF THE TESTICLE","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Stage (stratigraphy); Term (time); Testicle; Teratoma; Medicine; Surgery; Internal medicine; Biology; Physics","score_opus":0.05450385896392969,"score_gpt":0.39662950879118,"score_spread":0.3421256498272503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392807521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977984,0.0010311406,0.00007404124,0.000057775123,0.000012435095,0.000004245662,0.00042467617,0.0000036288686,0.00059359043],"genre_scores_gemma":[0.9990108,0.00017603047,0.000017159158,0.000020262132,0.000017346696,0.0000021168728,0.00060777477,0.0000014602166,0.00014695978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996438,0.00007295618,0.000034698976,0.000070602924,0.00005840358,0.000119509736],"domain_scores_gemma":[0.99740714,0.00065649056,0.0009417825,0.00016756184,0.00029342383,0.0005335803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072442763,0.0001704271,0.00034222085,0.00060709263,0.0003500915,0.0008026165,0.00039745076,0.00042283247,0.0009885337],"category_scores_gemma":[0.0039792997,0.00009674033,0.00062536786,0.0005844329,0.00032579905,0.000689651,0.0005101276,0.00047995374,0.00018910607],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012610166,0.0001510819,0.9859313,0.00003393168,0.00019481004,0.00051630376,0.00022006177,0.00030967017,0.0004227173,0.000055346452,0.00021987865,0.010683969],"study_design_scores_gemma":[0.000017904857,0.0008646507,0.9968964,0.000019950552,0.00019332561,0.0009755274,0.00027264087,0.00023180255,0.00015875226,0.00008070617,0.0002771703,0.000011308812],"about_ca_topic_score_codex":0.0038773944,"about_ca_topic_score_gemma":0.0041866093,"teacher_disagreement_score":0.0038773944,"about_ca_system_score_codex":0.0005561864,"about_ca_system_score_gemma":0.0003317584,"threshold_uncertainty_score":0.007709682},"labels":[],"label_agreement":null},{"id":"W4392807621","doi":"10.1016/j.urolonc.2024.01.079","title":"LONGITUDINAL CHANGES IN PATIENT-REPORTED OUTCOMES (PROs) IN PATIENTS WITH HIGH-RISK BIOCHEMICALLY RECURRENT (BCR) NONMETASTATIC CASTRATION-SENSITIVE PROSTATE CANCER (NMCSPC) FROM THE EMBARK STUDY","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Prostate cancer; Medicine; Castration; Oncology; Biochemical recurrence; Gynecology; Internal medicine; Cancer; Urology; Prostatectomy; Hormone","score_opus":0.026127470129433072,"score_gpt":0.32334838313691466,"score_spread":0.2972209130074816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392807621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950842,0.00061768404,0.00006455786,0.000119622426,0.000019542524,0.000012054552,0.0035104828,0.0000060254106,0.00056572846],"genre_scores_gemma":[0.99217814,0.00024573226,0.00007264352,0.000080100894,0.000034162138,0.000029600897,0.00681224,0.0000046977493,0.00054262],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991472,0.000291049,0.000104024824,0.0001551274,0.00013392052,0.00016876314],"domain_scores_gemma":[0.997554,0.0003289083,0.001003963,0.00025211304,0.00037676308,0.00048422153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023034797,0.00048031693,0.0004965454,0.00055290665,0.0003674142,0.001049843,0.00058375177,0.0006307933,0.001520861],"category_scores_gemma":[0.00351378,0.0002762169,0.0009522221,0.00113807,0.00022081322,0.0011496105,0.0011691354,0.0013811653,0.0004312893],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037840188,0.00016542657,0.99138707,0.000054542634,0.00066888274,0.00007803237,0.00010213947,0.00013008612,0.00015042207,0.00004308128,0.0006263589,0.0028098912],"study_design_scores_gemma":[0.00006878051,0.0003102063,0.9986513,0.00001052161,0.00023996111,0.000059049125,0.00010577917,0.000080071724,0.000048356822,0.000021907828,0.0003953186,0.00000865674],"about_ca_topic_score_codex":0.005787993,"about_ca_topic_score_gemma":0.0077934973,"teacher_disagreement_score":0.005787993,"about_ca_system_score_codex":0.00044479294,"about_ca_system_score_gemma":0.00051855424,"threshold_uncertainty_score":0.0121821165},"labels":[],"label_agreement":null},{"id":"W4392807631","doi":"10.1016/j.urolonc.2024.01.078","title":"PSMA PET/CT-DETECTED MESORECTAL NODAL METASTASIS IN BIOCHEMICALLY RECURRENT PROSTATE CANCER PATIENTS","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Toronto","funders":"","keywords":"Prostate cancer; Medicine; NODAL; Metastasis; Recurrent prostate cancer; Cancer; Prostate; Oncology; Radiology; Nuclear medicine; Internal medicine; Prostatectomy","score_opus":0.020696249885930565,"score_gpt":0.3220727754442896,"score_spread":0.30137652555835903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392807631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99571204,0.0015881466,0.00007701247,0.00012861246,0.000024614777,0.000008167495,0.0002290337,0.000013736924,0.002218658],"genre_scores_gemma":[0.999201,0.00028403406,0.0000478017,0.000032710315,0.000025713387,0.0000026740508,0.00012998596,0.00000218909,0.0002738822],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998673,0.000022794988,0.0000142097915,0.000025191095,0.000033441243,0.000036960984],"domain_scores_gemma":[0.9997794,0.000054077114,0.000062260246,0.000011612112,0.000026596515,0.000066135144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002154548,0.00026554253,0.00022650021,0.00073223154,0.0002381563,0.00065771886,0.00032044854,0.000403901,0.0024027398],"category_scores_gemma":[0.0010070916,0.0002555962,0.00029488458,0.00046234787,0.00025558646,0.00031646347,0.00024526517,0.00031131788,0.00031229734],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006746701,0.000046120702,0.98105353,0.000052273168,0.00007203426,0.0037719382,0.00010248165,0.00027832543,0.0036051946,0.000054040614,0.0005106009,0.009778864],"study_design_scores_gemma":[0.000015669677,0.00018102504,0.99030894,0.000014423005,0.00012506646,0.0067941262,0.0002130772,0.0007172213,0.00071641675,0.00006184512,0.0008432806,0.000008883519],"about_ca_topic_score_codex":0.0041933497,"about_ca_topic_score_gemma":0.007456552,"teacher_disagreement_score":0.0041933497,"about_ca_system_score_codex":0.0003729698,"about_ca_system_score_gemma":0.00032201043,"threshold_uncertainty_score":0.008337855},"labels":[],"label_agreement":null},{"id":"W4392807792","doi":"10.1016/j.urolonc.2024.01.206","title":"ACTIVE SURVEILLANCE VERSUS PRIMARY INTERVENTION FOR CLINICAL T1A KIDNEY TUMORS: CONTEMPORARY RESULTS AFTER FOURTEN-YEAR EXPERIENCE OF THE DISSRM PROSPECTIVE COMPARATIVE STUDY","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Intervention (counseling); Medicine; Prospective cohort study; Primary (astronomy); Oncology; Internal medicine; Nursing","score_opus":0.10768055679330706,"score_gpt":0.4072498784454719,"score_spread":0.2995693216521648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392807792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961623,0.0026803697,0.00016555119,0.000033312273,0.000026797254,0.000049153674,0.0002434011,0.0000047998255,0.0006343094],"genre_scores_gemma":[0.99796534,0.0008405092,0.00021686756,0.00006205897,0.000095737334,0.000042915148,0.0004846296,0.0000062479203,0.0002855906],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99757034,0.0014888125,0.00018114016,0.0003463207,0.00018662213,0.00022685337],"domain_scores_gemma":[0.9956489,0.0021839966,0.00066060666,0.0007347291,0.0002903421,0.00048144202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005935451,0.00057613954,0.001557496,0.00075888913,0.00046508422,0.0011561547,0.00076408044,0.0007643026,0.0023073107],"category_scores_gemma":[0.00465374,0.0002470863,0.0013812713,0.0010438473,0.0010295778,0.0011814856,0.0006154458,0.0008428362,0.00042814887],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.66564006,0.010987407,0.23639163,0.0004484891,0.0020077606,0.0002553493,0.0010536705,0.0006054447,0.0032250714,0.00034661262,0.0003854258,0.078653105],"study_design_scores_gemma":[0.028904676,0.31113568,0.6427693,0.00018851255,0.005297417,0.000760426,0.0017886151,0.0012277646,0.0043806015,0.0004464754,0.0029872193,0.00011337745],"about_ca_topic_score_codex":0.0016675522,"about_ca_topic_score_gemma":0.0015285129,"teacher_disagreement_score":0.005935451,"about_ca_system_score_codex":0.0007354169,"about_ca_system_score_gemma":0.00054115907,"threshold_uncertainty_score":0.03139001},"labels":[],"label_agreement":null},{"id":"W4392807828","doi":"10.1016/j.urolonc.2024.01.083","title":"A PHASE IIB RANDOMIZED PLACEBO-CONTROLLED TRIAL TESTING A LONG-CHAIN OMEGA-3 FATTY ACID MAG-EPA DIETARY SUPPLEMENT ON PROSTATE CANCER AND GUT MICROBIOME","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Diet and metabolism studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec; McGill University Health Centre; Université de Montréal; Université Laval","funders":"","keywords":"Gut microbiome; Placebo; Microbiome; Cancer; Omega 3 fatty acid; Medicine; Internal medicine; Prostate cancer; Randomized controlled trial; Omega; Gastroenterology; Physiology; Oncology; Food science; Fatty acid; Bioinformatics; Biology; Biochemistry; Pathology; Polyunsaturated fatty acid; Docosahexaenoic acid; Alternative medicine","score_opus":0.03671899666235546,"score_gpt":0.3481909003428991,"score_spread":0.31147190368054367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392807828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9311816,0.031807754,0.0021626174,0.0043650465,0.0041238256,0.0153849125,0.004006755,0.0003838833,0.0065835854],"genre_scores_gemma":[0.94999814,0.013007031,0.0037961467,0.006621141,0.0014914093,0.011541007,0.0023473548,0.00005640389,0.011141409],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99934906,0.00031145525,0.000048941136,0.00014577067,0.000038620296,0.00010611223],"domain_scores_gemma":[0.9990012,0.00030782638,0.00019985784,0.0000997611,0.000106079344,0.00028530194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018845291,0.0020032942,0.0040311967,0.0005290555,0.0007733271,0.0013763647,0.0008890641,0.0035753695,0.014676488],"category_scores_gemma":[0.002524669,0.00094308227,0.0029574079,0.00060943596,0.0012031021,0.0010832043,0.0004857988,0.0038293612,0.0018449619],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9826987,0.0037199138,0.00024260767,0.0013247516,0.0019705142,0.000024524974,0.000028703433,0.00009238493,0.0018971125,0.000061472834,0.00060058554,0.0073387297],"study_design_scores_gemma":[0.9677628,0.029432148,0.0006478794,0.00008587895,0.0010463345,0.00001123742,0.000024166531,0.00006973145,0.00020073076,0.000110124995,0.0005988337,0.000009997256],"about_ca_topic_score_codex":0.0018926995,"about_ca_topic_score_gemma":0.003781498,"teacher_disagreement_score":0.014676488,"about_ca_system_score_codex":0.0008612346,"about_ca_system_score_gemma":0.0013297132,"threshold_uncertainty_score":0.049097717},"labels":[],"label_agreement":null},{"id":"W4392807839","doi":"10.1016/j.urolonc.2024.01.154","title":"IMPACT OF SOCIOECONOMIC MARGINALIZATION STATUS ON STAGE AT DIAGNOSIS AND ONCOLOGICAL OUTCOMES IN NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Health and Wellbeing Research","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; Trillium Health Centre","funders":"","keywords":"Bladder cancer; Socioeconomic status; Medicine; Cancer; Stage (stratigraphy); Oncology; Internal medicine; Environmental health; Biology; Population","score_opus":0.0552659973594523,"score_gpt":0.45743393396807147,"score_spread":0.40216793660861916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392807839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99817955,0.00027673235,0.00001620102,0.00031290879,0.00001433271,0.0000038437265,0.0003337641,0.0000011934537,0.0008615633],"genre_scores_gemma":[0.9995883,0.00006980918,0.000006412472,0.00003133287,0.000010951177,0.0000021906026,0.00015407511,8.6833865e-7,0.00013608212],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99929523,0.00017701335,0.000049937145,0.00007237685,0.000066643304,0.00033890532],"domain_scores_gemma":[0.9975273,0.00041494457,0.0008568605,0.00007126028,0.0001701628,0.0009593815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061088364,0.00021481092,0.0003688223,0.00065397104,0.00085606705,0.0012426713,0.00048180996,0.0005041425,0.0054257466],"category_scores_gemma":[0.0052498793,0.00020367267,0.0010188338,0.0011922444,0.00050087745,0.00084028824,0.001497441,0.0012480303,0.00028426797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017190301,0.0000570748,0.9981078,0.000009793042,0.00007578849,0.00006173854,0.00019347438,0.000036256362,0.000025797835,0.000046299992,0.00012997867,0.0010841368],"study_design_scores_gemma":[0.0000047448048,0.00007635027,0.9985019,0.0000121381545,0.000033648517,0.000056123423,0.0010024944,0.00009988589,0.00000919829,0.00006375794,0.00013388177,0.000005855555],"about_ca_topic_score_codex":0.022954581,"about_ca_topic_score_gemma":0.024690207,"teacher_disagreement_score":0.022954581,"about_ca_system_score_codex":0.00069693464,"about_ca_system_score_gemma":0.0010311198,"threshold_uncertainty_score":0.04564196},"labels":[],"label_agreement":null},{"id":"W4392807855","doi":"10.1016/j.urolonc.2024.01.099","title":"REAL-WORLD ELIGIBILITY AND UTILIZATION OF AVELUMAB MAINTENANCE IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Seagen (Canada)","funders":"","keywords":"Avelumab; Metastatic Urothelial Carcinoma; Urothelial carcinoma; Oncology; Medicine; Internal medicine; Immunotherapy; Bladder cancer; Cancer; Nivolumab","score_opus":0.03236979243773534,"score_gpt":0.3382561816656844,"score_spread":0.30588638922794903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392807855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967347,0.0010419362,0.000056971287,0.00020909324,0.000010447635,0.0000058999253,0.0013065699,0.0000042918737,0.0006300234],"genre_scores_gemma":[0.99879587,0.00021901901,0.000045459088,0.00007867656,0.000017456765,0.0000062017375,0.00075035443,0.0000019939018,0.0000849363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993524,0.00019623585,0.00010342855,0.00013221298,0.000083205276,0.00013261176],"domain_scores_gemma":[0.9971827,0.0007557619,0.0014662576,0.00010477926,0.0001237362,0.0003667606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064029015,0.00010884511,0.000359036,0.0005693954,0.00028695283,0.0008196262,0.0003731012,0.00055364287,0.002021729],"category_scores_gemma":[0.0043206676,0.00013211754,0.0006075505,0.0011402376,0.00023114054,0.0007401014,0.00043853192,0.00065596134,0.00028160523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006936934,0.000038720584,0.99447215,0.00003037107,0.00010607098,0.000072337985,0.000048084472,0.00017525563,0.00014286267,0.000048230293,0.00032209614,0.0038500943],"study_design_scores_gemma":[0.00001917934,0.0001580302,0.9976305,0.000023034181,0.000069841364,0.0003317936,0.00027977896,0.0005658397,0.00008152872,0.00007158643,0.00075786136,0.000010884282],"about_ca_topic_score_codex":0.003786929,"about_ca_topic_score_gemma":0.005813248,"teacher_disagreement_score":0.003786929,"about_ca_system_score_codex":0.00066925545,"about_ca_system_score_gemma":0.00040932646,"threshold_uncertainty_score":0.0075297356},"labels":[],"label_agreement":null},{"id":"W4392807872","doi":"10.1016/j.urolonc.2024.01.162","title":"DEVELOPMENT AND EXTERNAL VALIDATION OF NIMBLE, AN ARTIFICIAL INTELLIGENCE-BASED TOOL TO PREDICT PROGRESSION IN NON-MUSCLE INVASIVE BLADDER CANCER: A RETROSPECTIVE MULTI-INSTITUTIONAL COHORT STUDY","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Sinai Health System; Mount Sinai Hospital; University of Toronto; University Health Network; Trillium Health Centre","funders":"","keywords":"Bladder cancer; Retrospective cohort study; Cancer; Medicine; Cohort; Artificial intelligence; Computer science; Internal medicine","score_opus":0.046616179545419495,"score_gpt":0.3640919495551017,"score_spread":0.3174757700096822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392807872","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943942,0.00014874955,0.0025894665,0.00004590764,0.000033155273,0.00041061357,0.00159106,0.000033622222,0.0007532656],"genre_scores_gemma":[0.98968774,0.000115288734,0.003541398,0.000077576784,0.000034374687,0.00067557313,0.0050132475,0.000046646608,0.0008082241],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99697053,0.0011255734,0.00034816487,0.00074839656,0.00057125586,0.00023600909],"domain_scores_gemma":[0.9908014,0.0021363327,0.0015263829,0.0025643595,0.0023769557,0.00059462135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008454284,0.0008617435,0.00068541133,0.0016976164,0.0010614177,0.0017358003,0.0013571732,0.0012355861,0.0011714045],"category_scores_gemma":[0.016111542,0.00053783384,0.0010401257,0.001117593,0.0010468409,0.0011059364,0.0018435717,0.0009636502,0.0007619954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018715486,0.0007586996,0.9811266,0.00007289861,0.00044774104,0.00013105755,0.00074970216,0.00058858213,0.0019260437,0.00018755588,0.0008749097,0.011264806],"study_design_scores_gemma":[0.00025624965,0.0016806505,0.9877592,0.000049072703,0.0004522616,0.0005591613,0.00064478134,0.0031717368,0.0015154047,0.0002502957,0.003619454,0.00004179488],"about_ca_topic_score_codex":0.00363693,"about_ca_topic_score_gemma":0.0050042192,"teacher_disagreement_score":0.008454284,"about_ca_system_score_codex":0.0007582559,"about_ca_system_score_gemma":0.0015008228,"threshold_uncertainty_score":0.044711053},"labels":[],"label_agreement":null},{"id":"W4392807873","doi":"10.1016/j.urolonc.2024.01.160","title":"ONCOLOGIC OUTCOMES OF GEMCITABINE-DOCETAXEL COMBINATION INTRAVESICAL BLADDER SPARING THERAPY COMPARED TO UPFRONT RADICAL CYSTECTOMY IN BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cystectomy; Gemcitabine; Medicine; Bladder cancer; Docetaxel; Urology; Oncology; Internal medicine; Cancer","score_opus":0.03656695570836435,"score_gpt":0.3458443997824544,"score_spread":0.3092774440740901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392807873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99514943,0.0034756886,0.000060638788,0.00010606065,0.00008094411,0.000033691336,0.0002239009,0.000006656373,0.00086304406],"genre_scores_gemma":[0.9983303,0.00081211125,0.000048613954,0.000094138835,0.000046247296,0.000019538627,0.0002890511,0.000003018755,0.000357019],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9996915,0.00010286272,0.000028354205,0.000061443294,0.00003148501,0.000084387735],"domain_scores_gemma":[0.99943286,0.00017292378,0.00013814958,0.00003815092,0.00003241967,0.0001853767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049209676,0.00026042893,0.0010494846,0.00028125403,0.0001959611,0.00059982564,0.00026686103,0.00038271013,0.0021799784],"category_scores_gemma":[0.0012281383,0.00012959709,0.0013989939,0.00036567508,0.0002582555,0.00049632305,0.0002548273,0.0009657739,0.0001894199],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6262116,0.009101197,0.080311246,0.001116504,0.0036838502,0.00036363426,0.00037955446,0.009136091,0.008570458,0.00040228633,0.00246103,0.25826254],"study_design_scores_gemma":[0.03343929,0.3524774,0.58367515,0.00046136623,0.012391416,0.00069585035,0.00057467114,0.0061191376,0.004746378,0.0010381052,0.004261174,0.0001200212],"about_ca_topic_score_codex":0.001894248,"about_ca_topic_score_gemma":0.004828198,"teacher_disagreement_score":0.0021799784,"about_ca_system_score_codex":0.00079771527,"about_ca_system_score_gemma":0.0005600327,"threshold_uncertainty_score":0.0072927475},"labels":[],"label_agreement":null},{"id":"W4392807945","doi":"10.1016/j.urolonc.2024.01.152","title":"NATURAL HISTORY OF BLADDER-SPARING THERAPY IN PATIENTS WITH BCG-UNRESPONSIVE DISEASE; RESULTS FROM A LARGE MULTI-CENTER COHORT","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Natural history; Medicine; Cohort; Center (category theory); Disease; Oncology; Internal medicine","score_opus":0.05259791911388194,"score_gpt":0.36581191939377006,"score_spread":0.3132140002798881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392807945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99923754,0.00015155466,0.000048782556,0.000022751929,0.000003064155,0.0000042606825,0.0003532631,0.000002476759,0.0001763329],"genre_scores_gemma":[0.9992811,0.00007604456,0.000032938053,0.000025546931,0.000009295664,0.0000048704383,0.00046974962,0.0000037248512,0.000096787604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995925,0.000089103516,0.000031894397,0.0001594802,0.000044936118,0.00008207959],"domain_scores_gemma":[0.99900657,0.00016724497,0.00039539323,0.000104139806,0.00007158414,0.00025515485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004269258,0.0002453559,0.00044422792,0.0006934769,0.00060415146,0.00088965654,0.00038238446,0.00043598303,0.0013186107],"category_scores_gemma":[0.0016154174,0.00031895933,0.0005316029,0.00081159634,0.00036820158,0.0008256815,0.00054729043,0.0005755361,0.00025962517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001499362,0.000039286693,0.99879634,0.000003210787,0.000049882092,0.000051094972,0.000049891132,0.00002461769,0.00021611413,0.000007486657,0.000063565436,0.0005485631],"study_design_scores_gemma":[0.000008812036,0.00011026906,0.99910957,0.0000031636134,0.00003397464,0.00029770914,0.00017157133,0.000099059325,0.00004187222,0.000011801852,0.00010825513,0.0000038128126],"about_ca_topic_score_codex":0.004012402,"about_ca_topic_score_gemma":0.004568416,"teacher_disagreement_score":0.004012402,"about_ca_system_score_codex":0.0003600871,"about_ca_system_score_gemma":0.00042633913,"threshold_uncertainty_score":0.007978082},"labels":[],"label_agreement":null},{"id":"W4392807963","doi":"10.1016/j.urolonc.2024.01.165","title":"US CLINICAL PRACTICE PATTERNS OF INTRAVESICAL CHEMOTHERAPY FOR BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER AMONG CARCINOMA IN SITU AND PAPILLARY-ONLY TUMORS","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Manitoba","funders":"","keywords":"Medicine; Cancer; Chemotherapy; Bladder cancer; Carcinoma in situ; Oncology; Urology; Internal medicine","score_opus":0.029253706451418535,"score_gpt":0.36721322682754515,"score_spread":0.3379595203761266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392807963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99057907,0.0025928353,0.00027728532,0.0011905535,0.00002144231,0.000024904657,0.0016243168,0.00002912691,0.003660367],"genre_scores_gemma":[0.99784863,0.0007084201,0.00025630742,0.00023773519,0.000017067412,0.00001652047,0.00059264735,0.000012799454,0.00030982337],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984523,0.00046528506,0.0004048431,0.0002527102,0.00023504173,0.00018976878],"domain_scores_gemma":[0.9878879,0.0029691656,0.0065946104,0.00029729353,0.0012643877,0.0009866727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076154206,0.000112861395,0.00020739528,0.001997839,0.00028328504,0.0007078167,0.00032900996,0.0004925144,0.0031098877],"category_scores_gemma":[0.011468532,0.00017752174,0.00030863628,0.0042802156,0.00029512422,0.00052470085,0.00051656616,0.0003557283,0.00034662287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011512805,0.000017648337,0.9919258,0.000034011933,0.000036339974,0.00008836211,0.0002327743,0.00007081647,0.00025819562,0.000074931755,0.0005431573,0.0066029243],"study_design_scores_gemma":[0.00000890234,0.00007123683,0.99570614,0.00008391436,0.000032141983,0.00083044963,0.00101441,0.0004291722,0.00024223072,0.00008437047,0.001488122,0.000008930622],"about_ca_topic_score_codex":0.011751045,"about_ca_topic_score_gemma":0.018599644,"teacher_disagreement_score":0.011751045,"about_ca_system_score_codex":0.00096548453,"about_ca_system_score_gemma":0.0011938352,"threshold_uncertainty_score":0.023365319},"labels":[],"label_agreement":null},{"id":"W4392807988","doi":"10.1016/j.urolonc.2024.01.232","title":"MICROULTRASOUND IN CANCER – ACTIVE SURVEILLANCE (MUSIC-AS)","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Photoacoustic and Ultrasonic Imaging","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cancer; Medicine; Internal medicine","score_opus":0.017091001784557594,"score_gpt":0.28597192038444286,"score_spread":0.2688809185998853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392807988","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5091576,0.40620252,0.009802646,0.014162482,0.0031859013,0.00014486823,0.00013278324,0.0004145163,0.05679663],"genre_scores_gemma":[0.91827065,0.056808427,0.0056592403,0.0025822148,0.005287919,0.000055566205,0.00007793357,0.000042482527,0.011215716],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998511,0.000048633432,0.000010742226,0.00002152704,0.000042046886,0.00002586299],"domain_scores_gemma":[0.99971586,0.00012745726,0.000053230673,0.000015492427,0.00004034581,0.000047536945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046068933,0.00034515202,0.00021744675,0.00080458866,0.00023221964,0.0006972974,0.0003067837,0.0009713406,0.0027744502],"category_scores_gemma":[0.0009217845,0.00010563356,0.00031929216,0.00038627657,0.0005443546,0.0004159509,0.00035289789,0.00071956037,0.00051244226],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00427698,0.00072697666,0.02204066,0.0012454409,0.00011914782,0.011569066,0.0002735704,0.00036458226,0.078292646,0.0027448386,0.008695994,0.86965007],"study_design_scores_gemma":[0.0012654194,0.023105377,0.2819532,0.002022668,0.0011593989,0.22250538,0.0017937858,0.0069226976,0.18283525,0.010519571,0.26569504,0.00022222288],"about_ca_topic_score_codex":0.0005623341,"about_ca_topic_score_gemma":0.000593872,"teacher_disagreement_score":0.0027744502,"about_ca_system_score_codex":0.00032911848,"about_ca_system_score_gemma":0.00028420103,"threshold_uncertainty_score":0.0092814565},"labels":[],"label_agreement":null},{"id":"W4392821325","doi":"10.1016/j.urolonc.2024.01.249","title":"ASSOCIATION OF PROTON PUMP INHIBITORS CUMULATIVE USE WITH PROSTATE CANCER RISK AND ADVERSE OUTCOMES: A POPULATION-BASED ANALYSIS","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; University of Toronto","funders":"","keywords":"Prostate cancer; Medicine; Oncology; Internal medicine; Adverse effect; Population; Cancer; Environmental health","score_opus":0.025568557512638146,"score_gpt":0.3465742573761265,"score_spread":0.32100569986348837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392821325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99784267,0.0004625317,0.000261709,0.000041727297,0.000014475408,0.000014781659,0.0010021306,0.000013629131,0.0003462224],"genre_scores_gemma":[0.9985623,0.00015424112,0.00014179996,0.000035043333,0.000025048521,0.000019442337,0.00077686703,0.0000067241303,0.00027861222],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985403,0.0004098135,0.00012970292,0.0005304104,0.00017863279,0.00021104587],"domain_scores_gemma":[0.9982685,0.0004383973,0.0005691763,0.0003212134,0.00015074047,0.0002518861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011928838,0.0005862489,0.000988856,0.0011444963,0.0005645321,0.0011708122,0.00083524786,0.0010626181,0.0033664831],"category_scores_gemma":[0.0022306745,0.00097232853,0.0036487007,0.0021678961,0.0004737439,0.0010171375,0.0008817171,0.0015703188,0.00040426504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013289531,0.00012820035,0.99381626,0.00002769208,0.0029699195,0.00009939051,0.000043476564,0.0001521958,0.00033106483,0.000023797758,0.00018404493,0.00089518755],"study_design_scores_gemma":[0.00008255465,0.0004445766,0.9972363,0.000005775119,0.0009468061,0.00023164244,0.00013869026,0.00065746193,0.00005423223,0.000043011878,0.00014386956,0.000015062691],"about_ca_topic_score_codex":0.007916761,"about_ca_topic_score_gemma":0.0062796483,"teacher_disagreement_score":0.007916761,"about_ca_system_score_codex":0.00041858913,"about_ca_system_score_gemma":0.00049057533,"threshold_uncertainty_score":0.015741348},"labels":[],"label_agreement":null},{"id":"W4392821330","doi":"10.1016/j.urolonc.2024.01.253","title":"IMPACT OF BLADDER CUFF MANAGEMENT ON ONCOLOGIC OUTCOMES FOLLOWING RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS","year":2024,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Urothelial carcinoma; Medicine; Meta-analysis; Cuff; Urology; Carcinoma; Oncology; General surgery; Bladder cancer; Surgery; Internal medicine; Cancer","score_opus":0.0983059789797866,"score_gpt":0.42606808411091734,"score_spread":0.32776210513113074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392821330","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0099059865,0.9891511,0.00020319028,0.00010148857,0.00012800893,0.00005815739,0.00027170838,0.0000134064785,0.00016699191],"genre_scores_gemma":[0.31312194,0.68323314,0.001081767,0.0010989397,0.00027854284,0.00018700074,0.00057703373,0.00002669765,0.00039492353],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99703324,0.0010590345,0.0009023775,0.0005073434,0.0003292116,0.00016880906],"domain_scores_gemma":[0.99394786,0.004035618,0.0012952752,0.00023503831,0.00036053697,0.00012561573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045625456,0.0017717631,0.009147005,0.0018954435,0.00044833057,0.0019467459,0.0015290363,0.0020223863,0.002949466],"category_scores_gemma":[0.012506897,0.0011959797,0.025943618,0.0031098847,0.00066088134,0.0012550033,0.0013637961,0.0020222506,0.00028353633],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039340593,0.00006407147,0.013150187,0.28842744,0.6711331,0.00012555801,0.00016993993,0.00054761156,0.00037942978,0.00009555739,0.0008964061,0.021076664],"study_design_scores_gemma":[0.0006385944,0.00028572144,0.009800832,0.012064724,0.9754039,0.00007019836,0.00007730073,0.000113297494,0.000087088265,0.00011543363,0.0013105923,0.000032225027],"about_ca_topic_score_codex":0.0074533946,"about_ca_topic_score_gemma":0.02391038,"teacher_disagreement_score":0.009147005,"about_ca_system_score_codex":0.0013407187,"about_ca_system_score_gemma":0.0017762217,"threshold_uncertainty_score":0.024129331},"labels":[],"label_agreement":null},{"id":"W4394823774","doi":"10.1016/j.urolonc.2024.03.011","title":"Estimation of the incidence of urachal cancer: A systematic review and meta-analysis of registry-based studies","year":2024,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Urinary and Genital Oncology Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Innovációs és Technológiai Minisztérium; Nemzeti Kutatási Fejlesztési és Innovációs Hivatal; Nemzeti Kutatási, Fejlesztési és Innovaciós Alap; Nemzeti Kutatási és Technológiai Hivatal; Magyar Tudományos Akadémia","keywords":"Medicine; Incidence (geometry); Meta-analysis; Bladder cancer; Cancer registry; Internal medicine; Cancer; Lymph node; Systematic review; Oncology; Basal cell; MEDLINE","score_opus":0.16069906523213814,"score_gpt":0.4487704697537544,"score_spread":0.2880714045216163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394823774","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0064076968,0.9902956,0.0009949703,0.00019509494,0.00010162867,0.00020756897,0.0015295518,0.000030182002,0.00023777009],"genre_scores_gemma":[0.18757288,0.8044864,0.0034557965,0.0005533959,0.00024892142,0.0010321867,0.002429814,0.000048790087,0.00017182974],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98352885,0.0066619045,0.00594052,0.0019298685,0.0015610482,0.00037789368],"domain_scores_gemma":[0.9540369,0.03467145,0.0066563254,0.0015482244,0.002788891,0.00029823216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019713603,0.0025438294,0.016292501,0.013749542,0.00064506003,0.0031920914,0.002306491,0.0016540635,0.002335818],"category_scores_gemma":[0.048719134,0.001661439,0.03308741,0.01577244,0.00080030435,0.0020390044,0.0015997955,0.0013484149,0.0002780946],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008460631,0.000021584186,0.018944057,0.4237594,0.5401992,0.0001941064,0.00011401647,0.0007762789,0.00019833253,0.00016597875,0.0007712825,0.014009655],"study_design_scores_gemma":[0.00021341153,0.000110150366,0.009517786,0.03399312,0.95342404,0.00019928011,0.00006471418,0.00023576098,0.00012262302,0.00022117468,0.0018699125,0.000027952978],"about_ca_topic_score_codex":0.004799194,"about_ca_topic_score_gemma":0.009889123,"teacher_disagreement_score":0.019713603,"about_ca_system_score_codex":0.0019188501,"about_ca_system_score_gemma":0.004046365,"threshold_uncertainty_score":0.10425669},"labels":[],"label_agreement":null},{"id":"W4394824703","doi":"10.1016/j.urolonc.2024.03.019","title":"Use of inpatient palliative care in metastatic urethral cancer","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Urinary and Genital Oncology Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Confidence interval; Odds ratio; Logistic regression; Cancer; Internal medicine; Palliative care; Cohort; Nursing","score_opus":0.09387261931933148,"score_gpt":0.3839128691005588,"score_spread":0.2900402497812273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394824703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973972,0.0013559652,0.000078061435,0.00018925573,0.0000047261997,0.000005183587,0.00048467165,0.0000050652625,0.0004798686],"genre_scores_gemma":[0.9989969,0.0005322104,0.00007930573,0.00003252293,0.000006598165,0.0000036944148,0.00029993217,0.0000011947157,0.00004774128],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995925,0.00013595127,0.00005289464,0.000055596705,0.00009359197,0.00006951723],"domain_scores_gemma":[0.997352,0.00041929356,0.0018056721,0.000057390316,0.0001393825,0.00022634458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035171077,0.00008626768,0.00016670872,0.0003633392,0.00020787476,0.00033159426,0.00025421794,0.0001798854,0.0016093059],"category_scores_gemma":[0.003485073,0.00009812401,0.00029191002,0.0008962691,0.00019834981,0.00024345955,0.0004542486,0.0003400644,0.000092817514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005448771,0.000017212637,0.992732,0.000073491974,0.00003310534,0.00010003137,0.00009156295,0.00013210173,0.00010256725,0.000021137284,0.00021060393,0.0064316816],"study_design_scores_gemma":[0.0000031629972,0.00007972569,0.99811697,0.00007389711,0.000017894326,0.00070536416,0.00019721857,0.00030302609,0.00007687067,0.000024648758,0.0003983235,0.0000028235277],"about_ca_topic_score_codex":0.008516914,"about_ca_topic_score_gemma":0.013356732,"teacher_disagreement_score":0.008516914,"about_ca_system_score_codex":0.00052500906,"about_ca_system_score_gemma":0.0005809803,"threshold_uncertainty_score":0.016934693},"labels":[],"label_agreement":null},{"id":"W4395045002","doi":"10.1016/j.urolonc.2024.04.003","title":"Prognostic significance of lymph node count in surgically treated patients with T2-4 stage nonmetastatic adrenocortical carcinoma","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Adrenal and Paraganglionic Tumors","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Adrenocortical carcinoma; Stage (stratigraphy); Lymph node; Oncology; Internal medicine; Carcinoma; Mitotane; Urology","score_opus":0.01780602817442068,"score_gpt":0.2768960676793609,"score_spread":0.25909003950494025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395045002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99835783,0.0005789413,0.000049336482,0.00009330732,0.000020990154,0.0000026490766,0.00015772159,0.000004008601,0.0007352605],"genre_scores_gemma":[0.99947983,0.00012272876,0.000019846066,0.000019459721,0.000027375792,0.0000024261785,0.00016946245,0.000001853276,0.00015698968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998865,0.000027737284,0.000010945452,0.000020404206,0.00002423605,0.00003014166],"domain_scores_gemma":[0.9993394,0.00027712737,0.00014188528,0.000025434601,0.000042879426,0.00017328978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016369898,0.00018238973,0.0002346447,0.00054054434,0.00027418399,0.00036726956,0.00030425048,0.00035527736,0.0015507104],"category_scores_gemma":[0.0013763793,0.00012039151,0.00024626666,0.00046639613,0.00029541357,0.00028098628,0.00021411158,0.00036110124,0.00018208686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005699905,0.000023480401,0.99537045,0.00001306288,0.000030241697,0.00044647828,0.00005300041,0.00014546239,0.0012802997,0.000015280431,0.00012711083,0.0019251688],"study_design_scores_gemma":[0.000014271481,0.000122998,0.9983461,0.000003304124,0.00003631084,0.0007130806,0.00015693188,0.00019967936,0.0001943471,0.000029741768,0.00017904042,0.0000042639267],"about_ca_topic_score_codex":0.0025140676,"about_ca_topic_score_gemma":0.0052302578,"teacher_disagreement_score":0.0025140676,"about_ca_system_score_codex":0.00037812893,"about_ca_system_score_gemma":0.00032577326,"threshold_uncertainty_score":0.0051876307},"labels":[],"label_agreement":null},{"id":"W4396581101","doi":"10.1016/j.urolonc.2024.03.017","title":"Contemporary morbidity and mortality of open versus robotic cystectomy for bladder cancer: An analysis of the National Surgical Quality Improvement Program (NSQIP) procedure targeted cystectomy database","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; General surgery; Database; Surgery; Cancer; Internal medicine","score_opus":0.12929032777667246,"score_gpt":0.45187719873509286,"score_spread":0.3225868709584204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396581101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994827,0.00075547653,0.00006782842,0.00009475853,0.000010905354,0.000010378213,0.0039458536,0.000005286189,0.0002826521],"genre_scores_gemma":[0.99568814,0.00030637218,0.00005328771,0.000070259324,0.000019852208,0.000011119481,0.0037698408,0.0000050170793,0.000076084165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983113,0.00038564688,0.000275037,0.00048148754,0.00031376173,0.00023280484],"domain_scores_gemma":[0.9950793,0.0010863398,0.0025985113,0.00034910365,0.00038870817,0.0004979767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001474626,0.00027693994,0.0007009165,0.0017871521,0.00035614514,0.0011418005,0.00091481727,0.00084381504,0.001130038],"category_scores_gemma":[0.0046878904,0.00038620108,0.0016200206,0.0036758727,0.00047242147,0.001191381,0.001148681,0.0008219394,0.00019783869],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017791173,0.000023387047,0.99852955,0.00001922506,0.0002720649,0.000015710892,0.000037553782,0.000080280544,0.00004234726,0.000017013463,0.00018995673,0.00059499376],"study_design_scores_gemma":[0.0000074140635,0.000029681523,0.999491,0.000004670875,0.00005700034,0.00004377889,0.00012402097,0.00014981514,0.000014333759,0.000010373378,0.00006420436,0.0000036374834],"about_ca_topic_score_codex":0.016034579,"about_ca_topic_score_gemma":0.024979627,"teacher_disagreement_score":0.016034579,"about_ca_system_score_codex":0.0011986729,"about_ca_system_score_gemma":0.00077946525,"threshold_uncertainty_score":0.031882465},"labels":[],"label_agreement":null},{"id":"W4397293643","doi":"10.1016/j.urolonc.2024.04.006","title":"Chemotherapy, immunotherapy, or combination first-line treatment for metastatic urothelial carcinoma of the bladder: A large real-world experience","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Immunotherapy; Urothelial carcinoma; Metastatic Urothelial Carcinoma; Medicine; Chemotherapy; Oncology; Carcinoma; Internal medicine; Line (geometry); Urology; Bladder cancer; Cancer","score_opus":0.05282015430096166,"score_gpt":0.36443208262366944,"score_spread":0.3116119283227078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397293643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93986034,0.051439814,0.0019266616,0.0008173559,0.000108800086,0.00014144876,0.00032546776,0.000029414527,0.00535068],"genre_scores_gemma":[0.96521753,0.030334232,0.0016856316,0.0008240009,0.00024598185,0.00006996417,0.0006411074,0.000040077543,0.00094151526],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99963415,0.000175333,0.000029132041,0.000052494463,0.00006175434,0.00004720986],"domain_scores_gemma":[0.9994467,0.0002699597,0.000060104627,0.00005650649,0.000025470516,0.00014124488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088906917,0.00033932703,0.0005483828,0.00025509615,0.0004302541,0.000602103,0.00027516627,0.00046519266,0.0013622092],"category_scores_gemma":[0.0014621957,0.00015664652,0.0008169596,0.00054911635,0.0005190285,0.00048270222,0.0005129686,0.00072095793,0.00031068543],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01863619,0.008215463,0.14361128,0.0020833642,0.0017617783,0.01844832,0.0017690896,0.0068564606,0.019666003,0.0009994146,0.009978527,0.7679741],"study_design_scores_gemma":[0.007542896,0.0732828,0.6437437,0.0014773266,0.0037571369,0.12005727,0.0024778533,0.0059377956,0.018182978,0.001914439,0.121308096,0.0003177427],"about_ca_topic_score_codex":0.0006349649,"about_ca_topic_score_gemma":0.001642998,"teacher_disagreement_score":0.0013622092,"about_ca_system_score_codex":0.0004787267,"about_ca_system_score_gemma":0.00047219117,"threshold_uncertainty_score":0.004701853},"labels":[],"label_agreement":null},{"id":"W4401063809","doi":"10.1016/j.urolonc.2024.07.008","title":"Organ-confined pT2 ISUP4/5 vs. nonorgan confined pT3/4 ISUP2 vs. ISUP3 prostate cancer: Differences in biochemical recurrence-free survival after radical prostatectomy","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Biochemical recurrence; Prostatectomy; Prostate cancer; Hazard ratio; Proportional hazards model; Urology; Stage (stratigraphy); Confidence interval; Prostate; Internal medicine; Cancer; Oncology; Pathology","score_opus":0.022472684346687578,"score_gpt":0.30081770812476816,"score_spread":0.27834502377808057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401063809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993837,0.00013886266,0.00004846743,0.000020550173,0.0000045535,0.0000037105015,0.0001734044,0.000001944686,0.00022483512],"genre_scores_gemma":[0.99971133,0.00002089699,0.000015681826,0.000007777502,0.0000059479335,0.0000021602596,0.00017759002,8.2084415e-7,0.00005773521],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99967945,0.00008446755,0.000026041607,0.000079708974,0.00005144612,0.00007886641],"domain_scores_gemma":[0.9988726,0.00030359143,0.00050418975,0.000050763774,0.000044012984,0.00022481575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000573846,0.00019940849,0.00020321623,0.0004577562,0.0001901865,0.0004553233,0.00039135266,0.0003076759,0.0022773955],"category_scores_gemma":[0.0013169905,0.00013746679,0.0005956304,0.00044506695,0.0002350641,0.00039295646,0.0003757433,0.00043201906,0.00020427072],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012412493,0.000038315018,0.99661034,0.000011632273,0.00011612704,0.000051142822,0.000028819846,0.00007628824,0.0003817145,0.000021544267,0.00009544473,0.0013273981],"study_design_scores_gemma":[0.000017304053,0.00020354801,0.99902713,0.0000028287398,0.000054909786,0.00015819592,0.000058642734,0.00025439158,0.000111628106,0.000026683803,0.00008220327,0.0000025643249],"about_ca_topic_score_codex":0.002211518,"about_ca_topic_score_gemma":0.0027173231,"teacher_disagreement_score":0.0022773955,"about_ca_system_score_codex":0.00028056384,"about_ca_system_score_gemma":0.00030487945,"threshold_uncertainty_score":0.0076186657},"labels":[],"label_agreement":null},{"id":"W4401478628","doi":"10.1016/j.urolonc.2024.06.023","title":"Intraoperative margin assessment with near real time pathology during partial gland ablation of prostate cancer: A feasibility study","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health","keywords":"Medicine; Prostate cancer; Ablation; Margin (machine learning); Prostate; Surgical margin; Cancer; Histology; Pathology; Radiology; Internal medicine; Machine learning","score_opus":0.022397935212765573,"score_gpt":0.34413806617528014,"score_spread":0.3217401309625146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401478628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957145,0.00014002173,0.0036255664,0.000022227647,0.000005977785,0.00015232808,0.000029271405,0.000028684064,0.00028141728],"genre_scores_gemma":[0.99113727,0.000094668714,0.00835641,0.000032112028,0.00001528852,0.00012596046,0.00006312427,0.000012778753,0.0001624689],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99938667,0.0002857285,0.000022155395,0.00011533317,0.00012365633,0.00006648384],"domain_scores_gemma":[0.9987686,0.00042744467,0.00015354496,0.00014688648,0.00027689777,0.00022643963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015002255,0.0005141513,0.00023881071,0.00039614463,0.0002750884,0.0003794504,0.00044624667,0.00050389674,0.0013417706],"category_scores_gemma":[0.0022462255,0.00039181238,0.00031678373,0.00012386873,0.00044246283,0.0005456442,0.0006321477,0.00030315312,0.00037807794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014145573,0.007911523,0.49459103,0.0006804129,0.00016861851,0.0073178452,0.0033619048,0.002534898,0.33962104,0.00021854365,0.00049868284,0.12894993],"study_design_scores_gemma":[0.0012217949,0.10735856,0.7594322,0.00007237931,0.00043339626,0.028590864,0.0038441208,0.02343786,0.07180298,0.0004174085,0.0031970588,0.00019146128],"about_ca_topic_score_codex":0.00060548534,"about_ca_topic_score_gemma":0.00095622975,"teacher_disagreement_score":0.0015002255,"about_ca_system_score_codex":0.00021245908,"about_ca_system_score_gemma":0.00045677656,"threshold_uncertainty_score":0.007934034},"labels":[],"label_agreement":null},{"id":"W4401931402","doi":"10.1016/j.urolonc.2024.07.012","title":"Lymph node density as a prognostic marker of relapse in patients who underwent primary retroperitoneal lymph node dissection","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lymph node; Dissection (medical); Retroperitoneal lymph node dissection; Radiology; Lymph; Surgery; Chemotherapy; Pathology","score_opus":0.013059437282371704,"score_gpt":0.2781868112968694,"score_spread":0.2651273740144977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401931402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999178,0.00033721657,0.00003647019,0.000041608695,0.000009109298,0.0000021083051,0.00007576823,0.0000036092333,0.0003161906],"genre_scores_gemma":[0.99968076,0.000074155956,0.000030003746,0.000014168104,0.000013906768,0.0000015735358,0.0000830033,9.17802e-7,0.00010150117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99987316,0.000035460595,0.000011486181,0.000020630512,0.000024827217,0.000034473975],"domain_scores_gemma":[0.99940217,0.00022998425,0.00013254819,0.00003211373,0.00004456344,0.00015855789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030618062,0.00014736613,0.00027123763,0.00044463246,0.000201824,0.00038675318,0.00026435175,0.00026736656,0.0009832615],"category_scores_gemma":[0.0016930004,0.00017823545,0.00021872745,0.0005068465,0.00027397808,0.00035430022,0.00027093754,0.00035943976,0.00014079647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020420077,0.000018527651,0.9978715,0.0000047313974,0.000021755402,0.00013121511,0.000027166076,0.00008119866,0.0003457645,0.0000101364685,0.00005986237,0.0012239971],"study_design_scores_gemma":[0.0000085882275,0.00013211938,0.99857354,0.0000034199425,0.00003767586,0.0004960723,0.00010236664,0.00040073882,0.00011514046,0.000025422112,0.000101373866,0.0000034070706],"about_ca_topic_score_codex":0.0021153772,"about_ca_topic_score_gemma":0.0042816834,"teacher_disagreement_score":0.0021153772,"about_ca_system_score_codex":0.00024360258,"about_ca_system_score_gemma":0.00028167237,"threshold_uncertainty_score":0.004206121},"labels":[],"label_agreement":null},{"id":"W4402422263","doi":"10.1016/j.urolonc.2024.08.011","title":"Salvage local treatment for recurrent prostate cancer after focal therapy: A systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Meta-analysis; Prostate cancer; Salvage therapy; Oncology; Internal medicine; Cancer; Chemotherapy","score_opus":0.12814115814473145,"score_gpt":0.42524661528816354,"score_spread":0.29710545714343206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402422263","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0059120636,0.99294347,0.00027703366,0.00009811374,0.0001035368,0.0000927016,0.0003611896,0.000019547475,0.00019236229],"genre_scores_gemma":[0.2556924,0.7398464,0.0014522488,0.0013195948,0.00021594636,0.00027852625,0.0006634561,0.000037414964,0.0004939447],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99700576,0.0011884815,0.00084196473,0.0004942592,0.00029494893,0.00017454725],"domain_scores_gemma":[0.99485165,0.0032768494,0.0012406829,0.00021338306,0.0002937133,0.00012376688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046458333,0.0020254296,0.011620171,0.0030328396,0.00046163992,0.0020697718,0.0018826742,0.0018977264,0.005719704],"category_scores_gemma":[0.011186298,0.0012743099,0.025099283,0.004107416,0.0006527341,0.0017146815,0.0014539901,0.002036772,0.00045779152],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028263968,0.00004644308,0.0051492816,0.34453836,0.6286423,0.00013057186,0.0001295141,0.00050410314,0.00028965235,0.00010114435,0.00090870756,0.016733484],"study_design_scores_gemma":[0.00093904475,0.00020571782,0.0043356395,0.016132684,0.9764746,0.00008286527,0.00006591523,0.000120673394,0.000060002305,0.00012943303,0.0014250167,0.00002845906],"about_ca_topic_score_codex":0.007478464,"about_ca_topic_score_gemma":0.032491576,"teacher_disagreement_score":0.011620171,"about_ca_system_score_codex":0.0017651612,"about_ca_system_score_gemma":0.0021047355,"threshold_uncertainty_score":0.024569869},"labels":[],"label_agreement":null},{"id":"W4402620682","doi":"10.1016/j.urolonc.2024.08.003","title":"Adjuvant immunotherapy in high-risk muscle invasive urothelial carcinoma: A systematic review and meta-analysis of randomized clinical trials","year":2024,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McMaster University; Juravinski Cancer Centre","funders":"National Institutes of Health","keywords":"Medicine; Meta-analysis; Internal medicine; Randomized controlled trial; Oncology; Systematic review; Cochrane Library; Placebo; Adverse effect; MEDLINE; Lymph node; Guideline; Pathology","score_opus":0.169781366701937,"score_gpt":0.45434342431627,"score_spread":0.284562057614333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402620682","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004907032,0.994142,0.00030122948,0.00008633803,0.000090774905,0.00012254642,0.00021670319,0.000012034044,0.000121310026],"genre_scores_gemma":[0.15861285,0.8373264,0.0016904464,0.00092505856,0.00022109112,0.00037931593,0.0005405404,0.000021301184,0.00028302523],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99511564,0.0022453167,0.0013607551,0.00065409654,0.00042839503,0.00019584496],"domain_scores_gemma":[0.9921366,0.005626303,0.001473187,0.0002603378,0.00035380083,0.00014984197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006903364,0.0021209035,0.01570368,0.0024383976,0.00044554216,0.0022941914,0.0017302525,0.0019740222,0.0031586406],"category_scores_gemma":[0.015117318,0.001140281,0.021109795,0.0037751838,0.00066336564,0.0015911305,0.0013170218,0.0021143518,0.00026063857],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005185072,0.00006000222,0.004690274,0.37755156,0.5901534,0.00010227496,0.000089522495,0.000580765,0.00038589886,0.00011016328,0.00071116455,0.020379901],"study_design_scores_gemma":[0.0020080663,0.00035147503,0.00474993,0.019152563,0.97151047,0.000076765835,0.000054414526,0.00014966656,0.00011112256,0.00020570835,0.0016006005,0.000029318064],"about_ca_topic_score_codex":0.0038387275,"about_ca_topic_score_gemma":0.0118543375,"teacher_disagreement_score":0.01570368,"about_ca_system_score_codex":0.0014353415,"about_ca_system_score_gemma":0.0020593738,"threshold_uncertainty_score":0.036508918},"labels":[],"label_agreement":null},{"id":"W4403192697","doi":"10.1016/j.urolonc.2024.09.014","title":"The efficacy of adjuvant mitotane therapy and radiotherapy following adrenalectomy in patients with adrenocortical carcinoma: A systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Adrenal and Paraganglionic Tumors","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"Agencja Badań Medycznych; Narodowa Agencja Wymiany Akademickiej; European Association of Urology","keywords":"Medicine; Mitotane; Adrenocortical carcinoma; Radiation therapy; Meta-analysis; Adjuvant; Oncology; Adrenalectomy; Internal medicine; Adjuvant therapy; Adjuvant radiotherapy; Chemotherapy","score_opus":0.05163401158578193,"score_gpt":0.3448317727092229,"score_spread":0.293197761123441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403192697","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00429928,0.99410546,0.00033189912,0.00015966968,0.00011992617,0.00021212958,0.0005398335,0.000018259883,0.00021357262],"genre_scores_gemma":[0.1680502,0.8266265,0.001698199,0.0010539254,0.00028878188,0.0009246106,0.0010347359,0.000030969793,0.00029199556],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99283123,0.0032232353,0.0022014729,0.0007450456,0.0007330164,0.00026593186],"domain_scores_gemma":[0.9857071,0.01047959,0.0022698755,0.00043148574,0.0009331618,0.00017886094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009761603,0.0021459095,0.016775474,0.0048779724,0.0005994904,0.0027553628,0.0017406225,0.0019742807,0.0032317364],"category_scores_gemma":[0.023734,0.0012438158,0.032960627,0.006247748,0.0006150541,0.0015019431,0.0012071162,0.0015238995,0.00027064607],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016187872,0.000024607414,0.0037687172,0.5035991,0.47951764,0.000107418164,0.00007522117,0.0004530937,0.00021457771,0.00009744234,0.000621651,0.0099017825],"study_design_scores_gemma":[0.00042382468,0.00015119118,0.003259602,0.029792147,0.9643249,0.00008306262,0.00003411345,0.00013121509,0.00009060254,0.00012481026,0.0015624235,0.000022122282],"about_ca_topic_score_codex":0.006988971,"about_ca_topic_score_gemma":0.016900623,"teacher_disagreement_score":0.016775474,"about_ca_system_score_codex":0.002148109,"about_ca_system_score_gemma":0.0036216183,"threshold_uncertainty_score":0.051624894},"labels":[],"label_agreement":null},{"id":"W4403361035","doi":"10.1016/j.urolonc.2024.09.035","title":"Critical care therapy and in-hospital mortality after radical nephroureterectomy for nonmetastatic upper urinary tract carcinoma","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Urology; Upper urinary tract; Urothelial carcinoma; Urinary system; General surgery; Oncology; Internal medicine; Cancer; Bladder cancer","score_opus":0.036588351008754315,"score_gpt":0.3547519681422988,"score_spread":0.3181636171335445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403361035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992611,0.00030022187,0.000038125923,0.00006654164,0.0000036194642,0.000002589491,0.00013035118,0.0000018692041,0.0001957124],"genre_scores_gemma":[0.9996824,0.00006310433,0.000019410112,0.000010984361,0.000006061451,0.0000022450995,0.00017955915,4.951708e-7,0.000035651465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997061,0.000063686166,0.000040732913,0.00004606985,0.000069107475,0.00007423807],"domain_scores_gemma":[0.9978009,0.00040825835,0.001254593,0.00006203657,0.00016127915,0.0003129709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041215503,0.00010469972,0.00015804362,0.0002978656,0.00025016814,0.00038592616,0.00026586326,0.00017703795,0.0011667818],"category_scores_gemma":[0.0034612452,0.000081210674,0.00024481822,0.0005041449,0.00016184831,0.00025182273,0.0003000743,0.0004073663,0.000085488966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004218149,0.000011257987,0.99916244,0.000005564228,0.000014820461,0.000021320795,0.000011118066,0.000035952795,0.000032850385,0.0000057960324,0.000050633724,0.00060621824],"study_design_scores_gemma":[0.0000029296516,0.000052251373,0.9993463,0.000006836935,0.000013323687,0.000151416,0.000060738566,0.00021047807,0.000059437803,0.0000132740715,0.00008164215,0.0000014406168],"about_ca_topic_score_codex":0.004064575,"about_ca_topic_score_gemma":0.0063834465,"teacher_disagreement_score":0.004064575,"about_ca_system_score_codex":0.000678819,"about_ca_system_score_gemma":0.00056621473,"threshold_uncertainty_score":0.008081794},"labels":[],"label_agreement":null},{"id":"W4403539272","doi":"10.1016/j.urolonc.2024.09.015","title":"Neoadjuvant chemotherapy before radical cystectomy in patients with organ-confined and non-organ-confined urothelial carcinoma","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Urothelial carcinoma; Chemotherapy; Urothelial cancer; Urology; Bladder cancer; Oncology; Internal medicine; General surgery; Cancer","score_opus":0.008901065744970394,"score_gpt":0.2608157947104071,"score_spread":0.2519147289654367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403539272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883668,0.0083505735,0.00009851726,0.0005116458,0.00014296047,0.000018226661,0.0001986747,0.000006327057,0.0023063864],"genre_scores_gemma":[0.99780434,0.0012534595,0.00008406048,0.0001721025,0.0000712187,0.000014066376,0.0002690995,0.0000021842795,0.00032954098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997706,0.00008099214,0.00002683854,0.000037032412,0.000027237043,0.000057305693],"domain_scores_gemma":[0.99931073,0.00031837414,0.00013066373,0.000021021933,0.000023677918,0.00019549324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002533732,0.00018177478,0.00061853096,0.00025507816,0.00031211134,0.00043707082,0.00014389155,0.0004265865,0.0013852702],"category_scores_gemma":[0.0020353708,0.00016808571,0.00039625526,0.0003924836,0.0002221237,0.00039378426,0.00014389923,0.00050838274,0.00011932268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03488396,0.00065248495,0.9094951,0.00027816108,0.0003221068,0.0014385264,0.00020570117,0.00094629306,0.005916924,0.00018599172,0.0013041084,0.044370618],"study_design_scores_gemma":[0.00041531053,0.0039730817,0.9893085,0.000090101,0.0003937526,0.0014616296,0.00035265373,0.0006549385,0.0007069833,0.00022606738,0.0023920848,0.000024884244],"about_ca_topic_score_codex":0.0016919046,"about_ca_topic_score_gemma":0.0060856934,"teacher_disagreement_score":0.0016919046,"about_ca_system_score_codex":0.00057272887,"about_ca_system_score_gemma":0.0007010418,"threshold_uncertainty_score":0.0046342015},"labels":[],"label_agreement":null},{"id":"W4403860183","doi":"10.1016/j.urolonc.2024.09.030","title":"Bempegaldesleukin plus nivolumab in first-line advanced/metastatic urothelial carcinoma: Results from a phase II single-arm study (PIVOT-10)","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Metastatic Urothelial Carcinoma; Nivolumab; Urothelial carcinoma; First line; Oncology; Internal medicine; Urology; Cancer; Bladder cancer; Immunotherapy","score_opus":0.05315875934705231,"score_gpt":0.34628738907932416,"score_spread":0.29312862973227183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403860183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99023235,0.0060078804,0.00036170546,0.0004054297,0.00027844255,0.00060687313,0.0009631815,0.00008650997,0.0010576069],"genre_scores_gemma":[0.9876138,0.0047921254,0.0011496559,0.00089249964,0.00020886694,0.0006656358,0.001854285,0.00004698742,0.002776171],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995296,0.00018151308,0.000018955392,0.000085018226,0.000043579006,0.00014134365],"domain_scores_gemma":[0.9993711,0.00011570881,0.00009905219,0.000051456354,0.00003896532,0.00032373038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016621922,0.0015021325,0.0026452986,0.00040866827,0.00032153892,0.0015591548,0.0009980652,0.0012201872,0.0024227328],"category_scores_gemma":[0.0008585169,0.0005943708,0.002451803,0.00042345625,0.0010533566,0.0011645273,0.0003327178,0.00385516,0.00078968157],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.79158,0.03411119,0.0044037686,0.0019695302,0.003666753,0.00013364237,0.00027688517,0.0034152807,0.022340726,0.00023961204,0.0037197925,0.13414274],"study_design_scores_gemma":[0.60799253,0.36877784,0.014441655,0.000106475134,0.0017505139,0.00017717945,0.00012082543,0.001225224,0.0028013496,0.000207941,0.0023388257,0.000059690636],"about_ca_topic_score_codex":0.0019206856,"about_ca_topic_score_gemma":0.005746981,"teacher_disagreement_score":0.0026452986,"about_ca_system_score_codex":0.0013011452,"about_ca_system_score_gemma":0.0014948922,"threshold_uncertainty_score":0.009440482},"labels":[],"label_agreement":null},{"id":"W4403912249","doi":"10.1016/j.urolonc.2024.08.023","title":"Statin use and oncological outcomes in a propensity-matched cohort of nonmetastatic castration resistant prostate cancer patients of the ARAMIS trial","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bayer (Canada); Princess Margaret Cancer Centre","funders":"Bayer","keywords":"Medicine; Prostate cancer; Oncology; Internal medicine; Statin; Cohort; Propensity score matching; Cancer; Gynecology","score_opus":0.026669623608947163,"score_gpt":0.30153874604754666,"score_spread":0.2748691224385995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403912249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991284,0.00028418167,0.000050795134,0.00003303695,0.000018854214,0.0000075718635,0.00025130872,0.0000021005942,0.00022377927],"genre_scores_gemma":[0.9994041,0.00008759581,0.0000176183,0.00003277183,0.000025596975,0.000006175799,0.00027681087,0.0000018250754,0.00014758222],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995004,0.00012891588,0.000046415957,0.00015983624,0.000054043932,0.000110298206],"domain_scores_gemma":[0.9993819,0.00008048375,0.00021894008,0.000116612464,0.000044460656,0.00015762911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006215794,0.0003489908,0.00077325664,0.00041280538,0.00052320235,0.0010366915,0.00038689034,0.00062924175,0.0017093779],"category_scores_gemma":[0.0013298444,0.00040343267,0.0010959833,0.0008582969,0.00034626003,0.00052326394,0.00047827058,0.0008865471,0.0002969169],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014692163,0.00025107968,0.97861725,0.000036238856,0.0015791901,0.00024118756,0.00010285977,0.00018275791,0.0016301622,0.00011308459,0.0004314457,0.00212259],"study_design_scores_gemma":[0.00072421256,0.0012469285,0.9947219,0.000011180346,0.0010258255,0.00036820574,0.0002638105,0.00072725094,0.0002090327,0.00016589933,0.0005132707,0.000022509017],"about_ca_topic_score_codex":0.0027891425,"about_ca_topic_score_gemma":0.0026437053,"teacher_disagreement_score":0.0027891425,"about_ca_system_score_codex":0.00026856965,"about_ca_system_score_gemma":0.00035031314,"threshold_uncertainty_score":0.00571841},"labels":[],"label_agreement":null},{"id":"W4404285065","doi":"10.1016/j.urolonc.2024.10.019","title":"Primary tumor ablation in metastatic renal cell carcinoma","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Primary tumor; Oncology; Ablation; Metastasis; Primary (astronomy); Internal medicine; Pathology; Cancer","score_opus":0.031147960956490958,"score_gpt":0.2933860459700578,"score_spread":0.2622380850135668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404285065","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926374,0.005129496,0.0007582515,0.0001931409,0.00001417324,0.000019679246,0.00040978965,0.000014384577,0.0008235607],"genre_scores_gemma":[0.9987192,0.0007737186,0.00017630329,0.00003374303,0.000019160398,0.0000061471546,0.00019646437,0.0000017958059,0.000073438656],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99943906,0.00015840669,0.000040300074,0.00012166505,0.00017893278,0.00006161217],"domain_scores_gemma":[0.99862874,0.00042834552,0.0006258242,0.000060338458,0.00010172551,0.00015501409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082607457,0.00011711596,0.0004968454,0.00034735192,0.00019318923,0.00033944822,0.00022221838,0.00020789479,0.0013329345],"category_scores_gemma":[0.003126019,0.000080138576,0.00047902818,0.0005351227,0.00019784305,0.00018738834,0.00042276856,0.00032528446,0.00013873266],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001395655,0.00009914175,0.9448552,0.0003929267,0.00037599995,0.000701763,0.000073950505,0.0020099329,0.0025955825,0.00020928647,0.00074906705,0.04654142],"study_design_scores_gemma":[0.00008605907,0.0011780298,0.98589075,0.00007262287,0.00033500142,0.0044517317,0.000087661836,0.0030821925,0.0016483516,0.0005037494,0.0026555313,0.000008371498],"about_ca_topic_score_codex":0.0029425134,"about_ca_topic_score_gemma":0.0040857717,"teacher_disagreement_score":0.0029425134,"about_ca_system_score_codex":0.00064373715,"about_ca_system_score_gemma":0.00068459334,"threshold_uncertainty_score":0.0058507323},"labels":[],"label_agreement":null},{"id":"W4404844019","doi":"10.1016/j.urolonc.2024.11.002","title":"Exploring the effect of patient characteristics on the association between warm ischemia time and the risk of postoperative acute kidney injury after partial nephrectomy","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nephrectomy; Warm ischemia; Acute kidney injury; Kidney; Ischemia; Kidney cancer; Surgery; Internal medicine; Kidney disease; Reperfusion injury","score_opus":0.017556215262720182,"score_gpt":0.266089648626238,"score_spread":0.24853343336351782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404844019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987551,0.0003883172,0.0002096538,0.00009392801,0.00002685235,0.0000055981463,0.00015706746,0.0000032613145,0.0003601681],"genre_scores_gemma":[0.999476,0.00008637698,0.00010300015,0.00003433592,0.000037806345,0.00000691597,0.00010436347,0.0000027630406,0.0001485263],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989158,0.00036975535,0.00015851474,0.00017570781,0.00014272796,0.00023750242],"domain_scores_gemma":[0.99474925,0.0024595563,0.0014742435,0.0003960015,0.00019053454,0.0007304186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001343032,0.00027792205,0.00046699654,0.0004986654,0.00043296133,0.0008255406,0.0004605734,0.00068128534,0.0028485805],"category_scores_gemma":[0.0056824866,0.00025713755,0.0016257113,0.00094089226,0.00042840384,0.00083506556,0.0005351112,0.0013454669,0.00025906216],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001784812,0.00013097355,0.9944654,0.000028147906,0.0004510891,0.000103460494,0.00006803947,0.000113270784,0.000396298,0.000054973032,0.00008145792,0.0023221406],"study_design_scores_gemma":[0.0000346055,0.00075174635,0.99748343,0.000009768873,0.00026973122,0.00019374928,0.00019416158,0.0005544658,0.00015778045,0.000117168864,0.00022100647,0.000012338736],"about_ca_topic_score_codex":0.0011700406,"about_ca_topic_score_gemma":0.0016193814,"teacher_disagreement_score":0.0028485805,"about_ca_system_score_codex":0.00030139118,"about_ca_system_score_gemma":0.0007730861,"threshold_uncertainty_score":0.009529471},"labels":[],"label_agreement":null},{"id":"W4405437382","doi":"10.1016/j.urolonc.2024.11.024","title":"Patient-reported functional outcomes and treatment-related regret in Hispanic and Spanish-speaking men following prostate cancer treatment","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Patient-Centered Outcomes Research Institute; Vanderbilt Institute for Clinical and Translational Research; National Cancer Institute; Agency for Healthcare Research and Quality; National Institutes of Health; Vanderbilt University; National Center for Advancing Translational Sciences; Foundation for the National Institutes of Health","keywords":"Medicine; Regret; Prostate cancer; Oncology; Cancer; Internal medicine; Gynecology; Family medicine; Gerontology","score_opus":0.03395862349265458,"score_gpt":0.31721285158273727,"score_spread":0.2832542280900827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405437382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994041,0.0002445001,0.000016487089,0.000028834867,0.0000037164987,0.0000029553185,0.00012082954,5.9794314e-7,0.00017798145],"genre_scores_gemma":[0.9996202,0.000082145685,0.000013574159,0.000021659054,0.000005266901,0.0000027507708,0.00016208297,4.7562227e-7,0.0000919211],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995301,0.00019063822,0.000035109828,0.00007094315,0.0000816261,0.0000915992],"domain_scores_gemma":[0.99841225,0.00025819207,0.0009083396,0.0000539322,0.000105625244,0.00026170284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012574794,0.00017196708,0.00030529624,0.00053257233,0.00028961943,0.0005748886,0.0002505704,0.00031444844,0.0010303663],"category_scores_gemma":[0.003012011,0.00011506826,0.0006453186,0.00055986294,0.0002501326,0.00036763828,0.00052522076,0.00040361116,0.00010612171],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018524399,0.00004966962,0.99826115,0.000008367531,0.00012088558,0.000027467577,0.00010526777,0.000051678086,0.000039398463,0.000008947102,0.000043755557,0.001098055],"study_design_scores_gemma":[0.000009484058,0.0001389252,0.999201,0.0000072415764,0.000030425,0.000065070104,0.00031686257,0.00011190624,0.000022357632,0.000012027796,0.00008131258,0.0000033996726],"about_ca_topic_score_codex":0.007529371,"about_ca_topic_score_gemma":0.00962529,"teacher_disagreement_score":0.007529371,"about_ca_system_score_codex":0.00027702312,"about_ca_system_score_gemma":0.0002672735,"threshold_uncertainty_score":0.014971077},"labels":[],"label_agreement":null},{"id":"W4406583829","doi":"10.1016/j.urolonc.2024.12.278","title":"Cancer-specific mortality after radical prostatectomy versus radiotherapy in incidental prostate cancer","year":2025,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Cancer; Radiation therapy; Urology; Oncology; Internal medicine","score_opus":0.029511107983828062,"score_gpt":0.35999398264414134,"score_spread":0.3304828746603133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406583829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925177,0.004021587,0.00026690846,0.000107336586,0.00005070173,0.000017038272,0.0023959032,0.000020692913,0.0006019765],"genre_scores_gemma":[0.9973947,0.00046057167,0.00007700963,0.000028608934,0.000042870168,0.000014417778,0.0018379844,0.0000066087755,0.0001372472],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990245,0.00026030815,0.00010323205,0.0002958758,0.0001415387,0.00017451447],"domain_scores_gemma":[0.9978835,0.0008288344,0.00067335705,0.00017155602,0.00013781653,0.0003048643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016505929,0.0002872334,0.00086529186,0.0008734268,0.00021583682,0.0006320007,0.0005163547,0.0003248955,0.001634159],"category_scores_gemma":[0.004899372,0.00019432578,0.002632001,0.0010770838,0.00021818402,0.00047102483,0.00079113524,0.00081251917,0.00013225002],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048718895,0.00008544213,0.9766113,0.00042368117,0.0015732847,0.00019517,0.00012665265,0.0009460671,0.00025520305,0.00018742913,0.00094473956,0.013779085],"study_design_scores_gemma":[0.00008375879,0.000635778,0.9954737,0.000064704516,0.0009988443,0.00032133172,0.00011568505,0.001202524,0.00013749368,0.00032375255,0.00062380306,0.000018671919],"about_ca_topic_score_codex":0.0045334795,"about_ca_topic_score_gemma":0.006842618,"teacher_disagreement_score":0.0045334795,"about_ca_system_score_codex":0.0004600576,"about_ca_system_score_gemma":0.0005485836,"threshold_uncertainty_score":0.009014189},"labels":[],"label_agreement":null},{"id":"W4406925873","doi":"10.1016/j.urolonc.2025.01.003","title":"Recurrence after surgery for clear cell and papillary renal cell carcinoma: Head-to head comparison of validated risk scores","year":2025,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Head (geology); Carcinoma; Clear cell renal cell carcinoma; Papillary renal cell carcinomas; Surgery; Oncology; Internal medicine","score_opus":0.04417852919462387,"score_gpt":0.33427448892369466,"score_spread":0.29009595972907076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406925873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998154,0.0005870477,0.0001074936,0.000031078318,0.000026796215,0.000010357902,0.0004333521,0.000007729529,0.00064217515],"genre_scores_gemma":[0.9988476,0.00013755925,0.000042626714,0.000024980784,0.00002784162,0.000005078805,0.0007392793,0.000006343973,0.00016859852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889815,0.0003192187,0.00009056778,0.00021738971,0.00023490866,0.00023962087],"domain_scores_gemma":[0.996068,0.0018383207,0.0010113624,0.00025220844,0.0004393906,0.00039073685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015059966,0.0003374548,0.0010049567,0.001307086,0.00038094475,0.0009650747,0.0004996329,0.00060153287,0.001384889],"category_scores_gemma":[0.0056177825,0.00018436623,0.0015328052,0.001228903,0.0003933207,0.0007590319,0.0008486288,0.00053101976,0.00034806877],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028280143,0.000044479686,0.98961663,0.000032626154,0.00080973865,0.00008082462,0.00014117575,0.00016545036,0.00029509515,0.0000358254,0.00023315758,0.005716991],"study_design_scores_gemma":[0.000033055425,0.00047419054,0.99832374,0.000006628041,0.00024270566,0.00011587915,0.0002574385,0.00022125385,0.000093028255,0.000052544277,0.00016567354,0.000013820586],"about_ca_topic_score_codex":0.0066959425,"about_ca_topic_score_gemma":0.01077014,"teacher_disagreement_score":0.0066959425,"about_ca_system_score_codex":0.00061595597,"about_ca_system_score_gemma":0.00054422754,"threshold_uncertainty_score":0.013313949},"labels":[],"label_agreement":null},{"id":"W4407724889","doi":"10.1016/j.urolonc.2025.01.016","title":"Is primary retroperitoneal lymph node dissection the way forward for patients with testicular seminoma and limited retroperitoneal metastases?","year":2025,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Retroperitoneal lymph node dissection; Seminoma; Dissection (medical); Retroperitoneal space; Radiology; Lymph node; Testicular cancer; General surgery; Internal medicine; Cancer; Chemotherapy","score_opus":0.024856041895050068,"score_gpt":0.3135589101922516,"score_spread":0.28870286829720154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407724889","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000048498358,0.9993855,0.000020062453,0.0002842258,0.00009341449,0.0000015676077,0.000006813984,0.0000016046723,0.00015836016],"genre_scores_gemma":[0.0004240768,0.99903154,0.000051125673,0.00026290162,0.00013042158,0.0000025302131,0.000012791869,4.952317e-7,0.00008411749],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998332,0.00004379931,0.000033186483,0.000026193877,0.000050152743,0.000013495622],"domain_scores_gemma":[0.9995345,0.00026878674,0.000080809696,0.000010201336,0.0000831102,0.000022617573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007243383,0.0004449494,0.001534053,0.0010723047,0.00015514191,0.00067358743,0.000726609,0.00079504965,0.0030300696],"category_scores_gemma":[0.0013021848,0.00017331693,0.0008048628,0.001181273,0.00039599114,0.0010642026,0.00032523606,0.0013806433,0.0008232017],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014774788,0.000030839074,0.00025614805,0.048715245,0.0002726008,0.00014623116,0.000046817782,0.0001883068,0.00039102932,0.0011926369,0.022569885,0.92604244],"study_design_scores_gemma":[0.00018687572,0.00029696545,0.0037017069,0.050455034,0.0013931014,0.0036212627,0.00017119497,0.000115240095,0.00036280134,0.003125246,0.9365373,0.000033261043],"about_ca_topic_score_codex":0.0012292536,"about_ca_topic_score_gemma":0.0031492126,"teacher_disagreement_score":0.0030300696,"about_ca_system_score_codex":0.00052172504,"about_ca_system_score_gemma":0.0013386263,"threshold_uncertainty_score":0.010136545},"labels":[],"label_agreement":null},{"id":"W4407763627","doi":"10.1016/j.urolonc.2024.11.001","title":"Change of the guards—Looking back at Michael Droller: Visionary and supporter—The perspective of the International Bladder Cancer Network","year":2025,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Supporter; Medicine; Perspective (graphical); Cancer; Bladder cancer; Internal medicine; Archaeology; Visual arts","score_opus":0.02592953384629358,"score_gpt":0.32497997666076645,"score_spread":0.29905044281447285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407763627","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009986756,0.0044728373,0.000037480273,0.96018815,0.034014214,0.0000019731804,0.000014717222,0.0000062737454,0.0011644798],"genre_scores_gemma":[0.0063386206,0.008998241,0.00025402932,0.9350069,0.036511935,0.000015732456,0.000035154026,0.000047821646,0.012791538],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9917637,0.002674083,0.00043745743,0.0009752941,0.00223082,0.0019187089],"domain_scores_gemma":[0.96588945,0.0046214205,0.0013626354,0.0006011375,0.0065404316,0.020984918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011111781,0.00087711005,0.0013469793,0.00088481035,0.008165164,0.011754628,0.0028302681,0.024572099,0.018735902],"category_scores_gemma":[0.041043334,0.00055212725,0.0012019491,0.0008261777,0.0065721963,0.011795083,0.0077265324,0.056846395,0.0036386305],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020830075,0.000021082167,0.00019843101,0.0000481544,0.000007245026,0.00011042106,0.00031306274,0.000025913314,0.000047439087,0.0039720545,0.98769975,0.007535666],"study_design_scores_gemma":[0.000026904649,0.000033927954,0.0005794909,0.0004852272,0.000011569615,0.00024342409,0.002728611,0.000050917617,0.000052242096,0.004073868,0.99166745,0.000046372515],"about_ca_topic_score_codex":0.0292587,"about_ca_topic_score_gemma":0.05782687,"teacher_disagreement_score":0.0292587,"about_ca_system_score_codex":0.009537568,"about_ca_system_score_gemma":0.028080804,"threshold_uncertainty_score":0.06920016},"labels":[],"label_agreement":null},{"id":"W4407763696","doi":"10.1016/j.urolonc.2024.10.029","title":"Short communication in honor of Dr Michael Droller","year":2025,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Honor; Library science; Gerontology; Internet privacy","score_opus":0.02255103146578463,"score_gpt":0.3834767878267968,"score_spread":0.36092575636101215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407763696","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008870543,0.006710501,0.0004220324,0.22669522,0.7357159,0.00007359614,0.00025727245,0.00013201284,0.029106408],"genre_scores_gemma":[0.007859764,0.0048884903,0.00038554406,0.09972365,0.5148905,0.00008443022,0.00025830916,0.000095102514,0.37181422],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99904174,0.00017301411,0.00008343977,0.00017926721,0.00033372885,0.00018879522],"domain_scores_gemma":[0.99542433,0.0012920853,0.00040078082,0.0002579908,0.0011728386,0.0014520511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094021927,0.0010076133,0.00088788656,0.0006912055,0.0011797459,0.0022471072,0.0013529183,0.008049185,0.0974591],"category_scores_gemma":[0.011368797,0.00036251816,0.0008260994,0.00036216894,0.0007872878,0.0013700677,0.001628083,0.009020872,0.06452271],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009087536,0.000016912538,0.00012090057,0.0000619283,0.000009243016,0.0010537631,0.000013906621,0.00003119762,0.00021706408,0.00036339177,0.9844834,0.013537466],"study_design_scores_gemma":[0.000035831417,0.000054634358,0.0006338222,0.000058665108,0.000008976326,0.0015608562,0.00004756594,0.000074129384,0.00024045215,0.0006259661,0.9966472,0.000011884104],"about_ca_topic_score_codex":0.000663062,"about_ca_topic_score_gemma":0.0014733811,"teacher_disagreement_score":0.0974591,"about_ca_system_score_codex":0.0012344033,"about_ca_system_score_gemma":0.0010647349,"threshold_uncertainty_score":0.32603317},"labels":[],"label_agreement":null},{"id":"W4407857554","doi":"10.1016/j.urolonc.2025.01.002","title":"Sex-related differences in response to neoadjuvant and adjuvant chemotherapy in urothelial carcinoma of urinary bladder treated with radical cystectomy","year":2025,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Urothelial carcinoma; Urology; Chemotherapy; Adjuvant chemotherapy; Adjuvant; Urinary bladder; Oncology; Bladder cancer; Internal medicine; Carcinoma; Cancer","score_opus":0.015456757536302806,"score_gpt":0.28890780753686457,"score_spread":0.27345105000056175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407857554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987503,0.0006096265,0.000026669873,0.000042426927,0.000014666409,0.0000026725668,0.00009724818,0.0000017806157,0.000454534],"genre_scores_gemma":[0.9995377,0.00011770558,0.000010896701,0.000026593914,0.000015296862,0.0000022163763,0.00008922908,0.0000019807137,0.00019849268],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983084,0.000050781033,0.000018722483,0.000028792429,0.000026493759,0.00004441823],"domain_scores_gemma":[0.9991398,0.00039279912,0.00021704989,0.000048076956,0.00004624239,0.0001561382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003015392,0.0001063322,0.00028302748,0.0003013932,0.00013066335,0.00029129285,0.00016192872,0.00023596655,0.0013699268],"category_scores_gemma":[0.0020748097,0.0000946128,0.00039886063,0.000382851,0.00016672256,0.00023299387,0.00015493746,0.00031687345,0.00017018807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008381413,0.00019232105,0.9772997,0.000025080533,0.00020655403,0.0002709044,0.00016156721,0.00020520829,0.004095794,0.000043421038,0.00013920275,0.008978897],"study_design_scores_gemma":[0.000026572197,0.0005076936,0.9987186,0.0000027122644,0.000043299824,0.00014649902,0.00008665488,0.000095039075,0.00019566642,0.000022005419,0.00015181626,0.0000034328375],"about_ca_topic_score_codex":0.0010060223,"about_ca_topic_score_gemma":0.0016349208,"teacher_disagreement_score":0.0013699268,"about_ca_system_score_codex":0.000234447,"about_ca_system_score_gemma":0.00020347236,"threshold_uncertainty_score":0.0045828223},"labels":[],"label_agreement":null},{"id":"W4408019021","doi":"10.1016/j.urolonc.2024.12.158","title":"STIMULATED RAMAN HISTOLOGY AND ARTIFICIAL INTELLIGENCE ALLOWS FOR PREDICTION OF PROSTATE CANCER EXTRAPROSTATIC EXTENSION AND POSITIVE SURGICAL MARGIN DURING RADICAL PROSTECTOMY","year":2025,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Spectroscopy Techniques in Biomedical and Chemical Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Prostate cancer; Surgical margin; Margin (machine learning); Histology; Prostatectomy; Urology; Cancer; Pathology; Internal medicine; Machine learning","score_opus":0.019658492404510088,"score_gpt":0.3487532417755979,"score_spread":0.32909474937108785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408019021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9194848,0.0019256948,0.07322848,0.00032746472,0.00012225812,0.000031850752,0.00023480447,0.0005031165,0.0041415975],"genre_scores_gemma":[0.9779057,0.0005651199,0.019846408,0.00006284984,0.00004358965,0.000011163617,0.000081202525,0.00002666285,0.0014573307],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997868,0.000070362694,0.00001198618,0.000039611074,0.000078656296,0.000012536468],"domain_scores_gemma":[0.9993851,0.00035512022,0.000073063515,0.00005133547,0.000111770816,0.000023639652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005624643,0.00027588263,0.00016954358,0.0005608647,0.00013285849,0.0006445401,0.0002456143,0.00032303558,0.00083936076],"category_scores_gemma":[0.0011450562,0.00022673834,0.00027869924,0.00022531644,0.00025299712,0.0002566859,0.0002376602,0.00034388143,0.00024403354],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013725328,0.00026725713,0.1393477,0.00019996257,0.00023830328,0.00047604446,0.00029971253,0.02432133,0.4280219,0.0014006544,0.00078609056,0.4032684],"study_design_scores_gemma":[0.000050644045,0.0015161963,0.2732652,0.00006946708,0.00052589155,0.0029930838,0.0005349947,0.42756888,0.28390056,0.005394821,0.004064329,0.000115964955],"about_ca_topic_score_codex":0.0007115198,"about_ca_topic_score_gemma":0.0013962659,"teacher_disagreement_score":0.00083936076,"about_ca_system_score_codex":0.00013835286,"about_ca_system_score_gemma":0.00017504835,"threshold_uncertainty_score":0.0029746294},"labels":[],"label_agreement":null},{"id":"W4408019614","doi":"10.1016/j.urolonc.2024.12.017","title":"METABOLIC, CARDIAC, AND BONE HEALTH TESTING IN PROSTATE CANCER PATIENTS ON ANDROGEN DEPRIVATION THERAPY: A POPULATION-BASED ASSESSMENT OF ADHERENCE TO THERAPEUTIC MONITORING GUIDELINES","year":2025,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Prostate cancer; Androgen deprivation therapy; Bone health; Intensive care medicine; Oncology; Population; Internal medicine; Cancer; Osteoporosis; Bone mineral","score_opus":0.10652709695974874,"score_gpt":0.4317137464390881,"score_spread":0.3251866494793394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408019614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987947,0.00020481642,0.00009657539,0.00008635368,0.000009359341,0.000022542456,0.00016722512,0.000004753009,0.00061352295],"genre_scores_gemma":[0.99943084,0.0000914331,0.00011110034,0.0000643953,0.000012086164,0.000016999144,0.00014187445,0.0000016101582,0.0001297894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987374,0.00049911055,0.00016134666,0.00018236041,0.00028414387,0.00013562542],"domain_scores_gemma":[0.99805284,0.00038291753,0.00093513425,0.00011863499,0.00023214472,0.00027839333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013621371,0.00026999504,0.0005611617,0.0011820968,0.00066706334,0.00092387444,0.0004076448,0.0011286271,0.00084077916],"category_scores_gemma":[0.0044459053,0.00042688896,0.0007946766,0.0016973595,0.00029185382,0.00092553394,0.0007191467,0.001306511,0.00018487145],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007006377,0.00015340216,0.9980738,0.0000073712285,0.00009043161,0.000027253722,0.000109530316,0.000027045011,0.00006668886,0.0000058796586,0.000050938706,0.0013175792],"study_design_scores_gemma":[0.000006393959,0.00020138144,0.9992036,0.000004370834,0.000034739307,0.00009139087,0.00019439164,0.00016660293,0.00001926418,0.000013281862,0.000060200084,0.000004466646],"about_ca_topic_score_codex":0.0047358787,"about_ca_topic_score_gemma":0.0074058804,"teacher_disagreement_score":0.0047358787,"about_ca_system_score_codex":0.00036445976,"about_ca_system_score_gemma":0.00029316594,"threshold_uncertainty_score":0.00941664},"labels":[],"label_agreement":null},{"id":"W4408020759","doi":"10.1016/j.urolonc.2024.12.219","title":"ADJUVANT VS. SALVAGE RADIOTHERAPY IN MEN WITH PATHOLOGICALLY NODE POSITIVE PROSTATE CANCER AFTER RADICAL PROSTATECTOMY: A SYSTEMATIC REVIEW AND META-ANALYSIS","year":2025,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Adjuvant radiotherapy; Meta-analysis; Radiation therapy; Salvage therapy; Adjuvant; Oncology; Urology; Internal medicine; Cancer; Chemotherapy","score_opus":0.039393911034384055,"score_gpt":0.38228558420460557,"score_spread":0.3428916731702215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408020759","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008035603,0.99067384,0.0002779184,0.00011939006,0.00016489174,0.000099437646,0.00043024262,0.000022409335,0.00017624626],"genre_scores_gemma":[0.3310291,0.6635902,0.0014870404,0.0018077246,0.0003370217,0.00034870848,0.0007093884,0.000056275312,0.00063467206],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99587315,0.0017353002,0.0011211374,0.00071037334,0.00032627923,0.00023382972],"domain_scores_gemma":[0.9936333,0.004238737,0.0013768923,0.00026258855,0.00033578355,0.00015275243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005590585,0.0023026953,0.012771345,0.0030150684,0.00051439955,0.0023514973,0.0019397129,0.002594796,0.004826597],"category_scores_gemma":[0.014117854,0.0016978419,0.033948023,0.0040456117,0.0007824875,0.0017114003,0.0017235064,0.0025010174,0.0004428162],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046622194,0.000039626913,0.005591153,0.2426045,0.7352862,0.0001192992,0.00013089526,0.00037017875,0.0003194406,0.0000832071,0.00063037366,0.010162941],"study_design_scores_gemma":[0.0011278853,0.0002239781,0.003947293,0.009870458,0.98343605,0.000059178852,0.000054176402,0.00007926711,0.000051631923,0.000105186875,0.0010205309,0.000024387124],"about_ca_topic_score_codex":0.009791613,"about_ca_topic_score_gemma":0.03665009,"teacher_disagreement_score":0.012771345,"about_ca_system_score_codex":0.0019534493,"about_ca_system_score_gemma":0.0022300815,"threshold_uncertainty_score":0.029566228},"labels":[],"label_agreement":null},{"id":"W4408021091","doi":"10.1016/j.urolonc.2024.12.079","title":"TEACHING ADVANCED SURGICAL TECHNIQUE USING PEER-REVIEWED MULTIMEDIA: AN ASSESSMENT OF TECHNICAL COMPETENCE IN CADAVERIC-BASED SIMULATION","year":2025,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Surgical Simulation and Training","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Cadaveric spasm; Competence (human resources); Medical education; Medical physics; Multimedia; Peer review; Peer assessment; Surgery; Computer science","score_opus":0.049713931226228844,"score_gpt":0.4441437314599778,"score_spread":0.39442980023374896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408021091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99087125,0.00013412726,0.0028898981,0.00011062412,0.000022892698,0.00034412037,0.00009462183,0.00005306538,0.005479254],"genre_scores_gemma":[0.9897031,0.00042852503,0.007058109,0.00007028211,0.000016876427,0.00020959225,0.00017840955,0.000017831862,0.0023172947],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99705255,0.0011084457,0.00030018747,0.00017255275,0.0011153339,0.00025079426],"domain_scores_gemma":[0.9804755,0.008007995,0.0026157566,0.0012840804,0.0052214824,0.0023952152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005783796,0.0005323386,0.00039703553,0.0017495671,0.000523244,0.0010552151,0.0009365638,0.00068686035,0.0056502237],"category_scores_gemma":[0.02272921,0.00022876238,0.00053993723,0.0005144846,0.00064676057,0.0011236297,0.001629952,0.0005515871,0.00074144517],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025474431,0.020204611,0.46675685,0.0013620185,0.00029612033,0.0020686937,0.047190223,0.008104394,0.028713131,0.0013584343,0.0045504346,0.41684765],"study_design_scores_gemma":[0.00044298772,0.03157008,0.8435218,0.0014269793,0.00045182617,0.0071467534,0.034717664,0.021801325,0.033017587,0.0019703945,0.023524698,0.00040799708],"about_ca_topic_score_codex":0.0006814568,"about_ca_topic_score_gemma":0.0017549511,"teacher_disagreement_score":0.005783796,"about_ca_system_score_codex":0.00082480157,"about_ca_system_score_gemma":0.0016909665,"threshold_uncertainty_score":0.03058803},"labels":[],"label_agreement":null},{"id":"W4408021197","doi":"10.1016/j.urolonc.2024.12.075","title":"STIMULATED RAMAN HISTOLOGY AND ARTIFICIAL INTELLIGENCE PROVIDE NEAR REAL-TIME PROSTATE CANCER DIAGNOSIS FROM MRI TARGETED PROSTATE BIOPSIES","year":2025,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Spectroscopy Techniques in Biomedical and Chemical Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Prostate cancer; Prostate; Histology; Multiparametric MRI; Radiology; Cancer; Pathology; Oncology; Internal medicine","score_opus":0.0152393313188793,"score_gpt":0.3385532055597908,"score_spread":0.3233138742409115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408021197","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3594935,0.0034124302,0.620444,0.0012094129,0.0003469854,0.00011303115,0.000503831,0.0054590134,0.009017811],"genre_scores_gemma":[0.740779,0.0012755065,0.24787962,0.00045010686,0.00013489755,0.000039465875,0.0003371341,0.00045889383,0.008645386],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997203,0.0000715118,0.000011371496,0.000050005146,0.00012457318,0.000022277729],"domain_scores_gemma":[0.9995009,0.00025944712,0.000048623682,0.0000622755,0.00009638081,0.00003244885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056720106,0.00049404183,0.00029208735,0.00069194334,0.0001946631,0.0011153729,0.0005523678,0.0010941941,0.003185612],"category_scores_gemma":[0.0013652386,0.0005416656,0.00036410848,0.00029875519,0.00042700334,0.00077774836,0.0007282603,0.00071611535,0.0016159796],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009401422,0.00008100395,0.0027187008,0.00024370218,0.000082597115,0.0003671179,0.00017288176,0.017193217,0.7404863,0.0018236572,0.0013496332,0.23454103],"study_design_scores_gemma":[0.000071380346,0.00046027108,0.015583464,0.000053587803,0.00015111841,0.0024986363,0.0003031376,0.5357698,0.4322295,0.0056896657,0.0070742993,0.00011516466],"about_ca_topic_score_codex":0.00058883015,"about_ca_topic_score_gemma":0.0019833418,"teacher_disagreement_score":0.003185612,"about_ca_system_score_codex":0.00023377132,"about_ca_system_score_gemma":0.00028470327,"threshold_uncertainty_score":0.010656893},"labels":[],"label_agreement":null},{"id":"W4408251780","doi":"10.1016/j.urolonc.2025.02.012","title":"Cirrhosis and liver disease vs. adverse in-hospital outcomes after radical prostatectomy","year":2025,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Adverse effect; Prostatectomy; Cirrhosis; Internal medicine; Odds ratio; Liver disease; Propensity score matching; Poisson regression; Logistic regression; Gastroenterology; Prostate cancer; Surgery; Cancer; Population","score_opus":0.008278952237570544,"score_gpt":0.27628645063259666,"score_spread":0.26800749839502613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408251780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981395,0.00064239005,0.00012918485,0.00017418254,0.000011594568,0.000006998634,0.00054334925,0.000005780405,0.00034713154],"genre_scores_gemma":[0.99945277,0.00009282533,0.00004147278,0.000024719886,0.000013592923,0.0000033310382,0.00031222336,9.728659e-7,0.000058058362],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994522,0.00015741771,0.00007963434,0.000100722355,0.00010712946,0.00010295173],"domain_scores_gemma":[0.9957243,0.0009043758,0.0025475675,0.00013718825,0.0001574666,0.0005290443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011110631,0.00014349064,0.00022895288,0.00048518146,0.0001922836,0.00045479604,0.0002833161,0.0001843049,0.0022620298],"category_scores_gemma":[0.003898169,0.000100730234,0.00056573946,0.00070464134,0.00022490905,0.00026293733,0.00049230317,0.00040688968,0.00010770578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022451459,0.000016365506,0.9978695,0.0000381628,0.00012016129,0.000027296466,0.000017756884,0.00010483062,0.000044511184,0.000026060186,0.00011239233,0.0013984484],"study_design_scores_gemma":[0.000008153945,0.00009814869,0.9991725,0.000015155817,0.00005091897,0.00013539135,0.00003720405,0.00027327825,0.000041126183,0.000054436543,0.00011054851,0.0000031848706],"about_ca_topic_score_codex":0.0026500972,"about_ca_topic_score_gemma":0.0032575969,"teacher_disagreement_score":0.0026500972,"about_ca_system_score_codex":0.0003908197,"about_ca_system_score_gemma":0.0006303119,"threshold_uncertainty_score":0.007567227},"labels":[],"label_agreement":null},{"id":"W4408656210","doi":"10.1016/j.urolonc.2025.02.014","title":"Bladder cuff excision at radical nephroureterectomy improved survival in upper tract urothelial carcinoma","year":2025,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cuff; Urothelial carcinoma; Urology; Upper urinary tract; Carcinoma; Urothelium; Urothelial cancer; Bladder cancer; Surgery; Internal medicine; Urinary bladder; Cancer; Urinary system","score_opus":0.023155762000314162,"score_gpt":0.31734632134100776,"score_spread":0.2941905593406936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408656210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921612,0.0062901615,0.00014654676,0.00028185706,0.00011803279,0.00000579198,0.00007248401,0.000023823719,0.00090007845],"genre_scores_gemma":[0.99841356,0.000974349,0.000086203,0.000057305195,0.000085845146,0.0000014286819,0.00007022157,0.0000033429567,0.0003077486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99988437,0.000042461164,0.00001029903,0.00001646223,0.000019692472,0.000026740569],"domain_scores_gemma":[0.99958307,0.00017528325,0.00008849363,0.000030606858,0.000035040266,0.00008747533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040897192,0.00016757891,0.0003432897,0.00016618354,0.00015465995,0.00031570825,0.00016983725,0.00019537902,0.0012505846],"category_scores_gemma":[0.0016025894,0.000073339135,0.00042151162,0.0002464367,0.00014395233,0.00026017975,0.00020887033,0.00041432778,0.00008404251],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018442275,0.0016330656,0.5236702,0.0006491741,0.00089553045,0.0010309817,0.00046399666,0.0025736352,0.026142942,0.00017458368,0.002052611,0.422271],"study_design_scores_gemma":[0.00011677494,0.0030275139,0.9917115,0.00004518907,0.0006270571,0.00042083766,0.00015669776,0.00069086417,0.001542747,0.00015063699,0.001499578,0.000010501559],"about_ca_topic_score_codex":0.0010545639,"about_ca_topic_score_gemma":0.0026502183,"teacher_disagreement_score":0.0012505846,"about_ca_system_score_codex":0.00016481083,"about_ca_system_score_gemma":0.00027058466,"threshold_uncertainty_score":0.00418365},"labels":[],"label_agreement":null},{"id":"W4408924878","doi":"10.1016/j.urolonc.2025.03.011","title":"Corrigendum to ‘Attainment of early, deep prostate-specific antigen response in metastatic castration-sensitive prostate cancer: A comparison of patients initiated on apalutamide or enzalutamide’[Urol Oncol: Semin Original Investigat 41(3) (2023) 253.e1-253.e9]","year":2025,"lang":"en","type":"erratum","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Enzalutamide; Medicine; Prostate cancer; Prostate-specific antigen; Urology; Oncology; Internal medicine; Cancer","score_opus":0.08016892901954187,"score_gpt":0.3852730194740512,"score_spread":0.3051040904545093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408924878","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004437902,0.0013972265,0.00012803843,0.07806933,0.91297936,0.000039317783,0.00072488573,0.00015563585,0.006461846],"genre_scores_gemma":[0.0027239819,0.006869276,0.0011000393,0.26521876,0.44159374,0.00021674522,0.0020374898,0.00046134676,0.27977863],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99631065,0.000548435,0.00068284833,0.00053629134,0.0015068745,0.00041501576],"domain_scores_gemma":[0.9812664,0.005537847,0.0009512032,0.00075604516,0.010303362,0.0011850533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003154306,0.0019599753,0.0025003585,0.0028675895,0.0028623845,0.0035907335,0.0028542993,0.009076653,0.07332704],"category_scores_gemma":[0.03298975,0.0013165685,0.0027256592,0.0019063053,0.0017540759,0.0017937628,0.0015620659,0.011515094,0.06151807],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011275767,0.000004654245,0.000021973434,0.000029941291,0.0000029942876,0.000057461326,0.0000037645136,0.000009165858,0.000007846572,0.000089330315,0.9981927,0.001568727],"study_design_scores_gemma":[0.000048967533,0.000025913672,0.0012586629,0.00025952316,0.000024953062,0.00025632084,0.00003125833,0.00009704481,0.00008575092,0.00056081114,0.99732155,0.000029235445],"about_ca_topic_score_codex":0.05717461,"about_ca_topic_score_gemma":0.08305198,"teacher_disagreement_score":0.07332704,"about_ca_system_score_codex":0.005039811,"about_ca_system_score_gemma":0.005307778,"threshold_uncertainty_score":0.24530339},"labels":[],"label_agreement":null},{"id":"W4411927737","doi":"10.1016/j.urolonc.2025.05.017","title":"Perioperative outcomes in testicular cancer patients treated with retroperitoneal lymph node dissection","year":2025,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Agency for Healthcare Research and Quality","keywords":"Medicine; Perioperative; Retroperitoneal lymph node dissection; Testicular cancer; Cancer; Lymph node; Logistic regression; Population; Surgery; Internal medicine","score_opus":0.01214428995149948,"score_gpt":0.3059734842087029,"score_spread":0.29382919425720344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411927737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99659616,0.001602613,0.00008880238,0.00012877713,0.000057818546,0.000007692423,0.00035061227,0.0000025639542,0.001164811],"genre_scores_gemma":[0.9986338,0.00059352675,0.000048103462,0.00006278171,0.000045882698,0.000008074708,0.00045194148,0.0000018419113,0.00015417642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997191,0.00005180669,0.000042916996,0.00003815552,0.00005427064,0.0000937819],"domain_scores_gemma":[0.99912196,0.00015853188,0.00038479242,0.000024113371,0.00007277061,0.0002377654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022830653,0.00013961131,0.00029570976,0.00036135025,0.00037976884,0.0006823656,0.0002380825,0.00024704437,0.001429913],"category_scores_gemma":[0.0019709864,0.00010921847,0.00048592547,0.0005874027,0.00019382594,0.0003886127,0.00045228764,0.00059929193,0.0001389078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004108398,0.00007985195,0.99305373,0.0000451572,0.00015290594,0.00033264287,0.00011192728,0.00015764042,0.00016497541,0.00006561054,0.0002540329,0.0051707067],"study_design_scores_gemma":[0.000015465332,0.00046674872,0.9970987,0.000032780063,0.00017058337,0.0007905893,0.0006103712,0.00021570976,0.00009279172,0.000098214085,0.0003956522,0.00001241923],"about_ca_topic_score_codex":0.002069044,"about_ca_topic_score_gemma":0.004034966,"teacher_disagreement_score":0.002069044,"about_ca_system_score_codex":0.000376187,"about_ca_system_score_gemma":0.00051223126,"threshold_uncertainty_score":0.0047835708},"labels":[],"label_agreement":null},{"id":"W4412196506","doi":"10.1016/j.urolonc.2025.06.004","title":"Survival outcomes for men with metastatic castration-resistant prostate cancer (mCRPC) with and without homologous recombination deficiencies (HRD) treated with radium 223: Princess Margaret Cancer Centre (PMCC) experience","year":2025,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Prostate cancer; Androgen deprivation therapy; Radium-223; Internal medicine; Urology; Cancer; Oncology; Prospective cohort study; Bone metastasis","score_opus":0.0363104111602161,"score_gpt":0.35423736587398685,"score_spread":0.31792695471377075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412196506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972274,0.00085995835,0.00007200157,0.00014774031,0.000012816104,0.000011919111,0.00072336034,0.000004408949,0.0009402838],"genre_scores_gemma":[0.99811053,0.0003701508,0.00004399728,0.000078821446,0.000026116022,0.0000066786624,0.0009819607,0.0000027919295,0.00037893804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997309,0.00006479565,0.000016997294,0.00006414509,0.000043846398,0.0000792028],"domain_scores_gemma":[0.9995104,0.000071846196,0.00010397296,0.000028770522,0.00005018161,0.00023473566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048601354,0.0001982908,0.00044828566,0.00031180025,0.00046186883,0.0005631762,0.0003208949,0.00042755506,0.0011580945],"category_scores_gemma":[0.00073543476,0.00012389649,0.00066362805,0.00060435326,0.00029997618,0.00042232947,0.0005632371,0.00052884244,0.00017980448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00821875,0.000485287,0.952078,0.00008491366,0.0006767342,0.0007861627,0.00089405535,0.0011990351,0.0011698618,0.00019852148,0.002109159,0.032099593],"study_design_scores_gemma":[0.00020495626,0.0023881157,0.9943493,0.000017952107,0.0003079385,0.0005234098,0.00048246255,0.00034108057,0.000147014,0.00008156461,0.0011363623,0.000019823397],"about_ca_topic_score_codex":0.009662232,"about_ca_topic_score_gemma":0.014359662,"teacher_disagreement_score":0.009662232,"about_ca_system_score_codex":0.00084574334,"about_ca_system_score_gemma":0.00038378956,"threshold_uncertainty_score":0.019212008},"labels":[],"label_agreement":null},{"id":"W4413257936","doi":"10.1016/j.urolonc.2025.07.017","title":"Prostate-specific antigen screening among transgender women in clinical care: A retrospective chart review study","year":2025,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"LGBTQ Health, Identity, and Policy","field":"Psychology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Wellesley Institute; Maple Leaf Medical Clinic; Montreal Police Service; Public Health Ontario; Women's College Hospital","funders":"Canadian Institutes of Health Research; Institute for Research on Women and Gender, University of Michigan; Gilead Sciences; Robert Wood Johnson Foundation","keywords":"Medicine; Prostate cancer screening; Prostate-specific antigen; Transgender; Logistic regression; Family medicine; Gynecology; Population; Prostate cancer; Retrospective cohort study; Cancer; Internal medicine; Environmental health","score_opus":0.06353758991056424,"score_gpt":0.4271376903741218,"score_spread":0.36360010046355756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413257936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99499434,0.0010955881,0.000118077594,0.00005939874,0.000008188498,0.00018085446,0.002858101,0.000006153477,0.0006792363],"genre_scores_gemma":[0.99713445,0.0006712263,0.00023057633,0.00012670159,0.000011259614,0.00013634123,0.0015413776,0.0000026266878,0.00014532839],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998725,0.00023111289,0.00025503454,0.0003163491,0.00030093917,0.00017151282],"domain_scores_gemma":[0.9957282,0.0004487749,0.0025102405,0.00020558506,0.0007106229,0.00039647895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011026962,0.00022394548,0.0003811093,0.0018959362,0.0008418791,0.00082557567,0.0005294626,0.00029665796,0.0013898237],"category_scores_gemma":[0.002441074,0.000328871,0.0003421117,0.0035649391,0.0004567874,0.00046055124,0.00068385224,0.0003535186,0.00026632778],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003279386,0.000024633577,0.9979741,0.00007816292,0.000019288484,0.00016261882,0.00047184556,0.0000072474813,0.000106063395,0.0000121667645,0.00020693138,0.0009041956],"study_design_scores_gemma":[0.0000069996117,0.00010615703,0.9967892,0.00007544939,0.000031303407,0.0005209067,0.0017975129,0.000038936327,0.00006030916,0.0000049460605,0.00056289206,0.000005388883],"about_ca_topic_score_codex":0.0735983,"about_ca_topic_score_gemma":0.1223422,"teacher_disagreement_score":0.0735983,"about_ca_system_score_codex":0.0016549887,"about_ca_system_score_gemma":0.002317836,"threshold_uncertainty_score":0.14633983},"labels":[],"label_agreement":null},{"id":"W4413603149","doi":"10.1016/j.urolonc.2025.07.015","title":"Outcomes of endoscopic management for upper tract urothelial carcinoma: A multi-center international cohort analysis","year":2025,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Urothelial carcinoma; Cohort; Center (category theory); General surgery; Oncology; Urology; Internal medicine; Bladder cancer; Cancer","score_opus":0.02579685490237768,"score_gpt":0.34680054229461504,"score_spread":0.3210036873922374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413603149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998648,0.00022129553,0.00011944489,0.00004038474,0.000007979225,0.000008375502,0.00071730936,0.000003975687,0.00023317094],"genre_scores_gemma":[0.99857163,0.0001240935,0.0000790605,0.00002447317,0.000012079115,0.000010112122,0.001066638,0.000006347993,0.00010556918],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893504,0.00018007323,0.00010731509,0.00037599483,0.00011681304,0.00028482635],"domain_scores_gemma":[0.99779737,0.00023479394,0.000998445,0.00035333037,0.00022777812,0.00038835537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001241695,0.0005864285,0.0007282801,0.001236286,0.0007283169,0.0012467869,0.0008056244,0.0006140741,0.001798971],"category_scores_gemma":[0.0024951298,0.000634383,0.002108306,0.002154317,0.00044891302,0.0013562585,0.0015246607,0.0011366268,0.00025452863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023986671,0.000034616005,0.9980566,0.000008924767,0.00039273154,0.000077473676,0.000085960084,0.000065821514,0.00015187095,0.000027892334,0.00017386039,0.00068455556],"study_design_scores_gemma":[0.000016755006,0.00007858296,0.9986822,0.000007339977,0.00020686285,0.00019203324,0.00037571957,0.00022915739,0.00003607468,0.000029249879,0.00013510582,0.000010973339],"about_ca_topic_score_codex":0.00861813,"about_ca_topic_score_gemma":0.010021359,"teacher_disagreement_score":0.00861813,"about_ca_system_score_codex":0.0006511888,"about_ca_system_score_gemma":0.0006442027,"threshold_uncertainty_score":0.017135918},"labels":[],"label_agreement":null},{"id":"W4413831406","doi":"10.1016/j.urolonc.2025.07.019","title":"Morbidity and mortality of salvage radical prostatectomy for prostate cancer: An analysis of the National surgical quality improvement program targeted prostatectomy database","year":2025,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; National database; Urology; Database; General surgery; Cancer; Internal medicine","score_opus":0.04633952129536598,"score_gpt":0.4097404958753811,"score_spread":0.3634009745800151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413831406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857179,0.0010878405,0.0001174394,0.00016581695,0.000015482401,0.000021740683,0.012370605,0.000011975379,0.00049114524],"genre_scores_gemma":[0.99146867,0.00038287434,0.0000903365,0.00008659304,0.00001829635,0.000019010376,0.0078032054,0.0000069124853,0.00012407417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973424,0.0007549349,0.0004235405,0.00064671424,0.0005481719,0.00028419925],"domain_scores_gemma":[0.9940445,0.0011425515,0.0031198494,0.00050539686,0.0005552239,0.00063255144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001844776,0.0003688515,0.00087051635,0.002545139,0.0004187967,0.0011303917,0.0011836607,0.00080223527,0.0011455892],"category_scores_gemma":[0.0054018768,0.00050179474,0.001783915,0.005180236,0.00039115554,0.0012196399,0.0014379114,0.0009012046,0.00021049756],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001134203,0.000023603285,0.99835396,0.000024516976,0.0003069942,0.000022876715,0.000037693884,0.00012290177,0.000033594704,0.00001744543,0.00031841104,0.00062460045],"study_design_scores_gemma":[0.0000058101937,0.000017906765,0.99951017,0.000004875608,0.000050591196,0.000047149344,0.00008313101,0.00018047924,0.000012702351,0.000007106128,0.00007651014,0.0000034872319],"about_ca_topic_score_codex":0.032740347,"about_ca_topic_score_gemma":0.04297718,"teacher_disagreement_score":0.032740347,"about_ca_system_score_codex":0.0015175331,"about_ca_system_score_gemma":0.0010849057,"threshold_uncertainty_score":0.0650996},"labels":[],"label_agreement":null},{"id":"W4413944626","doi":"10.1016/j.urolonc.2025.08.008","title":"Stimulated Raman histology as a novel method for rapid pathologic examination of unprocessed, fresh testicular biopsies to determine seminoma","year":2025,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Spectroscopy Techniques in Biomedical and Chemical Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Seminoma; Histology; Pathology; Biopsy; Urology; Internal medicine; Chemotherapy","score_opus":0.024938110236627172,"score_gpt":0.3700954667313742,"score_spread":0.34515735649474705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413944626","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8845891,0.0030680816,0.10811837,0.00029575208,0.00016244776,0.00033480756,0.00017772535,0.00077960093,0.0024740475],"genre_scores_gemma":[0.798589,0.0009452952,0.19862846,0.00012808379,0.00007782913,0.00014760417,0.00013482699,0.00005234267,0.0012964904],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99861383,0.000533097,0.00006734005,0.00021414996,0.0005223761,0.00004921547],"domain_scores_gemma":[0.9989968,0.00035637495,0.00017543958,0.000111449735,0.00029202548,0.00006801257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018977644,0.0005227562,0.0003018219,0.0012126953,0.00023333309,0.00038326473,0.00048748383,0.0005050337,0.0010082215],"category_scores_gemma":[0.0013233254,0.00046340688,0.00033804338,0.00030208536,0.0005151427,0.0004903579,0.00043362568,0.0004304303,0.00044510848],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091670454,0.00029105681,0.052039735,0.00028723877,0.00009643718,0.0012204464,0.00023817201,0.00061480043,0.86037225,0.00022242051,0.0003798738,0.08332087],"study_design_scores_gemma":[0.00028025446,0.009808572,0.23730502,0.00014047505,0.0004649781,0.07210299,0.00056528096,0.044458117,0.62551606,0.00048395837,0.008646658,0.0002276526],"about_ca_topic_score_codex":0.0003611899,"about_ca_topic_score_gemma":0.001307675,"teacher_disagreement_score":0.0018977644,"about_ca_system_score_codex":0.00022090378,"about_ca_system_score_gemma":0.00041508742,"threshold_uncertainty_score":0.0100364685},"labels":[],"label_agreement":null},{"id":"W4414010804","doi":"10.1016/j.urolonc.2025.08.006","title":"Cancer-specific mortality in secondary bladder cancer after nephroureterectomy for upper tract urothelial carcinoma","year":2025,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cancer; Urothelial cancer; Urothelial carcinoma; Urology; Oncology; Bladder cancer; Carcinoma; Internal medicine","score_opus":0.03370020825334547,"score_gpt":0.34964820926319,"score_spread":0.31594800100984455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414010804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990152,0.00034392683,0.000092600196,0.000028630475,0.000005441575,0.000004444873,0.00034774205,0.0000052047267,0.00015680453],"genre_scores_gemma":[0.99943966,0.000060346814,0.000024194464,0.0000066537064,0.000007369358,0.0000030787864,0.00040631578,0.0000010322522,0.000051314335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99962616,0.00009954819,0.00003232874,0.00009246096,0.00006519906,0.00008429623],"domain_scores_gemma":[0.99874866,0.00023923135,0.00056262634,0.000087590895,0.000116606505,0.00024522757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060119526,0.00021903214,0.00039591207,0.0005632771,0.00018195565,0.00035486,0.00033165974,0.00028091713,0.0011059749],"category_scores_gemma":[0.0025001634,0.00011274178,0.0009731826,0.00054226455,0.00015189536,0.00023213131,0.0005270663,0.0003757802,0.00012639657],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033798214,0.000015810114,0.9977296,0.000016054235,0.00010049814,0.000058124933,0.000019389034,0.00015058772,0.0001637649,0.000011155762,0.000075578646,0.0013216173],"study_design_scores_gemma":[0.000005338494,0.000086665656,0.99929535,0.0000033514148,0.00003025882,0.00013716938,0.000020681,0.0002938952,0.00006162129,0.000012218454,0.000051639156,0.0000018084614],"about_ca_topic_score_codex":0.0033942808,"about_ca_topic_score_gemma":0.0049101096,"teacher_disagreement_score":0.0033942808,"about_ca_system_score_codex":0.0003650822,"about_ca_system_score_gemma":0.00032259917,"threshold_uncertainty_score":0.006749034},"labels":[],"label_agreement":null},{"id":"W4414035402","doi":"10.1016/j.urolonc.2025.07.032","title":"Inflammatory bowel disease vs. adverse in-hospital outcomes after radical prostatectomy","year":2025,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostatectomy; Inflammatory bowel disease; Prostate cancer; Adverse effect; Disease; General surgery; Internal medicine; Urology; Cancer","score_opus":0.00461171198450087,"score_gpt":0.2546079965952023,"score_spread":0.24999628461070142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414035402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916242,0.0036194867,0.00013066102,0.00051621086,0.00020024556,0.0000101602145,0.0014154932,0.000011672263,0.002471849],"genre_scores_gemma":[0.99801326,0.0005398285,0.000032118594,0.00010352921,0.00024099609,0.0000072191924,0.0006527274,0.0000048320508,0.0004054365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990409,0.00021166075,0.00009568215,0.00016950892,0.000094469084,0.00038785438],"domain_scores_gemma":[0.99365497,0.0018514323,0.0022254179,0.0002871065,0.00022250561,0.0017586668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012284816,0.00038873017,0.0007524302,0.0006729144,0.00041862647,0.0013425626,0.0007376109,0.0010466883,0.0062057693],"category_scores_gemma":[0.005760544,0.00028050286,0.002149836,0.000977308,0.00039280363,0.0010176324,0.0010638706,0.0023728937,0.00046201437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031390234,0.000102834645,0.9901876,0.00015087573,0.0011019072,0.00012666792,0.00008313511,0.00030773715,0.00014259772,0.0001394396,0.0005834174,0.0039348],"study_design_scores_gemma":[0.00005728769,0.0005613664,0.9972276,0.000056459532,0.0005068545,0.00019282779,0.00029718722,0.00043018846,0.00005265815,0.0002604334,0.00033034204,0.000026736341],"about_ca_topic_score_codex":0.0025462904,"about_ca_topic_score_gemma":0.004051907,"teacher_disagreement_score":0.0062057693,"about_ca_system_score_codex":0.0004949829,"about_ca_system_score_gemma":0.00065985636,"threshold_uncertainty_score":0.020760357},"labels":[],"label_agreement":null},{"id":"W4414498519","doi":"10.1016/j.urolonc.2025.08.016","title":"The association between prior pelvic radiotherapy for cancer and surgical outcomes in patients undergoing radical cystectomy for bladder cancer: An analysis of national surgical quality improvement program targeted cystectomy database","year":2025,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cystectomy; Odds; Odds ratio; Bladder cancer; Multicenter study; Radiation therapy; Cancer","score_opus":0.02858455760598524,"score_gpt":0.39471119652205305,"score_spread":0.36612663891606784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414498519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970956,0.0005669955,0.0000860402,0.00013606314,0.000013841628,0.000009565659,0.001769653,0.000004500799,0.00031784567],"genre_scores_gemma":[0.9983004,0.00015794234,0.000065587046,0.000068474495,0.00001419552,0.000008535181,0.0012977001,0.0000026039768,0.00008457295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983127,0.00044028964,0.0003429831,0.00038258027,0.00029062957,0.00023080959],"domain_scores_gemma":[0.9923934,0.0015349444,0.004336735,0.00056220643,0.0005221862,0.0006505862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014508609,0.0001743306,0.0004350639,0.0012753542,0.00034769365,0.0008438761,0.0007116344,0.00062625326,0.0011499263],"category_scores_gemma":[0.0061991382,0.00031672575,0.0010481481,0.0031945354,0.00031250078,0.00080075447,0.0010069185,0.00085390196,0.000118955955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055893615,0.000018933097,0.9992046,0.000009482202,0.00013311389,0.000009611156,0.000026299767,0.00002798432,0.00002683624,0.000007040288,0.00007307408,0.0004072238],"study_design_scores_gemma":[0.0000030080016,0.000017381548,0.999711,0.0000028075492,0.000033772092,0.000023239903,0.00007836081,0.000066753615,0.000009906977,0.0000036277372,0.00004808706,0.0000019349168],"about_ca_topic_score_codex":0.017789096,"about_ca_topic_score_gemma":0.026616225,"teacher_disagreement_score":0.017789096,"about_ca_system_score_codex":0.00077804894,"about_ca_system_score_gemma":0.00090244494,"threshold_uncertainty_score":0.035371125},"labels":[],"label_agreement":null},{"id":"W4414712922","doi":"10.1016/j.urolonc.2025.09.004","title":"Prostate cancer screening in transgender women/transfeminine persons: Building on Canadian evidence","year":2025,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"LGBTQ Health, Identity, and Policy","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital; Women's College Hospital; Toronto Rehabilitation Institute; University of Toronto","funders":"Canadian Institutes of Health Research; University of Toronto","keywords":"Prostate cancer screening; Transgender; Prostate cancer; Cancer screening; MEDLINE","score_opus":0.07124175792751682,"score_gpt":0.40989488939570107,"score_spread":0.33865313146818427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414712922","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15517251,0.57564086,0.0024544303,0.18136686,0.003567914,0.001793526,0.008389582,0.00007618731,0.07153823],"genre_scores_gemma":[0.66481364,0.2909222,0.008289708,0.030676361,0.0007594125,0.00054086366,0.0021177891,0.00006776601,0.0018122296],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9864877,0.004433172,0.0017428555,0.0010743894,0.0043450696,0.0019168687],"domain_scores_gemma":[0.8884884,0.039649744,0.009936922,0.0021766024,0.051747203,0.008001083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.031540263,0.0008170015,0.0017402761,0.0065868073,0.0041355644,0.0053986423,0.0029281836,0.002162142,0.008272697],"category_scores_gemma":[0.10719409,0.0007557101,0.0019487017,0.011276713,0.0025389523,0.0027234475,0.004427188,0.003854525,0.00031761717],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013580642,0.00070460624,0.41660267,0.052926533,0.005150314,0.0005227836,0.01297193,0.0012827789,0.00039314342,0.01754101,0.06877348,0.42177275],"study_design_scores_gemma":[0.0012738034,0.0005326827,0.6141247,0.18634343,0.019747673,0.0002898932,0.028270727,0.0023005153,0.00055704126,0.0073740226,0.13869092,0.0004945284],"about_ca_topic_score_codex":0.9832561,"about_ca_topic_score_gemma":0.99398464,"teacher_disagreement_score":0.058730803,"about_ca_system_score_codex":0.058730803,"about_ca_system_score_gemma":0.17672557,"threshold_uncertainty_score":0.4261238},"labels":[],"label_agreement":null},{"id":"W4416406793","doi":"10.1016/j.urolonc.2025.10.017","title":"Partial vs. radical nephrectomy in pT3a renal cancer: Cancer-specific mortality according to fat invasion pattern","year":2025,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nephrectomy; Pathological; Adipose capsule of kidney; Kidney; Renal cell carcinoma; Adverse effect","score_opus":0.056288072754365974,"score_gpt":0.3541041343907145,"score_spread":0.2978160616363485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416406793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979882,0.00085088407,0.00014782061,0.0000777965,0.000021266658,0.0000048015477,0.00023958692,0.0000053432786,0.00066436885],"genre_scores_gemma":[0.99928313,0.00017468854,0.00004008368,0.000036735804,0.000032098153,0.0000029906369,0.00021965269,0.00000389521,0.00020678686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99965334,0.00006809602,0.000026940219,0.00008822732,0.00003984446,0.00012356482],"domain_scores_gemma":[0.99923074,0.00030058663,0.00016675513,0.000064725195,0.000027008893,0.00021011522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061794964,0.0002691851,0.00061215105,0.0003645739,0.00019599251,0.0005521454,0.0003524623,0.0004587861,0.0025309825],"category_scores_gemma":[0.0013746826,0.00018646404,0.0016214317,0.00041719188,0.00032093987,0.0007347836,0.00056112645,0.0007430207,0.00020778678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032309983,0.00026339668,0.9324516,0.00015996533,0.0014367173,0.00053327077,0.0001981357,0.0012686324,0.0038758516,0.00030399923,0.0008226811,0.026375879],"study_design_scores_gemma":[0.00016124742,0.0016739023,0.9940764,0.00002343161,0.0005379232,0.00060969946,0.0003911471,0.0012931086,0.00040782217,0.00045711588,0.00034414674,0.000024163239],"about_ca_topic_score_codex":0.0015988353,"about_ca_topic_score_gemma":0.0042314488,"teacher_disagreement_score":0.0025309825,"about_ca_system_score_codex":0.00033401707,"about_ca_system_score_gemma":0.0004612764,"threshold_uncertainty_score":0.008467019},"labels":[],"label_agreement":null},{"id":"W4417290913","doi":"10.1016/j.urolonc.2025.11.008","title":"Oncological outcomes of deferred systemic therapy for patients with metastatic renal cell carcinoma: A systematic review and quantitative analysis","year":2025,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Systemic therapy; Multidisciplinary approach; Kidney cancer; Renal cell carcinoma; MEDLINE; Risk assessment; Value (mathematics)","score_opus":0.06110670977565533,"score_gpt":0.362976739783401,"score_spread":0.3018700300077457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417290913","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004995148,0.9910328,0.0004308139,0.00024365626,0.00006977408,0.0007418928,0.0021421856,0.000012474242,0.00033122275],"genre_scores_gemma":[0.113501556,0.87833273,0.002311091,0.0007853064,0.0001080689,0.003084411,0.0016454662,0.000017639575,0.00021367442],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98701245,0.004302892,0.005622416,0.0009892315,0.0017931068,0.00027989026],"domain_scores_gemma":[0.95597476,0.030847521,0.009001094,0.0006474672,0.0032244367,0.00030467968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013338296,0.0014038266,0.010216602,0.011399403,0.00059031136,0.0023934608,0.0017618312,0.0013342483,0.0029625078],"category_scores_gemma":[0.050504673,0.00083395833,0.014039152,0.012844185,0.00090369553,0.002031079,0.0014716141,0.0010899054,0.00018920077],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032441228,0.000014772981,0.0027096136,0.94007593,0.04386691,0.0000688672,0.00017083086,0.00013713405,0.00010064248,0.0001516341,0.00056517834,0.0118141025],"study_design_scores_gemma":[0.00049682095,0.00035488387,0.013959824,0.59401333,0.38105214,0.00036256816,0.00038466149,0.0002430288,0.00017680562,0.00046856824,0.008412507,0.000074776086],"about_ca_topic_score_codex":0.0065293843,"about_ca_topic_score_gemma":0.019624481,"teacher_disagreement_score":0.013338296,"about_ca_system_score_codex":0.0032246707,"about_ca_system_score_gemma":0.006939861,"threshold_uncertainty_score":0.07054049},"labels":[],"label_agreement":null},{"id":"W7117578695","doi":"10.1016/j.urolonc.2025.12.002","title":"Safety of omitting pelvic imaging in patients with stage I germ cell tumor (GCT) on surveillance: A multi-institutional study","year":2025,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Pelvis; Pelvic tumor; Stage (stratigraphy); Germ cell; Radiation therapy; Testicular Germ Cell Tumor","score_opus":0.011151198302276295,"score_gpt":0.28976346382457135,"score_spread":0.27861226552229507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117578695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99717796,0.0017270956,0.00016556437,0.00011262742,0.000025451236,0.000020670881,0.00031815763,0.000004313063,0.0004480926],"genre_scores_gemma":[0.99885726,0.00042114375,0.00010468251,0.00013122505,0.00003205826,0.000014661909,0.00036647942,0.000003796717,0.00006872702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980241,0.0008942949,0.00019824655,0.0003967626,0.00028130497,0.00020535539],"domain_scores_gemma":[0.9888657,0.003958426,0.004917915,0.0009218774,0.00059700664,0.0007391432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020766498,0.0002724015,0.0007291353,0.00044295323,0.0004973991,0.0012410833,0.0005583035,0.0008119267,0.0012178511],"category_scores_gemma":[0.011373885,0.00022887517,0.0013112918,0.001277152,0.0006124428,0.0010359643,0.00056325184,0.00096287514,0.00012350653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056586238,0.00026214292,0.9834562,0.000118834876,0.00057821313,0.0000817273,0.0001293107,0.00013565701,0.00022232127,0.000053206844,0.00023397131,0.00906973],"study_design_scores_gemma":[0.00052728865,0.0075481622,0.9862797,0.00016715437,0.0015321061,0.00058839825,0.000644185,0.0008870157,0.0004214819,0.00023268363,0.0011356529,0.000036042202],"about_ca_topic_score_codex":0.001376406,"about_ca_topic_score_gemma":0.0016370985,"teacher_disagreement_score":0.0020766498,"about_ca_system_score_codex":0.0006041762,"about_ca_system_score_gemma":0.0010621763,"threshold_uncertainty_score":0.010982513},"labels":[],"label_agreement":null}]}